<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
<channel>
<title>The Upward ARC</title>
<description>Executive health that survives your actual week.</description>
<link>https://www.andreheeg.com</link>
<language>en</language>
<lastBuildDate>Sun, 08 Nov 2026 05:00:00 GMT</lastBuildDate>
<item>
<title><![CDATA[My Prostate Report Wanted 25%. I Had 10%.]]></title>
<description><![CDATA[How to interpret free PSA, repeat a raised result and decide whether a biopsy is needed.]]></description>
<link>https://www.andreheeg.com/archive/my-prostate-report-wanted-25-i-had-10</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/my-prostate-report-wanted-25-i-had-10</guid>
<pubDate>Sun, 08 Nov 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>On my way home from San Francisco, I checked my Function Health results. My PSA was 5.0, which is higher than the usual cut-off of 4. Only 10% of my PSA was floating free in the blood, but the report said it should be over 25%. The clinician note called this “a red flag” and told me to see a urologist “as soon as reasonably possible, even if you are asymptomatic.”</p><p>I’m a doctor, so I know PSA levels can change for harmless reasons. I stayed calmer than the note suggested, but I still made an appointment with a urologist.</p><p>That happened in May. Now it’s Movember, when men grow mustaches to raise awareness for men’s health and prostate cancer. So I’m sharing my full story, numbers and all.</p><p>A lot of men see a PSA test as a final verdict on cancer. That makes some delay the test, while others panic if their number is high. My verdict: Keep. Get your first PSA test between ages 45 and 50, or earlier if you’re at higher risk. Before you get your blood drawn, decide what you’ll do if the result is high, i.e., repeat the test, then get an MRI before any biopsy.</p><h2>Why men wait</h2><p>My urologist is a woman. She performed the rectal exam, where a gloved finger checks the prostate from behind.</p><p>I know a lot of men who skip the appointment because of that exam. Come on, guys, women have to go through gynecologist exams that aren’t enjoyable either. They don’t get to skip theirs, and neither should we.</p><p>I think of this as a case where information loses to incentives. You get a calendar invite for your Tuesday meeting, but not for your prostate. The appointment means one awkward morning now, while any benefit is years away. When life is busy, it’s easy to keep putting it off.</p><p>The odd part: the finger exam is on its way out as a screening test. Germany’s 2025 guideline says doctors should not use it for early detection <a href="#edition-ref-1">[1]</a>. Australia’s 2026 guideline suggests family doctors leave it out of screening <a href="#edition-ref-2">[2]</a>. Europe’s urologists now base screening on PSA and your personal risk <a href="#edition-ref-3">[3]</a>. A urologist may still examine you after a high result, as mine did. The screening test itself is a blood draw.</p><p>Germany has its own mismatch. Public insurance still pays for the yearly check from age 45 that includes the finger exam. It doesn’t pay for the PSA test <a href="#edition-ref-4">[4]</a>. So insurance pays for the exam that Germany’s own guideline advises against, and you usually pay for the blood test yourself. A decision on covering PSA plus MRI is due by October 2027 <a href="#edition-ref-4">[4]</a>.</p><p>I’ll stick to the basics you’d need when talking to your own doctor: just a few key numbers. You can find more details in the references.</p><h2>Screening saves lives, slowly</h2><p>The largest European trial invited men aged 55 to 69 to regular PSA tests and followed them for 23 years <a href="#edition-ref-5">[5]</a>. In the invited group, 13% fewer men died of prostate cancer. In plain numbers: one death prevented for every 456 men invited. For each death prevented, 12 extra men were diagnosed.</p><p>Some of those 12 men had cancers that would never have caused them problems. That’s the downside of screening: it can lead to worry, biopsies (where needle samples are taken from the prostate), and sometimes treatment for a cancer that would have stayed silent.</p><p>A British trial shows what happens when doctors watch instead of treating <a href="#edition-ref-6">[6]</a>. Men whose cancer was found through PSA testing were either monitored, operated on, or treated with radiation. After 15 years, about 97 in 100 had not died of prostate cancer, whatever their group. Monitoring wasn’t free: the cancer spread more often in the monitored men. Watching means real check-ups, not forgetting.</p><p>The strongest case against: in a June 2026 draft, Germany’s institute for medical evidence, IQWiG, said it could not yet show a benefit for PSA plus MRI screening, because the long-term data don’t exist yet <a href="#edition-ref-7">[7]</a>.</p><p><strong>The doctor’s take:</strong> the benefit for one person is small, but it’s real when you look at thousands of men. I’m willing to take a 1-in-456 chance on a blood test, as long as the next steps are careful. Doing an MRI first, only doing a biopsy when needed, and monitoring slow-growing cancers help avoid much of the harm that made screening unpopular.</p><h2>One number at 45 tells you a lot</h2><p>A Swedish study measured PSA in stored blood from men in their 40s and followed them for 25 years <a href="#edition-ref-8">[8]</a>. Men in the top tenth at age 45 to 49, with a PSA of 1.6 or more, accounted for 44% of later prostate cancer deaths. At 1.0 or below, fewer than 1 in 100 died of prostate cancer within 25 years.</p><p>That’s why guidelines now suggest having your first test in your mid-40s. The result helps decide how often you need to come back. In Germany, if your value is below 1.5, you wait five years for the next test <a href="#edition-ref-1">[1]</a>.</p><p>The American Urological Association says doctors may offer a first PSA between 45 and 50. For Black men, men with inherited gene changes such as BRCA2, and men with a strong family history, doctors should offer it from 40 to 45 <a href="#edition-ref-9">[9]</a>.</p><h2>A high PSA is a question</h2><p>PSA is a protein made by the prostate. Cancer can raise PSA levels, but so can many everyday things.</p><p>Two common reasons are prostate size and inflammation <a href="#edition-ref-10">[10]</a>. The prostate gets bigger as you age, and a larger gland makes more PSA. Ejaculation can raise PSA for a day or two <a href="#edition-ref-11">[11]</a>. Finasteride, which is used for hair loss or an enlarged prostate, lowers PSA by about 40 to 50% even at the hair-loss dose <a href="#edition-ref-12">[12]</a>. Be sure to tell your doctor if you take it, or a high PSA could be hidden.</p><p>PSA levels can also change on their own. In one American study, about 4 out of 10 men with a high PSA had a normal result at one or more later yearly checkups <a href="#edition-ref-13">[13]</a>. That’s why the first step after a high PSA is to repeat the test, ideally in the same lab and using the same method <a href="#edition-ref-3">[3]</a>.</p><p>My Berlin retest came back at 5.57. Still high.</p><h2>Where the 25% comes from</h2><p>The 25% cutoff for free PSA comes from a 1998 American study <a href="#edition-ref-14">[14]</a>. The study looked at men aged 50 to 75 with PSA levels between 4 and 10, and nearly half had cancer. Using 25% as the cutoff, 95 out of 100 men with cancer fell below it, but so did about 80 out of 100 men whose biopsies were normal. Cancer usually lowers the free PSA percentage, which is why labs worry about a low number. This cutoff is meant to catch almost everyone with cancer, so it makes sense for men already heading for a biopsy. But it can’t predict the risk for a healthy 47-year-old.</p><p>I was 47, had no symptoms, and was tested as part of a panel with over 100 markers. My Berlin lab uses 15% as the cutoff for the same ratio. Same person, same month, but two different cutoffs.</p><p>Show me the study. Every exact cutoff is based on research done with a specific group of men, so it’s fair to ask who was included.</p><p><strong>The doctor’s take:</strong> to be fair to Function Health, their advice was correct: see a urologist. The issue was calling it a “red flag.” Big test panels for healthy people often lead to this: a slightly unusual number, a scan, and days of worry. Most of the time, it’s a false alarm. When it’s not, you’re glad you checked. For your prostate, a simple plan works best: one PSA test in your mid-40s and a clear next step is better than 100 numbers with no plan.</p><h2>I chose by calendar</h2><p>My urologist gave me two options and explained them as equally good choices.</p><p>One option was an MRI scan of the prostate. The other was micro-ultrasound, a high-resolution ultrasound performed by one of the few specially trained examiners in Berlin. The advantage of micro-ultrasound is that if the examiner finds something, they can do a biopsy during the same visit.</p><p>I looked at the evidence and was open to either option. Then I checked my calendar. The MRI was available on June 1, while the ultrasound was scheduled for mid-June. I chose the earlier date.</p><p>Since then, I’ve learned about a randomized trial called OPTIMUM, done in 20 centers across 8 countries <a href="#edition-ref-15">[15]</a>. With certified examiners, micro-ultrasound found aggressive cancers about as often as MRI-guided biopsy. But there are two issues. All 678 men in the analysis had a biopsy, regardless of what their scan showed, so the trial couldn’t test whether a clean ultrasound means you can skip the biopsy. The device maker also funded the trial. Current guidelines still recommend MRI first <a href="#edition-ref-3">[3]</a>.</p><p>The main advantage of MRI is that it can let you avoid a biopsy. In an earlier study, 28% of men had a clean MRI and didn’t need a biopsy at all <a href="#edition-ref-16">[16]</a>. With the ultrasound option, you’re usually already set up for a biopsy.</p><p><strong>The doctor’s take:</strong> both options are good if you have an experienced examiner. Ask how many procedures they’ve done. If you need a biopsy, ask if it can be done through the skin between the scrotum and anus instead of through the rectum. European guidelines now strongly recommend this approach because it lowers the risk of infection <a href="#edition-ref-3">[3]</a>.</p><h2>What the MRI found</h2><p>No area that looked like cancer. PI-RADS 2, on a scale where 1 and 2 mean significant cancer is unlikely.</p><p>The scan showed a mildly enlarged prostate and signs of chronic inflammation. My report found two common reasons for a high PSA. No scan can say for sure which one caused my high PSA.</p><p>For a result like mine, with no family history and a PSA level that matches the size of my prostate, the European guideline recommends checking PSA again over time instead of doing a biopsy <a href="#edition-ref-3">[3]</a>. Even a clean MRI can miss cancer, so follow-up is important. My urologist wants me to have my PSA checked again in a year.</p><p>This fits into the Capacity pillar of my Upward ARC framework. Work and life add to your load, and capacity is what helps you handle it at age 50 or 70. One blood test at 45 is a small cost, and it tells you if you need to come back in two years or five.</p><h2>My verdicts</h2><ul><li>First PSA between 45 and 50, or 40 to 45 if you’re at higher risk: <strong>Keep.</strong></li></ul><ul><li>Repeat a high PSA before anything else: <strong>Keep.</strong></li></ul><ul><li>MRI before any biopsy: <strong>Keep.</strong></li></ul><ul><li>Micro-ultrasound with a biopsy in the same visit: <strong>Situational.</strong> Reason: it’s industry-funded. Good results with certified experts, in one trial paid for by the device maker, and no test yet showing you can skip the biopsy after a clean scan.</li></ul><ul><li>The finger exam as a screening test: <strong>Cut.</strong> Reason: wrong direction. Germany’s guideline gives it the strongest grade to exclude it.</li></ul><ul><li>A “red flag” from a 25% free-PSA cutoff at 47, on a 100-marker panel: <strong>Situational.</strong> Reason: I’m the wrong population.</li></ul><h2>Try this today</h2><ul><li>Figure out when to start: between 45 and 50, or earlier if you’re at higher risk (if you’re Black, have a BRCA2 gene change, or close relatives with prostate cancer, especially if they were diagnosed young). Ask your doctor which category you’re in, then schedule the blood test.</li></ul><ul><li>Don’t ejaculate for 48 hours before the blood draw <a href="#edition-ref-11">[11]</a>. Bring a list of your medications, especially if you take finasteride or testosterone.</li></ul><ul><li>If your PSA result is high, repeat the test. If it’s still high, get an MRI before any biopsy, and ask if the biopsy can be done through the skin.</li></ul><p>This coming week I’m in Boston, and will do my second Function Health test of the year. Same app, similar panel of biomarkers, but this time a more educated reader. I know what the 25% line was built for, I know what my prostate looks like on an MRI, and I know what can impact the PSA numbers.</p><p>Two documents sit in my folder now. The first came from an app, in English, with a red flag and “as soon as reasonably possible.” The second came from a radiology practice in Berlin: two pages of German so dry it could pass for a tax notice. It wasn’t even addressed to me. It went to my urologist, about “Ihren o.g. Patienten.” Your above-named patient.</p><p>I’ve written that phrase into more doctor’s letters than I can count. It’s strange to be the “o.g. Patient.”</p><p>The verdict took three words: “keine malignomsuspekten Läsionen.” No lesions suspicious for cancer. Nobody has ever made me happier by being boring.</p><p>Have you had your PSA checked? If not, what’s held you back? Reply and let me know. I read every message.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you don’t have a prostate, someone you care about does. Please forward this to him and ask when his test is scheduled. That’s how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If a friend sent you this, you can get Under Load, my Sunday edition, here: <a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a></p><div><hr></div><h2>References</h2><p id="edition-ref-1">[1] Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). (2025). S3-Leitlinie Prostatakarzinom, Kurzversion 8.1 (AWMF-Registernummer 043-022OL). <a href="https://register.awmf.org/assets/guidelines/043-022OLk_S3_Prostatakarzinom_2026-05.pdf" rel="external">https://register.awmf.org/assets/guidelines/043-022OLk_S3_Prostatakarzinom_2026-05.pdf</a></p><p id="edition-ref-2">[2] Prostate Cancer Foundation of Australia. (2026). 2026 guidelines for the early detection of prostate cancer in Australia: Summary of recommendations. <a href="https://www.prostate.org.au/wp-content/uploads/2026/08/2026-Guidelines-for-the-Early-Detection-of-Prostate-Cancer-Summary-of-Recommendations.pdf" rel="external">https://www.prostate.org.au/wp-content/uploads/2026/08/2026-Guidelines-for-the-Early-Detection-of-Prostate-Cancer-Summary-of-Recommendations.pdf</a></p><p id="edition-ref-3">[3] Cornford, P., Tilki, D., van den Bergh, R. C. N., et al. (2026). EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer (limited text update, March 2026). European Association of Urology. <a href="https://uroweb.org/guidelines/prostatecancer/chapter/diagnostic-evaluation" rel="external">https://uroweb.org/guidelines/prostatecancer/chapter/diagnostic-evaluation</a></p><p id="edition-ref-4">[4] Gemeinsamer Bundesausschuss. (2025, October 16). Früherkennung von Prostatakrebs: G-BA prüft risikoabhängiges Angebot [Press release]. <a href="https://www.g-ba.de/presse/pressemitteilungen-meldungen/1290/" rel="external">https://www.g-ba.de/presse/pressemitteilungen-meldungen/1290/</a></p><p id="edition-ref-5">[5] Roobol, M. J., de Vos, I. I., Månsson, M., et al. (2025). European study of prostate cancer screening: 23-year follow-up. New England Journal of Medicine, 393(17), 1669–1680. <a href="https://doi.org/10.1056/NEJMoa2503223" rel="external">https://doi.org/10.1056/NEJMoa2503223</a></p><p id="edition-ref-6">[6] Hamdy, F. C., Donovan, J. L., Lane, J. A., et al. (2023). Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. New England Journal of Medicine, 388(17), 1547–1558. <a href="https://doi.org/10.1056/NEJMoa2214122" rel="external">https://doi.org/10.1056/NEJMoa2214122</a></p><p id="edition-ref-7">[7] Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. (2026, June 16). Risikoadaptiertes PSA- und MRT-Screening: Vorbericht S25-02, Version 1.0. <a href="https://www.iqwig.de/download/s25-02_risikoadaptiertes-psa-und-mrt-screening_vorbericht_v1-0.pdf" rel="external">https://www.iqwig.de/download/s25-02_risikoadaptiertes-psa-und-mrt-screening_vorbericht_v1-0.pdf</a></p><p id="edition-ref-8">[8] Vickers, A. J., Ulmert, D., Sjoberg, D. D., et al. (2013). Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: Case-control study. BMJ, 346, f2023. <a href="https://doi.org/10.1136/bmj.f2023" rel="external">https://doi.org/10.1136/bmj.f2023</a></p><p id="edition-ref-9">[9] Lin, D. W., Carlsson, S., Filson, C. P., Kim, S. K., Kirkby, E., Konety, B. R., Purysko, A. S., &amp; Souter, L. H. (2026). Updates to early detection of prostate cancer: AUA/SUO guideline (2026). The Journal of Urology, 215(5), 491–501. <a href="https://doi.org/10.1097/JU.0000000000004995" rel="external">https://doi.org/10.1097/JU.0000000000004995</a></p><p id="edition-ref-10">[10] Nadler, R. B., Humphrey, P. A., Smith, D. S., Catalona, W. J., &amp; Ratliff, T. L. (1995). Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. Journal of Urology, 154(2 Pt 1), 407–413. <a href="https://doi.org/10.1097/00005392-199508000-00023" rel="external">https://doi.org/10.1097/00005392-199508000-00023</a></p><p id="edition-ref-11">[11] Tchetgen, M. B., Song, J. T., Strawderman, M., Jacobsen, S. J., &amp; Oesterling, J. E. (1996). Ejaculation increases the serum prostate-specific antigen concentration. Urology, 47(4), 511–516. <a href="https://doi.org/10.1016/S0090-4295(99)80486-5" rel="external">https://doi.org/10.1016/S0090-4295(99)80486-5</a></p><p id="edition-ref-12">[12] D’Amico, A. V., &amp; Roehrborn, C. G. (2007). Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: A randomised controlled trial. Lancet Oncology, 8(1), 21–25. <a href="https://doi.org/10.1016/S1470-2045(06)70981-0" rel="external">https://doi.org/10.1016/S1470-2045(06)70981-0</a></p><p id="edition-ref-13">[13] Eastham, J. A., Riedel, E., Scardino, P. T., Shike, M., Fleisher, M., Schatzkin, A., Lanza, E., Latkany, L., &amp; Begg, C. B. (2003). Variation of serum prostate-specific antigen levels: An evaluation of year-to-year fluctuations. JAMA, 289(20), 2695–2700. <a href="https://doi.org/10.1001/jama.289.20.2695" rel="external">https://doi.org/10.1001/jama.289.20.2695</a></p><p id="edition-ref-14">[14] Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., Lange, P. H., Subong, E. N., Parson, R. E., Gasior, G. H., Loveland, K. G., &amp; Southwick, P. C. (1998). Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial. JAMA, 279(19), 1542–1547. <a href="https://doi.org/10.1001/jama.279.19.1542" rel="external">https://doi.org/10.1001/jama.279.19.1542</a></p><p id="edition-ref-15">[15] Kinnaird, A., Luger, F., Cash, H., Ghai, S., Urdaneta-Salegui, L. F., Pavlovich, C. P., et al. (2025). Microultrasonography-guided vs MRI-guided biopsy for prostate cancer diagnosis: The OPTIMUM randomized clinical trial. JAMA, 333(19), 1679–1687. <a href="https://doi.org/10.1001/jama.2025.3579" rel="external">https://doi.org/10.1001/jama.2025.3579</a></p><p id="edition-ref-16">[16] Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., et al. (2018). MRI-targeted or standard biopsy for prostate-cancer diagnosis. New England Journal of Medicine, 378(19), 1767–1777. <a href="https://doi.org/10.1056/NEJMoa1801993" rel="external">https://doi.org/10.1056/NEJMoa1801993</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated November 10, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>What one in 456 measures:</strong> One prostate cancer death was prevented per 456 men invited to repeated screening over 23 years. The trial’s main analysis covered ages 55 to 69 at entry. The figure cannot estimate the benefit of a single blood test at 47. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>When to repeat a high PSA:</strong> The European recommendation to repeat PSA before further testing applies to asymptomatic men with a moderately elevated result of 3 to 10 ng/mL. Symptoms, examination findings and substantially higher values can call for a different diagnostic pathway. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://doi.org/10.1056/NEJMoa2503223" rel="external">Roobol, M. J., de Vos, I. I., Månsson, M., et al. (2025). European study of prostate cancer screening: 23-year follow-up. New England Journal of Medicine, 393(17), 1669–1680.</a></li><li id="correction-ref-2"><a href="https://uroweb.org/guidelines/prostatecancer/chapter/diagnostic-evaluation" rel="external">Cornford, P., Tilki, D., van den Bergh, R. C. N., et al. (2026). EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer (limited text update, March 2026). European Association of Urology.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/psa-screening-free-psa-and-mri">PSA screening, free PSA and MRI →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Two hours a week? Skip the Zone 2.]]></title>
<description><![CDATA[How intervals and steady cycling compare when the week leaves two hours for cardio.]]></description>
<link>https://www.andreheeg.com/archive/two-hours-a-week-skip-the-zone-2</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/two-hours-a-week-skip-the-zone-2</guid>
<pubDate>Wed, 04 Nov 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>Three to four hours of slow Zone 2 cardio a week became the longevity rule. If you have two hours, it’s not the best use.</p><p>Verdict: Situational. Reason: wrong population.</p><h2>What?</h2><p>Zone 2 is steady cardio just below the point where lactate starts to build. You can still talk in full sentences. Its best-known popularizer, Peter Attia, put the ideal at 3 to 4 hours a week back in 2020, and said you probably can’t do too much. On August 29, <a href="https://peterattiamd.com/a-better-way-to-think-about-zone-2/" rel="external">his own site changed the advice</a> for short weeks: with only two hours, he “might skip a dedicated Zone 2 training altogether.”</p><p>So I pulled the studies.</p><p>The best summary is a Cochrane review from March. Across 37 trials in healthy, inactive adults aged 18 to 64, intervals raised VO2max, the most oxygen your body can use at full effort, by 1.39 ml/kg/min more than steady cardio. A slight edge, and the authors rate the evidence as low certainty.</p><p>A 2024 trial from the University of Calgary shows what drives it. Researchers split 84 young adults into six groups. One didn’t train. The rest rode bikes three times a week for six weeks, steady at different intensities or in intervals. The steady group just below the lactate point, closest to Zone 2, gained 1.8. That was statistically no different from people who didn’t train. Steady riding above that point gained 3.3 to 5.4; the harder they rode, the more they gained. Intervals of 4 minutes gained 6.2.</p><p>The 2020 advice cites no trial for the 3 to 4 hours. The hours do fit the WHO range of 150 to 300 moderate minutes a week. The same guideline treats 75 vigorous minutes as equal to 150 moderate ones. Half the minutes.</p><h2>So what?</h2><p>I always felt guilty about not doing enough Zone 2. I couldn’t make the time. My mornings go to lifting. I’m glad the advice got an update.</p><p>Elite endurance athletes do most of their training easy because they train so many hours that fatigue sets the limit. Your limit is the calendar. Copy their easy hours and skip their hard ones, and you keep the part that moves your fitness least.</p><p>Zone 2 still counts. In a small 2025 trial in men, steady training added mitochondria, the parts of muscle cells that burn fuel with oxygen. Sprint intervals didn’t, though the steady group also trained far longer.</p><h2>Now what?</h2><ul><li>Two hours or less of cardio a week: make two sessions hard. Warm up for 10 minutes, then 4 minutes hard and 3 minutes easy, still moving, four times. Hard means you can only get out a few words, about 90 to 95% of max heart rate.</li></ul><ul><li>More time than that: keep the two hard sessions and make the rest easy. The more hours you have, the more of them can be Zone 2.</li></ul><ul><li>Count the easy minutes you already have. A brisk walk to the next meeting is moderate exercise.</li></ul><ul><li>Chest pain, unusual breathlessness, dizziness or palpitations when you exert yourself: see your doctor before any training. Heart, metabolic or kidney disease: get cleared before intervals, or before starting at all if you’re inactive now. Been inactive: start with a few weeks of steady sessions.</li></ul><p>Three habits you keep beat ten you intend. Boring. Works.</p><p>Stay healthy.</p><p>Andre</p>]]></content:encoded>
</item>
<item>
<title><![CDATA[14.8% vape. 3.4% smoke.]]></title>
<description><![CDATA[Smoking cessation, youth vaping and the evidence behind nicotine pouch claims.]]></description>
<link>https://www.andreheeg.com/archive/14-8-vape-3-4-smoke</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/14-8-vape-3-4-smoke</guid>
<pubDate>Sun, 01 Nov 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>The tumor is out, and the hole is bigger than you’d expect.</p><p>A cancer the size of a fingernail gets cut out with healthy tissue around it in every direction, and what’s left can change how a person talks for good. When it reaches the jaw, surgeons rebuild it from the fibula, the thin bone in the lower leg. During my surgical residency, I was at the table for dozens of these operations. Most of those patients smoked.</p><p>Years later, I put a nicotine pouch under my own lip to see if it would sharpen my focus. Fifteen minutes later, I was in the bathroom.</p><p>You know cigarettes kill. What changed is where the nicotine went: into vapes, into pouches, into the office fridge. My verdict: for a smoker, a vape is the best exit there is. For everyone else, nicotine costs more than it gives.</p><h2>Doctors know. Plenty still smoke.</h2><p>A maxillofacial ward is a weird mix. Babies with cleft lips. Children whose skulls grew the wrong shape. Kids and adults after accidents. People having a jaw moved back or a nose reshaped. And the cancer patients, most of them smokers, many of them drinkers. We had a name for the pattern we kept seeing: the deadly triad. Smoking, drinking, and a mouth nobody looked after.</p><p>None of those patients thought smoking was good for them. Neither do the doctors who smoke, and there are plenty of them. Plenty drink, too. Medical training shows you exactly where risk ends up, and it still doesn’t stop people. Knowing has never been the hard part.</p><p>I call this information loses to incentives. A cigarette pays out within minutes: relief, a break, a reason to step outside, a few minutes with the people in the smoking corner. The bill comes 20 or 30 years later, and rarely announces itself. You know the same pattern from work. The deadline with a meeting attached beats the health cost with no deadline.</p><p>Nicotine is made for this trade. It’s legal, it’s fast, and the payoff is immediate. Long days, late flights, a deck due first thing in the morning: that’s exactly when a quick lift looks reasonable. It’s also why nicotine moved so easily from the cigarette into new forms.</p><p>In some offices it now comes free. According to Fortune, a Palantir spokesperson told the Wall Street Journal that the company stocks nicotine pouches for employees and guests over 21 <a href="#edition-ref-1">[1]</a>. When the employer pays for the habit, the short-term reward gets even harder to argue with.</p><p>What follows is the version I’d give a friend: the few numbers that matter. The rest is in the references.</p><h2>Smoking plus drinking: 14 times the odds</h2><p>Smoke damages the DNA in the cells lining your mouth, the first tissue it touches. Over years of heavy smoking, the odds rise that one damaged cell stops obeying the signal to stop dividing. That’s how a tumor starts.</p><p>Alcohol multiplies the damage. A pooled analysis of 17 studies with more than 11,000 head and neck cancer patients compared people by both habits <a href="#edition-ref-2">[2]</a>. More than a pack a day plus three or more drinks a day came to about 14 times the odds of these cancers, compared with people who did neither. Heavy smoking alone came to about 4 times, heavy drinking alone about 2. Together, the effect was bigger than the two multiplied.</p><p>If you only change one of the two, change the cigarettes.</p><h2>Quit before 40, and most of the extra risk is gone</h2><p>In data from 1.48 million adults in the US, the UK, Canada and Norway, quitting before 40 was linked to avoiding about 90% of the extra risk of dying early that smoking adds <a href="#edition-ref-3">[3]</a>. Quitting in your 40s still avoided most of it. The benefit showed up within three years.</p><p>The mouth recovers too. For mouth and throat cancer, people who had quit for a few years had about 30% lower odds than people who kept smoking. After 20 years or more, their odds were close to those of people who never smoked <a href="#edition-ref-4">[4]</a>.</p><p>If you smoke, nothing else I will ever write in this newsletter comes close to the value of stopping.</p><h2>Young adults vape four times more than they smoke</h2><p>About 1 in 10 US adults smoked in 2024. Among 18- to 24-year-olds, 14.8% vaped and only 3.4% smoked <a href="#edition-ref-5">[5]</a>. The cigarette is shrinking, but the nicotine hasn’t gone anywhere.</p><p>Among US middle and high school students in 2025, about 1 in 20 had vaped in the past month, and about 9 in 10 used flavored products, mostly fruit, candy, and mint <a href="#edition-ref-6">[6]</a>. Youth vaping has come down since 2022, but it’s still the most common way teenagers use nicotine. Pouches are second.</p><p>I think taste explains a lot of this. A cigarette is harsh, and it smells. For a 15-year-old, that harshness used to be a barrier. A vape that tastes like mango takes the barrier away, and it leaves far less smell on their clothes for a parent to notice.</p><p>That matters more at 15 than at 45. The US Surgeon General concluded that nicotine during adolescence can cause addiction and can harm the developing brain <a href="#edition-ref-7">[7]</a>.</p><h2>For a smoker, a vape is the best exit</h2><p>This sounds wild coming from me, but the evidence is on the vape’s side, and I’ll say so plainly. Across 11 trials, about 4 more people in every 100 quit smoking with a vape than with patches or gum, and Cochrane rates that evidence as high certainty <a href="#edition-ref-8">[8]</a>. In one large UK trial, 18 in 100 were off cigarettes a year later with a vape, against 10 in 100 with patches or gum <a href="#edition-ref-9">[9]</a>.</p><p>Two catches, though. The goal has to be zero cigarettes. In a large US study, people who both smoked and vaped had the highest exposure to toxic chemicals of any group <a href="#edition-ref-10">[10]</a>. And the vape can become a habit of its own: in that UK trial, 8 in 10 people who quit with a vape were still vaping a year later <a href="#edition-ref-9">[9]</a>. For a smoker, that’s a good trade. It’s still a habit. My advice: once the cigarettes are gone, plan your way off the vape too, with your doctor if you need help.</p><p>Heated tobacco devices like IQOS are the other exit the tobacco industry sells. In the trials Cochrane reviewed, users took in fewer toxic chemicals than smokers but more than people who quit (not surprising), and every one of those trials was funded by tobacco companies <a href="#edition-ref-11">[11]</a>.</p><p>For someone who has never smoked, none of this applies. Vapes have been common only since the 2010s. Nobody knows yet what 30 years of vaping does to a pair of lungs.</p><h2>The pouch I tried once</h2><p>In January I wrote here about a tin of nicotine pouches I’d bought in Sweden, and the question behind it: could nicotine sharpen my focus, maybe even help with my ADHD?</p><p>I did try. One of my flaws is believing that more is always better, and I think I used a pouch that was too strong. I don’t remember the dose. I remember what happened 10 or 15 minutes after I put it under my lip. I was sweating heavily. I was agitated, and my stomach turned. I ended up in the bathroom, and that was the end of the experiment. I never tried again.</p><p>Heavy sweating, agitation, and nausea are the textbook signs of too much nicotine. Mine was a textbook case.</p><p>The case for nicotine as a focus tool is real, as far as it goes. A review of 41 lab studies found small to moderate improvements in attention, reaction time, and short-term memory, in non-smokers too <a href="#edition-ref-12">[12]</a>. Those were short lab tests. Nobody measured whether anyone did better work or made better decisions. That’s the mechanism trap: an effect you can measure in a lab, and no data on the outcome you care about.</p><p>The dose problem is real too. When German researchers tested 44 pouches from 20 manufacturers, bought online in Europe, the nicotine inside ranged from under 2 mg to 47.5 mg per pouch. Two out of three products had no clear nicotine label <a href="#edition-ref-13">[13]</a>.</p><h2>ZYN’s new claim has a comparison in the fine print</h2><p>On 30 June 2026, FDA authorized 20 ZYN products to carry this claim: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” <a href="#edition-ref-14">[14]</a></p><p>The strongest case for it: if you smoke, it’s almost certainly true, and the FDA reviewed the company’s evidence before allowing it. That’s a real win for every smoker who switches.</p><p>The gap sits in three words: instead of cigarettes. The claim compares ZYN with smoking. It says nothing about ZYN against no nicotine at all, and the FDA’s own announcement repeats that there is no safe tobacco product <a href="#edition-ref-14">[14]</a>. The order covers the 3- and 6-mg pouches, not the stronger ZYN Ultra. It runs for five years, and the FDA can withdraw it if use among young people rises significantly.</p><p>My verdict on the claim: Keep, if you smoke. Cut, if you don’t. You’re the wrong population in that case.</p><h2>My take on the matter:</h2><ul><li><strong>Quitting cigarettes, at any age:</strong> Strong yes.</li></ul><ul><li><strong>Switching completely from cigarettes to a vape:</strong> Yes, for smokers. Then try getting off vaping.</li></ul><ul><li><strong>Smoking and vaping at the same time:</strong> Cut. You’re heading in the wrong direction and could be adding even more health risks.</li></ul><ul><li><strong>Heated tobacco as the safer cigarette:</strong> Situational yes, for smokers who won’t quit any other way. Lower exposure to cancer-causing chemicals than smoking, but the research is industry-funded.</li></ul><ul><li><strong>A nicotine pouch for focus, if you don’t use nicotine:</strong> Don’t. You’d be betting on a mechanism, not a proven outcome.</li></ul><ul><li><strong>Any nicotine for a teenager:</strong> No. If focus is a challenge, work on the root causes instead.</li></ul><p>This is load versus capacity at its plainest. Your job adds load. Capacity is what lets you carry it, and at 70 it’s what lets you think clearly, eat what you like, and talk without effort. Tobacco takes from all of it. That’s the Capacity pillar of my Upward ARC framework, and I watched it go, one patient’s mouth at a time.</p><h2>Try this today</h2><ul><li>If you use nicotine in any form, write down every use for one week, then decide based on the number in front of you. If you smoke, book a doctor’s appointment about quitting that same week.</li></ul><ul><li>Ask your kids what their friends use before you ask what they use. Ask about flavors.</li></ul><ul><li>Any mouth ulcer that hasn’t healed within 3 weeks, and any red or white patch or new lump, gets checked by a dentist or doctor, especially if you smoke or drink <a href="#edition-ref-15">[15]</a>.</li></ul><p>Everything we rebuilt at that table came down to two ordinary things: eating and talking. Biting into a sandwich. Getting through a phone call without anyone asking you to repeat yourself. Most people only notice them when they’re gone.</p><p>If you quit smoking successfully, what finally did it? Press reply and tell me. I read every one, and I’m listening. If you’re still smoking, let this be the week you book that appointment.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If someone you love still smokes, send them the section on quitting before 40. Skip the lecture. This is how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If a friend sent you this, you can get Under Load, my Sunday edition, here: <a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a></p><div><hr></div><h2>References</h2><p id="edition-ref-1">[1] Gioino, C. (2026, March 4). Palantir and other tech companies are stocking offices with nicotine products to increase worker productivity. Fortune. <a href="https://fortune.com/2026/03/04/palantir-tech-companies-offices-vending-machines-tobacco-worker-productivity/" rel="external">https://fortune.com/2026/03/04/palantir-tech-companies-offices-vending-machines-tobacco-worker-productivity/</a></p><p id="edition-ref-2">[2] Hashibe, M., Brennan, P., Chuang, S.-C., Boccia, S., Castellsague, X., Chen, C., Curado, M. P., Dal Maso, L., Daudt, A. W., Fabianova, E., Fernandez, L., Wünsch-Filho, V., Franceschi, S., Hayes, R. B., Herrero, R., Kelsey, K., Koifman, S., La Vecchia, C., Lazarus, P., . . . Boffetta, P. (2009). Interaction between tobacco and alcohol use and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiology, Biomarkers &amp; Prevention, 18(2), 541–550. <a href="https://doi.org/10.1158/1055-9965.EPI-08-0347" rel="external">https://doi.org/10.1158/1055-9965.EPI-08-0347</a></p><p id="edition-ref-3">[3] Cho, E. R., Brill, I. K., Gram, I. T., Brown, P. E., &amp; Jha, P. (2024). Smoking cessation and short- and longer-term mortality. NEJM Evidence, 3(3), EVIDoa2300272. <a href="https://doi.org/10.1056/EVIDoa2300272" rel="external">https://doi.org/10.1056/EVIDoa2300272</a></p><p id="edition-ref-4">[4] Marron, M., Boffetta, P., Zhang, Z.-F., Zaridze, D., Wünsch-Filho, V., Winn, D. M., Wei, Q., Talamini, R., Szeszenia-Dabrowska, N., Sturgis, E. M., Smith, E., Schwartz, S. M., Rudnai, P., Purdue, M. P., Olshan, A. F., Eluf-Neto, J., Muscat, J., Morgenstern, H., Menezes, A., . . . Hashibe, M. (2010). Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. International Journal of Epidemiology, 39(1), 182–196. <a href="https://doi.org/10.1093/ije/dyp291" rel="external">https://doi.org/10.1093/ije/dyp291</a></p><p id="edition-ref-5">[5] Agaku, I. (2026). Tobacco product use among U.S. adults, 2023–2024. NEJM Evidence. <a href="https://doi.org/10.1056/EVIDpha2500339" rel="external">https://doi.org/10.1056/EVIDpha2500339</a></p><p id="edition-ref-6">[6] Park-Lee, E., Dutra, L. M., Cowan, H., Levine, B., Sawdey, M. D., Cooper, M., Merson, B., Valverde, R., Bradfield, B., Lennon, J., Freedman, N. D., Ambrose, B. K., &amp; Cullen, K. A. (2026). Tobacco product use among middle and high school students in the United States: National Youth Tobacco Survey, 2025. Nicotine &amp; Tobacco Research. Advance online publication. <a href="https://doi.org/10.1093/ntr/ntag116" rel="external">https://doi.org/10.1093/ntr/ntag116</a></p><p id="edition-ref-7">[7] U.S. Department of Health and Human Services. (2016). E-cigarette use among youth and young adults: A report of the Surgeon General. Office of the Surgeon General. <a href="https://www.ncbi.nlm.nih.gov/books/NBK538680/" rel="external">https://www.ncbi.nlm.nih.gov/books/NBK538680/</a></p><p id="edition-ref-8">[8] Lindson, N., Livingstone-Banks, J., Butler, A. R., McRobbie, H., Bullen, C. R., Hajek, P., Wu, A. D., Begh, R., Theodoulou, A., Ma, C., Notley, C., Rigotti, N. A., Turner, T., Fanshawe, T., &amp; Hartmann-Boyce, J. (2026). Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews, 8, CD010216. <a href="https://doi.org/10.1002/14651858.CD010216.pub11" rel="external">https://doi.org/10.1002/14651858.CD010216.pub11</a></p><p id="edition-ref-9">[9] Hajek, P., Phillips-Waller, A., Przulj, D., Pesola, F., Myers Smith, K., Bisal, N., Li, J., Parrott, S., Sasieni, P., Dawkins, L., Ross, L., Goniewicz, M., Wu, Q., &amp; McRobbie, H. J. (2019). A randomized trial of e-cigarettes versus nicotine-replacement therapy. New England Journal of Medicine, 380(7), 629–637. <a href="https://doi.org/10.1056/NEJMoa1808779" rel="external">https://doi.org/10.1056/NEJMoa1808779</a></p><p id="edition-ref-10">[10] Goniewicz, M. L., Smith, D. M., Edwards, K. C., Blount, B. C., Caldwell, K. L., Feng, J., Wang, L., Christensen, C., Ambrose, B., Borek, N., van Bemmel, D., Konkel, K., Erives, G., Stanton, C. A., Lambert, E., Kimmel, H. L., Hatsukami, D., Hecht, S. S., Niaura, R. S., . . . Hyland, A. J. (2018). Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Network Open, 1(8), e185937. <a href="https://doi.org/10.1001/jamanetworkopen.2018.5937" rel="external">https://doi.org/10.1001/jamanetworkopen.2018.5937</a></p><p id="edition-ref-11">[11] Tattan-Birch, H., Hartmann-Boyce, J., Kock, L., Simonavicius, E., Brose, L., Jackson, S., Shahab, L., &amp; Brown, J. (2022). Heated tobacco products for smoking cessation and reducing smoking prevalence. Cochrane Database of Systematic Reviews, 1, CD013790. <a href="https://doi.org/10.1002/14651858.CD013790.pub2" rel="external">https://doi.org/10.1002/14651858.CD013790.pub2</a></p><p id="edition-ref-12">[12] Heishman, S. J., Kleykamp, B. A., &amp; Singleton, E. G. (2010). Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology, 210(4), 453–469. <a href="https://doi.org/10.1007/s00213-010-1848-1" rel="external">https://doi.org/10.1007/s00213-010-1848-1</a></p><p id="edition-ref-13">[13] Mallock, N., Schulz, T., Malke, S., Dreiack, N., Laux, P., &amp; Luch, A. (2024). Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches. Tobacco Control, 33(2), 193–199. <a href="https://doi.org/10.1136/tc-2022-057280" rel="external">https://doi.org/10.1136/tc-2022-057280</a></p><p id="edition-ref-14">[14] U.S. Food and Drug Administration. (2026, June 30). FDA authorizes 20 ZYN nicotine pouches to be marketed with specific modified risk claim. <a href="https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-20-zyn-nicotine-pouches-be-marketed-specific-modified-risk-claim" rel="external">https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-20-zyn-nicotine-pouches-be-marketed-specific-modified-risk-claim</a></p><p id="edition-ref-15">[15] National Health Service. (n.d.). Mouth cancer: Symptoms. Retrieved October 31, 2026, from <a href="https://www.nhs.uk/conditions/mouth-cancer/symptoms/" rel="external">https://www.nhs.uk/conditions/mouth-cancer/symptoms/</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated November 10, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>What the quitting trials compared:</strong> Nicotine e-cigarettes helped more adults quit smoking than nicotine replacement in the trials cited. The wider evidence also supports varenicline and cytisine. It does not establish vaping as the best option for every smoker. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.cochrane.org/evidence/CD015226_how-effective-are-medications-and-e-cigarettes-quitting-smoking-and-what-works-best" rel="external">Lindson et al. (2023). Pharmacological and electronic cigarette interventions for smoking cessation in adults.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/quitting-cigarettes-vaping-and-nicotine-pouches">Quitting cigarettes, vaping and nicotine pouches →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Flu came early. The shot needs two weeks.]]></title>
<description><![CDATA[Flu vaccine timing and what the cardiac studies found in people with a recent heart attack.]]></description>
<link>https://www.andreheeg.com/archive/flu-came-early-the-shot-needs-two-weeks</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/flu-came-early-the-shot-needs-two-weeks</guid>
<pubDate>Wed, 28 Oct 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>On October 18, I suggested you consider getting a flu shot. I haven’t gotten mine yet either. The throat infection I mentioned delayed it until next week.</p><h2>What?</h2><p>Flu season started early in the US this year. For the week ending October 17, the CDC said the flu hospitalization rate was the highest for that time of year since 2010-2011. Still, overall activity is considered low.</p><p>Even with the “mutated H1N1” headlines, 82 out of 88 recent H1N1 samples tested by the CDC were still recognized by antibodies from this year’s vaccine. The CDC says it’s too soon to tell how the new variants might affect the shot’s effectiveness.</p><p>In Germany, the Robert Koch Institute still says flu activity is low. Last season, the flu wave began in late November.</p><p>The shot takes about two weeks to become effective. The CDC recommends getting vaccinated by the end of October but says it’s fine to get it later too. The Robert Koch Institute suggests getting it between October and mid-December.</p><p>Flu can also raise the risk of heart attacks. A study in the New England Journal of Medicine followed adults 35 and older in Ontario who had lab-confirmed flu. In the week after their diagnosis, they were hospitalized for heart attacks six times more often than during the rest of the year. After the first week, the extra risk disappeared. That week, there were 20 heart attack admissions among about 19,000 confirmed flu cases, or about 1 in 1,000. The study included only people sick enough to get tested.</p><h2>So what?</h2><p>Here’s my view: for a healthy adult, the flu shot is still a modest benefit, as I said on the 18th. For most people, the main question is when to get it. Think about Thanksgiving, December gatherings, travel, or seeing your parents. If you get the shot in mid-December, you’ll only be fully protected around New Year’s. I wouldn’t wait that long.</p><p>Whether the flu shot protects your heart depends on your situation. In a study of 2,571 people who had just had a heart attack, the shot lowered the combined risk of death, another heart attack, or a blocked stent within a year from 7.2% to 5.3% compared to a placebo. For people without a recent heart attack, studies haven’t clearly shown this benefit. So I wouldn’t recommend the shot to a healthy 45-year-old just for heart protection.</p><h2>Now what?</h2><ul><li>Schedule your flu shot for this week or next.</li></ul><ul><li>If you or your parents are 60 or older in Germany, or 65 or older in the US, ask for one of the stronger flu shots for older adults. These include high-dose or adjuvanted shots (in the US, recombinant counts too).</li></ul><ul><li>If you have heart disease or heart failure, make sure you get the shot. Both US and European cardiology guidelines recommend it every year, since flu can be more serious for you.</li></ul><ul><li>You can get the shot if you have a mild cold, a slight fever, or are taking antibiotics, as long as you otherwise feel okay. But if you’re really sick (with a fever of 101.3 °F (38.5 °C) or higher, or an infection that makes you feel clearly unwell, like I had), wait until you recover before getting vaccinated.</li></ul><p>The throat infection, and what I got wrong about pushing through → <a href="https://www.andreheeg.com/archive/i-pushed-through-my-right-tonsil-didnt" rel="external">Under Load No. 091</a></p><p>Stay healthy.</p><p>Andre</p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated November 10, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Protection after vaccination:</strong> Antibodies usually take about two weeks to develop. “Fully protected” overstates what that means. Vaccinated people can still catch flu, and protection varies with the season, age and health. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.cdc.gov/flu/vaccines/keyfacts.html" rel="external">CDC (2026). Key facts about seasonal flu vaccine.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section>]]></content:encoded>
</item>
<item>
<title><![CDATA[My Wife Keeps Waking at 3:30. I Went Looking for Why.]]></title>
<description><![CDATA[Night waking during perimenopause, hormone therapy and treatment for chronic insomnia.]]></description>
<link>https://www.andreheeg.com/archive/my-wife-keeps-waking-at-330-i-went-looking-for-why</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/my-wife-keeps-waking-at-330-i-went-looking-for-why</guid>
<pubDate>Sun, 25 Oct 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>Erna opens her eyes, and her body is already tense.</p><p>She feels restless and on edge, anxious about something she can’t quite name. It isn’t work or the kids. Nothing in particular is on her mind, but she still can’t fall back asleep.</p><p>It’s 3:30. Sometimes it’s 4. This has happened nearly every night for six months. She’s tried going to bed at 9 and at midnight. It makes no difference.</p><p>I sleep through it all next to her. If you read my July edition, you know I can fall asleep anywhere, even when I used to have a trauma pager on my chest. That skill doesn’t help the person next to you. Sometimes the bedside light wakes me, and I see her sitting up with a book. Most nights, I don’t even notice she’s not there.</p><p>This edition is personal. It’s Erna’s story, and she’s read and approved every word. She wants to share it openly, because there’s nothing to be ashamed of. Every woman goes through this transition. Some barely notice it, while others lose sleep. She says if her story helps even a few women, it was worth sharing.</p><p>One more thing before we start. I’m a doctor, but not a gynecologist, and hormones are complicated. What follows is a simplified version: broad strokes, so it’s easy to follow. Almost every sentence has more detail behind it. If you’re making a treatment decision, do it with your doctor.</p><h2>The woman who couldn’t get up before 7</h2><p>Fifteen years ago, we lived in New York, and I was focused on self-improvement. I got up at 5, did CrossFit in Brooklyn, had breakfast, then went to work. I had a morning routine I liked to talk about.</p><p>Erna was less keen. “I can’t get up before 7,” she told me, “no matter what I do.”</p><p>This is from a woman who moved from Kyrgyzstan to a new country at 10 and built a life from scratch. Mornings were the one challenge she couldn’t overcome. Over time, she started waking up earlier, and eventually we went to the gym together in the mornings.</p><p>Now she wakes up hours before the alarm she used to need, and she doesn’t choose to.</p><h2>Two hormones, explained over coffee</h2><p>To understand why she wakes at 3:30, you need to know about two hormones.</p><p>Estrogen is the main one. It controls the menstrual cycle, but it also works in other parts of the body, including the brain. For this story, one area matters most: the brain’s thermostat, the small part that keeps your body temperature steady <a href="#edition-ref-1">[1]</a>.</p><p>Progesterone is the quieter partner. After ovulation, it prepares the womb lining for a possible pregnancy. It also plays a role in sleep. The body turns some of it into a substance called allopregnanolone, which calms the brain <a href="#edition-ref-2">[2]</a>. Remember that for a second.</p><h2>What changes, and when</h2><p>Menopause is a single point in time: one year after your last period. In the US, the average age is about 51 <a href="#edition-ref-1">[1]</a>. Perimenopause is the run-up, and it can last several years.</p><p>During perimenopause, ovulation becomes irregular. Estrogen and progesterone don’t decrease in a straight line. They go up and down, sometimes a lot, before they finally drop <a href="#edition-ref-1">[1]</a>.</p><p>That’s why the symptoms are so mixed. These hormones affect so many parts of the body that their loss shows up in many ways: hot flushes and night sweats, irritability, anxiety, low mood, and trouble sleeping <a href="#edition-ref-1">[1]</a>.</p><p>For Erna, sleep is the main problem, and she’s not alone. A large 2026 analysis found insomnia symptoms in about 27% of women in perimenopause and 42% after menopause <a href="#edition-ref-3">[3]</a>. These women are in their 40s and 50s. Some run teams, companies, and boards, and some will be in your 9 a.m. meeting after a night like Erna’s.</p><h2>Why sleep breaks</h2><p>Most mornings, by the time I wake up, Erna is already in the kitchen. I hug her, and she tells me the time. “At least it was 4 tonight. Not 3:30.” In our house, that now counts as an ok night.</p><p>In <a href="https://www.andreheeg.com/archive/i-fall-asleep-in-ninety-seconds/" rel="external">my July edition</a>, I asked: when you wake at 3am, is it because of a specific worry, or for no clear reason? For Erna, it’s the second. Her body just wakes up. She also tried my July advice: get up, read in dim light, and go back to bed when tired. It hasn’t fixed the problem. Seeing your own advice tested at home is humbling.</p><p>So I started reading. Broad strokes again: three things seem to work together.</p><p>The first is the thermostat. With less estrogen, it becomes more sensitive, which leads to hot flashes and night sweats <a href="#edition-ref-4">[4]</a>. Many night flashes go unnoticed, but they still wake you up. In one study of 168 midlife women, the odds of waking were over five times higher during a measured flash than just before it, whether or not the woman noticed it <a href="#edition-ref-5">[5]</a>. So saying “I don’t get hot flashes” doesn’t answer the question.</p><p>The second is the missing calm, which I find most interesting. Your brain has a brake pedal, a messenger called GABA. Many sleeping pills work by acting on it. Allopregnanolone, which your body makes from progesterone, works on the same brake <a href="#edition-ref-2">[2]</a>. When progesterone goes up and down, some of that natural brake may go with it. The research can’t say if this explains why any one woman wakes up. But it’s a big reason doctors consider progesterone for sleep.</p><p>The third is the alarm. After weeks of broken nights, the brain can learn to wake up. Bed starts to mean lying awake and feeling frustrated, and waking becomes a habit. That’s what my July advice was meant to help. For Erna, that hasn’t been enough on its own.</p><p>Early-hour waking can be explained by sleep getting lighter and easier to disturb as morning approaches. And no, I couldn’t find good evidence for the “3am cortisol spike” that the internet often blames. Cortisol does rise toward morning. That’s normal.</p><h2>The doctor who wasn’t in the room</h2><p>Erna did the sensible thing and went to her gynecologist.</p><p>Hormone therapy wasn’t offered to her right away. I encouraged her to ask about it, which isn’t easy for someone who doesn’t like to question her doctor. She came home with an estrogen gel and instructions: start with one pump, then add another, and if your breasts get tender, use less. When she went back and said she still couldn’t sleep, her doctor added a progestin-only pill. Her mood got worse. She came home from those visits feeling like “there’s not much you can do.”</p><p>I wasn’t at those appointments, so I only know what she told me afterward. At first, I thought, who am I to question a specialist? My training is in reconstructive surgery. But I got frustrated and started reading the research myself. Now, I feel informed enough to help her ask better questions.</p><p><strong>The doctor’s take:</strong> Her pill contains desogestrel, a synthetic progestin approved in Germany for contraception, and depressed mood is one of its possible side effects <a href="#edition-ref-6">[6]</a>. It isn’t the body’s own progesterone, and it isn’t what the sleep studies tested. Those studies used micronized progesterone, the body-identical version that turns into allopregnanolone and acts as a brake. Its effect is modest. In a review of nine trials, it helped women fall asleep faster <a href="#edition-ref-7">[7]</a>. That prescription needed a second look.</p><p>Progesterone has another job here. If you have a uterus and use estrogen, you need enough progestogen to protect the womb lining, and not every option has evidence for that <a href="#edition-ref-8">[8]</a>. Your doctor should be able to tell you which one does.</p><h2>The fear that got in the way</h2><p>Erna had to ask for hormone therapy. I think much of the hesitation goes back to 2002, when a big US trial, the Women’s Health Initiative, was stopped early. Women on a combined estrogen and progestin pill had more breast cancers: 8 extra cases per 10,000 women per year <a href="#edition-ref-9">[9]</a>. That risk is real. But in February 2026, the US FDA approved new hormone therapy labels, removing the broad boxed warnings about breast cancer, heart disease, and dementia <a href="#edition-ref-10">[10]</a>.</p><p><strong>The doctor’s take:</strong> For women under 60 or within 10 years of menopause, and without reasons to avoid it, hormone therapy usually has a good balance of benefits and risks for bothersome hot flashes and night sweats <a href="#edition-ref-11">[11]</a>. Women deserve a clear conversation about these benefits and risks. No woman should have to fight for that conversation.</p><h2>What helps</h2><p>This fits into the Recover pillar of my Upward ARC framework: helping the nervous system return to baseline between stressors.</p><p>Each of these three things has its own approach.</p><p>For the thermostat, hormone therapy can help. It mainly improves sleep in women with hot flashes or night sweats <a href="#edition-ref-12">[12]</a>. There are also newer non-hormonal prescriptions for hot flashes.</p><p>For the missing calm, ask if taking micronized progesterone at night could help.</p><p>For the alarm, there’s CBT-I, or cognitive behavioral therapy for insomnia. For chronic insomnia, it’s the first-line treatment, and US sleep doctors give it their strongest recommendation <a href="#edition-ref-13">[13]</a>. In a US trial of women with hot flashes, 70% of those assessed in the CBT-I group were out of the insomnia range after 8 weeks, compared with 24% in a menopause-education group <a href="#edition-ref-14">[14]</a>. In Germany, your doctor can prescribe it as an app <a href="#edition-ref-15">[15]</a>.</p><p>Also ask about two similar conditions. Sleep apnea becomes more common after menopause, and in women it often appears as insomnia instead of loud snoring <a href="#edition-ref-16">[16]</a>. Low mood can also wake you early. Both deserve an honest conversation with your doctor.</p><p>When it comes to supplements, I’d recommend getting a proper sleep assessment before trying anything from the store.</p><h2>If you’re the one sleeping next to it</h2><p>Believe her when she says she can’t sleep. Don’t suggest another supplement right away. And never, under any circumstances, tell her how well you slept.</p><p>After a bad night, take care of the kids in the morning. She deals with this every night. At the very least, handle breakfast.</p><h2>Try this today</h2><ul><li>Keep a sleep diary while you book an appointment. Write down when you wake, how you feel, and any heat, sweating, or racing heart.</li></ul><ul><li>Ask about the thermostat: “Could night flashes be waking me, even if I don’t notice them?”</li></ul><ul><li>Ask about the calm: “Which progestogen am I on, and what is it for: my womb lining, my sleep, or contraception? Could micronized progesterone fit?”</li></ul><ul><li>Ask about the alarm: “Can I get CBT-I?”</li></ul><ul><li>Ask about the look-alikes: sleep apnea and low mood.</li></ul><h2>Seven o’clock</h2><p>Fifteen years ago in Brooklyn, she couldn’t get up before 7. But she managed it in her own way, and we eventually went to the gym together.</p><p>She has now stopped the pill and switched to micronized progesterone. It’s too soon to know how it will affect her nights, but she no longer feels stuck at “there’s not much you can do.” We haven’t solved this yet, but things are looking better. What I want for her is to have the choice again: a night that ends when she decides, and an alarm she actually needs.</p><p>If you’re going through this, or supporting someone who is, what did your doctor say when you brought it up? Reply and let me know. I read every message.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you know a woman who’s been lying awake at 3 or 4 and blaming herself, please forward this to her. If you’re her partner, read it first. That’s how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If a friend sent you this, you can get Under Load, my Sunday edition, here: <a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a></p><div><hr></div><h2>References</h2><p id="edition-ref-1">[1] Merck Manual Consumer Version. (2026). Menopause. Retrieved October 24, 2026, from <a href="https://www.merckmanuals.com/home/women-s-health-issues/menopause/menopause" rel="external">https://www.merckmanuals.com/home/women-s-health-issues/menopause/menopause</a></p><p id="edition-ref-2">[2] McEvoy, K., &amp; Osborne, L. M. (2019). Allopregnanolone and reproductive psychiatry: An overview. International Review of Psychiatry, 31(3), 237–244. <a href="https://doi.org/10.1080/09540261.2018.1553775" rel="external">https://doi.org/10.1080/09540261.2018.1553775</a></p><p id="edition-ref-3">[3] Balasubramanian, I., Abhijita, B., Krishnamoorthy, Y., Gnanadhas, J., Beg, M. J., &amp; Menon, V. (2026). Prevalence and incidence of depressive, anxiety, and insomnia symptoms in perimenopausal and postmenopausal women: Systematic review and meta-analysis. General Hospital Psychiatry, 100, 325–335. <a href="https://doi.org/10.1016/j.genhosppsych.2026.03.010" rel="external">https://doi.org/10.1016/j.genhosppsych.2026.03.010</a></p><p id="edition-ref-4">[4] Prague, J. K., et al. (2017). Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: A phase 2, randomised, double-blind, placebo-controlled trial. The Lancet, 389(10081), 1809–1820. <a href="https://doi.org/10.1016/S0140-6736(17)30823-1" rel="external">https://doi.org/10.1016/S0140-6736(17)30823-1</a></p><p id="edition-ref-5">[5] Thurston, R. C., Chang, Y., Buysse, D. J., Hall, M. H., &amp; Matthews, K. A. (2019). Hot flashes and awakenings among midlife women. Sleep, 42(9), zsz131. <a href="https://doi.org/10.1093/sleep/zsz131" rel="external">https://doi.org/10.1093/sleep/zsz131</a></p><p id="edition-ref-6">[6] Fachinfo-Service. (n.d.). Jubrele 75 Mikrogramm Filmtabletten: Fachinformation (Desogestrel). Retrieved October 24, 2026, from <a href="https://www.fachinfo.de/fi/detail/013955/jubrele" rel="external">https://www.fachinfo.de/fi/detail/013955/jubrele</a></p><p id="edition-ref-7">[7] Nolan, B. J., Liang, B., &amp; Cheung, A. S. (2021). Efficacy of micronized progesterone for sleep: A systematic review and meta-analysis of randomized controlled trial data. The Journal of Clinical Endocrinology &amp; Metabolism, 106(4), 942–951. <a href="https://doi.org/10.1210/clinem/dgaa873" rel="external">https://doi.org/10.1210/clinem/dgaa873</a></p><p id="edition-ref-8">[8] British Menopause Society. (n.d.). Progestogens and endometrial protection [BMS Tools for Clinicians]. Retrieved October 24, 2026, from <a href="https://thebms.org.uk/wp-content/uploads/2023/04/14-BMS-TfC-Progestogens-and-endometrial-protection-APR2023-A.pdf" rel="external">https://thebms.org.uk/wp-content/uploads/2023/04/14-BMS-TfC-Progestogens-and-endometrial-protection-APR2023-A.pdf</a></p><p id="edition-ref-9">[9] Rossouw, J. E., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 288(3), 321–333. <a href="https://doi.org/10.1001/jama.288.3.321" rel="external">https://doi.org/10.1001/jama.288.3.321</a></p><p id="edition-ref-10">[10] U.S. Food and Drug Administration. (2026, February 12). FDA approves labeling changes to menopausal hormone therapy products [Press release]. <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products" rel="external">https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products</a></p><p id="edition-ref-11">[11] The North American Menopause Society. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794. <a href="https://doi.org/10.1097/GME.0000000000002028" rel="external">https://doi.org/10.1097/GME.0000000000002028</a></p><p id="edition-ref-12">[12] Cintron, D., et al. (2017). Efficacy of menopausal hormone therapy on sleep quality: Systematic review and meta-analysis. Endocrine, 55(3), 702–711. <a href="https://doi.org/10.1007/s12020-016-1072-9" rel="external">https://doi.org/10.1007/s12020-016-1072-9</a></p><p id="edition-ref-13">[13] Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., Kazmi, U., Heald, J. L., &amp; Martin, J. L. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255–262. <a href="https://doi.org/10.5664/jcsm.8986" rel="external">https://doi.org/10.5664/jcsm.8986</a></p><p id="edition-ref-14">[14] McCurry, S. M., et al. (2016). Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: A MsFLASH randomized clinical trial. JAMA Internal Medicine, 176(7), 913–920. <a href="https://doi.org/10.1001/jamainternmed.2016.1795" rel="external">https://doi.org/10.1001/jamainternmed.2016.1795</a></p><p id="edition-ref-15">[15] somnio. (2025, August 1). So verordnen Sie somnio Ihren Patient:innen. <a href="https://somn.io/fachkreise/somnio-verschreiben/" rel="external">https://somn.io/fachkreise/somnio-verschreiben/</a></p><p id="edition-ref-16">[16] Dunietz, G. L., Chervin, R. D., Tauman, R., Shaklai, S., &amp; Sankari, A. (2026). OSA in women: Associations with reproductive aging and screening challenges. Chest, 169(3), 803–812. <a href="https://doi.org/10.1016/j.chest.2025.08.001" rel="external">https://doi.org/10.1016/j.chest.2025.08.001</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated November 10, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Contraception after a change of prescription:</strong> Micronized progesterone taken for menopausal hormone therapy does not prevent pregnancy. Anyone switching from a contraceptive pill who still needs contraception should discuss a separate method with their prescriber. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.nhs.uk/medicines/hormone-replacement-therapy-hrt/utrogestan-micronised-progesterone/common-questions-about-utrogestan/" rel="external">NHS (n.d.). Common questions about Utrogestan.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/perimenopause-sleep-and-night-waking">Night waking during perimenopause →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Sunset, Saturday 5:52. Sunday 4:50.]]></title>
<description><![CDATA[The autumn clock change, winter daylight and the limits of the health evidence.]]></description>
<link>https://www.andreheeg.com/archive/sunset-saturday-5-52-sunday-4-50</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/sunset-saturday-5-52-sunday-4-50</guid>
<pubDate>Wed, 21 Oct 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>On Saturday, the sun sets in Berlin at 5:52 pm. The next day, it sets at 4:50 pm. The sky stays the same, but most of Europe goes back an hour overnight. Most of the US does the same on November 1.</p><h2>What?</h2><p>Most studies people mention about changing the clocks focus on spring. A<a href="https://doi.org/10.3238/arztebl.m2024.0078" rel="external">2024 meta-analysis of 12 studies</a> found that heart attacks were about 4% more common in the weeks after clocks moved forward. When clocks go back, there was no clear change.</p><p>The autumn numbers look better. A<a href="https://doi.org/10.1136/bmj-2025-085962" rel="external">BMJ study</a> checked the health records of 683,809 people in England during the clock changes from 2008 to 2019. In the week after clocks went back, doctors recorded fewer cases than in the weeks around it: depression was 4% lower, anxiety 3% lower, acute cardiovascular events 2% lower, and sleep disorders 8% lower. These numbers are based on when doctors recorded each case, which might not be the day symptoms started. A<a href="https://doi.org/10.1007/s10654-026-01372-8" rel="external">review of 157 studies</a> from 36 countries, published in February, found no consistent effect of clock changes on mental health.</p><p>One study found something different. In<a href="https://doi.org/10.1097/EDE.0000000000000580" rel="external">Denmark</a>, hospital visits for depression went up by 11% after clocks went back, but this increase faded over about 10 weeks. The authors thought the sudden earlier sunset could be the reason. All these studies are observational.</p><h2>So what?</h2><p>My take: don’t stress about the hour. It’s just one night, and for most of us, it’s the easier change since we get an extra hour.</p><p>The time we return to on Sunday is standard time, the one sleep-and-body-clock<a href="https://doi.org/10.1503/cmaj.261089" rel="external">societies want</a> year-round.</p><p>I suggest planning for what happens after the switch. By December 12, the sun in Berlin sets at 3:52 pm and doesn’t rise until 8:08 am. You might commute in the dark, spend all day inside, and commute home in the dark, so it’s possible to go all week without seeing daylight. The grey Berlin winters really affect my mood, so I take this seriously.</p><p>The solution is in your calendar.</p><h2>Now what?</h2><ul><li>Keep your wake time on Monday. Set the alarm for your usual clock time.</li></ul><ul><li>Schedule time outside for daylight, just like you would book a meeting. Try to get outside around lunch every workday, since by December, that might be the only daylight you see between two dark commutes. Take a walk during a call, and choose a length you can stick with.</li></ul><ul><li>If winter affects your mood, try using a UV-free light box at breakfast. I wrote about my experience with one on October 11. For people diagnosed with winter depression, light boxes worked better than placebo in 19 small randomized trials. If you have bipolar disorder, an eye condition, or take medicines that make you sensitive to light, talk to your doctor first.</li></ul><ul><li>Know when to seek help. If you feel low most days for two weeks or more, or lose interest in things you usually enjoy, it’s time to see a doctor.</li></ul><p>Stay healthy.</p><p>Andre</p>]]></content:encoded>
</item>
<item>
<title><![CDATA[I pushed through. My right tonsil didn’t.]]></title>
<description><![CDATA[Working while sick, winter infections, flu vaccination and the evidence on supplements.]]></description>
<link>https://www.andreheeg.com/archive/i-pushed-through-my-right-tonsil-didnt</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/i-pushed-through-my-right-tonsil-didnt</guid>
<pubDate>Sun, 18 Oct 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>It started in my right ear.</p><p>Over the weekend, my ear canal swelled so much it was nearly closed. It was painful, but I ignored it, as usual.</p><p>By Tuesday, swallowing hurt. I stood at the bathroom sink, held a lamp into my mouth, and checked my own throat. The right side looked swollen and shiny, and behind my right tonsil was a large swelling I’d only seen in patients before.</p><p>As a maxillofacial surgeon, I’ve examined countless throats. But tonsils are the ENT doctors’ territory, and I always warn against doctors diagnosing themselves in the mirror. So I saw an ENT colleague.</p><p>On the first day, he found a large swelling but no obvious sign of infection. I had no fever and could open my mouth as usual. He treated the swelling, it got better for a day, and I went back to work.</p><p>By Thursday, the swelling was back and even worse. He took one look and said, &quot;Yeah, now it's fully there.&quot; Peritonsillitis. The infection had spread into the tissue around the tonsil, which can be the step before an abscess [1].</p><p>He gave me two choices: go to the hospital and have my tonsils removed right away, or take high-dose antibiotics and check again in a day or two. I’m just like any other patient, and chose to avoid the hospital bed. Without an abscess, that’s also the usual first step [1].</p><p>Two days later, the pain was gone. I knew I’d be fine.</p><p>Last November, I wrote here that I rarely get sick. This time, I wasn’t so lucky. And winter hasn’t even started yet. Flu season is coming, the kids will soon be swapping viruses at school, and my calendar is packed with dinners and meetings. Here’s what I’d tell a friend: why pushing through, what many of us tend to do, deserves a second thought, what’s worth doing this winter, and what isn’t.</p><h2>Two rounds at the Wiesn</h2><p>I think it probably started in Munich.</p><p>Every year I host a table at Bits &amp; Pretzels, the startup conference that runs during Oktoberfest. Founders pick which table they join, and there are two rounds. Mine always fills up with people building health care and medical science companies. They ask about business models and the market, and I get to hear what they're working on. I love it.</p><p>Part of the day is spent in a beer tent. I grew up in Bavaria and go to the “Wiesn” every year. Maybe it’s just in my nature, like birds migrating.</p><p>In Munich, there’s even a name for what people catch at the tents: the Wiesn flu. It’s whatever bug is spreading in the loudest, most crowded room of the year.</p><p>Most years, I avoid it. This year, I came home with what felt like a cold. It wasn’t bad enough to stop me, so I kept going. I think the throat infection started from that cold, though I can’t be sure.</p><p>I’ve had tonsil infections on and off since I was a teenager, so my throat has always been my weak spot.</p><h2>The loudest room of the year</h2><p>The tent is like an extreme version of any crowded winter room. After the 2022 Oktoberfest, the first after the pandemic break, COVID-19 cases in Munich rose during and after the festival, mostly among people aged 15 to 59 [2].</p><p>Shouting is part of the problem. Speaking loudly releases about ten times more particles than speaking quietly [3]. These are just particles, not actual viruses being counted. Now imagine a brass band, thousands of people, and an afternoon spent on the benches.</p><p>Beer is the other factor. In one study, 15 healthy volunteers drank about 60 grams of alcohol in 20 minutes. That’s about three to four and a half regular beers, depending on the size. Two hours later, their monocytes, which are key immune cells, had dropped by almost a third, and were still low five hours later [4]. The study only measured blood cells, not infections, so we don’t know how much this matters. Alcohol also disrupts the second half of your night’s sleep [5], and sleep is important here. I’ll get to that below.</p><p>Even without the beer and dancing on tables, the same risks apply in a packed restaurant, a bar, a classroom, or a meeting room where a dozen people talk over each other for two hours with the windows closed.</p><p><strong>The doctor's take:</strong> Last Sunday, I wrote that no amount of alcohol has been shown to help you live longer, and I still believe that. I still go to the Wiesn, and I still enjoy a glass of wine with friends at dinner. I drink to enjoy time with people I care about, not to end up asleep behind the tents. For me, the evening is worth the cost, and I accept that.</p><h2>The mat across the hallway</h2><p>This week, I didn’t work out. That hardly ever happens.</p><p>My gym in Berlin is just a spare room across the hall. I got up at my usual time, rolled out a mat, and moved a little, like slow shoulder exercises and some gentle mobility. No weights, no cardio. It was the right decision.</p><p>We have three kids, and with winter coming, we know what’s ahead. School and kindergarten kids catch everything, and the more kids you have, the more often those bugs come home. This time, I was the one who brought it in.</p><h2>Why we keep going anyway</h2><p>I pushed through twice. First with the cold after Munich, then by going back to work while the swelling was still there. I’ll never know if resting sooner would have made a difference.</p><p>In a study of 12,935 Danish workers, more than 70% went to work sick at least once a year. People with a supervisory role or more than 45 hours a week were more likely to do it [6]. In northwestern Europe, 52% of self-employed people said they worked while sick, compared with 44% of employees [7].</p><p>And it's linked to more sick leave later. In a Swedish study of more than 6,000 workers, those who went in sick more than five times a year were 40 to 51% more likely to need over 30 days of sick leave later [8].</p><p>It also costs the people around you. In experimental colds, the virus in the nose peaked on the second day after infection [9]. When US workers got access to paid sick leave, flu-like illness dropped by roughly 5 to 6% [10].</p><p>It’s the same with training. The old “neck check” says symptoms above the neck are okay. The International Olympic Committee says that’s just expert opinion with little research behind it, and if you have a fever, aching muscles, or exhaustion, it recommends rest [11]. And a throat infection on antibiotics is not just a head cold.</p><p>Some throat symptoms are an emergency. The NHS tells people with tonsillitis to call an ambulance or go to the emergency department if [12]:</p><ul><li>you have a severe sore throat that quickly gets worse</li></ul><ul><li>you have swelling inside the mouth and throat</li></ul><ul><li>you have difficulty speaking, breathing or opening your mouth</li></ul><ul><li>you cannot swallow</li></ul><p>Pay attention to your ears as well. The nerve that goes to the tonsils also supplies the middle ear [13], so throat problems often show up as earache on the same side [14]. I’m not sure if that explains my swollen ear canal, but I do know I ignored it.</p><p><strong>The doctor's take:</strong> Let’s be honest. Most of you won’t take a week off for a cold, and sometimes you really can’t. So make the illness as small as possible. Stay home while you have a fever and until you’re clearly getting better. If you need to work and feel up to it, work from home. Cancel dinner plans, but keep the call. Skip the gym until your fever is gone and you feel better, then ease back in. If you’re a leader, remember your team pays more attention to what you do when you’re sick than what you say about it. If you have a one-sided sore throat or an earache on the same side, see a doctor that day.</p><h2>What's worth doing this winter</h2><p><strong>Let fresh air in.</strong> In a study of office workers, those in areas with lower fresh-air supply took about 50% more short-term sick leave [15]. That's an association, not proof. Germany's Federal Environment Agency tells schools to open windows wide every 20 minutes for three to five minutes in winter and to keep carbon dioxide at or below 1,000 ppm [16]. A cheap CO2 monitor tells you when a meeting room needs it.</p><p><strong>Protect your sleep.</strong> In a study where researchers intentionally exposed 164 adults to a cold virus, those who slept less than six hours had about four times the odds of getting sick than those who slept more than seven [17]. The study was small: only 22 people slept more than seven hours.</p><p><strong>Consider the flu shot.</strong> In a Cochrane review of healthy adults, 2.3% of unvaccinated people caught confirmed flu, compared with 0.9% of vaccinated people. In those trials, you had to vaccinate 71 people to prevent one case. The same review found no clear drop in hospital stays or work days lost [18].</p><p>Germany's vaccine committee STIKO recommends it from age 60, and at any age for chronic conditions such as diabetes or asthma, pregnancy, medical staff, and anyone who lives with someone at higher risk [19]. The US CDC recommends it for everyone from 6 months [20].</p><p>If you get it, sleep well around it. In a small study, young men who slept four hours a night around their shot had less than half the antibodies of normal sleepers ten days later. After three to four weeks the difference had faded [21].</p><p><strong>The doctor's take:</strong> I usually get the flu shot. When I worked in the hospital, I got it every year because I didn’t want to bring the flu to patients who were more vulnerable than me. For a healthy adult like me, the personal benefit is sometimes small. Now, the people I want to protect are at my own breakfast table.</p><p><strong>Wash your hands.</strong> In trials with more than 52,000 people, better hand hygiene reduced respiratory infections from 380 to 327 per 1,000 people [22]. That's about one in seven infections avoided. Modest, but it costs you nothing.</p><p><strong>Keep moving.</strong> In studies with over 557,000 people, those who got at least 150 minutes of activity a week had about a third lower risk of everyday infections [23]. That’s just a link, not proof. In trials, exercise didn’t change how often people caught a respiratory infection, but the illness was milder and people had fewer sick days overall, though the evidence is weak [24]. Exercise probably won’t stop you from catching a cold, but I still think it’s one of the best things you can do for your health. That’s a hill I’m willing to die on.</p><p><strong>If you smoke, stop.</strong> In a Danish study, smokers had about two to five times the odds of a peritonsillar abscess, depending on age [25]. This can't be said enough: if you smoke, quitting beats everything else on this list.</p><p>In my Upward ARC framework, most of this falls under Activate: sleep, movement, and the daily habits you can control. Recover is the other half, knowing when to stop.</p><h2>What isn't worth buying</h2><p><strong>Vitamin C.</strong> Taken every day, it didn't prevent colds in the general population. It shortened adult colds by about 8% [26], about half a day on a seven-day cold. Starting it after the cold began showed no consistent effect.</p><p><strong>Vitamin D.</strong> In the main analysis of a 2025 review, 40 trials with 61,589 people, it showed no clear drop in respiratory infections [27]. If your doctor finds a real deficiency, treat it. As winter insurance, it doesn't hold up.</p><p><strong>Zinc</strong> made little or no difference to catching colds [28]. For treatment, the theory is that zinc ions released in the mouth and throat act right where the virus sits. That's why lozenges you let dissolve, not tablets. Three early trials of zinc acetate lozenges found colds about 40% shorter [29]. A later trial of a commercial zinc acetate lozenge found no difference, and more side effects [30]. If you still want to try it, lozenges are what the positive trials used. Don't expect miracles.</p><p><strong>Echinacea.</strong> The products vary too much to compare, and the results are small and inconsistent [31]. Many of the &quot;immune&quot; sachets at the pharmacy mix these same ingredients.</p><h2>Try this today</h2><ul><li><strong>Open the window</strong> in your next long meeting, wide, for a few minutes every 20 minutes or so.</li></ul><ul><li><strong>Protect your sleep</strong> through conference season and year-end dinners. Aim for seven hours.</li></ul><ul><li><strong>If you're getting a flu shot,</strong> book it for a week without overnight flights, and sleep normally the nights around it.</li></ul><ul><li><strong>Stay home while you have a fever</strong> and until you're clearly getting better. If you have to work and feel up to it, work from home.</li></ul><ul><li><strong>Know the throat red flags.</strong> If you cannot swallow, struggle to breathe, speak or open your mouth, or see swelling inside your mouth and throat: emergency department now. A one-sided sore throat or an earache on the same side: see a doctor today.</li></ul><h2>Next year’s migration</h2><p>Next September, I’ll be back at my table in the tent. Pretty sure about that. I’ll keep an eye on the beer and make sure I get enough sleep. And if I come home feeling a bit off, I’ll try to stay home.</p><p>When was the last time you pushed through something you should have stayed home for? Reply and let me know. I read every message.</p><p>Stay healthy.</p><p>Andre</p><p>PS: Forward this to the colleague who always comes to the office with a cold. That's how this newsletter grows, and it's the only way I want it to.</p><p>PPS: If a friend sent you this, you can get Under Load, my Sunday edition, here: <a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a></p><div><hr></div><h2>References</h2><p>[1] Cheng, A. G. (2026, June). Peritonsillar abscess and cellulitis. <em>MSD Manual Professional Version</em>. <a href="https://www.msdmanuals.com/professional/ear-nose-and-throat-disorders/oral-and-pharyngeal-disorders/peritonsillar-abscess-and-cellulitis" rel="external">https://www.msdmanuals.com/professional/ear-nose-and-throat-disorders/oral-and-pharyngeal-disorders/peritonsillar-abscess-and-cellulitis</a></p><p>[2] Herold, D., Klotz, P.-A., &amp; Schäfer, J. T. (2025). Munich goes viral: Measuring the impact of the Oktoberfest on COVID-19 infection rates using difference-in-differences. <em>Health Policy, 157</em>, 105332. <a href="https://doi.org/10.1016/j.healthpol.2025.105332" rel="external">https://doi.org/10.1016/j.healthpol.2025.105332</a></p><p>[3] Asadi, S., Wexler, A. S., Cappa, C. D., Barreda, S., Bouvier, N. M., &amp; Ristenpart, W. D. (2019). Aerosol emission and superemission during human speech increase with voice loudness. <em>Scientific Reports, 9</em>, 2348. <a href="https://doi.org/10.1038/s41598-019-38808-z" rel="external">https://doi.org/10.1038/s41598-019-38808-z</a></p><p>[4] Afshar, M., Richards, S., Mann, D., Cross, A., Smith, G. B., Netzer, G., Kovacs, E., &amp; Hasday, J. (2015). Acute immunomodulatory effects of binge alcohol ingestion. <em>Alcohol, 49</em>(1), 57–64. <a href="https://doi.org/10.1016/j.alcohol.2014.10.002" rel="external">https://doi.org/10.1016/j.alcohol.2014.10.002</a></p><p>[5] Ebrahim, I. O., Shapiro, C. M., Williams, A. J., &amp; Fenwick, P. B. (2013). Alcohol and sleep I: Effects on normal sleep. <em>Alcoholism: Clinical and Experimental Research, 37</em>(4), 539–549. <a href="https://doi.org/10.1111/acer.12006" rel="external">https://doi.org/10.1111/acer.12006</a></p><p>[6] Hansen, C. D., &amp; Andersen, J. H. (2008). Going ill to work—What personal circumstances, attitudes and work-related factors are associated with sickness presenteeism? <em>Social Science &amp; Medicine, 67</em>(6), 956–964. <a href="https://doi.org/10.1016/j.socscimed.2008.05.022" rel="external">https://doi.org/10.1016/j.socscimed.2008.05.022</a></p><p>[7] Nordenmark, M., Hagqvist, E., &amp; Vinberg, S. (2019). Sickness presenteeism among the self-employed and employed in Northwestern Europe: The importance of time demands. <em>Safety and Health at Work, 10</em>(2), 224–228. <a href="https://doi.org/10.1016/j.shaw.2019.01.003" rel="external">https://doi.org/10.1016/j.shaw.2019.01.003</a></p><p>[8] Bergström, G., Bodin, L., Hagberg, J., Aronsson, G., &amp; Josephson, M. (2009). Sickness presenteeism today, sickness absenteeism tomorrow? A prospective study on sickness presenteeism and future sickness absenteeism. <em>Journal of Occupational and Environmental Medicine, 51</em>(6), 629–638. <a href="https://doi.org/10.1097/JOM.0b013e3181a8281b" rel="external">https://doi.org/10.1097/JOM.0b013e3181a8281b</a></p><p>[9] Heikkinen, T., &amp; Järvinen, A. (2003). The common cold. <em>The Lancet, 361</em>(9351), 51–59. <a href="https://doi.org/10.1016/S0140-6736(03)12162-9" rel="external">https://doi.org/10.1016/S0140-6736(03)12162-9</a></p><p>[10] Pichler, S., &amp; Ziebarth, N. R. (2017). The pros and cons of sick pay schemes: Testing for contagious presenteeism and noncontagious absenteeism behavior. <em>Journal of Public Economics, 156</em>, 14–33. <a href="https://doi.org/10.1016/j.jpubeco.2017.07.003" rel="external">https://doi.org/10.1016/j.jpubeco.2017.07.003</a></p><p>[11] Schwellnus, M., Adami, P. E., Bougault, V., Budgett, R., Clemm, H. H., Derman, W., Erdener, U., Fitch, K., Hull, J. H., McIntosh, C., Meyer, T., Pedersen, L., Pyne, D. B., Reier-Nilsen, T., Schobersberger, W., Schumacher, Y. O., Sewry, N., Soligard, T., Valtonen, M., ... Engebretsen, L. (2022). International Olympic Committee (IOC) consensus statement on acute respiratory illness in athletes part 1: Acute respiratory infections. <em>British Journal of Sports Medicine, 56</em>(19), 1066–1088. <a href="https://doi.org/10.1136/bjsports-2022-105759" rel="external">https://doi.org/10.1136/bjsports-2022-105759</a></p><p>[12] National Health Service. (2024). <em>Tonsillitis</em>. Page last reviewed 8 March 2024. <a href="https://www.nhs.uk/conditions/tonsillitis/" rel="external">https://www.nhs.uk/conditions/tonsillitis/</a></p><p>[13] Earwood, J. S., Rogers, T. S., &amp; Rathjen, N. A. (2018). Ear pain: Diagnosing common and uncommon causes. <em>American Family Physician, 97</em>(1), 20–27. <a href="https://www.aafp.org/pubs/afp/issues/2018/0101/p20.html" rel="external">https://www.aafp.org/pubs/afp/issues/2018/0101/p20.html</a></p><p>[14] Galioto, N. J. (2017). Peritonsillar abscess. <em>American Family Physician, 95</em>(8), 501–506. <a href="https://www.aafp.org/pubs/afp/issues/2017/0415/p501.html" rel="external">https://www.aafp.org/pubs/afp/issues/2017/0415/p501.html</a></p><p>[15] Milton, D. K., Glencross, P. M., &amp; Walters, M. D. (2000). Risk of sick leave associated with outdoor air supply rate, humidification, and occupant complaints. <em>Indoor Air, 10</em>(4), 212–221. <a href="https://doi.org/10.1034/j.1600-0668.2000.010004212.x" rel="external">https://doi.org/10.1034/j.1600-0668.2000.010004212.x</a></p><p>[16] Umweltbundesamt. (2021, December 22). <em>Richtig lüften in Schulen</em>. <a href="https://www.umweltbundesamt.de/richtig-lueften-in-schulen" rel="external">https://www.umweltbundesamt.de/richtig-lueften-in-schulen</a></p><p>[17] Prather, A. A., Janicki-Deverts, D., Hall, M. H., &amp; Cohen, S. (2015). Behaviorally assessed sleep and susceptibility to the common cold. <em>Sleep, 38</em>(9), 1353–1359. <a href="https://doi.org/10.5665/sleep.4968" rel="external">https://doi.org/10.5665/sleep.4968</a></p><p>[18] Demicheli, V., Jefferson, T., Ferroni, E., Rivetti, A., &amp; Di Pietrantonj, C. (2018). Vaccines for preventing influenza in healthy adults. <em>Cochrane Database of Systematic Reviews, 2018</em>(2), CD001269. <a href="https://doi.org/10.1002/14651858.CD001269.pub6" rel="external">https://doi.org/10.1002/14651858.CD001269.pub6</a></p><p>[19] Kassenärztliche Bundesvereinigung. (2026, September). <em>Informationen und Hinweise zur saisonalen Influenzaimpfung</em> [PraxisInfo]. <a href="https://www.kbv.de/documents/infothek/publikationen/praxisinfo/praxisinfo-grippeschutzimpfung.pdf" rel="external">https://www.kbv.de/documents/infothek/publikationen/praxisinfo/praxisinfo-grippeschutzimpfung.pdf</a></p><p>[20] Centers for Disease Control and Prevention. (2025, September 18). <em>Who needs a flu vaccine</em>. <a href="https://www.cdc.gov/flu/vaccines/vaccinations.html" rel="external">https://www.cdc.gov/flu/vaccines/vaccinations.html</a></p><p>[21] Spiegel, K., Sheridan, J. F., &amp; Van Cauter, E. (2002). Effect of sleep deprivation on response to immunization. <em>JAMA, 288</em>(12), 1471–1472. <a href="https://doi.org/10.1001/jama.288.12.1471-a" rel="external">https://doi.org/10.1001/jama.288.12.1471-a</a></p><p>[22] Jefferson, T., Dooley, L., Ferroni, E., Al-Ansary, L. A., van Driel, M. L., Bawazeer, G. A., Jones, M. A., Hoffmann, T. C., Clark, J., Beller, E. M., Glasziou, P. P., &amp; Conly, J. M. (2023). Physical interventions to interrupt or reduce the spread of respiratory viruses. <em>Cochrane Database of Systematic Reviews, 2023</em>(1), CD006207. <a href="https://doi.org/10.1002/14651858.CD006207.pub6" rel="external">https://doi.org/10.1002/14651858.CD006207.pub6</a></p><p>[23] Chastin, S. F. M., Abaraogu, U., Bourgois, J. G., Dall, P. M., Darnborough, J., Duncan, E., Dumortier, J., Jiménez Pavón, D., McParland, J., Roberts, N. J., &amp; Hamer, M. (2021). Effects of regular physical activity on the immune system, vaccination and risk of community-acquired infectious disease in the general population: Systematic review and meta-analysis. <em>Sports Medicine, 51</em>(8), 1673–1686. <a href="https://doi.org/10.1007/s40279-021-01466-1" rel="external">https://doi.org/10.1007/s40279-021-01466-1</a></p><p>[24] Grande, A. J., Keogh, J., Silva, V., &amp; Scott, A. M. (2020). Exercise versus no exercise for the occurrence, severity, and duration of acute respiratory infections. <em>Cochrane Database of Systematic Reviews, 4</em>, CD010596. <a href="https://doi.org/10.1002/14651858.CD010596.pub3" rel="external">https://doi.org/10.1002/14651858.CD010596.pub3</a></p><p>[25] Klug, T. E., Rusan, M., Clemmensen, K. K. B., Fuursted, K., &amp; Ovesen, T. (2013). Smoking promotes peritonsillar abscess. <em>European Archives of Oto-Rhino-Laryngology, 270</em>(12), 3163–3167. <a href="https://doi.org/10.1007/s00405-013-2474-4" rel="external">https://doi.org/10.1007/s00405-013-2474-4</a></p><p>[26] Hemilä, H., &amp; Chalker, E. (2013). Vitamin C for preventing and treating the common cold. <em>Cochrane Database of Systematic Reviews, 2013</em>(1), CD000980. <a href="https://doi.org/10.1002/14651858.CD000980.pub4" rel="external">https://doi.org/10.1002/14651858.CD000980.pub4</a></p><p>[27] Jolliffe, D. A., Camargo, C. A., Sluyter, J. D., Aglipay, M., Aloia, J. F., Bergman, P., Bischoff-Ferrari, H. A., Borzutzky, A., Bubes, V. Y., Damsgaard, C. T., Ducharme, F. M., Dubnov-Raz, G., Esposito, S., Ganmaa, D., Gilham, C., Ginde, A. A., Golan-Tripto, I., Goodall, E. C., Grant, C. C., ... Martineau, A. R. (2025). Vitamin D supplementation to prevent acute respiratory infections: Systematic review and meta-analysis of stratified aggregate data. <em>The Lancet Diabetes &amp; Endocrinology, 13</em>(4), 307–320. <a href="https://doi.org/10.1016/S2213-8587(24)00348-6" rel="external">https://doi.org/10.1016/S2213-8587(24)00348-6</a></p><p>[28] Nault, D., Machingo, T. A., Shipper, A. G., Antiporta, D. A., Hamel, C., Nourouzpour, S., Konstantinidis, M., Phillips, E., Lipski, E. A., &amp; Wieland, L. S. (2024). Zinc for prevention and treatment of the common cold. <em>Cochrane Database of Systematic Reviews, 2024</em>(5), CD014914. <a href="https://doi.org/10.1002/14651858.CD014914.pub2" rel="external">https://doi.org/10.1002/14651858.CD014914.pub2</a></p><p>[29] Hemilä, H. (2017). Zinc lozenges and the common cold: A meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. <em>JRSM Open, 8</em>(5), 2054270417694291. <a href="https://doi.org/10.1177/2054270417694291" rel="external">https://doi.org/10.1177/2054270417694291</a></p><p>[30] Hemilä, H., Haukka, J., Alho, M., Vahtera, J., &amp; Kivimäki, M. (2020). Zinc acetate lozenges for the treatment of the common cold: A randomised controlled trial. <em>BMJ Open, 10</em>(1), e031662. <a href="https://doi.org/10.1136/bmjopen-2019-031662" rel="external">https://doi.org/10.1136/bmjopen-2019-031662</a></p><p>[31] Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R., Ardjomand-Woelkart, K., &amp; Linde, K. (2014). Echinacea for preventing and treating the common cold. <em>Cochrane Database of Systematic Reviews, 2014</em>(2), CD000530. <a href="https://doi.org/10.1002/14651858.CD000530.pub3" rel="external">https://doi.org/10.1002/14651858.CD000530.pub3</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated October 23, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>German flu-vaccination recommendations:</strong> The pregnancy recommendation starts in the second trimester, or the first when an underlying condition increases risk. Influenza vaccines can be used from six months of age; the phrase “at any age” in the original edition should be read with that lower age limit. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.rki.de/SharedDocs/FAQs/DE/Impfen/Influenza/FAQ-Liste_gesamt.html?nn=16779962" rel="external">Robert Koch Institute (2026). Answers to frequently asked questions about seasonal influenza vaccination. Updated 10 September 2026.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/winter-infections-flu-vaccines-and-supplements">Winter Infections, Flu Vaccines and Supplements →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[38% had a pitch. 9% named a source.]]></title>
<description><![CDATA[Commercial promotion and source citation in health and wellness posts.]]></description>
<link>https://www.andreheeg.com/archive/38-had-a-pitch-9-named-a-source</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/38-had-a-pitch-9-named-a-source</guid>
<pubDate>Wed, 14 Oct 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>Last Sunday, I shared how I tried to track down the numbers in a health book whose author I quoted for years. Out of 47 protocols, 22 gave specific amounts (minutes, grams, or degrees) that I couldn’t link to any study. Just a week ago, Pew Research Center released a report on where many of us now pick up health advice.</p><h2>What?</h2><p>Pew looked at over half a million<a href="https://www.pewresearch.org/data-labs/2026/10/07/what-do-health-and-wellness-influencers-post-about/" rel="external">Instagram, TikTok, and YouTube posts</a> from February to April this year. These posts came from more than 6,000 health and wellness influencers, each with at least 100,000 followers. They found that 38% of the posts promoted a product, service, or subscription, and only 9% mentioned an outside source when making a health claim.</p><p>Supplements topped the list. About 66% of posts about supplements and over-the-counter medicines promoted something. The same was true for 52% of posts about longevity and 52% about nutrition.</p><p>This study has some limits. The accounts target a US audience, and an AI sorted the posts, and its results were checked against 600 posts reviewed by people. Pew only counted if a source was named. They didn’t check if the claims were true.</p><h2>So what?</h2><p>That last limit matters most.</p><p>Having a named source is just the first step in checking information. The book I reviewed lists about 1,730 references, yet it still gives doses I couldn’t trace to any study. Even if a post cites a source, it can still be wrong. If there’s no source, you have nothing to verify.</p><p>A sales pitch might still be accurate, but it also shows you who benefits if you believe it.</p><p>Medical tests can get costly. A<a href="https://doi.org/10.1001/jamanetworkopen.2024.61940" rel="external">2025 study in JAMA Network Open</a> looked at 982 Instagram and TikTok posts about five tests, like full-body MRIs and testosterone. They found that 87% mentioned a benefit, 15% mentioned a harm, and only 6% talked about overdiagnosis or overuse. Overdiagnosis means finding something real that would never have caused you any trouble. About 68% of the accounts had a financial interest. Posts from doctors were more likely to mention the risks.</p><p>If a test finds something, it can lead to more scans, referrals, and weeks of worry. Most posts don’t show you that side.</p><h2>Now what?</h2><p>Before you let a post influence what you buy, take, or test, ask yourself three questions.</p><ul><li>Who profits if I believe this? Check for things like a discount code, an affiliate link, or a clinic booking page.</li></ul><ul><li>Is there a specific study, and did it test this dose on people like me? Look up the study name and the number. If the number isn’t in the study, it’s just someone’s guess.</li></ul><ul><li>Who shouldn’t use this? If a post doesn’t mention any downsides or who should avoid it, you’re only seeing the sales pitch. For any test or drug, ask your doctor before you decide.</li></ul><p>All three may take more time than the video, but they’re worth it.</p><p>Stay healthy.</p><p>Andre</p>]]></content:encoded>
</item>
<item>
<title><![CDATA[Ten Minutes of Morning Sun. I Went Looking for the Study.]]></title>
<description><![CDATA[Morning light, caffeine, alcohol and strength training, with the research and limits behind the numbers.]]></description>
<link>https://www.andreheeg.com/archive/ten-minutes-of-morning-sun-i-went-looking-for-the-study</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/ten-minutes-of-morning-sun-i-went-looking-for-the-study</guid>
<pubDate>Sun, 11 Oct 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>For years I've told people the same thing. Get outside in the morning. Move. Catch some daylight.</p><p>It's one of the few things I can suggest with hardly any risk. I never actually looked into it. It sounded reasonable, seemed safe, and came from a Stanford professor whose podcast I had followed for years.</p><p>His book, Protocols, was released on September 15. I pre-ordered it in April last year, as soon as the release date was announced. On his podcast, he described it as his life's work, putting everything he had learned about the human body into one book.</p><p>When my copy arrived, I started reading right away. After about 20 pages, I paused and realized I should have asked myself an important question much earlier.</p><p>The book gives a specific dose for morning light: five to ten minutes on a clear day, fifteen if it's cloudy, and thirty if it's heavily overcast, all within the first hour after waking. I had shared some version of these numbers for years. Some of my advice came straight from his podcast. I just assumed every number was backed by a study.</p><p>I never questioned where those numbers actually came from.</p><p>So I decided to find out.</p><h2>Where I'm coming from</h2><p>Andrew Huberman has done something unusual for a scientist: he brought lab science into everyday life. In my circle, people often quote his episodes, and many have started paying more attention to their sleep, light, and exercise because of him. He’s been at this for years. I’m newer to this conversation, and I’m not offering new science. What I can add is a doctor’s perspective and a busy person's perspective. The seven habits I share at the end of this piece all come from his book’s protocols. Most of my questions were about the numbers.</p><p>A book for the public needs to keep things simple. I do the same in this newsletter. If I qualified every sentence like a research paper, no one would keep reading.</p><p>&quot;Get daylight in the morning&quot; is a broad stroke. &quot;5 to 10 minutes, 15 if it's cloudy&quot; is a dose. A dose sounds more precise, like someone tested it.</p><p>We all run on n=1, me included. I wanted to find out which parts of the book are backed by research, and which are just one person’s routine.</p><h2>Twenty pages became a month</h2><p>The book includes 47 protocols. Its notes list 1,126 numbered entries and about 1,730 references, with some repeats. Tracking all of that by hand would take a team months, so I used AI.</p><p>The AI matched each reference to its protocol, found 1,243 different papers in PubMed (the main medical research database), and I pulled 438 Huberman Lab podcast transcripts. Then I reviewed all 47 protocols myself, one by one, and confirmed each result. Because the searches were focused, I call this a physician’s audit, with plenty of tech help.</p><p>PubMed marks 109 of those 1,243 papers as randomized trials, which is about one in eleven. At least 99 were animal studies. These tags might miss some studies, so consider these numbers as minimums. This count just describes the references; it doesn’t judge each claim.</p><p>Out of the 47 protocols, 22 give a specific number of minutes, grams, or degrees that I couldn’t find any study to support.</p><p>Next, I added up the time. For each protocol, I estimated how many minutes it would take per week if you followed it exactly. The total came to 32 hours a week.</p><p>That number isn’t entirely fair to the book. Some actions are counted twice, one is a writing exercise you do only once, and another applies only after a loss. Even after removing those, you’d still need 25 hours a week, or about three and a half hours a day.</p><p>No one is expected to do all 47 protocols. You still have to choose what works for you. My sorting has 13 to keep, 18 worth trying, 7 that depend on your situation, and 9 I’d skip.</p><h2>Where the minutes came from</h2><p>The research behind morning light is real. In the UK Biobank, more than 400,000 adults reported how long they spent outdoors in daylight. Each extra hour went with lower odds of depression and fewer insomnia symptoms [1]. In 88,905 people who wore a light sensor for a week, those with the brightest days had lower mortality over the next 8 years. Those with the brightest nights had higher mortality [2].</p><p>Both studies are observational, so they can’t prove cause and effect. People who spend more time outside are often healthier for other reasons. Both studies measured light exposure over the whole day.</p><p>What I couldn’t find was any study testing those exact minutes. No research compared 5, 15, and 30 minutes based on cloud cover, or looked at the first hour after waking.</p><p>The claim about cortisol was even less solid. The book says morning sunlight can raise your cortisol peak by up to 50%. The first study it cites for this is a lab experiment with eight men who stayed awake all night, then sat under bright lab lights for three hours starting at 5 a.m. [3]. That’s a real result, but it’s very different from spending ten minutes on your balcony.</p><p>A reader texted me this week: &quot;9 months out of the year, I get up in darkness. How important is this?&quot;</p><p>It’s less important than the stopwatch suggests. And I know the problem too well.</p><p>Berlin has its qualities, but its winters aren’t one of them. In December, it’s dark from around 4 pm until 8 am, and the sky is mostly gray in between. You can go weeks without seeing blue sky. It hits my mood hard.</p><p>So we set up a 10,000 lux daylight lamp on our breakfast table. I work in front of it each morning. I’ve never measured my cortisol, but I feel it helps me get through the Berlin winter. The book also recommends a lamp for dark winters, and I agree.</p><p>The evidence is real, but only for a specific group. In people diagnosed with winter depression, light boxes worked better than placebo across 19 small randomized trials [4]. I don’t have that diagnosis. I just have Berlin.</p><p><strong>The doctor's take:</strong> keep the habit, but don’t worry about the exact timing. Try to get outside in daylight most days, and in the morning if it works for you. The research supports bright days and dark nights. The specific minutes are just someone’s best guess. If you have bipolar disorder or an eye condition, check with your doctor before using a light box.</p><h2>Where my advice differs</h2><p>Coffee first, and here the book and the data mostly agree. The book says to avoid caffeine in the 8 to 10 hours before bed. A meta-analysis of 24 studies found that caffeine cut sleep by 45 minutes, pooled across the doses tested. It estimated that a regular coffee should come at least 8.8 hours before bed [5]. With an 11 pm bedtime, that's about 2 pm.</p><p>Where I’d differ is in the morning. If you tend to crash in the afternoon, the book suggests waiting 30 to 90 minutes after waking before your first cup. I couldn’t find any human trials on that delay. If you enjoy coffee right when you wake up, go ahead and have it.</p><p>Next is alcohol. The book says not to drink any alcohol in the eight hours before sleep. If you go to bed at 11 pm, that means your last drink would be at 3 pm. Most people don’t live that way.</p><p>I’d put it simply: no amount of alcohol has been shown to help you live longer. In 107 studies with more than 4.8 million people, drinking up to 24 grams a day (about two drinks) didn’t lower mortality compared to never drinking. At 45 grams a day, the risk was 19% higher; at 65 grams, 35% higher. For women, the risk started at even lower amounts [6].</p><p>Even one drink a day is linked to a higher cancer risk. The risk of one type of esophageal cancer goes up by 30%, mouth and throat cancer by 17%, and breast cancer in women by 5% [7]. These are relative increases, and the absolute risks remain small. Drinking also affects sleep: from about two drinks, REM sleep decreases [8].</p><p>Now for strength training. The protocol recommends three sessions a week, about an hour each. But a meta-analysis of cohort studies found the lowest mortality risk with just 30 to 60 minutes of strength training per week. More than that, the effect is unclear [9]. Two whole-body sessions of 20 to 30 minutes each are enough.</p><p>Personally, I do more than that.</p><h2>My n of 1</h2><p>I train six to seven hours a week. Almost every morning I'm up between 5:30 and 6 and in the gym for an hour.</p><p>That’s at least six times more than what the mortality data suggests. I started wrestling at six, made the youth national team, and won a national title. For as long as I can remember, training has helped me relax and start my day right. My hour in the gym is the one constant in my week, and it isn’t going anywhere.</p><p>It’s not easy. We have three kids, and our mornings are often hectic. My wife and I still debate whether to spend that hour helping everyone get ready. We haven’t settled it yet.</p><p>None of this is scientific evidence, but my n=1. I’d stand by it at my kitchen table, but I wouldn’t put it on a prescription pad.</p><p><strong>My doctor’s take:</strong> many of the doses in the book seem like personal routines. I couldn’t find studies to support them. That’s fine as a personal rule, but it becomes a problem when it’s presented as advice for everyone.</p><p>Most health research looks at the average person, but no one is truly average. We all differ in how we sleep, what foods suit us, how warm we like our bedroom, and when we train best. The list goes on. Use studies as a starting point, then see what works for you. If something feels good and helps you, it might be right for you. If it makes you feel worse, stop, no matter what the protocol says.</p><p>One note from me as a doctor: feeling good and being safe aren’t always the same. A nightcap can feel good, and so can a tan. The basics are clear: don’t smoke, don’t get sunburned, and go easy on alcohol. Beyond that, listen to your body. Doing more is fine if you enjoy it. Just be clear about what’s backed by data and what’s your own choice.</p><h2>Where low-risk stops</h2><p>Most of the 47 protocols are low risk. A few aren’t, and that’s where my view as a doctor comes in.</p><p>When I say &quot;try it,&quot; people hear it as advice from a doctor. If something goes wrong, they’ll say the doctor told them to do it. That’s why I consider the risks first. In two cases, the risks outweigh the benefits.</p><p>Warming the bed before you wake. The book says to warm the bedroom in the last one to two hours before waking, and links a warmer body to more REM sleep. A review of temperature and sleep found that with normal bedding, heat increases time awake and reduces REM [10]. I found no test showing that warming up late adds REM. It also requires a heating timer or an expensive mattress cover. Keep the bedroom cool all night.</p><p>Sun on bare skin. The book recommends 20 to 30 minutes of sun on bare skin at least three times a week. It also says sunburn is bad and that you should cover up when the UV index is high. My question was about the reason it gives: that the data showed higher testosterone linked to sun exposure in men and women. I read the study. Most of the paper is in mice. The 19 volunteers who went into the sun had their hormone activity inferred from blood proteins. The measured testosterone came from health records of young men, compared across the seasons. No woman's testosterone was measured [11].</p><p>Without a burn, UV is still UV. The WHO's cancer agency classifies solar radiation as carcinogenic to humans, its strongest level of evidence [12]. Be outside every day. Cover your face and scalp. From a UV index of 3, I use SPF 50.</p><p>The rest of my cut list would take more space than I have today. I’ll share more about the full audit in the coming weeks.</p><h2>Try this today</h2><p>Back to those 25 hours. Here’s what made the cut. Most of these habits don’t take extra time. The training adds about two hours a week. In my Upward ARC framework, almost all of this falls under Activate: sleep, movement, and food.</p><ul><li><strong>Fix your wake time.</strong> Keep it the same time seven days a week, with at least 7 hours in bed. If you can only do one thing, fix the wake time first, then the bedtime. In 60,977 people, the more regular sleepers had 20 to 48% lower mortality than the least regular fifth [13]. That's an association.</li></ul><ul><li><strong>Have your last coffee about nine hours before bed.</strong> Enjoy your morning coffee whenever you want.</li></ul><ul><li><strong>Skip the nightcap.</strong> If you drink, have no more than two drinks, have them early in the evening, and not every night.</li></ul><ul><li><strong>Aim for about 7,000 steps a day.</strong> Compared to 2,000 steps, this was linked to a 47% lower risk of death in a meta-analysis of cohort studies [14]. Try taking calls while walking.</li></ul><ul><li><strong>Do strength training twice a week for 20 to 30 minutes each session.</strong> Focus on whole-body movements: push, pull, squat, hinge, and carry.</li></ul><ul><li><strong>Do cardio twice a week for about 75 minutes total, including one higher-intensity session.</strong> Brisk walking counts toward the WHO’s 150 minutes of moderate activity per week [15]. If you’re inactive, have heart, metabolic, or kidney disease, or get symptoms when you exercise, check with your doctor before doing intense sessions.</li></ul><ul><li><strong>Eat protein and plants, mostly unprocessed foods.</strong> Have protein at every main meal, vegetables at two meals, use olive oil as your main fat, and eat fish twice a week. Cut out sugary drinks, processed meats, and packaged snacks. One tip from my own routine, though not backed by a study: do your shopping and meal prep on the weekend.</li></ul><h2>The light I still recommend</h2><p>I still encourage people to go outside in the morning. I just don’t mention the exact number of minutes anymore.</p><p>For the reader who wakes up in the dark nine months a year: when the sun rises, go for a walk. Research supports getting more daylight throughout the day. If winter affects your mood, try using a lamp at the breakfast table. That’s what works for me, but your experience may be different.</p><p>Is there a health rule you follow but have never actually checked? Reply and let me know. I read every message.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you know someone who follows a morning routine or protocol, please forward this to them. That’s how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If a friend sent you this, you can sign up for Under Load, my Sunday edition, at andreheeg.com.</p><div><hr></div><h2>References</h2><p>[1] Burns, A. C., Saxena, R., Vetter, C., Phillips, A. J. K., Lane, J. M., &amp; Cain, S. W. (2021). Time spent in outdoor light is associated with mood, sleep, and circadian rhythm-related outcomes: A cross-sectional and longitudinal study in over 400,000 UK Biobank participants. <em>Journal of Affective Disorders, 295</em>, 347–352. <a href="https://doi.org/10.1016/j.jad.2021.08.056" rel="external">https://doi.org/10.1016/j.jad.2021.08.056</a></p><p>[2] Windred, D. P., Burns, A. C., Lane, J. M., Olivier, P., Rutter, M. K., Saxena, R., Phillips, A. J. K., &amp; Cain, S. W. (2024). Brighter nights and darker days predict higher mortality risk: A prospective analysis of personal light exposure in &gt;88,000 individuals. <em>Proceedings of the National Academy of Sciences, 121</em>(43), e2405924121. <a href="https://doi.org/10.1073/pnas.2405924121" rel="external">https://doi.org/10.1073/pnas.2405924121</a></p><p>[3] Leproult, R., Colecchia, E. F., L'Hermite-Balériaux, M., &amp; Van Cauter, E. (2001). Transition from dim to bright light in the morning induces an immediate elevation of cortisol levels. <em>Journal of Clinical Endocrinology &amp; Metabolism, 86</em>(1), 151–157. <a href="https://doi.org/10.1210/jcem.86.1.7102" rel="external">https://doi.org/10.1210/jcem.86.1.7102</a></p><p>[4] Pjrek, E., Friedrich, M.-E., Cambioli, L., Dold, M., Jäger, F., Komorowski, A., Lanzenberger, R., Kasper, S., &amp; Winkler, D. (2020). The efficacy of light therapy in the treatment of seasonal affective disorder: A meta-analysis of randomized controlled trials. <em>Psychotherapy and Psychosomatics, 89</em>(1), 17–24. <a href="https://doi.org/10.1159/000502891" rel="external">https://doi.org/10.1159/000502891</a></p><p>[5] Gardiner, C., Weakley, J., Burke, L. M., Roach, G. D., Sargent, C., Maniar, N., Townshend, A., &amp; Halson, S. L. (2023). The effect of caffeine on subsequent sleep: A systematic review and meta-analysis. <em>Sleep Medicine Reviews, 69</em>, 101764. <a href="https://doi.org/10.1016/j.smrv.2023.101764" rel="external">https://doi.org/10.1016/j.smrv.2023.101764</a></p><p>[6] Zhao, J., Stockwell, T., Naimi, T., Churchill, S., Clay, J., &amp; Sherk, A. (2023). Association between daily alcohol intake and risk of all-cause mortality: A systematic review and meta-analyses. <em>JAMA Network Open, 6</em>(3), e236185. <a href="https://doi.org/10.1001/jamanetworkopen.2023.6185" rel="external">https://doi.org/10.1001/jamanetworkopen.2023.6185</a></p><p>[7] Bagnardi, V., Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V., Scotti, L., Jenab, M., Turati, F., Pasquali, E., Pelucchi, C., Bellocco, R., Negri, E., Corrao, G., Rehm, J., Boffetta, P., &amp; La Vecchia, C. (2013). Light alcohol drinking and cancer: A meta-analysis. <em>Annals of Oncology, 24</em>(2), 301–308. <a href="https://doi.org/10.1093/annonc/mds337" rel="external">https://doi.org/10.1093/annonc/mds337</a></p><p>[8] Gardiner, C., Weakley, J., Burke, L. M., Roach, G. D., Sargent, C., Maniar, N., Huynh, M., Miller, D. J., Townshend, A., &amp; Halson, S. L. (2025). The effect of alcohol on subsequent sleep in healthy adults: A systematic review and meta-analysis. <em>Sleep Medicine Reviews, 80</em>, 102030. <a href="https://doi.org/10.1016/j.smrv.2024.102030" rel="external">https://doi.org/10.1016/j.smrv.2024.102030</a></p><p>[9] Momma, H., Kawakami, R., Honda, T., &amp; Sawada, S. S. (2022). Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: A systematic review and meta-analysis of cohort studies. <em>British Journal of Sports Medicine, 56</em>(13), 755–763. <a href="https://doi.org/10.1136/bjsports-2021-105061" rel="external">https://doi.org/10.1136/bjsports-2021-105061</a></p><p>[10] Okamoto-Mizuno, K., &amp; Mizuno, K. (2012). Effects of thermal environment on sleep and circadian rhythm. <em>Journal of Physiological Anthropology, 31</em>, 14. <a href="https://doi.org/10.1186/1880-6805-31-14" rel="external">https://doi.org/10.1186/1880-6805-31-14</a></p><p>[11] Parikh, R., Sorek, E., Parikh, S., Michael, K., Bikovski, L., Tshori, S., Shefer, G., Mingelgreen, S., Zornitzki, T., Knobler, H., Chodick, G., Mardamshina, M., Boonman, A., Kronfeld-Schor, N., Bar-Joseph, H., Ben-Yosef, D., Amir, H., Pavlovsky, M., Matz, H., … Levy, C. (2021). Skin exposure to UVB light induces a skin-brain-gonad axis and sexual behavior. <em>Cell Reports, 36</em>(8), 109579. <a href="https://doi.org/10.1016/j.celrep.2021.109579" rel="external">https://doi.org/10.1016/j.celrep.2021.109579</a></p><p>[12] International Agency for Research on Cancer. (2012). <em>Radiation</em> (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100D). IARC.</p><p>[13] Windred, D. P., Burns, A. C., Lane, J. M., Saxena, R., Rutter, M. K., Cain, S. W., &amp; Phillips, A. J. K. (2024). Sleep regularity is a stronger predictor of mortality risk than sleep duration: A prospective cohort study. <em>Sleep, 47</em>(1), zsad253. <a href="https://doi.org/10.1093/sleep/zsad253" rel="external">https://doi.org/10.1093/sleep/zsad253</a></p><p>[14] Ding, D., Nguyen, B., Nau, T., Luo, M., del Pozo Cruz, B., Dempsey, P. C., Munn, Z., Jefferis, B. J., Sherrington, C., Calleja, E. A., Chong, K. H., Davis, R., Francois, M. E., Tiedemann, A., Biddle, S. J. H., Okely, A., Bauman, A., Ekelund, U., Clare, P., &amp; Owen, K. (2025). Daily steps and health outcomes in adults: A systematic review and dose-response meta-analysis. <em>The Lancet Public Health, 10</em>(8), e668–e681. <a href="https://doi.org/10.1016/S2468-2667(25)00164-1" rel="external">https://doi.org/10.1016/S2468-2667(25)00164-1</a></p><p>[15] Bull, F. C., Al-Ansari, S. S., Biddle, S., Borodulin, K., Buman, M. P., Cardon, G., Carty, C., Chaput, J.-P., Chastin, S., Chou, R., Dempsey, P. C., DiPietro, L., Ekelund, U., Firth, J., Friedenreich, C. M., Garcia, L., Gichu, M., Jago, R., Katzmarzyk, P. T., … Willumsen, J. F. (2020). World Health Organization 2020 guidelines on physical activity and sedentary behaviour. <em>British Journal of Sports Medicine, 54</em>(24), 1451–1462. <a href="https://doi.org/10.1136/bjsports-2020-102955" rel="external">https://doi.org/10.1136/bjsports-2020-102955</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated October 23, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>What the strength-training estimate means:</strong> The 30–60-minute weekly range comes from a meta-analysis of observational cohorts. It does not establish that two 20–30-minute sessions are sufficient for every strength or fitness goal. The schedule in the original edition is a practical suggestion, rather than a program tested by that review. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/35228201/" rel="external">Momma et al. (2022). Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: A systematic review and meta-analysis of cohort studies.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/morning-light-caffeine-and-strength-evidence">Morning Light, Caffeine and Strength: Evidence and Limits →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[People with the most self-control resist less often]]></title>
<description><![CDATA[Practice on a self-control task, immediate feelings after cold exposure and everyday impulse control are different outcomes.]]></description>
<link>https://www.andreheeg.com/archive/people-with-the-most-self-control-resist-less-often</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/people-with-the-most-self-control-resist-less-often</guid>
<pubDate>Wed, 07 Oct 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>On Sunday, I mentioned something Andrew Huberman said on Joe Rogan's podcast and left his claim unresolved. Later, I listened to the episode again and looked into the research.</p><h2>What?</h2><p>I focused on two sentences from that same episode, which came out on September 14.</p><p>The first sentence is the one I quoted: &quot;If I just keep doing really hard things, I'm going to stay in control of my impulses.&quot; I stopped there, but he continues: &quot;As long as I also touch the goodness that's there every day.&quot; This is a personal rule for him, and he doesn't mention any study to back it up.</p><p>The second sentence comes a few minutes earlier, and he presents it as scientific fact. He says, &quot;We know for certain&quot; that putting yourself in a high-adrenaline state &quot;gets you better at dealing with high stress states.&quot; He mentions ice baths, tough workouts, or very hot saunas as examples.</p><h2>So what?</h2><p>&quot;Certain&quot; feels like a strong word for the evidence available.</p><p>Let's look at impulses first. In the most direct study I found, <a href="https://eprints.whiterose.ac.uk/id/eprint/107549/" rel="external">174 people practiced self-control tasks</a> for six weeks, but the training didn't improve any measure of self-control. A <a href="https://journals.sagepub.com/doi/10.1177/1745691617697076" rel="external">2017 meta-analysis of 33 studies</a> found a small-to-medium benefit, but that effect shrank after correcting for publication bias. The most common training lasted two weeks, such as using your non-dominant hand.</p><p>Now for stress. In a <a href="https://www.nature.com/articles/s41598-025-29187-9" rel="external">2025 trial,</a> 404 adults did 29 days of Wim Hof breathing with cold exposure, or meditation. After each session, the cold-exposure groups reported feeling better able to handle stress than the meditators, and this feeling grew over the month. However, heart rate variability, resting heart rate, sleep quality, and fatigue did not differ. Since breathing and cold exposure were combined, the study can't tell which part made the difference.</p><p>People do feel more able to cope right after a session. I believe that, because I feel it myself. Still, that's a long way from being &quot;certain.</p><p>&quot;I'm not here to lecture anyone. A year ago, I wrote that controlled discomfort &quot;makes you more resilient,&quot; but I didn't have a study to back that up either.</p><p>The finding I would actually act on is less exciting. Researchers pinged <a href="https://experts.umn.edu/en/publications/everyday-temptations-an-experience-sampling-study-of-desire-confl/" rel="external">205 adults for a week</a> on a beeper and collected 7,827 desire reports. Those with the most self-control reported weaker desires and didn't have to resist as often. They simply had fewer temptations to fight. This is just an observation, so it doesn't prove that removing temptation works, but that's still where I'd put my money.</p><p>I still take very hot saunas because I enjoy them. But I no longer expect them to help me keep my phone in my pocket.</p><h2>Now what?</h2><ul><li>Think of the one impulse that costs you the most. For me, it's checking my phone when I'm with my kids. Consistent bedtime comes in second.</li></ul><ul><li>Remove the cue for that impulse. For example, put your phone in another room. Leave the charger outside your bedroom.</li></ul><ul><li>Write a simple if-then plan in one sentence. Mine is: &quot;If I'm with the kids, then my phone is in another room or stays in the bag.&quot; In <a href="https://doi.org/10.1080/10463283.2024.2334563" rel="external">642 tests</a>, plans like this worked, and they worked even better when people rehearsed them. So say your plan out loud twice.</li></ul><p>Do the hard thing you enjoy. Then, put your phone somewhere else.</p><p>Stay healthy.</p><p>Andre</p>]]></content:encoded>
</item>
<item>
<title><![CDATA[My kids make things all day. I forgot how.]]></title>
<description><![CDATA[The German panel links reading and maths use with skill trajectories. It does not prove that a particular hobby, hardship challenge or senior role causes cognitive change.]]></description>
<link>https://www.andreheeg.com/archive/my-kids-make-things-all-day-i-forgot-how</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/my-kids-make-things-all-day-i-forgot-how</guid>
<pubDate>Sun, 04 Oct 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>My flight from Berlin to Munich was delayed by an hour. Like most people in the lounge, I just found a seat and waited.</p><p>I opened the October issue of manager magazin. The cover story, “Das große Rauswerfen,” or “the great firing,” says tens of thousands of German executives are losing their jobs right now. [1]</p><p>The numbers back this up. In 2025, Germany had an average of 49,000 unemployed managers, up 14% from the previous year and the highest since 2015. [2] Three days after my flight, BMW announced it would cut its divisions and related management jobs by a fifth by mid-2027. [3] These figures are for Germany; I haven’t checked if it’s the same elsewhere.</p><p>As I read the article, many of these managers spent years coordinating other people's work. They collected reports, passed on updates, and set agendas. Their companies asked them to do exactly that and paid them well for it. Now those layers are being removed. I don't know why any one of them individually lost a job, and I won't guess.</p><p>The article made me reflect. I looked around at people having coffee and snacks and found myself wondering: What am I doing to protect myself from a professional setback?</p><p>I was asking myself this in a lounge, a place designed so we don’t have to stand while waiting at the gate.</p><h2>My kids make things all day</h2><p>The honest answer might be: over the years, I’ve lost the skill of making things.</p><p>I watch my kids do it all day. They make things up. They try something, it fails, and they try again. They aren’t ashamed of any of it. They keep going until they can do it.</p><p>As we grow up, we start shaping how we see ourselves and how we want others to see us. After that, we focus on adding details and perfecting that image.</p><p>A corporate career works the same way. You learn what the job requires, and you get better and better at being a corporate leader. I’ve watched myself do it. It takes skill. It’s also something entirely different from sitting down and creating.</p><p>Getting promoted changes what you do. Now you use skills like making decisions, judging people, and handling conflict every day. Other skills quietly disappear from your routine. Someone else builds the first version or runs the first analysis.</p><p>By Friday, you can feel exhausted without having made anything yourself.</p><p>Last Sunday, I wrote about friends who are counting down their remaining working years. During that hour in the lounge, I asked myself a more specific question: What can the people around me still make themselves?</p><p>I believe that if you stop using a skill, it fades. I also think my approach to this has been wrong. Let me explain both points.</p><h2>Use it or lose it</h2><p>In 2025, 4 economists published the best data I found on this. [4]</p><p>A representative sample of German adults aged 16 to 65 took a reading test and a math test. About 3.5 years later, 3,263 of them took the tests again. On average, skills kept improving well into midlife. Reading peaked at age 46 and math at 41. That’s good news if you’re 45 and feel slower than before.</p><p>The researchers also asked how often people used these skills at work and at home. For math, this included things like calculating budgets, making charts and tables, and using formulas. For reading, it meant reading manuals, articles, emails, and memos. Then they divided the group in half.</p><p>For those who used their skills more often, there was no average decline at any age. For those who used them less, skills started to decline in their mid-30s.</p><p>The study only measured reading and math. It doesn’t directly address creativity, judgment, or leadership. The authors say their data show a pattern but can’t prove that using a skill protects it. Another possibility is that people with stronger skills end up in jobs where they use them more.</p><p>The study also doesn’t show that getting promoted causes any decline. Senior roles involve plenty of emails, memos, and articles, so many executives likely fall into the high-use group for reading. My observation is that tasks like making budgets and charts are often the first things you hand off after a promotion.</p><p><strong>The doctor’s take:</strong> In my view, a senior job often takes away the chance to use certain skills. In my Upward ARC framework, this is the Capacity pillar: what you can still do, kept alive by actually doing it.</p><h2>The hardship we buy</h2><p>I have a theory about where our effort goes. When our jobs stop requiring us to make things, we look for challenges elsewhere.</p><p>The drive to the Baltic is one of the few times our kids get their screens. On Friday, all 3 were in the back with their shows. That gave Erna and me some peace, so we put on a podcast: Joe Rogan talking to the neuroscientist Andrew Huberman. [5]</p><p>At one point Huberman says, “If I just keep doing really hard things, I’m going to stay in control of my impulses.” Meanwhile, my three kids in the back seat were doing the opposite, and I let it happen.</p><p>I’m one of the people he’s talking to. I like pushing through things nobody asked me to do, and some of them are stupid. I could shower warm. I stand under the cold water for a minute anyway, and it does something to my mind. I do the same in the sauna. I stay when it gets uncomfortably hot.</p><p>I’m not alone in this. Michael Easter wrote a popular book called The Comfort Crisis, where he talks about the misogi. He learned it from Marcus Elliott, a Harvard-trained sports scientist. Once a year, Elliott chooses a challenge with two rules: it must be so hard you have a real 50% chance of finishing, and you can’t die. [6]</p><p>Jesse Itzler hired the Navy SEAL David Goggins to move in with him for a month and wrote a book about it. [7] Backyard ultra runners circle a 6.7-kilometer loop every hour until only one is left. The record is 119 loops, nearly 800 kilometers in close to 5 days. [8]</p><p>There is research about effort and value. In a 2011 experiment, researchers asked 52 students to bid on a plain IKEA storage box. Some had just built it themselves, while others got the same box already assembled. The builders bid $0.78 on average; the others bid $0.48. [9] This effect only appeared when people finished the job. If they built it and then took it apart, the effect disappeared. [9]</p><p><strong>The doctor’s take:</strong> This is where I’ve been mistaken. A cold shower makes me feel like I’ve done something hard, but it doesn’t create anything. In the experiment, the extra value went to the box people built. The study didn’t test if this effect carries over to other things. I doubt it does, and I haven’t found any evidence that a cold shower or a misogi keeps your work skills sharp. Do hard things because you enjoy them.</p><p>Whether hard things train your control over your impulses is a separate question. I leave it open here.</p><h2>The seat at the edge of the ring</h2><p>Later in the same episode, Huberman tells a story from a boxing gym in San Diego where he used to spar on Wednesday nights. One man there looked sharp on the bags. He sat at the edge of the ring and gave everyone advice. Huberman kept inviting him in for a couple of rounds, and the man always had a reason to say no. In the end, the gym’s owner told him the man had probably not boxed a round since he was a kid. [5]</p><p>It’s easy to end up in that position. I’m talking about myself here. What got me out of it was writing. When I started posting on LinkedIn, my posts got 5 likes. That includes the colleagues who clicked to show support.</p><p>I lead an office, so when I speak, people listen. My role, my reputation, and a familiar audience all help with that. I don’t know how much my confidence relies on these factors, so I wanted to test it.</p><p>Online, none of that carries over. No one has to listen; it’s their choice. It’s uncomfortable every time. I put my ego aside, publish, and do it again the next week.</p><p>Writing taught me to go back and do things myself. That’s what I mean by creating. It’s the doing. It’s learning by building something on your own. Watching tutorials and collecting a certificate doesn’t count.</p><p>Since then I’ve been building. Here are 4 examples out of many. A task manager for people with ADHD. A workout planner for people who travel, which adjusts to the equipment in a hotel gym. My own app store. And a website for my writing, which I set up so that AI assistants can find and quote it. People call that GEO or AEO. It seems to be working. This week, someone told me he asked Gemini who to interview as an expert on a topic, and it suggested my name!</p><p>Building things has brought back the joy of creating. I lost that feeling over the years, but now I’m getting it back.</p><p>I chose to start over from the bottom. The people in that magazine article didn’t have that choice.</p><p><strong>The doctor’s take:</strong> I don’t know of any study showing that returning to creating prepares you for job loss or protects you from restructuring. The German study is about keeping skills, which is a different issue. My view is that creating changes what you have in your hands the day after. That’s why I do it.</p><p>One more thought, and I’m leaving this open on purpose. A promotion lets you hand your tasks to others. AI lets us hand off even more of the thinking and doing, which probably makes us faster. I use it myself, even for things I build. What I can’t say is what happens over time if we become dependent on AI, or on the satisfaction of making something yourself. I don’t have an answer yet.</p><h2>Try this today</h2><p>What works is often small, and that’s what makes it tough. Doing a task you handed off years ago means you’ll be slower than the person who does it now. It also means asking someone junior to point out what’s wrong with your work. A cold shower costs me a minute of discomfort; this costs me some pride.</p><p><strong>Take a moment to reflect.</strong> Write down three things you made yourself ten years ago but don’t make anymore. Circle the one you’d like to bring back. Or something new that’s not in your job description but forces you out of your comfort zone.</p><p><strong>Create a first version yourself.</strong> Choose a small, useful task you’d usually delegate this week. It could be the first page of a memo or the first draft of a chart. Do it yourself from start to finish, without giving a briefing. Then ask someone who does this work daily for specific feedback.</p><p><strong>Try a small misogi at work.</strong> Use Elliott’s first rule, but make it smaller. Choose a task where you’re unsure if you can still do it well, and where failure would only be embarrassing, not costly. Do it yourself, where others can see the result. His second rule still stands.</p><h2>What my kids already know</h2><p>Our oldest, Tilda, is 12 and wants to be a lawyer to help people. I admire her sense of right and wrong, and I hope she gets to follow that path.</p><p>Whatever Tilda, Magnus, and Karla choose to do, I want them to keep what they have now. They make things without worrying if they’re good at it yet. I hope they’ll always be willing to start over, even if it’s embarrassing.</p><p>That’s not something I can teach from a lounge chair.</p><p>What did you stop making yourself, and do you want it back? Reply and let me know. I read every message.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you know someone who is taking stock of their own work right now, forward this to them. That’s how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If a friend sent you this, you can get Under Load, my Sunday edition, here:<a href="https://www.andreheeg.com/" rel="external">andreheeg.com</a></p><div><hr></div><h2>References</h2><p>[1] manager magazin. (2026, October). Das große Rauswerfen [Cover story]. <em>manager magazin</em>, (10/2026).</p><p>[2] Handelsblatt. (2026, January 14). Führungskräfte: Arbeitslosigkeit unter Managern erreicht Rekordniveau. <em>Handelsblatt</em>. <a href="https://www.handelsblatt.com/karriere/fuehrungskraefte-arbeitslosigkeit-unter-managern-erreicht-rekordniveau/100189439.html" rel="external">https://www.handelsblatt.com/karriere/fuehrungskraefte-arbeitslosigkeit-unter-managern-erreicht-rekordniveau/100189439.html</a></p><p>[3] Deutsche Presse-Agentur. (2026, September 30). Bis Mitte 2027: BMW schrumpft Topmanagement um ein Fünftel. <em>Autohaus</em>. <a href="https://autohaus.de/nachrichten/autohersteller/bis-mitte-2027-bmw-schrumpft-topmanagement-um-ein-fuenftel-3911004" rel="external">https://autohaus.de/nachrichten/autohersteller/bis-mitte-2027-bmw-schrumpft-topmanagement-um-ein-fuenftel-3911004</a></p><p>[4] Hanushek, E. A., Kinne, L., Witthöft, F., &amp; Woessmann, L. (2025). Age and cognitive skills: Use it or lose it. <em>Science Advances, 11</em>(10), eads1560. <a href="https://doi.org/10.1126/sciadv.ads1560" rel="external">https://doi.org/10.1126/sciadv.ads1560</a></p><p>[5] Rogan, J. (Host). (2026, September 14). Andrew Huberman (No. 2553) [Audio podcast episode]. In <em>The Joe Rogan Experience</em>.</p><p>[6] Roberts, R. (Host). (2021, July 19). Michael Easter on the comfort crisis [Audio podcast episode]. In <em>EconTalk</em>. Library of Economics and Liberty. <a href="https://www.econtalk.org/michael-easter-on-the-comfort-crisis/" rel="external">https://www.econtalk.org/michael-easter-on-the-comfort-crisis/</a></p><p>[7] Itzler, J. (2015). <em>Living with a SEAL: 31 days training with the toughest man on the planet</em>. Center Street.</p><p>[8] Runner’s Tribe. (2025, June 26). Phil Gore breaks backyard ultra world record with 119 loops. <a href="https://runnerstribe.com/latest-news/phil-gore-breaks-backyard-ultra-world-record-with-119-loops/" rel="external">https://runnerstribe.com/latest-news/phil-gore-breaks-backyard-ultra-world-record-with-119-loops/</a></p><p>[9] Norton, M. I., Mochon, D., &amp; Ariely, D. (2011). <em>The “IKEA effect”: When labor leads to love</em> (Working Paper No. 11-091). Harvard Business School.</p><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/skill-use-learning-and-the-ikea-effect">Skill Use, Learning and the IKEA Effect →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[The 83-disease REM study was measured at the wrist]]></title>
<description><![CDATA[The PLOS study links movement-derived sleep estimates with later diagnoses. It does not show that increasing a watch's REM score prevents disease.]]></description>
<link>https://www.andreheeg.com/archive/the-83-disease-rem-study-was-measured-at-the-wrist</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-83-disease-rem-study-was-measured-at-the-wrist</guid>
<pubDate>Wed, 30 Sep 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>Last week’s headline claimed that more REM sleep is linked to a lower risk of 83 diseases. Researchers estimated this REM sleep using wrist movement data.</p><h2>What?</h2><p>A PLOS Medicine study published on September 17 tracked 95,559 UK Biobank adults for about 9 years. Each person wore a wrist sensor for a week, and an algorithm used their movement to estimate sleep stages. For every extra 47.6 minutes of estimated REM, there was a 46% lower risk of dementia and a 26% lower risk of heart failure. This is just an association, not proof. Also, the 80% drop in risk that some outlets reported for “Parkinson’s” actually refers to parkinsonism, which is a broader diagnosis.</p><h2>So what?</h2><p>These numbers have two main problems.</p><p>First, consider the wrist measurements. Compared with a sleep lab, the algorithm matched only moderately well and tended to undercount REM by about 17 minutes each night. The authors themselves call these numbers “movement-based estimates.” So, remember that your own wrist REM score is just an estimate too.</p><p>Second, there’s the timing. The strongest links are for dementia and parkinsonism, which are diseases that can disrupt sleep years before they are diagnosed. Wrist sensors can pick up more night waking as early as seven years before someone is diagnosed with Parkinson’s. The study authors removed cases from the first two years, and the links with dementia and parkinsonism still showed up. But two years is a short window for diseases that can develop over a decade or more. Also, a 2025 study combined data from five groups whose sleep was measured with electrodes (4,657 people in total) and found no link between sleep stages and dementia.</p><p>My read: this study does not show that increasing REM prevents disease. I wouldn’t rearrange a single night to improve a watch score on this evidence. Two things have been tested in sleep labs, and both cut REM: short nights and alcohol.</p><h2>Now what?</h2><ul><li>Try to get enough sleep each night. In a 2018 sleep-lab study, 35 adults who were limited to six hours in bed for a week lost about half an hour of REM sleep each night on average, but their deep sleep stayed about the same. REM sleep is longest in the last third of the night, which early alarms often cut short. If you have an early flight, try to go to bed earlier.</li></ul><ul><li>Avoid drinking alcohol the night before an important day. A 2025 review of 27 studies found that REM sleep dropped even with low amounts of alcohol, which the authors define as about two standard drinks or less.</li></ul><ul><li>Don’t focus on your tracker’s nightly REM number. Instead, focus on your average sleep time over the week and try to wake up at the same time every day.</li></ul><ul><li>If your partner notices that you act out your dreams by punching, kicking, or shouting, talk to your doctor. REM sleep behavior disorder can show up years before Parkinson’s or similar conditions. It’s important to get it checked out.</li></ul><p>Your watch will keep giving you a REM score, but you don’t have to pay attention to it.</p><p>Stay healthy.</p><p>Andre</p><p>Sources:<a href="https://journals.plos.org/plosmedicine/article?id=10.1371%2Fjournal.pmed.1005213" rel="external">PLOS Medicine paper</a> ·<a href="https://doc.rero.ch/record/332326/files/SLEEP_41_7_zsy078.pdf" rel="external">Skorucak, Sleep 2018 (PDF)</a> ·<a href="https://academic.oup.com/sleep/article/48/9/zsaf129/8133870" rel="external">Yiallourou, Sleep 2025</a> ·<a href="https://pubmed.ncbi.nlm.nih.gov/39631226/" rel="external">Gardiner, Sleep Med Rev 2025</a> ·<a href="https://academic.oup.com/brain/article/142/3/744/5353011" rel="external">Postuma, Brain 2019</a> ·<a href="https://www.sciencedaily.com/releases/2026/09/260923035930.htm" rel="external">ScienceDaily headline</a></p>]]></content:encoded>
</item>
<item>
<title><![CDATA[I Started Counting Backwards. So Did Five Friends Who Don't Know Each Other.]]></title>
<description><![CDATA[Time-horizon research offers a way to understand changing priorities. Applying it to a career decision remains an interpretation, not a validated decision method.]]></description>
<link>https://www.andreheeg.com/archive/i-started-counting-backwards-so-did-five-friends-who-don-t-know-each-other</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/i-started-counting-backwards-so-did-five-friends-who-don-t-know-each-other</guid>
<pubDate>Sun, 27 Sep 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>&quot;No one knows this yet.&quot;</p><p>She said it just before the waiter arrived. I've known her for over 15 years. We met early in our consulting days, and I've followed her career ever since. From the outside, she seemed to be doing great.</p><p>&quot;I'm thinking about my next steps,&quot; she said. &quot;What I could do next.&quot;</p><p>&quot;Really? I've watched your career. It all looks very solid.&quot;</p><p>&quot;Yeah, yeah, no. All is good. There's no need to do anything. I'm just thinking about where I can achieve the most while I still learn. And do something I believe in.&quot;</p><p>We ordered. I looked down at the menu and stopped reading.</p><p>This was the third time in a few weeks I'd heard something like this. Three people who don't know each other had described their motivation in different ways, but the feeling behind their words was the same.</p><p>In the next two weeks, I heard it two more times.</p><p>When friends share something in confidence, I keep it private. You won't see any names, companies, or details here that could identify anyone.</p><h2>Five people, one question</h2><p>They were strong students who landed top jobs right out of university, mostly at big strategy firms. That's how I met most of them. Over the next 20 years, some climbed the corporate ladder while others started their own companies.</p><p>None of them are in trouble. They could stay on the same path until retirement, and it would work.</p><p>None of them want to retire, either, and that surprised me most. Plenty of stories online are about people at 55 or 60 who have made their money and are planning an active retirement. But these five are still building and still have financial goals. They're asking these questions while they're still in the middle of their careers.</p><p>Most of us are Generation X. I always thought our deal was simple: keep your head down, build your credentials, and do the work, even when it isn't exciting, because it pays off later. Purpose and passion were in the background, and no one asked if they should take the lead.</p><p>Now, twenty years later, they're asking these questions. Each one does it quietly, as if it's something to be embarrassed about.</p><h2>A psychologist wrote it down in 1968</h2><p>In all five conversations, some version of the same thought came up: How many more years do I want to keep doing this? How do I want to spend them? They had started counting backwards.</p><p>Bernice Neugarten, a psychologist at the University of Chicago, described it in 1968. She wrote: &quot;Life is restructured in terms of time-left-to-live rather than time-since-birth.&quot; She called the awareness that time is finite &quot;a particularly conspicuous feature of middle age.&quot; [1]</p><p>Five people, each in their own words, described what a researcher wrote down 58 years ago. Is this just a coincidence, a sign of the times, or simply our age?</p><p>From my perspective as a doctor, I think age is the main factor here. I haven't found any strong data showing that people in their forties ask this question more now than they did ten years ago. This question has come up at this stage of life for almost 60 years, and my friends and I just reached it together. If you're asking it, you're right on time.</p><p>Counting backwards tells you one thing: your sense of how much time you have left has changed. Age can do that, but so can a health issue or an uncertain future. Try to figure out what changed for you before you answer the career question.</p><p>The world around us has changed. Based on a survey of employers, the World Economic Forum projects that 92 million jobs will disappear and 170 million new ones will be created by 2030. [2] Headlines like that make the future feel less certain. Even the people building AI can't agree on whether we'll have more or less work. In my parents' time, doctors, lawyers, and managers could predict what the next few decades would look like. That's not true anymore. Now, people talk about having portfolio careers and multiple sources of income. One job doesn't feel as safe as it used to, and I think about that too.</p><h2>Why the brain starts counting</h2><p>Laura Carstensen at Stanford has spent decades studying what happens when people feel their time is limited. Her theory, called socioemotional selectivity, has a simple idea at its core. When time feels unlimited, we focus on gathering knowledge, contacts, options, and status. When time feels short, we focus on what matters most emotionally. [3]</p><p>This shift depends on how much time you think you have, no matter your age. Midlife is when the horizon often starts to feel closer.</p><p>Older adults usually prefer to spend time with people they know well. When researchers asked them to imagine a medical advance that added 20 years to their lives, that preference disappeared. [4] In Hong Kong, two months before the 1997 handover to China, when the city's future suddenly looked uncertain, young adults made the same choices as older adults. One year after the handover, the age difference was back. [4] Illness moves the horizon too. Carstensen's team saw the same shift in young men living with HIV. Their conclusion: &quot;the perception of limited time, rather than chronological age, is the critical variable.&quot; [5]</p><p>None of these studies looked at careers. Counting backwards is the same shift, applied to work. When the horizon moves closer, you start sorting your time by what matters to you. The AI headlines move that horizon for a lot of us, the way the handover moved it for those young adults in Hong Kong.</p><h2>The back that started it</h2><p>For me, it started with my back.</p><p>I know what pain feels like. I wrestled for 20 years, with more than ten of those years spent competing. Full-contact sports teach you about all kinds of pain. A bone hurts one way, a torn muscle another, and a shoulder about to pop out gives its own warning.</p><p>So when my back gave out, I knew this pain was different. It felt deeper than anything I'd experienced on the mat. As a doctor, I understood the anatomy, but I sensed this was about more than just the body.</p><p>My lowest point came in the summer of 2024. I was sitting on the terrace of our holiday home, on one of the big concrete steps leading down to the lawn. The sun was setting in front of me, turning the sky a deep orange you seem only to see near the sea. The windows behind me were open. My wife was getting the kids ready for bed, and the usual chaos had started. Karla was yelling about something, Magnus was running laps to burn off his last bit of energy, and Tilda was trying to find a room without the other two in it.</p><p>I sat on the step, looked at the lawn and trees, and started asking myself questions I'd avoided since my twenties. What am I doing? Why am I doing it? Who am I still trying to impress? Is it just about the money?</p><p>That was when I started counting backwards.</p><h2>Take away the business class</h2><p>Once I started asking these questions, I stripped away everything that comes with a senior job: the borrowed status of a company name, the title, the business-class seat, the nice hotels, the expensive dinners, and the way people treat you when you walk into a room. Over the years, all of that had become part of how I saw myself.</p><p>Then I wondered what would be left. What would I do if I could really choose? Building, helping, learning, creating: which one brings me the most satisfaction? How much of what I do is shaped by what others think? How much is about earning easy, safe money compared to facing an uncertain future?</p><p>And there was one question I couldn't let go: in two or three generations, no one will remember my name. So why am I putting so much into something that won't matter after I'm gone?</p><p>It took me a while to answer it.</p><p>Capacity is the part of my Upward ARC framework I think about most right now. It's about what you can still learn, the skills you build, and the reserves your mind and body carry into later life. My friend at lunch put it simply: she wants to keep learning. Capacity is what makes that possible.</p><h2>Why nobody says it out loud</h2><p>Five people, the same question. Each told me in confidence and seemed to think they were the only one feeling this way. Some of that silence is just being careful. Usually, no one wants to share career doubts with colleagues.</p><p>Psychologists call this pluralistic ignorance. Most people in a group privately feel one way, and each of them assumes everyone else feels the opposite. I have seen this unfold in many leadership trainings I took part in. In the closing round, participants often named it their biggest takeaway.</p><p>Boards show it clearly, too. When companies performed poorly, outside directors underestimated how many of their fellow directors shared their doubts about the strategy. The doubts stayed unspoken, and the strategy stayed the same. [6]</p><p>I think the same thing happens with this question. Everyone at the table is wondering about it, but each person assumes everyone else is confident.</p><p>The word &quot;crisis&quot; makes things harder. Nobody wants to be seen as having a midlife crisis. In a US study of 724 adults, 26% said they'd had one, using the word for many experiences like divorce, career setbacks, and illness. Among people aged 49 to 53, 44% described a crisis involving physical decline, changing priorities, blocked achievement, and &quot;shortened futures.&quot; Another 16% felt trapped in an unsatisfying job and wanted to change careers &quot;before it was too late.&quot; The numbers in that age group were small, to be transparent. [7] My friends are calm, successful, and grateful. They want to choose their next steps on purpose.</p><h2>Wanting to change, and staying</h2><p>A German study followed 2,835 workers born in 1959 or 1965 over four years. One in ten changed profession. Another 17.6% wanted to change but didn't. Most of that group wanted better conditions or less conflict between work and family, and they had worse mental health than the people who were content to stay. [8] The study can't show which came first.</p><p>Work shows up in the body, too. A 1991 study followed 3,020 aircraft-industry workers for just over four years. Those who &quot;hardly ever&quot; enjoyed their job tasks were 2.5 times more likely to report a back injury than those who &quot;almost always&quot; did. [9] Those were very different jobs from ours, but I've stopped seeing my back and my work as separate issues.</p><p>Purpose affects health too. A 2026 meta-analysis of nearly 490,000 people found that having more purpose was linked to about a 15% lower risk of dying during follow-up, even after accounting for health habits and existing disease. [10] This is observational, and here, purpose means purpose in life. It doesn't have to come from your job.</p><h2>The honeymoon problem</h2><p>Before you hand in your notice, consider what happens after a job change. Researchers found that when managers changed jobs voluntarily, their satisfaction rose at first, then fell back down. They called this the honeymoon-hangover effect. [11] The study didn't look at moves into more meaningful work, and I don't know of any good research showing which kind of change is best. Just changing your job title or company isn't enough by itself, though.</p><p>As a doctor, here's my take: chasing your passion while your family is worried about school fees isn't a good idea. I wouldn't do it, and I won't recommend it. I have three kids in school, with university still ahead. Any answer to this question has to cover the household first. My friends are still building too, and we're lucky to be asking this with some savings. Many people asking these questions have much less room to maneuver. So I plan for both: the household and whatever comes next.</p><p>And make sure you're counting the right years. In Germany, the gap between life expectancy and healthy life expectancy was 10.8 years in 2019. [12] This gap spans a lifetime, so you can't just subtract it from your next 20 years. But it's a reminder that years and healthy years aren't the same. Cardio fitness, strength, and sleep can help you make the most of the years you have.</p><h2>Try this today</h2><p><strong>The backwards count.</strong> Take a sheet of paper and write down your age, the age you'd like to stop working full time, and the years in between. Then list two or three things your body needs to do well during those years, like carrying your bags through an airport or climbing four flights of stairs without stopping. Pick the one you're least sure about and start working on it this week.</p><p><strong>The five-year test.</strong> Carstensen's research shows that having a shorter time horizon changes your priorities, so try shortening it on purpose. Write down what you'd do if you had only five working years left, then what you'd do if you had 20. The difference can show you what you might be putting off. This is just a thinking exercise. No one has tested it as a formal method.</p><p><strong>The small test.</strong> Before making any big changes, run a small experiment in the direction you're interested in. Have coffee with someone already doing that work or take on a side project. In my experience, a month of trying teaches you more than a year of thinking.</p><p><strong>Tell one person.</strong> Pluralistic ignorance starts to fade when someone speaks up. Choose a peer you trust this week and share what you've been thinking. I bet they've been thinking about it too.</p><p><strong>Put a number on your fear.</strong> When money worries are vague, they block every option. Figure out what your household and your kids' schooling will need for the next five years. Once you have a number, you can make a plan.</p><h2>What I'd tell her</h2><p>At that lunch, I ordered a large portion with extra chicken because I had a protein goal to hit. Some habits don't need a midlife review. We had a quick coffee afterward, and I thought about our conversation the entire bike ride home.</p><p>If I could sit down with her again, I'd tell her she's right on schedule, and that it's okay for this question to take center stage for a while. The thing she might have seen as a private flaw was something four other people were carrying too.</p><p>And I'd share what I realized after that evening on the terrace: my name will fade, but the work can last beyond me. Someone who can smile again. Something I built that still works.</p><p>What's the question you haven't said out loud yet? Feel free to reply. I read every message.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you know someone who's doing well but quietly wondering what comes next, please forward this to them. They'll understand why you sent it. That's how this newsletter grows, and it's the only way I want it to.</p><p>PPS: If a friend sent you this, you can subscribe to The Upward ARC at <a href="https://www.andreheeg.com" rel="external">andreheeg.com</a>.</p><div><hr></div><h2>References</h2><p>[1] Neugarten, B. L. (1968). The awareness of middle age. In B. L. Neugarten (Ed.), <em>Middle age and aging: A reader in social psychology</em> (pp. 93–98). University of Chicago Press.</p><p>[2] World Economic Forum. (2025). <em>The future of jobs report 2025</em>. World Economic Forum. <a href="https://www.weforum.org/publications/the-future-of-jobs-report-2025/" rel="external">https://www.weforum.org/publications/the-future-of-jobs-report-2025/</a></p><p>[3] Carstensen, L. L., Isaacowitz, D. M., &amp; Charles, S. T. (1999). Taking time seriously: A theory of socioemotional selectivity. <em>American Psychologist, 54</em>(3), 165–181. <a href="https://doi.org/10.1037/0003-066X.54.3.165" rel="external">https://doi.org/10.1037/0003-066X.54.3.165</a></p><p>[4] Fung, H. H., Carstensen, L. L., &amp; Lutz, A. M. (1999). Influence of time on social preferences: Implications for life-span development. <em>Psychology and Aging, 14</em>(4), 595–604. <a href="https://doi.org/10.1037/0882-7974.14.4.595" rel="external">https://doi.org/10.1037/0882-7974.14.4.595</a></p><p>[5] Carstensen, L. L., &amp; Fredrickson, B. L. (1998). Influence of HIV status and age on cognitive representations of others. <em>Health Psychology, 17</em>(6), 494–503. <a href="https://doi.org/10.1037/0278-6133.17.6.494" rel="external">https://doi.org/10.1037/0278-6133.17.6.494</a></p><p>[6] Westphal, J. D., &amp; Bednar, M. K. (2005). Pluralistic ignorance in corporate boards and firms' strategic persistence in response to low firm performance. <em>Administrative Science Quarterly, 50</em>(2), 262–298. <a href="https://doi.org/10.2189/asqu.2005.50.2.262" rel="external">https://doi.org/10.2189/asqu.2005.50.2.262</a></p><p>[7] Wethington, E. (2000). Expecting stress: Americans and the &quot;midlife crisis.&quot; <em>Motivation and Emotion, 24</em>(2), 85–103. <a href="https://doi.org/10.1023/A:1005611230993" rel="external">https://doi.org/10.1023/A:1005611230993</a></p><p>[8] Garthe, N., &amp; Hasselhorn, H. M. (2022). Changes of profession, employer and work tasks in later working life: An empirical overview of staying and leaving. <em>Ageing &amp; Society, 42</em>(10), 2393–2413. <a href="https://doi.org/10.1017/S0144686X21000088" rel="external">https://doi.org/10.1017/S0144686X21000088</a></p><p>[9] Bigos, S. J., Battié, M. C., Spengler, D. M., Fisher, L. D., Fordyce, W. E., Hansson, T. H., Nachemson, A. L., &amp; Wortley, M. D. (1991). A prospective study of work perceptions and psychosocial factors affecting the report of back injury. <em>Spine, 16</em>(1), 1–6. <a href="https://doi.org/10.1097/00007632-199101000-00001" rel="external">https://doi.org/10.1097/00007632-199101000-00001</a></p><p>[10] Sutin, A. R., Zavala, D., Milad, E., Stephan, Y., Karakose, S., Brown, J., Terracciano, A., &amp; Luchetti, M. (2026). Purpose in life and mortality: A meta-analysis of the published literature and individual-participant data of 488,765 participants followed for up to 32 years. <em>Psychological Medicine, 56</em>, e214. <a href="https://doi.org/10.1017/S0033291726104863" rel="external">https://doi.org/10.1017/S0033291726104863</a></p><p>[11] Boswell, W. R., Boudreau, J. W., &amp; Tichy, J. (2005). The relationship between employee job change and job satisfaction: The honeymoon-hangover effect. <em>Journal of Applied Psychology, 90</em>(5), 882–892. <a href="https://doi.org/10.1037/0021-9010.90.5.882" rel="external">https://doi.org/10.1037/0021-9010.90.5.882</a></p><p>[12] Garmany, A., &amp; Terzic, A. (2024). Global healthspan-lifespan gaps among 183 World Health Organization member states. <em>JAMA Network Open, 7</em>(12), e2450241. <a href="https://doi.org/10.1001/jamanetworkopen.2024.50241" rel="external">https://doi.org/10.1001/jamanetworkopen.2024.50241</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Who the 44% and 16% describe:</strong> In Wethington’s study, the 44% and 16% figures describe types of crises reported by respondents aged 49–53 who said they had experienced a midlife crisis. They are not percentages of everyone in that age group. The subgroup was small and the reports retrospective. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://midus.wisc.edu/findings/pdfs/103.pdf" rel="external">Wethington (2000). reported midlife crises.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/midlife-time-horizons-purpose-and-career-change">Midlife, Time Horizons, Purpose and Career Change →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Before you increase your creatine dose]]></title>
<description><![CDATA[The Alzheimer’s pilot establishes feasibility and a brain-creatine change. It cannot establish slowed disease progression without a comparison group.]]></description>
<link>https://www.andreheeg.com/archive/before-you-increase-your-creatine-dose</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/before-you-increase-your-creatine-dose</guid>
<pubDate>Wed, 23 Sep 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>There’s a claim <a href="https://www.reddit.com/r/Biohackers/comments/1wibjc0/scientists_found_that_the_creatine_supplement/" rel="external">going around again</a> that creatine can slow Alzheimer’s decline by 30%. That’s a big promise for something you can buy over the counter.</p><h2>What?</h2><p>The actual evidence in people is much more limited. In a pilot study by <a href="https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70101" rel="external">Smith and colleagues</a>, 20 people with Alzheimer’s took 20 grams of creatine each day for eight weeks. Their brain creatine levels rose by 11%, and some of their cognitive test scores improved.But the study had no placebo group. So we can’t know if the improvements were due to creatine or just because people got better at taking the tests. The study, published in May 2025, mainly checked if this creatine routine was doable. It doesn’t prove a 30% drop in decline.</p><h2>So what?</h2><p>I need to correct myself here. In my September 2025 creatine update, I said you’d think more clearly within two weeks. That was too optimistic.There could be some cognitive benefits. In a <a href="https://link.springer.com/article/10.1186/s12916-023-03146-5" rel="external">2023 trial</a>, 123 healthy adults took 5 grams a day for six weeks and showed a small possible improvement. Another trial in <a href="https://pubmed.ncbi.nlm.nih.gov/42578920/" rel="external">August 2026</a> gave 10 grams a day for 12 weeks to adults aged 45 to 65, and they also saw some benefits on certain cognitive tests. The senior author, Richard Kreider, is on the scientific advisory board of AlzChem, a company that makes creatine. The researchers called these cognitive results exploratory. Neither study shows that creatine protects against Alzheimer’s.My advice is still similar to what I said in July: creatine is worth considering if you lift weights. In a <a href="https://pubmed.ncbi.nlm.nih.gov/10449017/" rel="external">placebo-controlled trial with 19 trained men</a>, creatine helped them gain more strength over 12 weeks of lifting. The Alzheimer’s pilot study is just a first step for more research. Based on these results, I wouldn’t take more creatine for brain protection.</p><h2>Now what?</h2><p>Before you buy creatine or change how much you take:</p><ul><li>Think about what you want creatine to do for you. If you’re hoping it will sharpen your thinking, remember that benefit is still uncertain (but possible). I wouldn’t start taking it just to prevent Alzheimer’s based on what we know now.</li></ul><ul><li>If you’re healthy, lift weights, and want to try creatine, go for plain creatine monohydrate at 3 to 5 grams a day. Check the label for how many grams are in each serving. This is the <a href="https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/" rel="external">standard training dose</a>, even on rest days.</li></ul><ul><li>You don’t need to do a loading phase. In <a href="https://pubmed.ncbi.nlm.nih.gov/8828669/" rel="external">Hultman’s muscle study</a>, taking 3 grams a day slowly increased creatine stores over about four weeks. There’s no need to use the 20-gram dose from the Alzheimer’s study to build up muscle creatine.</li></ul><ul><li>If you have kidney disease, talk to your doctor before starting creatine. If you’re thinking about creatine for someone with Alzheimer’s, share the study with their doctor and ask for advice before changing any supplements or medications.</li></ul><p>Stay healthy.</p><p>Andre</p>]]></content:encoded>
</item>
<item>
<title><![CDATA[The man squatting in the embassy queue was me]]></title>
<description><![CDATA[Stretching can improve range of motion. Maintaining everyday mobility also involves strength, balance and task practice; the newsletter's short routine is an editorial suggestion.]]></description>
<link>https://www.andreheeg.com/archive/the-man-squatting-in-the-embassy-queue-was-me</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-man-squatting-in-the-embassy-queue-was-me</guid>
<pubDate>Sun, 20 Sep 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>The men were squatting on the dirt, talking while they waited for a minibus. They could stay there for half an hour.</p><p>I stood in a busy, dusty square in Kathmandu, about a head taller than most people around me and likely the only Westerner using this kind of transport. Each morning, I took the minibusses to the hospital, where I worked in traumatology.</p><p>The square was unpaved and crowded with commuters. A minibus that seemed built for ten people could actually fit 15 or 18 if everyone squeezed together. I kept watching those men rest comfortably in a position I rarely saw adults use back home.</p><p>Why wasn’t I doing that?</p><p>When I first tried, I could only hold the position for a minute or two before my legs went numb. It took time to get deeper into the squat. The numbness was a sign to stop, and I wouldn’t suggest pushing through it. I had to build up slowly over months.</p><p>Now, I include the squat in my hip-mobility routine. I also notice how everyday movements can become awkward for adults, like getting out of a car or lowering themselves to the floor.</p><p>I’m 47, and I don’t want to give up on these movements without seeing if I can keep them.</p><h2>Before you blame your birthday</h2><p>As a doctor, I don’t think age alone explains why we lose certain movements. If getting out of a chair or reaching the floor is hard, I want to understand the reason.</p><p>I also think we’ve gotten too used to spending our days moving from one chair to another. If you spend most of your week sitting, make time for the movements you want to keep. Don’t wait until it becomes a problem.</p><p>For me, the squat is important. For you, it might be kneeling in the garden or getting down to play on the floor. Pick a movement you care about and use it as your reason to practice. There’s no single squat shape to follow. Your stance and body shape will affect how it looks.[1]</p><p>Flexibility is how much your joints can move. Strength is what lets you move through that range. Getting down into a position, staying steady, and getting back up all take practice, not just stretching.</p><p>Think about getting out of a low car. You need to swing your legs around, place your feet well, and stand up. Where does it feel awkward for you? Maybe moving your leg is hard, or maybe standing up is the tough part. Noticing these details helps you explain what’s difficult if you need help, though it won’t tell you the cause on its own.</p><p>I’d pick one everyday task like that before choosing which exercises to focus on. Be clear about what you want to do comfortably. Getting down to the floor and back up is a good goal, even if you need a hand for support. Start practicing from your current level. If you work with a trainer or physiotherapist, share your goal with them. It gives you both a clear target and a reason for your exercise choices.</p><p>The LIFE trial asked a question I care about: could people still walk 400 meters? Its 1,635 participants were sedentary adults aged 70–89 with physical limitations. Over an average of 2.6 years, a walking-led program, with strength, balance, and flexibility work, reduced loss of that ability from 35.5% to 30.1% compared with health education and gentle upper-body stretching. Serious medical events were 49.4% versus 45.7%, a statistically uncertain difference; most hospitalizations were judged unrelated to the program.[2]</p><p>A 2024 review also found that exercise programs led to fewer fall injuries in older adults. Almost all these programs included balance, functional movement, and strength exercises.[3] I want to keep these abilities in my routine long before I ever need a fall-prevention program.</p><h2>A few minutes you can keep doing</h2><p>A 2025 review pooled 189 studies involving 6,654 adults. Their average age was 26.8, and 61% were male. Regular static stretching, where you hold a position, improved flexibility.[4]</p><p>The analysis suggested that improvements leveled off at about 10 minutes of stretching per muscle group each week. That’s a helpful starting point. The authors question if this is a real limit, so I wouldn’t treat it as a strict rule or a ten-minute total for the whole body.</p><p>The analysis didn’t find differences in results by age. A July 2026 review found the same, though only three of its 79 trials focused on people aged 40–64.[5] I think it’s worth working on flexibility in midlife, and you can adjust how much you do based on your own response.</p><p>A separate 2025 review examined what changes when people stretch regularly. It found a small reduction in tissue stiffness and increased stretch tolerance after repeated static stretching.[6]</p><p>Here, stiffness means the resistance measured as tissues are stretched. Tolerance describes how much resistance a participant would accept near the end of a stretch test. Both changed alongside improvements in range of motion. The review found no clear increase in muscle-fiber bundle length, another proposed explanation.</p><p>The evidence for these reasons was rated as low or very low certainty, and most participants were young. We still don’t fully know how extra flexibility develops, especially as we get older.</p><p>For someone starting at home, I’d use comfort and ease of movement to guide the practice. Pain or a persistent restriction deserves a closer look.</p><p>I’d begin with just a few movements and make sure you have time to repeat them. A routine that takes a long appointment is tough to fit into a busy week. I want the first version to be simple enough that you can do it again later in the week.</p><p>Keep your strength training, too. A review of 36 studies found that resistance training improved flexibility, with larger gains in the higher-intensity programs. The comparison came from studies of uneven quality, none rated at low risk of bias.[7]</p><p>That’s enough reason for me to keep adding more challenging strength work to my plan. It doesn’t mean lifting heavier always leads to better mobility. Pick a weight you can control through a comfortable range, and increase it as you get stronger. Starting light is fine; the important thing is to keep challenging yourself as you improve.</p><h2>I had an hour anyway</h2><p>This Thursday, the whole family made a special trip to an embassy. I’ll share more about that in the coming months.</p><p>We got there at eight. The doors opened at nine, and a line had already started. Some people stood or leaned against the wall. I dropped into a deep squat and waited.</p><p>I was the only person in the queue doing it.</p><p>Years after Kathmandu, I found myself using the same squat outside an embassy. Even waiting for a visa became part of my exercise routine.</p><h2>Try this today</h2><p>My mobility drill takes about seven to nine minutes after a walk. Try starting three times a week. I picked the sequence and starting amounts as a practical suggestion, though this exact routine hasn’t been tested in a study.</p><p>If you’ve been sitting, walk for five to ten minutes first.[8] Keep a fixed support within reach, and stop if you feel pain, numbness, or tingling; recent surgery, restricted joint replacements, or recurrent falls call for an individually adapted routine.</p><p><strong>The counter squat.</strong> Hold a fixed counter, keep your feet planted, and lower only as far as you can control. Hold for 20–30 seconds, stand up, and repeat once. Begin shallow if you need to. Five slow rises from a stable chair are another way to practice getting up and down.[9]</p><p><strong>The half-kneel.</strong> With padding under the rear knee and your other foot in front, keep your trunk upright and gently shift forward until you feel a stretch at the front of the rear hip. Hold for 30 seconds twice on each side. If kneeling bothers your knees, take a supported standing split stance and gently shift forward instead.[8,10]</p><p><strong>The wall calf stretch.</strong> Put your hands against a wall, step one foot back, and keep that heel down with the knee straight. Bend the front knee gently until you feel the rear calf stretch. Hold for 30 seconds twice on each side.[8]</p><p><strong>The one-leg stand.</strong> Stand beside the counter with your eyes open, using your fingertips for support as needed and keeping your free foot close to the floor. Try two 20-second holds per side. Start with five to ten seconds if that’s enough of a challenge.[11,12]</p><p>Find a way to track your progress. For the one-leg stand, use the same counter and start with the same amount of time. If you begin with ten seconds and a firm grip on the counter, that’s your baseline. As it gets easier, try using a lighter touch, but keep the support nearby. Work up to the suggested hold time without feeling like you have to make it harder every time.[11,12]</p><p>Change only one thing at a time. If you’re focusing on using less hand support, don’t change how long you hold the position yet. This way, you can see what’s getting easier. After each session, jot down which exercise you did, how much help you needed, and if it felt comfortable. After a few weeks, check back on the everyday movement you picked.</p><p>Keep regular strength sessions in your week along with this drill, starting with at least two days if you’re building the habit.[9,12] The supported squat helps you practice the position. As you improve, your strength work should get a bit harder. If the routine feels easy, that’s your cue to make it more challenging.</p><p>In my Upward ARC framework, this is Activate, with Capacity as the reason to continue.</p><p>Starting something new deserves some kindness. If you need both hands to get out of a chair, use them. If a shallow squat takes focus, give it your attention. Adults should feel okay about being beginners at a physical skill. I count the supported version as a real session and would do it again.</p><p>Also, be generous with others you see moving awkwardly. Watching someone struggle to get out of a car doesn’t tell you much about their story. As a doctor, I’d want to know their background before giving advice. As someone writing about health, I want to encourage you not to ignore a difficulty you could manage.</p><p>I’m also willing to look a bit unusual myself. I enjoy finding ways to use the squat outside of my regular practice time.</p><p>After about ten minutes in the squat outside the embassy, I stood up and walked around a bit. I still had plenty of time for a few rounds of deep squat holds.</p><p>Is there a movement you’ve started avoiding because it feels awkward? Let me know. I read every message!</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you know someone who blames a tough movement on getting older, please forward this to them. That’s how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If someone sent this to you, you can subscribe at<a href="https://www.andreheeg.com" rel="external">andreheeg.com</a>.</p><div><hr></div><h2>References</h2><p>[1] Demers, E., Pendenza, J., Radevich, V., &amp; Preuss, R. (2018). The effect of stance width and anthropometrics on joint range of motion in the lower extremities during a back squat. <em>International Journal of Exercise Science, 11</em>(1), 764–775.<a href="https://doi.org/10.70252/BWZE8275" rel="external">https://doi.org/10.70252/BWZE8275</a></p><p>[2] Pahor, M., Guralnik, J. M., Ambrosius, W. T., Blair, S., Bonds, D. E., Church, T. S., Espeland, M. A., Fielding, R. A., Gill, T. M., Groessl, E. J., King, A. C., Kritchevsky, S. B., Manini, T. M., McDermott, M. M., Miller, M. E., Newman, A. B., Rejeski, W. J., Sink, K. M., &amp; Williamson, J. D. (2014). Effect of structured physical activity on prevention of major mobility disability in older adults: The LIFE study randomized clinical trial. <em>JAMA, 311</em>(23), 2387–2396.<a href="https://doi.org/10.1001/jama.2014.5616" rel="external">https://doi.org/10.1001/jama.2014.5616</a></p><p>[3] Guirguis-Blake, J. M., Perdue, L. A., Coppola, E. L., &amp; Bean, S. I. (2024). Interventions to prevent falls in older adults: Updated evidence report and systematic review for the US Preventive Services Task Force. <em>JAMA, 332</em>(1), 58–69.<a href="https://doi.org/10.1001/jama.2024.4166" rel="external">https://doi.org/10.1001/jama.2024.4166</a></p><p>[4] Ingram, L. A., Tomkinson, G. R., d’Unienville, N. M. A., Gower, B., Gleadhill, S., Boyle, T., &amp; Bennett, H. (2025). Optimising the dose of static stretching to improve flexibility: A systematic review, meta-analysis and multivariate meta-regression. <em>Sports Medicine, 55</em>(3), 597–617.<a href="https://doi.org/10.1007/s40279-024-02143-9" rel="external">https://doi.org/10.1007/s40279-024-02143-9</a></p><p>[5] Oba, K., Matsuo, S., Nakamura, M., Nakao, G., Fukaya, T., Mizuno, T., &amp; Takeuchi, K. (2026). Moderating effects of individual characteristics and the target lower limb muscle group on flexibility adaptations to chronic static stretching in healthy individuals: A systematic review and meta-analysis of randomized controlled trials. <em>Sports Medicine – Open, 12</em>, Article 95.<a href="https://doi.org/10.1186/s40798-026-01066-1" rel="external">https://doi.org/10.1186/s40798-026-01066-1</a></p><p>[6] Ingram, L. A., Tomkinson, G. R., d’Unienville, N. M. A., Gower, B., Gleadhill, S., Boyle, T., &amp; Bennett, H. (2025). Mechanisms underlying range of motion improvements following acute and chronic static stretching: A systematic review, meta-analysis and multivariate meta-regression. <em>Sports Medicine, 55</em>(6), 1449–1466.<a href="https://doi.org/10.1007/s40279-025-02204-7" rel="external">https://doi.org/10.1007/s40279-025-02204-7</a></p><p>[7] Favro, F., Roma, E., Gobbo, S., Bullo, V., Di Blasio, A., Cugusi, L., &amp; Bergamin, M. (2025). The influence of resistance training on joint flexibility in healthy adults: A systematic review, meta-analysis, and meta-regression. <em>Journal of Strength and Conditioning Research, 39</em>(3), 386–397.<a href="https://doi.org/10.1519/JSC.0000000000005000" rel="external">https://doi.org/10.1519/JSC.0000000000005000</a></p><p>[8] Mayo Clinic Staff. (2024, June 18). <em>A guide to basic stretches</em>. Mayo Clinic.<a href="https://www.mayoclinic.org/healthy-lifestyle/fitness/in-depth/stretching/art-20546848" rel="external">https://www.mayoclinic.org/healthy-lifestyle/fitness/in-depth/stretching/art-20546848</a></p><p>[9] National Health Service. (2024, February 28). <em>Strength exercises</em>.<a href="https://www.nhs.uk/live-well/exercise/strength-exercises/" rel="external">https://www.nhs.uk/live-well/exercise/strength-exercises/</a></p><p>[10] My Joint Health Hub. (n.d.). <em>Iliopsoas syndrome</em>.<a href="https://myjointhealthhub.bnssg.nhs.uk/hip-pain/iliopsoas-syndrome/" rel="external">https://myjointhealthhub.bnssg.nhs.uk/hip-pain/iliopsoas-syndrome/</a></p><p>[11] National Health Service. (2023, November 7). <em>Balance exercises</em>.<a href="https://www.nhs.uk/live-well/exercise/balance-exercises/" rel="external">https://www.nhs.uk/live-well/exercise/balance-exercises/</a></p><p>[12] American College of Sports Medicine, Exercise is Medicine. (2024). <em>Being active as we get older</em>.<a href="https://acsm.org/wp-content/uploads/EIM_Being-Active-as-We-Get-Older_Flyer_English.pdf" rel="external">https://acsm.org/wp-content/uploads/EIM_Being-Active-as-We-Get-Older_Flyer_English.pdf</a></p><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/mobility-stretching-and-strength-in-midlife">Mobility, Stretching and Strength in Midlife →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Before your watch changes your workout]]></title>
<description><![CDATA[Accuracy of a heart-rate sensor and usefulness of a readiness recommendation require different evidence.]]></description>
<link>https://www.andreheeg.com/archive/before-your-watch-changes-your-workout</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/before-your-watch-changes-your-workout</guid>
<pubDate>Wed, 16 Sep 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<h2>What?</h2><p>Last week, Apple introduced a readiness score for the Watch Series 12 and Ultra 4. This score combines your activity, sleep, and vital signs into a number from 0 to 10, with advice like “Recover” or “Go For It.”<a href="https://www.apple.com/newsroom/2026/09/apple-advances-health-and-fitness-capabilities-using-apple-intelligence/" rel="external">According to Apple,</a> it can help you plan your workouts and daily routine.</p><p>The new heart-rate sensor is backed by solid evidence. In a<a href="https://www.apple.com/health/pdf/Heart_Rate_Accuracy_Study_2026.pdf" rel="external">study by Apple</a> with 1,254 participants, the Series 12 showed lower heart-rate errors than six competing devices during workouts and daily activities.</p><p>That study only measured heart rate. It did not test if following the readiness recommendations actually improves fitness. From the public sources I checked up to September 15, I did not find any trials that answer this question for Apple’s new score.</p><h2>So what?</h2><p>I want to correct something from my recovery series. I said heart rate variability, or HRV, was “the single most reliable indicator of recovery status.” That was too strong. I also gave too much credit to what a morning reading can tell us about brain recovery.</p><p>HRV measures the variation in time between heartbeats and can help guide training. In a<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8705715/" rel="external">2021 trial by DeBlauw with 55 adults aged 18 to 35</a>, the group using HRV had fewer hard training days. Both groups improved, but there was no clear difference in fitness gains. Since this was a small trial with a set training plan, it might have missed some differences.</p><p>This gives me a good reason to use HRV: it can help decide when to take it easy during a tough session. However, the trial doesn't show that Apple’s score can make that choice.</p><p>I recommend using your training plan as a starting point. Use the score as a reminder to check your sleep, symptoms, and recent effort before making any changes.</p><h2>Now what?</h2><p>Before your next workout:</p><ul><li>Look at the details behind your score. See what changed in your sleep, activity, or vital signs. Make sure the recorded sleep and exercise match what you actually did.</li></ul><ul><li>Write a sentence about how tired or sore you feel and how you have been sleeping. Add anything else that feels unusual.</li></ul><ul><li>If you get a low score and also feel unusually tired or have slept poorly, pick the easier option in your plan. If your score and how you feel do not match, check the data before changing your session. If you are still unsure, go with a lighter workout.</li></ul><ul><li>If you are worried about any symptoms, talk to a doctor before exercising, no matter what your score says.<a href="https://support.apple.com/en-us/128112" rel="external">Apple’s instructions</a> also note that the score doesn’t account for all health conditions or medications and should not be used alone to decide whether it is safe to exercise.</li></ul><p>My practical advice is to take it easy if you are unsure about a session. This checklist has not been tested as a protocol for Apple’s score.</p><p>Stay healthy.</p><p>Andre</p>]]></content:encoded>
</item>
<item>
<title><![CDATA[Karla said people were too loud]]></title>
<description><![CDATA[Hearing assessment can address present communication difficulties. The dementia discussion must retain ACHIEVE's overall null result and the limits of its subgroup finding.]]></description>
<link>https://www.andreheeg.com/archive/karla-said-people-were-too-loud</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/karla-said-people-were-too-loud</guid>
<pubDate>Sun, 13 Sep 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>Karla said people were too loud. Everyday voices and normal sounds suddenly felt overwhelming to her.</p><p>About 15 months ago, doctors put small ventilation tubes in her eardrums. After years of struggling to hear us, our youngest could finally hear well enough to complain.</p><p>She’s six now, but her hearing problems started when she was a toddler or even a baby.</p><p>She made noises, but the words we hoped for didn’t come. She didn’t say Mom or Dad. While other children started talking, we tried to figure out what was going on.</p><p>By age three or four, she had created her own way of speaking. We slowly figured out which sounds meant she was hungry or needed the bathroom. Our family understood her, but others did not.</p><p>Sometimes she tried to tell us something we just couldn’t understand. She would get upset, break down, and cry on the floor. I still remember those moments. Watching your child struggle to make you understand is heartbreaking.</p><p>We realized that some of her reactions meant she couldn’t hear us or didn’t understand. We kept talking to her, and she kept trying. Remembering this still hurts.</p><h2>Karla had declined to participate</h2><p>We'd seen ear specialists, but several exams didn’t give us any answers. Hearing tests were hard, partly because she was so young and partly because she’s Karla. She is a wild one, and she simply didn’t want to cooperate with the tests.</p><p>Eventually, we got her into an early-childhood assessment program in Berlin. The program included checks on her development and neurology. Another ear exam found fluid in both of her middle ears.</p><p>The medical name is otitis media with effusion, usually called glue ear. Fluid collects behind the eardrum without an acute ear infection and can interfere with sound passing through the middle ear. Those little tubes let air into that space [1,2].</p><p>I still don’t know why it took so long. She struggled for about three years, and those years felt endless to us. I can’t figure out what the earlier exams might have missed.</p><p><strong>The doctor’s take:</strong> Persistent trouble with hearing or speech deserves an assessment that fits the child’s age and development [1]. A toddler’s refusal to cooperate leaves a question that still needs answering.</p><p>For those of us who spend much of our work listening to others, there’s an adult version of that same problem. You might get through a meeting but still struggle to follow what was said. In a senior job, you have to make decisions based on what you heard. At home, someone may need you to listen with more patience than you feel you have.</p><p>That’s why hearing should be part of any conversation about long-term performance. The effort it takes to listen can matter long before dementia is ever mentioned.</p><h2>You got the words right</h2><p>A standard hearing test checks how soft a sound you can hear at different pitches. But following someone speaking in background noise is much harder. Researchers call the mental work needed to overcome hearing problems <em>listening effort</em> [3].</p><p>In a 2025 study, Maggie Zink and colleagues compared adults aged 40–55 with adults aged 18–25. Everyone had normal results on standard hearing tests. In one moderately noisy condition, the middle-aged adults got the speech about as accurately as the younger ones, while changes in their pupils suggested greater effort after the sentences [4].</p><p>This was a small lab study, and the results depended on the test conditions and timing. They didn’t look at fatigue after a full workday. I would pay close attention to anyone who says they struggle in group conversations even if their hearing test is normal. NICE’s adult hearing guidelines also recognize that standard tests may not explain trouble hearing in noisy places [5].</p><p>If this sounds familiar, tell your hearing specialist exactly when and where you have trouble. It helps to explain whether it’s during a quiet talk, a group dinner, or a call with people talking at once [5].</p><p>In two lab experiments, Anastasios Sarampalis and his team tested young adults with normal hearing. Noise made it harder for them to remember words or respond to a visual task at the same time [6]. I think it’s important to consider the listening conditions before blaming every missed detail on memory problems.</p><h2>We were adding English to this</h2><p>Our two older children attend an international school. We speak German at home, but their friends, books, and Netflix choices make English a big part of their lives.</p><p>We enrolled Karla in the same kindergarten. She was already having trouble communicating, and now we were adding another language. We worried she might feel left out if she didn’t learn English like her siblings. We hoped she’d manage in either language, but we also wondered if we were making things harder for her.</p><p>The American Speech-Language-Hearing Association says that being multilingual doesn’t cause speech or language disorders [7]. Still, our decision about kindergarten left us with doubts. Parenting would be much easier if the research came with instructions for your own child.</p><p>Since the procedure, her speech has been catching up at a rate I still find astonishing. She practices a LOT, talking and asking questions until you can barely think straight.</p><p>A Cochrane review found that tubes can bring small improvements in hearing for children in the short and medium term, but it’s unclear if the benefits last [2]. Karla has also been getting speech therapy. Our experience may not be the same for every family.</p><p><strong>The doctor’s take:</strong> I would look into ongoing listening problems in anyone who feels worn out by calls. I’d also check their workload and overall health. There are many things at work that an audiologist can’t solve.</p><p>It’s important to know what to treat. A five-year study of 587 working adults found that worse hearing in noisy places was linked to a small increase in the need to recover after work [8]. Another study showed that people who got their first hearing aids felt less listening-related fatigue than those who didn’t, but their overall tiredness didn’t always get better [9]. A workplace hearing program tested in 136 employees didn’t show much improvement in recovery needs compared to usual care over a year [10].</p><p>In my Upward ARC framework, hearing is part of Capacity. I want you to be able to follow the conversations at work and still have the patience for the ones at home.</p><h2>The ears were a badge of honor</h2><p>My own ears have a less emotional story. Wrestling damaged both of them, and now they’re different shapes.</p><p>In wrestling, deformed ears can signal that you’re a proper fighter. I was skeptical of this idea. It gives a sport that damages your ears a very convenient reason to celebrate the damage.</p><p>When it happened to my ears, I took extra care treating them. Now, my ears look normal unless you look closely. But regular earbuds always fell out. Whatever respect my ears earned in wrestling didn’t help when I just wanted to make a phone call.</p><p>Eventually, I spent a lot on custom earphones. I went to a hearing aid shop and had molds made of my ears. The finished earpieces looked like the monitors musicians use on stage, and each one fit its ear perfectly.</p><p>After that, I could hear small changes in people’s voices on the phone, even their breathing. With earphones that finally stayed in, listening on calls felt like a superpower.</p><p>These are high-end earphones, but they don’t amplify sound like hearing aids. I’m just sharing my excitement about the purchase, not making any health claims. If regular earbuds don’t stay in your ears either, I get why you’d spend extra for a custom pair.</p><p>You can also help improve the sound for everyone else. In interviews with 14 Swedish employees with hearing loss, clear audio, visible speakers, and taking turns made video meetings easier to follow. Some even found video meetings easier than meeting in person [11]. These are personal experiences, not measured productivity.</p><p>If you’re in a senior role, you can ask for better microphones and speakers, and encourage people not to talk over each other. Try using captions if they help, and ask anyone struggling what makes meetings easier for them [5,11].</p><p>For adults with mild to moderate hearing loss, a recent Cochrane review of 16 trials found that hearing aids probably help people listen and take part in daily life. Most participants were older adults [12]. A 2017 review found no clear drop in listening effort and rated the evidence as very low [13]. These are different results. At follow-up, I’d ask if the conversation that brought you in has become easier, and adjust the care plan based on what’s still hard [5].</p><h2>What I’d promise someone worried about dementia</h2><p>I wrote about dementia last August. If you’re concerned about your memory, hearing research gives you a reason to pay attention; and a number that’s easy to misinterpret.</p><p>ACHIEVE tested hearing care against health education in 977 adults aged 70–84 with untreated hearing loss. Across the full trial, hearing care did not slow decline in memory and thinking-test scores over three years [14].</p><p>The 48% result comes from a planned analysis of 238 participants recruited from a long-running heart study. Those who received hearing care declined 48% less on cognitive tests over three years than those who received health education. These recruits were older and had more risk factors than the other participants. Their health-education group also declined faster than the other trial controls [14].</p><p>That treatment difference was about one-fifth of a standard deviation, a measure of the spread in test scores. New cognitive impairment wasn’t significantly reduced, either overall or in the heart-study group. This outcome included diagnosed dementia, milder diagnosed thinking or memory problems, or a sustained drop in test scores [14].</p><p>A large Danish study found a link between hearing loss and later dementia [15]. But studies like this can miss differences in education or access to care. The ACHIEVE trial tested treatment, and its authors think that slower decline in healthier participants may have made it harder to see a benefit. Preventing dementia through hearing care in middle age is still unproven.</p><p><strong>The doctor’s take:</strong> I’d address a hearing problem for the conversations it’s affecting today. The cognitive results add a reason to take it seriously as we age. I wouldn’t offer a 48% promise to someone sitting across from me.</p><h2>Try this today</h2><ul><li>Write down one situation where you often have trouble following speech. Schedule a hearing test and share that example, including any problems you have at home [5].</li></ul><ul><li>On your next tough call, try changing one thing, like using a clearer microphone, turning on captions, or making sure people take turns. See if it helps you follow the conversation [5,11].</li></ul><ul><li>If you already use hearing aids, mention any ongoing problems at your follow-up. Sometimes the fit needs adjusting, and your care plan should focus on what you still need to hear [5].</li></ul><ul><li>Protect your hearing during loud activities by using proper ear protection and avoiding harmful noise. Distracting office noise and noise that can damage your hearing are two different issues [16].</li></ul><p>If your hearing suddenly gets worse over three days or less, see a doctor within 24 hours [5].</p><h2>First day of school</h2><p>Karla still attends speech therapy, usually twice a week. Some words are hard for her, her sentences need improvement, and she’s still behind other kids her age.</p><p>Karla started school a week ago, with her preschool teachers fully recommending her for first grade. She was so proud, and I loved seeing her that way. A year and a half ago, I never would have imagined this.</p><p>I’m surprised it took me this long to write about her. For a long time, it felt too personal and too painful. Now, I think we’re far enough along to share our story, even though remembering her crying on the floor still hurts.</p><p>When do you find it hardest to follow a conversation? Reply and let me know. I read every message.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If someone you know keeps struggling to follow calls or conversations, please forward this to them. This is how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If a friend sent you this, you can get Under Load, my Sunday edition, at<a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a>.</p><div><hr></div><h2>References</h2><p>[1] National Institute for Health and Care Excellence. (2023, August 30). <em>Otitis media with effusion in under 12s</em> (NICE Guideline NG233).<a href="https://www.nice.org.uk/guidance/ng233/chapter/Recommendations" rel="external">https://www.nice.org.uk/guidance/ng233/chapter/Recommendations</a></p><p>[2] MacKeith, S., Mulvaney, C. A., Galbraith, K., Webster, K. E., Connolly, R., Paing, A., Marom, T., Daniel, M., Venekamp, R. P., Rovers, M. M., &amp; Schilder, A. G. M. (2023). Ventilation tubes (grommets) for otitis media with effusion (OME) in children. <em>Cochrane Database of Systematic Reviews, 2023</em>(11), Article CD015215.<a href="https://doi.org/10.1002/14651858.CD015215.pub2" rel="external">https://doi.org/10.1002/14651858.CD015215.pub2</a></p><p>[3] Pichora-Fuller, M. K., Kramer, S. E., Eckert, M. A., Edwards, B., Hornsby, B. W. Y., Humes, L. E., Lemke, U., Lunner, T., Matthen, M., Mackersie, C. L., Naylor, G., Phillips, N. A., Richter, M., Rudner, M., Sommers, M. S., Tremblay, K. L., &amp; Wingfield, A. (2016). Hearing impairment and cognitive energy: The Framework for Understanding Effortful Listening (FUEL). <em>Ear and Hearing, 37</em>(Suppl. 1), 5S–27S.<a href="https://doi.org/10.1097/AUD.0000000000000312" rel="external">https://doi.org/10.1097/AUD.0000000000000312</a></p><p>[4] Zink, M. E., Zhen, L., McHaney, J. R., Klara, J., Yurasits, K., Cancel, V. E., Flemm, O., Mitchell, C., Datta, J., Chandresekaran, B., &amp; Parthasarathy, A. (2025). Increased listening effort and cochlear neural degeneration underlie speech-in-noise deficits in normal-hearing middle-aged adults. <em>eLife, 13</em>, Article RP102823.<a href="https://doi.org/10.7554/eLife.102823" rel="external">https://doi.org/10.7554/eLife.102823</a></p><p>[5] National Institute for Health and Care Excellence. (2023, October 2). <em>Hearing loss in adults: Assessment and management</em> (NICE Guideline NG98).<a href="https://www.nice.org.uk/guidance/ng98/chapter/recommendations" rel="external">https://www.nice.org.uk/guidance/ng98/chapter/recommendations</a></p><p>[6] Sarampalis, A., Kalluri, S., Edwards, B., &amp; Hafter, E. (2009). Objective measures of listening effort: Effects of background noise and noise reduction. <em>Journal of Speech, Language, and Hearing Research, 52</em>(5), 1230–1240.<a href="https://doi.org/10.1044/1092-4388(2009/08-0111)" rel="external">https://doi.org/10.1044/1092-4388(2009/08-0111)</a></p><p>[7] American Speech-Language-Hearing Association. (n.d.). <em>Spoken language disorders</em> [Practice Portal]. Retrieved September 11, 2026, from<a href="https://www.asha.org/practice-portal/clinical-topics/spoken-language-disorders/" rel="external">https://www.asha.org/practice-portal/clinical-topics/spoken-language-disorders/</a></p><p>[8] van Leeuwen, L. M., Goderie, T., van Wier, M. F., Lissenberg-Witte, B. I., Lemke, U., &amp; Kramer, S. E. (2022). The longitudinal relationship between speech recognition in noise, need for recovery after work, job demand, and job control over a period of 5 years. <em>Ear and Hearing, 43</em>(2), 659–668.<a href="https://doi.org/10.1097/AUD.0000000000001127" rel="external">https://doi.org/10.1097/AUD.0000000000001127</a></p><p>[9] Holman, J. A., Drummond, A., &amp; Naylor, G. (2021). Hearing aids reduce daily-life fatigue and increase social activity: A longitudinal study. <em>Trends in Hearing, 25</em>, Article 23312165211052786.<a href="https://doi.org/10.1177/23312165211052786" rel="external">https://doi.org/10.1177/23312165211052786</a></p><p>[10] Gussenhoven, A. H. M., Anema, J. R., Witte, B. I., Goverts, S. T., &amp; Kramer, S. E. (2017). The effectiveness of a vocational enablement protocol for employees with hearing difficulties: Results of a randomized controlled trial. <em>Trends in Hearing, 21</em>, Article 2331216517692304.<a href="https://doi.org/10.1177/2331216517692304" rel="external">https://doi.org/10.1177/2331216517692304</a></p><p>[11] Marsja, E., Signoret, C., &amp; Stenbäck, V. (2026). The digital workplace and meeting accessibility: A qualitative study on listening effort in video meetings for employees with hearing loss. <em>WORK, 84</em>(1), 197–209.<a href="https://doi.org/10.1177/10519815251398498" rel="external">https://doi.org/10.1177/10519815251398498</a></p><p>[12] Ferguson, M. A., Sarant, J. Z., Bennett, R. J., McIlhiney, P., Badcock, N., &amp; Bothe, E. (2026). Hearing aids for mild to moderate hearing loss in adults. <em>Cochrane Database of Systematic Reviews, 2026</em>(8), Article CD012023.<a href="https://doi.org/10.1002/14651858.CD012023.pub3" rel="external">https://doi.org/10.1002/14651858.CD012023.pub3</a></p><p>[13] Ohlenforst, B., Zekveld, A. A., Jansma, E. P., Wang, Y., Naylor, G., Lorens, A., Lunner, T., &amp; Kramer, S. E. (2017). Effects of hearing impairment and hearing aid amplification on listening effort: A systematic review. <em>Ear and Hearing, 38</em>(3), 267–281.<a href="https://doi.org/10.1097/AUD.0000000000000396" rel="external">https://doi.org/10.1097/AUD.0000000000000396</a></p><p>[14] Lin, F. R., Pike, J. R., Albert, M. S., Arnold, M., Burgard, S., Chisolm, T., Couper, D., Deal, J. A., Goman, A. M., Glynn, N. W., Gmelin, T., Gravens-Mueller, L., Hayden, K. M., Huang, A. R., Knopman, D., Mitchell, C. M., Mosley, T., Pankow, J. S., Reed, N. S., . . . ACHIEVE Collaborative Research Group. (2023). Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): A multicentre, randomised controlled trial. <em>The Lancet, 402</em>(10404), 786–797.<a href="https://doi.org/10.1016/S0140-6736(23)01406-X" rel="external">https://doi.org/10.1016/S0140-6736(23)01406-X</a></p><p>[15] Cantuaria, M. L., Pedersen, E. R., Waldorff, F. B., Wermuth, L., Pedersen, K. M., Poulsen, A. H., Raaschou-Nielsen, O., Sørensen, M., &amp; Schmidt, J. H. (2024). Hearing loss, hearing aid use, and risk of dementia in older adults. <em>JAMA Otolaryngology–Head &amp; Neck Surgery, 150</em>(2), 157–164.<a href="https://doi.org/10.1001/jamaoto.2023.3509" rel="external">https://doi.org/10.1001/jamaoto.2023.3509</a></p><p>[16] National Institute on Deafness and Other Communication Disorders. (2025, April 16). <em>Noise-induced hearing loss</em>.<a href="https://www.nidcd.nih.gov/health/noise-induced-hearing-loss" rel="external">https://www.nidcd.nih.gov/health/noise-induced-hearing-loss</a></p><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/hearing-loss-listening-effort-and-cognition">Hearing Loss, Listening Effort and Cognition →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Semaglutide raised median mouse lifespan by 92 days]]></title>
<description><![CDATA[The 92-day gain is a survival result in older female mice. It does not establish semaglutide as a human longevity treatment.]]></description>
<link>https://www.andreheeg.com/archive/semaglutide-raised-median-mouse-lifespan-by-92-days</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/semaglutide-raised-median-mouse-lifespan-by-92-days</guid>
<pubDate>Wed, 09 Sep 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>Nature published a mouse study last Wednesday. If you keep up with longevity news, you’ve probably already seen the headline.</p><h2>What?</h2><p>On September 2, a team at Berkeley reported that semaglutide, the drug in Ozempic and Wegovy, increased the median lifespan of older female mice. Their median lifespan rose from 742 days to 834 days, a gain of 92 days, or about 12%. The treatment began when the mice were 20 months old, which is similar to a woman in her sixties. These mice were healthy, not obese.</p><p>The drug reduced the mice’s food intake by 24%. To compare, the team put 10 mice on the drug and 10 others on a diet with the same 24% reduction, then followed both groups for five months. The mice given the drug did better in three areas: exploratory drive, spatial memory, and blood sugar control. This research was publicly funded, and the University of California has applied for a patent to use these drugs for healthy aging.</p><h2>So what?</h2><p>Calorie restriction has increased lifespan in many lab animal studies. But keeping up a 24% reduction is tough for people: those in the CALERIE study, assigned to 25% restriction, managed about 12% over two years. In mice, semaglutide matched the food reduction and led to better results in three functional areas. However, they tested its survival benefit only against untreated controls.</p><p>This is the first longevity result in a while that I find truly interesting. The key comparison (drug versus diet for survival) is still ongoing, and they haven’t reported results yet. Nir Barzilai, a longevity researcher at the Albert Einstein College of Medicine who wasn’t involved in the study, put it well: &quot;Maybe calorie restriction increases the lifespan more? The data is not there, and it bugs me.&quot; When asked why the drug outperformed the diet on those three measures, Danica Chen, who led the study, replied, &quot;The short answer is: we don't know yet.&quot;</p><p>The study only used female mice of one strain, all living in cages. While it measured muscle function, it didn’t address a question I often see in practice: what happens when people combine the drug with progressive resistance training and enough protein.</p><h2>Now what?</h2><p>If you’re already taking semaglutide for a medical reason, this mouse study doesn’t give you any reason to change or stop your treatment. Keep progressive resistance training in your routine and talk to your doctor about making sure you get enough protein.</p><p>If you’re thinking about using semaglutide to slow aging, keep in mind that no randomized trial has tested it for human aging or used lifespan or healthspan as the main goal. The SELECT trial found fewer deaths in people at high risk for heart problems, but it wasn’t a longevity study.</p><p>The main evidence for humans is in cardiovascular risk, so that’s what you should discuss with your doctor. In the trial, 17,604 adults with heart disease, a BMI of 27 or higher, and no diabetes saw major heart events drop from 8.0% to 6.5% over about three years. Novo Nordisk, the company that sells the drug, funded the study.</p><p>The next time you see a claim that something &quot;extends lifespan,&quot; check which species, the sex, and the age at first dose before looking at the percentage. It only takes a few seconds and helps you make sense of most claims.</p><p>I’ll share more on this topic when the results from the ongoing survival comparison are available.</p><p>Stay healthy.</p><p>Andre</p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Primary research reference:</strong> The mouse study discussed above is available in Nature. Its survival result concerns older female mice; the comparison with matched calorie restriction concerns selected functional outcomes. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Human cardiovascular evidence:</strong> The human cardiovascular comparison comes from SELECT, which studied adults with established cardiovascular disease and overweight or obesity, without diabetes. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.nature.com/articles/s41586-026-10940-7" rel="external">Feng et al. (2026). Late-life semaglutide study in female mice.</a></li><li id="correction-ref-2"><a href="https://doi.org/10.1056/NEJMoa2307563" rel="external">Lincoff et al. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section>]]></content:encoded>
</item>
<item>
<title><![CDATA[Before you skip breakfast again]]></title>
<description><![CDATA[A daily eating window can help someone limit intake. The trials do not establish a universal window for weight loss, autophagy or longer life.]]></description>
<link>https://www.andreheeg.com/archive/before-you-skip-breakfast-again</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/before-you-skip-breakfast-again</guid>
<pubDate>Sun, 06 Sep 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>I knocked a boiled egg against the table, and the crack cut through the silence.</p><p>People turned and laughed. We were staying at a hotel for a week of leadership training, a program I respected because of the commitment it required. Both the morning session and my eating window started at 8:00.</p><p>I took the eggs from the breakfast buffet because I was hungry (and pragmatic). I told everyone it was my time to eat, don’t mind me, and then started breakfast in front of them.</p><p>remainingI still understand why that rule is appealing. With 16:8, you eat during an 8-hour window and fast for the other 16 hours. Once you pick your hours, you have fewer decisions to make. That can help if you want to eat less.</p><p>The problem is expecting that one rule to deliver all the benefits you’ve heard about fasting.</p><p>People have asked for my opinion twice in the last two weeks. My answer always starts with their goal. Someone who wants to lose weight needs a different approach than someone focused on living longer. At 47, with an unstable shoulder and a back that acts up if I stop training, I have my own priorities.</p><h2>Give the eating window a job</h2><p>If a daily eating window helps you eat fewer calories without worrying about food all morning, it’s a useful tool. You can see if it’s working by watching your eating habits and your weight.</p><p>You can also lose weight without it. In a year-long trial, Liu and colleagues gave 139 adults with obesity the same calorie target. Those who also ate between 8 a.m. and 4 p.m. lost 8.0 kg; those cutting calories without the window lost 6.3 kg. The researchers’ statistical analysis estimated an additional 1.8 kg of weight loss with the window, though the difference wasn’t statistically significant (P = 0.11) [1].</p><p>That P value needs some explanation. If the eating window adds no real benefit, a difference this big could still show up by chance in about 11 out of 100 similar studies. Researchers usually use 5 out of 100 as their cutoff. In this case, they couldn’t be sure the extra benefit wasn’t just due to chance.</p><p>Maruthur and colleagues tested the timing more directly by providing the same calories to both groups for 12 weeks. An early 10-hour window produced no detectable extra weight loss or improvement in blood-sugar control compared with usual eating [2]. The 41 participants had obesity and prediabetes or diet-controlled diabetes, so this answers a question about that schedule in that population.</p><p>As a doctor, I think a daily eating window is helpful if it makes it easier to manage how much you eat. I wouldn’t add it to a diet that’s already working, just to get extra weight loss from changing meal times.</p><p>There is a stronger weight-loss result for a more demanding schedule. In 4:3 fasting, you eat normally on 4 days of the week and cut your usual calories by about 80% on the other 3, with at least one normal eating day between them. Catenacci and colleagues assigned 165 adults with overweight or obesity to that approach or daily calorie restriction. After a year, those assigned to 4:3 had lost 2.89 kg more [3].</p><p>The estimate isn’t exact: the 95% confidence interval, which shows the range of results that fit the data, goes from 0.14 to 5.65 kg of extra weight loss. Both groups had the same weekly calorie goal, coaching, and activity targets. In reality, the fasting group ended up eating fewer calories, which might explain why they lost more weight.</p><p>It comes down to “it depends.” If your goal is weight loss and that approach fits your life, go for it. Skipping breakfast until noon is a different kind of commitment and needs separate evidence.</p><p>Alternate-day fasting has also been studied on its own. In a review of 99 trials, it was the only fasting method that showed a clear advantage over daily calorie restriction, with an average difference of 1.29 kg. However, this advantage disappeared in the 17 trials that lasted at least 24 weeks [4].</p><h2>I came back to fasting for a different reason</h2><p>I already knew that eating less could help me lose weight. Later, I became interested in autophagy, the process where cells break down and reuse old or damaged parts. Learning about autophagy and longevity led me back to fasting with a 16:8 schedule.</p><p>That’s a good reason to put up with hunger. You hope something helpful is happening in your body while you wait to eat.</p><p>There’s a lot of science behind autophagy. Yoshinori Ohsumi won the 2016 Nobel Prize in Physiology or Medicine for discovering how autophagy works in baker’s yeast [5]. Figuring out how many hours of fasting trigger this process in people is a different research challenge.</p><p>Researchers can measure the process as it moves through human white blood cells. They call this autophagic flux. In 2017, Pietrocola and colleagues used a laboratory test that compared cells with and without a substance that blocks their breakdown machinery. Among volunteers fasting for up to 4 days, one type of white blood cell showed signs of activated autophagy [6].</p><p>The biggest nutrition trial using this method followed 121 adults with obesity for six months. They fasted for 20 hours on three days each week. An analysis after data collection found a difference compared to standard care, but the fasting group’s improvement wasn’t statistically significant. Some of the difference may have come from the comparison group getting worse [7].</p><p>Krista Varady, a fasting researcher at the University of Illinois Chicago, puts the uncertainty about timing plainly:</p><p>“We just don’t know the hours of fasting; we don’t know the level of nutrient deprivation with carbs or protein that’s required to induce it” [8].</p><p>The fasting app Zero claims autophagy increases after 16 hours. Fastic says intermittent fasting activates autophagy and can help you stay in your prime years longer. Both apps sell subscriptions [9,10].</p><p>Fasting might trigger autophagy, but no study has shown exactly how many hours are needed. As a doctor, I wouldn’t suggest using an eating window just for autophagy.</p><h2>My body needs something different now</h2><p>When I was 16, I would go even without water before wrestling weigh-ins.</p><p>By that point, I had spent weeks cutting calories. In the last days, I ate very little, sometimes just broth, sometimes nothing at all. On the final day, I used the sauna to sweat off the last kilogram.</p><p>The method brought the number on the scale down. It also belongs to a dangerous part of wrestling’s history. In late 1997, 3 previously healthy college wrestlers in different states died while rapidly cutting weight. All had restricted food and fluid and tried to maximize sweating; they developed fatal overheating [11]. That combination of dehydration and heat is distinct from restricting the hours you eat. Obviously.</p><p>Now, I need enough strength to keep training despite the injuries I’ve picked up. My right shoulder has dislocated several times, even after surgery, and is still unstable. I believe keeping the muscles around it strong helps keep it in place.</p><p>My back is another reason I keep lifting weights. When I go on holiday and skip the gym for a couple of weeks, I feel my body get weaker, notice more back pain and twitching, and then feel better once I get back to regular weight training.</p><p>Some of that might be mental. This is just my own observation. I’ve never actually measured muscle loss from a training pause or fasting.</p><p>Keeping my strength up is now more important to me than squeezing my meals into a shorter window.</p><p>When you read a claim about fasting and muscle, check what the researchers measured. A body scan’s fat-free mass includes water and other tissue as well as muscle. Moro and colleagues followed trained men for a year, with 10 in each group. The normal-diet group gained fat-free mass; the researchers couldn’t distinguish the 16:8 group’s change from chance [12].</p><p>The results differed between the groups, and the window group reported eating less. These findings are worth noting, but they don’t prove that fasting caused the men to lose muscle.</p><p>There’s also evidence that you can gain muscle while eating within a window. In an eight-week trial, women who lifted weights and ate about 1.6 grams of protein per kilogram of body weight each day gained 2% to 3% fat-free mass in all groups, with no clear difference between them [13]. It was a small study: only 24 of 40 women qualified for that analysis, and a supplement company funded it.</p><p>To me, these findings show it’s important to focus on what you eat during your window. My clinical advice is to make sure you get enough training and protein before you start limiting your meal times. The way I handle protein depends on how much I’m training, and I will write a refresher on protein soon.</p><p>In my Upward ARC framework, nutrition is part of the Activate step. I judge it partly by whether it lets me keep training and stay strong with the body I have.</p><h2>Try this today</h2><ul><li>For weight loss, see if a daily eating window helps you eat less and fits your routine. Think about the stricter 4:3 schedule separately.</li></ul><ul><li>If you’re only keeping an eating window to reach a certain hour for autophagy, it’s worth rethinking that choice.</li></ul><ul><li>If your goal is to stay strong, make sure you have enough food and time for training. A shorter eating window should fit around those needs.</li></ul><h2>You still have to get through your day</h2><p>When I used an eating window, I often crashed in the afternoon. Having a protein-rich breakfast after training worked better for me.</p><p>A review of 71 studies with 3,484 healthy adults found no clear difference in thinking skills between fasting and eating. Most fasts lasted 12 hours, but longer fasts showed small declines [14]. Your own workday is a good way to see if the schedule helps you focus or just leaves you hungry and distracted.</p><p>In 17 trials, fasting and daily calorie restriction didn’t show a clear difference in hunger or fullness, though all the studies had some bias concerns [15]. If you feel better using an eating window, that should count in your decision too.</p><p>My advice is to stop forcing yourself to stick to an eating window if you spend your mornings thinking about food, crash in the afternoon, or keep missing dinners you want to attend. I’d count business dinners just as much as family ones.</p><p>I usually finish dinner two to three hours before bed. There’s some evidence for eating earlier in the evening: a 7.5-week trial in 39 adults with overweight or obesity found that ending meals at least three hours before sleep improved the overnight drop in the lower blood pressure number. It didn’t help with the other main outcome: how well the body responds to insulin, the hormone that controls blood sugar [16]. Both groups dimmed the lights three hours before bed, so the only difference was meal timing. This doesn’t mean there’s a universal dinner deadline.</p><p>Long-term health effects are harder to pin down. A 2025 study followed 19,831 adults for about 8 years and found that eating within less than 8 hours was linked to a higher risk of death from heart and circulatory disease compared to eating over 12 to 14 hours [17]. But eating hours were estimated from just two days of food recall, so there’s a lot of uncertainty about people’s real habits and whether the short window actually caused the higher risk.</p><p>Another analysis of the same survey and death records found the lowest risk of death from any cause was around 11 to 12 hours [18]. The authors used different rules and statistical methods. Both papers used overlapping data, and neither one proves what a safe eating window is.</p><p>In a newsletter in May 2025, I was too sure about preserving lean mass and left out the mortality finding that was already in my research notes. So here's the full picture.</p><p>I don’t need a fixed eating window to manage my calories anymore. On training mornings, I drink my usual warm water, work out, and shower before breakfast. I usually have eggs or muesli with Greek yogurt, plus a big protein shake. On other mornings, I might write for about two hours before eating.</p><p>Reply and let me know what you hoped fasting would do for you. I read every message.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you know someone trying to pick a fasting schedule, feel free to share this with them. This is how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If someone forwarded this to you, you can sign up for free at<a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a>.</p><div><hr></div><h2>References</h2><p>[1] Liu, D., Huang, Y., Huang, C., Yang, S., Wei, X., Zhang, P., Guo, D., Lin, J., Xu, B., Li, C., He, H., He, J., Liu, S., Shi, L., Xue, Y., Zhang, H. (2022). Calorie restriction with or without time-restricted eating in weight loss. <em>New England Journal of Medicine, 386</em>(16), 1495-1504.<a href="https://doi.org/10.1056/NEJMoa2114833" rel="external">https://doi.org/10.1056/NEJMoa2114833</a></p><p>[2] Maruthur, N. M., et al. (2024). Effect of isocaloric, time-restricted eating on body weight in adults with obesity: A randomized controlled trial. <em>Annals of Internal Medicine, 177</em>(5), 549-558.<a href="https://doi.org/10.7326/M23-3132" rel="external">https://doi.org/10.7326/M23-3132</a></p><p>[3] Catenacci, V. A., et al. (2025). The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months. <em>Annals of Internal Medicine, 178</em>(5), 634-644.<a href="https://doi.org/10.7326/ANNALS-24-01631" rel="external">https://doi.org/10.7326/ANNALS-24-01631</a></p><p>[4] Semnani-Azad, Z., et al. (2025). Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: Systematic review and network meta-analysis of randomized clinical trials. <em>BMJ, 389</em>, e082007.<a href="https://doi.org/10.1136/bmj-2024-082007" rel="external">https://doi.org/10.1136/bmj-2024-082007</a></p><p>[5] Nobel Assembly at Karolinska Institutet. (2016, October 3). <em>The Nobel Prize in Physiology or Medicine 2016</em>.<a href="https://www.nobelprize.org/prizes/medicine/2016/press-release/" rel="external">https://www.nobelprize.org/prizes/medicine/2016/press-release/</a></p><p>[6] Pietrocola, F., et al. (2017). <em>Autophagy, 13</em>(3), 567-578.</p><p>[7] Bensalem, J., et al. (2025). <em>The Journal of Physiology, 603</em>, 3019-3032.<a href="https://doi.org/10.1113/JP287938" rel="external">https://doi.org/10.1113/JP287938</a></p><p>[8] Inverse. (2021, updated 2024). <em>Stop trying to trigger autophagy</em>.<a href="https://www.inverse.com/mind-body/stop-trying-to-trigger-autophagy" rel="external">https://www.inverse.com/mind-body/stop-trying-to-trigger-autophagy</a></p><p>[9] Zero. (n.d.). <em>Fast your way to autophagy</em>. Accessed September 5, 2026.<a href="https://zerolongevity.com/blog/fast-your-way-to-autophagy/" rel="external">https://zerolongevity.com/blog/fast-your-way-to-autophagy/</a></p><p>[10] Fastic. (n.d.). <em>Intermittent fasting app</em>. Accessed September 5, 2026.<a href="https://fastic.com/en" rel="external">https://fastic.com/en</a></p><p>[11] Centers for Disease Control and Prevention. (1998). Hyperthermia and dehydration-related deaths associated with intentional rapid weight loss in three collegiate wrestlers, North Carolina, Wisconsin, and Michigan, November-December 1997. <em>MMWR Morbidity and Mortality Weekly Report, 47</em>(6), 105-108.</p><p>[12] Moro, T., et al. (2021). Twelve months of time-restricted eating and resistance training improves inflammatory markers and cardiometabolic risk factors. <em>Medicine &amp; Science in Sports &amp; Exercise</em>.<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10115489/" rel="external">https://pmc.ncbi.nlm.nih.gov/articles/PMC10115489/</a></p><p>[13] Tinsley, G. M., et al. (2019). Time-restricted feeding plus resistance training in active females: A randomized trial. <em>American Journal of Clinical Nutrition, 110</em>(3), 628-640.<a href="https://doi.org/10.1093/ajcn/nqz126" rel="external">https://doi.org/10.1093/ajcn/nqz126</a></p><p>[14] Bamberg, C., &amp; Moreau, D. (2025). <em>Psychological Bulletin, 151</em>(9).<a href="https://doi.org/10.1037/bul0000492" rel="external">https://doi.org/10.1037/bul0000492</a></p><p>[15] Elsworth, R. L., et al. (2023). The effect of intermittent fasting on appetite: A systematic review and meta-analysis. <em>Nutrients, 15</em>(11), 2604.<a href="https://doi.org/10.3390/nu15112604" rel="external">https://doi.org/10.3390/nu15112604</a></p><p>[16] Grimaldi, D., et al. (2026). <em>Arteriosclerosis, Thrombosis, and Vascular Biology, 46</em>(4), e323355.<a href="https://pubmed.ncbi.nlm.nih.gov/41674465/" rel="external">https://pubmed.ncbi.nlm.nih.gov/41674465/</a></p><p>[17] Chen, M., et al. (2025). <em>Diabetes &amp; Metabolic Syndrome, 19</em>(7), 103278.<a href="https://doi.org/10.1016/j.dsx.2025.103278" rel="external">https://doi.org/10.1016/j.dsx.2025.103278</a></p><p>[18] Mao, Z., et al. (2025). <em>Aging Cell, 24</em>(11), e70230.<a href="https://doi.org/10.1111/acel.70230" rel="external">https://doi.org/10.1111/acel.70230</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Completed reference 6:</strong> The complete reference is Pietrocola et al. (2017), Metabolic effects of fasting on human and mouse blood in vivo, Autophagy, 13(3), 567–578. The title and DOI were missing from the sent bibliography. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://doi.org/10.1080/15548627.2016.1271513" rel="external">Pietrocola et al. (2017). fasting and human and mouse blood.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/intermittent-fasting-weight-loss-and-autophagy">Intermittent Fasting, Weight Loss and Autophagy →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[The number behind a 30% statin result]]></title>
<description><![CDATA[A 9,971-person statin trial cut cardiovascular events in healthy older adults. The absolute benefit depends on your starting risk.]]></description>
<link>https://www.andreheeg.com/archive/the-number-behind-a-30-statin-result</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-number-behind-a-30-statin-result</guid>
<pubDate>Wed, 02 Sep 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<h2>What?</h2><p>On Saturday, researchers shared the results of the STAREE trial at a cardiology congress in Munich, and the full paper appeared in the New England Journal of Medicine the same day. In this study, 9,971 adults aged 70 and older, who did not have heart disease, diabetes, or dementia at the start, received either 40 mg of atorvastatin or a placebo.</p><p>The trial set out to answer two main questions. First, it tracked heart attacks, strokes, cardiac deaths, and stent procedures. After about 5.9 years, 6.0% of people taking the drug had these events, compared to 8.3% on placebo. That 30% difference means 2.3 fewer people out of every 100 had these problems. Second, the study looked at whether the drug helped people live longer without dementia or physical disability. Here, those outcomes hit 12.8% of the drug group and 13.6% on placebo, a small difference that could have happened by chance.</p><h2>So what?</h2><p>Statins are among the most thoroughly studied drugs in medicine. Results from 27 randomized trials show they help prevent major vascular events, even for people at low risk. Even in that low-risk group, every 1 mmol/L drop in LDL cholesterol prevents about 11 events per 1,000 people over five years. The researchers concluded that the benefits are much greater than any known risks. If you already take a statin, there is no reason to stop based on this new study.</p><p>The real question is what benefit you personally might get. In Munich, that 2.3 in 100 came from adults with an average age of 74. In March, new US guidelines made 21.5 million more people eligible for statins. These people are younger and have a lower risk, with an average 3.1% risk over ten years. For them, the same 30% reduction means even fewer people benefit, but this is not always made clear. In Europe, the SCORE2 system is used, and the math works out the same.</p><p>The STAREE trial does not give information for people who are 50 years old. All participants were at least 70, and anyone with heart disease, diabetes, or dementia was excluded. So, you need to find out your own risk numbers.</p><h2>Now what?</h2><ul><li>If you already take a statin, do not change your prescription until you talk with your doctor. Make sure to mention any symptoms or concerns at that visit.</li></ul><ul><li>Ask your doctor for your current risk estimate. In the US, learn about PREVENT and its 10-year and 30-year risk numbers. In Europe, ask which SCORE2 or SCORE2-OP estimate applies to you.</li></ul><ul><li>Review your ApoB and your one-time Lp(a) test result with your doctor. Try to keep ApoB below 80 mg/dL, or below 65 if you already have disease or a strong family history. Ask if a CAC score could change your risk category.</li></ul><ul><li>Ask your doctor this specific question: “With this dose, how many percentage points will my risk go down over the years I am likely to take it?”</li></ul><ul><li>At the same visit, ask about possible downsides. Serious side effects happened at the same rate in both groups, 2.7%. However, muscle, liver, and blood sugar problems were more common in people taking the drug.</li></ul><p>You can find out your own risk number. Go and get it.</p><p>Stay healthy.</p><p>Andre</p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated September 3, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>A 30% relative result is not a personal estimate:</strong> STAREE's 30% relative reduction was observed in adults aged 70 or older without prior cardiovascular disease, diabetes or dementia. It should not be applied directly to younger or lower-risk people. Across statin trials, the relative reduction averages about 21% per 1 mmol/L reduction in LDL cholesterol, while the absolute benefit depends on starting risk, the LDL reduction achieved and time on treatment. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Using PREVENT and SCORE2:</strong> PREVENT estimates primary-prevention risk for US adults aged 30 to 79. SCORE2 and SCORE2-OP are calibrated for European populations aged 40 to 89 without known cardiovascular disease. The European guideline advises against recalculating risk with on-treatment cholesterol values. People already taking lipid-lowering medication need interpretation based on their pretreatment risk and response. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>The ApoB numbers are editorial targets:</strong> The ApoB targets below 80 mg/dL, or below 65 mg/dL for higher-risk readers, are not universal goals in the 2026 US guideline. That guideline centers LDL and non-HDL cholesterol goals and uses ApoB selectively, especially when triglycerides exceed 200 mg/dL, diabetes is present or LDL is already below 70 mg/dL. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>What Lp(a) and a calcium scan add:</strong> Current US guidance supports measuring lipoprotein(a) at least once, with 125 nmol/L or 50 mg/dL as a risk-enhancing level. Coronary-artery calcium can reclassify risk when a treatment decision remains uncertain. The scan informs the decision; it does not prescribe treatment by itself. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>What the 2.7% safety number covered:</strong> In STAREE, serious adverse events occurred in 2.7% of each group. That figure does not cover every symptom or side effect. Musculoskeletal, hepatobiliary and diabetes-related adverse-event categories were reported more often with atorvastatin, so individual tolerability and monitoring still matter. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/22607822/" rel="external">Cholesterol Treatment Trialists' Collaboration. Statins in people at low risk of vascular disease. The Lancet, 2012.</a></li><li id="correction-ref-2"><a href="https://academic.oup.com/eurheartj/article/46/42/4359/8234482" rel="external">European Society of Cardiology. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.</a></li><li id="correction-ref-3"><a href="https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia/top-things-to-know" rel="external">American Heart Association and American College of Cardiology. 2026 Guideline on the Management of Dyslipidemia.</a></li><li id="correction-ref-4"><a href="https://www.nejm.org/doi/abs/10.1056/NEJMoa2607314" rel="external">STAREE Investigators. Atorvastatin in Healthy Older Persons. New England Journal of Medicine, 2026.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section>]]></content:encoded>
</item>
<item>
<title><![CDATA[Sixty Kilos Felt Heavy on a Morning When Nothing Was Wrong]]></title>
<description><![CDATA[What sleep loss, cortisol testing, work detachment and falling capacity reveal about recovery under sustained load.]]></description>
<link>https://www.andreheeg.com/archive/sixty-kilos-felt-heavy-on-a-morning-when-nothing-was-wrong</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/sixty-kilos-felt-heavy-on-a-morning-when-nothing-was-wrong</guid>
<pubDate>Sun, 30 Aug 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>I slid 20 kilograms onto each side of the bar and stepped under it.</p><p>I started in my home gym with just the empty bar, which already felt heavier than normal. A weight I usually lift without thinking. Now the bar was 60 kilograms. Ten reps at that weight are usually just a warm-up for me. I know my body and what it can handle, so this should have been easy.</p><p>At 60 kilograms, I immediately felt that something was off.</p><p>I felt weak and my muscles just wouldn’t work the way they normally do. I tried jumping to wake myself up, slapped my face, and turned up the music, hoping for a burst of energy.</p><p>By rep 5, I had to stop and reset.</p><p>“This isn’t a warm-up.”</p><p>If this had only happened once, I would have just called it a bad session. But it kept going for a week or two.</p><p>When I say I did everything ‘right,’ I mean everything my career had taught me to do. But my body needed something else. I was doing everything ‘right’ except for the one thing I never thought of as work.</p><h2>When discipline stops paying</h2><p>I believed anyone could do it if they wanted it badly enough and went after it.</p><p>Discipline was always at the center of what I believed. If something was tough, I just pushed through. When my days got busy, I slept less. If I had 30 free minutes, I filled them with something productive. I was proud that I never just sat on the couch.</p><p>I also thought the usual rules about rest and recovery didn’t apply to me.</p><p>“I’m the one who’s built differently.”</p><p>I believed I could manage on just 4 or 5 hours of sleep. My favorite saying was, “I sleep when I’m dead.” Not giving my best felt like wasting time. I was proud of that attitude, and it helped me for much of my career. Whenever I felt tired or unfocused, I just pushed myself harder.</p><p>A 2022 meta-analysis pooled 227 outcomes from 77 participant pools involving 959 participants. The review compared sleep duration at or below 6 hours with duration above 6 hours. The pooled reduction in exercise performance was 7.56% (95% CI, 3.13% to 11.9% lower). For maximal-strength tests, 66 outcomes from 25 participant pools involving 289 participants produced a pooled reduction of 2.85% (95% CI, 1.23% to 4.47% lower) [1].</p><p><strong>The doctor’s take:</strong> The averages show that losing sleep can hurt exercise performance, but they don’t really explain what happened to me. Most of the study participants were men, and the results were all over the place. The review didn’t include people with ongoing sleep loss, sleep disorders, or shift work, and my struggles lasted a week or two. The strength results were from maximum-effort tests, but I was just doing warm-up reps. So, I see sleep loss as one possible reason, but this study doesn’t give me a clear answer.</p><h2>The gap between feeling and function</h2><p>In 2003, researchers put healthy adults aged 21 to 38 through 2 weeks of restricted sleep. Researchers assigned 35 people to 4, 6, or 8 hours in bed each night. The 4-hour and 6-hour groups developed cumulative, dose-dependent losses on tests of vigilance, working memory and cognitive throughput compared with the 8-hour group [2].</p><p>As a group, people felt sleepier at first, but that feeling didn’t change much after that. Their actual performance kept getting worse. The researchers said people didn’t really notice how much they were slipping. The study didn’t prove that those who did the worst were the least aware.</p><p>I’ve noticed this mentally too. Sometimes I read the same paragraph four times and still can’t remember it. I open a presentation and can’t finish a single slide without starting over. At home, I feel it emotionally. My patience runs thin, and I overreact to small problems with my kids.</p><p><strong>The doctor’s take:</strong> The study measured time in bed, not actual sleep, and only six women were included out of 48 people. It was done in a lab setting. The finding about awareness was seen in the group as a whole, not in individuals. If you keep struggling with a simple task, notice it before judging yourself. A tough squat, a blank slide, or a short temper can have many causes. I treat these changes as signals. If your usual performance drops, don’t just push harder without asking why.</p><h2>I kept driving</h2><p>My wife was asleep next to me during an evening drive on a weekend trip in Germany. The week before, I hadn’t slept well, ate at odd times, and drank too much coffee.</p><p>I fought off sleep for about an hour. I opened the window, had another energy drink, and turned up the music. Still, I kept driving.</p><p>I do not remember falling asleep.</p><p>I remember a loud rattling and the car shaking. When I looked up, we were off the road in the grass. I think I lost about 10 to 20 seconds, but I can’t be sure. I was probably driving around 130 to 140 kilometers per hour. Luckily, no other cars were nearby, and the only damage was a few scratches that could be fixed.</p><p>I pulled over at the next parking area, slept for a while, and then kept driving. I don’t see that nap as proof that the rest of the drive was safe.</p><p>Looking back, I know I was irresponsible. I put my life and my wife’s life at risk. I can’t let that happen again.</p><p>For adults aged 18 to 60, a joint sleep-medicine consensus recommends 7 or more hours of sleep each night on a regular basis. The same statement associates regular short sleep with impaired performance, more errors, and greater risk of accidents [3].</p><h2>Looking for a number</h2><p>I also took a salivary cortisol test while searching for a number that might explain what was happening.</p><p>A systematic review of 190 studies found insufficient evidence to establish cortisol secretion patterns in burnout, partly because burnout was measured inconsistently across studies [4]. A separate review by 2 endocrinologists covered 58 heterogeneous studies and found no proof of the specific condition called adrenal fatigue. In 16 of 26 studies of the daily salivary cortisol rhythm, fatigued patients did not differ from controls [5].</p><p><strong>The doctor’s take:</strong> These reviews cover different topics. Research on burnout hasn’t found a clear cortisol pattern for diagnosis. Adrenal fatigue is a separate idea, and not all 58 studies tested it directly. Neither review says burnout or exhaustion aren’t real. My test is just one part of my search, even though it didn’t give me an answer.</p><p>You can now buy a cortisol curve as a stress score. Saliva cortisol is a real test, and doctors use it to screen for Cushing’s syndrome, so the lab work is sound. Those kits skip how much your own curve moves from one day to the next. A meta-analysis across 11 studies and 3,307 people found agreement between one day and the next running from zero to moderate, and the morning cortisol rise that many kits sell scored 0.29, which the authors call poor [6]. If someone sells you a cortisol score, ask how many days they measured.</p><h2>What I can move</h2><p>From my experience, and in most work environments, it’s usually only possible to adjust your workload a little. I’ve found it’s easier to make changes to recovery, though that gets harder when demands go up or when things like caregiving, shift work, or money get in the way.</p><p>A meta-analysis found that greater job demands were associated with less psychological detachment across 60 effect sets involving 28,507 employees. Psychological detachment is the concept of your mind leaving your work, similar to your body. In 23 effect sets involving 7,007 employees, greater detachment was associated with less exhaustion [7].</p><p><strong>The doctor’s take:</strong> Job demands are more than just workload. The studies were very different, and the results weren’t always clear. Most of the data came from self-reports and single points in time, so we can’t say for sure that detachment lowers exhaustion. In my own life, I can’t usually get rid of work, but I can often save a bit of time in the evening, on weekends, or during the day.</p><p>One morning in our hallway in Berlin, while the kids got ready for school, I sat on a small stool to put on my shoes. My back pain had been getting worse for weeks. I kept avoiding my socks all morning because bending over hurt. I tried to make my request for help sound casual and blamed it on being in a hurry.</p><p>“Can you quickly help me?”</p><p>My wife looked at me. She had reason to check because I sometimes play tricks on her.</p><p>“Really? Are you serious? You can do this on your own, right?”</p><p>Soon I needed that help regularly.</p><h2>Recovery belongs in the equation</h2><p>I published The Upward ARC in May 2025, where I organized good habits into three categories: Activate, Recover, and Capacity. Looking back, I would write it differently now.</p><p>Activate means deliberate load on a system. A training session is load. So are sustained concentration, emotional control, and the repeated decisions of a senior role.</p><p>Recover is the time the system has to respond to that load.</p><p>Capacity is the output that follows.</p><p>Now, I see these three categories as a loop and focus more on what happens after the effort. Finishing a workout or a document is just the input. The real result is what I can do after my body or mind has had time to recover. If recovery time keeps shrinking, the same effort starts to feel harder.</p><p>This is the approach I use in my own life. There isn’t proof of one universal biological loop for strength, thinking, and emotions. Sports medicine gives us the clearest example. Experts from the European College of Sport Science and the American College of Sports Medicine agree that good athletic training needs enough challenge, but not too much without enough recovery. If you build up too much stress, from training or life, it can take days or even weeks to recover [8].</p><p>What I’ve learned at work is that load and recovery need to be balanced. If demands keep coming and recovery isn’t enough, pushing harder just adds more strain. Eventually, your capacity levels off and then drops.</p><p>I break down capacity into three areas: physical, cognitive, and social-emotional. Physical capacity is when the bar suddenly feels heavy. Cognitive capacity is when you can’t remember a paragraph. Social-emotional capacity is when you can’t find your usual patience. This is the framework I use in my work.</p><p><strong>The doctor’s take:</strong> If my usual performance drops for several days, I focus on recovery before pushing myself harder. I ask if I’ve given myself enough time to recover from what I’ve already done. There’s a time component to this. Sometimes it makes sense to push through and take on more. Then you recover and bounce back. But it doesn’t work to push for long periods without a break.</p><p>This changes how I read a recent edition about choosing the few habits that survive a hard week: <a href="https://www.andreheeg.com/archive/you-already-know-what-to-do-that/" rel="external">https://www.andreheeg.com/archive/you-already-know-what-to-do-that/</a></p><h2>Try this today</h2><ul><li>Set a minimum amount of sleep and stick to it. Experts recommend at least seven hours a night for adults aged 18 to 60 [3]. This is the minimum for good health, but seven hours doesn’t always mean you’ll feel fully rested.</li><li>When I have to choose, I pick sleep. If it’s between a 5:30 workout or an extra hour in bed, I choose the sleep. That’s what I do, even though no study has directly compared these two options.</li><li>Take short breaks during your workday. I like to go for a walk or do some breathing exercises. A meta-analysis of 22 samples found that breaks of 10 minutes or less gave a small boost in how people felt, but didn’t make a big difference in performance. Only less demanding tasks showed a clear benefit, and longer breaks helped more [9].</li><li>Stay in touch with people who aren’t connected to your work. When I’m in Berlin, or when my travel schedule allows, I try to meet a friend and talk about things outside of my job. Stronger social relationships were linked to a 50% higher chance of survival in 148 studies with over 300,000 people [10]. How social relationships are defined affects the size of this link. The study doesn’t prove that social contact helps with recovery, but that’s how I see it, and it’s why I keep up this habit.</li><li>Pay attention to slow changes over time. I watch for shifts in my physical, mental, and emotional capacity during everyday tasks, like how a warm-up feels, if I have to reread a document, or how I react to small family issues. This is what I do, without relying on any device or diagnosis.</li></ul><p>Recovery still isn’t easy for me. I usually manage to get enough sleep now, but it’s easy to let social connections slide. I often get caught up in work and realize late in the day that I haven’t eaten properly or had enough water.</p><p>Effort has paid off for me most of my life, and I still value it. Now, I try to use some of that discipline for sleep, breaks, and spending time with people outside of work.</p><p>Which type of capacity drops first for you: physical, cognitive, or social-emotional? Reply with just one word. I read every response.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you know someone who always tries to fight exhaustion by working harder, please forward this edition to them. That’s how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If a friend sent you this, you can sign up for Under Load, my Sunday edition, at <a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a></p><div><hr></div><h2>References</h2><p>[1] Craven, J., McCartney, D., Desbrow, B., Sabapathy, S., Bellinger, P., Roberts, L., &amp; Irwin, C. (2022). Effects of acute sleep loss on physical performance: A systematic and meta-analytical review. <em>Sports Medicine, 52</em>(11), 2669-2690.</p><p>[2] Van Dongen, H. P. A., Maislin, G., Mullington, J. M., &amp; Dinges, D. F. (2003). The cumulative cost of additional wakefulness: Dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. <em>Sleep, 26</em>(2), 117-126.</p><p>[3] Watson, N. F., Badr, M. S., Belenky, G., Bliwise, D. L., Buxton, O. M., Buysse, D., Dinges, D. F., Gangwisch, J., Grandner, M. A., Kushida, C., Malhotra, R. K., Martin, J. L., Patel, S. R., Quan, S. F., &amp; Tasali, E. (2015). Recommended amount of sleep for a healthy adult: A joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. <em>Journal of Clinical Sleep Medicine, 11</em>(6), 591-592.</p><p>[4] Rothe, N., Steffen, J., Penz, M., Kirschbaum, C., &amp; Walther, A. (2020). Examination of peripheral basal and reactive cortisol levels in major depressive disorder and the burnout syndrome: A systematic review. <em>Neuroscience &amp; Biobehavioral Reviews, 114</em>, 232-270.</p><p>[5] Cadegiani, F. A., &amp; Kater, C. E. (2016). Adrenal fatigue does not exist: A systematic review. <em>BMC Endocrine Disorders, 16</em>, 48.</p><p>[6] Norton, S. A., Baranger, D. A. A., Young, E. S., Voss, M., Hansen, I., Bondy, E., Rodrigues, M., Paul, S. E., Edershile, E., Hill, P. L., Oltmanns, T. F., Simpson, J., &amp; Bogdan, R. (2023). Reliability of diurnal salivary cortisol metrics: A meta-analysis and investigation in two independent samples. <em>Comprehensive Psychoneuroendocrinology, 16</em>, 100191.</p><p>[7] Wendsche, J., &amp; Lohmann-Haislah, A. (2017). A meta-analysis on antecedents and outcomes of detachment from work. <em>Frontiers in Psychology, 7</em>, 2072.</p><p>[8] Meeusen, R., Duclos, M., Foster, C., Fry, A., Gleeson, M., Nieman, D., Raglin, J., Rietjens, G., Steinacker, J., &amp; Urhausen, A. (2013). Prevention, diagnosis, and treatment of the overtraining syndrome: Joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. <em>Medicine &amp; Science in Sports &amp; Exercise, 45</em>(1), 186-205.</p><p>[9] Albulescu, P., Macsinga, I., Rusu, A., Sulea, C., Bodnaru, A., &amp; Tulbure, B. T. (2022). “Give me a break!” A systematic review and meta-analysis on the efficacy of micro-breaks for increasing well-being and performance. <em>PLOS ONE, 17</em>(8), e0272460.</p><p>[10] Holt-Lunstad, J., Smith, T. B., &amp; Layton, J. B. (2010). Social relationships and mortality risk: A meta-analytic review. <em>PLOS Medicine, 7</em>(7), e1000316.</p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated September 3, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>The 7.56% performance estimate:</strong> The pooled result came from 227 outcomes in 69 publications, not a prediction for one person's next session. Participants were 89% male, heterogeneity was very high, and timing mattered: afternoon performance was more consistently impaired than morning performance. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Cortisol is not a burnout score:</strong> Cortisol has valid clinical uses when the question, timing and collection protocol are defined. The burnout literature has not produced a consistent diagnostic pattern, and common one-day salivary features, especially the cortisol awakening response, have poor test-retest reliability. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>What microbreak trials measured:</strong> Microbreak studies suggest small improvements in vigor and fatigue, but effects vary with task and break length. They do not establish that a particular break schedule treats burnout or restores capacity after chronic sleep loss. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Social connection and survival:</strong> The 50% figure is a pooled association from observational studies using varied measures of social relationships. It is not a trial result and does not estimate how much a particular friendship habit changes an individual's survival or recovery. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/35708888/" rel="external">Craven, J., McCartney, D., Desbrow, B., et al. (2022). Effects of acute sleep loss on physical performance: A systematic and meta-analytical review. Sports Medicine, 52(11), 2669–2690. https://doi.org/10.1007/s40279-022-01706-y</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/32088345/" rel="external">Rothe, N., Steffen, J., Penz, M., Kirschbaum, C., &amp; Walther, A. (2020). Examination of peripheral basal and reactive cortisol levels in major depressive disorder and the burnout syndrome. Neuroscience &amp; Biobehavioral Reviews, 114, 232–270. https://doi.org/10.1016/j.neubiorev.2020.02.024</a></li><li id="correction-ref-3"><a href="https://doi.org/10.1371/journal.pone.0272460" rel="external">Albulescu, P., Macsinga, I., Rusu, A., Sulea, C., Bodnaru, A., &amp; Tulbure, B. T. (2022). Give me a break! A systematic review and meta-analysis on the efficacy of micro-breaks. PLOS ONE, 17(8), e0272460. https://doi.org/10.1371/journal.pone.0272460</a></li><li id="correction-ref-4"><a href="https://pubmed.ncbi.nlm.nih.gov/20668659/" rel="external">Holt-Lunstad, J., Smith, T. B., &amp; Layton, J. B. (2010). Social relationships and mortality risk: A meta-analytic review. PLOS Medicine, 7(7), e1000316. https://pubmed.ncbi.nlm.nih.gov/20668659/</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/recovery-sleep-cortisol-and-capacity">Recovery, Sleep, Cortisol, and Capacity →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[When cannabis becomes your sleep aid]]></title>
<description><![CDATA[What a 32-study cannabis and stroke analysis found, why its dose question remains unanswered, and when nightly sleep use deserves attention.]]></description>
<link>https://www.andreheeg.com/archive/when-cannabis-becomes-your-sleep-aid</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/when-cannabis-becomes-your-sleep-aid</guid>
<pubDate>Wed, 26 Aug 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>A Cambridge study on cannabis and stroke has been circulating again this week. It was first published in January, so the numbers people are seeing now are the same as those from March.</p><h2>What?</h2><p>Megan Ritson and colleagues looked at data from 32 studies, covering more than 100 million people. Of these, 19 studies gave 24 estimates about cannabis. When all the data was combined, cannabis was linked to 37% higher odds of stroke, cocaine to 96%, and amphetamines to 122%. In their main analysis, opioids did not show a significant link overall.</p><p>The cannabis studies had very mixed results. On the standard measure of how much studies disagree with each other, they came out at 99%, which is about as inconsistent as a meta-analysis can get. The authors found that smaller studies influenced the results, and after adjusting for this, the cannabis figure dropped from 37% to 12%. Only 14 of the 32 studies clearly showed that drug use happened before the stroke.</p><h2>So what?</h2><p>The study does not show how the risk changes with different doses or how often someone uses cannabis. Its strongest evidence is about cannabis use disorder, which means problematic or dependent use. This is very different from using cannabis occasionally, but the paper also cannot estimate the risk for people who use it only sometimes.</p><p>The genetic analysis suggests that cannabis use disorder might cause stroke, but it focused on genetic risk for cannabis use disorder, not just general cannabis use. For people under 55, the figure was 14% higher odds, but this is similar to the result for all ages. The authors say there was no significant difference by age.</p><p>For me, this study is a reminder to watch for patterns. If you find yourself using cannabis every night to help you sleep, it’s worth paying attention. In the 2024 National Health Interview Survey of 31,509 adults, 3.7% said they used marijuana or CBD most days or every day for sleep. A National Sleep Foundation survey of 1,367 adults found that current users still slept worse than nonusers, though it didn’t show whether cannabis helped. A 2025 review looked at 18 sleep-lab studies, and in the 9 that could be combined, there was no consistent change in sleep duration, how long it took to fall asleep, how much of the night was spent asleep, or sleep stages.</p><h2>Now what?</h2><p>Five questions are more helpful than any number this study could provide.</p><ul><li>How many nights out of the last 30?</li></ul><ul><li>Has the dose gone up?</li></ul><ul><li>Can you sleep without it?</li></ul><ul><li>Have you tried to cut down and failed?</li></ul><ul><li>Are you carrying on despite worse sleep, daytime fog or something else?</li></ul><p>Then three things worth doing regardless of your answers.</p><ul><li>If you have ongoing insomnia, address it directly. CBT-I is the best first treatment, even before trying medication. Two key parts of CBT-I are waking up at the same time every day and getting out of bed if you can’t sleep, but the full program includes more steps.</li></ul><ul><li>Check your average blood pressure with proper home readings. No matter how cannabis fits in, blood pressure is the main stroke risk factor you can control.</li></ul><ul><li>If you decide to take a break, expect the first few days to be the hardest, and remember that withdrawal can last several weeks. In a national sample of people who used cannabis at least three times a week, 12% had withdrawal syndrome, and 68% of those had trouble sleeping. This is a self-test, not a result from the stroke study.</li></ul><p>If you use cannabis just once a month, this study cannot tell you your risk. The genetic evidence is about cannabis use disorder, and the other studies did not track use often enough to set a safe limit.</p><p>I wrote in detail about sleep problems in July, including why most effective solutions are not for sale. You can read it here: [archive URL needed]</p><p>This paper is a warning about problematic cannabis use. It’s more helpful to ask yourself the five questions than to focus on a number the study never actually tested.</p><p>Stay healthy.</p><p>Andre</p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated September 3, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>What the 12% estimate means:</strong> The review's main observational estimate was 37% higher odds of stroke, with very high between-study heterogeneity. The 12% figure came from a trim-and-fill sensitivity analysis that estimated missing small studies. It is not a known corrected effect, and the underlying studies did not provide a consistent dose or frequency threshold. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>What the genetic analysis can show:</strong> The Mendelian-randomization analysis used genetic liability to cannabis use disorder, not a measured nightly dose. Its results support a possible causal relationship under the method's assumptions. They do not prove that cannabis caused a stroke in an individual or establish a safe exposure level. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>The sleep evidence remains limited:</strong> The US estimate cited in the edition counted adults using marijuana or CBD for sleep most days or every day. It measured prevalence, not benefit. A 2025 review of laboratory sleep studies found no consistent improvement in sleep duration, latency, wake time, efficiency or sleep stages, while evidence during withdrawal was more consistent for disturbed sleep. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>When CBT-I is first-line care:</strong> Cognitive behavioral therapy for insomnia is recommended as first-line treatment for chronic insomnia. That recommendation does not mean every short period of poor sleep needs formal CBT-I. Persistent symptoms, daytime impairment or signs of another sleep or mental-health condition deserve clinical assessment. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>The missing archive link:</strong> The sent edition contained the placeholder '[archive URL needed]'. The intended July article is I Fall Asleep in Ninety Seconds. This One's for Everyone Who Can't. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.repository.cam.ac.uk/items/ae2b3a0f-0375-4ae5-94cd-c3e0d26a24ef" rel="external">Ritson et al. Cannabis use and stroke risk: a systematic review, meta-analysis and Mendelian randomization study. International Journal of Stroke, 2026.</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/40967124/" rel="external">Suraev et al. The effects of cannabis and cannabinoids on sleep: a systematic review and meta-analysis of polysomnographic studies. 2025.</a></li><li id="correction-ref-3"><a href="https://www.acponline.org/acp-newsroom/acp-recommends-cognitive-behavioral-therapy-as-initial-treatment-forchronic-insomnia" rel="external">American College of Physicians. ACP recommends cognitive behavioral therapy as initial treatment for chronic insomnia.</a></li><li id="correction-ref-4"><a href="https://www.andreheeg.com/archive/i-fall-asleep-in-ninety-seconds" rel="external">The Upward ARC archive. I Fall Asleep in Ninety Seconds. This One's for Everyone Who Can't.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section>]]></content:encoded>
</item>
<item>
<title><![CDATA[Eighteen Experts Read the Same Glucose Reports. They Could Not Agree.]]></title>
<description><![CDATA[What CGM evidence shows in adults without diabetes, where interpretation breaks down and when the device has a clinical use.]]></description>
<link>https://www.andreheeg.com/archive/eighteen-experts-read-the-same-glucose-reports-they-could-not-agree</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/eighteen-experts-read-the-same-glucose-reports-they-could-not-agree</guid>
<pubDate>Sun, 23 Aug 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>The CES Las Vegas booth was bright and had shiny counters.</p><p>The healthcare company filled the booth with its products and set up a section for its over-the-counter continuous glucose monitor (CGM). Staff gave out little treats and packets of electrolyte powder.</p><p>I had just left their CES panel, “Tracking Your Body's Signals for Better Health,” at the Venetian Expo. Tunde Oyeneyin talked about using glucose data for cardio and preparation. I know her from Peloton and like her as a personality. Alexis Ohanian, Reddit's co-founder, brought in a tech and fatherhood perspective, which I find interesting. He also appeared in the product's “Spike Sessions” campaign, which is worth mentioning when considering his role on the company’s stage [1][2].</p><p>After 3 years of doubt, I wondered whether I should try one and later speak from experience.</p><p>The booth was big. My estimate is six figures, probably more. I spoke with someone I remember as a brand manager or salesperson. They kept explaining how eating order affects glucose, and how levels rise after eating carbs. I kept asking what a healthy person should do after a normal increase.</p><p>I never got an answer I could use. I left with a few samples, but not a glucose monitor. I still haven’t tried one.</p><h2>My doctor's take begins with me</h2><p>That’s a fair point. I’m judging a device I haven’t tried myself.</p><p>I’m a physician with medical and dental degrees, but I don’t specialize in endocrinology or diabetes. I look at health devices like any other treatment: identify the problem, decide what action to take based on the result, and see if that action improves health.</p><p>I use the same approach for myself. Twice a year, I check my fasting glucose and HbA1c, which shows long-term glucose levels. My results are 92 mg/dL (about 5.1 mmol/L) and 4.9%.</p><p>I also take valsartan with hydrochlorothiazide for high blood pressure, which is well controlled. I take my medication and check my blood pressure regularly because there’s a clear target, and lowering it reduces health risks.</p><p>Hydrochlorothiazide belongs to a family of blood-pressure drugs called thiazides. Across 95 randomized trials in which treatment was assigned by chance, these drugs raised fasting glucose by 3.6 mg/dL on average, or 2.7 mg/dL in trials lasting at least 6 months. The authors called the class effect too small to change care [3]. It cannot predict my result without the drug.</p><p>Blood-pressure treatment also counts as 1 of the 5 markers used to define metabolic syndrome, a cluster of linked health risks. The diagnosis requires 3 markers. My treated hypertension is a managed cardiovascular risk factor; by itself, it does not meet that definition [4].</p><h2>Where the evidence holds</h2><p>For the right patient with diabetes, continuous glucose monitoring earns its place.</p><p>A review published in <em>JAMA Internal Medicine</em> on 3 August 2026 summarized randomized evidence in type 2 diabetes. Average HbA1c fell by about 0.3 percentage points compared with finger-prick checks or usual care, and some patients gained more. Much of that evidence came from people taking insulin or other glucose-lowering drugs [5].</p><p>This was a narrative review, meaning the authors chose and explained existing research without the strict process of a systematic review. Published at the journal’s initiative, it found only limited and indirect support for CGM in people with type 2 diabetes not taking glucose-lowering treatment, or with prediabetes or obesity. No CGM-manufacturer conflict was disclosed.</p><p>Prediabetes is a different case, since the evidence is more promising there. Here, I’m focusing on healthy adults without symptoms.</p><p>Minna Johansson set the boundary in a university press statement: “This technology is tremendously valuable for certain groups of patients. But it is increasingly being used by groups where we simply do not know whether it provides any benefit at all—or if it could even be harmful” [6]. The review didn’t measure a harm rate. The authors suggested using CGM only when a specific patient problem gives the readings a purpose. This is not a clinical guideline.</p><p>The FDA cleared Lingo for over-the-counter sale to adults aged 18 or older who do not use insulin. This includes some people with diabetes. Its screen covers 55 to 200 mg/dL, and the agency says users should consult a qualified health professional before taking medical action based on the output [7].</p><h2>Even precise numbers can be misleading</h2><p>Hutchins and colleagues ran a randomized crossover study in 15 healthy adults. Each person completed the same set of meal tests, with the order chosen by chance, so the researchers could compare each person with themselves.</p><p>The continuous monitor read 0.9 mmol/L, about 16 mg/dL, higher than a finger-prick test both before and after meals. For one smoothie, the monitor gave a glycemic index of 69 and the finger-prick method gave 53. Glycemic index is a score for how strongly a food raises glucose [8].</p><p>Those estimates had wide confidence intervals. A confidence interval is the range that still fits the data. The monitor’s range was 48 to 99, while the finger-prick range was 40 to 69. These ranges overlap a lot.</p><p>The p-value was .05. A p-value asks how often a difference this big could happen by chance if both methods worked the same. Here, it was about 5 times in 100, which is the usual cutoff researchers use. This example comes from one smoothie and 15 people, not a general error rate.</p><p>After adjusting for each person’s starting point, the monitor still showed about twice as much time above 140 mg/dL compared to the finger-prick method. The p-value was below .01, meaning a gap this large would happen less than once in 100 times if there was no real difference. They measured time above 140, not the actual glucose concentration.</p><p>Innocent Drinks funded the study with an unrestricted grant and provided the test products. “Unrestricted” means the company didn’t control how the study was run. The authors also disclosed connections to ZOE, PepsiCo, and the European Fruit Juice Association.</p><p>Then 18 CGM experts looked at 20 reports from adults without diabetes and decided whether each person needed medical follow-up. The researchers had deliberately chosen difficult reports. Dexcom supplied discounted sensors, and several authors had ties to the manufacturer [9].</p><p>Fleiss kappa measures how much a group agrees beyond what chance alone would produce. A score of 0 means chance-level agreement; 1 means perfect agreement. These experts scored 0.36, which the authors called low. All 18 gave the same answer on only 3 of the 20 reports. They all wanted follow-up for 2 and all declined it for 1. This measured agreement in a small selected set. It did not test whether their decisions were medically correct.</p><p>One rough pattern appeared. When more than 2 out of every 100 readings were above 180 mg/dL, between 56% and 100% of the experts recommended follow-up, depending on the report. Simply put, the same cutoff convinced just over half of them in some cases and all of them in others. The study didn’t prove that 2% was the right alarm line. I think this number comes from diabetes care. The authors said there are no guidelines for interpreting these reports in people without diabetes. Diabetes care has its own guidelines.</p><h2>My doctor's take after the evidence</h2><p>This fits into the Activate part of the Upward ARC, which focuses on food and movement. It also relates to Capacity, since our attention is limited. Every new number asks you to look, interpret, and decide what to do.</p><p>Before buying a monitor, a healthy person should think about what reading would make them change their behavior.</p><h2>Try this today</h2><ul><li>Write down the exact number that would make you change your actions. Add what you would do next and what result you expect. If you can’t fill the page, that tells you something.</li><li>If you have diabetes, prediabetes, symptoms, pregnancy, medication concerns, or another metabolic risk, take the question to a clinician. This newsletter doesn’t cover you.</li><li>Try the habit without tracking it on a graph. Eat protein before carbs if you like. Take a 10- or 20-minute walk after eating. See if you can keep it up.</li><li>Consider what the experiment costs, both in money and attention. Lingo launched at $89 for two 14-day sensors in the US. On 21 August 2026, its US 4-week subscription showed an $89 standard price, and Boots in the UK listed two sensors for £118 [10][11]. Decide before you start when you’ll stop.</li></ul><h2>The unused patches</h2><p>About a year ago, I noticed an opened FreeStyle Libre package next to a monitor at the office. A blister pack of patches was still sealed. Since the desks were shared, I didn’t know whose it was. Later that day, a colleague told me they saw an influencer wearing one and bought it with a discount code. They showed me the sensor on their arm.</p><p>They learned that eating protein before carbohydrates seemed to flatten the curve. A 10- or 20-minute walk after eating had a similar effect. Fruit or something sweet made glucose rise and then fall.</p><p>I could have told them all of that without a sensor.</p><p>A few weeks later, I asked if they were still using it. They had stopped. I inferred that it had been an expensive way to learn basic lessons. They never said why they quit.</p><h2>Normal is broader than it seems</h2><p>The Framingham study followed 560 normoglycemic adults. That simply means their standard blood tests placed them in the normal glucose range [12].</p><p>Even so, their readings sat between 140 and 180 for almost 3 hours a day, then above 180 for another 19 minutes. Total time above 140 averaged roughly 3.3 hours. This was a group average, so it doesn’t predict one person's day. Participants averaged 58.8 years old and had an average body mass index of 26.5, which indicates overweight. The group was 93.2% non-Hispanic White, and Dexcom supplied discounted sensors.</p><p>A second study followed 153 healthy, non-obese people aged 7 to 80 [13]. The sample averaged 31 years old. Average glucose was 98 to 99 mg/dL below age 60 and 104 at 60 or older. The median person (the middle value after ranking) spent 96% of the day between 70 and 140. The interquartile range was 93% to 98%, meaning the middle half of participants fell between those values. The sample was 93% White, and an author disclosed ties to Dexcom and Sanofi.</p><p>I think the difference comes down to age and who was in each study. The younger group didn’t include people with obesity, while the Framingham study looked at an older community group. Neither paper tested this, so this is just my opinion. Both studies show that healthy glucose levels can vary. Seeing a colored line can make normal changes look like a problem.</p><h2>Curiosity still needs a purpose</h2><p>In PREDICT 1, 1,002 generally healthy UK adults ate identical standard meals. Their population coefficient of variation was 68% [14]. This compares the spread of responses with the average; 68% signals wide variation. It is neither the share of people who reacted differently nor a treatment effect. Several authors worked for or consulted with ZOE.</p><p>A 2026 systematic review used preset rules to find and assess 23 studies [15]. It found signs of benefit in prediabetes and no appreciable improvement in healthy groups. Only 5 studies could be combined numerically. Most randomized studies lasted 12 weeks or less and paired the sensor with education or coaching, leaving its separate effect unclear.</p><p>Another review covered 25 randomized behavior-change trials [16]. Only 3 involved people without diabetes, all with obesity, and every trial added other support. Eight supplied weight data. The combined result was 0.7 kg less, with P \= .066. If the true effect were zero, a result this large could appear by chance about 6.6 times in 100. It missed the usual cutoff and was not statistically significant. The analysis could not reliably separate a small loss from random variation, though it didn’t prove zero effect. Eleven trials reported CGM-industry conflicts, which proves neither funding nor bias.</p><p>When I visited the booth, I was open to trying a CGM. But after talking with them, I kept coming back to the same question: what should you do after seeing a normal rise in glucose from eating a banana?</p><p>I still don’t have a good answer for healthy people without symptoms. My first thought remains: for this group, a CGM is mostly a waste of money.</p><p>A monitor might encourage you to take a walk, but it can also turn normal body changes into warnings that even experts can’t interpret. I already have enough information to decide when to take a walk.</p><p>I took the electrolyte powder and left the monitor behind.</p><p>If you’ve worn a CGM without a diagnosis, what decisions are you still making differently six months later? Reply and tell me exactly what’s changed. I want to know if I’m missing something in my conclusion.</p><p>Stay healthy.</p><p>Andre</p><p>PS: This argument is for healthy, asymptomatic adults. If you know someone who uses a CGM, please forward this to them. That’s how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If someone forwarded this to you, you can get Under Load, my Sunday edition, here: <a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a></p><div><hr></div><h2>References</h2><p>[1] Consumer Technology Association. (2025, January 7). <em>Tracking your body's signals for better health, presented by Abbott</em> [Conference session]. CES 2025. <a href="https://www.ces.tech/videos/tracking-your-body-s-signals-for-better-health-presented-by-abbott/" rel="external">https://www.ces.tech/videos/tracking-your-body-s-signals-for-better-health-presented-by-abbott/</a></p><p>[2] RQ Agency. (n.d.). <em>Lingo</em>. <a href="https://rqagency.com/work/lingo" rel="external">https://rqagency.com/work/lingo</a></p><p>[3] Hall, J. J., Eurich, D. T., Nagy, D., Tjosvold, L., &amp; Gamble, J.-M. (2020). Thiazide diuretic-induced change in fasting plasma glucose: A meta-analysis of randomized clinical trials. <em>Journal of General Internal Medicine, 35</em>(6), 1849-1860. <a href="https://doi.org/10.1007/s11606-020-05731-3" rel="external">https://doi.org/10.1007/s11606-020-05731-3</a></p><p>[4] Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., &amp; Smith, S. C., Jr. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. <em>Circulation, 120</em>(16), 1640-1645. <a href="https://doi.org/10.1161/CIRCULATIONAHA.109.192644" rel="external">https://doi.org/10.1161/CIRCULATIONAHA.109.192644</a></p><p>[5] Dower, J. A., Johansson, M., Camp, A. W., Montori, V. M., &amp; Lipska, K. J. (2026). Continuous glucose monitoring in type 2 diabetes and beyond: A review. <em>JAMA Internal Medicine</em>. Advance online publication. <a href="https://doi.org/10.1001/jamainternmed.2026.2772" rel="external">https://doi.org/10.1001/jamainternmed.2026.2772</a></p><p>[6] University of Gothenburg. (2026, August 3). <em>No evidence that continuous glucose monitors improve health in people without diabetes</em> [Press release]. <a href="https://www.gu.se/en/news/no-evidence-that-continuous-glucose-monitors-improve-health-in-people-without-diabetes" rel="external">https://www.gu.se/en/news/no-evidence-that-continuous-glucose-monitors-improve-health-in-people-without-diabetes</a></p><p>[7] U.S. Food and Drug Administration. (2024, May 29). <em>510(k) premarket notification K233655: Lingo Glucose System</em>. <a href="https://www.accessdata.fda.gov/cdrh_docs/pdf23/K233655.pdf" rel="external">https://www.accessdata.fda.gov/cdrh\_docs/pdf23/K233655.pdf</a></p><p>[8] Hutchins, K., Betts, J., Thompson, D., Hengist, A., &amp; Gonzalez, J. (2025). Continuous glucose monitor overestimates glycemia, with the magnitude of bias varying by postprandial test and individual: A randomized crossover trial. <em>American Journal of Clinical Nutrition, 121</em>(5), 1025-1034. <a href="https://doi.org/10.1016/j.ajcnut.2025.02.024" rel="external">https://doi.org/10.1016/j.ajcnut.2025.02.024</a></p><p>[9] Spartano, N. L., Prescott, B., Walker, M. E., et al. (2025). Expert clinical interpretation of continuous glucose monitor reports from individuals without diabetes. <em>Journal of Diabetes Science and Technology, 20</em>(3), 727-735. <a href="https://doi.org/10.1177/19322968251315171" rel="external">https://doi.org/10.1177/19322968251315171</a></p><p>[10] Abbott. (2024, September 5). <em>Abbott's Lingo continuous glucose monitor for health and wellness now available in the U.S.</em> <a href="https://abbott.mediaroom.com/2024-09-05-Abbotts-Lingo-TM-Continuous-Glucose-Monitor-for-Health-and-Wellness-Now-Available-in-the-U-S" rel="external">https://abbott.mediaroom.com/2024-09-05-Abbotts-Lingo-TM-Continuous-Glucose-Monitor-for-Health-and-Wellness-Now-Available-in-the-U-S</a></p><p>[11] Boots. (2026). <em>Lingo continuous glucose monitor bundle</em>. Retrieved August 21, 2026, from <a href="https://www.boots.com/lingo-continuous-glucose-monitor-bundle-10390678" rel="external">https://www.boots.com/lingo-continuous-glucose-monitor-bundle-10390678</a></p><p>[12] Spartano, N. L., Sultana, N., Lin, H., et al. (2025). Defining continuous glucose monitor time in range in a large, community-based cohort without diabetes. <em>The Journal of Clinical Endocrinology &amp; Metabolism, 110</em>(4), 1128-1134. <a href="https://doi.org/10.1210/clinem/dgae626" rel="external">https://doi.org/10.1210/clinem/dgae626</a></p><p>[13] Shah, V. N., DuBose, S. N., Li, Z., et al. (2019). Continuous glucose monitoring profiles in healthy nondiabetic participants: A multicenter prospective study. <em>The Journal of Clinical Endocrinology &amp; Metabolism, 104</em>(10), 4356-4364. <a href="https://doi.org/10.1210/jc.2018-02763" rel="external">https://doi.org/10.1210/jc.2018-02763</a></p><p>[14] Berry, S. E., et al. (2020). Human postprandial responses to food and potential for precision nutrition. <em>Nature Medicine, 26</em>, 964-973. <a href="https://doi.org/10.1038/s41591-020-0934-0" rel="external">https://doi.org/10.1038/s41591-020-0934-0</a></p><p>[15] Liao, X., Li, Y., Tang, S., Xiao, Y., Yu, X., Huang, R., &amp; Zhong, T. (2026). Continuous glucose monitoring in non-diabetic populations: A systematic review of observational and interventional studies with meta-analysis. <em>European Journal of Medical Research, 31</em>, Article 397. <a href="https://doi.org/10.1186/s40001-026-03920-0" rel="external">https://doi.org/10.1186/s40001-026-03920-0</a></p><p>[16] Richardson, K. M., Jospe, M. R., Bohlen, L. C., et al. (2024). The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes: A systematic review and meta-analysis of randomised controlled trials. <em>International Journal of Behavioral Nutrition and Physical Activity, 21</em>, Article 145. <a href="https://doi.org/10.1186/s12966-024-01692-6" rel="external">https://doi.org/10.1186/s12966-024-01692-6</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated September 3, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>What FDA clearance means:</strong> The FDA cleared Lingo for adults 18 and older who do not use insulin. The clearance says it may help users understand lifestyle-related glucose excursions, but users are not meant to take medical action from its output without consulting a qualified clinician. Clearance does not establish that CGM improves health in healthy adults. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>The 18-expert exercise:</strong> Researchers deliberately selected 20 difficult reports rather than a representative sample. Agreement about follow-up was poor, and the paper did not validate a diagnostic threshold for people without diabetes. Several authors disclosed industry relationships, and Dexcom supplied discounted sensors. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Behavior-change evidence:</strong> The 25-trial review mainly studied people with diabetes. Only three trials involved participants without diabetes, all with obesity and added support beyond the device. The pooled weight estimate was not statistically significant, so it neither proves a weight-loss benefit nor proves no effect. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Normal ranges are not settled:</strong> Published cohorts describe glucose patterns in selected groups, but age, body composition, meals, sensor performance and sampling all affect the distributions. Diabetes time-in-range targets should not be treated as validated diagnostic cutoffs for asymptomatic people without diabetes. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.accessdata.fda.gov/cdrh_docs/reviews/K233655.pdf" rel="external">U.S. Food and Drug Administration. (2024). Lingo Glucose System 510(k) decision summary, K233655. https://www.accessdata.fda.gov/cdrh_docs/reviews/K233655.pdf</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/39936548/" rel="external">Spartano, N. L., Prescott, B., Walker, M. E., et al. (2026). Expert clinical interpretation of continuous glucose monitor reports from individuals without diabetes. Journal of Diabetes Science and Technology, 20(3). https://pubmed.ncbi.nlm.nih.gov/39936548/</a></li><li id="correction-ref-3"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11668089/" rel="external">Richardson, K. M., Jospe, M. R., Bohlen, L. C., et al. (2024). The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes. International Journal of Behavioral Nutrition and Physical Activity, 21, 145. https://doi.org/10.1186/s12966-024-01692-6</a></li><li id="correction-ref-4"><a href="https://doi.org/10.2337/dc26-s006" rel="external">American Diabetes Association Professional Practice Committee. (2026). Glycemic goals, hypoglycemia, and hyperglycemic crises: Standards of Care in Diabetes—2026. Diabetes Care, 49(Suppl. 1), S132–S162. https://doi.org/10.2337/dc26-s006</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/continuous-glucose-monitoring-without-diabetes">Continuous Glucose Monitoring Without Diabetes →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Same blood. Two tests. Nine years apart.]]></title>
<description><![CDATA[Biological age scores from DNA clocks, gym machines and wearables measure different inputs. What the numbers can track, and why they are not clinical diagnoses.]]></description>
<link>https://www.andreheeg.com/archive/same-blood-two-tests-nine-years-apart</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/same-blood-two-tests-nine-years-apart</guid>
<pubDate>Wed, 19 Aug 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>Last week, I saw a doctor post their BioAge online, treating it like a lab result. Now, gyms, fitness trackers, and mail-in kits all give you some version of your ‘age.’ I wanted to find out how these numbers are really calculated.</p><h2>What?</h2><p>Let’s start with the most reliable method. A USC-led study published in npj Aging on July 20 tested the five most popular epigenetic clocks on 3,227 adults from the Health and Retirement Study. These clocks, Horvath, Hannum, PhenoAge, GrimAge, and DunedinPACE, did not share a single gene in common. The authors said there were “more unique than common biological processes.”</p><p>These clocks can also give inconsistent results. A 2022 study in Nature Aging found that technical noise alone could make six of these clocks show up to a nine-year difference when testing the same sample twice. Newer versions have reduced this gap to about 1.5 years, so there is a fix. Still, most reports don’t say which version was used for your result.</p><p>Consumer options are even less accurate. EGYM gym machines use four fitness tests: strength, cardio, metabolism, and flexibility. WHOOP figures out your age from months of sleep, training, and recovery data. Garmin mostly uses your VO2max. This means the same person could get three different ages from three devices.</p><h2>So what?</h2><p>None of these tools truly measure aging. They look at your fitness and habits, then turn those results into years, since that’s a number people understand.</p><p>I think that’s okay. If a simple number gets someone to go to the gym on a Tuesday, that’s more useful than a perfect measurement no one pays attention to. Treat it like a game. If your watch pushes you to work out a fourth time this week, it’s working.</p><p>The problem is when doctors present a vendor’s score as if it’s a real lab result. Then the suggestion becomes a claim. Most people can’t tell the difference. That’s why credentials matter, and using them to support an unproven number isn’t a good idea.</p><h2>Now what?</h2><ul><li>See your ‘age’ score as a tool to track your habits, not as something for your official health record.</li></ul><ul><li>Focus on the numbers behind the score: your VO2max (in ml/kg/min), strength, waist size in centimeters, and blood pressure. Each of these can predict health outcomes on its own.</li></ul><ul><li>Only compare your results to your own past results, using the same device and conditions. Numbers from different brands can’t be compared.</li></ul><ul><li>If you get a score, ask your provider two questions: Has this score been tested against illness or death in people outside their database? And which version of the clock are they using?</li></ul><ul><li>If a gym blood pressure cuff shows 140/90 or higher, check your blood pressure at home over several days. The 2024 European Society of Cardiology guidelines recommend out-of-office readings before making a diagnosis.</li></ul><p>I made a similar point in July about the supplements in your cupboard. You can read more in The Doctor’s Edit on Your Longevity Drawer (https://www.andreheeg.com/archive/the-doctors-edit-on-your-longevity-drawer).</p><p>Let the number motivate you to go to the gym. That’s its only purpose.</p><p>Stay healthy.</p><p>Andre</p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated September 3, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>What the five clocks still predict:</strong> The 2026 study found that five DNA-methylation clocks emphasized different genes and pathways. It did not find that the clocks were useless. The same analysis reported that the clocks still predicted aspects of health, aging and mortality, with different strengths for different outcomes. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Where the nine-year figure came from:</strong> The nine-year difference was the upper end of repeat-test disagreement for the original clocks in one technical study. Retrained principal-component versions brought most repeat measurements within 1.5 years. Several authors disclosed commercial interests related to biological-age testing, and Elysium Health supplied datasets. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Consumer scores are not the same test:</strong> EGYM BioAge combines strength, cardiovascular, metabolic and flexibility measures. WHOOP Age uses six months of sleep, strain and fitness data, and WHOOP describes it as a wellness feature rather than a medical device. These scores measure different constructs. The evidence reviewed here does not establish that one is more accurate against a shared clinical reference. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Risk markers are context, not diagnoses:</strong> Cardiorespiratory fitness, strength, waist measures and blood pressure can help describe health risk and change over time. They are not interchangeable, and no single reading or score determines an individual's biological age, diagnosis or prognosis. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>How to follow up the 140/90 reading:</strong> A gym blood-pressure reading of 140/90 mmHg is a reason to repeat the measurement under standard conditions, not a diagnosis by itself. The 2024 ESC guideline defines office hypertension at 140/90 or higher and a home average at 135/85 or higher. Confirmation should use repeated office readings or validated home or ambulatory monitoring. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/42477337/" rel="external">Arpawong et al. DNA methylation clocks exhibit heterogeneity in associations with mortality and aging-related outcomes. 2026.</a></li><li id="correction-ref-2"><a href="https://www.nature.com/articles/s43587-022-00248-2" rel="external">Higgins-Chen et al. A computational solution for bolstering reliability of epigenetic clocks. Nature Aging, 2022.</a></li><li id="correction-ref-3"><a href="https://support.whoop.com/s/article/Healthspan-WHOOP-Age-Pace-of-Aging-Guide?language=en_US" rel="external">WHOOP. Healthspan: WHOOP Age and Pace of Aging Guide.</a></li><li id="correction-ref-4"><a href="https://academic.oup.com/eurheartj/article/45/38/3912/7741010" rel="external">European Society of Cardiology. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section>]]></content:encoded>
</item>
<item>
<title><![CDATA[Butter, MCT, Coconut, Ghee, Olive. Then I Read the Seed Oil Studies.]]></title>
<description><![CDATA[What human research says about seed oils, linoleic acid, butter, ghee and everyday cooking choices.]]></description>
<link>https://www.andreheeg.com/archive/butter-mct-coconut-ghee-olive-then-i-read-the-seed-oil-studies</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/butter-mct-coconut-ghee-olive-then-i-read-the-seed-oil-studies</guid>
<pubDate>Sun, 16 Aug 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>I started by adding the butter. I cut two tablespoons from the block and dropped them into the blender with my coffee. The blender was so loud for thirty seconds that I closed the kitchen door.</p><p>The result was a pale brown drink with a foamy, shiny layer that caught the morning light. I drank it at the counter before anyone else woke up, and I felt great about it.</p><p>I have both a medical and a dental degree. Even so, I ended up drinking butter for breakfast after hearing someone on a podcast explain the science. It made sense to me at the time.</p><p>These things always seem to make sense at first. That’s the real problem.</p><p>My butter phase lasted about two years. Then I switched to MCT oil, which cost almost as much as the whiskey on the shelf. After that came coconut oil, then ghee, which I thought was an upgrade. Now I use olive oil. Each choice felt reasonable at the time.</p><p>Each phase had its own expert, a scientific reason, and a type of fat to avoid. The latest trend has the most talked-about villain so far.</p><p>Before all of this, there was a hallway. After three training sessions that day, we would sit on the floor outside our rooms, leaning against the wall. On the youth national team, we shared rooms in a long corridor lined with doors. You could recognize another wrestler from across the room without saying anything. It was the ears that gave us away.</p><p>In May, Robert Saleh, in his first year coaching the Tennessee Titans, told reporters that removing every seed oil from the facility had been one of the first changes he made, part of an overhaul of how the team eats [1]. Canola and soybean oil, out of an NFL building.</p><p>Recently, more executives have asked me about seed oils than ever before. So I read everything I could find on the topic, including both sides and even the arguments I expected to disagree with.</p><h2><strong>The biology he describes is real</strong></h2><p>Paul Saladino is one of the most-followed voices arguing that seed oils are doing serious damage. He’s a physician, and he writes this on his own site: “we STORE these polyunsaturated fats in our cell membranes and mitochondrial membranes” [2].</p><p>He’s right about that.</p><p>Linoleic acid, the main omega-6 fat in conventional sunflower, corn, soybean, and canola oils, gets built into cell membranes and body fat. A review of 37 studies found that its share of American adipose fatty acids rose from 9.1% in 1959 to 21.5% in 2008 [3]. The review estimated a half-life in fat tissue of about 680 days.</p><p>Polyunsaturated fats oxidize more readily than saturated fats. In a laboratory study, peroxidized linoleic acid damaged isolated DNA [4].</p><p>In the most recent American dietary survey, foods coded as fats supplied 8% to 13% of people’s linoleic acid. Grains supplied 22% to 35%, meat 15% to 25% [5]. Those are categories of reported food, so oil baked into bread still counts as grain. The survey can’t isolate what came from a bottle. The bottle is the visible part of exposure spread across many foods.</p><p>Each of my phases started with a solid scientific explanation. Medium-chain fats are processed differently. Clarified butter removes milk solids. Now, I always ask a practical question: has anyone actually measured what happens to people who eat this?</p><h2><strong>Someone decided to test it</strong></h2><p>Saladino’s sharpest claim is about DNA. His words, as written: excess linoleic acid makes fat cells release free fats, and “These free fats induce insulin resistance in the peripheral muscles, causing inflammation and DNA damage” [6].</p><p>In 2003, the same group went looking in people. Thirty volunteers across three arms for six weeks, one taking 15 grams of linoleic acid a day against a palmitic acid control, measuring oxidative DNA damage in white blood cells. In the linoleic acid arm, the damage rose 13% from where it started and finished 23% below the control group. Neither difference was statistically significant [7].</p><p>Each group had ten people, and the study lasted six weeks. They measured only one marker in white blood cells, not muscle as Saladino’s theory suggests. With those limits, the study found no evidence that extra linoleic acid increased oxidative DNA damage.</p><p>The population data point the same way. Among 85,425 UK Biobank adults followed for almost 13 years, the top fifth for plasma omega-6 as a share of total fatty acids had 23% lower all-cause mortality than the bottom fifth [8].</p><p>That study also challenged an argument I believed for a year. The group with the highest ratio had 26% higher mortality. Both omega-6 and omega-3 were linked to lower mortality, but the link was stronger for omega-3 [8]. The authors thought the ratio result was probably due to omega-3.</p><p>Randomized trials don’t show much. In 19 studies with 6,461 adults followed for one to eight years, increasing omega-6 made little or no difference to deaths or heart problems overall. It did lower total cholesterol and might have reduced heart attacks, but the evidence for that is weak [9].</p><p>My own ratio was 3.6, which experts say is good. But that number didn’t tell me if I was getting enough of either fatty acid. I realized I might have been taking <a href="https://www.andreheeg.com/archive/i-took-fish-oil-for-10-years-i-was" rel="external">the wrong part of my fish oil for ten years</a>.</p><h2><strong>The two trials that should trouble me</strong></h2><p>Two randomized trials are central to the main arguments against seed oils. Anyone who thinks this debate is settled should take a close look at them.</p><p>The Minnesota Coronary Experiment randomized 9,423 people across six mental hospitals and a nursing home between 1968 and 1973. The intervention replaced saturated fat with corn oil. Cholesterol fell 13.8% among participants measured again after a year or more, with no mortality benefit [10]. People kept leaving the institutions, ending their follow-up. The diet also pushed linoleic acid to 13.2% of calories, well above typical US intake of 5.5% to 6% [5].</p><p>The Sydney Diet Heart Study is the harder one. It randomized 458 men, 221 to safflower oil and safflower margarine and 237 to continue their usual diet. 86% had had a heart attack, on average about 11 weeks earlier. More of the intervention group died: 17.6% against 11.8%, a hazard ratio of 1.62, with a confidence interval from 1.00 to 2.64 [11].</p><p>I wish I could say the margarine was the reason. Margarine back then contained trans fats, but the exact makeup of this one wasn’t measured. However, the study’s authors considered this and ruled it out: the intervention also removed the usual margarines and shortenings, which were the main sources of trans fats at the time. So, trans fat intake probably went down, not up, and they thought it was unlikely to explain the results [11].</p><p>The study had clear limits: it involved men who had recently had heart problems, linoleic acid made up about 15% of their energy, there were several dietary changes, and the original protocol couldn’t be recovered. It was just one trial, in men who were already sick, at much higher intakes than usual. Still, it matters.</p><h2><strong>Why the evidence disagrees</strong></h2><p>My training taught me to look at each study and think about what kinds of errors it might have.</p><p>Plasma fatty acids depend on diet and metabolism. The UK Biobank authors adjusted for many known differences between participants. They still could not rule out factors they had missed or measured poorly, and they sampled blood once, at the start [8].</p><p>Randomization addresses confounding. Cochrane rated most of the clinical-outcome evidence low or very low certainty because of bias and imprecision [9].</p><p>Looking at all the studies together, I see two main gaps. The UK Biobank can’t prove cause and effect, and the trials only give rough estimates for real-world outcomes. No one has run a large, long-term trial at typical modern intake levels yet.</p><h2><strong>What the ears were for</strong></h2><p>No one planned to talk that night. My roommate brought up weight cutting, and soon everyone joined in, sharing stories about injuries, long hours inside, and the smell that never leaves a gym bag. We said things to each other we’d never say to a coach.</p><p>Someone joked that our parents should be prosecuted for signing us up. We all laughed, and while we half-meant it, none of us would have quit.</p><p>That’s what the ears meant. When you saw another guy across the room, you knew he’d gone through the same things you had, and you didn’t have to say a word.</p><p>I stopped wrestling in my mid-twenties, after my shoulder gave out for the last time. There was no final match or big decision, just a scan and a surgeon giving me practical advice. The training hall kept going every night without me. No one was unkind. What I wasn’t prepared for was how something that had shaped my whole life could just end, with everyone else carrying on while I stood outside.</p><p>Then there was nothing.</p><p>Nutrition groups offer the same sense of belonging, but without the physical cost. A jar on the counter shows everyone which side you’re on, and no one needs to check your ears.</p><p>That’s why the debate never ends. Each position gives you a group identity along with a health rule, and it’s harder to let go of the identity than the rule. I’ve been through this five times myself.</p><p>I went through all five phases on my own. Standing at the kitchen counter before anyone else was awake, blending butter into my coffee, I felt like I was part of something.</p><h2><strong>What I keep in the kitchen</strong></h2><p>At a work dinner a few weeks ago, a man sitting two seats away put down his fork and turned to me. “Andre, what do you think this was cooked in? Should I worry if it’s seed oils?” He wanted to know if his dinner was safe, and he was asking the doctor at the table.</p><p>The practical answer is simpler than the debate makes it seem. In the largest relevant study I found, 221,054 American health professionals were followed for up to 33 years. Replacing 10 grams of butter a day with plant oil was linked to a 17% lower risk of death [12]. This was an observational study, and the swap was modeled, not actually done.</p><p>Two of my own phases don’t look so good. Coconut oil raises LDL cholesterol by about 10 mg/dL compared to other vegetable oils, and none of the studies measured heart attacks or deaths [13]. Turning butter into ghee removes water and milk solids, so gram for gram, ghee has more saturated fat. As a percentage of total fat, butter and ghee are only a few points apart [14]. I swapped one for a more concentrated version and thought I was making a smart choice.</p><p>Olive oil, which I use now, compares well to butter. In a study of 92,383 people, it didn’t show a significant advantage over other vegetable oils [15].</p><h2><strong>What I told him</strong></h2><p>No, don’t worry about it, and eat your dinner.</p><p>The longer answer is that the bottle is just a distraction, and the scientific explanation is what convinces you. I went through five versions of this over 15 years, and each one was biochemically accurate. This is the Activate part of the Upward ARC, which is about what you put into your body. It’s also where marketing is strongest and the incentives are hardest to spot.</p><p>In one study, twenty people in a metabolic ward ate 508 more calories a day on an ultra-processed diet than on an unprocessed one, gaining about a kilogram in two weeks [16]. The trial didn’t test seed oil or figure out which differences in the diets caused the result. It was the overall eating pattern that changed how much people ate.</p><p>So, to answer his specific question: at the amounts people usually eat, there’s no human evidence that seed oils are especially harmful. Replacing butter and other saturated fats with plant oils lowers cholesterol, and studies link that swap to living longer. Whether purposely adding more omega-6 changes lifespan is still an open question.</p><h2><strong>Try this today</strong></h2><p>Each phase I went through added another rule. This list is about letting go of some of them.</p><p><strong>Don’t treat the ratio as a final answer.</strong> In the UK Biobank data, both omega-6 and omega-3 were linked to lower mortality, and the authors believed the ratio was mostly influenced by omega-3. If you don’t eat oily fish often, start there before getting another test.</p><p><strong>Stop overthinking and just keep two bottles:</strong> extra virgin olive oil for everyday cooking and finishing, and refined canola or high-oleic oil for frying and roasting. The difference between these sensible choices is so small that worrying about it costs you more than picking the wrong one.</p><p><strong>Use frying oil only once, throw it out after cooking, and keep the pan below the oil’s smoke point.</strong> I do this as a kitchen habit, not because of any proven health outcome.</p><p><strong>Ask what would make someone change their mind.</strong> For me, it would be a well-designed, independently funded trial at the amounts people actually eat. If I ever call a food poison and can’t answer that question, just stop reading.</p><h2><strong>Maybe I was just lucky</strong></h2><p>Throughout all five phases, my blood tests stayed normal. Maybe the type of fat mattered less than I believed. Maybe I was just lucky. I still keep butter in the fridge and use it in normal amounts.</p><p>Five times, an expert with a clear explanation convinced me before I checked the evidence myself, and five times I changed my mind later. I don’t regret making those changes.</p><p>I still miss that hallway and my wrestling tribe.</p><p>Stay healthy.</p><p>Andre</p><p>PS: I’ve told you my five eras. What was yours? The one you’d rather not admit to. Reply and tell me; I read every message and never share them. And if you know someone with strong opinions about oil who has never read a study on it, send this along. That’s how this newsletter grows, and the only way I want it to.</p><p>PPS: If someone forwarded this to you, you can get Under Load, my Sunday edition, here: <a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a>.</p><div><hr></div><h2><strong>References</strong></h2><p>[1] Titans’ Robert Saleh sparks nutritional value debate with seed oil ban for players, team-provided meals. (2026, May). <em>Fox News</em>. <a href="https://www.foxnews.com/sports/titans-robert-saleh-sparks-nutritional-value-debate-seed-oil-ban-players-team-provided-meals" rel="external">https://www.foxnews.com/sports/titans-robert-saleh-sparks-nutritional-value-debate-seed-oil-ban-players-team-provided-meals</a></p><p>[2] Saladino, P. (2025, November 10). Don’t read this if you love your bacon. <a href="http://paulsaladinomd.com" rel="external">*paulsaladinomd.com*</a>. <a href="https://www.paulsaladinomd.com/psmd-newsletters/dont-read-this-if-you-love-your-bacon" rel="external">https://www.paulsaladinomd.com/psmd-newsletters/dont-read-this-if-you-love-your-bacon</a></p><p>[3] Guyenet, S. J., &amp; Carlson, S. E. (2015). Increase in adipose tissue linoleic acid of US adults in the last half century. <em>Advances in Nutrition, 6</em>(6), 660-664. <a href="https://doi.org/10.3945/an.115.009944" rel="external">https://doi.org/10.3945/an.115.009944</a></p><p>[4] de Kok, T. M., ten Vaarwerk, F., Zwingman, I., van Maanen, J. M., &amp; Kleinjans, J. C. (1994). Peroxidation of linoleic, arachidonic and oleic acid in relation to the induction of oxidative DNA damage and cytogenetic effects. <em>Carcinogenesis, 15</em>(7), 1399-1404. <a href="https://doi.org/10.1093/carcin/15.7.1399" rel="external">https://doi.org/10.1093/carcin/15.7.1399</a></p><p>[5] Momin, S. R., Senn, M. K., Manichaikul, A., Tintle, N. L., Herrington, D. M., Rich, S. S., Kabagambe, E. K., &amp; Wood, A. C. (2023). Dietary sources of linoleic acid (LA) differ by race/ethnicity in adults participating in NHANES between 2017-2018. <em>Nutrients, 15</em>(12), 2779. <a href="https://doi.org/10.3390/nu15122779" rel="external">https://doi.org/10.3390/nu15122779</a></p><p>[6] Saladino, P. (2024, July 28). Seed oils &amp; processed foods: How they’re harming you. <a href="http://paulsaladinomd.com" rel="external">*paulsaladinomd.com*</a>. <a href="https://www.paulsaladinomd.com/psmd-newsletters/seed-oils-processed-foods-how-theyre-harming-you" rel="external">https://www.paulsaladinomd.com/psmd-newsletters/seed-oils-processed-foods-how-theyre-harming-you</a></p><p>[7] de Kok, T. M. C. M., Zwingman, I., Moonen, E. J., Schilderman, P. A. E. L., Rhijnsburger, E., Haenen, G. R. M. M., &amp; Kleinjans, J. C. S. (2003). Analysis of oxidative DNA damage after human dietary supplementation with linoleic acid. <em>Food and Chemical Toxicology, 41</em>(3), 351-358. <a href="https://doi.org/10.1016/S0278-6915(02)00237-5" rel="external">https://doi.org/10.1016/S0278-6915(02)00237-5</a></p><p>[8] Zhang, Y., Sun, Y., Yu, Q., Song, S., Brenna, J. T., Shen, Y., &amp; Ye, K. (2024). Higher ratio of plasma omega-6/omega-3 fatty acids is associated with greater risk of all-cause, cancer, and cardiovascular mortality: A population-based cohort study in UK Biobank. <em>eLife, 12</em>, RP90132. <a href="https://doi.org/10.7554/eLife.90132" rel="external">https://doi.org/10.7554/eLife.90132</a></p><p>[9] Hooper, L., Al-Khudairy, L., Abdelhamid, A. S., Rees, K., Brainard, J. S., Brown, T. J., Ajabnoor, S. M., O’Brien, A. T., Winstanley, L. E., Donaldson, D. H., Song, F., &amp; Deane, K. H. O. (2018). Omega-6 fats for the primary and secondary prevention of cardiovascular disease. <em>Cochrane Database of Systematic Reviews, 2018</em>(11), CD011094. <a href="https://doi.org/10.1002/14651858.CD011094.pub4" rel="external">https://doi.org/10.1002/14651858.CD011094.pub4</a></p><p>[10] Ramsden, C. E., Zamora, D., Majchrzak-Hong, S., Faurot, K. R., Broste, S. K., Frantz, R. P., Davis, J. M., Ringel, A., Suchindran, C. M., &amp; Hibbeln, J. R. (2016). Re-evaluation of the traditional diet-heart hypothesis: Analysis of recovered data from Minnesota Coronary Experiment (1968-73). <em>BMJ, 353</em>, i1246. <a href="https://doi.org/10.1136/bmj.i1246" rel="external">https://doi.org/10.1136/bmj.i1246</a></p><p>[11] Ramsden, C. E., Zamora, D., Leelarthaepin, B., Majchrzak-Hong, S. F., Faurot, K. R., Suchindran, C. M., Ringel, A., Davis, J. M., &amp; Hibbeln, J. R. (2013). Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: Evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. <em>BMJ, 346</em>, e8707. <a href="https://doi.org/10.1136/bmj.e8707" rel="external">https://doi.org/10.1136/bmj.e8707</a></p><p>[12] Zhang, Y., Chadaideh, K. S., Li, Y., Li, Y., Gu, X., Liu, Y., Guasch-Ferré, M., Rimm, E. B., Hu, F. B., Willett, W. C., Stampfer, M. J., &amp; Wang, D. D. (2025). Butter and plant-based oils intake and mortality. <em>JAMA Internal Medicine, 185</em>(5), 549-560. <a href="https://doi.org/10.1001/jamainternmed.2025.0205" rel="external">https://doi.org/10.1001/jamainternmed.2025.0205</a></p><p>[13] Neelakantan, N., Seah, J. Y. H., &amp; van Dam, R. M. (2020). The effect of coconut oil consumption on cardiovascular risk factors: A systematic review and meta-analysis of clinical trials. <em>Circulation, 141</em>(10), 803-814. <a href="https://doi.org/10.1161/CIRCULATIONAHA.119.043052" rel="external">https://doi.org/10.1161/CIRCULATIONAHA.119.043052</a></p><p>[14] U.S. Department of Agriculture, Agricultural Research Service. (2019). <em>FoodData Central: Butter, salted (FDC 173410); Butter, clarified (ghee) (FDC 171314)</em>. <a href="https://fdc.nal.usda.gov" rel="external">https://fdc.nal.usda.gov</a></p><p>[15] Guasch-Ferré, M., Li, Y., Willett, W. C., Sun, Q., Sampson, L., Salas-Salvadó, J., Martínez-González, M. A., Stampfer, M. J., &amp; Hu, F. B. (2022). Consumption of olive oil and risk of total and cause-specific mortality among U.S. adults. <em>Journal of the American College of Cardiology, 79</em>(2), 101-112. <a href="https://doi.org/10.1016/j.jacc.2021.10.041" rel="external">https://doi.org/10.1016/j.jacc.2021.10.041</a></p><p>[16] Hall, K. D., Ayuketah, A., Brychta, R., Cai, H., Cassimatis, T., Chen, K. Y., Chung, S. T., Costa, E., Courville, A., Darcey, V., Fletcher, L. A., Forde, C. G., Gharib, A. M., Guo, J., Howard, R., Joseph, P. V., McGehee, S., Ouwerkerk, R., Raisinger, K., … Zhou, M. (2019). Ultra-processed diets cause excess calorie intake and weight gain: An inpatient randomized controlled trial of ad libitum food intake. <em>Cell Metabolism, 30</em>(1), 67-77.e3. <a href="https://doi.org/10.1016/j.cmet.2019.05.008" rel="external">https://doi.org/10.1016/j.cmet.2019.05.008</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated September 3, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>What the old randomized trials can establish:</strong> The Minnesota and Sydney trials tested unusually high linoleic-acid diets in institutionalized or post-infarction populations decades ago. The Sydney intervention also supplied safflower-oil margarine, and the recovered materials could not establish its trans-fat content. These trials matter, but neither isolates the effect of the seed oils used in an ordinary modern diet. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>The butter-to-oil estimate:</strong> The reported 17% lower mortality estimate came from a modeled substitution in three long-running cohorts of health professionals. It was not a randomized butter swap and cannot prove that changing one person's cooking fat will produce that effect. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Omega-6 and cardiovascular outcomes:</strong> A Cochrane review found that increasing omega-6 fat may have little or no effect on death or cardiovascular events, while probably lowering myocardial-infarction risk. The evidence does not support calling ordinary seed-oil intake toxic, but it also does not make extra omega-6 a proven longevity intervention. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Coconut oil and LDL cholesterol:</strong> The coconut-oil estimate concerns an average rise in LDL cholesterol versus non-tropical vegetable oils. The trials were short and did not measure heart attacks or mortality, so the result supports a lipid warning rather than a direct claim about clinical events. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.bmj.com/content/353/bmj.i1246" rel="external">Ramsden, C. E., Zamora, D., Majchrzak-Hong, S., et al. (2016). Re-evaluation of the traditional diet-heart hypothesis: Analysis of recovered data from Minnesota Coronary Experiment. BMJ, 353, i1246. https://doi.org/10.1136/bmj.i1246</a></li><li id="correction-ref-2"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2831265" rel="external">Zhang, Y., Zhuang, P., Wu, F., et al. (2025). Butter and plant-based oils intake and mortality. JAMA Internal Medicine, 185(5), 549–560. https://doi.org/10.1001/jamainternmed.2025.0205</a></li><li id="correction-ref-3"><a href="https://doi.org/10.1002/14651858.CD011094.pub4" rel="external">Hooper, L., Al-Khudairy, L., Abdelhamid, A. S., et al. (2018). Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, 11, CD011094. https://doi.org/10.1002/14651858.CD011094.pub4</a></li><li id="correction-ref-4"><a href="https://doi.org/10.1161/CIRCULATIONAHA.119.043052" rel="external">Neelakantan, N., Seah, J. Y. H., &amp; van Dam, R. M. (2020). The effect of coconut oil consumption on cardiovascular risk factors. Circulation, 141(10), 803–814. https://doi.org/10.1161/CIRCULATIONAHA.119.043052</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/seed-oils-butter-and-plant-oils">Seed Oils, Butter, and Plant Oils: What Human Evidence Supports →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[0.8 kg: the once-a-week workout headline, checked]]></title>
<description><![CDATA[What a 315-person HIIT trial found about weekly exercise frequency, fat loss and fitness, and which parts of the tested protocol matter before trying it.]]></description>
<link>https://www.andreheeg.com/archive/0-8-kg-the-once-a-week-workout-headline-checked</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/0-8-kg-the-once-a-week-workout-headline-checked</guid>
<pubDate>Wed, 12 Aug 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>A study from January made headlines again this month, focusing on whether one workout per week can help reduce belly fat. It’s worth taking a closer look than most coverage did.</p><h2>What?</h2><p>Researchers led by Parco Siu in Hong Kong assigned 315 inactive adults with central obesity to 3 groups: one group performed one workout a week, another performed 3, and the third attended health education classes. After 16 weeks, the once-a-week group lost 0.8 kg of fat compared to the control, while the 3-times-a-week group lost 1.0 kg. The difference between the 2 exercise groups was too small to be significant. Both groups reduced their waist size by about 2 cm. The study was published in Nature Communications.</p><p>There are two important details that most reports missed. The exercise involved supervised treadmill sessions: 4 intervals of 4 minutes each at 85-95% of peak heart rate, with 3 minutes of easy walking between intervals. For the once-a-week group, the session meant doing 3 of these blocks in a row with rest breaks, making it almost 2 hours at the gym, not just a long walk.</p><h2>So what?</h2><p>The main difference between the groups was in fitness. The once-a-week group improved their VO2 peak by 1.5 ml/kg/min, while the 3-times-a-week group improved by 2.6. 16 weeks after the training ended, only the 3-times-a-week group still had better fitness than the control group. By then, the fat loss was gone, but both groups kept their smaller waists.</p><p>I’ve said before that VO2 max is the best measure of how long you’ll live and how well you’ll function. From that perspective, the headline is only partly true. The once-a-week plan matched the others for fat loss, but it didn’t keep up in fitness; fitness was the lasting benefit at week 32.</p><p>The other side is important too. For living longer, how you spread out your workouts might not matter much. A 2025 review of 21 studies found that people who exercise only on weekends and those who exercise more regularly both experienced similar reductions in death rates. If you can only fit in one session a week, it’s still worth doing.</p><p>The real difference came from working at 85-95% of your peak heart rate.</p><h2>Now what?</h2><ul><li>Try the workout as it was tested: start with 5 minutes of easy effort, then do 4 rounds of 4 minutes hard and 3 minutes easy, and finish with another 5 minutes of easy effort. The whole session takes about 35 minutes.</li><li>‘Hard’ means you shouldn’t be able to finish a sentence. If you can talk easily during the 4-minute intervals, you’re not pushing hard enough. You don’t need a heart rate monitor for this.</li><li>Aim for 3 sessions a week if you can, since that group kept their fitness gains. The study didn’t test 2 sessions a week, so I can’t speak to that.</li><li>If your week gets busy, still try to fit in at least one session. Even one workout was better than just attending the education class.</li><li>Don’t let the scale be your only measure. Choose a set route or stairwell, time yourself today, and check your progress again in 8 weeks.</li></ul><p>8 weeks from today is October 7. Mark your calendar for your retest.</p><p>Stay healthy.</p><p>Andre</p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated August 13, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>The 35-minute protocol:</strong> The 35-minute session in the action list was the study's three-times-weekly session. The once-weekly group completed three 25-minute HIIT bouts, separated by 15 to 30 minute breaks, in one supervised visit. Participants had a maximal cardiopulmonary exercise test, progressed over 4 weeks, trained with certified instructors and wore continuous heart-rate monitors. The study did not test an unsupervised 35-minute once-weekly plan without a monitor. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>What the frequency comparison can show:</strong> The primary fat-mass difference between the once- and three-times-weekly groups was not statistically significant. The trial was not powered to establish that the schedules were equivalent. At week 32, fat mass was no longer different from control, waist circumference remained lower in both exercise groups and only the three-times-weekly group remained fitter than control. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>The weekend-warrior mortality evidence:</strong> The 21-study review pooled observational studies in which activity was concentrated into 1 or 2 days. The result supports similar mortality associations for weekend-warrior and regularly active patterns compared with inactivity. It does not show that one 35-minute session reduces mortality, and the observational evidence cannot prove that the schedule caused the lower death rate. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>The intensity claim:</strong> The trial compared one versus three weekly sessions while holding the weekly HIIT dose at 75 minutes. It did not compare 85 to 95 percent of peak heart rate with moderate-intensity exercise. The study therefore cannot establish that high intensity was the reason for the outcomes. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>What VO2 peak predicts:</strong> Cardiorespiratory fitness, often measured through VO2 max or VO2 peak, is a strong predictor of mortality and future disease across cohort research. It is not a direct measure of how long an individual will live or function. The certainty of the 2024 overview ranged from very low to moderate across outcomes. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.nature.com/articles/s41467-025-68149-7" rel="external">Siu et al. Once and thrice weekly interval training in adults with central obesity: a randomized controlled trial. Nature Communications, 2026.</a></li><li id="correction-ref-2"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12604259/" rel="external">Zhang et al. The weekend warrior phenomenon: comparable mortality reduction to regular exercise with enhanced neuroprotective effects. BMC Public Health, 2025.</a></li><li id="correction-ref-3"><a href="https://clinicaltrials.gov/study/NCT04887454" rel="external">ClinicalTrials.gov. Optimal Frequency of High-Intensity Interval Training for Centrally Obese Adults. NCT04887454.</a></li><li id="correction-ref-4"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11103301/" rel="external">Lang et al. Cardiorespiratory fitness is a strong and consistent predictor of morbidity and mortality among adults. British Journal of Sports Medicine, 2024.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section>]]></content:encoded>
</item>
<item>
<title><![CDATA[The Peptide I Almost Injected]]></title>
<description><![CDATA[BPC-157, weak human evidence, peptide marketing, product quality, and the choice not to inject an unapproved compound.]]></description>
<link>https://www.andreheeg.com/archive/the-peptide-i-almost-injected</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-peptide-i-almost-injected</guid>
<pubDate>Sun, 09 Aug 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>I had the transfer form open and my bank app in the other hand.</p><p>The shop sold vials. The shipping terms said the contents were for lab research only and not for people. Sites include that so whatever happens next is your responsibility.</p><p>I have both a medical and dental degree, but I was still about to send money to strangers for something I planned to inject into myself.</p><p>By August 2024, my wife was putting my socks on for me. Underwear was even harder because you have to balance on one leg. I washed my face in stages. After 18 months of this, things only got worse. On work mornings with travel, I took the strongest painkiller I had.</p><p>I wore headphones most of the day. That August, while half-listening to a podcast, I heard Andrew Huberman tell Joe Rogan something about a compound called BPC-157:</p><p>&gt; “while only animal data, it’s very clear, you know, it has the propensity to encourage fibroblasts, which is cells that, you know, make up things like, you know, tendon and cartilage, et cetera, and can really repair tissues… I certainly have experienced it can help repair things.” [1]</p><p>I missed the warning. The words that stayed with me were tendon and cartilage.</p><p>I had heard about it before and ignored it. That afternoon, I ended up on a vendor’s website.</p><h2><strong>The vote that changed nothing</strong></h2><p>I first heard about BPC-157 in July 2021 from the same two men on the same show [2]. Three years later, I was at my lowest point when it came up again. Two years after that, on July 23, an FDA advisory panel voted 8 to 6 to recommend letting pharmacies compound it, even though the agency’s own reviewers disagreed. Eight panelists were recent appointees, and six of them ran clinics that sell peptides. One person voted yes but admitted the data was disappointingly incomplete [3].</p><p>But nothing changed after that. A panel can only recommend. The list of what pharmacies can legally make hasn’t changed since February 2019 [4], so no pharmacy in America can legally make BPC-157 today. The vote only changed what people expect might happen.</p><p>There was a vote, but still not a single randomized trial in humans. That’s why people keep asking me the same question: Are peptides safe?</p><p>No one can answer that, because the word itself doesn’t refer to a single thing.</p><h2><strong>The word is a size</strong></h2><p>Insulin is a peptide. It has 51 amino acids and is the reason a 14-year-old in Toronto, who weighed just 65 pounds when admitted, lived another 13 years [5]. Semaglutide (Ozempic/Wegovy) is also a peptide, and someone on your leadership team is probably using it quietly.</p><p>A peptide is simply a short chain of amino acids. That’s the definition. In the U.S., regulators set the cutoff at 40. Anything above that is considered a biologic, which is protected from copies for 12 years and can’t be made by compounding pharmacies. Regular drugs get 5 years [6][7]. Tirzepatide (Mounjaro/Zepbound) is just under the limit, at 39 [8].</p><p>That number only affects the paperwork and nothing else.</p><p>Abud Bakri is an internist who has used these compounds himself and says so, sits on the medical commission of Enhanced, which sells peptides, and has consulted for a group planning a BPC-157 trial. On Huberman’s show in June:</p><p>&gt; “everyone online talks about peptides are good or peptides are bad. There’s no actual scientific category of peptides that gives you a functional definition that’s discussable between two people. Because what do you mean by peptide? Do you mean carnosine or do you mean [retatrutide]?” [9]</p><h2><strong>What I ask myself before taking anything</strong></h2><p>Three questions, in order.</p><p>Has this ever been given to humans in a study I can read? Who funded that study, and do they also sell the compound? And does the result actually matter in real life, or is it just a number in my blood that’s never been shown to make a difference?</p><p>Most so-called longevity peptides don’t even pass the first question.</p><h2><strong>One lab in Zagreb</strong></h2><p>In the early 1980s, a group in Croatia went looking for whatever keeps the stomach from digesting itself. By 1989 they said they had it: a fragment of a larger protein, 15 amino acids long [10][11].</p><p>The full sequence of that larger protein has never been published. When a reporter asked why, Predrag Sikirić said that if you have your own child, you want it to be yours forever. Anna Mapp, a chemist at Michigan and president of the American Peptide Society, told the same reporter that without the full sequence, it’s impossible to reproduce the original work [11].</p><p>Then came the animal studies: rats with severed tendons, cut ligaments, burns, and crushed muscles healed faster, again and again, mostly in studies by the same group. About four out of five BPC-157 papers on PubMed list Sikirić or his Zagreb colleague as an author, a number his critics published last year, and he disputed in the same journal [12].</p><p>There are no randomized controlled trials in humans. A systematic review last year looked at 544 papers and included 36; 35 were animal studies [13]. The only human study was a survey: 12 patients who had already received knee injections were asked how they felt afterward; 7 said they felt better, but there was no placebo and no blinding [14]. The rest are a small intravenous pilot in two people [15] and a couple of Croatian trials from the early 2000s where the compound was given as an enema and never fully published.</p><p>Bakri says that when researchers checked those patients’ blood afterward, they couldn’t find the compound [9]. Maybe it stayed local, broke down too quickly to measure, or was never absorbed. No one outside that group can verify it.</p><p>And almost no one takes it the way those trials did.</p><h2><strong>What I won’t write down</strong></h2><p>I should be clear that I’m not a purist. I’m curious and have tried plenty of things on myself that aren’t standard medicine. I’ve written before about experimenting with psychedelics. I know my own body, and I understand physiology and pharmacology well enough to take a calculated risk. I’m comfortable being the one who finds out.</p><p>What I get from that is a study with one participant, me, unblinded, and run by someone who wanted it to work. That’s a long way from real advice. I wouldn’t give it to my own family.</p><p>People still ask me for prescriptions. Metformin, because they read about its link to longevity. Stimulants. Testosterone. And lately, peptides.</p><p>Some of these would be easy to prescribe, and the risk would be small. I could write the prescription in 20 seconds and say what everyone says: this is off-label, I’ve explained it to you, you’re doing it at your own risk, I take no responsibility. All of that is true, but it still makes me the one who signed.</p><p>Most of my surgical years went on cancers of the mouth: the lip, the tongue, the floor of the mouth, the lining of the cheek. Surgery is the backbone; radiation comes after it, sometimes with chemotherapy alongside. Surgery means cutting in three dimensions with a margin of a centimeter around the tumor. Take something the size of a walnut out of the tongue, and you have changed how that person speaks for the rest of their life, how they move food around their mouth, whether they can swallow at all.</p><p>Most were men in their sixties, smokers, with a lesion on the side of the tongue they’d called a mouth ulcer for months. I would sit down and explain the situation. The consequences would be permanent, and they’d be reminded every time they spoke. It was their best chance, but no one could promise it wouldn’t return.</p><p>They said yes, almost all of them.</p><p>I would see them months later, eating, talking, holding a cup of coffee.</p><p>I’ve already been the person who said yes and then watched someone go home and live with the outcome. That’s why I won’t do it casually for something untested, just because someone wants it.</p><p>The argument back is always the same. If you don’t, someone else will.</p><p>Fine. Then someone else can take responsibility for that.</p><h2><strong>The correction that didn’t travel</strong></h2><p>In July 2021, Huberman told Rogan that things like it “definitely do accelerate the healing of an injury and there’s no question about that.” Rogan, same conversation: “I’ve used it myself, and I had a tendonitis in my elbow that I just could not fix. I started using [BPC-157]. It was gone in two weeks” [2].</p><p>By August 2024, Huberman had moved. The sentence now started with “while only animal data” [1]. And 5 months before that, on his own show, he had gone further still: BPC-157 may raise tumor growth risk through the same blood-vessel mechanism that makes it interesting, and he does not suggest anyone buy black-market peptides [16]. He has since said he took it himself, on a prescription, and no longer does [9].</p><p>He was more cautious than people think, and he became even more careful as time went on.</p><p>Still, I found myself on a vendor’s website.</p><p>The warning and the claim both leave the podcast studio, but only the claim spreads.</p><h2><strong>The evidence trail is contaminated too</strong></h2><p>Say you do the responsible thing and check. The American trials registry is where a careful person looks, and as of August 4 it returns Phase 2 studies for BPC-157 and TB-500, marked recruiting.</p><p>Three of the records in that cluster say inside their own text that they are fictional or mock entries [17].</p><p>They seem like practice submissions that accidentally got out of a test system. I have no proof anyone meant to mislead. But the effect is the same. You search for evidence and find something that looks real, from a sponsor with a real name, marked as enrolling patients. The BPC-157 record doesn’t have any disclaimer.</p><h2><strong>The Wolverine stack</strong></h2><p>Few people take BPC-157 alone, and the bundles have names.</p><p>BPC-157 with TB-500 is sold as the Wolverine stack. Add copper peptide, and it becomes the glow stack. Someone picked those names. An adult decided that a man injecting two untested compounds into his shoulder should picture himself as a comic book hero with claws. It works, because people buy it. I used the male pronouns on purpose.</p><p>Bakri described what he calls the Trinity stack: a GLP-1, a growth hormone drug, a hormone layer on top. “A lot of these transformations you see in CEOs and celebrities and stuff is using a combination of those three things,” he said. On whether it’s healthy: “We’ll find out” [9].</p><p>We’ll find out. By watching what happens to people like you.</p><p>He also explained how people get there: buy one, see a result, add three more, and “the average sale value goes up from these research sites” [9]. I couldn’t find any study on what these combinations do together.</p><p>The GLP-1s are the exception, and the reason everyone else is comfortable holding a syringe. Semaglutide and tirzepatide went through the full process, and they are the best evidence in this field.</p><p>I couldn’t find any published analysis of what’s actually in gray-market BPC-157. Researchers bought semaglutide from online sellers. The vials were overfilled with material that was only 7.7% to 14.4% semaglutide, against a label claiming 99%, which still left the dose 28% to 39% above what the label promised. Every sample carried bacterial endotoxin. Mostly unknown material, and more drug than you think [18].</p><p>Bakri told a story about a man who ordered a weight loss compound and saw his skin darken, only to realize he was injecting a tanning peptide [9]. That’s the kind of mistake you can see in the mirror. The others, you can’t.</p><p>Insulin and the GLP-1s are medicine, with the trials to prove it. BPC-157 is unfinished. TB-500 is a 7-amino-acid piece of a bigger molecule whose own trial record is mixed, and the fragment inherits none of it [19]. Melanotan II, the tanning one, has published case reports of muscle breakdown, kidney infarction, priapism, and new atypical moles [20][21][22][23]. KPV, dihexa, PEG-MGF, and epitalon have no registered Western human trial, which didn’t stop the July panel recommending KPV alongside BPC-157 [3].</p><h2><strong>Where I’m on thin ice</strong></h2><p>I can’t say BPC-157 doesn’t work. The animal data is better than I expected after a week of research, and there’s no published series of humans harmed by it either because no one has done the study that would answer that question.</p><p>And by my own three questions, my own back wouldn’t count as evidence. One participant, no blinding, no comparison group, and a condition that sometimes gets better on its own. I know that. I’d still begin with what I did before. If physiotherapy fails, you’ve lost 12 weeks. If a vial fails, you can’t take back whatever it already did.</p><p>This is the Activate pillar of the Upward ARC, the part about what you put into your body, and it’s where that risk hits hardest.</p><h2><strong>Try this today</strong></h2><p>Some of you are already taking something. Some of you are just thinking about it. This is for both groups.</p><p><strong>If you have any history of cancer, or anything undiagnosed, this is where I stop being neutral.</strong> BPC-157 appears to work partly by growing blood vessels. Tumors need blood vessels. Nobody has run the study that would tell us whether that matters in a person, and I wouldn’t volunteer to find out. Huberman said the same on his own show, and almost nobody quotes that one [16]. If you compete under anti-doping rules, all three of these are prohibited at all times on the WADA list: BPC-157 as a non-approved substance, TB-500 as a thymosin derivative, MOTS-c as a metabolic modulator. A prescription is no defense [24].</p><p><strong>Ask yourself those three questions before trying any compound.</strong> Most options will drop off the list.</p><p><strong>Find out what’s actually in the vial, and ask about the markup.</strong> Who made it, which lab tested it, and is that lab independent from the seller? Then ask your clinician what the pharmacy charges them and what they charge you. That price gap is legal in many places and goes into someone’s pocket. Treat the seller’s certificate as marketing: in one analysis, two custom-made peptides were found to be 20% and 43% undeclared mannitol by weight, which standard purity tests wouldn’t catch [25].</p><p><strong>Decide what failure looks like before you start.</strong> What will you measure, by when, and what result will make you stop? Write it down. Without this, every intervention seems to work forever.</p><h2><strong>Two years of boring</strong></h2><p>Looking at that transfer form, I realized what I had become: a man in an alley, buying something from a stranger and just hoping.</p><p>I had become someone willing to put an unknown substance into my body just because I couldn’t put on a sock. No vial could fix what that said about me.</p><p>So I chose the other path. I sought guidance from physiotherapists, back pain specialists, nutritionists, and others. I rebuilt my training routine twice, changed my diet, lost weight, and kept habits I still follow, like a walk before my first call and a proper shutdown routine after 10pm. It took months, but it worked. I haven’t needed a painkiller in almost two years.</p><p>At some point, my wife stopped needing to help me with my socks. I can’t say which morning it was, and that’s how I know it was the slow, steady approach that worked.</p><p>I’d listened to every podcast. The only thing I never did was take action on a random Tuesday, in a life that doesn’t stop for experiments.</p><p>I was lucky because of where I lived. The compound was hard to get in Germany, and that delay gave the rational part of me time to catch up with the desperate part. If I’d been somewhere with next-day delivery that August, things might have turned out differently.</p><p>Stay healthy.</p><p>Andre</p><p>PS: I’m not judging anyone, because I was one click away from doing the same thing. Have you ever come close? It doesn’t have to be peptides, just anything you considered when pain or exhaustion dragged on too long. Reply and tell me about it. I read every message, and I never share them. If you know someone who needs this, forward this edition to them. This is how this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If a friend forwarded this to you, you can get Under Load, my Sunday edition, here: <a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a>.</p><div><hr></div><h2><strong>References</strong></h2><p>[1] Rogan, J. (Host). (2024, August 27). <em>#2195 – Andrew Huberman</em> [Audio podcast episode]. In <em>The Joe Rogan Experience</em>. Speaker-labeled transcript, approximately 3:02:52.</p><p>[2] Rogan, J. (Host). (2021, July 14). <em>#1683 – Andrew Huberman</em> [Audio podcast episode]. In <em>The Joe Rogan Experience</em>. Approximately 2:39:14-2:40:37. Automated transcript; both speakers render the compound inconsistently, and bracketed corrections are marked.</p><p>[3] Lovelace, B., Jr., &amp; Miller, S. G. (2026, July 23). FDA panel recommends easing some peptide restrictions despite disapproval from scientists. <em>NBC News</em>. <a href="https://www.nbcnews.com/health/health-news/peptides-restrictions-ease-fda-panel-recommend-bpc-157-scientists-rcna588879" rel="external">https://www.nbcnews.com/health/health-news/peptides-restrictions-ease-fda-panel-recommend-bpc-157-scientists-rcna588879</a></p><p>[4] List of bulk drug substances that can be used to compound drug products in accordance with section 503A of the Federal Food, Drug, and Cosmetic Act, 84 Fed. Reg. 4696 (February 19, 2019), codified at 21 C.F.R. § 216.23. No subsequent amendment as of August 2026.</p><p>[5] Rogol, A. D., Laffel, L. M., Bode, B., &amp; Sperling, M. A. (2023). Celebration of a century of insulin therapy in children with type 1 diabetes. <em>Archives of Disease in Childhood, 108</em>(1), 3-10. <a href="https://doi.org/10.1136/archdischild-2022-323975" rel="external">https://doi.org/10.1136/archdischild-2022-323975</a></p><p>[6] Definitions, 21 C.F.R. § 600.3(h)(6).</p><p>[7] Biologics Price Competition and Innovation Act of 2009, 42 U.S.C. § 262(k)(7); Drug Price Competition and Patent Term Restoration Act of 1984, 21 U.S.C. § 355(j)(5)(F)(ii); Federal Food, Drug, and Cosmetic Act § 503A, 21 U.S.C. § 353a.</p><p>[8] Coskun, T., Sloop, K. W., Loghin, C., Alsina-Fernandez, J., Urva, S., Bokvist, K. B., Cui, X., Briere, D. A., Cabrera, O., Roell, W. C., Kuchibhotla, U., Moyers, J. S., Benson, C. T., Gimeno, R. E., D’Alessio, D. A., &amp; Haupt, A. (2018). LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. <em>Molecular Metabolism, 18</em>, 3-14. <a href="https://doi.org/10.1016/j.molmet.2018.09.009" rel="external">https://doi.org/10.1016/j.molmet.2018.09.009</a></p><p>[9] Huberman, A. D. (Host). (2026, June 1). <em>Peptides: The science, uses &amp; safety | Dr. Abud Bakri</em> [Audio podcast episode]. In <em>Huberman Lab</em>. Quotations at approximately 0:00:29, 0:21:12, 0:34:15, 2:30:20 and 2:37:50.</p><p>[10] Józwiak, M., Bauer, M., Kamysz, W., &amp; Kleczkowska, P. (2025). Multifunctionality and possible medical application of the BPC 157 peptide: Literature and patent review. <em>Pharmaceuticals, 18</em>(2), 185. <a href="https://doi.org/10.3390/ph18020185" rel="external">https://doi.org/10.3390/ph18020185</a></p><p>[11] Talpos, S. (2026, May 29). A peptide, a secretive scientist, and a debate over evidence. <em>Undark Magazine</em>. <a href="https://undark.org/2026/05/29/stress-test-bpc-157-history/" rel="external">https://undark.org/2026/05/29/stress-test-bpc-157-history/</a> (Co-published by <em>STAT News</em>, June 1, 2026.)</p><p>[12] Józwiak, M., Bauer, M., Kamysz, W., &amp; Kleczkowska, P. (2025). Reply to Sikiric et al. Comment on “Józwiak et al. Multifunctionality and possible medical application of the BPC 157 peptide: Literature and patent review.” <em>Pharmaceuticals, 18</em>(10), 1451. <a href="https://doi.org/10.3390/ph18101451" rel="external">https://doi.org/10.3390/ph18101451</a></p><p>[13] Vasireddi, N., Hahamyan, H., Salata, M. J., Karns, M., Calcei, J. G., Voos, J. E., &amp; Apostolakos, J. M. (2025). Emerging use of BPC-157 in orthopaedic sports medicine: A systematic review. <em>HSS Journal, 21</em>(4), 485-495. <a href="https://doi.org/10.1177/15563316251355551" rel="external">https://doi.org/10.1177/15563316251355551</a></p><p>[14] Lee, E., &amp; Padgett, B. (2021). Intra-articular injection of BPC 157 for multiple types of knee pain. <em>Alternative Therapies in Health and Medicine, 27</em>(4), 8-13.</p><p>[15] Lee, E., &amp; Burgess, K. (2025). Safety of intravenous infusion of BPC157 in humans: A pilot study. <em>Alternative Therapies in Health and Medicine, 31</em>(5), 20-24.</p><p>[16] Huberman, A. D. (Host). (2024, April 1). <em>Benefits &amp; risks of peptide therapeutics for physical &amp; mental health</em> [Audio podcast episode]. In <em>Huberman Lab</em>. <a href="https://www.hubermanlab.com/episode/benefits-risks-of-peptide-therapeutics-for-physical-mental-health" rel="external">https://www.hubermanlab.com/episode/benefits-risks-of-peptide-therapeutics-for-physical-mental-health</a></p><p>[17] U.S. National Library of Medicine. (2026). <a href="http://ClinicalTrials.gov" rel="external">*ClinicalTrials.gov*</a> records NCT07437547, NCT07487363, NCT07481734 and NCT07437560, first posted February-March 2026. Retrieved August 4, 2026.</p><p>[18] Ashraf, A. R., Mackey, T. K., Vida, R. G., Kulcsár, G., Schmidt, J., Balázs, O., Domián, B. M., Li, J., Csákó, I., &amp; Fittler, A. (2024). Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription: Market surveillance, content analysis, and product purchase evaluation study. <em>Journal of Medical Internet Research, 26</em>, e65440. <a href="https://doi.org/10.2196/65440" rel="external">https://doi.org/10.2196/65440</a></p><p>[19] Sosne, G., Kleinman, H. K., Springs, C., Gross, R. H., Sung, J., &amp; Kang, S. (2023). 0.1% RGN-259 (thymosin β4) ophthalmic solution promotes healing and improves comfort in neurotrophic keratopathy patients in a randomized, placebo-controlled, double-masked Phase III clinical trial. <em>International Journal of Molecular Sciences, 24</em>(1), 554. <a href="https://doi.org/10.3390/ijms24010554" rel="external">https://doi.org/10.3390/ijms24010554</a> (Primary endpoint not met, p=0.0656; funded by ReGenTree, with authors employed by the sponsor or its parent.)</p><p>[20] Nelson, M. E., Bryant, S. M., &amp; Aks, S. E. (2012). Melanotan II injection resulting in systemic toxicity and rhabdomyolysis. <em>Clinical Toxicology, 50</em>(10), 1169-1173. <a href="https://doi.org/10.3109/15563650.2012.740637" rel="external">https://doi.org/10.3109/15563650.2012.740637</a></p><p>[21] Peters, B., Hadimeri, H., Wahlberg, R., &amp; Afghahi, H. (2020). Melanotan II: A possible cause of renal infarction. <em>CEN Case Reports, 9</em>(2), 159-161. <a href="https://doi.org/10.1007/s13730-020-00446-0" rel="external">https://doi.org/10.1007/s13730-020-00446-0</a></p><p>[22] Dreyer, B. A., Amer, T., &amp; Fraser, M. (2019). Melanotan-induced priapism: A hard-earned tan. <em>BMJ Case Reports, 12</em>(2), e227644. <a href="https://doi.org/10.1136/bcr-2018-227644" rel="external">https://doi.org/10.1136/bcr-2018-227644</a></p><p>[23] Reid, C., Fitzgerald, T., Fabre, A., &amp; Kirby, B. (2013). Atypical melanocytic naevi following melanotan injection. <em>Irish Medical Journal, 106</em>(5), 148-149.</p><p>[24] World Anti-Doping Agency. (2026). <em>The 2026 prohibited list</em>. BPC-157 under S0 (non-approved substances); thymosin beta-4 and its derivatives, including TB-500, under S2.3 (growth factors); MOTS-c under S4.4 (AMPK activators, metabolic modulators). All prohibited at all times.</p><p>[25] Choules, M. P., Bisson, J., Simmler, C., McAlpine, J. B., Giancaspro, G., Bzhelyansky, A., Niemitz, M., &amp; Pauli, G. F. (2020). NMR reveals an undeclared constituent in custom synthetic peptides. <em>Journal of Pharmaceutical and Biomedical Analysis, 178</em>, 112915. <a href="https://doi.org/10.1016/j.jpba.2019.112915" rel="external">https://doi.org/10.1016/j.jpba.2019.112915</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated August 11, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>The human BPC-157 record:</strong> The FDA's July 2026 review identified five small human studies, not only the knee report, two-person intravenous pilot, and two Croatian studies described above. The fifth was a 12-person single-arm bladder study. Two short rectal studies were randomized and placebo-controlled, but were reported only as meeting abstracts. There is still no fully published, adequately powered randomized trial supporting injected BPC-157 for musculoskeletal injury, and long-term safety remains uncharacterized. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>The FDA vote and current compounding status:</strong> The 8-6 vote, with one abstention, was advisory and did not change federal compounding rules. As reviewed on August 11, 2026, BPC-157 was still absent from the 503A bulk-drug list. FDA staff recommended against adding BPC-157 because identity, effectiveness, and safety data were inadequate. The committee's recommendation is non-binding, so this status may change only through a later FDA action. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>The 40-amino-acid boundary:</strong> The 40-amino-acid line is part of FDA's regulatory definition of a protein. It is not a universal scientific boundary, and it does not by itself determine whether a product may be compounded. The 12-year and 5-year periods mentioned above are pathway-specific exclusivity rules, not automatic protection for every molecule on either side of the line. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Angiogenesis and cancer risk:</strong> BPC-157 has promoted angiogenic signaling in laboratory and animal work. That creates a plausible theoretical concern, but no human study has shown that BPC-157 causes or accelerates cancer. The FDA review found no carcinogenicity studies, so the risk remains unknown rather than established. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>What the gray-market test establishes:</strong> The online-product study tested three semaglutide vials, not BPC-157 and not the entire gray market. All three had much lower purity than advertised, more semaglutide than the labeled amount, and detectable endotoxin. The result demonstrates that serious quality failures can occur; it cannot estimate how common they are across sellers or peptide products. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>ClinicalTrials.gov records:</strong> The registry anomaly described above was still present on August 11, 2026. The TB-500 and tesamorelin records explicitly described themselves as fictional, example, or mock studies. The BPC-157 record did not contain that disclaimer. A ClinicalTrials.gov listing records submitted registration data; it does not by itself verify that a functioning trial is recruiting. <span class="correction-ref-links"><a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.fda.gov/media/193343/download" rel="external">U.S. Food and Drug Administration. (2026). Evaluation of the bulk drug substances BPC-157 free base and BPC-157 acetate for use in compounding under sections 503A and 503B. https://www.fda.gov/media/193343/download</a></li><li id="correction-ref-2"><a href="https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026" rel="external">U.S. Food and Drug Administration. (2026). July 23-24, 2026 meeting of the Pharmacy Compounding Advisory Committee. https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026</a></li><li id="correction-ref-3"><a href="https://www.fda.gov/about-fda/economic-impact-analyses-fda-regulations/definition-term-biological-product-final-regulatory-impact-analysis" rel="external">U.S. Food and Drug Administration. (2020). Definition of the term biological product: Final regulatory impact analysis. https://www.fda.gov/about-fda/economic-impact-analyses-fda-regulations/definition-term-biological-product-final-regulatory-impact-analysis</a></li><li id="correction-ref-4"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11582493/" rel="external">Ashraf, A. R., Mackey, T. K., and Schmidt, J. (2024). Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription. Journal of Medical Internet Research, 26, e65440. https://doi.org/10.2196/65440</a></li><li id="correction-ref-5"><a href="https://clinicaltrials.gov/study/NCT07437547" rel="external">ClinicalTrials.gov. (2026). BPC-157 for chronic hamstring tendinopathy, NCT07437547. https://clinicaltrials.gov/study/NCT07437547</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/bpc-157-peptide-therapies-and-product-risk">BPC-157, Peptide Therapies, and Product Risk →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[356 studies on protein. Almost none in people.]]></title>
<description><![CDATA[What a new protein-restriction review says about longevity, where the human evidence stops, and how activity and age affect practical protein targets.]]></description>
<link>https://www.andreheeg.com/archive/356-studies-on-protein-almost-none-in-people</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/356-studies-on-protein-almost-none-in-people</guid>
<pubDate>Wed, 05 Aug 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>Last Friday, a review covering 356 studies came out. By Sunday, news headlines were already asking if your protein shake might be making you age faster.</p><h2>What?</h2><p>On July 31, Bailey Knopf and Dudley Lamming published a paper called &quot;The hallmarks of protein and amino acid restriction in aging and longevity&quot; in Cell Press Blue. They say that eating less protein can improve metabolic health and, in some species, might even help them live longer.</p><p>If you look closer, the paper gets specific fast. It's a narrative review, so it sums up existing studies instead of combining their data. Most of the strong evidence comes from research on flies, worms, mice, and rats. The best human data is from Lamming's own 43-day trial, where people on a low-protein diet lost weight and fat, and had lower fasting glucose, even though they ate more calories. That is a real result, but the study only lasted six weeks and only measured blood sugar and body fat. No one tracked how long anyone lived.</p><p>Paul Greenhaff, a professor of muscle metabolism at Nottingham, summed it up that same day. The main question &quot;has not been addressed in humans.&quot;</p><h2>So what?</h2><p>The paper doesn't actually tell you to eat less protein. Instead, it says your protein needs depend on how active you are. Lamming himself said, &quot;It's absolutely crystal clear that there are benefits of protein to muscle growth and exercise response of active individuals.&quot; But here's what the headlines missed: most people aren't very active, yet many eat as if they train much more than they really do.</p><p>I've made this point before. Last February, I said most people need 1.6 to 2.2 grams of protein per kilogram, then quickly added, &quot;less if you're sedentary,&quot; and moved on. Those four words were actually the most important.</p><p>Think of protein as your body's repair budget. You use it for the work your body actually does. If you train, eating at the higher end of the range makes sense. If you don't train, you're paying the metabolic cost for muscle you never built.</p><p>There's something else you should know, though it doesn't make the science wrong. Lamming is on the scientific advisory board of a company working on mTOR inhibitors, and mTOR is central to his paper. He disclosed this, but I think it's important for you to know.</p><p>The other side of the story is strong too. In the Nurses' Health Study, nearly 49,000 women were tracked from 1984 to 2016. More protein in midlife, especially from plants, was linked to better odds of aging well. This result is about chronic disease, not muscle, and it only shows an association. For muscle, animal protein still has more leucine and a more complete amino acid profile. That difference matters most if you're not eating enough protein to start with. Once you get enough, studies stop finding a difference in strength or lean mass.</p><h2>Now what?</h2><ul><li>Count the lifting sessions you actually did last week, not the ones you planned. If you did two or more, stick with 1.6 grams per kilogram or more. If you did zero or one, drop to about 1.2.</li><li>Are you over 65 or already losing strength? Ignore the headline. This review agrees with the usual advice. Your minimum is 1.0 to 1.2 grams per kilogram.</li><li>Keep your protein intake steady throughout the week instead of loading up only on gym days. Your muscles stay sensitive to protein for 24 to 48 hours after you lift, so Sunday's chicken still helps pay for Saturday's workout.</li><li>Compare what you eat on a typical day to your target number. If you go over it during a week when you didn't train, cutting out fortified snacks is the easiest way to adjust.</li></ul><p>Stay healthy.<br>Andre</p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated August 11, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>The human protein-restriction trial:</strong> The trial described in the third paragraph was a 27-day randomized study in 21 adults with metabolic syndrome by Ferraz-Bannitz and colleagues. It was not a 43-day trial by Lamming. The protein-restricted group received more calories than the calorie-restricted comparison group, lost weight and fat, and improved glucose measures. The study did not test aging or lifespan. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>The Nurses' Health Study outcome:</strong> The 2024 analysis followed 48,762 women and used a composite definition of healthy aging: freedom from 11 major chronic diseases, good mental health, and no cognitive or physical-function impairment. The association was strongest for plant protein. The observational design cannot establish that protein source caused the outcome. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Activity and protein targets:</strong> The split between two lifting sessions and zero or one is an editorial rule, not a guideline threshold. A resistance-training meta-analysis estimated that gains in fat-free mass levelled off near 1.62 grams per kilogram per day on average. The estimate does not support a universal instruction to eat at least 1.6 after two sessions, and it does not establish a general metabolic penalty above a sedentary target. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Plant and animal protein:</strong> A 2025 meta-analysis found no pooled difference between plant and animal protein for strength or physical performance, alongside a small advantage for animal protein in muscle mass that was driven by non-soy plant comparisons. Soy and milk did not differ for muscle mass. The evidence does not support the broader claim that adequate total intake removes every difference in lean mass. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>Protein advice after 65:</strong> The 1.0 to 1.2 grams per kilogram range for adults over 65 is a professional-group recommendation for average daily intake, not a universal minimum. The group recommends at least 1.2 grams per kilogram for active older adults. Severe kidney disease is an important exception that may require protein restriction and clinical advice. <span class="correction-ref-links"><a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9268415/" rel="external">Ferraz-Bannitz et al. Dietary Protein Restriction Improves Metabolic Dysfunction in Patients with Metabolic Syndrome in a Randomized, Controlled Trial. Nutrients, 2022.</a></li><li id="correction-ref-2"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10884611/" rel="external">Ardisson Korat et al. Dietary protein intake in midlife in relation to healthy aging. American Journal of Clinical Nutrition, 2024.</a></li><li id="correction-ref-3"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5867436/" rel="external">Morton et al. Protein supplementation and resistance training-induced gains in muscle mass and strength. British Journal of Sports Medicine, 2018.</a></li><li id="correction-ref-4"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12166177/" rel="external">Reid-McCann et al. Effect of Plant Versus Animal Protein on Muscle Mass, Strength, Physical Performance, and Sarcopenia. Nutrition Reviews, 2025.</a></li><li id="correction-ref-5"><a href="https://pubmed.ncbi.nlm.nih.gov/23867520/" rel="external">Bauer et al. Evidence-based recommendations for optimal dietary protein intake in older people. Journal of the American Medical Directors Association, 2013.</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section>]]></content:encoded>
</item>
<item>
<title><![CDATA[I Couldn't Remember My Password. That Was the Best News of the Trip.]]></title>
<description><![CDATA[What psychological detachment, family workload, sleep, and workplace incentives reveal about whether a holiday restores you.]]></description>
<link>https://www.andreheeg.com/archive/i-couldnt-remember-my-password</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/i-couldnt-remember-my-password</guid>
<pubDate>Sun, 02 Aug 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>Before we had kids, my wife and I made a list of countries that are easier to visit without a toddler. It started as a bit of a joke. Then we actually began ticking them off, and in 2012, that list took us from China to Pyongyang, North Korea.</p><p>At the border, they took my passport, phone, and laptop. Someone asked about my job, and I wasn’t sure if 'consultant' would make sense or cause trouble, so I said I was a doctor. The next morning, they brought us to a hospital, where I met the head physician. He asked how I’d treat a patient with shortness of breath, then chest pain, then a stubborn headache. The questions were simple enough for me to answer. I passed. It actually felt a bit more stressful than my final exams, but we did get to see a North Korean hospital from the inside.</p><p>We spent two weeks there with a driver and two guides, following a route we didn’t pick, in a place with almost no phone signal anyway. For the first few days, I kept reaching for my pocket, only to find it empty. By the third day, I stopped, and my mind finally quieted in a way it hadn’t for years.</p><p>That sense of calm happened within a tightly controlled system. We followed a set itinerary, always with our guides and driver, and paid to be part of a state-run tourism program. I don’t want to make the regime sound better than it was (it’s bad, and we saw enough to judge even on a tightly controlled trip), but the quiet is what stayed in my memory.</p><p>Fourteen years later, no holiday I’ve picked has given me that same distance from work.</p><h2><strong>How would you even know</strong></h2><p>That bothers me more than it probably should, because I honestly can’t say if any holiday since then has really worked. I usually come home saying I feel better, even after a week where I checked email twice a day and spent six out of seven days thinking about a budget decision.</p><p>Feeling rested is a terrible measure. It depends on things like the last morning, the weather, or a good breakfast, and it often just tells you what you want to hear. So I started looking for something else.</p><h2><strong>The password test</strong></h2><p>On a family holiday, in a place with no reception or somewhere so new I’d stopped checking, I opened my laptop for something and couldn’t remember my password. The whole thing just vanished. I typed something, got it wrong, and stared at the screen. I’ve entered that password loads of times, usually without even thinking about it.</p><p>My company made us change our passwords every few months, so it never really became automatic. Do you know that little shock, and then a feeling almost like satisfaction when this happens? The part of me that remembered those characters had finally let go.</p><p>Researchers have a name for the state I had stumbled into. Sonnentag and Fritz call it psychological detachment, one of four parts of recovery alongside relaxation, mastery, and control [1]. Your head leaves the job, which turns out to be a completely separate event from your body leaving the office. They measure it by asking people whether they have stopped thinking about work, and I should be straight with you: nobody has validated password recall as a measure of anything. People forget passwords for dull reasons.</p><p>I took that blank screen as a personal sign that I’d finally let go of a work habit, and I’ve used it ever since. I’ve also stopped trying to plan the perfect destination. Grant’s meta-analysis couldn’t say if location matters, and it did find that trip length makes a difference, but didn’t say how much or in which direction [2]. So I’m going beyond the evidence when I say I don’t worry about either anymore. In 20 years, I haven’t seen an executive come back changed just because they stayed in a nicer hotel. Now, I just pay attention to whether my mind let go of work at all.</p><h2><strong>Nobody is going to reward you for this</strong></h2><p>Eva Buechel and Elisa Solinas did 16 studies on how detachment is seen at work, and their findings surprised me [3]. Managers say detachment is good for their teams when asked directly. But when they see an employee actually switch off, they rate that person as less promotable. This was true for out-of-office replies, vacation requests, and even when the reason for disconnecting was valid. Managers seem to see detachment as a sign of low commitment.</p><p>There’s another surprising result. In a meta-analysis of 89 samples with 39,085 employees, the six studies that measured work performance found that people who worked during their off-hours actually scored higher [4]. But these studies were mostly self-reported and cross-sectional, so no one was independently assessed. We can’t say if the extra work really caused better performance.</p><p>If you find it hard to switch off, it’s probably because of the incentives at work, not a flaw in your character. The tricky part is that if you’re in a senior role, you help set those incentives. Your out-of-office message is a policy statement. The email you send at 11pm from an airport is, too. Your team pays more attention to that than to any wellbeing presentation.</p><h2><strong>Somebody in this house is still working</strong></h2><p>I’ve never asked my wife if she’s ever forgotten her password on holiday. I think I already know the answer.</p><p>Musick, Meier and Flood analyzed 12,163 people across 36,036 activities, asking how they had felt during three randomly selected activities from the previous day [5]. Parents reported more positive affect in time with their children than in time without. Mothers reported less happiness, more stress, and more fatigue in that same time than fathers did.</p><p>Some of the difference had to do with context. Mothers spent twice as much time on basic care as on play, while fathers split those activities evenly. A partner was present for 31% of mothers’ time with their kids, compared to 61% for fathers. But even after accounting for activity type, solo parenting, sleep, and leisure, mothers were still more tired. That’s the part I keep thinking about, because avoiding fatigue is the whole point of a holiday.</p><p>Holiday-specific research is thin and mostly qualitative, though it exists. A study of self-catering trips found that mothers’ domestic roles largely persisted through the holiday [6]. A more recent interview study found women, and mothers especially, still did more of the housework in home-like accommodation, while hotels shifted couples toward a more equal split, because somebody else does the cooking and the cleaning [7].</p><p>Thinking about our own holiday trips, not just the data. A family holiday takes away the school run, the office, and the usual bedtime routine. But it also removes the structure that decides who does what, so the usual patterns take over. Someone still has to find the pharmacy, pack the bags, remember what each child ate, and handle bedtime in a room without blackout curtains. That person is running a household in an unfamiliar kitchen with worse tools and no schedule to lean on. It feels more like a business trip than a real break.</p><p>This is part of the Recover part of my Upward ARC framework, and a holiday is usually the biggest chunk of recovery time you get all year. Many executives spend it feeling refreshed, while someone else in the house is running an under-resourced operation in a place where they can’t even find the scissors.</p><h2><strong>What the trip does to you</strong></h2><p>The good news is that holidays do work, and they work better than I once thought. Ty Ferguson’s team tracked movement using Fitbits on 308 Australian parents of primary school kids, over 13 months and 9,778 holiday days across 806 trips [8]. The average age was 40, and most had two or three kids at home.</p><p>During holidays, they slept about 21 minutes more each night, did about 5 more minutes of moderate-to-vigorous activity, and sat about half an hour less each day. The extra sleep lasted even after the trip, staying 8 minutes above normal in the first week back and 7 minutes in the second.</p><p>Their light activity dropped, though. All the small movements that fill a normal day went down by about 10 minutes a day in the first week back and stayed about 10 minutes below normal even four weeks later. So they came home sleeping a bit more, but moving less, and that lasted a month.</p><h2><strong>Where this gets shaky</strong></h2><p>In an earlier edition, I said a holiday doesn’t fix burnout, and last summer I called that idea complete “bullshit.” I still don’t think two weeks in Greece will cure a burnt-out executive. But I underestimated the effect. The evidence I used came from seven studies [9]. A much bigger analysis last year looked at 32 studies and found a larger benefit that fades more slowly [2]. Another analysis, which reworks the original data instead of testing it independently, still finds the benefit gone within a week [10].</p><p>There is more uncertain ground. Detachment is the best sign researchers have that you’ve left work behind, but calling it the main driver of recovery is a stretch. In one Dutch study of 54 people, detachment didn’t link to health or wellbeing during or after the holiday [11]. The biggest review found it lowers exhaustion, but doesn’t clearly boost engagement or performance; relaxation and mastery do that instead [12]. Most of this research is based on self-reported questionnaires, and the holiday-specific studies on households are just a few interviews.</p><h2><strong>Try this today</strong></h2><p><strong>Divide up the responsibilities before you leave, and write them down.</strong> Give each parent two hours completely off and unreachable by anyone under 140cm, then switch. If you just play it by ear, the usual patterns take over, just like in Musick’s study [5]. No one has tested this, so it’s my practical suggestion, not a proven method. Have this talk at home on a Tuesday when you’re both calm.</p><p><strong>Consider choosing a hotel instead of a rental.</strong> This is the most useful thing I learned while writing this. In the interview study mentioned earlier, staying in a home-like place kept the usual domestic roles going, while hotels led to a more equal split, mainly because someone else does the cooking and cleaning [7]. It’s a small study with just ten couples and wasn’t meant to test your family, but it’s still worth considering.</p><p><strong>Take care of the month after you get back.</strong> Schedule some movement before you leave. Ferguson’s study found people were still about 10 minutes a day below their usual light activity four weeks after returning [8], and most don’t notice. As a doctor, I recommend adjusting your wake-up time gradually over the first few mornings and keeping your caffeine intake close to your usual amount and timing until you’ve settled in. That’s standard circadian hygiene, and it’s what I do myself.</p><p><strong>Deal with the mental loop in your head.</strong> Airplane mode is the simple fix. What really predicts a rough return is negative work reflection. That’s the technical term for lying by the pool and thinking about everything wrong with your job. In a study of 221 employees, those who did this came back with more health complaints and more exhaustion, even two weeks later [13]. If you catch yourself going over a decision, write down the one action you’ll take when you’re back, put it somewhere you’ll see it, and then let it go.</p><p><strong>Pay attention to your first login when you get home.</strong> If your password doesn’t come to you right away, take it as a personal sign that you really let go of a work habit. It won’t tell you if the holiday worked, but it’s an easy thing to notice.</p><p><strong>If you are in a senior role, say it out loud.</strong> Tell people you will be unreachable, then be unreachable. Buechel and Solinas found that a formal no-weekend-email policy may reduce the promotion penalty [3], and detachment turns out to be learnable, with the biggest gains in older people and those who began with health or recovery-related issues [14].</p><h2><strong>The price of the quiet</strong></h2><p>It took eleven days without work on my mind, a surrendered passport, a driver, two guides, and a skills test from a stranger in a Pyongyang hospital to get that kind of mental break. That’s a ridiculous amount of effort for something we’re supposed to manage on a regular holiday.</p><p>The “wild places to visit before kids” list is in a drawer now. We have three children, the holidays are louder and shorter and considerably more negotiated, and I have stopped expecting any of them to feel like North Korea.</p><p>What I want to know is whether at some point my hands forget the password, and whether my wife’s do, too.</p><p>One question, and I read every reply. What is the one thing your head refuses to put down when you are away? Name it in a sentence.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you are the one in your house who books the pharmacy run and knows which child ate what, this edition was written with you in mind. Send it to the person you are on holiday with. That’s the way this newsletter grows, and it’s the only way I want it to.</p><p>PPS: If a friend forwarded this to you, you can get Under Load, my Sunday edition, here: <a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a>.</p><div><hr></div><h2><strong>References</strong></h2><p>[1] Sonnentag, S., &amp; Fritz, C. (2007). The Recovery Experience Questionnaire: Development and validation of a measure for assessing recuperation and unwinding from work. <em>Journal of Occupational Health Psychology, 12</em>(3), 204-221. <a href="https://doi.org/10.1037/1076-8998.12.3.204" rel="external">https://doi.org/10.1037/1076-8998.12.3.204</a></p><p>[2] Grant, R. S., Buchanan, B. E., &amp; Shockley, K. M. (2025). I need a vacation: A meta-analysis of vacation and employee well-being. <em>Journal of Applied Psychology, 110</em>(7), 887-905. <a href="https://doi.org/10.1037/apl0001262" rel="external">https://doi.org/10.1037/apl0001262</a></p><p>[3] Buechel, E. C., &amp; Solinas, E. (2025). The detachment paradox: Employers recognize the benefits of detachment for employee well-being and performance, yet penalize it in employee evaluations. <em>Organizational Behavior and Human Decision Processes, 188</em>, 104403. <a href="https://doi.org/10.1016/j.obhdp.2025.104403" rel="external">https://doi.org/10.1016/j.obhdp.2025.104403</a></p><p>[4] Kühner, C., Rudolph, C. W., Derks, D., Posch, M., &amp; Zacher, H. (2023). Technology-assisted supplemental work: A meta-analysis. <em>Journal of Vocational Behavior, 142</em>, 103861. <a href="https://doi.org/10.1016/j.jvb.2023.103861" rel="external">https://doi.org/10.1016/j.jvb.2023.103861</a></p><p>[5] Musick, K., Meier, A., &amp; Flood, S. (2016). How parents fare: Mothers’ and fathers’ subjective well-being in time with children. <em>American Sociological Review, 81</em>(5), 1069-1095. <a href="https://doi.org/10.1177/0003122416663917" rel="external">https://doi.org/10.1177/0003122416663917</a></p><p>[6] Mottiar, Z., &amp; Quinn, D. (2012). Is a self-catering holiday with the family really a holiday for mothers? Examining the balance of household responsibilities while on holiday from a female perspective. <em>Hospitality &amp; Society, 2</em>(2), 197-214. <a href="https://doi.org/10.1386/hosp.2.2.197_1" rel="external">https://doi.org/10.1386/hosp.2.2.197\_1</a></p><p>[7] Yao, X., Hua, C., &amp; Jordan, E. J. (2025). Housework stress in home and travel living spaces: A gender space and housework industrialization perspective. <em>Annals of Tourism Research, 112</em>, 103937. <a href="https://doi.org/10.1016/j.annals.2025.103937" rel="external">https://doi.org/10.1016/j.annals.2025.103937</a></p><p>[8] Ferguson, T., Curtis, R., Fraysse, F., Olds, T., Dumuid, D., Brown, W., Esterman, A., &amp; Maher, C. (2023). How do 24-h movement behaviours change during and after vacation? A cohort study. <em>International Journal of Behavioral Nutrition and Physical Activity, 20</em>(1), 24. <a href="https://doi.org/10.1186/s12966-023-01416-2" rel="external">https://doi.org/10.1186/s12966-023-01416-2</a></p><p>[9] de Bloom, J., Kompier, M., Geurts, S., de Weerth, C., Taris, T., &amp; Sonnentag, S. (2009). Do we recover from vacation? Meta-analysis of vacation effects on health and well-being. <em>Journal of Occupational Health, 51</em>(1), 13-25. <a href="https://doi.org/10.1539/joh.K8004" rel="external">https://doi.org/10.1539/joh.K8004</a></p><p>[10] Speth, F., Wendsche, J., &amp; Wegge, J. (2023). We continue to recover through vacation!: Meta-analysis of vacation effects on well-being and its fade-out. <em>European Psychologist, 28</em>(4), 274-287. <a href="https://doi.org/10.1027/1016-9040/a000518" rel="external">https://doi.org/10.1027/1016-9040/a000518</a></p><p>[11] de Bloom, J., Geurts, S. A. E., &amp; Kompier, M. A. J. (2013). Vacation (after-)effects on employee health and well-being, and the role of vacation activities, experiences and sleep. <em>Journal of Happiness Studies, 14</em>(2), 613-633. <a href="https://doi.org/10.1007/s10902-012-9345-3" rel="external">https://doi.org/10.1007/s10902-012-9345-3</a></p><p>[12] Headrick, L., Newman, D. A., Park, Y. A., &amp; Liang, Y. (2023). Recovery experiences for work and health outcomes: A meta-analysis and recovery-engagement-exhaustion model. <em>Journal of Business and Psychology, 38</em>(4), 821-864. <a href="https://doi.org/10.1007/s10869-022-09821-3" rel="external">https://doi.org/10.1007/s10869-022-09821-3</a></p><p>[13] Fritz, C., &amp; Sonnentag, S. (2006). Recovery, well-being, and performance-related outcomes: The role of workload and vacation experiences. <em>Journal of Applied Psychology, 91</em>(4), 936-945. <a href="https://doi.org/10.1037/0021-9010.91.4.936" rel="external">https://doi.org/10.1037/0021-9010.91.4.936</a></p><p>[14] Karabinski, T., Haun, V. C., Nübold, A., Wendsche, J., &amp; Wegge, J. (2021). Interventions for improving psychological detachment from work: A meta-analysis. <em>Journal of Occupational Health Psychology, 26</em>(3), 224-242. <a href="https://doi.org/10.1037/ocp0000280" rel="external">https://doi.org/10.1037/ocp0000280</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated August 3, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Activity after the holiday:</strong> In the 2023 Fitbit study, light physical activity was about 10 minutes per day below baseline in the first week after a holiday, not four weeks later. The estimated difference was about 5 minutes per day below baseline in week four. Sleep remained about 7 minutes per night above baseline in the second week after returning. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>The 2023 vacation meta-analysis:</strong> The 2023 analysis did not only rework the seven studies from the 2009 review. It repeated that analysis and added a systematic search for studies published from 2009 through 2020, producing a 13-study meta-analysis. It still found that the post-holiday benefit was no longer statistically detectable after the first week. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Jet lag, sleep, and caffeine:</strong> Circadian advice depends on the direction and number of time zones crossed. Current CDC guidance times sleep, light exposure, and caffeine to the destination schedule; caffeine can support alertness during destination daylight hours but should stop about six hours before planned sleep. Gradually shifting sleep before travel can help, but keeping caffeine at its usual clock time is not a universal jet-lag protocol. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976678/" rel="external">Ferguson et al. How do physical activity, sedentary behaviour, and sleep change during and after vacation? International Journal of Behavioral Nutrition and Physical Activity, 2023.</a></li><li id="correction-ref-2"><a href="https://doi.org/10.1027/1016-9040/a000518" rel="external">Speth, F., Wendsche, J., &amp; Wegge, J. (2023). We continue to recover through vacation: Meta-analysis of vacation effects on well-being and its fade-out. European Psychologist, 28(4), 274–287. https://doi.org/10.1027/1016-9040/a000518</a></li><li id="correction-ref-3"><a href="https://www.cdc.gov/yellow-book/hcp/travel-air-sea/jet-lag-disorder.html" rel="external">U.S. Centers for Disease Control and Prevention. (2026). Jet lag disorder. CDC Yellow Book. https://www.cdc.gov/yellow-book/hcp/travel-air-sea/jet-lag-disorder.html</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/vacation-recovery-and-psychological-detachment">Vacation Recovery and Psychological Detachment →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[About the coffee number I gave you in January]]></title>
<description><![CDATA[What a new UK Biobank liver study adds to the coffee evidence, why its effect sizes need caution, and four ways to use the result without drinking more.]]></description>
<link>https://www.andreheeg.com/archive/about-the-coffee-number-i-gave-you-in-january</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/about-the-coffee-number-i-gave-you-in-january</guid>
<pubDate>Wed, 29 Jul 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>Coffee had a good week in the press. A new liver study landed with a 47% attached, and it spread fast.</p><h2>What?</h2><p>Researchers at Cedars-Sinai followed 354,957 adults in the UK Biobank for a median of 13 years, published July 1 in <a href="https://pubmed.ncbi.nlm.nih.gov/42385787/" rel="external">Clinical Gastroenterology and Hepatology</a>. Against people who drank none, those drinking 5 or more cups a day had 32% less cirrhosis, 47% less liver cancer and 42% fewer liver-related deaths. They backed it with MRI scans on 28,961 of them: less liver fat, less iron, less scarring. Caffeinated and decaf tracked the same. The study is observational, and its authors said they would not tell anyone to start drinking coffee for their liver.</p><h2>So what?</h2><p>Hold that headline loosely, and I'll go first. In January I wrote a full coffee playbook and told you liver risk drops 40 to 50 percent in habitual drinkers. That came from a real umbrella review. I'd write it with more caution now, because of a paper I missed: in 2024, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11243528/" rel="external">a reanalysis in the journal Nutrients</a> ran 455,870 people from the same biobank with tighter statistical control, and the liver-mortality benefit vanished. The authors concluded that earlier studies might have overestimated coffee's effect on the liver.</p><p>So the direction is probably real, and the scans make it more believable than the usual coffee headline. The size is probably flattered. People who drink 5 cups a day and volunteer for a biobank are not average people.</p><p>Two things in the new paper do hold up, and both are usable today. Decaf carried the same signal, so moving your afternoon cup to decaf costs you nothing on the liver side. And people who sweetened their coffee kept the risk reductions but had 1.36 times the odds of a raised scan marker for liver inflammation and scarring. One marker, one cohort, not proof. It's also the only coffee variable in the study that moved the wrong way, and the only one you can change before lunch.</p><h2>Now what?</h2><ul><li>Hold your count. If you drink 2 to 4 cups, stay there. The study authors don't recommend climbing to 5.</li><li>Take it black. If you sweeten, take it out of the first cup this week and the rest next week.</li><li>Push the afternoon cup to decaf. Count back 9 to 10 hours from your bedtime for the caffeine cutoff. Bed at 11pm means last call at 1 or 2pm.</li><li>Keep the paper filter. Drip and pour-over strip out the oils that raise LDL cholesterol. French press, moka pot and espresso leave them in.</li></ul><p>Science moves. Correcting a line in public beats defending it. Take the sugar out of the cup.</p><p>Stay healthy.<br>Andre</p>]]></content:encoded>
</item>
<item>
<title><![CDATA[The Doctor's Edit on Your Longevity Drawer. I Read the Trials.]]></title>
<description><![CDATA[Rapamycin, NAD precursors, creatine, metformin, and the gap between a changed biomarker and a longer life.]]></description>
<link>https://www.andreheeg.com/archive/the-doctors-edit-on-your-longevity-drawer</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-doctors-edit-on-your-longevity-drawer</guid>
<pubDate>Sun, 26 Jul 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>The gym and the drip clinic were both on the top floor of the hotel, just about ten steps from each other.</p><p>After your run, while you're still catching your breath, you could step through a glass door and be in a chair with an IV in your arm before your heart rate even drops. On one side, people put in the slow, steady effort that really keeps you healthy. On the other, someone built a business on the idea that you could skip all that. Just a bag of vitamins, forty minutes, and you leave feeling younger.</p><p>I stood in the hallway between the two doors longer than I planned. There was no doctor's name on the glass and no hours listed. Just a logo and a price list. I was traveling for work and felt tired, and I remember thinking how odd it was that this was now a hotel amenity, somewhere between the sauna and the minibar.</p><p>Some time ago, I wrote about similar clinics opening in Berlin and thought the whole trend was just another fad that would fade away. The IV bars, the rapamycin talk at dinner, the NAD+ everyone mentioned. I thought the craze had ended.</p><p>But last Sunday, a 27-year-old woman went into a clinic in the Bronx for an NAD+ infusion. She never walked out.</p><p>She lost consciousness just minutes after the IV began and was pronounced dead later that afternoon [1]. As I write this, no one knows exactly what caused her death. It could have been the molecule, the dose, the method, or something else entirely. The person who gave her the IV told police he wasn't licensed to practice medicine in New York.</p><p>I read the news on my phone and thought about it for a while. It wasn't the science that surprised me, but I had let myself believe we were past this. We're not.</p><p>There's a simple reason these things are so popular. We want something that promises big results, feels certain, comes quickly, and doesn't take much effort. A drip offers all of that at once. Be younger today, without the training, the sleep, or the years of work. Real health doesn't offer shortcuts, because what really works is slow, takes effort, and rarely feels certain.</p><p>The drip sounds great when someone is selling it. But the problems show up in real studies. So I spent the last week looking at actual human research on these molecules. The results are tough to read.</p><h2>The test that keeps saying no</h2><p>Let's start with the drug that has the best story: rapamycin. In mice, it works. When given to genetically varied mice, it makes them live longer. This is one of the most repeated results in the field [2]. That part is real.</p><p>But when it comes to people, the story changes. The biggest and longest trial of low-dose rapamycin in healthy adults, called PEARL, lasted 48 weeks. It was mostly a safety study, and for safety it looked fine. But for what people actually want, it came up empty: the visceral fat it was supposed to reduce didn't change, and the epigenetic aging clock didn't move [3]. There were a couple of small positive signs in a subgroup of women, on lean mass and pain. None of this tells you if rapamycin helps people live longer. No human trial has ever been set up to answer that, because you can't just run a 40-year study. That answer is still far away. Right now, people are treating a guess as if it's proof.</p><p>This is the pattern for almost everything in the drawer. Most of these are mouse studies. There's a strict, independent check they have to pass: the Interventions Testing Program. It's a government-run test that tries the same compound in genetically diverse mice across three labs at once, so one lucky lab can't fake a win.</p><p>A lot of promising results don't survive this test. Acarbose, a diabetes drug, extends life in that test, but mostly in males (22% longer median life in males, 5% in females) [4]. In the one large human trial that mattered, with 6,522 people who had heart disease and prediabetes, it did nothing for cardiac events [5]. Fisetin, the supplement sold to clear your &quot;zombie cells,&quot; did not extend lifespan in the mouse test, and in a completed knee-arthritis trial it did no better than placebo on pain, function, or cartilage [6][7]. Alpha-ketoglutarate, the main ingredient in the supplement Rejuvant, failed the same mouse test in 2026 [8].</p><p>Taurine is the clearest example. In 2023, a paper in Science said taurine drops as we age and that giving more to mice made them live about 10% longer. The internet ran with it [9]. Two years later, a bigger study followed people and animals over time and found taurine doesn't consistently fall with age. The main claim, that taurine drops with age, didn't hold up [10]. That's how science works. The problem starts when someone sells the first result before the second even comes out.</p><h2>Chasing a number</h2><p>Supplements play a subtler game. They change a number in your blood and make you think that number means you're healthier.</p><p>NAD+ is the main attraction. NMN and nicotinamide riboside, the two top sellers, really do raise NAD+ in your blood. For nicotinamide riboside, one careful study measured a jump of 40 to 60% [11]. That's true, and that's where the marketing ends. When researchers checked if anything you actually care about improved, the answer was still no. The one positive NMN trial looked at 25 prediabetic women. It improved insulin sensitivity in muscle and a few related signaling measures, but nothing you would notice in your life, and it started with the two groups unevenly matched [12]. When eight NMN trials were combined, about 342 people, there was no benefit to blood sugar, insulin, HbA1c, or cholesterol [13]. The best nicotinamide riboside trials found the same flat results on the things that matter [14]. You're paying to raise a number that no human trial has linked to a longer or better life.</p><p>Resveratrol, the old red-wine molecule, is even worse. The whole idea was that it switches on a longevity enzyme called SIRT1. The famous result came from a test that was set up in a way that produced misleading activation. Later work found resveratrol can nudge SIRT1 only for certain substrates, far more narrowly than the original story claimed [15]. When researchers followed older adults for years, those with more resveratrol in their bodies were no less likely to die or get heart disease or cancer [16].</p><p>Then there's alpha-ketoglutarate, sold with the boldest claim of all: &quot;8 years younger.&quot; That number comes from a single report on 42 people who had already bought the product, with no comparison group, measured on a special aging clock from a lab connected to the company [17]. Even the authors say a real trial is needed. It's basically a testimonial with a p-value.</p><h2>Who paid for the study</h2><p>Once you start reading these papers, you notice the same names keep showing up in two places: in the study, and at the company selling the product the study is about.</p><p>The PEARL rapamycin trial was run by staff from a telehealth company that prescribes rapamycin. All seven authors were employees and shareholders, though to be fair, most of the funding came from crowdfunding [3]. The two main trials behind Urolithin A, sold as Mitopure, were funded by the company selling it, and both missed their main muscle targets. The strength number on the label came from a secondary result the trial wasn't mainly designed to prove [18]. The best trial of spermidine, a full year in older adults with memory complaints, found nothing [19].</p><p>Even the rules can't keep up. In 2022, the FDA ruled that NMN could not be sold as a supplement, because it had first been studied as a drug. In 2025 it reversed course and made it legal again [20]. The bottle in your cabinet comes from a regulator that changed its position inside three years.</p><p>At the far, unregulated end of all this is a clinic on a top floor, or on a Bronx side street, with a bag on a pole and no one qualified to use it. Most of the time, the gap between the science and the sales pitch is just about money. Once in a while, like in the Bronx last week, it ends with someone dead and no one able to say why.</p><h2>The one you can keep</h2><p>I didn't write all this to say everything is fake. One thing in the drawer actually belongs there. Creatine, the cheap powder from the gym, has real evidence in people.</p><p>When combined with lifting, in people over 50, creatine adds a small amount of muscle and a bit of strength [21]. It may also help the aging brain: across trials, it gives a modest boost to memory, small on average and drawn mostly from a couple of small studies in older adults, with almost nothing in the young [22]. If someone takes a big single dose after a sleepless night, it measurably protects their thinking for a few hours [23].</p><p>The brain effect mostly shows up when you're already low, older, or sleep-deprived, and usually at doses much higher than the 3 to 5 grams people actually take. When a creatine company asked European regulators if they could claim the powder sharpens thinking, the regulators looked at all the evidence and said no [24]. The newer headlines about &quot;creatine helps you live longer&quot; are based on surveys of what people eat, not real trials. The study's author has a commercial tie to creatine, an advisory-board seat, and related patents, and the effect almost disappears when you account for the obvious [25]. So use creatine to help your training, and if you're older, maybe your memory. But not to add years.</p><p>Look at where creatine's benefits come from. The muscle gain only happens if you lift. The brain benefit mostly shows up when you're older or short on sleep. Both point back to the same basics: sleep and training.</p><p>The clearest sign that this whole category has it backward is metformin. It's a good, affordable diabetes drug and a popular choice for longevity. But two separate randomized trials found that in older adults, metformin reduces the muscle you gain from resistance training [26] and lessens the improvement in insulin sensitivity that exercise usually brings [27]. The so-called longevity pill actually interferes with exercise, one of the few things that genuinely extends healthy life. For a healthy person without diabetes, it works against the very thing that keeps you alive longer.</p><p>A fair question is that most of these are cheap and safe, so why not hedge your bets? I think a pill you believe in quietly tells you that you've taken care of your longevity, and that belief can keep a busy person out of the gym. And the hedge isn't always free. You just saw what metformin does to the training that actually works.</p><p>This is the Capacity pillar of the Upward ARC, the framework I write about here. It's about the limit on what your body and mind can still do in 20 years. You can't buy a higher limit while sitting in a chair. You raise it slowly, with habits that build up over time, and most of them are free.</p><h2>Try this today</h2><p>Before you take any supplement, ask yourself three questions. Is there a human trial, not just a mouse study? Who paid for that trial? And is the result just a marker, or a real outcome on something that actually matters, like living longer or getting sick less? Most of the options in the drawer fail the first question.</p><p>Put your money and effort where the evidence is strongest: into your muscles. A study of 147,374 adults followed for up to 30 years found that 90 to 120 minutes a week of strength training was linked to about a 13% lower chance of dying, with no extra benefit above two hours, and bigger drops in death from heart and neurological disease [28]. That's an association, not a trial. It's the same kind of evidence I've questioned throughout this piece. But here, every layer agrees: the mechanism, the trials on strength and function, and the population data all point the same way. With the supplements, each layer comes back empty or biased. Exercise is the real medicine. It costs nothing and comes with the side effect of a body that works.</p><p>If you want one supplement that's earned its place, take creatine, 3 to 5 grams a day, alongside your training, not instead of it. That's the honest way to use it.</p><p>And if a number on your body is really worrying you, talk to a doctor who has nothing to sell you, not a clinic that profits from saying yes.</p><h2>The two doors</h2><p>Those two doors are still there, ten steps apart on that hotel floor. The gym and the drip clinic.</p><p>Everything on the drip side is designed to fit the sales formula: fast, certain, easy, and dressed up as science. Almost none of it holds up when you look at the actual studies. Everything on the gym side doesn't fit that formula because it's slow, hard, and quiet. But it's the only side with real evidence behind it.</p><p>A woman is dead, and no one can yet say why. What fills these clinics isn't a strange or foolish wish. It's the same one we all have: wanting the good outcome without the long, boring cost. The real work, if you know how or have someone to help, is to notice when a promise sounds too perfect and ask who's selling it.</p><p>One honest question before you go: What's the one thing in your own longevity drawer that you've never actually checked the evidence on? Reply and tell me. I read every message.</p><p>I still walk into hotel gyms. I've never once walked into the clinic next door.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you know a friend about to spend real money on a drip or a shelf of these bottles, send this to them first. Be kind about it. That's how this newsletter grows, and it's the only way I want it to.</p><p>PPS: Wednesdays are now a thing too. The Next Move is a two-minute mid-week short I started this month: one finding, what it means for you, and one action. It runs alongside these Sunday pieces, not instead of them.</p><p>PPPS: If a friend sent you this, you can get The Upward ARC here: https://www.andreheeg.com</p><div><hr></div><h2>References</h2><p>[1] Kriegstein, B. (2026, July 21). NYPD says unlicensed Bronx doc admitted &quot;I made a very big mistake&quot; after woman died. Gothamist. https://gothamist.com/news/nypd-says-unlicensed-bronx-doc-admitted-i-made-a-very-big-mistake-after-woman-died</p><p>[2] Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., Pahor, M., Javors, M. A., Fernandez, E., &amp; Miller, R. A. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature, 460(7253), 392-395. https://doi.org/10.1038/nature08221</p><p>[3] Moel, M., Harinath, G., Lee, V., Nyquist, A., Morgan, S. L., Isman, A., &amp; Zalzala, S. (2025). Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging, 17(4). https://doi.org/10.18632/aging.206235</p><p>[4] Harrison, D. E., Strong, R., Allison, D. B., Ames, B. N., Astle, C. M., Atamna, H., Fernandez, E., Flurkey, K., Javors, M. A., Nadon, N. L., Nelson, J. F., Pletcher, S., Simpkins, J. W., Smith, D., Wilkinson, J. E., &amp; Miller, R. A. (2014). Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell, 13(2), 273-282. https://doi.org/10.1111/acel.12170</p><p>[5] Holman, R. R., Coleman, R. L., Chan, J. C. N., Chiasson, J.-L., Feng, H., Ge, J., Gerstein, H. C., Gray, R., Huo, Y., Lang, Z., McMurray, J. J., Rydén, L., Schröder, S., Sun, Y., Theodorakis, M. J., Tendera, M., Tucker, L., Tuomilehto, J., Wei, Y., … Hu, D. (2017). Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): A randomised, double-blind, placebo-controlled trial. The Lancet Diabetes &amp; Endocrinology, 5(11), 877-886. https://doi.org/10.1016/S2213-8587(17)30309-1 (Note: trial funded by Bayer, the drug's maker; acarbose reduced new-onset diabetes by \~18% but had no effect on the cardiovascular primary endpoint.)</p><p>[6] Harrison, D. E., Strong, R., Reifsnyder, P., Rosenthal, N., Korstanje, R., Fernandez, E., Flurkey, K., Ginsburg, B. C., Murrell, M. D., Javors, M. A., Lopez-Cruzan, M., Nelson, J. F., Willcox, B. J., Allsopp, R., Watumull, D. M., Watumull, D. G., Cortopassi, G., Kirkland, J. L., Tchkonia, T., … Miller, R. A. (2024). Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used. GeroScience, 46(1), 795-816. https://doi.org/10.1007/s11357-023-01011-0</p><p>[7] Tashman, et al. (2025). Results from a randomized clinical trial evaluating the senolytic fisetin for treating knee osteoarthritis [Conference abstract]. Osteoarthritis and Cartilage, 33(Suppl.). https://doi.org/10.1016/j.joca.2025.02.667 [PIN: conference abstract, not a full article; primarily a safety trial with efficacy as a secondary outcome; confirm full author list]</p><p>[8] Korstanje, R., Strong, R., Salmon, A. B., Bogue, M. A., Curran, S. P., Diaz, V., Fernandez, E., Ginsburg, B., Han, M., Harrison, D. E., Kaczorowski, C., Kaeberlein, M., Kennedy, B. K., Kumar, N., LaCroix-Fralish, M., Leiser, S. F., Nelson, J. F., Polymenis, M., Reifsnyder, P. C., … Miller, R. A. (2026). Astaxanthin, meclizine, mitoglitazone, pioglitazone, alpha-ketoglutarate, mifepristone, methotrexate, and atorvastatin-telmisartan do not increase lifespan in UM-HET3 mice. GeroScience, 48(3), 3821-3830. https://doi.org/10.1007/s11357-026-02201-2 (The ITP tested alpha-ketoglutarate; the AKG in the supplement Rejuvant is the calcium salt. The salt form of the tested compound was not verified from the accessible abstract.)</p><p>[9] Singh, P., Gollapalli, K., Mangiola, S., Schranner, D., Yusuf, M. A., Chamoli, M., … Yadav, V. K. (2023). Taurine deficiency as a driver of aging. Science, 380(6649), eabn9257. https://doi.org/10.1126/science.abn9257</p><p>[10] Fernandez, M. E., Bernier, M., Price, N. L., Camandola, S., Aon, M. A., Vaughan, K., Mattison, J. A., Preston, J. D., Jones, D. P., Tanaka, T., Tian, Q., González-Freire, M., Ferrucci, L., &amp; de Cabo, R. (2025). Is taurine an aging biomarker? Science, 388(6751), eadl2116. https://doi.org/10.1126/science.adl2116</p><p>[11] Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., &amp; Seals, D. R. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 9, 1286. https://doi.org/10.1038/s41467-018-03421-7 (Tests nicotinamide riboside, not NMN; the \~40-60% NAD+ rise in the text is scoped to NR accordingly.)</p><p>[12] Yoshino, M., Yoshino, J., Kayser, B. D., Patti, G. J., Franczyk, M. P., Mills, K. F., Sindelar, M., Pietka, T., Patterson, B. W., Imai, S., &amp; Klein, S. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224-1229. https://doi.org/10.1126/science.abe9985</p><p>[13] Chen, F., Zhou, D., Kong, A. P.-S., Yim, N. T., Dai, S., Chen, Y. N., &amp; Hui, L. L. (2024). Effects of nicotinamide mononucleotide on glucose and lipid metabolism in adults: A systematic review and meta-analysis of randomised controlled trials. Current Diabetes Reports, 25(1), Article 4. https://doi.org/10.1007/s11892-024-01557-z</p><p>[14] Dollerup, O. L., Christensen, B., Svart, M., Schmidt, M. S., Sulek, K., Ringgaard, S., Stødkilde-Jørgensen, H., Møller, N., Brenner, C., Treebak, J. T., &amp; Jessen, N. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: Safety, insulin-sensitivity, and lipid-mobilizing effects. The American Journal of Clinical Nutrition, 108(2), 343-353. https://doi.org/10.1093/ajcn/nqy132</p><p>[15] Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., Qiu, X., Stockman, B., Thanabal, V., Varghese, A., Ward, J., Withka, J., &amp; Ahn, K. (2010). SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. Journal of Biological Chemistry, 285(11), 8340-8351. https://doi.org/10.1074/jbc.M109.088682 (Later work, e.g. Hubbard et al., 2013, Science, found substrate-dependent direct activation; the text is worded to reflect that the broad-activation story was overstated, not that no activation occurs.)</p><p>[16] Semba, R. D., Ferrucci, L., Bartali, B., Urpí-Sardà, M., Zamora-Ros, R., Sun, K., Cherubini, A., Bandinelli, S., &amp; Andres-Lacueva, C. (2014). Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Internal Medicine, 174(7), 1077-1084. https://doi.org/10.1001/jamainternmed.2014.1582</p><p>[17] Demidenko, O., Barardo, D., Budovskii, V., Finnemore, R., Palmer, F. R., III, Kennedy, B. K., &amp; Budovskaya, Y. V. (2021). Rejuvant, a potential life-extending compound formulation with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging, after an average of 7 months of use, in the TruAge DNA methylation test. Aging, 13(24), 24485-24499. https://doi.org/10.18632/aging.203736 (Biological age read on the TruMe/TruAge methylation clock, from a lab with a service agreement to the product company.)</p><p>[18] Liu, S., D'Amico, D., Shankland, E., Bhayana, S., Garcia, J. M., Aebischer, P., Rinsch, C., Singh, A., &amp; Marcinek, D. J. (2022). Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: A randomized clinical trial. JAMA Network Open, 5(1), e2144279. https://doi.org/10.1001/jamanetworkopen.2021.44279 (with Singh, A., et al. (2022), ATLAS trial, Cell Reports Medicine — peak-power primary endpoint not met; positive strength/endurance results were prespecified secondary endpoints; funded by Amazentis, with author employees/shareholders/patent holders.)</p><p>[19] Schwarz, C., Benson, G. S., Antonenko, D., Horn, N., Köbe, T., Klimecki, O., Sommer, W., Wirth, M., &amp; Flöel, A. (2022). Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge): A randomized clinical trial. JAMA Network Open, 5(5), e2213875. https://doi.org/10.1001/jamanetworkopen.2022.13875</p><p>[20] U.S. Food and Drug Administration. (2022, November). Responses to new dietary ingredient notifications for β-nicotinamide mononucleotide (NDIN 1247, SyncoZymes; NDIN 1259, Inner Mongolia Kingdomway): NMN excluded from the dietary-supplement definition under FD\&amp;C Act § 201(ff)(3)(B), the drug-preclusion provision. Regulations.gov docket FDA-2022-S-0023. https://www.regulations.gov/docket/FDA-2022-S-0023. Reversed by FDA determination letters dated September 29, 2025 (D. Prater), concluding NMN is not excluded; reported in Daniells, S. (2025, September 30), FDA declares NMN lawful in dietary supplements, NutraIngredients-USA, https://www.nutraingredients.com/Article/2025/09/30/fda-declares-nmn-lawful-in-dietary-supplements/. A legal-classification decision, not a ruling on safety or effectiveness.</p><p>[21] Liu, S., Huang, N., Wu, W., OuYang, X., Luo, Y., Zhong, Y., Wang, M., &amp; Xiao, L. (2025). The impact of creatine supplementation associated with resistance training on muscular strength and lean tissue mass in the aged: A systematic review and meta-analysis. European Review of Aging and Physical Activity, 22, Article 26. https://doi.org/10.1186/s11556-025-00392-9</p><p>[22] Prokopidis, K., Giannos, P., Triantafyllidis, K. K., Kechagias, K. S., Forbes, S. C., &amp; Candow, D. G. (2023). Effects of creatine supplementation on memory in healthy individuals: A systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 81(4), 416-427. https://doi.org/10.1093/nutrit/nuac064 (Older-adult memory benefit rests on a small subgroup, \~57 participants across 2 studies, with high heterogeneity.)</p><p>[23] Gordji-Nejad, A., Matusch, A., Kleedörfer, S., Jayeshkumar Patel, H., Drzezga, A., Elmenhorst, D., Binkofski, F., &amp; Bauer, A. (2024). Single dose creatine improves cognitive performance and induces changes in cerebral high energy phosphates during sleep deprivation. Scientific Reports, 14, 4937. https://doi.org/10.1038/s41598-024-54249-9 (Single 0.35 g/kg dose, roughly 25-35 g, well above the usual 3-5 g maintenance dose.)</p><p>[24] EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA); Turck, D., Bohn, T., et al. (2024). Creatine and improvement in cognitive function: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 22(12), e9100. https://doi.org/10.2903/j.efsa.2024.9100 (EU Commission refusal, 2026)</p><p>[25] Ostojic, S. M. (2025). Dietary creatine intake and all-cause mortality among U.S. adults: A linked mortality analysis from the NHANES study. Applied Physiology, Nutrition, and Metabolism, 50, 1-6. https://doi.org/10.1139/apnm-2025-0001 (Single-author paper. Observational dietary-intake association, not a supplementation trial; author disclosed an AlzChem creatine advisory-board seat and creatine-related patents; no study sponsor/funder reported.)</p><p>[26] Walton, R. G., Dungan, C. M., Long, D. E., Tuggle, S. C., Kosmac, K., Peck, B. D., Bush, H. M., Villasante Tezanos, A. G., McGwin, G., Windham, S. T., Ovalle, F., Bamman, M. M., Kern, P. A., &amp; Peterson, C. A. (2019). Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: The MASTERS trial. Aging Cell, 18(6), e13039. https://doi.org/10.1111/acel.13039 (NIH-funded.)</p><p>[27] Konopka, A. R., Laurin, J. L., Schoenberg, H. M., Reid, J. J., Castor, W. M., Wolff, C. A., Musci, R. V., Safairad, O. D., Linden, M. A., Biela, L. M., Bailey, S. M., Hamilton, K. L., &amp; Miller, B. F. (2019). Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell, 18(1), e12880. https://doi.org/10.1111/acel.12880 (Cited for the significant blunting of exercise-induced insulin sensitivity, p=0.02; the VO2max reduction in the same trial was a non-significant trend, p=0.08, and is not claimed in the text. Supported in part by Dairy Management, Inc. and Dexcom, Inc., not government funding.)</p><p>[28] Zhang, Y., Lee, D. H., Rezende, L. F. M., Ma, Y., &amp; Giovannucci, E. (2026). Long-term resistance training with all-cause and cause-specific mortality: Assessing dose-response and joint associations with aerobic physical activity. British Journal of Sports Medicine, 60(12), 874-883. https://doi.org/10.1136/bjsports-2025-110503 (Harvard T.H. Chan cohort, 147,374 adults, up to 30 years; 90-119 min/week resistance training associated with \~13% lower all-cause mortality, HR \~0.87, plateau \~120 min, with larger reductions in cardiovascular and neurological mortality. Observational association.)</p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated July 27, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>PEARL rapamycin trial:</strong> PEARL did not test lifespan. It enrolled healthy adults for 48 weeks and found no effect on its visceral-fat primary outcome. The compounded rapamycin used in the trial produced about one-third lower 24-hour blood concentrations than the commercial comparator, so the effective exposure was lower than planned. The trial was run by AgelessRx, and the authors disclosed company employment or ownership interests. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Alpha-ketoglutarate:</strong> The 2026 Interventions Testing Program result was a mouse experiment with alpha-ketoglutarate. It did not test the commercial Rejuvant formulation, which combines calcium alpha-ketoglutarate with vitamins, and it did not test people. The negative result weakens the general longevity case but is not a direct trial of that product. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>NAD infusions:</strong> A 2026 systematic review found that oral NR and NMN consistently raise NAD-related biomarkers, while clinical effects were mixed or absent. It found no eligible outcomes trial of intravenous or intramuscular NAD itself. The Bronx death remained under investigation when the edition was sent, so neither NAD nor the infusion could be established as the cause from the available report. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>NMN regulatory status:</strong> The FDA's September 2025 decision removed the drug-preclusion barrier that had excluded NMN from the dietary-supplement definition. It was not a blanket ruling that every NMN product is lawful, safe, or effective. Products still have to meet the other requirements that apply to dietary supplements. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>Metformin and exercise:</strong> The two cited trials involved older adults and measured training adaptations, not mortality. A 2026 meta-analysis found that adding metformin modestly reduced gains in peak aerobic capacity and blood-pressure improvement, while several metabolic and body-composition outcomes did not differ. This does not establish that metformin works against exercise in every healthy person, and it does not apply to stopping clinically indicated diabetes treatment. <span class="correction-ref-links"><a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12074816/" rel="external">Moel, M., Harinath, G., Lee, V., et al. (2025). Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging, 17(4), 1009–1030. https://doi.org/10.18632/aging.206235</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/41843349/" rel="external">Korstanje, R., Strong, R., Salmon, A. B., et al. (2026). Alpha-ketoglutarate and other compounds do not increase lifespan in UM-HET3 mice. GeroScience, 48(3), 3821–3830. https://pubmed.ncbi.nlm.nih.gov/41843349/</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/41655607/" rel="external">Barskova, A., et al. (2026). NAD+ precursor supplementation and parenteral NAD+ in humans: A systematic review. GeroScience. https://pubmed.ncbi.nlm.nih.gov/41655607/</a></li><li id="correction-ref-4"><a href="https://downloads.regulations.gov/FDA-2023-P-1867-0007/attachment_1.pdf" rel="external">U.S. Food and Drug Administration. (2025). Response to citizen petitions concerning beta-nicotinamide mononucleotide and the dietary-supplement definition. https://downloads.regulations.gov/FDA-2023-P-1867-0007/attachment_1.pdf</a></li><li id="correction-ref-5"><a href="https://pubmed.ncbi.nlm.nih.gov/42051241/" rel="external">Wang, Z., et al. (2026). Metformin added to structured exercise: A systematic review and meta-analysis. Diabetology &amp; Metabolic Syndrome. https://pubmed.ncbi.nlm.nih.gov/42051241/</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/longevity-drugs-supplements-and-human-evidence">Longevity Drugs and Supplements: Human Evidence, Limits, and Safety →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[560 fewer steps a day: the GLP-1 effect I didn't flag]]></title>
<description><![CDATA[New wearable data suggests physical activity may fall after people start GLP-1 treatment, and why movement and muscle still need attention during weight loss.]]></description>
<link>https://www.andreheeg.com/archive/560-fewer-steps-a-day-the-glp-1-effect-i-didnt-flag</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/560-fewer-steps-a-day-the-glp-1-effect-i-didnt-flag</guid>
<pubDate>Wed, 22 Jul 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[THE NEXT MOVE]]></category>
<content:encoded><![CDATA[<p>First time for this one: you're reading the inaugural edition of The Next Move, a mid-week short I'm adding to The Upward ARC. Every Wednesday, two minutes: one timely finding, what it means for you, and one thing you can use immediately. Your Sunday edition, now called Under Load, isn't going anywhere. Here's the first.</p><p>A while back I argued GLP-1 drugs work, and that if you take one, you lift. No exceptions. New data this summer adds a second rule.</p><h2>What?</h2><p>At the Endocrine Society's June meeting, researchers tracked 753 adults on GLP-1 drugs through their own fitness trackers. After starting, they walked 560 fewer steps a day and did about 20% less moderate activity. Measured on the wrist, not self-reported. The drop was steepest in men and in anyone with sore joints. (Conference data, not yet published, so treat it as a strong signal.)</p><h2>So what?</h2><p>The muscle-loss panic is aimed at the wrong thing. The share of weight you lose as lean mass is the same on the drug as it is dieting without one, and strength holds in people who keep training. The real cost is quieter. These drugs switch off your appetite and your urge to move at the same time. Muscle you stop using is muscle you lose, and the scale keeps dropping, so you never notice it going.</p><h2>Now what?</h2><p>If you or someone on your team is on one of these:</p><ul><li>Lift 2 to 3 times a week. Non-negotiable.</li><li>Push protein toward 1.6 g per kilo of body weight. Hard once the drug kills your hunger, so plan it.</li><li>Put a floor under your daily steps, say 7,000, and protect a walking call the way you protect the injection.</li><li>Track your working weights, not the scale. If the weights hold, the muscle holds.</li></ul><p>The drug takes care of your appetite. Your movement is still your job.</p><p>Stay healthy.<br>Andre</p>]]></content:encoded>
</item>
<item>
<title><![CDATA[I Fall Asleep in Ninety Seconds. This One's for Everyone Who Can't.]]></title>
<description><![CDATA[Why tired people stay awake, what to do after a 3 a.m. awakening, and why the most reliable insomnia treatments rarely come in a bottle.]]></description>
<link>https://www.andreheeg.com/archive/i-fall-asleep-in-ninety-seconds</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/i-fall-asleep-in-ninety-seconds</guid>
<pubDate>Sun, 19 Jul 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>The on-call room is hardly bigger than a closet, and the bed is just a plank with a sheet. I stay in my scrubs and keep my shoes on, since there’s no point taking them off. The trauma pager rests on my chest, face up. I close my eyes, and within ninety seconds, I’m asleep.</p><p>Sometimes I’d get half an hour of sleep, maybe a few hours if the night was quiet. Then the pager would go off, and I’d rush down the corridor into the bright trauma bay, where someone needed their face rebuilt. As a young reconstructive surgeon, I worked 24- and 36-hour weekend shifts. You learn two rules quickly, and they’re really the same: eat when there’s food, not just when you’re hungry, and sleep when there’s time, not just when you’re tired. You never know when the next call will come. So you lie down, fall asleep in minutes, and get rest whenever you can.</p><p>Maybe I was lucky, or maybe I learned it under pressure. Either way, I could fall asleep on a hard bed in a noisy hospital with a pager on my chest, and then do it again a few hours later. I still sleep that way. After reading a page or two of a book, I’m out. You could move me to another room and I wouldn’t wake up.</p><p>On paper, that probably makes me the wrong person to write about sleep problems.</p><p>Sleep is the topic you ask me about most. Whenever someone new joins this newsletter, I ask what they’re looking for, and the answer I hear most often is sleep. Not how to make it perfect, but how to get any at all. How to fall asleep when your body is tired but your mind won’t stop. How to get back to sleep after waking at 3am with your thoughts racing, when it feels like the night is over even though there are still hours left.</p><p>That’s not my struggle, so I did the next best thing. I read what sleep experts say, looked through the research, and listened to dozens of your replies. Most sleep problems come down to one main issue with a real name, and the real solutions are rarely things you can buy.</p><h2><strong>The Night Shift</strong></h2><p>While you sleep, your body takes care of things it can’t do when you’re awake.</p><p>You might have heard that sleep clears the brain of the plaque linked to Alzheimer’s. It’s a good story, but it’s often overstated. The idea comes from a 2013 mouse study showing that sleeping brains cleared waste faster, including amyloid-beta [1]. But a 2024 mouse study found the opposite. The debate continues in animal studies.</p><p>The evidence in humans is less dramatic. If a healthy adult stays awake for one night, amyloid levels rise about 5% by morning [2]. Sleep brings those levels back down. Over many years, though, the risk adds up. One study followed nearly 8,000 adults for 25 years and found that those who slept six hours or less in midlife had about a 30% higher rate of dementia [3]. This is a link, not proof, since early disease can shorten sleep before symptoms appear. Still, a 30% increase over 25 years is hard to ignore.</p><p>The effects you feel the next day show up quickly. After just one night without sleep, your amygdala (the brain’s threat detector) becomes about 60% more active, while the part that keeps it in check gets quieter [4]. That’s why you might have a short fuse or make a decision at 4pm you wouldn’t make if you were rested. Your judgment slips before you even realize it.</p><h2><strong>The Hangover You Didn’t Drink For</strong></h2><p>If you lose sleep, your hormones start to show it within just a few days.</p><p>When healthy young men sleep only four hours a night for six nights, their blood sugar control becomes as poor as someone decades older and at risk for diabetes, all in less than a week [5]. A week of five-hour nights lowers their daytime testosterone by 10 to 15%, which is about what aging does over 10 to 15 years [6]. These are small studies in young men, so take the numbers with caution. Still, the trend is clear, and it explains why you might feel foggy on a Tuesday.</p><p>You also can’t make up for lost sleep on the weekend. When researchers had people sleep short nights and then let them sleep in, the extra rest didn’t fix the damage. Their blood sugar levels remained poor, and some even worsened because they ate more and shifted their sleep schedules later [7]. Sleeping in on Saturday doesn’t undo a week of short nights.</p><p>Your immune system notices too. In one study, healthy adults tracked their sleep for a week, then were exposed to a cold virus. Those who slept less than six hours were about four times more likely to get sick than those who got seven or more [8]. Same exposure, but a different defense.</p><h2><strong>The Basics, Fast</strong></h2><p>You already know the basics: get seven to eight hours, keep your room cool and dark, and avoid screens before bed. All of that is true, but it’s not the reason you’re lying awake. There are two less obvious things worth mentioning.</p><p>Consistency might matter more than total sleep time. In a study of 60,000 adults wearing wrist monitors, regular sleep patterns predicted longer life better than total hours slept [9]. Going to bed and waking up at the same time every day is better than sleeping in on Sunday to make up for lost sleep during the week. Your body runs on a clock, and it doesn’t like when that clock keeps changing.</p><p>And remember, you’re not the same as your neighbor. I’ve always woken up at first light. As a kid, I’d be up at seven while my cousin would sleep until someone dragged him out at eleven. Sleep is personal, even though most advice makes it seem like it isn’t.</p><p>Even careful people can get tripped up by two basics. Caffeine stays in your body for five to six hours, so a coffee at 4pm still has a quarter of its effect at 10pm. In one study, 400mg of caffeine six hours before bed cut sleep by more than an hour [10]. Alcohol can also backfire. It might help you fall asleep faster, but it breaks up the second half of the night and reduces your REM sleep. That’s why two glasses of wine can leave you wide awake at 4am, feeling like you never slept [11].</p><h2><strong>Why You Can’t Switch Off</strong></h2><p>For most high performers, the problem isn’t sleep itself. It’s the 90 minutes before bed, and a nervous system that stays active even after you lie down. Insomnia in someone who’s trying hard is really about being too alert. The body is too tense to relax, and trying to force sleep only makes it worse.</p><p>That’s why using a sleep tracker can sometimes make things worse. There’s even a name for it now: orthosomnia. Sleep doctors use this term for people who worry so much about getting a perfect sleep score that it actually ruins their sleep [12]. And those scores aren’t even that reliable. When researchers compared seven trackers to a sleep lab, the devices could tell sleep from waking, but missed 30 to 50% of deep and REM sleep [13]. People end up worrying about a deep-sleep number that the device is only guessing at.</p><p>Trying to sleep is often what keeps you awake. Clinicians call this sleep effort. The harder you try to fall asleep, the more you activate the alert, goal-focused part of your brain, which is exactly what sleep doesn’t need [14]. You can’t force yourself to sleep. The best you can do is stop getting in your own way.</p><p>This is the Recover part of my Upward ARC framework, which is about helping your nervous system return to calm between stresses. Sleep is also an input, so it connects to Activate as well. But the reason you’re awake is usually in Recover, and you can’t reset by trying harder. The reset happens when you slow down and stop pushing.</p><h2><strong>The Theory That Didn’t Survive</strong></h2><p>My wife is away tonight. She travels a few times a year, never far, and tonight she’s a few hours from here, still in Germany. The kids are asleep down the hall, and I’m the only adult in the house.</p><p>And here I am, lying in the dark with my eyes open.</p><p>This never happens to me. But tonight, I’m very aware of how deeply I usually sleep. If Karla calls out at 3am, the part of me that normally sleeps through anything won’t hear her. So I keep myself just below waking, listening, not willing to fall all the way asleep. For once, I can’t let go.</p><p>As I lay there, I thought I understood something. Maybe this is why so many women sleep more lightly than men. They keep an ear out for the kids, just like I was doing tonight, always a little alert. It seemed obvious, even a bit profound, at 1am. So I did what I always do now. I checked the data. And it humbled me.</p><p>Women do carry the heavier load. Insomnia is about 1.4 times more common in women than in men across more than a million people [15]. If you’re a woman reading this at 3am, that struggle is real, and I won’t wave it away with a lab result.</p><p>But when sleep is measured with electrodes rather than surveys, healthy women actually get more deep sleep than men of the same age, fall asleep faster, and spend more time asleep [16]. The hard nights are real, but so is the deeper sleep. The difference between the two is the real story.</p><p>My caretaker theory didn’t hold up. When researchers tested it directly, women woke up a little faster, but only to the faintest sounds, and just as quickly to a beeping alarm as to a baby’s cry [17]. That’s just a small difference in hearing. It’s not the mother’s radar I imagined. Who gets up at night depends on who’s on duty, and that’s shaped by life, not biology.</p><p>Two things explain the gap, and both are stronger than my late-night theory. On average, women go to bed with a more alert, worried mind, which breaks up sleep [18]. And women deal with hormonal changes, I never will. Throughout the monthly cycle, during pregnancy, and especially during menopause, sleep can really suffer. 40 to 60% of women say their sleep falls apart during menopause, mostly because they wake up during the night [19]. If that’s you, know this: you’re not failing at sleep, and you’re not imagining it. Your biology changed, and that deserves a real conversation with a doctor, not just a shrug or a supplement.</p><h2><strong>Try This Today</strong></h2><p>None of these are supplements or gadgets. These are the tools sleep clinicians actually use, organized by the kind of sleep problem you have.</p><p><strong>If you can’t fall asleep, stop trying so hard.</strong> The effort itself is the problem, so take the pressure off. First, get tomorrow’s worries out of your head and onto paper. In one study, people who spent five minutes writing a to-do list for the next day fell asleep about nine minutes faster than those who wrote about their day [20]. The more specific your list, the better, because it helps your brain stop running through tasks. Next, slow your body down with your breath. Five minutes of cyclic sighing, a double breath in through the nose, and a long, slow breath out through the mouth calmed people better than meditation in a controlled trial [21]. The goal is to slow down, so sleep can come naturally.</p><p><strong>If you wake up at 3am and can’t get back to sleep, get out of bed.</strong> It might feel wrong, but it works. If you’ve been awake for more than about 15 or 20 minutes (just by feel, not by watching the clock), get up. Leave the bedroom, sit somewhere dim, do something boring, and only go back to bed when you feel sleepy. This is called stimulus control, and it’s one of the best-proven tools [22]. Lying in bed, frustrated, teaches your brain that bed is a place to be awake and anxious, so you’re breaking that link. Also, remember that waking up in the night isn’t the emergency it feels like. For most of history, people slept in two shifts, with an hour of quiet awake time in between, and didn’t think anything of it [23]. Waking up is normal. It’s the panic that turns a 20-minute gap into a lost night.</p><p><strong>If you wake up at every little sound, focus on fixing your room before trying to fix yourself.</strong> Make it cool, dark, and as quiet as possible. Earplugs or steady background noise can help cover sudden sounds that wake you up. One honest note: the machines that promise deeper sleep are overhyped. Steady sound can help mask a barking dog or a snoring partner, which is useful, but it doesn’t actually make your sleep deeper like the ads claim.</p><p><strong>If you wake up every couple of hours, try spending less time in bed, not more.</strong> It might sound backward, but if you lie in bed for nine hours to get six hours of broken sleep, you’re actually training your body for broken sleep. Instead, shorten your time in bed to match the sleep you actually get, with a minimum of about five hours. Keep a fixed wake time, and let your sleep pressure build until your nights become more solid. Then, you can gradually increase your time in bed again. Even a nurse-led version of this approach worked better than standard advice in a large 2023 trial [24]. Also, rule out one thing: if you wake up tired no matter how long you sleep, and you snore, get checked for sleep apnea. Nearly a billion adults have it, most without knowing, and it’s common in middle-aged or heavier people [25]. No breathing trick can fix a blocked airway.</p><p><strong>Most importantly, anchor your wake time.</strong> Get up at the same time every day. This is the strongest signal you can send your body clock [9], and it’s more effective than any bedtime rule, because morning light and a steady start set the tone for the rest of the day.</p><p><strong>If you’ve been struggling for months, seek real treatment.</strong> Insomnia that happens three nights a week for three months or more is a diagnosable condition, and the best first treatment is cognitive behavioral therapy for insomnia (CBT-I), which major medical organizations recommend over sleeping pills [26]. It works. In studies, people fall asleep about 19 minutes faster and spend much less time awake at night, and the benefits last even after stopping [27]. Talk to your doctor, or try a reputable CBT-I app.</p><h2><strong>What the Pager Taught Me</strong></h2><p>I still fall asleep in an instant, and now I understand why. Those years in the trauma unit taught me, without me realizing it, how to lower my alertness on command. I could go from fully awake to asleep fast, because the next emergency could happen at any moment, and I had to get rest when I could. The pager trained my nervous system to let go quickly.</p><p>That’s the real secret, and it’s what most people are missing—the ability to turn down the volume and stop fighting. I learned it the hard way, under bright lights with a pager on my chest. You can build this skill on purpose, using the tools above, and skip the trauma unit. And if it’s not just your nights but your whole week that’s wearing you down, check out my earlier piece on choosing the few habits that last when everything else is falling apart: <a href="https://www.andreheeg.com/archive/three-bikes-four-habits-how-i-pick" rel="external">Three Bikes, Four Habits</a>.</p><p>Readers who tell me sleep is what they want most are really asking for one thing: permission. Permission to stop trying so hard and just let sleep happen. So here it is. You don’t have to earn your sleep tonight. Let it happen.</p><p>One question, since I read every reply and it shapes what I write next: When you wake up at 3am, is it because of a specific worry, or are you just awake for no clear reason? Reply with the one that fits you. The solution is different for each, and I’ll write a future piece based on what most of you say.</p><p>Stay healthy.</p><p>Andre</p><p>PS: I wrote this because so many of you replied to my welcome email with one word: sleep. Thank you for being honest about what keeps you up. If you know someone who lies awake at 3am and quietly blames themselves, please forward this to them tonight. That’s how this newsletter grows, and it’s the main way I want it to.</p><p>PPS: If a friend sent you this, you can get the Sunday editions here: <a href="https://www.andreheeg.com" rel="external">https://www.andreheeg.com</a>.</p><div><hr></div><h2><strong>References</strong></h2><p>[1] Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., Takano, T., Deane, R., &amp; Nedergaard, M. (2013). Sleep drives metabolite clearance from the adult brain. <em>Science, 342</em>(6156), 373-377. <a href="https://doi.org/10.1126/science.1241224" rel="external">https://doi.org/10.1126/science.1241224</a></p><p>[2] Shokri-Kojori, E., Wang, G.-J., Wiers, C. E., Demiral, S. B., Guo, M., Kim, S. W., Lindgren, E., Ramirez, V., Zehra, A., Freeman, C., Miller, G., Manza, P., Srivastava, T., De Santi, S., Tomasi, D., Benveniste, H., &amp; Volkow, N. D. (2018). β-Amyloid accumulation in the human brain after one night of sleep deprivation. <em>Proceedings of the National Academy of Sciences, 115</em>(17), 4483-4488. <a href="https://doi.org/10.1073/pnas.1721694115" rel="external">https://doi.org/10.1073/pnas.1721694115</a></p><p>[3] Sabia, S., Fayosse, A., Dumurgier, J., van Hees, V. T., Paquet, C., Sommerlad, A., Kivimäki, M., Dugravot, A., &amp; Singh-Manoux, A. (2021). Association of sleep duration in middle and old age with incidence of dementia. <em>Nature Communications, 12</em>, 2289. <a href="https://doi.org/10.1038/s41467-021-22354-2" rel="external">https://doi.org/10.1038/s41467-021-22354-2</a></p><p>[4] Yoo, S.-S., Gujar, N., Hu, P., Jolesz, F. A., &amp; Walker, M. P. (2007). The human emotional brain without sleep: A prefrontal amygdala disconnect. <em>Current Biology, 17</em>(20), R877-R878. <a href="https://doi.org/10.1016/j.cub.2007.08.007" rel="external">https://doi.org/10.1016/j.cub.2007.08.007</a></p><p>[5] Spiegel, K., Leproult, R., &amp; Van Cauter, E. (1999). Impact of sleep debt on metabolic and endocrine function. <em>The Lancet, 354</em>(9188), 1435-1439. <a href="https://doi.org/10.1016/S0140-6736(99)01376-8" rel="external">https://doi.org/10.1016/S0140-6736(99)01376-8</a></p><p>[6] Leproult, R., &amp; Van Cauter, E. (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. <em>JAMA, 305</em>(21), 2173-2174. <a href="https://doi.org/10.1001/jama.2011.710" rel="external">https://doi.org/10.1001/jama.2011.710</a></p><p>[7] Depner, C. M., Melanson, E. L., Eckel, R. H., Snell-Bergeon, J. K., Perreault, L., Bergman, B. C., Higgins, J. A., Guerin, M. K., Stothard, E. R., Morton, S. J., &amp; Wright, K. P. (2019). Ad libitum weekend recovery sleep fails to prevent metabolic dysregulation during a repeating pattern of insufficient sleep and weekend recovery sleep. <em>Current Biology, 29</em>(6), 957-967.e4. <a href="https://doi.org/10.1016/j.cub.2019.01.069" rel="external">https://doi.org/10.1016/j.cub.2019.01.069</a></p><p>[8] Prather, A. A., Janicki-Deverts, D., Hall, M. H., &amp; Cohen, S. (2015). Behaviorally assessed sleep and susceptibility to the common cold. <em>Sleep, 38</em>(9), 1353-1359. <a href="https://doi.org/10.5665/sleep.4968" rel="external">https://doi.org/10.5665/sleep.4968</a></p><p>[9] Windred, D. P., Burns, A. C., Lane, J. M., Saxena, R., Rutter, M. K., Cain, S. W., &amp; Phillips, A. J. K. (2024). Sleep regularity is a stronger predictor of mortality risk than sleep duration: A prospective cohort study. <em>Sleep, 47</em>(1), zsad253. <a href="https://doi.org/10.1093/sleep/zsad253" rel="external">https://doi.org/10.1093/sleep/zsad253</a></p><p>[10] Drake, C., Roehrs, T., Shambroom, J., &amp; Roth, T. (2013). Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed. <em>Journal of Clinical Sleep Medicine, 9</em>(11), 1195-1200. <a href="https://doi.org/10.5664/jcsm.3170" rel="external">https://doi.org/10.5664/jcsm.3170</a></p><p>[11] Ebrahim, I. O., Shapiro, C. M., Williams, A. J., &amp; Fenwick, P. B. (2013). Alcohol and sleep I: Effects on normal sleep. <em>Alcoholism: Clinical and Experimental Research, 37</em>(4), 539-549. <a href="https://doi.org/10.1111/acer.12006" rel="external">https://doi.org/10.1111/acer.12006</a></p><p>[12] Baron, K. G., Abbott, S., Jao, N., Manalo, N., &amp; Mullen, R. (2017). Orthosomnia: Are some patients taking the quantified self too far? <em>Journal of Clinical Sleep Medicine, 13</em>(2), 351-354. <a href="https://doi.org/10.5664/jcsm.6472" rel="external">https://doi.org/10.5664/jcsm.6472</a></p><p>[13] Chinoy, E. D., Cuellar, J. A., Huwa, K. E., Jameson, J. T., Watson, C. H., Bessman, S. C., Hirsch, D. A., Cooper, A. D., Drummond, S. P. A., &amp; Markwald, R. R. (2021). Performance of seven consumer sleep-tracking devices compared with polysomnography. <em>Sleep, 44</em>(5), zsaa291. <a href="https://doi.org/10.1093/sleep/zsaa291" rel="external">https://doi.org/10.1093/sleep/zsaa291</a></p><p>[14] Broomfield, N. M., &amp; Espie, C. A. (2003). Initial insomnia and paradoxical intention: An experimental investigation of putative mechanisms using subjective and actigraphic measurement of sleep. <em>Behavioural and Cognitive Psychotherapy, 31</em>(3), 313-324. <a href="https://doi.org/10.1017/S1352465803003060" rel="external">https://doi.org/10.1017/S1352465803003060</a></p><p>[15] Zhang, B., &amp; Wing, Y.-K. (2006). Sex differences in insomnia: A meta-analysis. <em>Sleep, 29</em>(1), 85-93. <a href="https://doi.org/10.1093/sleep/29.1.85" rel="external">https://doi.org/10.1093/sleep/29.1.85</a></p><p>[16] Mong, J. A., &amp; Cusmano, D. M. (2016). Sex differences in sleep: Impact of biological sex and sex steroids. <em>Philosophical Transactions of the Royal Society B, 371</em>(1688), 20150110. <a href="https://doi.org/10.1098/rstb.2015.0110" rel="external">https://doi.org/10.1098/rstb.2015.0110</a></p><p>[17] Vermillet, A.-Q., Skewes, J. C., &amp; Parsons, C. E. (2025). Men and women’s waking patterns to infant crying: Preparenthood differences are insufficient to explain uneven sharing of nighttime care. <em>Emotion, 25</em>(5), 1108-1121. <a href="https://doi.org/10.1037/emo0001478" rel="external">https://doi.org/10.1037/emo0001478</a></p><p>[18] Hantsoo, L., Khou, C. S., White, C. N., &amp; Ong, J. C. (2013). Gender and cognitive-emotional factors as predictors of pre-sleep arousal and trait hyperarousal in insomnia. <em>Journal of Psychosomatic Research, 74</em>(4), 283-289. <a href="https://doi.org/10.1016/j.jpsychores.2013.01.014" rel="external">https://doi.org/10.1016/j.jpsychores.2013.01.014</a></p><p>[19] Baker, F. C., Lampio, L., Saaresranta, T., &amp; Polo-Kantola, P. (2018). Sleep and sleep disorders in the menopausal transition. <em>Sleep Medicine Clinics, 13</em>(3), 443-456. <a href="https://doi.org/10.1016/j.jsmc.2018.04.011" rel="external">https://doi.org/10.1016/j.jsmc.2018.04.011</a></p><p>[20] Scullin, M. K., Krueger, M. L., Ballard, H. K., Pruett, N., &amp; Bliwise, D. L. (2018). The effects of bedtime writing on difficulty falling asleep: A polysomnographic study comparing to-do lists and completed activity lists. <em>Journal of Experimental Psychology: General, 147</em>(1), 139-146. <a href="https://doi.org/10.1037/xge0000374" rel="external">https://doi.org/10.1037/xge0000374</a></p><p>[21] Balban, M. Y., Neri, E., Kogon, M. M., Weed, L., Nouriani, B., Jo, B., Holl, G., Zeitzer, J. M., Spiegel, D., &amp; Huberman, A. D. (2023). Brief structured respiration practices enhance mood and reduce physiological arousal. <em>Cell Reports Medicine, 4</em>(1), 100895. <a href="https://doi.org/10.1016/j.xcrm.2022.100895" rel="external">https://doi.org/10.1016/j.xcrm.2022.100895</a></p><p>[22] Bootzin, R. R. (1972). Stimulus control treatment for insomnia. <em>Proceedings of the 80th Annual Convention of the American Psychological Association, 7</em>, 395-396.</p><p>[23] Ekirch, A. R. (2001). Sleep we have lost: Pre-industrial slumber in the British Isles. <em>The American Historical Review, 106</em>(2), 343-386. <a href="https://doi.org/10.1086/ahr/106.2.343" rel="external">https://doi.org/10.1086/ahr/106.2.343</a></p><p>[24] Kyle, S. D., Siriwardena, A. N., Espie, C. A., Yang, Y., Petrou, S., Ogburn, E., Begum, N., Maurer, L. F., Robinson, B., Gardner, C., Lee, V., Armstrong, S., Pattinson, J., Mort, S., Temple, E., Harris, V., Yu, L.-M., Bower, P., &amp; Aveyard, P. (2023). Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): A pragmatic, superiority, open-label, randomised controlled trial. <em>The Lancet, 402</em>(10406), 975-987. <a href="https://doi.org/10.1016/S0140-6736(23)00683-9" rel="external">https://doi.org/10.1016/S0140-6736(23)00683-9</a></p><p>[25] Benjafield, A. V., Ayas, N. T., Eastwood, P. R., Heinzer, R., Ip, M. S. M., Morrell, M. J., Nunez, C. M., Patel, S. R., Penzel, T., Pépin, J. L., Peppard, P. E., Sinha, S., Tufik, S., Valentine, K., &amp; Malhotra, A. (2019). Estimation of the global prevalence and burden of obstructive sleep apnoea: A literature-based analysis. <em>The Lancet Respiratory Medicine, 7</em>(8), 687-698. <a href="https://doi.org/10.1016/S2213-2600(19)30198-5" rel="external">https://doi.org/10.1016/S2213-2600(19)30198-5</a></p><p>[26] Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., &amp; Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. <em>Annals of Internal Medicine, 165</em>(2), 125-133. <a href="https://doi.org/10.7326/M15-2175" rel="external">https://doi.org/10.7326/M15-2175</a></p><p>[27] Trauer, J. M., Qian, M. Y., Doyle, J. S., Rajaratnam, S. M. W., &amp; Cunnington, D. (2015). Cognitive behavioral therapy for chronic insomnia: A systematic review and meta-analysis. <em>Annals of Internal Medicine, 163</em>(3), 191-204. <a href="https://doi.org/10.7326/M14-2841" rel="external">https://doi.org/10.7326/M14-2841</a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It may use ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide important uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated July 20, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Amyloid recovery:</strong> The cited human study found an approximately 5% regional increase in amyloid-beta signal after one night of sleep deprivation in 20 healthy adults. It did not show that a subsequent night of sleep brought those levels back down. Whether and how quickly that signal resolves was not established. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Testosterone:</strong> The 10-to-15-percent finding came from 10 healthy lean young men after one week of five-hour nights. A later meta-analysis did not find a statistically significant reduction after partial sleep deprivation overall, so the article's general statement that the trend is clear is too broad. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a> <a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Weekend recovery sleep:</strong> One short metabolic-ward trial found that a weekend of recovery sleep did not prevent metabolic disruption during a repeated sleep-restriction protocol. It does not establish that recovery sleep is always useless or that lost sleep can never be partly recovered. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>Cyclic sighing:</strong> The cited 2023 trial used five minutes daily for 28 days. Cyclic sighing improved positive affect and lowered resting respiratory rate. It did not show a sleep benefit and was not an insomnia or bedtime trial. <span class="correction-ref-links"><a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><p><strong>Sleep trackers:</strong> Device performance varies. Sleep-stage estimates should be treated as rough trends rather than diagnoses, and the cited comparison does not support one universal 30 to 50 percent miss rate. <span class="correction-ref-links"><a href="#correction-ref-6" aria-label="Reference 6">[6]</a> <a href="#correction-ref-7" aria-label="Reference 7">[7]</a></span></p><p><strong>Chronic insomnia:</strong> Hyperarousal and sleep effort are important mechanisms, but insomnia should not be framed as one single issue. Pain, apnea, restless legs, medication, mood, menopause, and circadian disorders can present similarly. <span class="correction-ref-links"><a href="#correction-ref-8" aria-label="Reference 8">[8]</a> <a href="#correction-ref-9" aria-label="Reference 9">[9]</a></span></p><p><strong>Sleep restriction:</strong> A five-hour sleep window should not be presented as a do-it-yourself starting rule. Sleep-restriction therapy is a structured CBT-I component with safety exceptions and clinical tailoring. <span class="correction-ref-links"><a href="#correction-ref-10" aria-label="Reference 10">[10]</a></span></p><p><strong>Night waking and assessment:</strong> Historical segmented sleep does not establish that recurrent modern 3 a.m. waking is harmless. Frequency, time awake, daytime impairment, and associated symptoms matter. Persistent difficulty at least three nights weekly for three months warrants assessment, with earlier help for drowsy driving, gasping, severe mood change, suicidal thoughts, mania, or seizures. <span class="correction-ref-links"><a href="#correction-ref-11" aria-label="Reference 11">[11]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://doi.org/10.1073/pnas.1721694115" rel="external">Shokri-Kojori, E., Wang, G.-J., Wiers, C. E., et al. (2018). β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proceedings of the National Academy of Sciences, 115(17), 4483–4488. https://doi.org/10.1073/pnas.1721694115</a></li><li id="correction-ref-2"><a href="https://doi.org/10.1001/jama.2011.710" rel="external">Leproult, R., &amp; Van Cauter, E. (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA, 305(21), 2173–2174. https://doi.org/10.1001/jama.2011.710</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/34801825/" rel="external">Cignarelli, A., Castellana, M., Castellana, C., et al. (2021). Effect of partial and total sleep deprivation on serum testosterone in healthy males: A systematic review and meta-analysis. Sleep Medicine, 88, 267–273. https://doi.org/10.1016/j.sleep.2021.10.031</a></li><li id="correction-ref-4"><a href="https://doi.org/10.1016/j.cub.2019.01.069" rel="external">Depner, C. M., Melanson, E. L., Eckel, R. H., et al. (2019). Ad libitum weekend recovery sleep fails to prevent metabolic dysregulation during a repeating pattern of insufficient sleep and weekend recovery sleep. Current Biology, 29(6), 957–967.e4. https://doi.org/10.1016/j.cub.2019.01.069</a></li><li id="correction-ref-5"><a href="https://doi.org/10.1016/j.xcrm.2022.100895" rel="external">Balban, M. Y., Neri, E., Kogon, M. M., et al. (2023). Brief structured respiration practices enhance mood and reduce physiological arousal. Cell Reports Medicine, 4(1), 100895. https://doi.org/10.1016/j.xcrm.2022.100895</a></li><li id="correction-ref-6"><a href="https://doi.org/10.5664/jcsm.6472" rel="external">Baron, K. G., Abbott, S., Jao, N., Manalo, N., &amp; Mullen, R. (2017). Orthosomnia: Are some patients taking the quantified self too far? Journal of Clinical Sleep Medicine, 13(2), 351–354. https://doi.org/10.5664/jcsm.6472</a></li><li id="correction-ref-7"><a href="https://doi.org/10.1093/sleep/zsaa291" rel="external">Chinoy, E. D., Cuellar, J. A., Huwa, K. E., et al. (2021). Performance of seven consumer sleep-tracking devices compared with polysomnography. Sleep, 44(5), zsaa291. https://doi.org/10.1093/sleep/zsaa291</a></li><li id="correction-ref-8"><a href="https://doi.org/10.1017/S1352465803003060" rel="external">Broomfield, N. M., &amp; Espie, C. A. (2003). Initial insomnia and paradoxical intention: An experimental investigation of putative mechanisms using subjective and actigraphic measurement of sleep. Behavioural and Cognitive Psychotherapy, 31(3), 313–324. https://doi.org/10.1017/S1352465803003060</a></li><li id="correction-ref-9"><a href="https://doi.org/10.1016/j.jsmc.2018.04.011" rel="external">Baker, F. C., Lampio, L., Saaresranta, T., &amp; Polo-Kantola, P. (2018). Sleep and sleep disorders in the menopausal transition. Sleep Medicine Clinics, 13(3), 443–456. https://doi.org/10.1016/j.jsmc.2018.04.011</a></li><li id="correction-ref-10"><a href="https://doi.org/10.1016/S0140-6736(23)00683-9" rel="external">Kyle, S. D., Siriwardena, A. N., Espie, C. A., et al. (2023). Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): A pragmatic, superiority, open-label, randomised controlled trial. The Lancet, 402(10406), 975–987. https://doi.org/10.1016/S0140-6736(23)00683-9</a></li><li id="correction-ref-11"><a href="https://doi.org/10.1111/jsr.14035" rel="external">Riemann, D., Espie, C. A., Altena, E., et al. (2023). The European insomnia guideline: An update on the diagnosis and treatment of insomnia 2023. Journal of Sleep Research, 32(6), e14035. https://doi.org/10.1111/jsr.14035</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/sleep-and-insomnia">Sleep and Insomnia: What Helps, What Does Not, and When to Seek Care →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[ADHD Is Not a Superpower. I Have It, and So Does My Son.]]></title>
<description><![CDATA[A doctor who missed his own ADHD for 40 years, and the son who has it too. What the science really says about the "superpower," and what actually helps.]]></description>
<link>https://www.andreheeg.com/archive/adhd-is-not-a-superpower-i-have-it</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/adhd-is-not-a-superpower-i-have-it</guid>
<pubDate>Sun, 12 Jul 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p><span>Magnus is nine, and he cannot stay in his chair long enough to finish a math worksheet.</span></p><p><span>After only two minutes, he asks for water. Then he needs to use the bathroom. He checks the clock. Soon his nose is running, but the tissues are in another room. It takes us thirty minutes to finish half the worksheet. He really wants to do well. He asks if he is getting the answers right, and he means it. But his body just will not let him stay still.</span></p><p><span>I know exactly what I am watching. I was him.</span></p><p><span>I grew up in the Bavarian countryside in the 1980s. I was the lively one, the class clown, the boy who read everything but never finished, and I could never follow a lesson to the end. Where I lived, no one used the word ADHD. You were just called spirited. If you remembered things easily, like I did, you still passed your exams, and no one looked any further.</span></p><p><span>Nobody looked any closer. For forty years.</span></p><p><span>Now I sit across the kitchen table from my son and see the same patterns in a smaller body. This time, it has a name.</span></p><p><span>At home, we have another name for it, one that came before the diagnosis: the monkey. It is the part in his head that jumps from thought to thought and never sits still. When I ask Magnus if the monkey is loud today, he knows exactly what I mean. Most days, it is.</span></p><p><span>Now I see this from three sides. I have it myself. I am raising a boy who has it. And for years, I have worked with people who have it, even if they did not know it.</span></p><p><span>So here is my view as a doctor on ADHD: what it really is when you take away the panic and the hype, how to spot it, what truly helps, what is just for show, and the one thing that decides if this trait helps or hurts you. This advice is the same whether the person in the chair is your child, your coworker, or yourself.</span></p><h2><strong><span>It Is Real, and It Runs in Families</span></strong></h2><p><span>Let’s start with what answers the blame question. If your child has ADHD, it is not because of anything you did as a parent. ADHD is one of the most inherited conditions in medicine: across 37 twin studies, the average heritability is 74% [1]. That is closer to height than to anything you can control as a parent. You probably passed it down, which is a strange kind of comfort.</span></p><p><span>The brain develops more slowly in ADHD. If you track brain growth in hundreds of children, those with ADHD follow the same pattern as others, just later. Peak thickness comes about three years later overall, and about five years later in the prefrontal cortex, which controls planning and self-control [2].</span></p><p><span>ADHD is common, and it does not stop at age eighteen. In the United States, 11.4% of children have been diagnosed, and nearly 78% of them also have another condition, usually anxiety or a learning difficulty [3]. It continues into adulthood. About 2.6% of adults have the full diagnosis [4], and by age 25, only about 15% still meet the strict criteria, while around 65% still have some impairment [5]. Most people do not outgrow it. They either learn to work around it, or they do not.</span></p><h2><strong><span>How to Spot It, in a Child and in Yourself</span></strong></h2><p><span>Having lots of energy is not enough for a diagnosis. The clinical standard is stricter. Symptoms must appear in more than one setting, cause real problems, and start before age twelve [6]. They need to show up at home and at school, not just at home.</span></p><p><span>The diagnosis can be wrong in both directions. Sometimes, it is given out too easily. The youngest child in a class gets diagnosed much more often than the oldest, just for being a few months less mature. Across nearly a million children, the youngest boys were 30% more likely to be diagnosed than the oldest, and the youngest girls 70% more [7]. Some of what we call ADHD is just being five in a room made for six-year-olds.</span></p><p><span>In the other direction, real cases get missed. In childhood, the diagnosis is about three boys for every girl. By adulthood, it is nearly even, because the quiet, inattentive girl who does not disrupt anyone gets overlooked and is treated for anxiety first [8]. The clever get missed most of all. In adults who had never been medicated, a high IQ hid the problem so well they failed only one test, while others failed many [9]. That was me. I remembered enough to pass, so no one looked, and no one saw the cost underneath: the meetings I sat through without catching a word, the restlessness that never showed on my face.</span></p><p><span>One sign the checklist leaves out is emotion. Trouble managing feelings is one of the biggest causes of impairment, and this is true even after you consider every other diagnosis [10]. Having a short fuse is part of the condition itself.</span></p><h2><strong><span>Superpower or Limitation</span></strong></h2><p><span>Here, I disagree with most of what you may have read online. The internet often says ADHD is a superpower. But the evidence does not support that.</span></p><p><span>The costs come first, and they are serious. A Danish study of 1.9 million people found those with ADHD died at about twice the rate of everyone else, mostly from accidents [11]. A 2025 UK analysis estimated that diagnosed adults lose about 7 years of life expectancy if they are men, and 9 years if they are women [12]. Both numbers need caution: the mortality figure is relative, not a high absolute risk, and the life-expectancy estimate is for diagnosed adults, who tend to be more severe cases. But the direction is clear. Untreated, this shortens lives.</span></p><p><span>Now for the superpower side, judged by the same standard. The link to entrepreneurship is real but limited: the sensation-seeking part of ADHD draws people to start things, while the inattentive part makes it hard to finish them [13]. Studies that highlight strengths often recruit people who have already succeeded. The most-cited study interviewed six successful men and asked what was good about having ADHD [14]. A 2026 review of 125 studies found that 70% looked for strengths on purpose, and concluded the benefits show up “in contexts where they are most likely to flourish” [15]. The loudest source fails completely: of the 100 most-viewed ADHD videos on TikTok, 52% were misleading, and most were posted by people with no medical training [16].</span></p><p><span>The honest answer is less exciting than the headlines. ADHD is a real impairment, and whether it helps or hurts depends almost entirely on where you direct it. Here is what the superpower posts leave out, both from my own experience and from watching my son: this is a lot of work. It is hard for the person who has it and hard for the parent raising them, and it shows you your own limits. It is not fun, and it is not something I would wish on my son or anyone else.</span></p><h2><strong><span>What Decides It Is the Environment</span></strong></h2><p><span>If the trait is fixed but the outcome is not, something in between makes the difference. That something is the environment you put the wiring into.</span></p><p><span>Consider one strange study. A dopamine-receptor variant tied to ADHD was carried by men in two branches of the same Kenyan people, one still nomadic, one recently settled into farming. Among the nomads, carriers were better nourished than non-carriers. Among the settled, the same variant left them worse off [17]. Same gene. Opposite lives. The environment cast the deciding vote.</span></p><p><span>I know that difference from my own life. For more than five years, early in my medical career, I worked in a hospital emergency and trauma room, where the ambulance doors would swing open and you never knew if it was a sprained wrist or a major accident. Chaos was normal, and I was always the calmest person in the room. The worse things got, the more settled I became. For years I thought that was discipline. It was not. It was a brain built for emergencies finally given a job that was all emergencies.</span></p><p><span>The opposite is also true. The worst four months of my career were during a corporate reorganization: the same org chart on the same slide, the same boxes moved in the same order, week after week, with nothing ever really decided. The brain that thrived in the trauma room could not handle that setting. It is not built for it. It shows up in smaller ways too. Over the years I have ignored a steady stream of invoices, traffic fines, and forms, and my brain declared victory every time. The fines disagreed.</span></p><p><span>Most of the time, the environment does not organize itself, so I do it. My phone has no notifications. None, from anything. Every screen I own has a plain black background, because a photo of my kids would distract me. When I need to get something done, I use a Time Timer, a clock for children that shows the minutes disappearing, because otherwise thirty minutes and four hours feel the same to me until the deadline hits. And when a subject grabs me, the systems do not matter: I disappear into it for hours, unreachable, as my wife can easily confirm.</span></p><p><span>You could call it a treatment plan, the way I manage myself: remove distractions, make time visible, and focus attention on work the brain can actually handle.</span></p><p><span>That is what a parent has to do, too, even though it goes against every instinct. The instinct is to push harder: correct, repeat, sit the child down, and demand focus. But pushing harder backfires. Children whose parents stayed very critical over the years were more likely to stay stuck in the severe form [18]. Cause goes both ways, and none of it is about blame. But the practical answer is clear: you cannot argue a child out of this, and shame only makes it worse. What helps is quieter and less satisfying. Fewer open tabs on his desk. A timer he can see. A task that matches his attention span. A parent who has stopped keeping score.</span></p><p><span>This is part of the Capacity pillar in my Upward ARC framework, which is about raising the ceiling on what a person can handle over a lifetime. For ADHD, you raise that ceiling by fitting the environment to the person, and this is true from all three perspectives. For me, it means a working life full of variety and deadlines. For Magnus, it means a childhood built around how he actually learns. And on a team, the colleague who cannot stand paperwork is often the one you want beside you when the ambulance doors swing open.</span></p><h2><strong><span>Try This Today</span></strong></h2><p><strong><span>Get assessed, and do not stop at therapy alone.</span></strong><span> Get a real evaluation, not just an online checklist. The diagnosis usually comes from a psychologist or psychiatrist. Once medication is considered, that part is a psychiatrist’s or physician’s job. We spent more than two years on occupational therapy with Magnus because it seemed like a gentler start. It helped a little, but it was not enough. For young children, the guidelines rightly put behavioral parent training first [6], but do not let “we tried therapy” be the reason you wait for years.</span></p><p><strong><span>See medication as the most effective tool, and do not be afraid of it.</span></strong><span> Stimulants are among the most effective treatments in psychiatry, with strong effects on symptoms in both children and adults [19]. And it is not just about grades: across 2.3 million patients, the months people took their medication saw 38% fewer car crashes for men and 42% fewer for women [20]. At the right dose, this is a safety measure.</span></p><p><strong><span>Fix sleep at the same time.</span></strong><span> ADHD and poor sleep make each other worse. In a trial of children with both, a short behavioral sleep program clearly lowered their ADHD symptoms months later [21]. Protect the wind-down, keep a steady bedtime, and treat sleep as part of the treatment.</span></p><p><strong><span>Shape the environment, and skip the showy solutions.</span></strong><span> Build the day around the way the brain works: single-task blocks, outside deadlines, and let someone or something else handle the boring follow-through. Skip the brain-training apps that claim to fix attention. In blinded tests, their benefit for real-world symptoms is limited at best [22].</span></p><p><strong><span>If you lead someone like this, focus on the fit.</span></strong><span> When they keep struggling, it is usually the wiring, not a lack of effort. Give them work that sparks their brain: novelty, variety, or the crisis no one else wants. Take the ongoing admin tasks off their plate, or pair them with someone who can handle it. Provide structure from outside, and never use shame as a tool. You get their best work the same way a parent does: by shaping the environment.</span></p><h2><strong><span>The Chair He Can Stay In</span></strong></h2><p><span>For the first time in my life, I sat at the same desk, working on the same task, for two hours last week. I did not get up. I did not reach for my phone. I did not get distracted by something I never meant to open.</span></p><p><span>I am forty-seven, a few weeks into treatment, and the quiet in my head is so unfamiliar it is almost loud.</span></p><p><span>I did not do this for myself. I did it because of a nine-year-old who cannot sit through eight math problems, and whom I recognized right away, because he is me. We got his diagnosis. Then, in solidarity, I got mine. The psychologist said it was about as clear a case as she had seen.</span></p><p><span>Two months ago, we added medication to the years of therapy. One evening, a few weeks later, Magnus looked up from his worksheet and said, “The monkey in my head isn’t jumping around all the time anymore. I can focus now.” He was nine years old, and he found the words before I ever did.</span></p><p><span>The worksheet still takes time. He still gets up. But now he finishes it, and he knows why he is in the chair.</span></p><p><span>That is why naming it early matters. Not to label a child, but to give him what I spent forty years without: a chair he can stay in when it matters, and the choice of when to leave it.</span></p><p><span>We are doing this together. That was never the plan, but it turned out to be the point.</span></p><p><span>Stay healthy.</span></p><p><span>Andre</span></p><p><span>PS: If you read this and thought of someone, your child, your colleague, or the version of yourself who could never sit still, please forward it to them. Not everyone gets to find the name for this at nine. Those who find it at forty-seven still feel lucky. That is how this newsletter grows, and it is the only way I want it to.</span></p><div><hr></div><h2><strong><span>References</span></strong></h2><p><span>[1] Faraone, S. V., &amp; Larsson, H. (2019). Genetics of attention deficit hyperactivity disorder. </span><em><span>Molecular Psychiatry, 24</span></em><span>(4), 562-575.</span><a href="https://doi.org/10.1038/s41380-018-0070-0" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1038/s41380-018-0070-0</span></a></p><p><span>[2] Shaw, P., Eckstrand, K., Sharp, W., Blumenthal, J., Lerch, J. P., Greenstein, D., Clasen, L., Evans, A., Giedd, J., &amp; Rapoport, J. L. (2007). Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. </span><em><span>Proceedings of the National Academy of Sciences, 104</span></em><span>(49), 19649-19654.</span><a href="https://doi.org/10.1073/pnas.0707741104" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1073/pnas.0707741104</span></a></p><p><span>[3] Danielson, M. L., Claussen, A. H., Bitsko, R. H., Katz, S. M., Newsome, K., Blumberg, S. J., Kogan, M. D., &amp; Ghandour, R. (2024). ADHD prevalence among U.S. children and adolescents in 2022: Diagnosis, severity, co-occurring disorders, and treatment. </span><em><span>Journal of Clinical Child &amp; Adolescent Psychology, 53</span></em><span>(3), 343-360.</span><a href="https://doi.org/10.1080/15374416.2024.2335625" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1080/15374416.2024.2335625</span></a></p><p><span>[4] Song, P., Zha, M., Yang, Q., Zhang, Y., Li, X., &amp; Rudan, I. (2021). The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. </span><em><span>Journal of Global Health, 11</span></em><span>, 04009.</span><a href="https://doi.org/10.7189/jogh.11.04009" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.7189/jogh.11.04009</span></a></p><p><span>[5] Faraone, S. V., Biederman, J., &amp; Mick, E. (2006). The age-dependent decline of attention-deficit hyperactivity disorder: A meta-analysis of follow-up studies. </span><em><span>Psychological Medicine, 36</span></em><span>(2), 159-165.</span><a href="https://doi.org/10.1017/S003329170500471X" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1017/S003329170500471X</span></a></p><p><span>[6] Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., Holbrook, J. R., Lehmann, C. U., Lessin, H. R., Okechukwu, K., Pierce, K. L., Winner, J. D., &amp; Zurhellen, W. (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. </span><em><span>Pediatrics, 144</span></em><span>(4), e20192528.</span><a href="https://doi.org/10.1542/peds.2019-2528" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1542/peds.2019-2528</span></a></p><p><span>[7] Morrow, R. L., Garland, E. J., Wright, J. M., Maclure, M., Taylor, S., &amp; Dormuth, C. R. (2012). Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. </span><em><span>CMAJ, 184</span></em><span>(7), 755-762.</span><a href="https://doi.org/10.1503/cmaj.111619" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1503/cmaj.111619</span></a></p><p><span>[8] Attoe, D. E., &amp; Climie, E. A. (2023). Miss. Diagnosis: A systematic review of ADHD in adult women. </span><em><span>Journal of Attention Disorders, 27</span></em><span>(7), 645-657.</span><a href="https://doi.org/10.1177/10870547231161533" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1177/10870547231161533</span></a></p><p><span>[9] Milioni, A. L. V., Chaim, T. M., Cavallet, M., de Oliveira, N. M., Annes, M., dos Santos, B., Louzã, M., da Silva, M. A., Miguel, C. S., Serpa, M. H., Zanetti, M. V., Busatto, G., &amp; Cunha, P. J. (2017). High IQ may “mask” the diagnosis of ADHD by compensating for deficits in executive functions in treatment-naïve adults with ADHD. </span><em><span>Journal of Attention Disorders, 21</span></em><span>(6), 455-464.</span><a href="https://doi.org/10.1177/1087054714554933" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1177/1087054714554933</span></a></p><p><span>[10] Shaw, P., Stringaris, A., Nigg, J., &amp; Leibenluft, E. (2014). Emotion dysregulation in attention deficit hyperactivity disorder. </span><em><span>American Journal of Psychiatry, 171</span></em><span>(3), 276-293.</span><a href="https://doi.org/10.1176/appi.ajp.2013.13070966" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1176/appi.ajp.2013.13070966</span></a></p><p><span>[11] Dalsgaard, S., Østergaard, S. D., Leckman, J. F., Mortensen, P. B., &amp; Pedersen, M. G. (2015). Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: A nationwide cohort study. </span><em><span>The Lancet, 385</span></em><span>(9983), 2190-2196.</span><a href="https://doi.org/10.1016/S0140-6736(14)61684-6" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/S0140-6736(14)61684-6</span></a></p><p><span>[12] O’Nions, E., El Baou, C., John, A., Lewer, D., Mandy, W., McKechnie, D. G. J., Petersen, I., &amp; Stott, J. (2025). Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: Matched cohort study. </span><em><span>The British Journal of Psychiatry, 226</span></em><span>(5), 261-268.</span><a href="https://doi.org/10.1192/bjp.2024.199" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1192/bjp.2024.199</span></a></p><p><span>[13] Wiklund, J., Yu, W., Tucker, R., &amp; Marino, L. D. (2017). ADHD, impulsivity and entrepreneurship. </span><em><span>Journal of Business Venturing, 32</span></em><span>(6), 627-656.</span><a href="https://doi.org/10.1016/j.jbusvent.2017.07.002" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/j.jbusvent.2017.07.002</span></a></p><p><span>[14] Sedgwick, J. A., Merwood, A., &amp; Asherson, P. (2019). The positive aspects of attention deficit hyperactivity disorder: A qualitative investigation of successful adults with ADHD. </span><em><span>ADHD Attention Deficit and Hyperactivity Disorders, 11</span></em><span>(3), 241-253.</span><a href="https://doi.org/10.1007/s12402-018-0277-6" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1007/s12402-018-0277-6</span></a></p><p><span>[15] Rafael, R. B., Jia, H., Rouel, M., Wootton, B. M., &amp; Mitchison, D. (2026). Attention deficit/hyperactivity disorder (ADHD)-related strengths in adults: A scoping review. </span><em><span>Journal of Attention Disorders</span></em><span>. Advance online publication.</span><a href="https://doi.org/10.1177/10870547261425737" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1177/10870547261425737</span></a></p><p><span>[16] Yeung, A., Ng, E., &amp; Abi-Jaoude, E. (2022). TikTok and attention-deficit/hyperactivity disorder: A cross-sectional study of social media content quality. </span><em><span>The Canadian Journal of Psychiatry, 67</span></em><span>(12), 899-906.</span><a href="https://doi.org/10.1177/07067437221082854" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1177/07067437221082854</span></a></p><p><span>[17] Eisenberg, D. T. A., Campbell, B., Gray, P. B., &amp; Sorenson, M. D. (2008). Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: An exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya. </span><em><span>BMC Evolutionary Biology, 8</span></em><span>, 173.</span><a href="https://doi.org/10.1186/1471-2148-8-173" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1186/1471-2148-8-173</span></a></p><p><span>[18] Musser, E. D., Karalunas, S. L., Dieckmann, N., Peris, T. S., &amp; Nigg, J. T. (2016). Attention-deficit/hyperactivity disorder developmental trajectories related to parental expressed emotion. </span><em><span>Journal of Abnormal Psychology, 125</span></em><span>(2), 182-195.</span><a href="https://doi.org/10.1037/abn0000097" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1037/abn0000097</span></a></p><p><span>[19] Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., Hollis, C., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Steinhausen, H.-C., Shokraneh, F., Xia, J., &amp; Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. </span><em><span>The Lancet Psychiatry, 5</span></em><span>(9), 727-738.</span><a href="https://doi.org/10.1016/S2215-0366(18)30269-4" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/S2215-0366(18)30269-4</span></a></p><p><span>[20] Chang, Z., Quinn, P. D., Hur, K., Gibbons, R. D., Sjölander, A., Larsson, H., &amp; D’Onofrio, B. M. (2017). Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. </span><em><span>JAMA Psychiatry, 74</span></em><span>(6), 597-603.</span><a href="https://doi.org/10.1001/jamapsychiatry.2017.0659" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1001/jamapsychiatry.2017.0659</span></a></p><p><span>[21] Hiscock, H., Sciberras, E., Mensah, F., Gerner, B., Efron, D., Khano, S., &amp; Oberklaid, F. (2015). Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: Randomised controlled trial. </span><em><span>BMJ, 350</span></em><span>, h68.</span><a href="https://doi.org/10.1136/bmj.h68" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1136/bmj.h68</span></a></p><p><span>[22] Cortese, S., Ferrin, M., Brandeis, D., Buitelaar, J., Daley, D., Dittmann, R. W., Holtmann, M., Santosh, P., Stevenson, J., Stringaris, A., Zuddas, A., &amp; Sonuga-Barke, E. J. S. (2015). Cognitive training for attention-deficit/hyperactivity disorder: Meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. </span><em><span>Journal of the American Academy of Child &amp; Adolescent Psychiatry, 54</span></em><span>(3), 164-174.</span><a href="https://doi.org/10.1016/j.jaac.2014.12.010" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/j.jaac.2014.12.010</span></a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC uses ordinary language to make technical evidence readable. It is an educational newsletter, not a diagnosis or treatment plan. The historical article remains unchanged. These notes identify places where population evidence or treatment research needs tighter limits.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Mortality evidence:</strong> Register studies have found higher premature mortality among people diagnosed with ADHD. They do not show that untreated ADHD alone caused the difference. Psychiatric comorbidity, injury, substance use, access to care, and other factors contribute, and many people with ADHD live long, healthy lives. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Medication and driving:</strong> In a large observational cohort, crash-related emergency visits were less common during months when ADHD medication was dispensed. This does not prove that medication prevents crashes for every person or that a particular dose is automatically safe. Diagnosis, medicine choice, dose, adverse effects, contraindications, monitoring, and driving fitness require individual clinical assessment. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Diagnosis and development:</strong> Heritability and cortical-maturation results describe population averages. They do not determine one child's cause, identify which parent contributed risk, or provide a personal developmental clock. ADHD diagnosis requires persistent impairment, more than one setting, developmental history, and consideration of other explanations. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/25726514/" rel="external">Dalsgaard, S., Østergaard, S. D., Leckman, J. F., Mortensen, P. B., &amp; Pedersen, M. G. (2015). Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: A nationwide cohort study. The Lancet, 385(9983), 2190–2196. https://doi.org/10.1016/S0140-6736(14)61684-6</a></li><li id="correction-ref-2"><a href="https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2626505" rel="external">Chang, Z., Quinn, P. D., Hur, K., et al. (2017). Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry, 74(6), 597–603. https://doi.org/10.1001/jamapsychiatry.2017.0659</a></li><li id="correction-ref-3"><a href="https://www.nice.org.uk/guidance/ng87/chapter/recommendations" rel="external">National Institute for Health and Care Excellence. (2018). Attention deficit hyperactivity disorder: Diagnosis and management (NICE Guideline NG87). https://www.nice.org.uk/guidance/ng87</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/adhd-diagnosis-treatment-and-safety">ADHD Diagnosis, Treatment, and Safety: What the Evidence Supports →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[I Ate Raw Sauerkraut by the Jar for 20 Years. Then I Read the Trials.]]></title>
<description><![CDATA[I ate raw sauerkraut for two decades, sure it was medicine. Then I read every trial. Fine to eat, but its reputation ran far ahead of the evidence.]]></description>
<link>https://www.andreheeg.com/archive/i-ate-raw-sauerkraut-by-the-jar-for</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/i-ate-raw-sauerkraut-by-the-jar-for</guid>
<pubDate>Sun, 05 Jul 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p><span>I pulled the jar from the fridge, still cold. Standing at the kitchen counter between two training sessions, I ate 300 grams of raw minced meat and 300 grams of raw sauerkraut. It felt like I was doing something for my body that most people were too soft to do.</span></p><p><span>In my twenties, I wrestled competitively and weighed every meal. The sauerkraut had to be raw and unpasteurized. I just knew, without needing proof, that the live cultures mattered most. Heat destroyed them. The canned, shelf-stable kind seemed inferior. So most days, I ate it cold and sour, alongside the raw meat.</span></p><p><span>I never questioned any of it, not during my wrestling years, not in medical school, and not in the twenty years since. Fermented food was good for me. My doctor said so, my social feed said so, and my mother said so. It was one of the few health beliefs I never examined, because it seemed too old and obvious to be wrong.</span></p><p><span>Last month, I did what I usually do for everything else, but rarely for beliefs I enjoy: I looked for proof. I read every human trial I could find on the four fermented foods people call medicine: sauerkraut, kimchi, kefir, and kombucha.</span></p><p><span>What I found was not the reason I ate all that raw cabbage.</span></p><p><span>The gap between what we believe about these foods and what research has actually shown is wide, wider than I expected. Fermented food is fine to eat, but its reputation got ahead of the evidence, and no one updated the story.</span></p><h2><strong><span>The Yogurt That Won a Nobel Prize</span></strong></h2><p><span>This story begins with a Nobel laureate and a mistake.</span></p><p><span>In 1907, Élie Metchnikoff, one of the founders of immunology, published a book called The Prolongation of Life [1]. In it, he argued that Bulgarian peasants lived unusually long because they drank soured milk full of lactic acid bacteria, and that these bacteria fought the rot in the gut, which he believed caused aging. He won the Nobel Prize the next year (specifically for his discovery of phagocytosis, the process by which certain cells engulf and destroy foreign bodies and bacteria). The idea that fermented dairy means a long life is his.</span></p><p><span>There was one problem. It was wrong. By the early 1920s, work at Yale by the bacteriologist Leo Rettger had shown that the bacteria in Bulgarian yogurt do not survive the human gut, let alone settle there [2]. Metchnikoff’s specific claim was dead within about 15 years of the book. His reputation and the reputation of the foods were not. The belief outlived its own disproof by a century.</span></p><p><span>That pattern runs through this entire field. You do not have to take my word for how weak the evidence is. Listen to the people who most want it to be strong.</span></p><p><span>In 2021, the International Scientific Association for Probiotics and Prebiotics, the field’s own leading scientific association, published a consensus statement [3]. Inside the careful language is a sentence that should stop anyone selling you a bottle: “with the exception of yoghurt and other cultured dairy products, few well-designed, randomized controlled trials on the health benefits of the array of fermented foods have been published.” For foods like kombucha, they wrote, the evidence “is mostly limited to chemical analyses and animal and cell culture models.” Cells in a dish. Mice. Not people.</span></p><p><span>So how did such a weak belief become so widespread?</span></p><p><span>Part of the reason is that lab results are often mistaken for proof. The science is real and interesting: fermented foods have live bacteria, and those bacteria make compounds that calm inflammation in test tubes. But what works in a dish or in a mouse quietly turns into ‘good for you’ by the time it becomes a headline.</span></p><p><span>Then there are population studies, which cannot separate cause from coincidence. People who eat a lot of kimchi or sauerkraut also tend to eat more vegetables, avoid junk food, exercise more, and smoke less. Their better health is often credited to the fermented foods. Even the researchers behind these studies say clearly that this kind of evidence “does not establish causation” [4].</span></p><p><span>Money also plays a role. Many of the existing trials are funded by the companies that sell these foods. In one well-studied example, reviews of artificially sweetened drinks written by authors with industry ties were much more likely to be positive than those without [5]. There is a big business in promoting kombucha, and little incentive to prove that cabbage does nothing.</span></p><h2><strong><span>The Part That Holds Up</span></strong></h2><p><span>So keep eating fermented food. I do most weeks. Just judge it by the same standard as anything else you eat, and the claims become more modest and honest.</span></p><p><span>I still train hard for a man in his forties, and what I am actually trying to hold down is the low, constant background inflammation that rises with age. Researchers call it inflammaging, and it is one of the shared roots of heart disease, dementia, and metabolic decline [6]. It is not abstract. In adults over 80, high levels of two inflammatory markers, IL-6 and CRP, roughly doubled the risk of dying over the following years [7]. And your gut sits at the center of this, because it holds as much as 70% of your immune system [8]. Anything that genuinely lowers that inflammatory load has my attention.</span></p><p><span>There is one good study suggesting fermented food does exactly that. In 2021, a Stanford team put 36 healthy adults on one of two diets for ten weeks. One group worked up to six servings of fermented foods per day. The other added fiber. The fermented group’s gut diversity rose, and 19 inflammatory proteins in their blood fell. The fiber group did not move [9]. A genuinely striking result.</span></p><p><span>To be honest, because you deserve it, that study only included 36 people. When another team ran a larger trial in 2025 with 147 participants, the fermented-food group did not show the same broad drop in inflammatory proteins. In fact, some markers of immune-cell activation even increased [10]. When researchers combined 26 controlled trials involving 1,461 participants, they found a real drop in the marker TNF-alpha, but no significant change in CRP or IL-6 [11]. The effect is real, but it is small. I will not pretend it is more than that.</span></p><p><span>There is one finding I trust most, and it is not the loudest. A study of over 9,000 people found that a healthy gut becomes more unique as you age, and this pattern predicts who lives into their late eighties [12]. Diversity, the thing fermented foods seem to support, goes hand in hand with healthy aging. That is the real reason to eat these foods. The label still promises more than the science shows.</span></p><h2><strong><span>Best to Worst</span></strong></h2><p><span>So which of the four is worth including? I read the human trials on each, and they are not all equal.</span></p><p><span>Kefir (unsweetened) has the strongest case. I make a point of buying it when I see it in the supermarket or think of it. It is closest to yogurt, the only fermented food with solid evidence. Pooled trials show kefir lowers fasting insulin fairly consistently [13]. Blood sugar drops by about 10 mg/dL in one analysis, but only across six small trials with wide error margins [13]. Beyond that, the numbers are quiet: long-term blood sugar and blood pressure stay about the same [13][14]. There are only six to eight small trials, none large. Still, kefir is the lowest in salt of the four and easy to add to a normal day, so it is the one I choose on purpose.</span></p><p><span>Kimchi has one strong modern trial, but there is an important detail. In a 2024 randomized, double-blind study, 55 overweight adults took kimchi for twelve weeks. The kimchi group lost body fat, while the placebo group gained it [15]. That is a real result. However, the kimchi was freeze-dried and put into capsules, with one version made low in sodium, and the World Institute of Kimchi ran the study (I swear this is real). A capsule of dried kimchi is not the same as a bowl of the real thing. And real kimchi is very high in salt. The same Korean data that show benefits also link heavy kimchi intake to a higher risk of stomach cancer, likely due to the salt and N-nitroso compounds formed during fermentation [16]. Enjoy kimchi, but do not treat it as a supplement or eat it in huge amounts.</span></p><p><span>Sauerkraut, which I have eaten my whole life, has the weakest evidence. I found only two small controlled human studies that used sauerkraut alone, with about 120 people in total, and not one well-powered trial on a major outcome [17][18]. Its reputation is based on tradition and theory, not on strong human results. I still eat it, but I no longer call it medicine.</span></p><p><span>Kombucha has the weakest case and the most hype. I found about eight human trials, with mixed effects on blood sugar and one promising result in just twelve people [19][20]. A 16-ounce bottle has about 12 to 19 grams of carbohydrates, most of it leftover sugar [21]. I do not drink much kombucha, and reading the studies did not change my mind. For the most part, it is a fermented soft drink with a health image. If you like the taste, choose the low-sugar version and do not count it as a health habit.</span></p><h2><strong><span>The Jar in My Fridge</span></strong></h2><p><span>Right now, there is a jar of sauerkraut in my Berlin fridge that I paid too much for because the label promised raw, unpasteurized, live cultures.</span></p><p><span>The reason for that purchase makes sense. Most fermented foods in stores are pasteurized to last longer, but the heat kills the bacteria you want. A shelf-stable can is mostly dead food [22]. If you want live cultures, choose the refrigerated jar labeled raw or unpasteurized, and eat it cold.</span></p><p><span>Here is what the label does not say: when researchers compared raw, living sauerkraut to pasteurized, dead sauerkraut in people, the raw version did not come out ahead. In one trial, the pasteurized one did more [18]. The label promises more than the science supports. Still, buy the raw jar if you want more live bacteria and less sugar than the pasteurized kind. Just know the word on the front is not the main reason.</span></p><p><span>In my Upward ARC framework, fermented food belongs in Activate, the part about what you put into your body. Also, it touches on Recover, which is about calming your system back to normal, since lowering inflammation helps you reset. That is the right place for it: a cheap, low-risk, enjoyable food with potential benefits. It is not a miracle, but it is not worthless either.</span></p><h2><strong><span>Try This Today</span></strong></h2><p><strong><span>Try making your own sauerkraut.</span></strong><span> Here is how we do it at home: use a scale and a big glass jar, and get one of the kids to help stomp the cabbage. It is almost impossible to mess up, and homemade sauerkraut is better than anything you can buy. Shred the cabbage, weigh it, add 2% of its weight in salt, and pack it into a jar until the brine covers it. Keep it under the liquid and away from air. Let it sit at room temperature, ideally around 20 degrees Celsius, for one to four weeks [23]. For safety, Fred Breidt, a USDA microbiologist, says there has never been a recorded case of food poisoning from properly fermented vegetables, because the acid produced by the bacteria lowers the pH below what pathogens can handle [24]. Botulism is a risk with sealed, low-acid canning, not with salted open ferments, where the acidity keeps the bacteria from growing. A fresh homemade jar can have hundreds of millions of live bacteria per gram, especially in the first three months [25]. All you need is cabbage, salt, a jar, and time.</span></p><p><strong><span>Make kefir your daily choice.</span></strong><span> Of the four, it has the most evidence from human studies and the least salt. Buy it plain and unsweetened, or make it at home with grains, and use it as you would use yogurt.</span></p><p><strong><span>Read labels carefully, like a clinician would.</span></strong><span> For any fermented food, look for raw, unpasteurized, refrigerated, live cultures, and skip shelf-stable versions if you want live bacteria. For kombucha, ignore the health claims on the front and check the carbohydrate content on the back. Twelve grams of sugar in a health drink is still twelve grams of sugar.</span></p><p><strong><span>Know who needs to be careful.</span></strong><span> Fermented vegetables are high in salt and biogenic amines such as histamine and tyramine. If you have high blood pressure, histamine intolerance, or take an older antidepressant called an MAO inhibitor, which can make tyramine dangerous, these foods can be a real problem instead of a health food [26]. For everyone else, a serving or two a day is enough; you do not need a whole jar.</span></p><h2><strong><span>My Mother’s Kitchen</span></strong></h2><p><span>I still eat sauerkraut most weeks without thinking about it, just as I have since I was a boy. That has not changed, and it will not.</span></p><p><span>Every time I visit my parents, I ask for the same dish: my mother’s sauerkraut, cooked slowly from her mother’s recipe, from the Bavarian farm where the cabbage fermented in a stone crock in the cellar. She always expects it and starts making it before I even ask.</span></p><p><span>For decades, I ate these foods as medicine, convinced of a benefit I never actually checked. When I finally did, my certainty did not last, but the food did.</span></p><p><span>Eat these foods because they are real, you enjoy them, and they might offer a small benefit. That has always been reason enough.</span></p><p><span>The rest was just a story I told myself, even though I am supposed to be someone who tests his stories. I let this one go unchecked for decades, in the very field where checking is my job. We all have a few beliefs like that. The real work is figuring out which ones they are.</span></p><p><span>Stay healthy.</span></p><p><span>Andre</span></p><p><span>PS: If you know someone certain their kombucha is doing something, forward this to them. Be kind about it. That is how this newsletter grows, and it is the only way I want it to.</span></p><div><hr></div><h2><strong><span>References</span></strong></h2><p><span>[1] Metchnikoff, É. (1908). </span><em><span>The prolongation of life: Optimistic studies</span></em><span> (P. C. Mitchell, Ed. &amp; Trans.). G. P. Putnam’s Sons. (Original work published 1907)</span></p><p><span>[2] Rettger, L. F., &amp; Cheplin, H. A. (1921). </span><em><span>A treatise on the transformation of the intestinal flora, with special reference to the implantation of Bacillus acidophilus.</span></em><span> Yale University Press.</span></p><p><span>[3] Marco, M. L., Sanders, M. E., Gänzle, M., Arrieta, M. C., Cotter, P. D., De Vuyst, L., Hill, C., Holzapfel, W., Lebeer, S., Merenstein, D., Reid, G., Wolfe, B. E., &amp; Hutkins, R. (2021). The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods. </span><em><span>Nature Reviews Gastroenterology &amp; Hepatology, 18</span></em><span>(3), 196-208.</span><a href="https://doi.org/10.1038/s41575-020-00390-5" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1038/s41575-020-00390-5</span></a></p><p><span>[4] Paveljšek, D., Pertziger, E., Fardet, A., et al. (2025). A systematic review of prospective evidence linking non-alcoholic fermented food consumption with lower mortality risk. </span><em><span>Frontiers in Nutrition, 12</span></em><span>, 1657100.</span><a href="https://doi.org/10.3389/fnut.2025.1657100" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.3389/fnut.2025.1657100</span></a></p><p><span>[5] Mandrioli, D., Kearns, C. E., &amp; Bero, L. A. (2016). Relationship between research outcomes and risk of bias, study sponsorship, and author financial conflicts of interest in reviews of the effects of artificially sweetened beverages on weight outcomes: A systematic review of reviews. </span><em><span>PLoS ONE, 11</span></em><span>(9), e0162198.</span><a href="https://doi.org/10.1371/journal.pone.0162198" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1371/journal.pone.0162198</span></a></p><p><span>[6] Franceschi, C., &amp; Campisi, J. (2014). Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. </span><em><span>The Journals of Gerontology: Series A, 69</span></em><span>(Suppl 1), S4-S9.</span><a href="https://doi.org/10.1093/gerona/glu057" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1093/gerona/glu057</span></a></p><p><span>[7] Giovannini, S., Onder, G., Liperoti, R., Russo, A., Carter, C., Capoluongo, E., Pahor, M., Bernabei, R., &amp; Landi, F. (2011). Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. </span><em><span>Journal of the American Geriatrics Society, 59</span></em><span>(9), 1679-1685.</span><a href="https://doi.org/10.1111/j.1532-5415.2011.03570.x" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1111/j.1532-5415.2011.03570.x</span></a></p><p><span>[8] Vighi, G., Marcucci, F., Sensi, L., Di Cara, G., &amp; Frati, F. (2008). Allergy and the gastrointestinal system. </span><em><span>Clinical &amp; Experimental Immunology, 153</span></em><span>(Suppl 1), 3-6.</span><a href="https://doi.org/10.1111/j.1365-2249.2008.03713.x" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1111/j.1365-2249.2008.03713.x</span></a></p><p><span>[9] Wastyk, H. C., Fragiadakis, G. K., Perelman, D., Dahan, D., Merrill, B. D., Yu, F. B., Topf, M., Gonzalez, C. G., Van Treuren, W., Han, S., Robinson, J. L., Elias, J. E., Sonnenburg, E. D., Gardner, C. D., &amp; Sonnenburg, J. L. (2021). Gut-microbiota-targeted diets modulate human immune status. </span><em><span>Cell, 184</span></em><span>(16), 4137-4153.e14.</span><a href="https://doi.org/10.1016/j.cell.2021.06.019" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/j.cell.2021.06.019</span></a></p><p><span>[10] van den Belt, M., et al. (2025). Distinct modulatory effects of high-fiber and fermented-food diets on gut microbiota, immune function, transit time, and sleep quality in a citizen science randomized controlled trial [Preprint]. </span><em><span>medRxiv.</span></em><a href="https://doi.org/10.1101/2025.08.05.25332853" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1101/2025.08.05.25332853</span></a></p><p><span>[11] SaeidiFard, N., Djafarian, K., &amp; Shab-Bidar, S. (2020). Fermented foods and inflammation: A systematic review and meta-analysis of randomized controlled trials. </span><em><span>Clinical Nutrition ESPEN, 35</span></em><span>, 30-39.</span><a href="https://doi.org/10.1016/j.clnesp.2019.10.010" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/j.clnesp.2019.10.010</span></a></p><p><span>[12] Wilmanski, T., Diener, C., Rappaport, N., Patwardhan, S., Wiedrick, J., Lapidus, J., Earls, J. C., Zimmer, A., Glusman, G., Robinson, M., Yurkovich, J. T., Kado, D. M., Cauley, J. A., Zmuda, J., Lane, N. E., Magis, A. T., Lovejoy, J. C., Hood, L., Gibbons, S. M., … Price, N. D. (2021). Gut microbiome pattern reflects healthy ageing and predicts survival in humans. </span><em><span>Nature Metabolism, 3</span></em><span>(2), 274-286.</span><a href="https://doi.org/10.1038/s42255-021-00348-0" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1038/s42255-021-00348-0</span></a></p><p><span>[13] Salari, A., Ghodrat, S., Gheflati, A., Jarahi, L., Hashemi, M., &amp; Afshari, A. (2021). Effect of kefir beverage consumption on glycemic control: A systematic review and meta-analysis of randomized controlled clinical trials. </span><em><span>Complementary Therapies in Clinical Practice, 44</span></em><span>, 101443.</span><a href="https://doi.org/10.1016/j.ctcp.2021.101443" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/j.ctcp.2021.101443</span></a></p><p><span>[14] Rashidbeygi, E., Mehrzad Samarin, M., Sheikhhossein, F., et al. (2025). The effect of kefir consumption on blood pressure and C-reactive protein: A systematic review and meta-analysis of randomised controlled trials. </span><em><span>Endocrinology, Diabetes &amp; Metabolism, 8</span></em><span>(6), e70124.</span><a href="https://doi.org/10.1002/edm2.70124" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1002/edm2.70124</span></a></p><p><span>[15] Lee, W., Kwon, M.-S., Yun, Y.-R., Choi, H., Jung, M.-J., Hwang, H., et al. (2024). Effects of kimchi consumption on body fat and intestinal microbiota in overweight participants: A randomized, double-blind, placebo-controlled, single-center clinical trial. </span><em><span>Journal of Functional Foods, 122</span></em><span>, 106401.</span><a href="https://doi.org/10.1016/j.jff.2024.106401" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/j.jff.2024.106401</span></a></p><p><span>[16] Nan, H. M., Park, J. W., Song, Y. J., Yun, H. Y., Park, J. S., Hyun, T., Youn, S. J., Kim, Y. D., Kang, J. W., &amp; Kim, H. (2005). Kimchi and soybean pastes are risk factors of gastric cancer. </span><em><span>World Journal of Gastroenterology, 11</span></em><span>(21), 3175-3181.</span><a href="https://doi.org/10.3748/wjg.v11.i21.3175" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.3748/wjg.v11.i21.3175</span></a></p><p><span>[17] Nielsen, E. S., Garnås, E., Jensen, K. J., Hansen, L. H., Olsen, P. S., Ritz, C., Krych, L., &amp; Nielsen, D. S. (2018). Lacto-fermented sauerkraut improves symptoms in IBS patients independent of product pasteurisation: A pilot study. </span><em><span>Food &amp; Function, 9</span></em><span>(10), 5323-5335.</span><a href="https://doi.org/10.1039/c8fo00968f" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1039/c8fo00968f</span></a></p><p><span>[18] Schropp, N., Bauer, A., Stanislas, V., Huang, K. D., Lesker, T. R., Bielecka, A. A., Strowig, T., &amp; Michels, K. B. (2025). The impact of regular sauerkraut consumption on the human gut microbiota: A crossover intervention trial. </span><em><span>Microbiome, 13</span></em><span>, 52.</span><a href="https://doi.org/10.1186/s40168-024-02016-3" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1186/s40168-024-02016-3</span></a></p><p><span>[19] Costa, M. A. C., et al. (2025). Benefits of kombucha consumption: A systematic review of clinical trials focused on microbiota and metabolic health. </span><em><span>Fermentation, 11</span></em><span>(6), 353.</span><a href="https://doi.org/10.3390/fermentation11060353" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.3390/fermentation11060353</span></a></p><p><span>[20] Mendelson, C., Sparkes, S., Merenstein, D. J., Christensen, C., Sharma, V., Desale, S., Auchtung, J. M., Kok, C. R., Hallen-Adams, H. E., &amp; Hutkins, R. (2023). Kombucha tea as an anti-hyperglycemic agent in humans with diabetes: A randomized controlled pilot investigation. </span><em><span>Frontiers in Nutrition, 10</span></em><span>, 1190248.</span><a href="https://doi.org/10.3389/fnut.2023.1190248" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.3389/fnut.2023.1190248</span></a></p><p><span>[21] Yang, J., Lagishetty, V., Kurnia, P., Henning, S. M., Ahdoot, A. I., &amp; Jacobs, J. P. (2022). Microbial and chemical profiles of commercial kombucha products. </span><em><span>Nutrients, 14</span></em><span>(3), 670.</span><a href="https://doi.org/10.3390/nu14030670" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.3390/nu14030670</span></a></p><p><span>[22] Rezac, S., Kok, C. R., Heermann, M., &amp; Hutkins, R. (2018). Fermented foods as a dietary source of live organisms. </span><em><span>Frontiers in Microbiology, 9</span></em><span>, 1785.</span><a href="https://doi.org/10.3389/fmicb.2018.01785" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.3389/fmicb.2018.01785</span></a></p><p><span>[23] NC State Extension. (2023). </span><em><span>Lactic acid fermentation.</span></em><span> NC State Extension Publications.</span><a href="https://content.ces.ncsu.edu/lactic-acid-fermentation" target="_blank" rel="noopener noreferrer"><span> https://content.ces.ncsu.edu/lactic-acid-fermentation</span></a></p><p><span>[24] Beecher, C. (2014, March 11). </span><em><span>Fermenting veggies at home: Follow food safety ABCs</span></em><span> [quoting F. Breidt, USDA ARS]. Food Safety News.</span><a href="https://www.foodsafetynews.com/2014/03/fermenting-veggies-at-home-follow-food-safety-abcs/" target="_blank" rel="noopener noreferrer"><span> https://www.foodsafetynews.com/2014/03/fermenting-veggies-at-home-follow-food-safety-abcs/</span></a></p><p><span>[25] Thierry, A., Madec, M.-N., Chuat, V., Bage, A.-S., Picard, O., Grondin, C., Rué, O., Mariadassou, M., Marché, L., &amp; Valence, F. (2023). Microbial communities of a variety of 75 homemade fermented vegetables. </span><em><span>Frontiers in Microbiology, 14</span></em><span>, 1323424.</span><a href="https://doi.org/10.3389/fmicb.2023.1323424" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.3389/fmicb.2023.1323424</span></a></p><p><span>[26] Turna, N. S., Chung, R., &amp; McIntyre, L. (2024). A review of biogenic amines in fermented foods: Occurrence and health effects. </span><em><span>Heliyon, 10</span></em><span>(2), e24501.</span><a href="https://doi.org/10.1016/j.heliyon.2024.e24501" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/j.heliyon.2024.e24501</span></a></p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and safety update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience. It may simplify complex biology, but safety instructions and quantitative claims need enough detail to preserve their practical meaning. The historical article remains unchanged.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Gut immune function:</strong> The gut has a major mucosal immune role, but the phrase '70% of the immune system' depends on what is counted and should not be read as 70% of all immune cells. A quantitative census estimated that the gastrointestinal tract contains about 3% of immune cells and 5% of lymphocytes, while housing a much larger share of antibody-producing plasma cells. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Trial and dose:</strong> The Stanford fermented-food study was a small intensive diet experiment with 18 completers in the fermented-food arm. It does not establish one or two daily servings as a universal dose, and observational microbiome ageing research does not show that fermented food causes longer survival. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Home-fermentation safety:</strong> Home vegetable fermentation is not impossible to get wrong. A tested process uses the correct salt proportion, clean food-grade equipment, full submersion, an appropriate temperature and time, safe storage, and clear discard rules. Questionable food should not be tasted to test its safety. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Live organisms:</strong> Fermented foods do not have to contain live microorganisms, and live organisms are not automatically probiotics. Pasteurization can remove live organisms while leaving nutrients and fermentation-derived compounds. 'Dead food' is therefore too broad a description. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10623016/" rel="external">Sender, R., Weiss, Y., Navon, Y., et al. (2023). The total mass, number, and distribution of immune cells in the human body. Proceedings of the National Academy of Sciences, 120(44), e2308511120. https://doi.org/10.1073/pnas.2308511120</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/34256014/" rel="external">Wastyk, H. C., Fragiadakis, G. K., Perelman, D., et al. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137–4153.e14. https://doi.org/10.1016/j.cell.2021.06.019</a></li><li id="correction-ref-3"><a href="https://nchfp.uga.edu/how/ferment/recipes/sauerkraut/" rel="external">National Center for Home Food Preservation. (n.d.). Sauerkraut. https://nchfp.uga.edu/how/ferment/recipes/sauerkraut/</a></li><li id="correction-ref-4"><a href="https://www.nature.com/articles/s41575-020-00390-5" rel="external">Marco, M. L., Sanders, M. E., Gänzle, M., et al. (2021). The International Scientific Association for Probiotics and Prebiotics consensus statement on fermented foods. Nature Reviews Gastroenterology &amp; Hepatology, 18(3), 196–208. https://doi.org/10.1038/s41575-020-00390-5</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/fermented-foods-probiotics-and-safety">Fermented Foods, Probiotics, and Food Safety →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[I Took Fish Oil for 10 Years. I Was Taking the Wrong Half.]]></title>
<description><![CDATA[I took fish oil for 10 years and was dosing the wrong half. A doctor on EPA vs DHA, the test that ends the guessing, and how to read the label.]]></description>
<link>https://www.andreheeg.com/archive/i-took-fish-oil-for-10-years-i-was</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/i-took-fish-oil-for-10-years-i-was</guid>
<pubDate>Sun, 28 Jun 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>Magnus is nine. He can’t eat dairy, eggs, most nuts, or sesame.</p><p>Karla is six. She can’t eat fish.</p><p>Two kids, two lists, one kitchen. Dinner here is a problem to solve before it is a meal. We start with protein. Which one, how to cook it, what to put with it. Then we check the basics. Are they getting enough to grow, the vitamins, the nutrients they would get if they could eat everything. Milk is a huge challenge here.</p><p>For years, we’ve just done this. It’s normal now.</p><p>Last week, we ran into a new problem. Omega-3. The best source is oily fish, and the child who needs it most cannot have it. How do you supplement it for a six-year-old? Flaxseed or a capsule? Which one, what dose?</p><p>I did not have a clear answer. Thinking about it reminded me of something in my inbox.</p><p>A few weeks earlier, I was in San Francisco and signed up for Function Health to test the service and see what it was like. They check more than a hundred biomarkers. I skimmed the cholesterol and hormone numbers, the ones I know well. I had never opened the omega panel.</p><p>I’m a doctor. I write about this every Sunday. For ten years, my omega-3 plan was simple: buy the best-rated bottle online, take two or three a day, and move on.</p><p>That night I opened the panel.</p><p>What I found surprised me.</p><p>My total omega-3 was 9.2%. Most labs call anything above 8 good. I had cleared it without effort. I felt confident.</p><p>Then I read the breakdown. My DHA was high, at 5.6%. My EPA was lower, 1.9. The two omega-3s I had taken as one for years were not equal, and the one that does most of the anti-inflammatory work was the one I had the least of.</p><p>I had been taking fish oil. I did not realize I was taking mostly the wrong part.</p><p>Here’s what I learned in the rabbit hole that followed.</p><h2><strong>The Two Halves of Fish Oil</strong></h2><p>Start here, because almost every mistake comes from missing it.</p><p>“Omega-3” on a label usually means two different fatty acids doing two different jobs. EPA and DHA. They share a family name and not much else.</p><p>DHA is structural. It’s the omega-3 your brain is mostly built from. Brain tissue contains 250-300 times more DHA than EPA [1]. It sits in the membranes of your neurons and your retina.</p><p>EPA is the worker. Your body uses it to make the signaling molecules that calm inflammation, the resolvins and protectins, and often milder versions of the inflammatory compounds that arachidonic acid produces [1][2]. EPA is the one with cardiovascular and mood data to back it up. DHA builds the structure. EPA runs the maintenance.</p><p>A standard capsule treats them as the same. Your blood does not. My results were uneven, just as I had been dosing for years.</p><h2><strong>The 8% Test</strong></h2><p>Most people taking omega-3 supplements have never measured their levels. I was one of them. We take it on faith and a five-star rating.</p><p>There is a real test. The Omega-3 Index measures EPA plus DHA in your red blood cell membranes, as a percentage. Bill Harris and Clemens von Schacky proposed it in 2004 as a graded risk marker for dying of heart disease. 8% or higher was the protected end; 4% or lower was the exposed end [3].</p><p>It holds up. In the Framingham Heart Study, people in the top fifth of the Omega-3 Index had a 34% lower risk of dying from any cause and a 39% lower risk of a new cardiovascular event than those in the bottom fifth [4].</p><p>Raise your number. There is a second number people often focus on, but it is less solid than it seems.</p><p>It’s the AA/EPA ratio. Arachidonic acid against EPA. The two compete for the same enzymes, so the balance between them determines how much inflammatory versus calming signaling your cells produce [5]. A higher ratio means more inflammatory raw material relative to EPA. Mine came back at 6.1. On the functional-medicine chart that reads as high: the target, they’ll tell you, sits between 1.5 and 3, so 6.1 looks like I’m running hot.</p><p>So I looked for the trial behind it. There isn’t one. The 1.5-to-3 target comes from clinical reference ranges, not randomized data, and the literature treats the ratio as a continuous signal: lower values tend to be better, with no proven cutoff. So my 6.1 isn’t an alarm. It mostly tells me what the EPA number already did, that my EPA is low.</p><p>And even that effect has conditions. In the Hisayama study, a large Japanese cohort, each drop in the EPA-to-AA ratio was associated with about 1.5 times the cardiovascular risk, but mostly in people whose inflammation was already elevated on a CRP test [6].</p><p>I had cleared the validated number and was being told to chase one that is not. That should make you pause.</p><h2><strong>Three Things, One Bottle</strong></h2><p>So I went looking for the right product, this time for Karla.</p><p>Three things had to be true at once. A disclosed split of DHA and EPA, so I knew what was in the capsule. The triglyceride form, the one that absorbs (more on this later). And no fish, because she can’t have it.</p><p>That overlap is small. I gave the problem to an AI to sort the market, as I do now. Even then, few products met all three. We found one.</p><p>The harder part is earlier. Most people never learn these are the three questions to ask.</p><h2><strong>Does Any of It Even Work?</strong></h2><p>This is where marketing and evidence separate.</p><p>The best case comes from one trial. REDUCE-IT, 2019. 8,000 high-risk patients on statins, given 4 grams a day of pure EPA, a high-dose prescription ethyl ester. Their rate of major cardiac events dropped by 25% compared with placebo [7]. A real, large, hard-outcome win.</p><p>Then the results changed. A similar trial, STRENGTH, used the same 4 grams per day, but with a mix of EPA and DHA rather than EPA alone. It found no benefit and stopped early for futility [8]. Same dose, same patients, opposite result. Two of the largest fish oil trials do not agree. Pure high-dose EPA may work, the mixed product may not, and the answer is not settled.</p><p>Looking at more data, the effect is smaller. A Cochrane review of 86 trials and 162,796 people found that omega-3 supplements have little or no effect on overall mortality [9]. They lower triglycerides by about 15%. There is a real effect on one blood marker, but nothing clear on lifespan.</p><p>The brain data is similar. In one Framingham analysis, people with the highest red-cell DHA had about half the Alzheimer’s rate, a 49% lower risk [10]. But in a large trial, giving 1 g/day to older adults with adequate levels did not slow cognitive decline compared with placebo [11].</p><p>The pattern is consistent. Omega-3 matters most when you are low. Adding more to someone who already has enough does little.</p><h2><strong>The Seed Oil Panic Is Mostly Wrong</strong></h2><p>A quick note, since people ask. Many worry about omega-6, seed oils, and a high omega-6-to-omega-3 ratio [12]. My ratio was 3.6, and it does not matter much. Higher linoleic acid, the main seed-oil fat, is associated with about a 22% lower risk of cardiovascular death across 30 cohorts [13]. It does not raise inflammatory markers [14], and the American Heart Association advises against focusing on the ratio [15]. The key is raising omega-3. I will cover this in detail another time.</p><h2><strong>The Brain You’ll Need at 70</strong></h2><p>In my Upward ARC framework, this is mostly Activate, the pillar about what you put into the system. Food first, then the few supplements that earn their place. Omega-3 earns its place, in the right form and dose, checked against your Omega-3 Index.</p><p>It also affects Capacity, the long-term view. DHA is part of the brain you will need at 70. You are not supplementing for now. You are building the hardware for later life.</p><h2><strong>Try This Today</strong></h2><p><strong>Measure before you medicate.</strong> Order an Omega-3 Index test. It’s the same red-cell measure used in the research, and the only way to know if your routine is doing anything. Aim for 8% or higher. Below 4 is the danger zone [3]. Retest three to four months after any change. One number ends years of guessing.</p><p><strong>Read the label like a clinician.</strong> Four checks. One, form. You want “triglyceride” or “rTG,” the shape omega-3 takes in the fish itself, rebuilt after concentration. Avoid “ethyl ester,” the cheaper version where the fatty acid is attached to an alcohol to pack it more tightly. The triglyceride form absorbs at 124% of natural fish oil; the ethyl ester sits at 73 [16][17]. (The one big trial that worked, REDUCE-IT, used a high-dose prescription ethyl ester. At that dose, the form barely matters. For the modest dose in your daily capsule, it decides how much you actually absorb.) Two, a third-party seal: IFOS five-star, USP, or a printed oxidation number. In one test of 32 fish oils, half were oxidized beyond the accepted limit, and 69% contained less omega-3 than the label promised [18]. Three, read the actual EPA and DHA milligrams, not the “1,000 mg fish oil” on the front. The targets are set for the two combined: 250 to 500 mg per day for general health, and 2 to 4 grams per day for a specific job, like lowering triglycerides, under medical supervision. Same number for men and women, and no special older-adult dose, whatever the marketing says. Pregnancy is the one exception, adding about 200 mg of DHA. Four, smell it. Crack a capsule; rancid means oxidized, so trash it. Then keep the bottle somewhere cool and dark. Light and heat accelerate oxidation.</p><p><strong>Match the molecule to the goal.</strong> If your aim is brain and baseline, balanced or DHA-leaning is fine. If your aim is inflammation, triglycerides, or mood, you want an EPA-dominant supplement. The antidepressant signal in the trials only shows up above 60% EPA [19], and the one cardiovascular win used pure EPA [7]. Swap to the right one rather than stacking a second bottle on the first. I’m moving to an EPA-heavy form and will retest in autumn.</p><p><strong>Take it with a fatty meal, and not just any fat.</strong> Co-ingest your omega-3 with 10 to 15 grams of long-chain fat: olive oil, avocado, eggs, oily fish. With a high-fat meal, EPA absorption from fish oil climbs to about 90% [20]. Don’t take it with MCT or coconut oil. Those are medium-chain fats; they bypass the route your long-chain omega-3 needs, so part of the dose is wasted. A capsule on an empty stomach is the worst version.</p><p><strong>Eat the fish. Or, if you can’t, the algae.</strong> Two to three servings a week of salmon, sardines, or mackerel will move your index better than any stack. And for the people who can’t eat fish, my six-year-old included, algal oil works just as well. In a head-to-head trial, omega-3 from microalgae was absorbed as well as fish oil, around 111% [21].</p><h2><strong>The Patient I’d Have Corrected</strong></h2><p>Dinner tonight is the same engineering problem it always is. Magnus’s list, Karla’s list, the protein, the sides, the macros. None of that changes.</p><p>The change is small and specific. I read a panel I had ignored for ten years and found fish oil was two molecules I had taken out of balance. I am changing one bottle, not adding more. I booked the retest.</p><p>I spent a decade as the patient I would have corrected. The fix was a single blood test and the willingness to look at it.</p><p>The question that started this now has an answer. Karla cannot eat fish, and she has never minded. She’ll get her omega-3 from where the fish get theirs, the algae. She will grow up with what I never thought to measure in myself.</p><p>Stay healthy.</p><p>Andre</p><p>​<br>​</p><p>PS: If you take fish oil every morning and have never measured whether it works, you are where I was. Forward this to someone who would say their routine is fine. That is how this newsletter grows, and it is the only way I want it to.</p><p>​</p><div><hr></div><h2><strong>References</strong></h2><p>[1] Dyall, S. C. (2015). Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA. <em>Frontiers in Aging Neuroscience, 7</em>, 52.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjMzODkvZm5hZ2kuMjAxNS4wMDA1Mg==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.3389/fnagi.2015.00052</a>​</p><p>[2] Calder, P. C. (2013). Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? <em>British Journal of Clinical Pharmacology, 75</em>(3), 645-662.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExMTEvai4xMzY1LTIxMjUuMjAxMi4wNDM3NC54" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1111/j.1365-2125.2012.04374.x</a>​</p><p>[3] Harris, W. S., &amp; von Schacky, C. (2004). The Omega-3 Index: A new risk factor for death from coronary heart disease? <em>Preventive Medicine, 39</em>(1), 212-220.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvai55cG1lZC4yMDA0LjAyLjAzMA==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1016/j.ypmed.2004.02.030</a>​</p><p>[4] Harris, W. S., Tintle, N. L., Etherton, M. R., &amp; Vasan, R. S. (2018). Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study. <em>Journal of Clinical Lipidology, 12</em>(3), 718-727.e6.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvai5qYWNsLjIwMTguMDIuMDEw" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1016/j.jacl.2018.02.010</a>​</p><p>[5] Nelson, J. R., &amp; Raskin, S. (2019). The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease. <em>Postgraduate Medicine, 131</em>(4), 268-277.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwODAvMDAzMjU0ODEuMjAxOS4xNjA3NDE0" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1080/00325481.2019.1607414</a>​</p><p>[6] Ninomiya, T., Nagata, M., Hata, J., Hirakawa, Y., Ozawa, M., Yoshida, D., Ohara, T., Kishimoto, H., Mukai, N., Fukuhara, M., Kitazono, T., &amp; Kiyohara, Y. (2013). Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: The Hisayama Study. <em>Atherosclerosis, 231</em>(2), 261-267.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvai5hdGhlcm9zY2xlcm9zaXMuMjAxMy4wOS4wMjM=" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1016/j.atherosclerosis.2013.09.023</a>​</p><p>[7] Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., Tardif, J.-C., &amp; Ballantyne, C. M. (2019). Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. <em>New England Journal of Medicine, 380</em>(1), 11-22.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwNTYvTkVKTW9hMTgxMjc5Mg==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1056/NEJMoa1812792</a>​</p><p>[8] Nicholls, S. J., Lincoff, A. M., Garcia, M., Bash, D., Ballantyne, C. M., Barter, P. J., Davidson, M. H., Kastelein, J. J. P., Koenig, W., McGuire, D. K., Mozaffarian, D., Ridker, P. M., Ray, K. K., Katona, B. G., Himmelmann, A., Loss, L. E., Rensfeldt, M., Lundström, T., &amp; Nissen, S. E. (2020). Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: The STRENGTH randomized clinical trial. <em>JAMA, 324</em>(22), 2268-2280.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMDEvamFtYS4yMDIwLjIyMjU4" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1001/jama.2020.22258</a>​</p><p>[9] Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H. O., Summerbell, C. D., Worthington, H. V., Song, F., &amp; Hooper, L. (2020). Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. <em>Cochrane Database of Systematic Reviews, 2020</em>(3), Article CD003177.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMDIvMTQ2NTE4NTguQ0QwMDMxNzcucHViNQ==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1002/14651858.CD003177.pub5</a>​</p><p>[10] Sala-Vila, A., Satizabal, C. L., Tintle, N., Melo van Lent, D., Vasan, R. S., Beiser, A. S., Seshadri, S., &amp; Harris, W. S. (2022). Red blood cell DHA is inversely associated with risk of incident Alzheimer’s disease and all-cause dementia: Framingham Offspring Study. <em>Nutrients, 14</em>(12), 2408.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjMzOTAvbnUxNDEyMjQwOA==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.3390/nu14122408</a>​</p><p>[11] Kang, J. H., Kim, E., Cook, N. R., &amp; Manson, J. E. (2022). Marine n-3 fatty acids and cognitive change among older adults in the VITAL randomized trial. <em>Alzheimer’s &amp; Dementia: Translational Research &amp; Clinical Interventions, 8</em>(1), e12288.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMDIvdHJjMi4xMjI4OA==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1002/trc2.12288</a>​</p><p>[12] Simopoulos, A. P. (2008). The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. <em>Experimental Biology and Medicine, 233</em>(6), 674-688.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjMxODEvMDcxMS1NUi0zMTE=" target="_blank" rel="noopener noreferrer"> https://doi.org/10.3181/0711-MR-311</a>​</p><p>[13] Marklund, M., Wu, J. H. Y., Imamura, F., Del Gobbo, L. C., Fretts, A., de Goede, J., Shi, P., Tintle, N., Wennberg, M., Aslibekyan, S., Chen, T.-A., de Oliveira Otto, M. C., Hirakawa, Y., Qureshi, W., Guan, W., Bork, C. S., … Mozaffarian, D. (2019). Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality: An individual-level pooled analysis of 30 cohort studies. <em>Circulation, 139</em>(21), 2422-2436.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExNjEvQ0lSQ1VMQVRJT05BSEEuMTE4LjAzODkwOA==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1161/CIRCULATIONAHA.118.038908</a>​</p><p>[14] Johnson, G. H., &amp; Fritsche, K. (2012). Effect of dietary linoleic acid on markers of inflammation in healthy persons: A systematic review of randomized controlled trials. <em>Journal of the Academy of Nutrition and Dietetics, 112</em>(7), 1029-1041.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvai5qYW5kLjIwMTIuMDMuMDI5" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1016/j.jand.2012.03.029</a>​</p><p>[15] Harris, W. S., Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, L. L., Appel, L. J., Engler, M. M., Engler, M. B., &amp; Sacks, F. (2009). Omega-6 fatty acids and risk for cardiovascular disease: A science advisory from the American Heart Association Nutrition Subcommittee. <em>Circulation, 119</em>(6), 902-907.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExNjEvQ0lSQ1VMQVRJT05BSEEuMTA4LjE5MTYyNw==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1161/CIRCULATIONAHA.108.191627</a>​</p><p>[16] Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., &amp; Schmidt, E. B. (2010). Bioavailability of marine n-3 fatty acid formulations. <em>Prostaglandins, Leukotrienes and Essential Fatty Acids, 83</em>(3), 137-141.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvai5wbGVmYS4yMDEwLjA2LjAwNw==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1016/j.plefa.2010.06.007</a>​</p><p>[17] Schuchardt, J. P., &amp; Hahn, A. (2013). Bioavailability of long-chain omega-3 fatty acids. <em>Prostaglandins, Leukotrienes and Essential Fatty Acids, 89</em>(1), 1-8.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvai5wbGVmYS4yMDEzLjAzLjAxMA==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1016/j.plefa.2013.03.010</a>​</p><p>[18] Albert, B. B., Derraik, J. G. B., Cameron-Smith, D., Hofman, P. L., Tumanov, S., Villas-Boas, S. G., Garg, M. L., &amp; Cutfield, W. S. (2015). Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. <em>Scientific Reports, 5</em>, 7928.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMzgvc3JlcDA3OTI4" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1038/srep07928</a>​</p><p>[19] Sublette, M. E., Ellis, S. P., Geant, A. L., &amp; Mann, J. J. (2011). Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. <em>The Journal of Clinical Psychiatry, 72</em>(12), 1577-1584.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjQwODgvSkNQLjEwbTA2NjM0" target="_blank" rel="noopener noreferrer"> https://doi.org/10.4088/JCP.10m06634</a>​</p><p>[20] Lawson, L. D., &amp; Hughes, B. G. (1988). Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. <em>Biochemical and Biophysical Research Communications, 156</em>(2), 960-963.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvczAwMDYtMjkxeCg4OCk4MDkzNy05" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1016/s0006-291x(88)80937-9</a>​</p><p>[21] Bailey, E., Wojcik, J., Rahn, M., Roos, F., Spooren, A., &amp; Koshibu, K. (2025). Comparative bioavailability of DHA and EPA from microalgal and fish oil in adults. <em>International Journal of Molecular Sciences, 26</em>(19), 9343.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjMzOTAvaWptczI2MTk5MzQz" target="_blank" rel="noopener noreferrer"> https://doi.org/10.3390/ijms26199343</a>​</p><p>​<br>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It sometimes uses ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Editorial clarification:</strong> The edition describes EPA as the ‘worker’ and DHA as ‘structural.’ Those are nontechnical metaphors, not medical categories. EPA and DHA have overlapping as well as distinct biological roles. The wording was intended to help a general reader follow the distinction, not to imply that either fatty acid has only one function or that a lower EPA value is automatically the ‘wrong half.’ <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Evidence qualification:</strong> The Omega-3 Index is a biomarker with observational associations, but an 8% result is not a universally adopted treatment target and routine testing is not standard population screening. Whether to use or test an omega-3 supplement depends on diet, indication, cardiovascular risk, medicines, and clinical context. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Trial qualification:</strong> REDUCE-IT tested 4 grams daily of prescription icosapent ethyl in high-risk, statin-treated adults with elevated triglycerides. STRENGTH tested a different EPA-plus-DHA formulation in another high-risk population. These trials do not show that one capsule form is best for every person or that the same benefit applies to routine supplements in healthy adults. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Dose and safety:</strong> General dietary advice, prescription treatment for high triglycerides, pregnancy guidance, and dosing for a child with a fish allergy are separate questions. High-dose omega-3 products can increase atrial-fibrillation risk and may interact with medicines. A child-specific product and dose require allergy and clinical review. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Product claims:</strong> Small short-term studies suggest that triglyceride forms can be more bioavailable than ethyl esters under some conditions, but they do not justify a universal instruction to avoid ethyl esters. One 32-product New Zealand analysis does not establish the quality of every current product, and smell is not a validated oxidation test. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Meal and purpose qualification:</strong> Taking omega-3 with food can affect absorption, but the cited study compared a 44-gram high-fat meal with an 8-gram low-fat meal. It did not establish a 10-to-15-gram target or prove that coconut or MCT oil wastes the dose. Evidence for using EPA-dominant supplements for mood or inflammation is not a general treatment recommendation. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/" rel="external">National Institutes of Health, Office of Dietary Supplements. (n.d.). Omega-3 fatty acids: Fact sheet for health professionals. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/</a></li><li id="correction-ref-2"><a href="https://www.nejm.org/doi/10.1056/NEJMoa1812792" rel="external">Bhatt, D. L., Steg, P. G., Miller, M., et al. (2019). Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New England Journal of Medicine, 380(1), 11–22. https://doi.org/10.1056/NEJMoa1812792</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/20638827/" rel="external">Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., &amp; Schmidt, E. B. (2010). Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes and Essential Fatty Acids, 83(3), 137–141. https://doi.org/10.1016/j.plefa.2010.06.007</a></li><li id="correction-ref-4"><a href="https://doi.org/10.1016/S0006-291X(88)80937-9" rel="external">Lawson, L. D., &amp; Hughes, B. G. (1988). Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochemical and Biophysical Research Communications, 156(2), 960–963. https://doi.org/10.1016/S0006-291X(88)80937-9</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/fish-oil-and-omega-3">Fish Oil and Omega-3: Testing, Doses, Products, and Safety →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[I Told a Parent Group My Daughter Was Missing. It Was a Joke.]]></title>
<description><![CDATA[Laughter is the best medicine is mostly a myth. What a real laugh actually does to your body, the four humor styles, and why the audience decides.]]></description>
<link>https://www.andreheeg.com/archive/i-told-a-parent-group-my-daughter</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/i-told-a-parent-group-my-daughter</guid>
<pubDate>Sun, 21 Jun 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>The kids were at the zoo. That was the whole crisis.</p><p>There were three preschool classes, about 50-60 kids, all around six years old, plus teachers and support staff. They were supposed to be back by three. For a week, the parent WhatsApp group had been arguing about the school’s updates. There weren’t enough updates, or they were the wrong kind, or they arrived too late. It was the usual drama, and I can’t stand the usual drama.</p><p>At three o’clock, the bus still wasn’t back. By 3:10, the chat had gone from worried to full-on crisis mode. “Are they back?” “Does anyone have eyes on them?” “We were told three.” There was supposed to be a buffer, and everyone knew about it, but it didn’t help.</p><p>So I did what I always do. I typed, “My daughter is missing. I’m calling the police.” Then I put my phone down, feeling pretty pleased with myself.</p><p>I was acting. I played the over-the-top, panicked parent for a group of parents who had been working themselves up all week. Anyone who knows me would have seen right through it.</p><p>But a preschool WhatsApp group isn’t full of people who know you.</p><p>The panic came right back. “Oh my god.” “What happened??” “How can we help?” I gave in immediately. “Sorry, everyone, that was a joke.”</p><p>That’s when one of them called me sick.</p><p>Karla, who’s six, was on the bus. The bus was just twelve minutes late.</p><p>I wish I could say this was out of character, but it wasn’t. My family would laugh if I tried. My brain is often about half a step ahead of my judgment, which is just how ADHD works for me. Most days, that half-step is where my best ideas come from. Other days, it’s where I end up posting a joke about a missing child to 40 strangers.</p><p>I’m usually the last person to realize when a joke has flopped. That afternoon, I managed to do it live, in writing, in front of everyone. I deleted the message within a minute, apologized, still got called sick, and then decided to do something more useful than argue. I started looking into whether laughter is actually good for you, physically, like all those posters claim.</p><p>We’ve all heard that claim without ever really checking it. Laughter is the best medicine. It’s been on mugs and hospital walls for decades. I wanted to see if there’s any real evidence behind it, or if the parent chat just punished me for using bad folk medicine.</p><h2><strong>What the Mug Gets Wrong</strong></h2><p>Let’s start with the slogan, because it’s mostly not true.</p><p>“Laughter is the best medicine” traces to Norman Cousins, a magazine editor who in 1976 wrote in the New England Journal of Medicine that he had recovered from a painful spinal condition on a regimen of Marx Brothers films and vitamin C [1]. A lovely story. Also, one uncontrolled case. Self-reported. A condition that can clear up on its own, while he was also taking high doses of vitamin C, which means the films get no clean credit either way. One patient. No control group. 50 years of a medical myth.</p><p>The claims grew from there. You have read that laughter boosts your immune system, lifts your natural killer cells, and helps fight cancer. Those headlines come from a few tiny studies, 10-30 people, that measured a small blip in a blood marker for an hour or two [2]. None followed a patient to a real outcome. Laughter yoga, the organized-circle kind, has been properly reviewed: weak evidence, small, biased trials, and no clear edge over any other group activity [3].</p><p>The most honest voice is the field’s own. Rod Martin, who built the standard tool for measuring humor, reviewed the entire literature and found the immune effects inconsistent, the physical health benefits thin, and no good evidence that funnier people live longer [4]. The leading man in the field looked at the folklore and said, in effect: Slow down.</p><p>I could have stopped there, punished by a parent chat for a remedy that doesn’t even work. But the evidence doesn’t end there.</p><h2><strong>What a Laugh Actually Does</strong></h2><p>Beneath the slogans, there’s what laughter actually does to your body right after you laugh. Here, the evidence is solid because it’s measurable.</p><p>Laughter and stress move the cardiovascular system in opposite directions. In a randomized, controlled experiment, arterial stiffness fell after people laughed and rose after a stressful task. The same laughter lowered cortisol too [5]. Real, and gone within a day.</p><p>Cortisol shows your stress load. A 2023 meta-analysis pooled trials that had participants sit in front of something funny and measured the hormone before and after. Laughter cut it by roughly a third, most of that in a single session [6]. The authors are careful, and so am I. The studies are small, and none can be blinded, because there is no placebo joke. The effect is real, and the evidence is thin. Both are true.</p><p>The sturdiest finding is, in evolutionary terms, the oldest. Robin Dunbar at Oxford ran six experiments showing that genuine laughter, the helpless kind, raised people’s pain threshold, most likely by releasing endorphins [7]. Feeling good on its own did not do it. The laughing did. The effect was strongest when people laughed together, and Dunbar thinks the physical act of real laughter is what matters. He argues it evolved to do the job grooming does for other primates: hold the group together. It is, first, how humans bond.</p><p>What bothered me that evening wasn’t being called sick. I’ve been called worse by people whose opinions actually matter to me. What really bothered me was simpler: I thought the joke was good, but I was wrong about the only thing that mattered. Who was reading it.</p><p>The same eight words, if I sent them to my wife or to the two friends who always reply with something even darker, would be a good joke. Sending it to 40 strangers stressed about pickup made me look like someone who doesn’t take a missing child seriously.</p><p>Same words, completely different meaning. The difference was the audience, and I got it wrong.</p><h2><strong>Four Kinds of Funny</strong></h2><p>Psychology has spent 20 years measuring the exact thing I got wrong. It starts, again, with Rod Martin, who in 2003 showed that humor comes in four distinct styles [8]. Two tend to help you. Two tend to cost you.</p><p>The two that help: affiliative humor, which brings people together, and self-enhancing humor, which you use on yourself to keep a bad day in proportion. The two that cost: aggressive humor, at someone else’s expense, and self-defeating humor, putting yourself down to buy a laugh.</p><p>The style matters more than the amount. A meta-analysis of 37 studies and nearly 13,000 people found that the two adaptive styles show lower depression and higher self-esteem. At the same time, self-defeating humor is the only one that reliably tracks worse mental health [9]. A second, 85 studies and over 27,000 people, put numbers on it: adaptive and maladaptive humor move well-being in opposite directions, the signs cleanly reversed [10]. The effects are modest in magnitude, and they recur across studies. In this kind of research, consistency counts for more than a big number that fails to replicate.</p><p>There is a mechanism behind this. In one experiment, people looked at upsetting images and found a kind, funny way to see them. Their bad feeling dropped. A cruel joke did not work nearly as well [11]. Humor is one way the mind decides how big a threat really is, and the kind you reach for changes the answer. Under real stress, the helpful styles soften the blow, and the self-defeating ones deepen it [12].</p><p>None of this research told me my joke was wrong. I figured that out on my own, sitting on the sofa that evening. The research just explained why.</p><h2><strong>Whose Joke Is It</strong></h2><p>Now, let’s move from a parent chat to something more familiar for most of you, a team you’re responsible for. The same rules apply, but the stakes are higher.</p><p>A meta-analysis of 49 studies found that positive humor at work is associated with higher performance, more trust, better teamwork, and lower burnout. The link was about 0.36, which is strong for this kind of research [13]. Leaders who use warm humor well get more from their people. That much holds up.</p><p>The catch is that it depends on you. A review of leadership studies found that humor helps when the leader is already trusted and seen as competent, but it backfires if they’re not [14]. Another study followed the same leaders for six weeks and found that affiliative humor improved their standing within the team, whereas aggressive humor worsened it [15].</p><p>And dark humor, the kind I reached for, is not the clean tool people assume it is. Among more than 500 investigators who work on the worst cases imaginable, lighthearted humor was associated with lower traumatic stress, whereas gallows humor was associated with higher traumatic stress [16]. Joking about horror did not protect these people. The darkest humor went with the most stress, not the least.</p><p>Which brings us back to the late bus and my bad joke. What really matters is your standing and where you’re coming from: whether you’re laughing with the people who are dealing with the problem, or at them from the outside. That afternoon, I was on the outside, even though I thought I was in.</p><p>In my Upward ARC framework, this falls under Recover, the work of bringing your nervous system back to normal between stressful moments. A real laugh does that quickly: it lowers cortisol, relaxes your arteries, gives you a boost of endorphins, and usually happens with someone else. It also affects Capacity. The kind of humor you use under pressure either builds your resilience over time or slowly wears it down. You reset every day, and your style adds up.</p><h2><strong>Does It Buy You Years</strong></h2><p>The last promise on the mug is the biggest. Does humor make you live longer?</p><p>The honest answer is a quiet maybe, and it gets weaker the more you look into it. One study of over 66,000 Norwegians found that people with a stronger sense of humor were less likely to die over 7 years [17]. But when the same group was followed for 15 years, the effect persisted among women but largely disappeared among men [18]. A Japanese study of 17,000 adults found that people who rarely laughed had nearly double the death rate of frequent laughers, even after adjusting for obvious risk factors [19]. It’s interesting, but far from settled, and could just mean that sick and lonely people laugh less.</p><p>The stronger evidence is actually for optimism. A meta-analysis of nearly 230,000 people found that optimism is linked to lower rates of heart disease and early death [20]. But that’s about optimism as a personality trait, and optimism isn’t the same as humor.</p><p>So I won’t tell you that humor adds years to your life. The evidence just isn’t strong enough. What humor really changes is how today feels, how your team works, and how you handle tough moments.</p><h2><strong>Try This Today</strong></h2><p><strong>The Hard Laugh.</strong> Not just a smile. A real, full laugh. Find what really cracks you up, whether it’s a comedian, a video, or a friend who does the voice, and give yourself ten minutes of it when your day gets heavy. The studies that showed a drop in cortisol did it just like this: healthy adults, something funny, nothing else [6]. The key is that it has to be genuine. In the study, the effect only stemmed from real, uncontrollable laughter, not just from feeling amused [7]. Think of it as a dose. Use it when you need it, not just once in a while.</p><p><strong>The Style Audit.</strong> For a week, pay attention to which of the four types of humor you use. Affiliative brings people together. Self-enhancing helps you keep your own bad day in perspective. Aggressive is at someone else’s expense. Self-defeating is at your own. The first two are worth keeping. If you often use the fourth, making fun of yourself for a laugh, that’s the one most clearly linked to feeling worse [9][10]. Try to cut those.</p><p><strong>The Standing Check.</strong> Before you make a joke that might go too far, ask yourself quietly: am I laughing with the person who’s dealing with this, or at them from the outside? If you’re sharing the burden, almost anything goes. If you’re not, almost nothing does. I didn’t ask myself that question at three o’clock that afternoon. I’ve asked it many times since.</p><p><strong>The Room Rule.</strong> If you’re a leader, your humor isn’t just yours. Warm humor from a trusted leader brings the team together, but the same joke from someone who isn’t trusted yet, or aimed at someone with less power, does the opposite [14][15]. Earn trust first. Then you’ll get the laughs.</p><h2><strong>The Morning After</strong></h2><p>The next morning, I thought about writing a proper apology to the group. A calm one, after a night’s sleep. But I didn’t.</p><p>I had already apologized right away, as soon as I saw the joke land badly. That was real, and it was enough. A second apology wouldn’t have been for them. It would have been for me, just to feel better. The two who called me sick weren’t waiting for me to change. They just wanted me to grovel. I don’t grovel to a group chat.</p><p>So I let it go. I admit I messed up. They’re right that it landed badly. I still stand by why I made the joke, but I won’t defend how I sent it.</p><p>Karla doesn’t know that any of this happened. She came back twelve minutes late, after seeing elephants and monkeys and eating ice cream, three scoops, according to her, and she was as happy as one can be. The crisis that took over the chat that afternoon turned out to be the best day of the month for the only person it was really about.</p><p>I’ll keep making jokes. I wouldn’t be any use to my kids, or to you, if I tried to make myself smaller and safer just to please strangers. But I will choose my audience more carefully. The best laughs I’ve ever had come from a few people who know me well enough to joke right back. They’re what really matters.</p><p>Stay healthy.</p><p>Andre</p><p>​<br>​</p><p>PS: If you have a friend who would have answered my text with something far worse and made you laugh harder for it, send them this. That’s how this newsletter grows, and it’s the only way I want it to.</p><p>​</p><div><hr></div><p>​</p><h2><strong>References</strong></h2><p>[1] Cousins, N. (1976). Anatomy of an illness (as perceived by the patient). <em>New England Journal of Medicine, 295</em>(26), 1458-1463.</p><p>[2] Bennett, M. P., Zeller, J. M., Rosenberg, L., &amp; McCann, J. (2003). The effect of mirthful laughter on stress and natural killer cell activity. <em>Alternative Therapies in Health and Medicine, 9</em>(2), 38-45.</p><p>[3] Bressington, D., Mui, J., Yu, C., Leung, S. F., Cheung, K., Wu, C. S. T., Bollard, M., &amp; Chien, W. T. (2018). The effects of group-based laughter yoga interventions on mental health in adults: A systematic review. <em>Journal of Psychiatric and Mental Health Nursing, 25</em>(8), 517-527.</p><p>[4] Martin, R. A. (2001). Humor, laughter, and physical health: Methodological issues and research findings. <em>Psychological Bulletin, 127</em>(4), 504-519.</p><p>[5] Vlachopoulos, C., Xaplanteris, P., Alexopoulos, N., Aznaouridis, K., Vasiliadou, C., Baou, K., Stefanadi, E., &amp; Stefanadis, C. (2009). Divergent effects of laughter and mental stress on arterial stiffness and central hemodynamics. <em>Psychosomatic Medicine, 71</em>(4), 446-453.</p><p>[6] Kramer, C. K., &amp; Leitao, C. B. (2023). Laughter as medicine: A systematic review and meta-analysis of interventional studies evaluating the impact of spontaneous laughter on cortisol levels. <em>PLOS ONE, 18</em>(5), e0286260.</p><p>[7] Dunbar, R. I. M., Baron, R., Frangou, A., Pearce, E., van Leeuwen, E. J. C., Stow, J., Partridge, G., MacDonald, I., Barra, V., &amp; van Vugt, M. (2012). Social laughter is correlated with an elevated pain threshold. <em>Proceedings of the Royal Society B: Biological Sciences, 279</em>(1731), 1161-1167.</p><p>[8] Martin, R. A., Puhlik-Doris, P., Larsen, G., Gray, J., &amp; Weir, K. (2003). Individual differences in uses of humor and their relation to psychological well-being: Development of the Humor Styles Questionnaire. <em>Journal of Research in Personality, 37</em>(1), 48-75.</p><p>[9] Schneider, M., Voracek, M., &amp; Tran, U. S. (2018). “A joke a day keeps the doctor away?” Meta-analytical evidence of differential associations of habitual humor styles with mental health. <em>Scandinavian Journal of Psychology, 59</em>(3), 289-300.</p><p>[10] Jiang, F., Lu, S., Jiang, T., &amp; Jia, H. (2020). Does the relation between humor styles and subjective well-being vary across culture and age? A meta-analysis. <em>Frontiers in Psychology, 11</em>, 2213.</p><p>[11] Samson, A. C., &amp; Gross, J. J. (2012). Humour as emotion regulation: The differential consequences of negative versus positive humour. <em>Cognition &amp; Emotion, 26</em>(2), 375-384.</p><p>[12] Fritz, H. L., Russek, L. N., &amp; Dillon, M. M. (2017). Humor use moderates the relation of stressful life events with psychological distress. <em>Personality and Social Psychology Bulletin, 43</em>(6), 845-859.</p><p>[13] Mesmer-Magnus, J., Glew, D. J., &amp; Viswesvaran, C. (2012). A meta-analysis of positive humor in the workplace. <em>Journal of Managerial Psychology, 27</em>(2), 155-190.</p><p>[14] Rosenberg, C., Walker, A., Leiter, M., &amp; Graffam, J. (2021). Humor in workplace leadership: A systematic search scoping review. <em>Frontiers in Psychology, 12</em>, 610795.</p><p>[15] Pundt, A., &amp; Herrmann, F. (2015). Affiliative and aggressive humour in leadership and their relationship to leader-member exchange. <em>Journal of Occupational and Organizational Psychology, 88</em>(1), 108-125.</p><p>[16] Craun, S. W., &amp; Bourke, M. L. (2014). The use of humor to cope with secondary traumatic stress. <em>Journal of Child Sexual Abuse, 23</em>(7), 840-852.</p><p>[17] Svebak, S., Romundstad, S., &amp; Holmen, J. (2010). A 7-year prospective study of sense of humor and mortality in an adult county population: The HUNT-2 study. <em>International Journal of Psychiatry in Medicine, 40</em>(2), 125-146.</p><p>[18] Romundstad, S., Svebak, S., Holen, A., &amp; Holmen, J. (2016). A 15-year follow-up study of sense of humor and causes of mortality: The Nord-Trondelag Health Study. <em>Psychosomatic Medicine, 78</em>(3), 345-353.</p><p>[19] Sakurada, K., Konta, T., Watanabe, M., Ishizawa, K., Ueno, Y., Yamashita, H., &amp; Kayama, T. (2020). Associations of frequency of laughter with risk of all-cause mortality and cardiovascular disease incidence in a general population: Findings from the Yamagata Study. <em>Journal of Epidemiology, 30</em>(4), 188-193.</p><p>[20] Rozanski, A., Bavishi, C., Kubzansky, L. D., &amp; Cohen, R. (2019). Association of optimism with cardiovascular events and all-cause mortality: A systematic review and meta-analysis. <em>JAMA Network Open, 2</em>(9), e1912200.</p><p>​<br>​</p><div><hr></div><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/humor-stress-and-health">Humor, Stress, and Health: What a Laugh Can and Cannot Do →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[The Night a Wearable Would Score as a Failure]]></title>
<description><![CDATA[Alcohol is not good for you, and obsessing over your tracker is worse. A doctor on the real drivers of a long life, and why the dinner matters more.]]></description>
<link>https://www.andreheeg.com/archive/the-night-a-wearable-would-score</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-night-a-wearable-would-score</guid>
<pubDate>Sun, 14 Jun 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>It’s past midnight, and the waiter has stopped pretending he wants us to leave.</p><p>He stacks chairs at the far end of the room, moving slowly, as if he no longer cares. The candle on our table is gone. We’re the last two in the restaurant, taking our time.</p><p>An old friend, one of my closest. We started the night with a Negroni each, just like we used to. Then we shared a bottle of red that was better than it needed to be. The steaks are gone. The table is covered in empty glasses and bread.</p><p>We talked about his relationship. We talked about my kids. We talked about work, especially the parts we never share online. We talked about the future, our plans, and ideas that aren’t fully formed. We even talked about our fears, the kind of conversation you only have this late, with this friend, after a bottle of wine.</p><p>I’m a doctor. I know what those drinks will do to me over the next two days. I sleep better now than I used to. I stopped wearing my Oura ring a year ago. I feel the trade-off as it happens, and I choose it on purpose.</p><p>I wouldn’t trade this night for a perfect recovery score. Not even for ten perfect scores.</p><p>There’s an honesty at this table you don’t find in a quiet office with a professional. Two old friends, past midnight, telling each other the truth about their lives.</p><p>It’s one of the best things I’ll do for my health all month. No wearable device would ever count it as a success.</p><h2><strong>A Few Days Later</strong></h2><p>I saw a man say that a night like this has ruined three days of his life.</p><p>He was speaking into a podcast microphone. He hadn’t been drunk. Just a couple of glasses of wine at dinner, he said, and it affected him for three days. He slept worse, ate worse the next day, and skipped the gym. Then he said the line that went viral: “I podcasted worse.”</p><p>Oh boy. That escalated fast.</p><p>The man was Steven Bartlett, host of Diary of a CEO, one of the world’s biggest podcasts. Within two days, he became a symbol of something many people were tired of. A BBC Radio 1 host even called for an anti-optimization movement. A man with a fitness tracker had called a normal evening with wine a three-day disaster, and people online had had enough.</p><p>I watched with mixed feelings. The physical effects he described are real. I’ve written about them before. But I see things differently.</p><p>He blamed the wine. But the wine wasn’t the real problem. What really cost him three days was the tracker on his wrist and the story it told him about a normal night.</p><h2><strong>The Part Where I Agree With Him</strong></h2><p>Let me be clear about the science. This is where I stand, and I won’t change it just to make a point.</p><p>Alcohol isn’t good for you. The largest analysis we have, covering 195 countries, found that the amount of drinking that does the least harm to your health is zero [1]. Not one glass. Zero. Even light drinking raises the risk of several cancers. For women, every 10 grams of alcohol a day, about one small glass of wine, raises breast cancer risk by roughly 10 percent. Wine is no exception [2].</p><p>And it does disturb your sleep. Alcohol helps you fall asleep faster at any dose, but then it breaks up the second half of the night. At moderate and higher doses, it also reduces your REM sleep [3]. So when Bartlett says the wine cost him a bad night and a worse next day, he’s right. I’ve felt it. You’ve felt it.</p><p>That’s why I made alcohol the exception, not the rule. I don’t have a glass most nights. I save it for special occasions, like the dinner I described. I knew the cost ahead of time, and I’m fine with it.</p><p>So if the evidence is on his side, what did he get so wrong?</p><h2><strong>The Cost of Keeping Score</strong></h2><p>Here’s where the optimized life goes wrong. The harm from an occasional glass of wine is small and lasts a day or two. But treating your body like a business report does much more harm and lasts for years.</p><p>Start with the tracker. Sleep researchers have a name for this: orthosomnia. In several cases, patients became so focused on perfecting their sleep scores that the obsession made their insomnia worse [4]. The device meant to help them ended up causing trouble.</p><p>Then there’s stress. A study of nearly 29,000 adults found something I think about often. People under high stress had a 43% higher risk of dying early, but only if they believed stress was harming them. Those under the same high stress who didn’t see it as a threat had no higher risk [5]. The belief did as much damage as the stress.</p><p>The way you think about a bad recovery score might hurt you more than what caused it in the first place.</p><p>And we’re getting worse at this. The pressure to meet other people’s standards, what researchers call socially prescribed perfectionism, keeps rising. By 2017, two-thirds of young adults scored above the 1989 average [6]. We’re making ourselves anxious by trying to be perfect. That slow, steady stress has a name too: allostatic load, the biological cost your body pays after years of stress. Over time, it wears down your heart, metabolism, and brain [7].</p><p>One more honest note, because it cuts both ways. The old idea that moderate drinking helps you live longer was mostly a statistical artifact. Once you stop counting the “non-drinkers” who are really sick people who quit, the apparent benefit mostly disappears [8]. The largest recent review, almost five million people, found no real protection at low levels [9]. So don’t drink for your health. And don’t punish yourself over the glass you had with a friend. Both follow from the same evidence.</p><h2><strong>What the Trackers Miss</strong></h2><p>If the small things are just for show, what really matters? The things that affect how long you live are usually simple, and most can’t be tracked by any device.</p><p>Connection is near the top. A review of 148 studies involving more than 300,000 people found that those with strong social relationships had a 50% higher chance of surviving the follow-up period. The authors put it on par with quitting smoking, ahead of obesity and inactivity [10]. The reverse holds. Isolation, loneliness, and living alone each raise the risk of early death by around 30%, on the scale of obesity itself [11].</p><p>It runs deeper than a headcount. Adults over 50 with the weakest sense of purpose had nearly two and a half times the risk of dying compared to those with the strongest [12]. Even meaning shows up in the mortality tables.</p><p>Think back to that restaurant table. Two old friends, talking honestly late into the night. There’s real science behind this. The same endorphins released when we laugh or sing also appear when we share a drink. This chemistry brings people closer, and those who keep up these social habits have bigger support networks and more trust in their communities [13]. The dinner was the real medicine that night. The wine was just there.</p><h2><strong>Do the Basics, Then Stop</strong></h2><p>There’s one more thing, and it’s what lets you relax.</p><p>The basics work, and then doing more doesn’t help. A pooled study of 661,000 adults found that the risk of early death dropped quickly as people went from doing nothing to meeting the basic activity guidelines, then kept improving up to three to five times that level, and then leveled off. Doing ten times the minimum added nothing [14]. Almost all the benefits come from the first ordinary dose.</p><p>That’s how most things in health work. Sleep seven to eight hours. Move and lift something heavy a few times a week. Eat mostly real food. Stay close to people you care about. Do work that matters to you. If you get these right, you’ve covered most of what matters.</p><p>It’s fun to try new things, like the cold plunge, the latest breathing app, or the supplement of the month. I do it too. But the basics give you almost all the benefits. The new stuff is just the last one percent, and you only get there after you’ve handled the basic 99%.</p><p>A landmark study followed five simple habits: never smoking, keeping a healthy weight, regular movement, a decent diet, and, believe it or not, moderate drinking. Those five added 12-14 years to life expectancy [15]. You could argue, as the alcohol researchers earlier would, whether that last one truly belongs. But notice the pattern. The gold standard for a long, healthy life includes a glass of wine. It was never about living like a monk.</p><h2><strong>We’re Coming Back to Our Senses</strong></h2><p>I think we’re at a turning point, and the way people reacted to that clip shows it clearly.</p><p>For years, the culture pushed us in one direction: more tracking, more routines, more new health trends. Some of it helped. But things kept escalating until someone could say a glass of wine ruined three days, and a million people finally said enough.</p><p>That reaction wasn’t really about him. It was a sign. People are starting to remember that connection, a few good habits, and some moderation have always been the answer. Common sense is coming back.</p><p>This doesn’t mean you should ignore the science. Your tracker can teach you something real. Wear it for a month, see how alcohol and late nights affect your numbers, and then trust what you’ve learned. The readiness score is just information. It’s not a judgment on your day, and it’s not worth chasing for its own sake.</p><p>In my Upward ARC framework, this idea fits into two pillars. Recover, because connection and a calm mind help you reset, while constant self-scoring keeps you stressed. And Capacity, because moderation, the discipline to do the basics and then stop, is what helps you keep going for years instead of burning out over a number.</p><h2><strong>Try This Today</strong></h2><p><strong>The Occasion Rule: </strong>The goal isn’t zero. It’s to stop pouring a glass out of habit on a random Tuesday and save it for nights that matter. A dinner with an old friend is worth it. A glass alone in front of your laptop isn’t. Make your choice on purpose.</p><p><strong>The Sunday Check:</strong> If you use a tracker, stop worrying about single mornings. One bad number means almost nothing. Check your numbers once a week, maybe every Sunday, compare this week to last, and see if you missed one of your basics. Then adjust. Checking every day mostly just adds stress.</p><p><strong>The Standing Table: </strong>Schedule one relaxed evening with people you care about, and protect it as you would a board meeting. Keep your phone in your pocket. Don’t leave early for an alarm. Don’t feel guilty the next day. That evening is part of your health. Treat it that way.</p><p><strong>The Subtraction Audit: </strong>List everything you do for your health right now. Then cut the one with the weakest evidence and the most effort. Maybe it’s the cold plunge you hate, the eleventh supplement, or the routine you follow just because. Cutting back often helps more than adding something new.</p><h2><strong>Last Call</strong></h2><p>It’s almost one in the morning. My friend and I finally get up, because the staff deserves to go home and we’ve said what we needed to say. I’ll sleep worse tonight. I knew that when I ordered the second bottle. Tomorrow I’ll move a little slower, drink some water, and get back to the basics I always stick to.</p><p>It will have been worth every minute.</p><p>Somewhere else, someone with a perfect recovery score is going to bed on time, proud of his podcast and tracking every detail of his evening. I don’t envy him. I think he’s missing the point.</p><p>A glass of wine might cost you a day. But obsessing over the numbers can cost you the dinner, the friend, and the honest talk at midnight. Those are the real reasons any of this matters.</p><p>Do the basics as if your life depends on them, because it does. Then put the tracker away, pour a drink for someone you care about, and stay at the table.</p><p>Moderation is the harder skill. It means knowing the science well and still choosing to enjoy the night.</p><p>Stay healthy.</p><p>Andre</p><p>​<br>​</p><p>PS: If this message came at the right time for you, send it to the friend you’d want to sit with at midnight. Tell them dinner’s on you. That’s how this newsletter grows, and it’s the only way I want it to.</p><p>​<br>​</p><div><hr></div><h2><strong>References</strong></h2><p>[1] GBD 2016 Alcohol Collaborators. (2018). Alcohol use and burden for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. <em>The Lancet, 392</em>(10152), 1015-1035.</p><p>[2] Sun, Q., Xie, W., Wang, Y., Chong, F., Song, M., Li, T., Yang, Y., &amp; Tang, H. (2020). Alcohol consumption by beverage type and risk of breast cancer: A dose-response meta-analysis of prospective cohort studies. <em>Alcohol and Alcoholism, 55</em>(3), 246-253.</p><p>[3] Ebrahim, I. O., Shapiro, C. M., Williams, A. J., &amp; Fenwick, P. B. (2013). Alcohol and sleep I: Effects on normal sleep. <em>Alcoholism: Clinical and Experimental Research, 37</em>(4), 539-549.</p><p>[4] Baron, K. G., Abbott, S., Jao, N., Manalo, N., &amp; Mullen, R. (2017). Orthosomnia: Are some patients taking the quantified self too far? <em>Journal of Clinical Sleep Medicine, 13</em>(2), 351-354.</p><p>[5] Keller, A., Litzelman, K., Wisk, L. E., Maddox, T., Cheng, E. R., Creswell, P. D., &amp; Witt, W. P. (2012). Does the perception that stress affects health matter? The association with health and mortality. <em>Health Psychology, 31</em>(5), 677-684.</p><p>[6] Curran, T., &amp; Hill, A. P. (2019). Perfectionism is increasing over time: A meta-analysis of birth cohort differences from 1989 to 2016. <em>Psychological Bulletin, 145</em>(4), 410-429.</p><p>[7] Guidi, J., Lucente, M., Sonino, N., &amp; Fava, G. A. (2021). Allostatic load and its impact on health: A systematic review. <em>Psychotherapy and Psychosomatics, 90</em>(1), 11-27.</p><p>[8] Stockwell, T., Zhao, J., Panwar, S., Roemer, A., Naimi, T., &amp; Chikritzhs, T. (2016). Do “moderate” drinkers have reduced mortality risk? A systematic review and meta-analysis of alcohol consumption and all-cause mortality. <em>Journal of Studies on Alcohol and Drugs, 77</em>(2), 185-198.</p><p>[9] Zhao, J., Stockwell, T., Naimi, T., Churchill, S., Clay, J., &amp; Sherk, A. (2023). Association between daily alcohol intake and risk of all-cause mortality: A systematic review and meta-analyses. <em>JAMA Network Open, 6</em>(3), e236185.</p><p>[10] Holt-Lunstad, J., Smith, T. B., &amp; Layton, J. B. (2010). Social relationships and mortality risk: A meta-analytic review. <em>PLoS Medicine, 7</em>(7), e1000316.</p><p>[11] Holt-Lunstad, J., Smith, T. B., Baker, M., Harris, T., &amp; Stephenson, D. (2015). Loneliness and social isolation as risk factors for mortality: A meta-analytic review. <em>Perspectives on Psychological Science, 10</em>(2), 227-237.</p><p>[12] Alimujiang, A., Wiensch, A., Boss, J., Fleischer, N. L., Mondul, A. M., McLean, K., Mukherjee, B., &amp; Pearce, C. L. (2019). Association between life purpose and mortality among US adults older than 50 years. <em>JAMA Network Open, 2</em>(5), e194270.</p><p>[13] Dunbar, R. I. M., Launay, J., Wlodarski, R., Robertson, C., Pearce, E., Carney, J., &amp; MacCarron, P. (2017). Functional benefits of (modest) alcohol consumption. <em>Adaptive Human Behavior and Physiology, 3</em>(2), 118-133.</p><p>[14] Arem, H., Moore, S. C., Patel, A., Hartge, P., Berrington de Gonzalez, A., Visvanathan, K., Campbell, P. T., Freedman, M., Weiderpass, E., Adami, H. O., Linet, M. S., Lee, I. M., &amp; Matthews, C. E. (2015). Leisure time physical activity and mortality: A detailed pooled analysis of the dose-response relationship. <em>JAMA Internal Medicine, 175</em>(6), 959-967.</p><p>[15] Li, Y., Pan, A., Wang, D. D., Liu, X., Dhana, K., Franco, O. H., Kaptoge, S., Di Angelantonio, E., Stampfer, M., Willett, W. C., &amp; Hu, F. B. (2018). Impact of healthy lifestyle factors on life expectancies in the US population. <em>Circulation, 138</em>(4), 345-355.</p><p>​<br>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The dinner story and the warning against letting a wearable define a good night remain intact. Population associations about stress, alcohol, and social connection need narrower language when they are applied to one person's health.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Stress beliefs:</strong> The cited survey found that self-reported stress and the belief that stress affects health were associated with mortality. It did not show that the belief caused death or that the belief did as much harm as the stress exposure itself. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Alcohol and longevity:</strong> Moderate alcohol was one component of an observational lifestyle score. That study did not isolate alcohol as the cause of longer life, and it should not be read as a reason to start drinking. Population alcohol research does not provide a risk-free level for every outcome, but it also cannot predict the effect of one drink in one person. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Connection:</strong> Social connection is associated with better health and survival across populations. The evidence does not prove that one dinner offsets sleep loss, alcohol exposure, or another personal risk. The scene is storytelling, not a treatment equation. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/22201278/" rel="external">Keller, A., Litzelman, K., Wisk, L. E., et al. (2012). Does the perception that stress affects health matter? Health Psychology, 31(5), 677–684. https://pubmed.ncbi.nlm.nih.gov/22201278/</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/37000449/" rel="external">Zhao, J., Stockwell, T., Naimi, T., et al. (2023). Association between daily alcohol intake and risk of all-cause mortality: A systematic review and meta-analysis. JAMA Network Open, 6(3), e236185. https://pubmed.ncbi.nlm.nih.gov/37000449/</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/20668659/" rel="external">Holt-Lunstad, J., Smith, T. B., &amp; Layton, J. B. (2010). Social relationships and mortality risk: A meta-analytic review. PLOS Medicine, 7(7), e1000316. https://pubmed.ncbi.nlm.nih.gov/20668659/</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/alcohol-wearables-and-social-connection">Alcohol, Wearables, and Social Connection →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[He Named a Surgery He Couldn't See: A Doctor's Audit of 5,000 Years of Chinese Medicine]]></title>
<description><![CDATA[Is Chinese medicine ancient wisdom or elaborate theater? It is both. A doctor separates what survives the evidence from what can give you cancer.]]></description>
<link>https://www.andreheeg.com/archive/he-named-a-surgery-he-couldnt-see</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/he-named-a-surgery-he-couldnt-see</guid>
<pubDate>Sun, 07 Jun 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>There’s a paper bag in my house I’m not allowed to open indoors.</p><p>Inside are eight packages of dried herbs, some tree bark shavings, and scorpions. Dried scorpions. I promise, this is real.</p><p>I brought it back from Beijing about eight years ago. A traditional Chinese medicine doctor gave me the prescription during a free afternoon on a work trip. I was supposed to boil everything into a broth and drink it. When my wife saw it, she took a careful sniff and decided that if I ever made it, I’d have to do it outside, in the garden, far from the kitchen.</p><p>I still haven’t done it. The bag is still there.</p><p>I went for one reason: curiosity. I often try things on myself before I can explain why. That afternoon, I got a tongue exam, a pulse reading on both wrists, a diagnosis that mentioned a shoulder surgery the doctor couldn’t have known about, two hours lying on a bench with needles, and a bag of scorpions I’ll probably never use.</p><p>Somewhere in that strange afternoon, a real question stuck with me. I finally spent a weekend digging into the research to find an answer.</p><p>The question is simple to ask but tough to answer. Is traditional Chinese medicine 5,000 years of wisdom that modern medicine ignores? Or is it just elaborate theater with ancient branding?</p><p>The truth is, it’s both, mixed together so closely that most people never separate them. Supporters focus on the successes and ignore the rest. Critics focus on the nonsense and ignore the successes. Neither approach really helps.</p><p>So I did what I always do when unsure about a treatment. I looked at the evidence rather than the reputation, kept what held up to a doctor’s review, and set aside what didn’t. You could call it the doctor’s edit.</p><p>Surprisingly, quite a bit holds up. But some of it can also land you in a cancer ward. It’s important to know the difference.</p><h2><strong>The 5,000-Year Story</strong></h2><p>Every brochure claims traditional Chinese medicine is 5,000 years old, but that number is mostly marketing. The oldest main text, the Huangdi Neijing or Yellow Emperor’s Inner Classic, was put together between 400 BCE and 260 CE [1]. So the written tradition is about 2,000 years old. Still old, just not 5,000.</p><p>What’s even more surprising is how recent the unified system is. The version of TCM we know today was mostly put together in the 1950s and early 1960s in communist China, under Mao [2]. There weren’t enough Western-trained doctors, so the government combined different classical and folk practices, settled the disagreements, and created a single curriculum. The tidy, “ancient” system sold to wellness tourists is mostly a product of mid-20th-century health policy.</p><p>But that hasn’t slowed its growth. Today, 170 World Health Organization member countries officially recognize that their people use traditional or complementary medicine [3]. In 2019, the WHO even added 150 traditional-medicine disorder categories, based on classical Chinese medicine, to the ICD-11, the global disease classification manual [4].</p><p>TCM is built on a few main ideas: qi, a vital energy said to flow through the body; yin and yang; the five phases; and a network of meridians, or channels for qi [5]. These ideas lead to the practices most people know: acupuncture, herbal formulas, cupping, tui na massage, tai chi, and qigong.</p><h2><strong>What Survives the Audit</strong></h2><p>Let’s start with the best thing TCM has given us, which is also one of the most important drugs of the last century.</p><p>In the 1960s, a Chinese chemist named Tu Youyou was asked to find a malaria treatment. She worked through hundreds of old texts and kept returning to one line from Ge Hong, written around 340 CE, which described soaking sweet wormwood in cold water and drinking the juice for fevers [6]. Every extraction she had tried with heat had failed. That detail, cold water, told her heat was destroying the active compound. She switched to a low-temperature extraction in 1971, and it worked [6]. The active molecule, isolated soon after, was artemisinin.</p><p>Today, it reduces malaria deaths by over 20% overall and more than 30% in children, saving more than 100,000 lives a year in Africa alone [7]. Tu Youyou won the Nobel Prize in 2015 [7]. The old text gave her the clue, and modern chemistry did the rest. That’s the best way to look at TCM: a huge, ancient list of ideas, most untested, with a few real gems.</p><p>Acupuncture is a trickier case. The biggest analysis combined 39 trials and 20,827 patients with chronic pain [8]. Acupuncture worked much better than doing nothing, and a little better than fake “sham” acupuncture [8]. The researchers, who supported the practice, said the effect is real but can’t be explained by needling alone [8]. It works, to some extent, but not for all the reasons its theory suggests. We’ll return to this later.</p><p>Then there’s tai chi, which I’ve come to respect most. A New England Journal of Medicine trial found it worked better than wellness education and stretching for fibromyalgia, a tough pain condition [9]. A bigger BMJ study showed tai chi was as effective as aerobic exercise [10]. A Cochrane review, our strictest evidence, found tai chi reduced falls in older adults by 19% [11]. For an aging executive or parent, fewer falls can mean the difference between staying independent and a hip fracture.</p><h2><strong>What Fails the Audit</strong></h2><p>After 2,000 years of searching, no one has ever found a meridian. Anatomists have looked for the channels where qi is supposed to flow and found nothing. Even acupuncture researchers agree there’s no physical structure matching the meridian map [12]. The lines on the chart aren’t in the body.</p><p>The data on needling tells a similar story. In a large German trial, 1,162 patients with chronic back pain got either real acupuncture or fake acupuncture, with needles placed randomly and shallowly [13]. Both groups improved, and both did better than standard drugs and physiotherapy. The difference between real and fake was just 3.4%, which wasn’t statistically significant [13]. If the “wrong” points work as well as the “right” ones, meridian theory isn’t the reason. Something else is at play.</p><p>There’s another issue for anyone who relies on Chinese research. A review of controlled trials found that 99% of studies published in China said the treatment worked [14]. Not just most.. almost all. When almost nothing ever fails, the research stops showing whether treatments actually work.</p><h2><strong>What Can Hurt You</strong></h2><p>The risks are real, and this is where the appeal of tradition has to end.</p><p>Some Chinese herbs contain aristolochic acid, a potent carcinogen so distinctive it leaves its own signature mutation in your DNA. In Taiwan, where these herbs were widely prescribed, researchers studying patients with upper urinary tract cancer found that 60% carried the chemical’s fingerprint in their DNA and 31% carried its signature mutation [15]. Taiwan has the world’s highest rate of that cancer [15]. These herbs cause cancer, traceably, at the level of the gene.</p><p>Contamination is common. In one review, a Taiwan survey found that 24% of Chinese herbal products contained undeclared pharmaceutical drugs, like corticosteroids, anti-inflammatories, and sedatives [16]. You might think you’re taking a gentle plant remedy, but you could be getting an unregulated dose of something else.</p><p>Some herbs are simply dangerous on their own. Ma huang, or ephedra, caused strokes, seizures, and heart problems so severe that the FDA banned it from supplements in 2004 [17].</p><p>The harm goes beyond the clinic. Demand for traditional remedies has pushed animals like the pangolin, rhino, and tiger toward extinction for their scales, horns, and bones. China banned the medicinal trade in tiger bone and rhino horn in 1993, but the pressure continues. The pangolin is now the most trafficked mammal in the world.</p><h2><strong>Where Our Own Medicine Runs Out</strong></h2><p>So why does any of this last? Why did a fairly skeptical doctor bring home a bag of scorpions and a story he still tells?</p><p>Part of the answer is uncomfortable, because it’s really about us.</p><p>When I was in that Beijing clinic, the doctor spent almost an hour with me before prescribing anything. He checked my tongue, held both wrists, and asked about my work, sleep, and previous illnesses. Compare that to today’s reality: in 67 countries, doctors in 18 of them, covering about half the world’s population, spend five minutes or less with each patient [18]. Even in well-funded places, an American study found doctors spend only 27% of their day with patients, and 49% on paperwork and screens [19].</p><p>Then there was my shoulder. He guessed a surgery he couldn’t have seen, and for years, I thought of it as a small miracle. But the more likely explanation is more interesting. He was a skilled observer who had examined thousands of bodies, looking at someone my age and build, with the signs of old contact sports and a guarded injury. He made some confident guesses; the ones that hit stand out, and the misses are forgotten. And he spent more time looking at me, calmly, than any doctor had in years. When you give someone that much attention, you notice things too.</p><p>Here’s something modern medicine is only now admitting: the attention itself is a treatment. In a Harvard trial, patients with irritable bowel syndrome were split into three groups: a waiting list, fake acupuncture alone, and fake acupuncture given by a warm, attentive practitioner [20]. Relief rates went from 28% on the waiting list, to 44% with the ritual, to 62% when a caring person delivered it [20]. The needles were fake in both groups, but the relationship made the difference.</p><p>The benefit came from simple things: time, ritual, and a caring person. Our five-minute, screen-focused system has quietly stopped offering all three. Now, Western medicine is trying to bring them back with new names like systems medicine, whole-person care, and the P4 model of prevention over rescue [21]. We’re reinventing the bedside manner we once cut to save time.</p><p>This belongs in the Recover pillar of my Upward ARC framework, and it matters more than most high performers admit. Recover means bringing the nervous system back to baseline: giving unhurried attention, resetting stress, and treating stress as a real factor, not just a personality trait. Movement, like tai chi, fits in Activate, alongside the one proven molecule from the tradition. The metaphysics doesn’t fit anywhere. That’s my edit.</p><h2><strong>Try This Today</strong></h2><p><strong>The Enforced Stillness.</strong> The most helpful thing in that clinic was being forced to stay still for two hours. Most high performers never plan rest, so set up something that makes you rest. Try one 90-minute block a week with no screen, no phone, and no agenda. A long walk without headphones counts. Lying on the floor counts. The key is to have a break from input.</p><p><strong>The Tai Chi Floor.</strong> Of all the traditional practices, tai chi has real studies behind it: it helps with pain, balance, fewer falls, and lower stress [9][10][11]. The studies used it twice a week. It’s gentle enough for anyone from 50 to 80, and it trains both balance and a calm nervous system. Try a class or a video, and give it eight weeks before deciding if it works for you.</p><p><strong>The Long Consult Rule.</strong> What worked in Beijing was unhurried attention, and you can get that at home if you ask. When something matters, book the longest appointment you can, write down your three main questions ahead of time, and don’t let the visit end with the doctor typing. If your system only gives you 7 minutes, find a way to get at least 45 once a year.</p><p><strong>The Natural-Label Audit.</strong> If you use herbal or traditional supplements, remember that “natural” is just a marketing term, not a safety guarantee. A quarter of these products contain undeclared pharmaceutical drugs [16], and some have a known carcinogen [15]. Only buy from suppliers who share third-party testing for contaminants. If a product can’t tell you exactly what’s in it, don’t take it.</p><h2><strong>The Bag in the Garden</strong></h2><p>The bag of scorpions is still in my house. Every so often, I move it, think about making the broth, imagine my wife’s reaction, and put it back.</p><p>I think about that afternoon more than I expected. The needles were probably just theater. The meridians weren’t real. The diagnosis was a skilled man making good guesses about a tired executive. But he did something no doctor had done for me in years: he made me lie still, doing nothing, for two hours. He saw a stressed, overworked man with a bad back and prescribed the one thing I’d never give myself.</p><p>That’s the part worth keeping: the stillness, the attention, the unhurried hour. The scorpions and the qi can be left behind.</p><p>Here’s my doctor’s edit on 5,000 years: keep the one proven molecule, keep the movement that’s backed by studies, and keep the unhurried hour that modern medicine lost. The rest can go out in the garden, where it belongs.</p><p>Stay healthy.</p><p>Andre</p><p>​<br>​</p><p>PS: I still try things on myself that I can’t fully explain, and I keep that bag as a reminder. If you know someone who swears by all of this, or someone who dismisses it, share this with them. Both are half right, and that’s what makes it interesting.</p><p>​</p><div><hr></div><p>​</p><h2><strong>References</strong></h2><p>[1] Unschuld, P. U. (2003). <em>Huang Di nei jing su wen: Nature, knowledge, imagery in an ancient Chinese medical text.</em> University of California Press.</p><p>[2] Taylor, K. (2005). <em>Chinese medicine in early communist China, 1945-1963: A medicine of revolution.</em> RoutledgeCurzon.</p><p>[3] World Health Organization. (2019). <em>WHO global report on traditional and complementary medicine 2019.</em> World Health Organization.</p><p>[4] World Health Organization. (2019). <em>International statistical classification of diseases and related health problems (11th ed.), Chapter 26: Supplementary chapter traditional medicine conditions, Module I.</em> World Health Organization.</p><p>[5] Zhang, Q., et al. (2021). An introduction to traditional Chinese medicine, including acupuncture. <em>The Anatomical Record, 304</em>(11), 2675-2682.</p><p>[6] Su, X.-Z., &amp; Miller, L. H. (2015). The discovery of artemisinin and the Nobel Prize in Physiology or Medicine. <em>Science China Life Sciences, 58</em>(11), 1175-1179.</p><p>[7] The Nobel Assembly at Karolinska Institutet. (2015). <em>The Nobel Prize in Physiology or Medicine 2015</em> [Press release].<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cDovL25vYmVscHJpemUub3Jn" target="_blank" rel="noopener noreferrer"> NobelPrize.org</a>.</p><p>[8] Vickers, A. J., Vertosick, E. A., Lewith, G., MacPherson, H., Foster, N. E., Sherman, K. J., Irnich, D., Witt, C. M., Linde, K., &amp; Acupuncture Trialists’ Collaboration. (2018). Acupuncture for chronic pain: Update of an individual patient data meta-analysis. <em>The Journal of Pain, 19</em>(5), 455-474.</p><p>[9] Wang, C., Schmid, C. H., Rones, R., Kalish, R., Yinh, J., Goldenberg, D. L., Lee, Y., &amp; McAlindon, T. (2010). A randomized trial of tai chi for fibromyalgia. <em>New England Journal of Medicine, 363</em>(8), 743-754.</p><p>[10] Wang, C., Schmid, C. H., Fielding, R. A., Harvey, W. F., Reid, K. F., Price, L. L., Driban, J. B., Kalish, R., Rones, R., &amp; McAlindon, T. (2018). Effect of tai chi versus aerobic exercise for fibromyalgia: Comparative effectiveness randomized controlled trial. <em>BMJ, 360</em>, k851.</p><p>[11] Sherrington, C., Fairhall, N. J., Wallbank, G. K., Tiedemann, A., Michaleff, Z. A., Howard, K., Clemson, L., Hopewell, S., &amp; Lamb, S. E. (2019). Exercise for preventing falls in older people living in the community. <em>Cochrane Database of Systematic Reviews,</em> (1), CD012424.</p><p>[12] Longhurst, J. C. (2010). Defining meridians: A modern basis of understanding. <em>Journal of Acupuncture and Meridian Studies, 3</em>(2), 67-74.</p><p>[13] Haake, M., Müller, H.-H., Schade-Brittinger, C., Basler, H. D., Schäfer, H., Maier, C., Endres, H. G., Trampisch, H. J., &amp; Molsberger, A. (2007). German Acupuncture Trials (GERAC) for chronic low back pain. <em>Archives of Internal Medicine, 167</em>(17), 1892-1898.</p><p>[14] Vickers, A., Goyal, N., Harland, R., &amp; Rees, R. (1998). Do certain countries produce only positive results? A systematic review of controlled trials. <em>Controlled Clinical Trials, 19</em>(2), 159-166.</p><p>[15] Chen, C.-H., Dickman, K. G., Moriya, M., Zavadil, J., Sidorenko, V. S., Edwards, K. L., Gnatenko, D. V., Wu, L., Turesky, R. J., Wu, X.-R., Pu, Y.-S., &amp; Grollman, A. P. (2012). Aristolochic acid-associated urothelial cancer in Taiwan. <em>Proceedings of the National Academy of Sciences, 109</em>(21), 8241-8246.</p><p>[16] Ernst, E. (2002). Adulteration of Chinese herbal medicines with synthetic drugs: A systematic review. <em>Journal of Internal Medicine, 252</em>(2), 107-113.</p><p>[17] Haller, C. A., &amp; Benowitz, N. L. (2000). Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. <em>New England Journal of Medicine, 343</em>(25), 1833-1838.</p><p>[18] Irving, G., Neves, A. L., Dambha-Miller, H., Oishi, A., Tagashira, H., Verho, A., &amp; Holden, J. (2017). International variations in primary care physician consultation time: A systematic review of 67 countries. <em>BMJ Open, 7</em>(10), e017902.</p><p>[19] Sinsky, C., Colligan, L., Li, L., Prgomet, M., Reynolds, S., Goeders, L., Westbrook, J., Tutty, M., &amp; Blike, G. (2016). Allocation of physician time in ambulatory practice: A time and motion study in 4 specialties. <em>Annals of Internal Medicine, 165</em>(11), 753-760.</p><p>[20] Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., Park, M., Rivers, A. L., McManus, C., Kokkotou, E., Drossman, D. A., Goldman, P., &amp; Lembo, A. J. (2008). Components of placebo effect: Randomised controlled trial in patients with irritable bowel syndrome. <em>BMJ, 336</em>(7651), 999-1003.</p><p>[21] Hood, L., &amp; Flores, M. (2012). A personal view on systems medicine and the emergence of proactive P4 medicine: Predictive, preventive, personalized and participatory. <em>New Biotechnology, 29</em>(6), 613-624.</p><p>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">This edition distinguishes historical systems, testable interventions, and product safety. The notes below tighten institutional, trial, and prevalence claims without changing the historical article.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>WHO and ICD-11:</strong> WHO reports that traditional medicine is used in 170 Member States. Reporting use is not an endorsement of efficacy. WHO also states that the ICD-11 traditional-medicine chapter neither judges nor endorses the scientific validity of a practice or intervention. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Artemisinin:</strong> The mortality estimates in the Nobel summary concern artemisinin-based combination therapy for malaria, not artemisinin used alone. Combination therapy matters because monotherapy can promote resistance. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Acupuncture:</strong> A 39-trial individual-participant meta-analysis found that acupuncture had a modest advantage over sham and a larger advantage over no-acupuncture controls for specified chronic pain conditions. This does not establish efficacy for every condition or validate a meridian anatomy. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Product adulteration:</strong> The often-quoted 24% adulteration result came from 2,609 samples referred by eight Taiwan hospitals because adulteration was suspected. It demonstrates a serious problem in that selected sample, not a worldwide prevalence for every Chinese herbal product. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>Exercise scope:</strong> Tai chi can be useful in selected populations and programs. No trial makes one frequency or format suitable for every adult aged 50 to 80. Balance, symptoms, comorbidity, supervision, and the purpose of the program affect safety and dose. <span class="correction-ref-links"><a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.who.int/standards/classifications/frequently-asked-questions/traditional-medicine" rel="external">World Health Organization. (n.d.). Traditional medicine: Frequently asked questions. https://www.who.int/standards/classifications/frequently-asked-questions/traditional-medicine</a></li><li id="correction-ref-2"><a href="https://www.nobelprize.org/prizes/medicine/2015/press-release/" rel="external">Nobel Prize Outreach. (2015). The Nobel Prize in Physiology or Medicine 2015: Press release. https://www.nobelprize.org/prizes/medicine/2015/press-release/</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/29198932/" rel="external">Vickers, A. J., Vertosick, E. A., Lewith, G., et al. (2018). Acupuncture for chronic pain: Update of an individual patient data meta-analysis. The Journal of Pain, 19(5), 455–474. https://doi.org/10.1016/j.jpain.2017.11.005</a></li><li id="correction-ref-4"><a href="https://pubmed.ncbi.nlm.nih.gov/9115061/" rel="external">Huang, W. F., Wen, K. C., &amp; Hsiao, M. L. (1997). Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. Journal of Clinical Pharmacology, 37(4), 344–350. https://doi.org/10.1002/j.1552-4604.1997.tb04312.x</a></li><li id="correction-ref-5"><a href="https://pubmed.ncbi.nlm.nih.gov/29563100/" rel="external">Wang, C., Schmid, C. H., Fielding, R. A., et al. (2018). Effect of tai chi versus aerobic exercise for fibromyalgia: Comparative effectiveness randomized controlled trial. BMJ, 360, k851. https://doi.org/10.1136/bmj.k851</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/traditional-chinese-medicine-evidence-and-safety">Traditional Chinese Medicine: Evidence, Safety, and Product Risk →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[The Hollow Win: What the Climb Costs You by Forty-Seven]]></title>
<description><![CDATA[You can win every game and feel nothing the next morning. The three inner drives behind midlife emptiness, and how to audit which one runs you.]]></description>
<link>https://www.andreheeg.com/archive/the-hollow-win-what-the-climb-costs</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-hollow-win-what-the-climb-costs</guid>
<pubDate>Sun, 31 May 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>It’s 1996. I’m seventeen, lying face down on a wrestling mat in a sports hall that smells like old leather and sweat. My coach presses his knee into my back.</p><p>“You break him, or he breaks you. There is no third option.”</p><p>I heard some version of that line four times a week starting at age twelve. By the time I stopped competing at twenty-five, it was second nature. Read the room. Find the leverage. Finish the point. Everything became a point: school, exams, even client meetings in my thirties.</p><p>Thirty years later, I’m sitting on a terrace in Malta with eight other men. Six are surgeons, and three run hospital departments. Each of us learned some version of what my coach taught me. In different places, we were all trained to find leverage and finish the point.</p><p>It’s Friday night. One of the men at the end of the table has a brain tumor that has come back. This trip is on his list. The surgeon with the longest CV refills his glass before his own.</p><p>There’s no leverage here. No point to finish. None of our training prepared us for tonight, and this is the only thing that matters.</p><h2>The Experiment on the Terrace</h2><p>For two days, I’ve watched nine versions of the same experiment.</p><p>Each of us was picked for the same trait, in our own way. You don’t run a department, build a practice, make partner, or close a Series B without it. Psychiatrist Paul Conti describes three drives that compete in every adult: Generative, the urge to create, contribute, and build something lasting; Aggressive, the energy to compete, control, assert, and accumulate; and Pleasure, the pull toward satisfaction and enjoyment [1].</p><p>In a healthy system, Generative is in charge. Aggressive and Pleasure are still there, but they support the one in the chair.</p><p>The corner office, senior partner role, chief surgeon position, and founder seat are all twenty-year filters for the opposite setup. They select for Aggressive being in charge. By forty-seven, your inner system has run this way for so long you don’t notice it. You think it’s just who you are.</p><p>That’s the experiment I’m watching this weekend: nine men trained in Aggressive, but none of them using it.</p><h2>The Three Drives</h2><p>Every adult has all three drives running at all times. The real question is which one is in charge.</p><p>The Generative drive builds, teaches, creates, and contributes. It writes the chapter that took three years to learn. It operates on the patient who can’t pay the full fee because the case is interesting and the family is scared. It stays the extra hour with the junior who’s going to leave the firm anyway. It grows with age because it doesn’t depend on winning.</p><p>The Aggressive drive engages with the world; not violence, but the urge to compete, control, defend, and take ground. Healthy people use it as a tool. It builds practices, closes deals, and runs operating rooms under pressure. When it’s in charge, every flat surface looks like a hill.</p><p>The Pleasure drive pulls us toward sensation, satisfaction, and enjoyment. The wine, the holiday, the meal, the achievement as a trophy. It’s useful when it serves the others, but when it’s in charge, it ends up consuming what it was supposed to enjoy.</p><p>Conti’s model is hierarchical. For mental health, Generative should be in charge, Aggressive provides the drive, and Pleasure adds flavor. The order matters [1].</p><h2>Why Aggressive Wins by Forty-Five</h2><p>Two forces come together to put Aggressive in charge by midlife. The first is selection.</p><p>The path to seniority in any high-stakes field is a twenty-year competition: medical school, residency, fellowship, attending, division chief; associate, manager, principal, partner; analyst, founder, exit, next company. At each stage, those with the most Aggressive drive move forward. Usually not the most generative or curious, but the most willing to compete, defend ground, and take the next hill.</p><p>The second force is neurobiological. Robert Sapolsky spent decades with a baboon troop in Kenya’s Masai Mara. In stable hierarchies, dominant animals carry the lowest cortisol and the lowest atherosclerosis incidence. The system rewards the position. In unstable hierarchies, where the dominants must constantly defend their standing, the pathology load inverts. The dominants now carry the most severe cardiovascular, immunological, and adrenocortical damage in the troop [2]. They keep the rank. The body pays for it.</p><p>Modern corporate, surgical, and professional hierarchies are always unstable. Markets shift. Boards reorganize. Partners get pushed out at fifty-five. Hospital departments change with every new chief executive.</p><p>Erik Erikson named the developmental cost seventy-five years ago. He called it stagnation. The forty-seven-year-old who has won every external game and stopped generating internally is in Erikson’s clinical category, not a metaphor [3]. The Aggressive-dominant operator wins the climb and stalls when he gets there.</p><h2>The Hollow Win</h2><p>The cost builds up quietly over decades. The data has names.</p><p>Steptoe, Deaton, and Stone looked at Gallup data from 160 countries and found a U-shaped curve for well-being. The lowest point is ages 45 to 54 in high-income English-speaking countries [4]. The time of peak organizational seniority matches the lowest point of personal experience.</p><p>Hedonic adaptation adds to this. In the classic 1978 study by Brickman, Coates, and Janoff-Bulman, both recent lottery winners and recent accident-paralysis victims returned toward baseline well-being within months [5]. The next title doesn’t really change things.</p><p>For me, the 1996 Kasser and Ryan paper stands out most. Adults who put extrinsic goals (financial success, image, social recognition) above intrinsic ones (self-acceptance, affiliation, community feeling) reported lower energy and more physical symptoms [6]. You can win the game and still lose your health, your relationships, and your sense of self the next morning.</p><p>Envy keeps coming up. Richard Smith and Sung Hee Kim defined it as feeling inferior, hostile, and resentful when someone else has something you want. Environments where people compare status (like partner tracks, boardrooms, or surgical conferences) make it worse [7]. The people you envy show you where you’re still keeping score.</p><p>Nora Volkow’s PET scans showed that repeated dopamine hits lower D2 receptors, and the reduction lasts for months [8]. Anna Lembke at Stanford described the pleasure-pain seesaw in her 2021 book: the more pleasure you get, the more pain you borrow from the future [9]. Wins bring less pleasure as time goes on. This holds for the drink, the deal, and the screen.</p><h2>What Generative Drive Produces</h2><p>The Harvard Grant Study started in 1938 with 268 sophomore men and ran for over seventy years. George Vaillant, who led the study from 1972 to 2004, reported in 2012 that the warmth of relationships at age 47 was a stronger predictor of flourishing later in life than income, social class, or IQ [10]. The usual Aggressive drive scorecards (salary, rank, cognitive ability) were measured and found less important.</p><p>Robert Waldinger, who leads the study now, has made this point many times: the quality of relationships at age 50 predicts physical health at age 80 better than cholesterol levels do [11]. Investments in the Generative drive add up over time. Aggressive drive scorecards don’t.</p><p>This idea has been measured directly. Dan McAdams’ Loyola Generativity Scale, validated for over thirty years, links generativity scores to life satisfaction, coherence, and meaning [12]. Generativity is an outcome, not just a value.</p><p>A 2016 meta-analysis of 10 studies and 136,265 people found that having a higher sense of purpose in life was associated with a 17% lower risk of death from any cause (RR 0.83, 95% CI 0.75-0.91) [13]. A 2019 JAMA Network Open study of 6,985 adults over 50 found that those with the lowest sense of purpose had more than twice the four-year mortality risk compared to those with the highest (HR 2.43, 95% CI 1.57-3.75) [14]. The Generative drive helps you live longer.</p><p>These ideas aren’t new. Deci and Ryan’s Self-Determination Theory lists autonomy, competence, and relatedness as the three basic psychological needs that predict well-being across cultures [15]. Csikszentmihalyi described flow as the state where skill meets challenge, creating lasting satisfaction unlike passive pleasure [16]. Frankl’s clinical observation from the camps, that the main human motivation is the will to meaning, underlies all of this [17].</p><p>This structure is older than any of us reading this.</p><h2>The Upward ARC</h2><p>This belongs in the Capacity pillar of my Upward ARC framework, the long arc of what you can know, decide, and become over thirty years. The second part is Recover. An Aggressive-dominant system runs on constant stress, and no amount of vacation, retreat, or executive coaching can fix that after the fact. The real decision about your system comes before any other change you try to make.</p><h2>Try This Today</h2><p>Five protocols. They cost time, not money. You don’t need a coach or therapist for any of them.</p><p><strong>The Three-Drive Inventory. </strong>Sit down with a notepad and look back at the last ninety days. Make three columns: Generative, Aggressive, Pleasure. Where did your hours, attention, and energy actually go? Be specific. Not just “leadership work,” but “the board prep that was really about not losing the chair.” Not just “client time,” but “the call I took on the holiday because I couldn’t stand the idea of someone else handling it.” The unbalanced output is your audit. Most senior leaders find the Generative column is only ten to twenty percent of the page.</p><p><strong>The Morning-After Test.</strong> Pick your three biggest wins from the past year. Without overthinking, write down how each one actually felt the next morning. If it felt flat, joyless, or like “what’s next,” that’s the Aggressive drive at work. Generative wins are remembered with warmth, not just relief. The pattern across your three wins is your audit.</p><p><strong>The Generative Slot.</strong> Set aside a recurring ninety-minute slot each week for something that’s only about contributing or creating. Teach a mentee who can’t promote you, write something, or build something for someone who won’t return the favor. This slot is sacred and doesn’t move for your calendar. After eight weeks, run the Morning-After Test on this slot and compare it to your Aggressive-drive wins.</p><p><strong>The Envy Audit.</strong> List the five most recent times you felt envy. Name the person, what they had, and what you felt. Conti says envy is the Aggressive drive without a chance to win. Your list shows where you’re still keeping score and which Generative slot might be missing from your week.</p><p><strong>The Two Cupboards.</strong> Take twenty minutes with just paper, no devices. Write down five things you’d still want to do if no one ever knew. Then list five things you spend a lot of time on that you’d stop tomorrow if no one ever saw. The gap between these lists shows who’s really running your life.</p><h2>Back to the Terrace</h2><p>There were nine men at the table on the terrace: the chiefs of surgery, the partners, and the man with the brain tumor. None of them got there without the trait my coach drilled into me back in 1996. But none of them were using it tonight.</p><p>In a healthy system, the Generative drive comes before the Aggressive drive. The Aggressive drive doesn’t disappear, but the order just changes. The surgeon who refilled the wine glass before his own is the same one who runs his department by Monday morning. The ability to take the hill is still there. It just isn’t in charge on a Friday night in Malta.</p><p>The leaders who age well, exit well, and enjoy what they built are the ones who do this audit at forty-seven, not sixty-seven. The Aggressive drive won’t give up control on its own. You have to move it.</p><p>For most of us, the climb picked for this trait so thoroughly that we mistake it for our character. That mistake matters. The Aggressive drive is just one of three, and it shouldn’t be in charge of any of us.</p><p>The friend at the end of the table laughs at something. The surgeon next to him passes him a piece of bread. The protocols above are a deliberate way back to what these nine men already had on Friday night.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><p>PS: If you read this and thought of a peer who has everything but feels nothing, please forward it to them. That’s how this newsletter grows, and it’s the only way I want it to.</p><div><hr></div><h2>References</h2><p>[1] Conti, P. (Guest), &amp; Huberman, A. (Host). (2023, September). <em>Guest series: Dr. Paul Conti on mental health</em> [Four-part audio podcast series]. Huberman Lab. https://www.hubermanlab.com/episode/guest-series-dr-paul-conti-how-to-understand-and-assess-your-mental-health</p><p>[2] Sapolsky, R. M. (2005). The influence of social hierarchy on primate health. <em>Science, 308</em>(5722), 648-652. https://doi.org/10.1126/science.1106477</p><p>[3] Erikson, E. H. (1950). <em>Childhood and society</em>. W. W. Norton.</p><p>[4] Steptoe, A., Deaton, A., &amp; Stone, A. A. (2015). Subjective wellbeing, health, and ageing. <em>The Lancet, 385</em>(9968), 640-648. https://doi.org/10.1016/S0140-6736(13)61489-0</p><p>[5] Brickman, P., Coates, D., &amp; Janoff-Bulman, R. (1978). Lottery winners and accident victims: Is happiness relative? <em>Journal of Personality and Social Psychology, 36</em>(8), 917-927. https://doi.org/10.1037/0022-3514.36.8.917</p><p>[6] Kasser, T., &amp; Ryan, R. M. (1996). Further examining the American dream: Differential correlates of intrinsic and extrinsic goals. <em>Personality and Social Psychology Bulletin, 22</em>(3), 280-287. https://doi.org/10.1177/0146167296223006</p><p>[7] Smith, R. H., &amp; Kim, S. H. (2007). Comprehending envy. <em>Psychological Bulletin, 133</em>(1), 46-64. https://doi.org/10.1037/0033-2909.133.1.46</p><p>[8] Volkow, N. D., Fowler, J. S., Wang, G. J., &amp; Swanson, J. M. (2004). Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. <em>Molecular Psychiatry, 9</em>(6), 557-569. https://doi.org/10.1038/sj.mp.4001507</p><p>[9] Lembke, A. (2021). <em>Dopamine nation: Finding balance in the age of indulgence</em>. Dutton.</p><p>[10] Vaillant, G. E. (2012). <em>Triumphs of experience: The men of the Harvard Grant Study</em>. Belknap Press of Harvard University Press.</p><p>[11] Waldinger, R. J., &amp; Schulz, M. S. (2023). <em>The good life: Lessons from the world’s longest scientific study of happiness</em>. Simon &amp; Schuster.</p><p>[12] McAdams, D. P., &amp; de St. Aubin, E. (1992). A theory of generativity and its assessment through self-report, behavioral acts, and narrative themes in autobiography. <em>Journal of Personality and Social Psychology, 62</em>(6), 1003-1015. https://doi.org/10.1037/0022-3514.62.6.1003</p><p>[13] Cohen, R., Bavishi, C., &amp; Rozanski, A. (2016). Purpose in life and its relationship to all-cause mortality and cardiovascular events: A meta-analysis. <em>Psychosomatic Medicine, 78</em>(2), 122-133. https://doi.org/10.1097/PSY.0000000000000274</p><p>[14] Alimujiang, A., Wiensch, A., Boss, J., Fleischer, N. L., Mondul, A. M., McLean, K., Mukherjee, B., &amp; Pearce, C. L. (2019). Association between life purpose and mortality among US adults older than 50 years. <em>JAMA Network Open, 2</em>(5), e194270. https://doi.org/10.1001/jamanetworkopen.2019.4270</p><p>[15] Deci, E. L., &amp; Ryan, R. M. (2000). The “what” and “why” of goal pursuits: Human needs and the self-determination of behavior. <em>Psychological Inquiry, 11</em>(4), 227-268. https://doi.org/10.1207/S15327965PLI1104_01</p><p>[16] Csikszentmihalyi, M. (1990). <em>Flow: The psychology of optimal experience</em>. Harper &amp; Row.</p><p>[17] Frankl, V. E. (2006). <em>Man’s search for meaning</em> (I. Lasch, Trans.). Beacon Press. (Original work published 1946)</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The language of a hollow win can be useful storytelling. The models used to interpret it should not be mistaken for diagnoses or settled biological explanations.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Drive model:</strong> Paul Conti's drive hierarchy is one clinician's conceptual framework. It is not a validated diagnostic system or a universal account of motivation. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Erikson:</strong> Erik Erikson described psychosocial stages, including generativity versus stagnation. He did not define the hollow win as a clinical category or diagnosis. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Lottery and paralysis study:</strong> The 1978 study was small and cross-sectional. It did not follow lottery winners and people with paralysis back to their own happiness baseline over several months. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Dopamine:</strong> Brain-imaging findings in addiction do not establish that ordinary achievement, business deals, or screens create the same dopamine adaptation. That comparison is metaphor, not a medical mechanism. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.hubermanlab.com/episode/guest-series-dr-paul-conti-how-to-understand-and-assess-your-mental-health" rel="external">Huberman Lab. (2023). Guest series: Dr. Paul Conti—How to understand and assess your mental health. https://www.hubermanlab.com/episode/guest-series-dr-paul-conti-how-to-understand-and-assess-your-mental-health</a></li><li id="correction-ref-2"><a href="https://dictionary.apa.org/generativity-versus-stagnation" rel="external">American Psychological Association. (n.d.). Generativity versus stagnation. In APA dictionary of psychology. https://dictionary.apa.org/generativity-versus-stagnation</a></li><li id="correction-ref-3"><a href="https://doi.org/10.1037/0022-3514.36.8.917" rel="external">Brickman, P., Coates, D., &amp; Janoff-Bulman, R. (1978). Lottery winners and accident victims: Is happiness relative? Journal of Personality and Social Psychology, 36(8), 917–927. https://doi.org/10.1037/0022-3514.36.8.917</a></li><li id="correction-ref-4"><a href="https://pubmed.ncbi.nlm.nih.gov/15464121/" rel="external">Volkow, N. D., Fowler, J. S., &amp; Wang, G.-J. (2004). The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies. Neuropharmacology, 47(Suppl. 1), 3–13. https://pubmed.ncbi.nlm.nih.gov/15464121/</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/midlife-drive-meaning-and-wellbeing">Midlife Drive, Meaning, and Wellbeing →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[At 47, I Was Supposed to Be at the Bottom. My 12-Year-Old Might Get There First.]]></title>
<description><![CDATA[For decades happiness bottomed out at 47. New data shows the floor moved to the young. What changed, and how to protect a midlifer and a teen at once.]]></description>
<link>https://www.andreheeg.com/archive/at-47-i-was-supposed-to-be-at-the</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/at-47-i-was-supposed-to-be-at-the</guid>
<pubDate>Sun, 24 May 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>It’s Friday night. We’re at the dinner table when Tilda says Jane’s name.</p><p>Jane (not her real name) is in her class. They sit together at lunch.</p><p>“Jane is out of school,” Tilda says. “She isn’t coming back this year.”</p><p>I ask what happened.</p><p>“She’s going into therapy.”</p><p>I put my fork down. Tilda leans back, balancing her chair on two legs. Her mother has reminded her not to do that so many times. I did not think I would hear that word from my 12-year-old, slipped so casually into a story about her friend.</p><p>“What do you mean, therapy?”</p><p>“She has a lot of dark thoughts. She’s depressed. She’ll be in a clinic.”</p><p>She says it like she’s telling me a friend has a dentist appointment. The words just sit there. Dark thoughts. Depressed. Clinic. When I was twelve, I didn’t have words like that for a friend.</p><p>I ask another question. She answers. We keep eating. Both the 12-year-old at our table and the one in the clinic know words I never did at their age.</p><p>After the kids go to bed, my wife and I stay at the table. It’s all we talk about.</p><h2><strong>Two Curves</strong></h2><p>I am 47. Every paper I read in residency said this would be the lowest year of my life.</p><p>The U-curve of life satisfaction is one of the most replicated findings in modern social science. Plot self-reported well-being across the human lifespan, and you get a U. High in your 20s, low in your late 40s, high again in your 70s. The shape is the headline.</p><p>Tilda is 12. Every recent paper says this is the edge of her own cliff.</p><p>There’s a turning point between us at this table. The low point I was told to expect at her age is where I am now. The low point she faces is right here, as she eats risotto and names a friend who is being treated for depression.</p><p>Both stories matter. Most of what I learned about midlife came from the curve I was taught. What I see now, in friends raising teens, is shaped by a curve no textbook has described yet.</p><p>This piece is about both.</p><h2><strong>The Floor I Was Taught</strong></h2><p>The U-curve found its modern shape in the work of David Blanchflower at Dartmouth. His 2021 paper in the <em>Journal of Population Economics</em> pooled data from 145 countries and 14 survey series and found the average minimum at age 46.7 in advanced economies and 49.9 in developing ones [1]. Whatever sample, whatever instrument, whatever decade, the U showed up again and again.</p><p>The pattern persisted after controlling for income, marriage, employment, and health. A separate 2010 <em>PNAS</em> paper from Stone, Schwartz, Broderick, and Deaton tracked psychological well-being across 340,847 US adults: daily stress peaked in the 20s and declined with age, but worry peaked around age 50 [2]. The 47-year-old reads as the most worried adult in the room because she is.</p><p>Why 47, specifically? The drivers stack in the same year. Children are still dependent, parents are starting to decline, both at once. Career complexity peaks: senior responsibility, the narrowing pyramid, the colleagues who were not going to make partner now know. Hedonic adaptation is maxed out. The aspiration-reality gap has nowhere left to hide. The first funerals shift from grandparents to peers. The hours do not lengthen. The demands do.</p><p>The most striking confirmation came from chimpanzees. In 2012, Weiss, King, and colleagues published a <em>PNAS</em> paper on 508 great apes [3]. Caretakers rated each animal’s well-being. The chimps and orangutans showed the same U-shape, with a low point at their species-equivalent midlife. The apes had no mortgage and no career. The U was older than either.</p><p>Not everyone bought it. Frijters and Beatton (2012) showed the U flattened in within-person data [4]. Cheng, Powdthavee, and Oswald (2017) reported four longitudinal panels and a within-person nadir at ages 40 to 42 [5]. The U held.</p><p>For my generation of doctors, the U-curve was a comfort. If you hit the floor, you knew there was a way back up.</p><h2><strong>The Floor That Moved</strong></h2><p>In August 2025, Blanchflower himself published the obituary of his own curve.</p><p>The paper, published in <em>PLOS One</em>, was titled “<em>The declining mental health of the young and the global disappearance of the unhappiness hump shape in age”</em> [6]. Across the BRFSS (US, 1993 to 2024), UKHLS (UK, 2009 to 2022), and the Global Minds Project (44 countries, 1.7 million observations), the hump shape was gone. Ill-being now decreases monotonically with age. The youngest people are the unhappiest. The 47-year-olds are no longer at the bottom because the bottom moved.</p><p>These are the numbers to remember.</p><p>Despair among US women under 25 rose from 5.6% in 2009 to 9.3% in 2023/24. Among UK women under 25, the same measure went from 4.4% to 12.7%. Across the 44-country Global Minds dataset, 48% of under-25s are now clinically at-risk, 13.4% classified as distressed.</p><p>A companion working paper by Twenge and Blanchflower (2025) examined six English-speaking countries (US, UK, Canada, Australia, Ireland, and New Zealand) and found the U-shape had gone in all six [7]. Young adults’ life satisfaction has fallen sharply across all six since around 2014. The Anglo-Nordic axis is where the floor moved first. The global generalization rests on thinner evidence than the US/UK claim, but the direction is consistent.</p><p>The person who shaped the U-curve is now the one closing the chapter.</p><h2><strong>Where the Descent Begins</strong></h2><p>The empirical bottom of the new curve lies in the 18-24 band. The descent begins earlier.</p><p>The CDC’s 2023 Youth Risk Behavior Survey reported that 52.6% of US female high school students experienced persistent sadness or hopelessness in the past year. 27.1% seriously considered suicide. 12.6% attempted [8]. Half the girls are feeling it. A quarter considering it. One in eight is trying.</p><p>The US Surgeon General’s 2023 advisory documented the exposure: 95% of US teens 13 to 17 use social media, a third “almost constantly,” and more than three hours a day doubles the risk of depression and anxiety symptoms [9]. Pew Research, surveying US teens in 2024 (published April 2025), found 48% of them now say social media has a “mostly negative” effect on others their age, up from 32% in 2022 [10]. The kids themselves are naming it.</p><p>The <em>Lancet Psychiatry</em> Commission on Youth Mental Health (McGorry et al., 2024) synthesized the international evidence across more than 20 countries and called the deterioration an early warning signal accelerating across two decades, predating COVID but worsened by it [11].</p><p>Jane is what the data describes. Tilda stands at the edge.</p><h2><strong>What Is Driving It</strong></h2><p>The trend is real. The mechanism is contested.</p><p>The strongest peer-reviewed causal evidence is Braghieri, Levy, and Makarin (2022) in the <em>American Economic Review</em> [12]. They used the staggered rollout of Facebook across 775 US colleges between 2004 and 2006 as a natural experiment. When Facebook arrived on a campus, the share of students with severe depression rose by about 7%. Generalized anxiety disorder rose by about 20%. A natural experiment with random timing of treatment is as close to a causal claim as a social scientist gets.</p><p>The synthesizing hypothesis lives in Jonathan Haidt’s 2024 book <em>The Anxious Generation</em> [13]. The argument is that phone-based childhood replaced play-based childhood, with early adolescence as the most vulnerable window. Girls take the worst of the social-comparison and body-dysmorphia load. Boys retreat into gaming and pornography. The losses are different. The neural substrate is the same.</p><p>One layer specific to this audience: Suniya Luthar’s work on affluent-youth distress (Luthar &amp; Latendresse, 2005) [14]. Children of high-achieving parents show elevated rates of anxiety, depression, and substance use compared to peers. The drivers Luthar identified (achievement pressure and parental isolation) predate the smartphone era. They compound the load.</p><p>The counter-position is in <em>Nature</em>. Candice Odgers (2024) argued that most empirical evidence shows small or null effects, that the smartphone-causation thesis outruns its data, and that structural causes (post-2008 precarity, climate anxiety, declining civic infrastructure) may be undercounted [15]. Orben and Przybylski (2019) in <em>Nature Human Behaviour</em> found that digital technology use explains roughly 0.4% of variance in adolescent well-being [16]. The mechanism is contested even when the trend is not.</p><p>If your child is at this table, all three pressures are here at once.</p><h2><strong>The Upward ARC</strong></h2><p>This sits in the Capacity pillar of my Upward ARC framework. The long arc of what you can know, decide, and become over thirty years. Recover is the second pillar. The infrastructure that lets the climb back happen at all.</p><p>Lachman, Teshale, and Agrigoroaei (2015) identified the protective factors that predict midlife recovery: sense of control, physical activity, and social engagement [17]. My generation needs them for the climb back. She has to build the foundation for the first time. The protocols below are split for that reason.</p><h2><strong>Try This Today</strong></h2><p><strong>The Floor Acknowledgment.</strong> Say where you are. The floor is a real dip with a known shape and a real way back up. Calling it a crisis leads to the wrong choices: the convertible, the affair, the boat. Calling it a floor leads to the right ones: the protective factors, the relationships you still have, the work that still matters. Different posture, different next step.</p><p><strong>The Protective Three.</strong> Lachman’s factors, weekly cadence. Sense of control: one immovable 90-minute block this week that is yours. Physical activity: 150 minutes of moderate-intensity work across the week, the WHO floor. Social engagement: one in-person conversation with someone outside your work circle, this week.</p><p><strong>The Aspiration-Reality Audit.</strong> One scheduled hour, no device, paper, and pen. Two columns. What you thought at 30, you would have by now. What you actually have. The gap is the source of the dip. Engage it honestly. The 47-year-olds who climb back are the ones who do this audit on purpose.</p><p><strong>The Phone-Free Bedroom (for the parent).</strong> The charger lives in the kitchen. The phone is not in the child’s bedroom overnight. The Surgeon General advisory is explicit on this one because the sleep displacement effect is among the cleanest mechanisms we have. The conversation with your 12-year-old is not optional. The “her phone, her choice” position is what the data calls a mistake.</p><p><strong>The In-Person Calendar (for the parent).</strong> Restore the lost hours deliberately. One sleepover, one in-person hang, one unmediated weekend afternoon per week. Calendar them. The protective effect of in-person socialization runs throughout the literature. “She will find her friends online” is the default that is hurting her.</p><h2><strong>Back to the Table</strong></h2><p>The conversation ends. Tilda is in bed. Her chair is back on all four legs. The dishwasher hums in the background.</p><p>My wife and I stay at the table. We talk about a 12-year-old we love who now uses the words of a 25-year-old in therapy, and about her friend who already has the diagnosis. The curve I expected at her age was still 35 years away. The curve she faces was never in any chart I saw in residency.</p><p>The work is bigger than this dinner table. It is also just as small as this dinner table.</p><p>For the 47-year-olds: the floor is real, the climb back is proven, the steps are simple, and the work is the work. For parents of 12-year-olds: the protective factors are the same, but you have to build the foundation, and the window is now.</p><p>Both happen at the same table.</p><p>Stay healthy.</p><p>Andre</p><p>​<br>​<br>​</p><p>PS: If you read this and you are either standing at the empirical floor of the old curve or raising a kid at the cliff edge of the new one, forward it to one parent of a teenager you trust. The conversation my wife and I had at that table after the kids were in bed is the one they may not have had yet.</p><p>​</p><div><hr></div><h2><strong>References</strong></h2><p>[1] Blanchflower, D. G. (2021). Is happiness U-shaped everywhere? Age and subjective well-being in 145 countries. <em>Journal of Population Economics, 34</em>(2), 575-624.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMDcvczAwMTQ4LTAyMC0wMDc5Ny16" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1007/s00148-020-00797-z</a>​</p><p>[2] Stone, A. A., Schwartz, J. E., Broderick, J. E., &amp; Deaton, A. (2010). A snapshot of the age distribution of psychological well-being in the United States. <em>Proceedings of the National Academy of Sciences, 107</em>(22), 9985-9990.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwNzMvcG5hcy4xMDAzNzQ0MTA3" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1073/pnas.1003744107</a>​</p><p>[3] Weiss, A., King, J. E., Inoue-Murayama, M., Matsuzawa, T., &amp; Oswald, A. J. (2012). Evidence for a midlife crisis in great apes consistent with the U-shape in human well-being. <em>Proceedings of the National Academy of Sciences, 109</em>(49), 19949-19952.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwNzMvcG5hcy4xMjEyNTkyMTA5" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1073/pnas.1212592109</a>​</p><p>[4] Frijters, P., &amp; Beatton, T. (2012). The mystery of the U-shaped relationship between happiness and age. <em>Journal of Economic Behavior &amp; Organization, 82</em>(2-3), 525-542.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvai5qZWJvLjIwMTIuMDMuMDA4" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1016/j.jebo.2012.03.008</a>​</p><p>[5] Cheng, T. C., Powdthavee, N., &amp; Oswald, A. J. (2017). Longitudinal evidence for a midlife nadir in human well-being: Results from four data sets. <em>The Economic Journal, 127</em>(599), 126-142.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExMTEvZWNvai4xMjI1Ng==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1111/ecoj.12256</a>​</p><p>[6] Blanchflower, D. G., Bryson, A., &amp; Xu, X. (2025). The declining mental health of the young and the global disappearance of the unhappiness hump shape in age. <em>PLOS One, 20</em>(8), e0327858.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEzNzEvam91cm5hbC5wb25lLjAzMjc4NTg=" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1371/journal.pone.0327858</a>​</p><p>[7] Twenge, J. M., &amp; Blanchflower, D. G. (2025). <em>Declining life satisfaction and happiness among young adults in six English-speaking countries</em> (NBER Working Paper No. 33490). National Bureau of Economic Research.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjMzODYvdzMzNDkw" target="_blank" rel="noopener noreferrer"> https://doi.org/10.3386/w33490</a>​</p><p>[8] Centers for Disease Control and Prevention. (2024). Mental health and suicide risk among high school students and protective factors: Youth Risk Behavior Survey, United States, 2023. <em>MMWR Supplements, 73</em>(4), 79-86.</p><p>[9] Office of the U.S. Surgeon General. (2023). <em>Social media and youth mental health: The U.S. Surgeon General’s advisory</em>. U.S. Department of Health and Human Services.</p><p>[10] Faverio, M., &amp; Sidoti, O. (2025, April 22). <em>Teens, social media and mental health</em>. Pew Research Center.</p><p>[11] McGorry, P. D., Mei, C., Dalal, N., Alvarez-Jimenez, M., Blakemore, S.-J., Browne, V., Dooley, B., Hickie, I. B., Jones, P. B., McDaid, D., Mihalopoulos, C., Wood, S. J., … Killackey, E. (2024). The Lancet Psychiatry Commission on youth mental health. <em>The Lancet Psychiatry, 11</em>(9), 731-774.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvUzIyMTUtMDM2NigyNCkwMDE2My05" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1016/S2215-0366(24)00163-9</a>​</p><p>[12] Braghieri, L., Levy, R., &amp; Makarin, A. (2022). Social media and mental health. <em>American Economic Review, 112</em>(11), 3660-3693.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEyNTcvYWVyLjIwMjExMjE4" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1257/aer.20211218</a>​</p><p>[13] Haidt, J. (2024). <em>The anxious generation: How the great rewiring of childhood is causing an epidemic of mental illness</em>. Penguin Press.</p><p>[14] Luthar, S. S., &amp; Latendresse, S. J. (2005). Children of the affluent: Challenges to well-being. <em>Current Directions in Psychological Science, 14</em>(1), 49-53.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExMTEvai4wOTYzLTcyMTQuMjAwNS4wMDMzMy54" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1111/j.0963-7214.2005.00333.x</a>​</p><p>[15] Odgers, C. L. (2024). The great rewiring: Is social media really behind an epidemic of teenage mental illness? <em>Nature, 628</em>(8006), 29-30.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMzgvZDQxNTg2LTAyNC0wMDkwMi0y" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1038/d41586-024-00902-2</a>​</p><p>[16] Orben, A., &amp; Przybylski, A. K. (2019). The association between adolescent well-being and digital technology use. <em>Nature Human Behaviour, 3</em>(2), 173-182.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMzgvczQxNTYyLTAxOC0wNTA2LTE=" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1038/s41562-018-0506-1</a>​</p><p>[17] Lachman, M. E., Teshale, S., &amp; Agrigoroaei, S. (2015). Midlife as a pivotal period in the life course: Balancing growth and decline at the crossroads of youth and old age. <em>International Journal of Behavioral Development, 39</em>(1), 20-31.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExNzcvMDE2NTAyNTQxNDUzMzIyMw==" target="_blank" rel="noopener noreferrer"> https://doi.org/10.1177/0165025414533223</a>​</p><p>​<br>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">Youth mental health deserves careful attention. Population averages and social-media studies do not predict one child's outcome or establish a universal age or screen threshold.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>The midlife floor:</strong> A U-shaped age pattern appears in many population datasets, but its shape and lowest point vary by country, cohort, health, employment, and time period. Age 47 is not a personal biological deadline. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Facebook rollout:</strong> The study used the staggered rollout of Facebook across colleges as a quasi-experimental natural experiment. Colleges and students were not randomly assigned, and the reported changes should not be restated as simple population prevalences of severe depression or generalized anxiety. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Screen time:</strong> More than three hours of social media use has been associated with poorer mental-health outcomes in some adolescent studies. The evidence does not establish a universal threshold or diagnose harm in an individual child. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Suicide statistics:</strong> The cited CDC estimates apply to surveyed US high-school students, specific questions, and a defined period. They should not be generalized to all children or countries. Immediate risk or thoughts of self-harm require urgent local professional help. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/32929308/" rel="external">Blanchflower, D. G. (2021). Is happiness U-shaped everywhere? Age and subjective well-being in 145 countries. Journal of Population Economics, 34, 575–624. https://pubmed.ncbi.nlm.nih.gov/32929308/</a></li><li id="correction-ref-2"><a href="https://doi.org/10.1257/aer.20211218" rel="external">Braghieri, L., Levy, R., &amp; Makarin, A. (2022). Social media and mental health. American Economic Review, 112(11), 3660–3693. https://doi.org/10.1257/aer.20211218</a></li><li id="correction-ref-3"><a href="https://www.hhs.gov/sites/default/files/sg-youth-mental-health-social-media-advisory.pdf" rel="external">Office of the U.S. Surgeon General. (2023). Social media and youth mental health: The U.S. Surgeon General’s advisory. https://www.hhs.gov/sites/default/files/sg-youth-mental-health-social-media-advisory.pdf</a></li><li id="correction-ref-4"><a href="https://www.cdc.gov/mmwr/volumes/73/su/su7304a9.htm" rel="external">Verlenden, J. V., Fodeman, A., Wilkins, N., et al. (2024). Mental health and suicide risk among high school students and protective factors—Youth Risk Behavior Survey, United States, 2023. MMWR Supplements, 73(4), 79–86. https://www.cdc.gov/mmwr/volumes/73/su/su7304a9.htm</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/life-satisfaction-youth-distress-and-screens">Life Satisfaction, Youth Distress, and Screen-Time Evidence →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[The Twenty Percent: Where AI Stops and Your Doctor Starts]]></title>
<description><![CDATA[ChatGPT handles 80% of what your doctor does with your bloodwork. The 20% it misses can cost you a decade, and the nightly habit wrecking your sleep.]]></description>
<link>https://www.andreheeg.com/archive/the-twenty-percent-where-ai-stops</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-twenty-percent-where-ai-stops</guid>
<pubDate>Sun, 17 May 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>It’s 7:55 in the hotel breakfast room, day three of the global partner meeting. Over two thousand people are here, riding elevators, picking up badges, ordering coffees they’ll leave unfinished. At my table, there are four of us. Eggs and bacon on our plates, two coffee refills, a phone face down next to the salt and pepper.</p><p>The senior partner across from me, maybe mid-fifties, picks up his phone, checks the screen, and places it on the napkin in front of me. His latest annual physical is open in ChatGPT, the AI’s answer in blue under the labs. He says, Tell me what I’m missing.</p><p>I read through it. The numbers are his. The interpretation is solid. The recommendations aren’t quite what I’d give.</p><p>I look up. He’s watching my face, like clients do when the slides go silent. Three things are obvious. He’s got the right instinct. He’s reading his own body the way he reads a P&amp;L. The tool covers about 80% of what a good doctor would do for him, without needing to fly anywhere. The missing 20% is what can cost you years, a decade from now, if nobody calls it out.</p><p>“What’s it not catching?” he says. The bacon is getting cold.</p><h2><strong>The Week That Made the Question</strong></h2><p>This is the conversation of the week. Two thousand partners in San Francisco for our annual offsite. AI is the topic in every panel, every hallway, every drink. The questions keep landing with me.</p><p>I’ve been on both sides of this all week. Bloodwork drawn. DEXA scan two blocks away. In my hotel room at 10:47 pm, lab dashboard open, Claude on my MacBook, checking where my markers line up beyond just a normal range. The results came back. Ten years ago, this would have meant a long trip to the doctor and a substantial bill.</p><p>Two truths from this week. The access upgrade is the biggest expansion of clinical reasoning for patients in 50 years. The new cognitive tax is real. The layer AI changes is narrower than the conference rooms make it sound.</p><h2><strong>Where the Model Wins</strong></h2><p>Start with imaging and the trace. This is where the evidence is clearest.</p><p>A 2017 <em>Nature</em> paper trained a convolutional network on 129,450 images and matched 21 board-certified dermatologists in diagnosing biopsy-proven melanoma [1]. A 2019 <em>Nature Medicine</em> deep neural network beat the average cardiologist on 12 rhythm classes across 91,232 single-lead ECGs, achieving F1 0.837 vs 0.780 [2]. A Mayo AI-ECG screen for asymptomatic left-ventricular dysfunction achieved an AUC of 0.93, a better screening test than mammography (0.85) or cervical cytology (0.70) [3]. A Google Health mammography system reduced false positives by 5.7% and false negatives by 9.4% versus US radiologists [4]; <em>Nature</em> published a reproducibility challenge the same year, so cite the headline with the caveat.</p><p>That’s the specialist layer. The harder part is that the model now matches primary care on the conversational side.</p><p>A 2020 dermatology system achieved top-1 accuracy of 0.66, compared with 0.44 for primary care physicians, across conditions accounting for 80% of primary-care visits [5]. Med-PaLM 2 hit 86.5% on USMLE-style questions; physicians preferred its consumer-question answers to physician-written ones on eight of nine clinical-utility axes [6]. GPT-4 achieved 57% accuracy in diagnosing NEJM clinicopathologic cases, outperforming 99.98% of simulated human readers [7]. Google’s AMIE, in a double-blind OSCE with 159 cases, beat 20 primary care physicians on 30 of 32 specialist-rated axes [8]. A 2025 <em>NEJM AI</em> RCT of an AI therapy chatbot reported a 51% reduction in depression symptoms over 4 weeks; therapeutic alliance comparable to that of human clinicians [9].</p><p>This is what the phone in the senior partner’s hand does. He uploads his ECG strip, maybe from his Apple Watch. It’s real. The model works.</p><h2><strong>The Twenty Percent</strong></h2><p>The opener made a promise. Here’s what it is.</p><p><strong>The de-prescribing layer.</strong> I’ve reviewed a senior executive’s medication list and asked the basic questions. The statin started in 2014, twelve years after the event. Is anyone planning to revisit? The PPI for reflux that cleared up in 2019. Still needed? The beta-blocker for situational anxiety from 2017. Has anyone looked at it this decade? AI adds to the list. The clinician who knows your story edits it down.</p><p><strong>The hands-on layer.</strong> Roughly 1 in 20 adult men has a thyroid nodule that you can feel that’s never been imaged. A hand exam detects tendon xanthomas, a sign of inherited dyslipidemia, before the lipid panel results come back. The difference between standing and sitting blood pressure is a frailty marker you won’t see on the panel. None of this is in the PDF you uploaded.</p><p><strong>The non-quantifiable signal.</strong> The patient who pauses when you ask about alcohol. The wife who insisted on the appointment. Fingers tapping on the chair. The way he says the kids are fine three times. AI gets data. The clinician gets the person.</p><p><strong>Realistic behavior change.</strong> A good doctor knows this person, with this calendar, this travel, this marriage, won’t do 14 things. They’ll do one. The doctor picks which lever to move.</p><p>From my week: My DEXA shows total body fat at the 6th percentile for men forty-five to forty-nine (13.1%). Visceral fat at the 39th (VAT mass 0.6kg or 639cm³). The model finds the mismatch. I’m carrying more visceral fat than you’d expect for how lean I am (leaner than 94% of men my age). Probably genetic; central adiposity runs in my family. The doctor knows what to do: a specific cardio plan, watch ApoB and insulin trends, and factor in family history on Lp(a) no matter the number. AI spots the pattern. The clinician knows what it means for me.</p><p>A coda on what the model gets wrong. All four major LLMs returned race-based medicine errors on clinical questions [10]. Medical hallucination benchmarks find models confidently endorsing wrong multiple-choice answers even with “none of the above” available [11]. USMLE-style benchmarks miss the clinical dialogue and longitudinal reasoning that real care requires [12]. And the human-in-the-loop is poorly trained: in a 2024 <em>JAMA Network Open</em> trial, physicians plus GPT-4 scored 76% on diagnostic reasoning; GPT-4 alone scored 92% [13]. The model has the capability that the clinician has not yet extracted.</p><h2><strong>The Cognitive Tax</strong></h2><p>A breakfast later, a different partner. He looks gray. That’s what happens when you sleep five hours for six nights. He admits he’s been asking Claude one more thing every night until 1 am this week. Eight specific things. None moved.</p><p>The cost. Attention residue is the measurable performance drag when you switch from an unfinished Task A to a new Task B; the cleaner the close-out of A, the less the drag [14]. Cognitive offloading is the broader pattern: when future access is expected, recall of the information drops, and recall of where to find it rises [15], driven by metacognitive misjudgment in which we offload even when internal cognition would be more accurate [16]. Interrupted work finishes faster at the same quality level, but at higher stress and frustration [17].</p><p>Then sleep. Four hours of evening iPad reading in a 2015 <em>PNAS</em> study suppressed melatonin by 55% and delayed circadian phase by over ninety minutes compared to print [18]. Late-night work-related smartphone use among mid- and high-level managers reduced sleep and increased next-morning depletion, more than for TV, laptop, or tablet use [19]. The evidence is smartphone-specific. The mechanism is the same.</p><h2><strong>The Fourteen Vials</strong></h2><p>Three days before the breakfast, at a Quest Diagnostics lab, the phlebotomist labeled the last of 14 vials and pointed me to the bathroom. The blood draw took two minutes. The urine cup would take 90 seconds.</p><p>I came out of the bathroom, and she was on the phone.</p><p>I didn’t need to hear the words. Her shoulders told me. She was on the phone with her supervisor. Behind her, the 14 vials of my blood were still lined up on the counter like a teaching demo. The reagent for one of the assays was missing from the kit. The panel couldn’t be run. They apologized. Could I come back tomorrow.</p><p>I came back the next day. The other arm. Two more minutes. Another bathroom trip. This time, the reagent was there. Somewhere in a centrifuge, my 100+ biomarkers became data.</p><p>This is the part the AI conversation in San Francisco kept missing. At least in health.</p><p>The model on my phone reads 100 biomarkers for $20 a month. Function Health, through Quest, runs the panel for a dollar a day. The interpretation and the test are now cheap. What isn’t cheap or automated is the person who puts the needle in your arm. The phlebotomist who finds your vein on the first try while you look away. Who tells you to keep breathing while she’s doing her thing. Who knows which vial will get agitated and which won’t. Who calls her supervisor when the reagent is missing. Nobody has built an AI for the inside of your elbow (yet).</p><p>The bottleneck didn’t disappear. It moved.</p><p>This sits in the Capacity pillar of my Upward ARC framework, the long arc of what you can know, decide, and do for yourself over thirty years. The second tether is Recover. Expanded medical reasoning is useless if running it every night costs you the sleep and parasympathetic foundation on which everything else depends. Both halves are the same edit. Be deliberate about what you let into your head, and when you let it out.</p><h2><strong>Try This Today</strong></h2><p><strong>Build the Baseline First.</strong> Before you paste a lab into the model, build your context doc. AI without context defaults to population norms, which is the worst answer for a senior executive. Write three sections and save them. <em>Family history</em>: cause and age of death for grandparents and parents, first-degree relatives’ chronic conditions, and any cardiovascular event under sixty. <em>Current meds and supplements</em>: every pill, every dose, since when, why. <em>Lifestyle context</em>: work schedule including travel, sleep timing, training routine, alcohol honestly, diet, and mental state. Past data points go here too: prior bloodwork, BP, and weight trends, imaging. Save it as your patient context prompt. Add the question that matters for the next ten years: <em>what biomarkers should I track in future readings so the next interpretation has trajectory, not just snapshots?</em> Everything else depends on it.</p><p><strong>The Six-Question Prompt.</strong> With the baseline set, when new labs or imaging come in, ask these: <em>Trajectory, not snapshot. Family history is weighted on the markers near the top of the panel. What tests are missing that I should request. Cross-correlations between markers, the syndrome that a single marker might miss. De-prescribing review. The one or two changes that would move the most.</em> The model does useful work on questions one to four and decent work on five and six. The doctor’s edit on five and six is in your physical exam. Bring both.</p><p><strong>The Physical-First Rule.</strong> AI doesn’t replace the annual physical with a doctor who puts hands on you. The orthostatic blood pressure, the thyroid check, the hand exam, the conversation where you finally say what you haven’t told a GP in 15 years. Do both. AI interprets what the physical produces. The 20% is in the room.</p><p><strong>The AI Curfew.</strong> No LLM after 9 pm on a workday. I spend six to eight hours a day in Claude Code right now. The capabilities are addictive. I learn, I experiment, I build. It’s a tool. Without boundaries, it turns into a video game. The same discipline that keeps your twelve-year-old off Fortnite at 9 pm applies to you and the model. It’ll be there at 7 am, with a clearer head, not at the cost of your sleep.</p><p><strong>The Deliberate-Tool Rule.</strong> Don’t use five AI tools at once. Pick one or two and go deep. Learn their prompt patterns, their failure modes, your workflow. The knowledge transfers to other tools later. Depth beats breadth.</p><h2><strong>Back to the Breakfast Room</strong></h2><p>The senior partner is still waiting. I put my coffee down. <em>Ask it three things it did not ask you</em>, I tell him. Family history<em> weighting on the markers near the top of the panel. What it would take off your medication list, not just add to it. What test it would order if it were sitting across from you.</em> He pulls up ChatGPT and starts typing. The bacon is cold now.</p><p>This is the wave for the corner office’s relationship with its own body. Done well, it’s the biggest gift of clinical reasoning to the senior executive in 50 years. The second opinion you waited 6 weeks for is now available at 7 am, between a board call and a flight. Done badly, it’s a new cortisol drip with no off switch.</p><p>The senior executives who win this decade will be the ones who use it well and know when to turn it off. That’s one skill, not two.</p><p>Stay healthy.</p><p>Andre</p><p>PS: If you read this and you’re either anything like the partner who got 80% from ChatGPT or the partner asking Claude at 1 in the morning, forward it to one peer on the other side of that line. That’s how this newsletter grows, and it’s the only way I want it to.</p><div><hr></div><h2><strong>References</strong></h2><p>[1] Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., &amp; Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. <em>Nature, 542</em>(7639), 115-118.</p><p>[2] Hannun, A. Y., Rajpurkar, P., Haghpanahi, M., Tison, G. H., Bourn, C., Turakhia, M. P., &amp; Ng, A. Y. (2019). Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. <em>Nature Medicine, 25</em>(1), 65-69.</p><p>[3] Attia, Z. I., Kapa, S., Lopez-Jimenez, F., McKie, P. M., Ladewig, D. J., Satam, G., Pellikka, P. A., Enriquez-Sarano, M., Noseworthy, P. A., Munger, T. M., Asirvatham, S. J., Scott, C. G., Carter, R. E., &amp; Friedman, P. A. (2019). Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. <em>Nature Medicine, 25</em>(1), 70-74.</p><p>[4] McKinney, S. M., Sieniek, M., Godbole, V., Godwin, J., Antropova, N., Ashrafian, H., Back, T., Chesus, M., Corrado, G. S., Darzi, A., Etemadi, M., Garcia-Vicente, F., Gilbert, F. J., Halling-Brown, M., Hassabis, D., Jansen, S., Karthikesalingam, A., Kelly, C. J., King, D., … Shetty, S. (2020). International evaluation of an AI system for breast cancer screening. <em>Nature, 577</em>(7788), 89-94.</p><p>[5] Liu, Y., Jain, A., Eng, C., Way, D. H., Lee, K., Bui, P., Kanada, K., de Oliveira Marinho, G., Gallegos, J., Gabriele, S., Gupta, V., Singh, N., Natarajan, V., Hofmann-Wellenhof, R., Corrado, G. S., Peng, L. H., Webster, D. R., Ai, D., Huang, S. J., … Coz, D. (2020). A deep learning system for differential diagnosis of skin diseases. <em>Nature Medicine, 26</em>(6), 900-908.</p><p>[6] Singhal, K., Azizi, S., Tu, T., Mahdavi, S. S., Wei, J., Chung, H. W., Scales, N., Tanwani, A., Cole-Lewis, H., Pfohl, S., Payne, P., Seneviratne, M., Gamble, P., Kelly, C., Babiker, A., Schärli, N., Chowdhery, A., Mansfield, P., Demner-Fushman, D., … Natarajan, V. (2023). Large language models encode clinical knowledge. <em>Nature, 620</em>(7972), 172-180.</p><p>[7] Eriksen, A. V., Möller, S., &amp; Ryg, J. (2024). Use of GPT-4 to diagnose complex clinical cases. <em>NEJM AI, 1</em>(1), AIp2300031.</p><p>[8] Tu, T., Palepu, A., Schaekermann, M., Saab, K., Freyberg, J., Tanno, R., Wang, A., Li, B., Amin, M., Cheng, Y., Vedadi, E., Tomasev, N., Azizi, S., Singhal, K., Hou, L., Webson, A., Kulkarni, K., Mahdavi, S. S., Semturs, C., … Natarajan, V. (2025). Towards conversational diagnostic artificial intelligence. <em>Nature, 642</em>(8068), 442-450.</p><p>[9] Heinz, M. V., Mackin, D. M., Trudeau, B. M., Bhattacharya, S., Wang, Y., Banta, H. A., Jewett, A. D., Salzhauer, A. J., Griffin, T. Z., &amp; Jacobson, N. C. (2025). Randomized trial of a generative AI chatbot for mental health treatment. <em>NEJM AI, 2</em>(4), AIoa2400802.</p><p>[10] Omiye, J. A., Lester, J. C., Spichak, S., Rotemberg, V., &amp; Daneshjou, R. (2023). Large language models propagate race-based medicine. <em>npj Digital Medicine, 6</em>(1), 195.</p><p>[11] Pal, A., Umapathi, L. K., &amp; Sankarasubbu, M. (2023). Med-HALT: Medical domain hallucination test for large language models. In <em>Proceedings of the 27th Conference on Computational Natural Language Learning (CoNLL)</em> (pp. 314-334). Association for Computational Linguistics.</p><p>[12] Mehandru, N., Miao, B. Y., Almaraz, E. R., Sushil, M., Butte, A. J., &amp; Alaa, A. (2024). Evaluating large language models as agents in the clinic. <em>npj Digital Medicine, 7</em>(1), 84.</p><p>[13] Goh, E., Gallo, R., Hom, J., Strong, E., Weng, Y., Kerman, H., Cool, J. A., Kanjee, Z., Parsons, A. S., Ahuja, N., Horvitz, E., Yang, D., Milstein, A., Olson, A. P. J., Rodman, A., &amp; Chen, J. H. (2024). Large language model influence on diagnostic reasoning: A randomized clinical trial. <em>JAMA Network Open, 7</em>(10), e2440969.</p><p>[14] Leroy, S. (2009). Why is it so hard to do my work? The challenge of attention residue when switching between work tasks. <em>Organizational Behavior and Human Decision Processes, 109</em>(2), 168-181.</p><p>[15] Sparrow, B., Liu, J., &amp; Wegner, D. M. (2011). Google effects on memory: Cognitive consequences of having information at our fingertips. <em>Science, 333</em>(6043), 776-778.</p><p>[16] Risko, E. F., &amp; Gilbert, S. J. (2016). Cognitive offloading. <em>Trends in Cognitive Sciences, 20</em>(9), 676-688.</p><p>[17] Mark, G., Gudith, D., &amp; Klocke, U. (2008). The cost of interrupted work: More speed and stress. In <em>Proceedings of the SIGCHI Conference on Human Factors in Computing Systems (CHI ‘08)</em> (pp. 107-110). Association for Computing Machinery.</p><p>[18] Chang, A.-M., Aeschbach, D., Duffy, J. F., &amp; Czeisler, C. A. (2015). Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. <em>Proceedings of the National Academy of Sciences, 112</em>(4), 1232-1237.</p><p>[19] Lanaj, K., Johnson, R. E., &amp; Barnes, C. M. (2014). Beginning the workday yet already depleted? Consequences of late-night smartphone use and sleep. <em>Organizational Behavior and Human Decision Processes, 124</em>(1), 11-23.</p><p>​<br>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">AI benchmarks can be useful, but they are narrow tests rather than measures of how much of a doctor's work a model can safely replace. The historical article remains unchanged. These notes correct the claims that could change a reader's health or privacy decision.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>The 80% estimate:</strong> The statement that ChatGPT handles 80% of what a good doctor does with bloodwork was editorial shorthand, not a validated estimate. Performance varies by model, task, prompt, input quality, population, and clinical context. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Benchmark comparisons:</strong> Accuracy and AUC values from ECGs, mammograms, cytology, skin images, medical exams, and diagnostic cases cannot be placed in one league table. They use different diseases, populations, outcomes, thresholds, and study designs. Each result is meaningful only within its own validation setting. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Primary-care denominator:</strong> The skin model's 26 categories represented 80% of skin cases in the source setting, not 80% of all primary-care visits. Its 0.66 versus 0.44 top-1 comparison used 963 teledermatology cases and six primary-care physician readers. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Diagnostic-reasoning trial:</strong> In the 50-physician trial, clinicians using GPT-4 scored 76% versus 74% with conventional resources, a difference that was not statistically significant. The model alone scored 16 percentage points above the conventional-resources group under the study rubric. The article's 92% figure is not the reported model-alone result. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Mental-health chatbot:</strong> Therabot was tested for four weeks in 210 adults with selected symptom profiles against a waitlist. The trial found a larger mean symptom reduction, but it did not establish a general 51% treatment effect or equivalence to clinician-delivered therapy. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Health data and clinical review:</strong> A consumer AI tool can help organize questions, but it cannot safely replace diagnosis, examination, longitudinal context, or clinician review. Health records are sensitive. Product, privacy settings, connected apps, eligibility, jurisdiction, and data controls should be checked before any health information is shared. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825395" rel="external">Goh, E., Gallo, R., Hom, J., et al. (2024). Large language model influence on diagnostic reasoning: A randomized clinical trial. JAMA Network Open, 7(10), e2440969. https://doi.org/10.1001/jamanetworkopen.2024.40969</a></li><li id="correction-ref-2"><a href="https://www.nature.com/articles/s41591-020-0842-3" rel="external">Liu, Y., Jain, A., Eng, C., et al. (2020). A deep learning system for differential diagnosis of skin diseases. Nature Medicine, 26(6), 900–908. https://doi.org/10.1038/s41591-020-0842-3</a></li><li id="correction-ref-3"><a href="https://doi.org/10.1056/AIoa2400802" rel="external">Heinz, M. V., Mackin, D. M., Trudeau, B. M., et al. (2025). Randomized trial of a generative AI chatbot for mental health treatment. NEJM AI, 2(4). https://doi.org/10.1056/AIoa2400802</a></li><li id="correction-ref-4"><a href="https://openai.com/policies/health-privacy-policy/" rel="external">OpenAI. (n.d.). Health privacy policy. https://openai.com/policies/health-privacy-policy/</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/ai-health-advice-and-clinical-review">AI Health Advice: What It Can Do and Where Clinicians Matter →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[The Recovery Tool I Stopped Using at 25 and Should Have Kept]]></title>
<description><![CDATA[Massage does not flush lactic acid or lower cortisol. What it actually does for muscle, fascia, and your nervous system, and why desk workers need it.]]></description>
<link>https://www.andreheeg.com/archive/the-recovery-tool-i-stopped-using</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-recovery-tool-i-stopped-using</guid>
<pubDate>Sun, 10 May 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>It’s Friday afternoon, and I’m face down on the table. My right arm is pinned behind my back, palm resting on my opposite hip. That stretch pulls the muscles over my shoulder blade in a way nothing else can. The therapist finds the gap and presses her elbow in, slow and steady. I make a noise I hope nobody ever records.</p><p>It’s the third time today she’s found a spot I didn’t know was there.</p><p>Earlier, she put her full weight on my quads, working deep into the muscle. Then she rolled my arm aside and pressed into the space between my shoulder and neck. I had to count my breaths to stay present.</p><p>This is the best massage I’ve had in years. Maybe even one of the top three ever.</p><p>It’s also a kind of audit.</p><p>You think you know how your body is doing because you train, sleep, and walk your twelve thousand steps. But when someone skilled puts an elbow into your scapula, you realize your soft tissue has been keeping score for years.</p><p>I walked out and, for the first time in twenty years, decided to make this a regular part of my life again.</p><h2><strong>Twenty Years Ago, This Was Tuesday</strong></h2><p>When I was wrestling competitively, the massage bench was the slot at the end of every full training day. You finished the session. You got worked on. You ate. You slept. You came back. Nobody called it recovery. Nobody talked about parasympathetic activation or fascial glide. The science was not the point. The bench was the point.</p><p>Five days a week, every week. The months blurred together until I stopped noticing.</p><p>When I stopped competing in my mid-twenties, the bench disappeared. Massage became a spa treat, something for holidays. Your partner might call it self-care, but to me, it just looked like another expense.</p><p>The wellness industry rushed in to fill the gap with the wrong things: wearables, supplements, a ring that tells you on Tuesday if you’re allowed to feel rested. None of it actually reaches your fascia.</p><p>Most of the executives I work with have the same missing piece. They went from college teams or serious sports to desk jobs, and somewhere along the way, their recovery routines vanished with the locker room. Now it’s just calendar invites. The cost builds up, even if your bloodwork looks fine.</p><p>If you sit for ten hours a day, bodywork isn’t a luxury. It’s the recovery system for tissue that’s lost its other means of recovery. The science supports this, though not always in the way the wellness industry says. Sometimes it even points the other way. Let’s look at three layers: muscle, fascia, and the nervous system.</p><h2><strong>Eleven Men and a Quadriceps</strong></h2><p>In 2012, a team at McMaster gave eleven young men a single bout of intense leg exercise. Then they massaged one quadriceps for ten minutes and left the other alone. They biopsied the muscle on both legs at three time points: baseline, immediately after, and two and a half hours later [1].</p><p>The massaged muscle showed three things the rested muscle did not. Inflammatory signaling was reduced. Tumor necrosis factor and interleukin-6 production dropped. The transcription factor that switches on mitochondrial biogenesis, called PGC-1 alpha, moved into the cell nucleus and was activated.</p><p>That is the canonical paper for what massage does to muscle at the cellular level. There are also eleven people. Single lab. Unreplicated in fourteen years. The mechanism story everyone repeats with confidence has not actually been re-run. Hold it as the best candidate we have, not as bedrock.</p><p>What survives at higher rigor is the clinical effect. A 2018 systematic review pooled ninety-nine controlled trials of post-exercise recovery techniques. Massage produced the largest pooled effect on delayed-onset muscle soreness among the tested modalities, outranking cryotherapy, contrast water, and compression garments [2]. A separate meta-analysis of twenty-two trials found the dose-response is specific: short sessions of five to twelve minutes outperformed longer ones, and the benefit was largest within the first ten minutes after intensity-loaded work [3].</p><p>What gets repeated in gym lore is that massage flushes lactic acid out of your muscles. It does not. A direct-measurement study showed that massage actually impeded local blood flow during application and reduced lactate clearance compared to passive rest [4]. The folk theory is wrong. If your therapist tells you they are flushing your lactic acid, you have a therapist who does not read.</p><h2><strong>Fascia Is Not a Wrapper</strong></h2><p>The Fascia Research Society defines the fascial system as a body-wide three-dimensional continuum of soft connective tissues that interpenetrates and surrounds organs, muscles, bones, nerves, and vessels [5]. Not a wrapper. An organ system.</p><p>It is contractile. Fascia contains myofibroblasts capable of smooth-muscle-like contraction [6]. It is also densely innervated with mechanoreceptors. Ruffini endings, Pacinian corpuscles, free interstitial nerve fibers [7]. Translation: the connective tissue around your muscles is alive, twitchy, and wired straight to your brainstem. When the therapist’s elbow goes in, your nervous system is the first to know.</p><p>Now imagine what happens to that tissue when you sit for ten hours a day, every day, for twenty years.</p><p>The leading mechanistic hypothesis involves hyaluronan. Hyaluronan sits between fascial layers and acts as the gliding lubricant. Under sustained pressure, immobility, and shifts in temperature or pH, hyaluronan polymerizes, and the gliding layer turns sticky. The clinical term is densification, and it is mechanistically distinct from fibrosis. Reversible, in theory, through heat and mechanical shear [8]. Strong cell-biology support, limited human in vivo verification. The honest summary: this is the leading mechanism, not the proven mechanism.</p><p>The imaging evidence is real but in flux. A 2011 ultrasound elasticity study of 121 subjects found that patients with chronic low back pain showed approximately 20% less shear strain in the thoracolumbar fascia than pain-free controls [9]. A 2025 replication of 64 subjects using different region-of-interest methods found the opposite direction [10]. The signal that the fascia is mechanically altered in chronic pain holds. Whether the altered tissue is stiffer or more compliant depends on which paper you read. Both are in good journals. Both are real findings. The field has not yet agreed.</p><h2><strong>The Cortisol Story Is Mostly Wrong</strong></h2><p>The third layer is the autonomic nervous system, and this is where the case for executives becomes specific.</p><p>A 2020 randomized controlled trial in <em>Scientific Reports</em> compared two massage protocols with rest in 60 healthy women. Both massage arms produced significantly higher high-frequency heart rate variability than the rest control [11]. High-frequency HRV is the vagally mediated parasympathetic component, the marker of how well your nervous system can shift out of threat mode. Ten minutes of structured touch was enough to move it. A 2024 meta-analysis of post-exercise recovery techniques confirmed the effect at the pooled level [12].</p><p>So far, so good. Now here’s where the wellness industry has been getting it wrong for fifteen years.</p><p>The dominant claim about massage and stress is that it lowers cortisol. The number changes depending on which article you read. The claim does not withstand scrutiny. The best independent meta-analysis of 19 studies and 704 adults found that massage’s effect on cortisol is “very small, in most cases not statistically distinguishable from zero” [13]. A 2024 meta-analysis of 137 touch-intervention studies, totaling almost 13,000 participants, found that cortisol effects are concentrated in newborns and are very modest in adults [14].</p><p>If you’ve read that massage lowers your cortisol, you’ve read someone quoting studies they didn’t actually check. What’s really happening is parasympathetic activation through the vagus nerve, not HPA-axis suppression. That difference matters. A massage will calm your nervous system, but it won’t change your cortisol numbers. Those are two separate things.</p><p>The mechanotransduction signal goes deeper. Mechanical loading of connective tissue in animal models activates pro-resolving lipid mediators that help clear inflammation [15]. The same substrate that responds to manual therapy responds to stretching. The body has a built-in resolution pathway that requires mechanical input to fire.</p><p>Then there is the lymphatic system. Most adults could not draw it in a diagram, and most do not know that it has no central pump. Lower-extremity lymph transport is roughly two-thirds intrinsic, from autonomous lymphatic muscle, and one-third extrinsic, from skeletal muscle compression and respiratory pressure [16]. Sit for ten hours, and the extrinsic share collapses. Manual lymphatic drainage in clinical lymphedema populations adds modest additional volume reduction beyond compression alone [17]. Bounded, real, not “detox.”</p><p>Now layer in who you are. A 2017 cohort study of nearly 8,000 adults found that the highest sedentary quartile had a hazard ratio of 2.63 for all-cause mortality [18]. That is who is reading this. The complication: a 2012 PNAS study found that senior leaders had lower cortisol levels than non-leaders matched on demographics, a finding that was mediated by a sense of control [19]. The corner office is not, on paper, harder on your HPA axis. The accumulated load lands somewhere else. In the soft tissue. In the autonomic system. In the lymphatic plumbing your body had forgotten. McEwen’s allostatic load framework explains the rest. Chronic stress remodels the hippocampus, the amygdala, and the prefrontal cortex [20]. Downregulating sympathetic drive is neuroanatomy, not soft.</p><p>This is the Recover pillar in my Upward ARC framework. Most people hear ‘recovery’ and think of sleep or rest days. That’s part of it. But your body also needs skilled hands on tissue that movement can’t reach. Activate (sleep, training, nutrition), and Capacity (fitness, skills, cognitive reserve) both depend on a soft-tissue and nervous-system base that can actually reset. Without that, you’re just building up debt.</p><h2><strong>Try This Today</strong></h2><p><strong>The Skilled Hands Slot:</strong> Book a recurring sixty-minute session with a therapist who can actually find your trouble spots. Once a month is the minimum. Every two weeks is better. Skip the hotel spa. Look for words like ‘myofascial,’ ‘deep tissue,’ or ‘sports massage,’ and a therapist who asks where it hurts before starting. If you hear whale music or get asked if you just want to relax, you’re in the wrong place. The data is clear [3]: longer sessions for built-up tension, shorter ones after workouts. Block this time on your calendar like a board meeting. Most people skip it because it doesn’t feel like work, so it’s the first thing to go when the week gets busy. Don’t let it.</p><p><strong>The Self-Audit:</strong> Spend ten minutes with a foam roller three nights a week before bed: quads, glutes, lats, upper back. Even if you’re not an expert, the pressure sends a real signal to your tissue [15], and your fascia responds to steady load over time [8]. This isn’t a replacement for skilled hands, just maintenance between sessions. If you can’t feel where you’re stuck, that’s your answer: spend more time there.</p><p><strong>The Lymphatic Walk: </strong>Take a twenty-minute walk after lunch, or do five minutes of calf raises every ninety minutes at your desk. Your lymphatic pump only works when you move [16], and sitting all day shuts it down. Calf raises are the simplest fix. No gear, no scheduling, no need to shower. They work because of anatomy, not magic. Your soleus muscle is a pump for your veins and lymph, and it only turns on when you move.</p><h2><strong>Back to the Table</strong></h2><p>The therapist’s elbow on my scapula. The audit. Walking home after, my body felt different.</p><p>Back when I wrestled, the bench was just part of the routine. I never realized it was infrastructure. Twenty years of treating it as a luxury caught up to me in one hour with a skilled therapist on a Friday. The cost was clear the moment someone knew where to press.</p><p>Most of you are on the same path. Maybe you played college rugby. Maybe you swam in your twenties. Maybe you used to take care of your body, and now your calendar fills the space your body used to have. The bench disappeared, and nobody told you what you lost.</p><p>This is what you left behind.</p><p>The protocols above aren’t heroic. They’re just the slot at the end of the day. You do them because tissue under chronic load needs a reset, and your body has no backup pump.</p><p>Put the bench back. It’s not exciting. Neither is brushing your teeth.</p><p>Stay healthy.</p><p>Andre</p><p>​<br>​</p><p>PS: If you read this and thought of someone who has not put the bench back yet, forward it to them. That is how this newsletter grows, and it is the only way I want it to. Past editions live in the archive:<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9hbmRyZWhlZWcua2l0LmNvbS9wcm9maWxl" target="_blank" rel="noopener noreferrer"> https://andreheeg.kit.com/profile</a>.</p><p>​</p><div><hr></div><h2><strong>References</strong></h2><p>[1] Crane, J. D., Ogborn, D. I., Cupido, C., Melov, S., Hubbard, A., Bourgeois, J. M., &amp; Tarnopolsky, M. A. (2012). Massage therapy attenuates inflammatory signaling after exercise-induced muscle damage. <em>Science Translational Medicine, 4</em>(119), 119ra13.</p><p>[2] Dupuy, O., Douzi, W., Theurot, D., Bosquet, L., &amp; Dugué, B. (2018). An evidence-based approach for choosing post-exercise recovery techniques to reduce markers of muscle damage, soreness, fatigue, and inflammation: A systematic review with meta-analysis. <em>Frontiers in Physiology, 9</em>, 403.</p><p>[3] Poppendieck, W., Wegmann, M., Ferrauti, A., Kellmann, M., Pfeiffer, M., &amp; Meyer, T. (2016). Massage and performance recovery: A meta-analytical review. <em>Sports Medicine, 46</em>(2), 183-204.</p><p>[4] Wiltshire, E. V., Poitras, V., Pak, M., Hong, T., Rayner, J., &amp; Tschakovsky, M. E. (2010). Massage impairs postexercise muscle blood flow and “lactic acid” removal. <em>Medicine &amp; Science in Sports &amp; Exercise, 42</em>(6), 1062-1071.</p><p>[5] Adstrum, S., Hedley, G., Schleip, R., Stecco, C., &amp; Yucesoy, C. A. (2017). Defining the fascial system. <em>Journal of Bodywork and Movement Therapies, 21</em>(1), 173-177.</p><p>[6] Schleip, R., Gabbiani, G., Wilke, J., Naylor, I., Hinz, B., Zorn, A., Jäger, H., Breul, R., Schreiner, S., &amp; Klingler, W. (2019). Fascia is able to actively contract and may thereby influence musculoskeletal dynamics: A histochemical and mechanographic investigation. <em>Frontiers in Physiology, 10</em>, 336.</p><p>[7] Tesarz, J., Hoheisel, U., Wiedenhöfer, B., &amp; Mense, S. (2011). Sensory innervation of the thoracolumbar fascia in rats and humans. <em>Neuroscience, 194</em>, 302-308.</p><p>[8] Pratt, R. L. (2021). Hyaluronan and the fascial frontier. <em>International Journal of Molecular Sciences, 22</em>(13), 6845.</p><p>[9] Langevin, H. M., Fox, J. R., Koptiuch, C., Badger, G. J., Greenan-Naumann, A. C., Bouffard, N. A., Konofagou, E. E., Lee, W.-N., Triano, J. J., &amp; Henry, S. M. (2011). Reduced thoracolumbar fascia shear strain in human chronic low back pain. <em>BMC Musculoskeletal Disorders, 12</em>, 203.</p><p>[10] Tomita, N., Roy-Cardinal, M. H., Chayer, B., Daher, S., Attiya, A., Boulanger, A., Gaudreault, N., Cloutier, G., &amp; Bureau, N. J. (2025). Thoracolumbar fascia ultrasound shear strain differs between low back pain and asymptomatic individuals: Expanding the evidence. <em>Insights into Imaging, 16</em>, 18.</p><p>[11] Meier, M., Unternaehrer, E., Dimitroff, S. J., Benz, A. B. E., Bentele, U. U., Schorpp, S. M., Wenzel, M., &amp; Pruessner, J. C. (2020). Standardized massage interventions as protocols for the induction of psychophysiological relaxation in the laboratory: A block randomized, controlled trial. <em>Scientific Reports, 10</em>, 14774.</p><p>[12] Laborde, S., Allen, M. S., Borges, U., Dosseville, F., Hosang, T. J., Iskra, M., Mosley, E., Salvotti, C., Spolverato, L., Zammit, N., &amp; Javelle, F. (2024). Influence of physical post-exercise recovery techniques on vagally-mediated heart rate variability: A systematic review and meta-analysis. <em>Clinical Physiology and Functional Imaging</em>.</p><p>[13] Moyer, C. A., Seefeldt, L., Mann, E. S., &amp; Jackley, L. M. (2011). Does massage therapy reduce cortisol? A comprehensive quantitative review. <em>Journal of Bodywork and Movement Therapies, 15</em>(1), 3-14.</p><p>[14] Packheiser, J., Hartmann, H., Fredriksen, K., Gazzola, V., Keysers, C., &amp; Michon, F. (2024). A systematic review and multivariate meta-analysis of the physical and mental health benefits of touch interventions. <em>Nature Human Behaviour, 8</em>, 1088-1107.</p><p>[15] Berrueta, L., Muskaj, I., Olenich, S., Butler, T., Badger, G. J., Colas, R. A., Spite, M., Serhan, C. N., &amp; Langevin, H. M. (2016). Stretching impacts inflammation resolution in connective tissue. <em>Journal of Cellular Physiology, 231</em>(7), 1621-1627.</p><p>[16] Scallan, J. P., Zawieja, S. D., Castorena-Gonzalez, J. A., &amp; Davis, M. J. (2016). Lymphatic pumping: Mechanics, mechanisms and malfunction. <em>The Journal of Physiology, 594</em>(20), 5749-5768.</p><p>[17] Ezzo, J., Manheimer, E., McNeely, M. L., Howell, D. M., Weiss, R., Johansson, K. I., Bao, T., Bily, L., Tuppo, C. M., Williams, A. F., &amp; Karadibak, D. (2015). Manual lymphatic drainage for lymphedema following breast cancer treatment. <em>Cochrane Database of Systematic Reviews, 2015</em>(5), CD003475.</p><p>[18] Diaz, K. M., Howard, V. J., Hutto, B., Colabianchi, N., Vena, J. E., Safford, M. M., Blair, S. N., &amp; Hooker, S. P. (2017). Patterns of sedentary behavior and mortality in U.S. middle-aged and older adults: A national cohort study. <em>Annals of Internal Medicine, 167</em>(7), 465-475.</p><p>[19] Sherman, G. D., Lee, J. J., Cuddy, A. J. C., Renshon, J., Oveis, C., Gross, J. J., &amp; Lerner, J. S. (2012). Leadership is associated with lower levels of stress. <em>Proceedings of the National Academy of Sciences, 109</em>(44), 17903-17907.</p><p>[20] McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: Central role of the brain. <em>Physiological Reviews, 87</em>(3), 873-904.</p><p>​<br>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">Massage can feel useful and may modestly reduce short-term soreness. The evidence does not establish a universal dose, a preventive lymphatic treatment, or a replacement for movement and condition-specific care.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Inflammation and recovery:</strong> The muscle-biopsy experiment involved 11 healthy men and one exercised quadriceps. It supports a small mechanistic observation, not a general anti-inflammatory treatment claim. Reviews support modest short-term effects on soreness and fatigue, while performance effects are small or uncertain. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Massage duration:</strong> The evidence does not establish that five to twelve minutes is consistently better than longer massage. The cited review described only a subgroup tendency within an overall small and unclear performance effect. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Lymph and sitting:</strong> Sedentary-behavior research does not show that sitting collapses lymph flow or that routine massage prevents sedentary harm. Manual lymphatic drainage has specific clinical indications and is not a general preventive treatment for healthy readers. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Frequency:</strong> Monthly or fortnightly massage is a personal preference, not an evidence-based medical minimum. Individual needs, symptoms, health conditions, contraindications, and cost can change whether massage is suitable. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/22301554/" rel="external">Crane, J. D., Ogborn, D. I., Cupido, C., et al. (2012). Massage therapy attenuates inflammatory signaling after exercise-induced muscle damage. Science Translational Medicine, 4(119), 119ra13. https://pubmed.ncbi.nlm.nih.gov/22301554/</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/26744335/" rel="external">Poppendieck, W., Wegmann, M., Ferrauti, A., et al. (2016). Massage and performance recovery: A meta-analytical review. Sports Medicine, 46(2), 183–204. https://pubmed.ncbi.nlm.nih.gov/26744335/</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/32803533/" rel="external">Thompson, B., Gaitatzis, K., Janse de Jonge, X., Blackwell, R., &amp; Koelmeyer, L. A. (2021). Manual lymphatic drainage treatment for lymphedema: A systematic review of the literature. Journal of Cancer Survivorship, 15(2), 244–258. https://doi.org/10.1007/s11764-020-00928-1</a></li><li id="correction-ref-4"><a href="https://www.nccih.nih.gov/health/massage-therapy-what-you-need-to-know" rel="external">National Center for Complementary and Integrative Health. (n.d.). Massage therapy: What you need to know. https://www.nccih.nih.gov/health/massage-therapy-what-you-need-to-know</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/massage-recovery-pain-and-soreness">Massage and Recovery: Pain, Soreness, and Limits →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Three Bikes, Four Habits. How I Pick the Four Things When the Week Tries to Break Me]]></title>
<description><![CDATA[A doctor's filter for health overload: three questions, four habits, no more. How to cut the noise and keep only what survives a chaotic week.]]></description>
<link>https://www.andreheeg.com/archive/three-bikes-four-habits-how-i-pick</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/three-bikes-four-habits-how-i-pick</guid>
<pubDate>Sun, 03 May 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>I just got back from the bike shop. Three bikes. Three.</p><p>Tilda’s bike got a flat tire. She borrowed Erna’s bike, but that one went flat the next day. Magnus lost his brake pads, those small parts that press on the wheel. I do not even know what they are really called. He realized he had no brakes halfway down a hill and managed to stop before anything worse happened.</p><p>Three bikes, one trip to the shop. And that was only part of the week.</p><p>The list goes on.</p><p>Two things in the house are broken. The repair guy still has not called me back. The school called twice. It is the kind of issue with kids that takes more than one call to sort out. I need to schedule a follow-up with the pediatrician, but I cannot get through on the phone. There are invoices on the kitchen counter, two weeks overdue.</p><p>By Wednesday, my wife stopped saying anything reassuring. She usually keeps track when I start to lose it. That was the sign.</p><p>On Monday, I thought, fine. I’ll handle it.</p><p>By Wednesday, I hoped this was not turning into a streak.</p><p>On Friday, sitting at the kitchen table, I just thought, how is this even possible.</p><p>This was the week.</p><h2><strong>The Letter Under the Letters</strong></h2><p>I am sure some of you have had a week like this, too.</p><p>A few weeks ago, I asked what you wanted me to write about. The replies were long. People wrote in detail. Sleep that does not help. Bloodwork at forty-five. Tendons that do not heal. Racing thoughts at midnight. Supplements, dementia, GLP-1 at a normal weight.</p><p>I read every reply twice. The topics were different, but underneath, the message was the same.</p><p>I cannot do everything.</p><p>One of you put it simply: there are too many good things to do, but you cannot do them all. Someone else wrote that tips do not stick. Give me the system. Tell me why.</p><p>That is what I want to give you this Sunday: a filter. Something to help you decide what fits into your week and what does not. It should be simple enough to use even on a Friday night when three bikes are at the shop.</p><h2><strong>The Jam Study</strong></h2><p>In 2000, two psychologists from Columbia and Stanford set up a tasting booth in an upscale grocery store in California. On some days, they put out 24 jars of jam. On other days, they put out six. Same store. Same day. Same shoppers.</p><p>The 24-jar booth attracted bigger crowds. More people stopped. More people sampled. By every measure of attention, more was better.</p><p>Then they checked who actually bought a jar.</p><p>Three percent of the people at the 24-jar booth went home with jam. Thirty percent of the people at the 6-jar booth did. Ten times the conversion rate from one quarter of the selection [1].</p><p>Sheena Iyengar and Mark Lepper put a number on something every executive already knows. After a certain point, more options do not help. They make it harder to choose. This effect is real, and in about 100 follow-up studies, it appears most often when decisions are complex, the stakes are high, or the person is unsure what they want [2]. That describes almost every health decision a busy adult faces.</p><p>The body has the same problem in different clothes. Hans Selye described it in the 1950s. Bruce McEwen named it in 1998. Allostatic load. The wear and tear of carrying physiological stress across multiple systems at once [3]. Your hippocampus, your immune system, and your metabolic regulation. They do not get stronger when you load them with seven new interventions on a Monday. They get worse. The body adapts to a small, repeated signal. It does not adapt to a long list.</p><p>Now add in every podcast, every protocol, every supplement, every breathwork app, every cold plunge, and every blood marker on the panel you are not even sure how to read. You are not weak. You are facing the same problem as the jam shoppers. Your aisle is just longer.</p><h2><strong>The Filter</strong></h2><p>The filter is three questions and one constraint.</p><p><strong>Question one. Does it pull a lever I am not already pulling?</strong></p><p>Most health routines are full of overlapping interventions. You are already doing Zone 2 cardio, and now you add a supplement that promises to improve VO2 max. You sleep for 8 hours, then add magnesium glycinate, magnesium threonate, and ashwagandha for nervous system support. The body is not a slot machine. Pulling the same lever twice does not give you double the results.</p><p>The dose-response curve flattens past a threshold. The first two sessions of a week of resistance training do most of the work. The third adds a bit more. After that, the gains shrink [4].</p><p>Choose interventions that target different areas. One should work your cardiovascular system. Another should work your muscles and bones. One should help your sleep. Another should help you manage stress. Taking three types of magnesium is just pulling the same lever three times.</p><p><strong>Question two. Will it survive a bad week?</strong></p><p>This is where most health advice falls short. A routine that needs twelve hours of free time on the weekend, four supplements taken three hours apart, and a cold plunge before sunrise is not a routine. It is a vacation.</p><p>The body responds to consistency over time, not to heroics on the days you happen to be free. Habits run when their context is stable. They die when it is not [5]. Phillippa Lally tracked how long it actually takes habits to become automatic in real life. The median was 66 days. The range went from 18 to 254 [6]. If your habit cannot survive a Tuesday with a sick child, it will not last long enough to become a habit at all.</p><p><strong>Question three. Can I see the signal within eight weeks?</strong></p><p>This is the rule that separates a real intervention from blind faith.</p><p>If you cannot detect a change after eight weeks, you are operating on faith. Some interventions are worth doing on faith. Most are not.</p><p>Eight weeks is not arbitrary. Aerobic capacity improves measurably in 4 to 12 weeks of structured training [7]. Strength gains show up within four to six weeks, much of it neurological at first [8]. If your intervention should affect biology’s clock and it hasn’t after eight weeks, change something.</p><p><strong>The constraint: only four active habits at a time. No more.</strong></p><p>Why four. The working memory of the average adult can hold about 4 items at once under load [9]. And because every executive I know who tried to install seven habits in January is down to one by March, and that one is usually the worst of the seven.</p><p>You have four slots. If you want to add something new, you have to remove something old. That process is the real work, and most people avoid it.</p><h2><strong>My Four</strong></h2><p>Here are mine.</p><p><strong>Strength training, two or three times a week.</strong> Two is the floor. Three, when I have the energy and the calendar. Sessions are 45 to 60 minutes. Compound lifts. I do not chase variety. I track three or four numbers and try to move them slowly. In each session, I add 10 to 15 minutes of mobility and bodyweight strength work. At my age, the future cost of poor balance and stability is greater than most people think. A 2019 meta-analysis in the European Journal of Preventive Cardiology found that resistance training, on its own, was associated with a 21% lower risk of all-cause mortality, independent of cardio [10]. Two sessions a week is the dose where the curve starts to flatten. Three would be marginally better. The flexibility is the point.</p><p><strong>Cardio, two or three times a week.</strong> Same idea. Two is the floor, three when the body says yes. One Zone 2 session, 40 to 60 minutes at a pace where I could still hold a conversation. Another is harder, focused on VO2 max. Mostly cycling. Sometimes rowing or the echo bike. Sometimes rucking with a weighted vest or pack. Running is not an option for me. My back complains every time I try, and I have stopped fighting it. VO2 max is one of the strongest predictors of all-cause mortality across age groups [11]. The Erickson trial in PNAS showed that a year of brisk walking three times a week increased hippocampal volume by 2% in older adults [12]. The same mechanism is running in your forties. You just cannot see it yet.</p><p><strong>Sleep protection.</strong> No phone in the bedroom. Lights out by eleven on a normal night. Alcohol has been the big cut. I drink far less than I used to and rarely within four hours of bed. This is the lever everyone wants to swap for a supplement. The supplement does not exist. Slow-wave sleep is when growth hormone pulses and the body undertakes deep recovery [13]. Lose that, and you cannot lift, think, or recover from the rest of your week.</p><p><strong>Sauna, twice a week.</strong> Twenty minutes per session. This is the goal, and I hit it most reliably when we are at our vacation place, where the sauna is part of the rhythm. The Finnish cohort study from Kuopio followed 2,300 men for over twenty years. Four to seven sauna sessions per week were associated with a 50% reduction in cardiovascular death and a 40% reduction in all-cause mortality compared to one session per week [14]. The mechanism is partly cardiovascular load, partly heat-shock protein expression, and partly stress recovery. Two is not seven. The point is the lever, not perfection.</p><p>What I take. Three things, daily. Creatine. Vitamin D through the winter. Omega-3. That is the base load. Anything beyond that, I add only when there is a specific deficit or a stretch of stress I want to counter. Then it comes off again. The default is no.</p><p>What is not on the list? Cold plunge. The Oura ring. The Whoop band. Continuous glucose monitor. Tracking apps in general. Most other supplements. The list of what failed the filter is longer than the list of what passed. That is correct.</p><p>Letting go of old habits is the real work.</p><h2><strong>Your Sunday Audit</strong></h2><p>Take ten minutes today. Do this once.</p><p>Write down everything you currently do for your health. List your morning routine, supplements, workout schedule, sleep habits, meditation app, cold plunge plan, and food rules. Be honest. Include both what you say you do and what you actually do. Make two lists.. they are not the same.</p><p>Now run the filter on each one.</p><p>Does it target an area you are not already working on? If two things do the same job, keep only one.</p><p>Will this habit survive a tough week? If it falls apart when your child is sick or work gets busy, it is not a habit. It is just a hobby.</p><p>Can you see a result within eight weeks? If not, set a way to measure it. If you cannot measure it, either drop it or accept that you are doing it on faith.</p><p>Four is the maximum, not the goal. If three habits fit your life right now, then three is right for you.</p><p>Then the implementation. Peter Gollwitzer at NYU has spent thirty years on what he calls implementation intentions. The simple version: a habit attached to a specific cue, time, and place is much more likely to actually happen than a habit you “plan to do” [15]. Not “I will train more this month.” But “Tuesday and Friday at 7 am, I drive to the gym, I do the same five lifts.” Obviously, the load progresses, and the program varies as you adapt through the year. What stays fixed is the cue, the time, the place.</p><p>Choose a specific cue, time, and place for each habit. Write these down next to each of your four.</p><p>That is your task for this Sunday.</p><h2><strong>On Your Replies</strong></h2><p>I have read every reply, some of them twice or even three times. I will keep reading them, and the topics you share will keep appearing here, one Sunday at a time.</p><p>Thank you for taking the time to write. I know how busy your weeks are. Taking a moment to share your thoughts means a lot.</p><p>Many of you wrote something I did not expect: that this newsletter is your steady Sunday read, your favorite, and that it arrives when other things do not. That moved me. It is why I write.</p><p>I will keep writing. If you know someone who would benefit, please forward this issue and encourage them to subscribe. That is how this newsletter grows, and it is the only way I want it to.</p><p>In the Upward ARC framework, this whole piece is about Capacity. The discipline to keep doing the four things that matter, even when your week tries to break you. My week tried to break me. Three bikes are still at the shop. Two things in the house are still broken. The pediatrician responded to my email and said they will send me an appointment slot. The invoices will get paid on Sunday afternoon ;-)</p><p>The four things still ran. That is what they are for.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><h2><strong>References</strong></h2><p>[1] Iyengar, S. S., &amp; Lepper, M. R. (2000). When choice is demotivating: Can one desire too much of a good thing? <em>Journal of Personality and Social Psychology, 79</em>(6), 995-1006.</p><p>[2] Chernev, A., Böckenholt, U., &amp; Goodman, J. (2015). Choice overload: A conceptual review and meta-analysis. <em>Journal of Consumer Psychology, 25</em>(2), 333-358.</p><p>[3] McEwen, B. S. (1998). Stress, adaptation, and disease: Allostasis and allostatic load. <em>Annals of the New York Academy of Sciences, 840</em>(1), 33-44.</p><p>[4] Schoenfeld, B. J., Ogborn, D., &amp; Krieger, J. W. (2016). Effects of resistance training frequency on measures of muscle hypertrophy: A systematic review and meta-analysis. <em>Sports Medicine, 46</em>(11), 1689-1697.</p><p>[5] Wood, W., &amp; Rünger, D. (2016). Psychology of habit. <em>Annual Review of Psychology, 67</em>, 289-314.</p><p>[6] Lally, P., van Jaarsveld, C. H. M., Potts, H. W. W., &amp; Wardle, J. (2010). How are habits formed: Modelling habit formation in the real world. <em>European Journal of Social Psychology, 40</em>(6), 998-1009.</p><p>[7] Murias, J. M., Kowalchuk, J. M., &amp; Paterson, D. H. (2010). Time course and mechanisms of adaptations in cardiorespiratory fitness with endurance training in older and young men. <em>Journal of Applied Physiology, 108</em>(3), 621-627.</p><p>[8] Sale, D. G. (1988). Neural adaptation to resistance training. <em>Medicine and Science in Sports and Exercise, 20</em>(5), S135-S145.</p><p>[9] Cowan, N. (2001). The magical number 4 in short-term memory: A reconsideration of mental storage capacity. <em>Behavioral and Brain Sciences, 24</em>(1), 87-114.</p><p>[10] Saeidifard, F., Medina-Inojosa, J. R., West, C. P., Olson, T. P., Somers, V. K., Bonikowske, A. R., Prokop, L. J., Vinciguerra, M., &amp; Lopez-Jimenez, F. (2019). The association of resistance training with mortality: A systematic review and meta-analysis. <em>European Journal of Preventive Cardiology, 26</em>(15), 1647-1665.</p><p>[11] Mandsager, K., Harb, S., Cremer, P., Phelan, D., Nissen, S. E., &amp; Jaber, W. (2018). Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. <em>JAMA Network Open, 1</em>(6), e183605.</p><p>[12] Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., Wojcicki, T. R., Mailey, E., Vieira, V. J., Martin, S. A., Pence, B. D., Woods, J. A., McAuley, E., &amp; Kramer, A. F. (2011). Exercise training increases size of hippocampus and improves memory. <em>Proceedings of the National Academy of Sciences, 108</em>(7), 3017-3022.</p><p>[13] Van Cauter, E., Spiegel, K., Tasali, E., &amp; Leproult, R. (2008). Metabolic consequences of sleep and sleep loss. <em>Sleep Medicine, 9</em>(Suppl 1), S23-S28.</p><p>[14] Laukkanen, T., Khan, H., Zaccardi, F., &amp; Laukkanen, J. A. (2015). Association between sauna bathing and fatal cardiovascular and all-cause mortality events. <em>JAMA Internal Medicine, 175</em>(4), 542-548.</p><p>[15] Gollwitzer, P. M., &amp; Sheeran, P. (2006). Implementation intentions and goal achievement: A meta-analysis of effects and processes. <em>Advances in Experimental Social Psychology, 38</em>, 69-119.</p><p>​<br>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">Choosing four habits can be a useful personal constraint. It is not a cognitive limit established by science, and exercise and sauna research does not provide one universal schedule.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Four-habit limit:</strong> The cited work concerns short-term memory capacity, not the maximum number of health habits a person can maintain. Four is the author's chosen constraint, not a human biological limit. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Training dose and timing:</strong> Resistance and aerobic training are commonly beneficial, but the evidence does not establish that the first two weekly sessions do most of the work or that adaptation becomes real only after eight weeks. Programs and response vary. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a> <a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Brain mechanism:</strong> The cited hippocampal trial tested aerobic walking in older adults. It does not establish one identical hippocampal mechanism for all exercise or for every person in their forties. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>Sauna:</strong> The mortality findings came from an observational cohort of 2,315 middle-aged Finnish men. They do not prove that sauna caused lower mortality or set a personal dose. Safety can differ with cardiovascular instability, low blood pressure, dehydration, alcohol, and medicines. <span class="correction-ref-links"><a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/11515286/" rel="external">Cowan, N. (2001). The magical number 4 in short-term memory: A reconsideration of mental storage capacity. Behavioral and Brain Sciences, 24(1), 87–114. https://pubmed.ncbi.nlm.nih.gov/11515286/</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/30558493/" rel="external">Schoenfeld, B. J., Grgic, J., &amp; Krieger, J. (2019). How many times per week should a muscle be trained to maximize muscle hypertrophy? Journal of Sports Sciences, 37(11), 1286–1295. https://pubmed.ncbi.nlm.nih.gov/30558493/</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/35728627/" rel="external">Khalafi, M., Sakhaei, M. H., Rosenkranz, S. K., &amp; Symonds, M. E. (2022). Impact of concurrent training versus aerobic or resistance training on cardiorespiratory fitness and muscular strength in middle-aged to older adults: A systematic review and meta-analysis. Physiology &amp; Behavior, 254, 113888. https://doi.org/10.1016/j.physbeh.2022.113888</a></li><li id="correction-ref-4"><a href="https://pubmed.ncbi.nlm.nih.gov/21282661/" rel="external">Erickson, K. I., Voss, M. W., Prakash, R. S., et al. (2011). Exercise training increases size of hippocampus and improves memory. Proceedings of the National Academy of Sciences, 108(7), 3017–3022. https://pubmed.ncbi.nlm.nih.gov/21282661/</a></li><li id="correction-ref-5"><a href="https://pubmed.ncbi.nlm.nih.gov/25705824/" rel="external">Laukkanen, T., Khan, H., Zaccardi, F., &amp; Laukkanen, J. A. (2015). Association between sauna bathing and fatal cardiovascular and all-cause mortality events. JAMA Internal Medicine, 175(4), 542–548. https://doi.org/10.1001/jamainternmed.2014.8187</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/minimum-effective-health-habits">Minimum Effective Health Habits for Busy Weeks →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[The Names I Forget: A Confession, a Dogma, and Some New Wiring]]></title>
<description><![CDATA[Your adult brain grows 700 new neurons a day. A 100-year argument just ended, and the four habits that decide the brain you will have at 75.]]></description>
<link>https://www.andreheeg.com/archive/the-names-i-forget-a-confession-a</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-names-i-forget-a-confession-a</guid>
<pubDate>Sun, 26 Apr 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>My wife gives me a look across the school playground. Patient. Tired, but trying not to show it. I have just done another stealth greeting. Warm, friendly, no name. Her daughter has been in Karla’s class since they were three. I have eaten her cake. The name is gone, as always.</p><p>I have always been bad with names. Not just a little forgetful. Catastrophic.</p><p>I spent over a decade in management consulting, a job where you are supposed to know everyone’s name. I still managed to forget. That is its own kind of achievement.</p><p>A man I have worked with for ten years shakes my hand at a Christmas party. I know him instantly. I remember the projects, the dinners, the flights. His name is gone. My wife has given up trying.</p><p>We have known some couples for over a decade: birthday parties, sleepovers, all of it. I still walk in and cannot remember a name.</p><p>So I work around it. I say, “It’s the mom of the girl in Magnus’s class, the one with blonde hair.” My wife sighs. “That’s &lt;any name&gt;. We have known her for eight years.” Right. I’m sorry, &lt;any name&gt;.</p><p>In public, my wife steps in. She says the name first so that I can follow. I use “good to see you” and “hello again” like someone who remembers everything. At home, I ask, “What was the name of that guy again? The one who works in film and writes books?” Another small tax on the marriage.</p><p>Here is the absurd part. I can name the GLP-1 receptor agonist subclass that includes tirzepatide. Instantly. I can recite the carnitine shuttle pathway. The biochemistry of cortisol release. Drug names, molecules, signaling cascades. All memorized.</p><p>People’s names? A polite white screen.</p><p>This is not decline. My brain has always been wired this way. The real question is different. Can the brain grow into a place it has never been?</p><p>For most of the last hundred years, the answer was no. Read Cajal.</p><h2>The Argument That Just Ended</h2><p>Santiago Ramón y Cajal won a Nobel Prize for figuring out, almost by hand, that the brain is made of individual cells called neurons. His ink drawings of nerve tissue are still in textbook chapters today. He had an iron pen and an iron certainty. In 1928, he wrote the sentence that closed the field for seventy years. “In the adult centers, the nerve paths are something fixed, ended, immutable. Everything may die, nothing may be regenerated” [1]. The brain you had at twenty-five was the brain you would die with. The verdict held.</p><p>It started cracking in the 1990s. Rodent studies kept finding new neurons in animal hippocampi, and the rodents were stubbornly refusing to be wrong.</p><p>Then 1998. A Swedish neurologist named Peter Eriksson got hold of brain tissue from cancer patients who had been injected with BrdU, a chemical that labels dividing cells. He sliced their dentate gyrus, the curved ribbon of tissue inside the hippocampus where memory gets made. Under the microscope, lit up by the BrdU label, were brand-new neurons. Born after the patients had become adults. In human brains. The Nature Medicine paper that came out of this was the first hard evidence that Cajal had been wrong [2].</p><p>The field was not happy. Some senior careers depended on the idea that no new neurons grew.</p><p>In 2013, Kirsty Spalding’s group in Stockholm used carbon-14 from atmospheric nuclear-test residues, absorbed by every human alive in the second half of the twentieth century, as a biological clock. Their estimate: 700 new neurons per day in the adult hippocampus. Annual turnover of 1.75% [3]. The brain was not a fossil. It was a slow stonemason.</p><p>Then, in 2018, it got ugly. Two papers, weeks apart, in the same family of journals. Maura Boldrini at Columbia: neurogenesis persists into the eighth decade [4]. Shawn Sorrells in San Francisco: undetectable in adults [5]. Scientists publicly accused each other of degraded tissue, dirty antibodies, and sloppy staining.</p><p>A 2019 Madrid paper from María Llorens-Martín’s group reaffirmed neurogenesis in healthy older adults and showed it collapses in Alzheimer’s [6]. Evidence kept stacking on one side. Objections kept coming from the other.</p><p>Science journalists called it the neurogenesis war. Neuroscientists called each other worse. The fight lasted almost a decade.</p><p>In February 2026, Ahmed Disouky, Tamar Gefen, and Orly Lazarov published a paper in Nature that put an end to the argument [7]. Multiomic single-cell sequencing on 355,997 hippocampal nuclei. They could read the molecular signatures of neural stem cells, neuroblasts, and immature granule neurons across adult brains of every age. The evidence was no longer arguable.</p><p>The adult human brain grows new neurons. All through life. Cajal was wrong. We have known this for about ten weeks.</p><h2>What the SuperAgers Have</h2><p>The same paper carried a second finding, just as interesting.</p><p>Northwestern has run a program called SuperAging for 25 years. The criteria: you are over 80, and your memory performance matches that of healthy people in their fifties [8]. Imagine an 84-year-old who can hold fifteen new words for an hour and out-recall your colleague in marketing.</p><p>Disouky’s team looked specifically at the hippocampi of these SuperAgers. They were producing roughly twice as many new neurons as their healthy age-matched peers. Two and a half times more than peers with Alzheimer’s [7]. Their hippocampal microenvironment, the chemical soup these neurons grow in, carried what the researchers called a resilience signature. A pattern of gene activity that supports the birth and survival of new cells.</p><p>SuperAgers are social. Curious. Physically active. Many still work at 80. They challenge their brains every day, not with brain training, but by learning instruments, arguing at dinner, and showing up.</p><p>This is not just genetics. Their brains are shaped every day by what they do.</p><p>Two people, both 47, both with the same job, can have very different brains at 77. The difference is invisible now. It is obvious later.</p><h2>What Is on the Other Side of That Fork</h2><p>Cortisol shrinks the exact tissue SuperAgers are growing.</p><p>Robert Sapolsky has spent decades documenting this at Stanford. Chronic exposure to glucocorticoids damages hippocampal neurons. CA1 and CA3 regions get smaller. Dendrites retract. New neuron production stops [9]. Even short bouts of stress suppress neurogenesis in the dentate gyrus [10].</p><p>Hippocampal volume in depressed patients is consistently 10 to 15% smaller than in matched controls [9]. Treat the underlying stress, and some of that volume comes back [11].</p><p>Bruce McEwen called the cumulative effect allostatic load. The wear and tear of cortisol that never fully comes down [12]. Sonia Lupien has shown the hippocampus is exquisitely sensitive to chronic stress across the lifespan, including the decades when most executives are running hardest [13].</p><p>A 60-hour week. Broken sleep. Alcohol to wind down. Colleagues as your only social life. This is how you shrink your hippocampus.</p><p>Most executives I know in their late forties live this way. Then they buy a brain supplement.</p><p>The wellness industry has it exactly backward.</p><h2>What Actually Works</h2><p>The four things that work are boring.</p><p><strong>Aerobic exercise.</strong> In 2011, Kirk Erickson published a randomized trial in PNAS. 120 sedentary older adults. Half put on a walking program: 40 minutes, three times a week. Just walking. After 1 year, the walkers had increased their hippocampal volume by 2%, reversing 1 to 2 years of shrinkage. The control group kept losing [14]. Aerobic exercise increases BDNF (brain-derived neurotrophic factor), a key signal that supports the survival of new neurons [15].</p><p><strong>Sleep.</strong> Slow-wave sleep, especially in the first half of the night. This is when memory consolidates, waste is cleared, and new neurons survive [16]. Neurogenesis drops fast with sleep loss. The third whisky takes this from you. So does Netflix at midnight.</p><p><strong>Effortful thinking.</strong> The Rush Memory and Aging Project tracked older adults for years. People who read hard books, wrote, or worked through tough problems every day declined more slowly, no matter their education [17]. The key was doing hard things often, not just trying something new once in a while.</p><p><strong>Social complexity matters. </strong>Not just how many people you know, but the different roles they play. People with more diverse social ties get sick less often [18]. Social connection is as important as not smoking [19]. SuperAgers stay engaged with people. It is not extra. It is essential.</p><h2>What the Industry Sells You Instead</h2><p>In 2016, Daniel Simons and a team of leading psychologists reviewed the entire evidence base behind brain training programs. 130 pages, Psychological Science in the Public Interest. Their conclusion: people who train on these games get better at the games, and almost nothing transfers to real-world cognition [20].</p><p>The same year, the FTC ordered Lumosity to pay $2 million for deceptive advertising. The agency’s words: the company “preyed on consumers’ fears about age-related cognitive decline” [21].</p><p>The cognitive supplement market is no better. Lion’s Mane, alpha-GPC, modafinil microdoses, nootropic stacks in tubs. Most studies are small, short, and funded by the sellers. The people buying these are the same ones sleeping six hours, drinking wine on a Tuesday, and working weekends. The real problem is high cortisol. The industry gets the diagnosis wrong and sells the wrong fix.</p><h2>Capacity, Built Decades Before You Need It</h2><p>In the Upward ARC framework, this is Capacity. The long-term reserve. Activate is the stimulus. Recover protects the gains. Capacity is the brain you will need at seventy-five.</p><p>The 80-year-old SuperAger did not start last week. They built that brain in their forties and fifties. The heart, the hippocampus, the social network. None of it was bought at the last minute.</p><p>The brain you will have at 75 is being built now. I don’t say this like a motivational slogan. I point out biology.</p><h2>Try This Today</h2><p><strong>Follow Erickson’s protocol.</strong> Walk briskly or cycle in Zone 2 for at least 150 minutes a week. The PNAS trial used walking and still grew hippocampal volume [14]. You do not need a coach.</p><p><strong>Protect your slow-wave sleep.</strong> Get seven hours without interruption, especially the first three. No alcohol within four hours of bed. No phone in the bedroom. Deep sleep is when new neurons survive.</p><p><strong>Spend twenty minutes a day on something that makes you concentrate.</strong> Trade news scrolling for a harder book or a course in something new. The Rush study found that doing hard things consistently matters, not just trying something new once [17].</p><p><strong>Cut two stressors that do not matter.</strong> Most executive stress comes from a few things that are not important. The pointless status meeting. The check-in that became mandatory. Remove or buffer two of them. Your hippocampus depends on it.</p><h2>The Names</h2><p>I still forget names. The mom of the girl in Magnus’s class is still a workaround. My wife is not expecting a change.</p><p>But I see it differently now. This is not a flaw to hide. My brain is just wired this way, and the science says I can keep building. 700 new neurons today. Another 700 tomorrow. Into my eighties, if I do the work. The question I have carried finally has an answer.</p><p>Pray for me that I use it for name recalling.</p><p>Cajal was wrong. The brain is not fixed at twenty-five. Not at forty-seven. Maybe not even at eighty-seven, if you look at SuperAgers.</p><p>The hundred-year argument is over. Build your brain accordingly.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><div><hr></div><h2>References</h2><p>[1] Ramón y Cajal, S. (1928). <em>Degeneration and regeneration of the nervous system</em> (R. M. May, Trans.). Oxford University Press.</p><p>[2] Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A. M., Nordborg, C., Peterson, D. A., &amp; Gage, F. H. (1998). Neurogenesis in the adult human hippocampus. <em>Nature Medicine, 4</em>(11), 1313-1317.</p><p>[3] Spalding, K. L., Bergmann, O., Alkass, K., Bernard, S., Salehpour, M., Huttner, H. B., Boström, E., Westerlund, I., Vial, C., Buchholz, B. A., Possnert, G., Mash, D. C., Druid, H., &amp; Frisén, J. (2013). Dynamics of hippocampal neurogenesis in adult humans. <em>Cell, 153</em>(6), 1219-1227.</p><p>[4] Boldrini, M., Fulmore, C. A., Tartt, A. N., Simeon, L. R., Pavlova, I., Poposka, V., Rosoklija, G. B., Stankov, A., Arango, V., Dwork, A. J., Hen, R., &amp; Mann, J. J. (2018). Human hippocampal neurogenesis persists throughout aging. <em>Cell Stem Cell, 22</em>(4), 589-599.</p><p>[5] Sorrells, S. F., Paredes, M. F., Cebrian-Silla, A., Sandoval, K., Qi, D., Kelley, K. W., James, D., Mayer, S., Chang, J., Auguste, K. I., Chang, E. F., Gutierrez, A. J., Kriegstein, A. R., Mathern, G. W., Oldham, M. C., Huang, E. J., Garcia-Verdugo, J. M., Yang, Z., &amp; Alvarez-Buylla, A. (2018). Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. <em>Nature, 555</em>(7696), 377-381.</p><p>[6] Moreno-Jiménez, E. P., Flor-García, M., Terreros-Roncal, J., Rábano, A., Cafini, F., Pallas-Bazarra, N., Ávila, J., &amp; Llorens-Martín, M. (2019). Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. <em>Nature Medicine, 25</em>(4), 554-560.</p><p>[7] Disouky, A., Gefen, T., Lazarov, O., et al. (2026). Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease. <em>Nature.</em></p><p>[8] Rogalski, E. J., Gefen, T., Shi, J., Samimi, M., Bigio, E., Weintraub, S., Geula, C., &amp; Mesulam, M. M. (2013). Youthful memory capacity in old brains: Anatomic and genetic clues from the Northwestern SuperAging Project. <em>Journal of Cognitive Neuroscience, 25</em>(1), 29-36.</p><p>[9] Sapolsky, R. M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. <em>Archives of General Psychiatry, 57</em>(10), 925-935.</p><p>[10] Mirescu, C., &amp; Gould, E. (2006). Stress and adult neurogenesis. <em>Hippocampus, 16</em>(3), 233-238.</p><p>[11] Starkman, M. N., Giordani, B., Gebarski, S. S., &amp; Schteingart, D. E. (2003). Improvement in learning associated with increase in hippocampal formation volume. <em>Biological Psychiatry, 53</em>(3), 233-238.</p><p>[12] McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: Central role of the brain. <em>Physiological Reviews, 87</em>(3), 873-904.</p><p>[13] Lupien, S. J., McEwen, B. S., Gunnar, M. R., &amp; Heim, C. (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. <em>Nature Reviews Neuroscience, 10</em>(6), 434-445.</p><p>[14] Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., Wojcicki, T. R., Mailey, E., Vieira, V. J., Martin, S. A., Pence, B. D., Woods, J. A., McAuley, E., &amp; Kramer, A. F. (2011). Exercise training increases size of hippocampus and improves memory. <em>Proceedings of the National Academy of Sciences, 108</em>(7), 3017-3022.</p><p>[15] Cotman, C. W., &amp; Berchtold, N. C. (2002). Exercise: A behavioral intervention to enhance brain health and plasticity. <em>Trends in Neurosciences, 25</em>(6), 295-301.</p><p>[16] Stickgold, R. (2005). Sleep-dependent memory consolidation. <em>Nature, 437</em>(7063), 1272-1278.</p><p>[17] Wilson, R. S., Boyle, P. A., Yu, L., Barnes, L. L., Schneider, J. A., &amp; Bennett, D. A. (2013). Life-span cognitive activity, neuropathologic burden, and cognitive aging. <em>Neurology, 81</em>(4), 314-321.</p><p>[18] Cohen, S., Doyle, W. J., Skoner, D. P., Rabin, B. S., &amp; Gwaltney, J. M. (1997). Social ties and susceptibility to the common cold. <em>JAMA, 277</em>(24), 1940-1944.</p><p>[19] Holt-Lunstad, J. (2024). Social connection as a critical factor for mental and physical health: Evidence, trends, challenges, and future implications. <em>World Psychiatry, 23</em>(3), 312-332.</p><p>[20] Simons, D. J., Boot, W. R., Charness, N., Gathercole, S. E., Chabris, C. F., Hambrick, D. Z., &amp; Stine-Morrow, E. A. L. (2016). Do “brain-training” programs work? <em>Psychological Science in the Public Interest, 17</em>(3), 103-186.</p><p>[21] Federal Trade Commission. (2016, January 5). <em>Lumosity to pay $2 million to settle FTC deceptive advertising charges for its “brain training” program.</em> FTC Press Release.</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The evidence for adult human hippocampal neurogenesis has strengthened. It still does not provide a personal daily neuron count or prove that a short list of habits determines one person's future brain.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Seven hundred neurons:</strong> The often-quoted figure is a model-based estimate from retrospective carbon dating of postmortem tissue. It is not a direct count in a living person and should not be treated as an individual production rate. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>The 2026 study:</strong> The Nature study identified molecular signatures of proliferating progenitors and immature neurons across adulthood, ageing, and Alzheimer disease. It did not establish that SuperAgers make twice as many new neurons as everyone else. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Habits and future cognition:</strong> Exercise, sleep, learning, and social connection are commonly associated with broader brain and health benefits. Current human evidence cannot reduce those benefits to a guaranteed neuron count or predict the brain one reader will have at 75. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/23746839/" rel="external">Spalding, K. L., Bergmann, O., Alkass, K., et al. (2013). Dynamics of hippocampal neurogenesis in adult humans. Cell, 153(6), 1219–1227. https://pubmed.ncbi.nlm.nih.gov/23746839/</a></li><li id="correction-ref-2"><a href="https://www.nature.com/articles/s41586-026-10169-4" rel="external">Disouky, A., Sanborn, M. A., Sabitha, K. R., et al. (2026). Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease. Nature, 652, 1264–1273. https://doi.org/10.1038/s41586-026-10169-4</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/39096926/" rel="external">Livingston, G., Huntley, J., Liu, K. Y., et al. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet, 404, 572–628. https://doi.org/10.1016/S0140-6736(24)01296-0</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/adult-neurogenesis-and-brain-health">Adult Neurogenesis and Brain Health: What Is Established →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[The Healthy Guy Who Almost Died]]></title>
<description><![CDATA[Looking healthy is not being healthy. Five heart tests, mostly left out of your checkup, that flag silent disease ten years before it strikes.]]></description>
<link>https://www.andreheeg.com/archive/the-healthy-guy-who-almost-died</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/the-healthy-guy-who-almost-died</guid>
<pubDate>Sun, 19 Apr 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>I was eight. Maybe nine. Third or fourth grade.</p><p>I woke up in a house that wasn’t mine. A doctor I’d never seen stood in the hallway. Red overalls. Paramedics moved quickly, silent. My mother was there, holding it all together because no one else would.</p><p>My father was only 38, and he was the strongest person I knew. But that morning, he was having a heart attack.</p><p>He survived, but he was different after that. I’ll return to this later.</p><p>Like most kids, I tried to hide that fear. I put that morning out of my mind and let life move on: school, wrestling, exams, med school, my first job, my own children, my career.</p><p>Then you hear about people like Bob Harper or Jim Fixx, and suddenly those memories and feelings come back.</p><h2><strong>Bob Harper, nine minutes dead</strong></h2><p>February 12, 2017. A gym in Manhattan. Bob Harper was 51, finishing a workout [1]. If you watched TV between 2004 and 2016, you know him from The Biggest Loser. He was the loud coach who built his career on the idea that you can outwork any body.</p><p>He collapsed on the gym floor. No pulse for what he has said was nine minutes. [2].</p><p>The only reason he’s alive today is that a cardiologist happened to be there and started CPR while someone else called an ambulance [2]. Being without a pulse for nine minutes is extremely rare to survive. Most people don’t come back from that.</p><p>The blocked artery was the left anterior descending. Cardiologists call it the widowmaker, and the name fits.</p><p>In the workup after he survived, they found the root cause. An inherited genetic condition. High lipoprotein(a). One of the strongest hereditary risk factors for a heart attack we know about [1]. It had been sitting in his bloodstream since the day he was born. He’d had a cholesterol test every year of his adult life. Nobody had ever ordered the one that would have found it.</p><p>This newsletter is about the difference between looking healthy and actually being healthy. Five numbers can close that gap. Most aren’t included in your yearly checkup. All of them would have warned Bob Harper, at 40, that he was at serious risk.</p><p>They would have warned my father too.</p><h2><strong>Training didn’t erase the disease</strong></h2><p>This information isn’t new.</p><p>Masters endurance athletes over 40, with otherwise clean cardiovascular risk profiles, have been imaged and re-imaged in study after study. Nearly half have visible coronary plaque [4]. The MASTER@HEART trial ran the proper comparison in 2023 and confirmed the pattern: lifelong endurance athletes carry more atherosclerosis than healthy non-athletes, not less [5]. Their plaque skews toward the calcified, more stable form, and whether that translates to worse outcomes is still debated. But the simple protective narrative sold by the running industry is not supported.</p><p>When men over 40 drop dead during a marathon, the autopsy most often shows the same cause. Coronary artery disease. Plaque that’s been building for 20 years while the runner logged his miles, ate his salads, and told himself the training was protecting him [6].</p><p>Training helped, but it couldn’t get rid of the disease.</p><p>This isn’t a modern problem. In July 1984, a man called Jim Fixx collapsed on a run in Vermont. He was 52. He wrote The Complete Book of Running. Sold around 4 million copies. Helped launch the jogging boom in America [7]. The autopsy was clean. One coronary artery 95% blocked. A second 85%. A third 70% [7]. His father had died of a heart attack at 43.</p><p>42 years later, we have better tests, better treatments, and enough evidence to spot this pattern ten years before it becomes deadly. But almost nobody is getting these tests.</p><p>Your yearly checkup was designed to find disease, not prevent it. The lipid panel you get was created in the 1970s [8]. ApoB has been a better predictor of heart risk for 20 years [9], but most primary care doctors still don’t order it. It’s not out of malice, just habit.</p><p>It’s this habit, more than any lab result, that leads to so many health problems for executives.</p><h2><strong>Five numbers. Remember them.</strong></h2><p>I’m a doctor and health nerd, and I read this research for fun. Here are the five numbers I want you to remember.</p><p><strong>ApoB.</strong> Your LDL result tells you how much cholesterol is floating inside your lipoprotein particles. ApoB tells you how many particles there are. Plaque is driven by the number of atherogenic particles depositing in artery walls, not just the cholesterol they carry. Count the particles, not the passenger. When the two numbers disagree, ApoB is the one telling the truth.</p><p>The most rigorous analysis we have covers 15 studies and close to 600,000 people. In every single head-to-head comparison, ApoB beat LDL as a predictor of heart attack and stroke [9].</p><p>Your LDL might look normal while your ApoB is high. This happens most often in people with some belly fat, rising triglycerides, or insulin that’s not working right. Honestly, that’s most people reading this. Some of you might even be in a weekly strategy meeting, thinking you’re fine because your Peloton stats look good.</p><p>Target: ApoB under 80 mg/dL. Under 65 if you already have disease or a strong family history.</p><p><strong>Lipoprotein(a), or Lp(a).</strong> This is the number Bob Harper had never been tested for.</p><p>It’s genetic. You’re born with it, and that’s it. No lifestyle intervention moves it, and currently available drug therapies only offer modest reductions. Statins don’t lower it, and some research suggests statins might even raise it a bit [10]. The first effective, dedicated Lp(a)-lowering therapies are the RNA-based agents in late-stage trials.</p><p>1 in 5 adults carries elevated Lp(a). Around 64 million people in the US alone [10]. At high levels, it multiplies your cardiovascular risk by 2 to 4x on top of everything else you’ve got going on. Threshold: 50 mg/dL, or 125 nmol/L. Above 180 mg/dL is the extreme-risk zone. You measure it once in your life.</p><p>A treatment is coming. A Phase 2 trial published in 2025 showed that one injection of lepodisiran lowered Lp(a) by up to 94%, and the effect lasted almost a year [11]. Phase 3 trials are underway. Approval is expected in the next few years, but you shouldn’t wait to get screened.</p><p>If the level is high, drive ApoB low, treat blood pressure aggressively, avoid smoking, consider a PCSK9 inhibitor in high-risk cases, and await new therapies. As always, talk to your doctor about your specific case.</p><p><strong>HOMA-IR.</strong> A simple calculation from your fasting insulin and fasting glucose.</p><p>Insulin resistance appears a decade before type 2 diabetes, and about the same amount of time before heart disease [12]. Your yearly checkup measures fasting glucose, but glucose is the last thing to change. By the time it’s abnormal, the disease has been developing quietly for years.</p><p>Fasting insulin changes first. A HOMA-IR above 2 to 2.5, depending on which cutoff your lab uses, indicates insulin resistance [12]. This is behind many of the health problems that affect executives before age 70.</p><p><strong>hs-CRP.</strong> Inflammation is what turns stable plaque into a heart attack. The plaque itself isn’t deadly, but when it ruptures, it is.</p><p>A major 2023 analysis of more than 31,000 statin-treated patients found that hs-CRP predicted the next heart attack, stroke, and cardiovascular death more strongly than LDL cholesterol did [13]. The inflammation number beat the cholesterol number.</p><p>In a dedicated trial, an anti-inflammatory drug that didn’t lower LDL still reduced heart events by 15% [15]. The 2025 ACC scientific statement now treats inflammation as a direct target for treatment [14]. The goal is to keep it under 2 mg/L. If it’s higher, even with perfect LDL, you still have real risk.</p><p><strong>The coronary artery calcium (CAC) scan.</strong> The other four tests show causes. This one shows the result, made visible.</p><p>A 30-second low-dose CT scan of your chest. It returns a single number that measures how much calcified plaque is already in your coronary arteries. Each doubling of the CAC score is associated with a roughly 25% increase in near-term event risk [16]. A score of zero buys you a multi-year warranty period of low near-term risk [17]. However, a zero CAC is a strong reassurance but not absolute, especially in younger people or those with high Lp(a), where soft plaque can still be present. A score above 100 for someone under 55 means advanced disease for age, right now. In older adults, the threshold shifts.</p><p>It’s arguably the most useful single preventive test for asymptomatic adults. Most people you know have never had one. Disclaimer: The radiation dose is roughly 1 mSv, low, but non-zero.</p><p>That’s just the truth.</p><h2><strong>Fitness helps protect you, but it doesn’t erase the risk.</strong></h2><p>You can’t exercise away an ApoB of 130. You can’t meditate away an Lp(a) of 200. You can’t fix a HOMA-IR of 4 with cold plunges.</p><p>The men and women who die running marathons in their late 40s weren’t out of shape. They just weren’t screened.</p><p>The wellness industry has taught you to focus on the wrong things. You track your sleep, monitor your HRV, count your steps, and drink turmeric. But the real numbers that show if your arteries are closing have never been checked.</p><p>Check the foundation before you start fixing the roof.</p><p>I mean this seriously.</p><h2><strong>Where this fits in the Upward ARC</strong></h2><p>Regular readers know the three pillars. Activate. Recover. Capacity.</p><p>These five numbers sit upstream of all three.</p><p>You can’t Activate with any precision if you don’t know whether you’re carrying a decade of silent disease. You can’t Recover from a process you haven’t measured. You can’t build Capacity on a foundation that’s been quietly cracking for 20 years.</p><p>One appointment and five tests can make everything you do next much clearer.</p><h2><strong>Try this today</strong></h2><p>Schedule your bloodwork this week. Ask your doctor for four tests: ApoB, Lp(a), fasting insulin (with fasting glucose), and hs-CRP. But, the pattern compounds with age. If you’re under 35 with no family history, ApoB and Lp(a) alone are high-yield. The full panel becomes clearly indicated from the late 30s onwards.</p><p>If your doctor resists or doesn’t know these tests, find another one who is up to date. Most big cities have private screening clinics, preventive cardiology practices, and doctors focused on longevity. They’re out there and run these tests every day. You can find them if you look.</p><p>Schedule a coronary artery calcium scan before you turn 45. If you’re over 45 and haven’t had one, do it as soon as you can. The scan takes 30 seconds. If your first score isn’t zero, repeat it every 3 to 5 years. That one number will guide your medical decisions for the next decade more than anything else.</p><p>Measure your waist at your belly button and divide by your height. If the result is over 0.5, you have visceral fat, no matter what the scale or mirror says [18]. All you need is a tape measure and two minutes. Being thin on the outside doesn’t mean you’re thin on the inside.</p><p>Change the conversation with your doctor when you bring in your results. Don’t just ask if your LDL is fine. Instead, ask: What is my ApoB? What is my Lp(a)? What is my CAC? What can I do to lower my real risk?</p><p>Asking a new question can shape the next ten years of your life.</p><p>And while you’re at it: if you smoke, stop. If your resting blood pressure is above 130/80, get it under. Those two sit alongside the five numbers, not underneath them.</p><h2><strong>Back to my father</strong></h2><p>My father survived. He did the rehab, took his medications, and did everything right. But he never fully recovered.</p><p>The man who left the hospital wasn’t the same as the one who went in. His energy, strength, drive, and even his patience for daily life were all a little less. That change was permanent.</p><p>He retired early. In our family, we always knew that choice went back to that morning when I was eight. It wasn’t just the heart attack, but what it took from him.</p><p>We often talk about heart attacks as if it’s just about surviving or not. But the real story is quieter and lasts much longer. You don’t get the same body back. You get what doctors and your own body can rebuild, minus what the heart attack took away.</p><p>Get these numbers checked while you still can.</p><p>This body is the only one you have.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><div><hr></div><h2><strong>References</strong></h2><ol><li><p><span>Harper, B. (2017–2024). Public statements on the February 2017 cardiac arrest, recovery, and lipoprotein(a) diagnosis. </span><em><span>Today Show</span></em><span>; </span><em><span>CNN Health</span></em><span>; </span><em><span>AARP The Magazine</span></em><span>; </span><em><span>Family Heart Foundation</span></em><span> speaking engagements.</span></p></li><li><p><span>Marquez, M. (2017, February 17). Bob Harper opens up about his “widowmaker” heart attack. </span><em><span>CNN Health</span></em><span>.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly93d3cuY25uLmNvbS8yMDE3LzAyLzE3L2hlYWx0aC9ib2ItaGFycGVyLWJpZ2dlc3QtbG9zZXItaGVhcnQtYXR0YWNrL2luZGV4Lmh0bWw=" target="_blank" rel="noopener noreferrer"><span> https://www.cnn.com/2017/02/17/health/bob-harper-biggest-loser-heart-attack/index.html</span></a><span>​</span></p></li><li><p><span>Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., et al. (2023). Heart Disease and Stroke Statistics: 2023 Update. A Report From the American Heart Association. </span><em><span>Circulation, 147</span></em><span>(8), e93–e621.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExNjEvQ0lSLjAwMDAwMDAwMDAwMDExMjM=" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1161/CIR.0000000000001123</span></a><span>​</span></p></li><li><p><span>Merghani, A., Maestrini, V., Rosmini, S., Cox, A. T., Dhutia, H., Bastiaenan, R., et al. (2017). Prevalence of subclinical coronary artery disease in masters endurance athletes with a low atherosclerotic risk profile. </span><em><span>Circulation, 136</span></em><span>(2), 126–137.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExNjEvQ0lSQ1VMQVRJT05BSEEuMTE2LjAyNjk2NA==" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1161/CIRCULATIONAHA.116.026964</span></a><span>​</span></p></li><li><p><span>Aengevaeren, V. L., Mosterd, A., Sharma, S., Prakken, N. H. J., Möhlenkamp, S., Thompson, P. D., et al. (2023). Exercise volume versus intensity and the progression of coronary atherosclerosis in middle-aged and older athletes: findings from the MASTER@HEART study. </span><em><span>European Heart Journal, 44</span></em><span>(48), 5092–5102.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwOTMvZXVyaGVhcnRqL2VoYWQ1NzE=" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1093/eurheartj/ehad571</span></a><span>​</span></p></li><li><p><span>Kim, J. H., Malhotra, R., Chiampas, G., d’Hemecourt, P., Troyanos, C., Cianca, J., et al. (2012). Cardiac arrest during long-distance running races. </span><em><span>New England Journal of Medicine, 366</span></em><span>(2), 130–140.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwNTYvTkVKTW9hMTEwNjQ2OA==" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1056/NEJMoa1106468</span></a><span>​</span></p></li><li><p><span>Altman, L. K. (1984, July 22). James F. Fixx dies jogging; author on running was 52. </span><em><span>The New York Times.</span></em><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly93d3cubnl0aW1lcy5jb20vMTk4NC8wNy8yMi9vYml0dWFyaWVzL2phbWVzLWYtZml4eC1kaWVzLWpvZ2dpbmctYXV0aG9yLW9uLXJ1bm5pbmctd2FzLTUyLmh0bWw=" target="_blank" rel="noopener noreferrer"><span> https://www.nytimes.com/1984/07/22/obituaries/james-f-fixx-dies-jogging-author-on-running-was-52.html</span></a><span>​</span></p></li><li><p><span>Friedewald, W. T., Levy, R. I., &amp; Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. </span><em><span>Clinical Chemistry, 18</span></em><span>(6), 499–502.</span></p></li><li><p><span>Sniderman, A. D., Thanassoulis, G., Glavinovic, T., Navar, A. M., Pencina, M., Catapano, A., &amp; Ference, B. A. (2025). Apolipoprotein B versus low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as the marker of atherogenic risk: a systematic review. </span><em><span>Journal of Clinical Lipidology.</span></em><span> Advance online publication.</span></p></li><li><p><span>Reyes-Soffer, G., Ginsberg, H. N., Berglund, L., Duell, P. B., Heffron, S. P., Kamstrup, P. R., et al. (2022). Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease. A scientific statement from the American Heart Association. </span><em><span>Arteriosclerosis, Thrombosis, and Vascular Biology, 42</span></em><span>(1), e48–e60.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExNjEvQVRWLjAwMDAwMDAwMDAwMDAxNDc=" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1161/ATV.0000000000000147</span></a><span>​</span></p></li><li><p><span>Nissen, S. E., Wang, Q., Nicholls, S. J., Navar, A. M., Ray, K. K., Schwartz, G. G., et al. (2025). Lepodisiran, a long-duration small interfering RNA targeting lipoprotein(a): a Phase 2 randomized clinical trial (ALPACA). </span><em><span>New England Journal of Medicine.</span></em><span> Advance online publication.</span></p></li><li><p><span>Tabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., &amp; Witte, D. R. (2009). Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. </span><em><span>Lancet, 373</span></em><span>(9682), 2215–2221.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvUzAxNDAtNjczNigwOSk2MDYxOS1Y" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/S0140-6736(09)60619-X</span></a><span>​</span></p></li><li><p><span>Ridker, P. M., Bhatt, D. L., Pradhan, A. D., Glynn, R. J., MacFadyen, J. G., &amp; Nissen, S. E., for the PROMINENT, REDUCE-IT, and STRENGTH Investigators. (2023). Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. </span><em><span>Lancet, 401</span></em><span>(10384), 1293–1301.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwMTYvUzAxNDAtNjczNigyMykwMDIxNS01" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1016/S0140-6736(23)00215-5</span></a><span>​</span></p></li><li><p><span>American College of Cardiology. (2025). 2025 ACC scientific statement on inflammation in atherosclerotic cardiovascular disease. </span><em><span>Journal of the American College of Cardiology.</span></em><span> Advance online publication.</span></p></li><li><p><span>Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., et al., for the CANTOS Trial Group. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. </span><em><span>New England Journal of Medicine, 377</span></em><span>(12), 1119–1131.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwNTYvTkVKTW9hMTcwNzkxNA==" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1056/NEJMoa1707914</span></a><span>​</span></p></li><li><p><span>Detrano, R., Guerci, A. D., Carr, J. J., Bild, D. E., Burke, G., Folsom, A. R., et al. (2008). Coronary calcium as a predictor of coronary events in four racial or ethnic groups. </span><em><span>New England Journal of Medicine, 358</span></em><span>(13), 1336–1345.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjEwNTYvTkVKTW9hMDcyMTAw" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1056/NEJMoa072100</span></a><span>​</span></p></li><li><p><span>Blaha, M. J., Cainzos-Achirica, M., Greenland, P., McEvoy, J. W., Blankstein, R., Budoff, M. J., et al. (2016). Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). </span><em><span>Circulation, 133</span></em><span>(9), 849–858.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExNjEvQ0lSQ1VMQVRJT05BSEEuMTE1LjAxODUyNA==" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1161/CIRCULATIONAHA.115.018524</span></a><span>​</span></p></li><li><p><span>Ashwell, M., Gunn, P., &amp; Gibson, S. (2012). Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. </span><em><span>Obesity Reviews, 13</span></em><span>(3), 275–286.</span><a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cHM6Ly9kb2kub3JnLzEwLjExMTEvai4xNDY3LTc4OVguMjAxMS4wMDk1Mi54" target="_blank" rel="noopener noreferrer"><span> https://doi.org/10.1111/j.1467-789X.2011.00952.x</span></a><span>​</span></p></li></ol><p>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and screening update</h2><p class="correction-context">Cardiovascular prevention is risk-based. A public case can illustrate a risk factor, but it cannot establish one root cause or prove that a test would have prevented an event. The historical article remains unchanged.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Case interpretation:</strong> Elevated lipoprotein(a) can be an important inherited cardiovascular risk factor. Public information about one cardiac arrest cannot establish a single root cause or prove that a particular test panel at age 40 would have predicted or prevented the event. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Endurance-athlete evidence:</strong> MASTER@HEART was a cross-sectional observational study of 558 low-risk White men, not a randomized trial. Lifelong endurance athletes had more coronary plaque than active controls, but the design cannot prove that exercise caused plaque or worsened clinical outcomes. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Lp(a) and ApoB:</strong> The 2026 ACC/AHA guideline recommends measuring Lp(a) at least once in adulthood. ApoB can refine risk in selected people, especially when residual risk or discordance remains. Neither result should be turned into one universal target or treatment plan without the rest of the cardiovascular context. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Insulin and inflammation:</strong> Fasting insulin, HOMA-IR, and hsCRP can be informative in selected contexts. There is no single HOMA-IR cutoff that diagnoses insulin resistance across assays and populations, and hsCRP below 2 mg/L is not a universal treatment target for every asymptomatic adult. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Coronary calcium:</strong> The 2026 guideline supports selective coronary calcium testing in men aged 40 or older and women aged 45 or older with borderline or intermediate estimated risk when the result would change a lipid-treatment decision. It does not recommend a scan for every adult before or immediately after a birthday. Follow-up depends on the score, baseline risk, treatment, radiation, and clinical question. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.ahajournals.org/doi/abs/10.1161/CIR.0000000000001423" rel="external">American Heart Association &amp; American College of Cardiology. (2026). 2026 guideline on the management of dyslipidemia. Circulation. https://doi.org/10.1161/CIR.0000000000001423</a></li><li id="correction-ref-2"><a href="https://academic.oup.com/eurheartj/article/44/26/2388/7069916" rel="external">De Bosscher, R., Dausin, C., Claus, P., et al. (2023). Lifelong endurance exercise and its relation with coronary atherosclerosis. European Heart Journal, 44(26), 2388–2399. https://doi.org/10.1093/eurheartj/ehad152</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/cardiovascular-screening-in-midlife">Cardiovascular Screening in Midlife: ApoB, Lp(a), and Coronary Calcium →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[I Tried Botox. It Didn't Work. That's Not the Point.]]></title>
<description><![CDATA[Caring how you look is not vanity, it is biology. A surgeon ranks what actually works for your face, skin, hair, and teeth, and what to skip.]]></description>
<link>https://www.andreheeg.com/archive/i-tried-botox-it-didnt-work-thats</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/i-tried-botox-it-didnt-work-thats</guid>
<pubDate>Sun, 12 Apr 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>It’s July 2020. I’m on my twelfth video call of the day. Maybe thirteenth. I stopped counting around June.</p><p>The pandemic turned my home office into a place where I stared at my own face for more than ten hours a day. I had never spent this much time looking at myself. Nobody had. Before, you saw yourself in the bathroom mirror or checked your hair in the elevator, then moved on. Now my face stayed in the corner of my laptop screen from eight in the morning until the last call.</p><p>By the tenth call, my brain stopped pretending to look interested. I stopped watching the other people and started watching myself.</p><p>That’s when I noticed the frown lines.</p><p>Two deep lines between my eyes. The kind that makes you look angry even when you are not. In German, they are called Zornesfalte, or ‘wrath folds.’ The name fits. They deepened as the day went on. By afternoon, they looked permanent. I trained in facial surgery. I know the muscle responsible: corrugator supercilii [1]. I have seen this anatomy in cadavers, textbooks, and patients.</p><p>Knowing the Latin name did not make it less annoying.</p><p>I did what a responsible and sensible person with too much screen time would do. I booked an appointment with a plastic surgeon. I did not tell anyone. It felt a bit ridiculous. A doctor seeing another doctor for something cosmetic. Not urgent. Not medical. Maybe just vanity. I did not have a better word.</p><p>He did the injections. Standard Botox, but a higher dose for my build. Thirty units across my forehead and between my brows. It was quick and clinical. I drove home and waited for the lines to fade.</p><p>The lines stayed.</p><p>I went back after a week. “No effect at all,” I told him. He did seem surprised. He injected more. Maximum dose. “This is as high as I can go.”</p><p>Still nothing.</p><p>Apparently, I am in the under-one-percent group. I do not respond to botulinum toxin. My neuromuscular junction ignores it [2]. Some people win the lottery. I got the version where nothing happens, and there is no fix. I still had to pay.</p><p>The frown lines are still there. I see them every morning. I have made peace with it.</p><p>What stayed with me was not the injections. The hardest part was driving to the appointment. That was when I admitted I cared enough about my appearance to do something about it.</p><h2><strong>The Quiet Tax</strong></h2><p>Men don’t talk about this. Researchers at Promundo studied the pressure and gave it a name: “The Man Box” [3]. The expectation to project toughness, self-reliance, and a general indifference to anything that might be coded as caring about your appearance. The American Psychological Association flagged it in their 2018 guidelines on men’s health: boys learn early to manage their problems on their own [4]. A 2023 study in Cultural Sociology found that men actively buy skincare and grooming products but deliberately hide the fact [5]. They maintain themselves in secret. Like a fight club, but with moisturizer.</p><p>Women face a different version of the same trap. There’s an unspoken expectation to look put-together at all times, but God forbid anyone catches you investing real effort in it. Too much time on appearance? Not serious. Spent money on a procedure? Vain. The double bind is brutal: maintain yourself, but make it look like it happens naturally. Like you woke up like this. Nobody woke up like this.</p><p>Both versions end the same way. Quiet, private shame about caring.</p><p>In 2024, more than 20.5 million non-surgical cosmetic procedures were performed worldwide [6]. The industry trend called “Brotox” saw a 403% increase in male procedures between 2000 and 2018 [7]. Women still make up 85.5% of patients [6], but the gap is closing. Minimal downtime. Nobody at the office needs to know. Most people make sure nobody does.</p><h2><strong>Sixty Newsletters About the Inside</strong></h2><p>I have written about sleep. Nutrition. Hormones. Recovery. Mitochondria. VO2 max. Grip strength. Fiber. More than sixty editions, all focused on what happens inside your body.</p><p>I never wrote about the outside. The part you see when you brush your teeth in the morning.</p><p>The research shows this is a blind spot that needs attention.</p><p>In 1920, psychologist Edward Thorndike studied evaluations of military officers and found something odd. Officers who looked physically impressive received higher ratings on traits unrelated to appearance: intelligence, dependability, and leadership [8]. The correlation was 0.28-0.39 [8], so appearance alone accounted for about 9% of how someone was rated on leadership. Not everything. But not noise either. Across thousands of evaluations, hiring decisions, and promotions, it adds up. He called it the halo effect. A hundred years of research shows it never went away.</p><p>Economist Daniel Hamermesh put a dollar figure on it. Men seen as attractive earn, on average, 4% more than those seen as less attractive [9]. Over a career, that gap added up to about $230,000 [9]. Attractive candidates get more interview callbacks, better performance evaluations, and advance faster [10].</p><p>Self-perception works the same way. Research on workplace attire found that people who felt well-presented rated themselves as more competent, authoritative, and trustworthy [11]. Your nervous system does not separate how you look from how you feel about yourself. The outside affects the inside.</p><p>In the Upward ARC framework, this is part of Capacity. What you see in your reflection before a meeting either gives you energy or takes it away. This happens every day.</p><h2><strong>The Honest Part</strong></h2><p>The simple story is to fix the problem, feel better, and move on. The research is not that simple.</p><p>A systematic review and meta-analysis in Plastic and Reconstructive Surgery found that body-specific satisfaction after cosmetic procedures is high. At six months, 87.2% of patients report satisfaction with the specific area they changed. At twenty-four months, 93.8% [12]. People are generally pleased with what they fixed.</p><p>But when researchers looked at broader measures like overall happiness, mental health, and social functioning, the evidence was described as limited and inconclusive [13]. A 2025 systematic review confirmed this gap: short-term improvements in body-area satisfaction and self-esteem. The link to lasting psychological well-being is still unclear [13].</p><p>So what is actually happening?</p><p>I got Invisalign in my mid-30s. Crooked teeth I’d lived with since I was a teenager. I have a dental degree. I literally studied orthodontics. And I still waited years before doing anything about my own teeth.</p><p>The treatment lasted about a year. People noticed the aligners. Clear plastic trays on your teeth are not invisible, no matter what the marketing says. I had decided to fix it, and the fact that wired braces were no longer needed made the decision easier. A small, modern fix for something that had bothered me for two decades.</p><p>When the aligners came off, I did not feel a rush of happiness. My life stayed the same. What changed was simple. I stopped thinking about my teeth. I stopped angling my smile in photos. I stopped running my tongue over the spot that bothered me. The background noise was gone.</p><p>That is what matters. It is not about transformation, but removal. You take away a small, constant drain on your attention. Something you worked around for years without realizing how much space it took.</p><p>The research supports fixing a specific issue. It does not show that fixing your nose will change your life. The value is smaller and more honest: one less thing to work around.</p><h2><strong>What the Evidence Actually Supports</strong></h2><p>Most things do not work. Most products have weak evidence. Here is what actually works.</p><p><strong>Sunscreen.</strong> A randomized controlled trial in the Annals of Internal Medicine followed 903 adults over 4.5 years. Daily broad-spectrum SPF 30 or higher reduced skin aging by 24% compared to the control group [14]. Ten seconds in the morning. Costs almost nothing. Highest-return intervention for your face.</p><p><strong>Retinoids.</strong> Tretinoin is the most studied topical for reversing fine lines and improving skin texture [15]. It increases collagen and speeds up cell turnover. It is prescription-only in most countries. Expensive serums at the store do not compare. Your dermatologist can prescribe what works for much less.</p><p><strong>Teeth.</strong> Align Technology has treated over 20 million patients with Invisalign [16], and other clear aligner providers serve millions more. Adults are the largest segment of the clear aligner market, holding about 59% of global share [17]. Treatment takes six to eighteen months. Teeth whitening has one of the highest satisfaction rates of any simple cosmetic procedure. If you have been working around a smile you do not like, the fix is faster, easier, and cheaper than most expect.</p><p><strong>Hair.</strong> In androgenetic alopecia, a 5-year clinical trial found that 86% of men on finasteride maintained or increased their hair count compared with baseline [18]. A large observational study of 5% minoxidil showed results in about two out of three users, with about 16% seeing no benefit [19]. Hair transplantation works but is expensive and needs realistic expectations. Supplements and devices have little to no evidence supporting their use. Do not waste your money.</p><p><strong>Posture and body composition.</strong> No procedure can replace resistance training and daily movement. Forward head, rounded shoulders, the office body from years of sitting. Two resistance training sessions a week change how you carry yourself more than losing five kilos [20].</p><p><strong>Injectables.</strong> Botulinum toxin works for most people, but not for me. It reduces dynamic wrinkles for three to six months and is safe when given by qualified doctors [21]. Hyaluronic acid fillers can restore lost volume and are reversible [6]. Both require a skilled provider. In aesthetics, who does the injection matters more than the brand.</p><h2><strong>Try This Today</strong></h2><p><strong>The Sunscreen Default.</strong> Use SPF 30 or higher on your face every morning. The trial data are clear [14]. If you do one thing, do this. Your future self will thank you.</p><p><strong>The Maintenance Calendar.</strong> You schedule oil changes for your car. Do the same for yourself. Teeth cleaning every six months. Skin check once a year. Bloodwork, depending on your needs. Posture check if you sit more than six hours a day. Put it on your calendar. Treat it like any other regular investment.</p><p><strong>The Honest Look.</strong> Not at the mirror, but at yourself. Is there something you have been working around for years? Something small that takes up more space in your mind than you admit? You have two options: fix it or make peace with it. I tried Botox, and it did not work. I made peace with the frown lines. I got Invisalign, and it worked. I fixed my teeth. Both choices were right. The only mistake would have been pretending not to notice.</p><h2><strong>The Screen</strong></h2><p>I still have those frown lines. They show up on every video call, every morning in the bathroom.</p><p>The Botox did not work. The lines stayed. Somewhere along the way, I stopped caring about them. Not because I think frown lines are beautiful. They are not. But because I stopped following a rule I did not know I had: that caring about how you look is for other people. For weaker people. For vain people. For people without real problems.</p><p>That rule feels comfortable. It is also not true.</p><p>You maintain your career. Your finances. Your children’s health. Your team. Your car. Your house.</p><p>The body you live in gets whatever time is left. Most weeks, that is nothing.</p><p>In the Upward ARC framework, Capacity is not just cognitive reserve and physical fitness. It is also how you feel when you look at yourself. That feeling either gives you a bit of energy every morning or takes some away. Over the years, that adds up.</p><p>The change does not need to be dramatic. Most of the time, it is sunscreen, a retinoid, and fixing the thing you have put off since your twenties.</p><p>Start with one thing. The one you already know about.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><h2><strong>References</strong></h2><p>[1] Carruthers, J., &amp; Carruthers, A. (2003). Aesthetic botulinum A toxin in the mid and lower face and neck. <em>Dermatologic Surgery, 29</em>(5), 468-476.</p><p>[2] Dressler, D. (2004). Clinical presentation and management of antibody-induced failure of botulinum toxin therapy. <em>Movement Disorders, 19</em>(S8), S92-S100.</p><p>[3] Heilman, B., Barker, G., &amp; Harrison, A. (2017). <em>The Man Box: A study on being a young man in the US, UK, and Mexico.</em> Promundo-US and Unilever.</p><p>[4] American Psychological Association. (2018). <em>APA guidelines for psychological practice with boys and men.</em></p><p>[5] Byrne, A., &amp; Milestone, K. (2023). ‘He wouldn’t be seen using it.’ Men’s use of male grooming products as a form of invisible consumption. <em>Cultural Sociology, 17</em>(1), 89-108.</p><p>[6] International Society of Aesthetic Plastic Surgery. (2024). <em>ISAPS International Survey on Aesthetic/Cosmetic Procedures Performed in 2024.</em></p><p>[7] American Society of Plastic Surgeons. (2024). <em>2024 Plastic Surgery Statistics Report.</em></p><p>[8] Thorndike, E. L. (1920). A constant error in psychological ratings. <em>Journal of Applied Psychology, 4</em>(1), 25-29.</p><p>[9] Hamermesh, D. S. (2011). <em>Beauty pays: Why attractive people are more successful.</em> Princeton University Press.</p><p>[10] Hosoda, M., Stone-Romero, E. F., &amp; Coats, G. (2003). The effects of physical attractiveness on job-related outcomes: A meta-analysis of experimental studies. <em>Personnel Psychology, 56</em>(2), 431-462.</p><p>[11] Peluchette, J. V., &amp; Karl, K. (2007). The impact of workplace attire on employee self-perceptions. <em>Human Resource Development Quarterly, 18</em>(3), 345-360.</p><p>[12] Dreher, R., Blaya, C., Tenorio, J. L., &amp; Saltz, R. (2016). Quality of life and aesthetic plastic surgery: A systematic review and meta-analysis. <em>Plastic and Reconstructive Surgery - Global Open, 4</em>(9), e862.</p><p>[13] Hart, T., et al. (2025). The psychosocial outcomes following cosmetic surgery are largely unknown: A systematic review. <em>Journal of Plastic, Reconstructive &amp; Aesthetic Surgery.</em></p><p>[14] Hughes, M. C. B., Williams, G. M., Baker, P., &amp; Green, A. C. (2013). Sunscreen and prevention of skin aging: A randomized trial. <em>Annals of Internal Medicine, 158</em>(11), 781-790.</p><p>[15] Mukherjee, S., Date, A., Patravale, V., Korting, H. C., Roeder, A., &amp; Weindl, G. (2006). Retinoids in the treatment of skin aging: An overview of clinical efficacy and safety. <em>Clinical Interventions in Aging, 1</em>(4), 327-348.</p><p>[16] Align Technology. (2025). <em>First quarter 2025 financial results.</em> Investor Relations.</p><p>[17] Grand View Research. (2025). <em>Clear aligners market size &amp; share: Industry report, 2025-2033.</em></p><p>[18] Kaufman, K. D., Olsen, E. A., Whiting, D., Savin, R., DeVillez, R., Bergfeld, W., Price, V. H., Van Neste, D., Roberts, J. L., Hordinsky, M., Shapiro, J., Binkowitz, B., &amp; Gormley, G. J. (1998). Finasteride in the treatment of men with androgenetic alopecia. <em>Journal of the American Academy of Dermatology, 39</em>(4), 578-589.</p><p>[19] Olsen, E. A., Dunlap, F. E., Funicella, T., Koperski, J. A., Swinehart, J. M., Tschen, E. H., &amp; Trancik, R. J. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. <em>Journal of the American Academy of Dermatology, 47</em>(3), 377-385.</p><p>[20] Westcott, W. L. (2012). Resistance training is medicine: Effects of strength training on health. <em>Current Sports Medicine Reports, 11</em>(4), 209-216.</p><p>[21] Carruthers, A., &amp; Carruthers, J. (2017). Botulinum toxin products overview. <em>Dermatologic Surgery, 43</em>(S2), S67-S73.</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">Cosmetic choices are personal. Evidence on response, appearance, skin care, and procedures needs treatment-specific limits and should not be turned into universal screening or safety advice.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Botulinum-toxin response:</strong> Antibody-related treatment failure does not explain every unsuccessful cosmetic session. Product, dose, dilution, placement, target muscle, timing, expectations, antibodies, and individual anatomy can all contribute. The cited evidence does not support the claim that fewer than 1% fail because their neuromuscular junction is different. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Halo-effect arithmetic:</strong> Squaring one attractiveness correlation does not show that appearance explains 9% of career outcomes across people and settings. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Sunscreen trial:</strong> The randomized Australian trial supplied broad-spectrum SPF 15+ sunscreen for instructed daily use, not SPF 30. Daily sun protection remains sensible, but the product and comparison should be reported accurately. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Fillers and skin screening:</strong> Some hyaluronic-acid filler can be dissolved, but filler complications can include vascular occlusion, visual loss, tissue injury, and infection. Annual clinician skin screening is not established for every asymptomatic adult; risk, skin changes, and local guidance matter. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/21134050/" rel="external">Dressler, D., Wohlfahrt, K., Meyer-Rogge, E., et al. (2010). Antibody-induced failure of botulinum toxin A therapy in cosmetic indications. Dermatologic Surgery, 36(Suppl. 4), 2182–2187. https://pubmed.ncbi.nlm.nih.gov/21134050/</a></li><li id="correction-ref-2"><a href="https://doi.org/10.1111/j.1744-6570.2003.tb00157.x" rel="external">Hosoda, M., Stone-Romero, E. F., &amp; Coats, G. (2003). The effects of physical attractiveness on job-related outcomes: A meta-analysis of experimental studies. Personnel Psychology, 56(2), 431–462. https://doi.org/10.1111/j.1744-6570.2003.tb00157.x</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/23732711/" rel="external">Hughes, M. C. B., Williams, G. M., Baker, P., &amp; Green, A. C. (2013). Sunscreen and prevention of skin aging: A randomized trial. Annals of Internal Medicine, 158(11), 781–790. https://pubmed.ncbi.nlm.nih.gov/23732711/</a></li><li id="correction-ref-4"><a href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening" rel="external">U.S. Preventive Services Task Force. (2023). Skin cancer: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/skin-hair-injectables-and-prevention">Skin, Hair, Injectables, and Preventive Care →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[You Already Know What to Do. That Was Never the Problem.]]></title>
<description><![CDATA[You do not have an information problem, you have an execution debt. Why elite health protocols fail busy professionals, and the one-action fix.]]></description>
<link>https://www.andreheeg.com/archive/you-already-know-what-to-do-that</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/you-already-know-what-to-do-that</guid>
<pubDate>Sun, 05 Apr 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>Flying over Frankfurt at 35,000 feet, I listen to Andrew Huberman talk about winding down for sleep. He says to dim the lights two hours before bed, avoid screens in the last hour, and let melatonin work without blue light interference.</p><p>It’s Monday morning, and I’m flying to a client. I’m on my third coffee after five hours of sleep. The podcast is solid. Clear science, sharp delivery. I jot down mental notes, planning to start tonight: screens off by ten, lights low, the whole routine.</p><p>That night, I’m in another hotel room. Could be Zurich, could be Munich, they all blur together. It’s 11:30 p.m., and I’m still working on my laptop. The client deck was supposed to be done by nine. Fourteen messages wait. The room is bright, the screen cutoff long past. I know exactly what this blue light is doing to my melatonin, but I can’t close the laptop. The partner review is at 8 a.m., and the deck isn’t ready.</p><p>That morning’s episode? Bookmarked. Filed away with the other hundred-plus episodes, articles, and papers I’d saved and never acted on. My collection kept growing, and so did the gap between what I knew and what I actually did.</p><p>This went on for years.</p><p>I am a BCG managing director and partner. Three kids. A medical degree and a background in competitive wrestling. Since my wrestling days, I’ve been obsessed with performance: researching, testing, looking for any edge I could find. That drive never faded. It just changed targets. Instead of finding that 1% edge over an opponent, I was collecting health content to edge out my work performance. Podcasts, books, research papers. Hundreds of hours saved. But something else was missing, and it took me a long time to see it.</p><h2>150 Bookmarked Episodes and Nothing to Show for It</h2><p>In software, there’s a concept called technical debt. You take shortcuts to ship faster, and those shortcuts accumulate. They don’t sit quietly. They slow everything down until one day the whole system grinds to a halt. Not because of one bad decision, but because of a hundred small ones that compounded.</p><p>Health works the same way. Every episode you listen to and don’t act on, every paper you save, every protocol you bookmark for Monday, adds to what I call execution debt. It compounds like the financial kind, except the interest payments are guilt, paralysis, and the growing sense that you’re too far behind to start.</p><p>A meta-analysis of nearly 30,000 people found that 47.6% of those who intended to exercise never followed through [1]. Half. Not people who didn’t care. People who genuinely wanted to move their bodies and couldn’t close the distance between wanting and doing.</p><p>Researchers at Duke found something worse. They studied a thousand adults with Type II diabetes. Two-thirds reported high knowledge of what they needed to do. Nearly all agreed it was important. Zero correlation between their knowledge and their actual disease management [3]. The people who knew the most did no better than the people who knew the least.</p><p>You’ve seen this before. Just not in a mirror. Jeffrey Pfeffer and Robert Sutton at Stanford called it the knowing-doing gap [12]. Organizations with brilliant strategy decks that can’t execute to save their lives. You’ve probably sat in that room. Maybe you were the one presenting the strategy. The organization that knows the right answer but can’t act on it, and the executive who knows the right protocol but can’t follow it, are the same problem wearing different clothes.</p><h2>Built for Someone Else</h2><p>I overlooked this for a long time. The health advice filling my feed wasn’t wrong. It just wasn’t meant for me.</p><p>Huberman’s full morning protocol, sunlight exposure, cold plunge, and specific supplement timing, takes ninety minutes before your workday starts. That’s a part-time job. Peter Attia, whose reputation has since collapsed for reasons unrelated to his training advice, built a framework that demands 10+ hours per week across zone 2, strength, stability, and mobility. Bryan Johnson spends two million dollars a year on a personal medical team, blood draws at dawn, and protocols that treat the human body like a space shuttle [10]. In February 2026, he launched “Immortals,” a program offering his exact protocol to clients for $1 million per year each [11]. That’s not health. That’s a hobby for the very rich.</p><p>Meanwhile, the CDC’s actual recommendation is 150 minutes of moderate physical activity per week [14]. That’s 30 minutes across five days. No cold plunge. No supplement stack. No personal chef.</p><p>Popular health protocols often require 10 hours a week, while the CDC recommends only 2.5. The difference between these numbers is where the industry makes money and where people start to feel guilty.</p><p>As a BCG partner, my schedule is set by teams, partners, and clients across time zones. My day often starts before my kids are awake and ends after midnight. I cannot find ninety minutes for a morning routine or ten hours a week for training. Every week I could not follow these protocols, my execution debt increased. The science was accurate, but it was designed for someone whose full-time job is their body. My full-time job is something else.</p><p>The advice wasn’t the problem. The audience was.</p><h2>Your Brain at 11 p.m.</h2><p>When you run a high-demand job for years, your body keeps a physiological ledger. Researchers call it allostatic load, the cumulative wear from sustained stress. It shows up in your bloodwork, your inflammation markers, and eventually your brain tissue. A 2025 study in Frontiers in Aging Neuroscience found that higher allostatic load was associated with lower global cognition and reduced gray matter volume [4]. Not mood. Not “feeling tired.” Structural changes in the brain.</p><p>This explains why evening routines never worked for me. It was not a matter of discipline. After fourteen hours of work, my ability to make good decisions was gone. By 11 p.m., the part of my brain responsible for planning was spent. I would just react and take the easiest option. Using screens late at night was not a real choice. It was the result of being too tired to choose differently.</p><p>CEO lifespan drops by 1.5 years during industry downturns [5]. Not because they stopped exercising. Because stress itself is more destructive than any health routine is protective. Anti-takeover legislation that shielded CEOs from hostile bids extended their lives by roughly two years [5]. That’s the equivalent of quitting smoking before thirty. The protection wasn’t a gym membership. It was reduced stress.</p><p>And then there’s the sitting. Sedentary time beyond 10.6 hours per day is associated with a 30% increase in cardiovascular disease risk. Every additional hour adds another 5%. This holds even for people who meet exercise guidelines [6]. You can go to the gym every morning and still carry the risk if you spend the other fourteen hours in a chair.</p><p>If expertise solved health, doctors would be the healthiest people alive. In the general population, men die by suicide four times more often than women. Among physicians, that gap disappears. Female doctors die by suicide at the same rate as male doctors [7]. 58% of medical students screen positive for depression [8]. I trained inside this system. I know what it looks like when the most knowledgeable people in the room can’t apply their own knowledge. The problem was never what you know.</p><h2>Try This Today</h2><p>You do not reduce execution debt by adding another protocol. You do it by choosing one action that is so simple you can do it even when you are tired.</p><p><strong><span>Pick one thing and delete the rest.</span></strong><span> The supplements you never took, the 5 a.m. routine you stopped, the training plan saved since October. Gone. All of it. Now pick one action. Not the optimal one. The one you’ll actually do. That might be sleep. It might be moving. It might be eating a real meal instead of whatever you grabbed between meetings. There’s no universal answer here, but if I had to push you: start with sleep or movement. Sleep because it affects everything downstream. Movement because even ten minutes changes your neurochemistry for the rest of the day. Do only that for two weeks. You don’t owe the other protocols anything.</span></p><p><strong><span>Set up tomorrow tonight.</span></strong><span> Researchers call these implementation intentions: if-then rules that remove the decision from the equation. They’ve been tested across 94 studies with consistent results [9]. In one study, every participant who formed a specific if-then plan completed a health task, compared with 53% who just intended to [9]. Here’s what this looks like in practice. Every night, I lay out my workout clothes next to the bed. When I wake up, the decision is already made. I move, even if it’s just ten minutes. On travel days, I grab protein bars, fruit, and nuts from the hotel breakfast buffet and keep them in my bag. When I’m hungry at 3 p.m. in a client meeting, I’m not relying on willpower to avoid the vending machine. The food is already there. At team or client dinners, I don’t open the menu in hopes of inspiration. I look for two or three meal options: steak, fish, or another high-quality protein source, plus vegetables. I order one of those. I also order the fries, because life is short.</span></p><p><strong><span>Redesign the 11 p.m. moment.</span></strong><span> The decisions you make at 11 p.m. are not the same as those you plan in the morning. Set a 9:30 alarm to turn off screens. Charge your phone outside the bedroom. The goal is not more discipline. The goal is to make the right choice automatic, since by nightfall your ability to make active choices will be spent.</span></p><p><strong><span>Run the 80/20 health audit.</span></strong><span> Write down everything you think you should do for your health. Circle the 20% that would give you most of the results if you actually did them. Cross out the rest. The crossed-out items are your execution debt, and letting them go may be the most helpful thing you do this week. 70+ years of longevity research boils down to five things: sleep 7+ hours, move 4-5 times a week, eat mostly real food, maintain relationships that matter, and find meaning beyond your job title. Your grandmother knew all five.</span></p><h2>The Question That Changed the Math</h2><p>A few weeks into our recent sabbatical in Cape Town, I was sitting on the floor with Karla. She’s six. She was trying to explain some game she’d invented, and the rules made no sense, but she was fully committed to them. I was half-listening, mentally sorting through a training protocol I’d bookmarked that morning. Reps, rest intervals, weekly periodization. My body was in the room. My head was in another spreadsheet.</p><p>She looked up and said something like, “You’re not playing right.”</p><p>She was right. I wasn’t.</p><p>That was the moment I stopped asking “How do I implement this protocol?” and started asking a different question. How do I actually want to live? What example do I want to set for these three kids? What does it mean to be healthy for a purpose, not for a scoreboard someone else built?</p><p>The hundred-plus bookmarked episodes and saved papers looked different after that. They were not a failed to-do list. They were a symptom. The same overachiever instinct that filled my calendar also filled my content library. Collecting and organizing as a substitute for doing.</p><p>That’s what I mean by Capacity in my Upward ARC framework. Building systems that work when you’re running on fumes. After a fourteen-hour day, you will be depleted. That’s the operating condition. The question is whether you’ve set things up so the right choice happens anyway, without needing the rare, well-rested version of yourself.</p><p>I still sit in hotel rooms past midnight, sometimes. I write newsletter editions and LinkedIn posts at 5 a.m. before the kids are up. Working hard isn’t going anywhere. That was never the thing I wanted to fix. What needed fixing was the belief that I had to earn my health through some perfect protocol, instead of building it into the life I already have.</p><p>The other night, in another interchangeable hotel room, the deck was done by ten. I closed the laptop. The lights were already low. I didn’t check my phone. I just sat there for a few minutes, in the quiet, and went to bed.</p><p>Not because I finally found the right protocol. Because I finally asked the right question.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><div><hr></div><h2>References</h2><p>[1] Feil, K., et al. (2023). The intention-behavior gap in physical activity: A meta-analysis. British Journal of Sports Medicine. N=29,600.</p><p>[2] Sheeran, P., &amp; Webb, T. L. (2016). The intention-behavior gap. Social and Personality Psychology Compass, 10(9), 503-518.</p><p>[3] Health Behavior: From Paradox to Paradigm. Diabetes Spectrum, American Diabetes Association.</p><p>[4] Frontiers in Aging Neuroscience (2025). Allostatic load and brain structure: associations with global cognition and gray matter volume.</p><p>[5] Borgschulte, M., Guenzel, M., Liu, C., &amp; Malmendier, U. (2025). CEO stress, aging, and death. The Journal of Finance, 80, 3401-3442. Originally NBER Working Paper No. 28550.</p><p>[6] Journal of the American College of Cardiology (2024). Sedentary behavior and cardiovascular disease risk: accelerometer-based analysis.</p><p>[7] Duarte, D., et al. (2024). Suicide rates among physicians compared with the general population: gender stratified systematic review and meta-analysis. BMJ, 386, e078964. Also: Kiraly, I., et al. (2025). Female physician suicide compared to the general population. JAMA Psychiatry.</p><p>[8] Dyrbye, L. N., Thomas, M. R., &amp; Shanafelt, T. D. (2006). Systematic review of depression, anxiety, and other indicators of psychological distress among U.S. and Canadian medical students. Academic Medicine, 81(4), 354-373.</p><p>[9] Gollwitzer, P. M., &amp; Sheeran, P. (2006). Implementation intentions and goal achievement: A meta-analysis of effects and processes. Advances in Experimental Social Psychology, 38, 69-119. 94 studies, d = 0.65.</p><p>[10] Fortune (2025). Tech founder who spends $2 million a year to live forever. January 10, 2025.</p><p>[11] TechCrunch (2026). For $1M, you can pay Bryan Johnson to teach you how to live longer. February 12, 2026.</p><p>[12] Pfeffer, J., &amp; Sutton, R. I. (2000). The Knowing-Doing Gap: How Smart Companies Turn Knowledge into Action. Harvard Business School Press.</p><p>[13] McEwen, B. S. (1998). Stress, adaptation, and disease: Allostasis and allostatic load. Annals of the New York Academy of Sciences, 840(1), 33-44.</p><p>[14] Centers for Disease Control and Prevention. (2024). How much physical activity do adults need? Physical Activity Guidelines for Americans.</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">Knowing and doing are different problems, but stress and behavior research does not explain every person's choices or support literal zeroes, universal rankings, or guaranteed neurochemical effects.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Knowledge and diabetes behavior:</strong> Knowledge alone is commonly insufficient for behavior change. The evidence cited in the edition does not establish zero correlation between diabetes knowledge and behavior. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Stress mechanism:</strong> Allostatic-load imaging and executive-stress research describe population associations. They do not show that stress is more destructive than every routine or explain one reader's evening decisions. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Medical-student distress:</strong> The 2006 review combined depression, anxiety, burnout, and other indicators across heterogeneous studies. It does not support the statement that 58% of medical students have depression. Physician suicide findings also vary by sex, country, era, and comparator and should not be used as individual prognosis. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Ten minutes of movement:</strong> Brief movement can be useful, but the cited guidance does not show that ten minutes produces a neurochemical effect lasting the full day. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/36792169/" rel="external">Teoh, K. W., Ng, C. M., Chong, C. W., et al. (2023). Knowledge, attitude, and practice toward pre-diabetes among the public, patients with pre-diabetes and healthcare professionals: A systematic review. BMJ Open Diabetes Research &amp; Care, 11(1), e003203. https://doi.org/10.1136/bmjdrc-2022-003203</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/40230487/" rel="external">Palix, C., Chauveau, L., Felisatti, F., et al. (2025). Allostatic load, a measure of cumulative physiological stress, impairs brain structure but not β-accumulation in older adults: An exploratory study. Frontiers in Aging Neuroscience, 17, 1508677. https://doi.org/10.3389/fnagi.2025.1508677</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/16342655/" rel="external">Dyrbye, L. N., Thomas, M. R., &amp; Shanafelt, T. D. (2005). Medical student distress: Causes, consequences, and proposed solutions. Mayo Clinic Proceedings, 80(12), 1613–1622. https://pubmed.ncbi.nlm.nih.gov/16342655/</a></li><li id="correction-ref-4"><a href="https://www.who.int/publications/i/item/9789240014886" rel="external">World Health Organization. (2020). WHO guidelines on physical activity and sedentary behaviour. https://www.who.int/publications/i/item/9789240014886</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/behavior-change-under-load">Behavior Change Under Load: From Knowledge to Action →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Why We Die: The Midlife Risk Factors You Can See and the Ones You Can't]]></title>
<description><![CDATA[What actually kills people in their 40s, ranked. Why the deadliest risks wear the mask of productivity, and the two that cost nothing to fix.]]></description>
<link>https://www.andreheeg.com/archive/why-we-die-the-midlife-risk-factors</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/why-we-die-the-midlife-risk-factors</guid>
<pubDate>Sun, 29 Mar 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>Back home, getting your motorcycle license at 16 was just what you did. It wasn’t about loving motorcycles. It was about living out in the German countryside, where you needed one to get anywhere at all.</p><p>Small town life meant no buses after six. Friends were always a village away, and the sports club took twenty minutes by road. So as soon as you could, you got your license. Everyone did. That motorcycle was your link to everything beyond your doorstep.</p><p>Teenagers on fast bikes, twisting through forest roads without guardrails. Sooner or later, the odds caught up. I lost friends. Kids from wrestling, classmates, people I’d known my whole life. Some died in cars, some on motorcycles. When you’re seventeen, risk is just a word.</p><p>Drive through that part of Germany, and you’ll see crosses by the roadside, each one marking someone who never made it home.</p><p>The danger was right there for everyone to see. Wet roads, someone going too fast. Nobody pretended otherwise.</p><p>In the next thirty years, death slips into the background. Now it’s older relatives, just as you’d expect. You go to the funeral, grieve, and move on. It happens to someone else, someone further along.</p><p>But in your mid-40s, it circles back. A classmate gets cancer. Someone from college has a heart attack. A colleague’s partner is gone. Even suicide. These aren’t relatives at the end of their story. They’re within your age range. People who seemed healthy, with families, jobs, plans.</p><p>I still try to convince my wife to let me get another motorcycle. She grew up here, too. She remembers those crosses. It’s one of the few things she won’t budge on. Looks like I’ll need a new plan for my midlife crisis.</p><p>Those crosses spelled out the risk. At 47, the dangers have changed. You can’t see them. There are no signs. Most of us are already carrying at least two of these risks.</p><p>I write about health and longevity all the time, but I’d never stepped back to see the whole picture. What’s really taking out people like us? What are the true midlife risks, ranked by how much they shorten your life? I spent a weekend digging into the research. The answer is here.</p><h2>The Landscape</h2><p>In the United States in 2024, heart disease killed 683,000 people. Cancer killed 620,000. Then, there are unintentional injuries, stroke, and chronic lung disease [1][2]. Cancer is the number one killer for adults under 65 [3]. Suicide replaced COVID as number ten [2].</p><p>But those diseases are just the result. The real question is what causes them. When you line up the risk factors you can actually change, sorted by how much they cut your life short, the list isn’t what most people think.</p><p>That’s why I built the Upward ARC framework. Three pillars: Activate, Recover, Capacity. It’s about movement, nutrition, and what you put in your body. It’s about sleep and social ties. It’s about keeping your mind sharp and handling stress. This isn’t wellness theory. It’s the math of staying alive.</p><h2>The Ones with Warning Labels</h2><p>Some risks have had decades of public attention. Warning labels on cigarette packs. Calorie counts on menus. Drunk driving campaigns on Super Bowl Sunday. These are the risks you know about, even if you ignore them.</p><p>Quick note on the numbers that follow. A “hazard ratio” is a multiplier on your risk of dying. 1.0 means normal risk. 1.50 means 50% higher. The higher it is above 1.0, the worse it is.</p><p><strong>Smoking</strong> remains the benchmark. Current smokers face two to three times the mortality risk of people who never smoked [4]. Even moderate smoking, fewer than 20 cigarettes per day, carries a hazard ratio of 1.54, meaning 54% higher mortality risk [5]. Heavy smoking pushes that to 2.09 [5]. A meta-analysis of over 239 prospective studies with 10.6 million participants confirmed that the relationship between smoking and death is about as settled as science gets [4].</p><p><strong>Obesity</strong> follows what researchers call a U-shaped curve, meaning both extremes are dangerous. Being significantly underweight raises mortality risk, and so does being significantly overweight, with the lowest risk sitting somewhere in the middle. A BMI of 30 to 35 (grade 1 obesity) is associated with a hazard ratio of 1.45. BMI 35 to 40 jumps to 1.94. Above 40, it reaches 2.76 [6]. The numbers come from individual-participant data across 239 studies and four continents.</p><p><strong>Alcohol</strong> is worth a hard look. The WHO’s position since January 2023 is clear: no level of alcohol consumption is safe for your health [7a]. At high doses, 65 or more grams per day (roughly five or more drinks), mortality risk rises by 35% [7]. The Global Burden of Disease study added age-specific detail: for adults under 40, there is zero health benefit from any amount of alcohol. For those over 40, very small amounts may offer a slight reduction in cardiovascular risk, but even then, the risks from cancer and injury still apply [7b]. The days of “a glass of red wine is good for you” are over.</p><p>These risks have one thing going for them: everyone can see them. We’ve built public health campaigns, social pressure, and policies around them. Even if you’ve never read a study, you know smoking is deadly.</p><p>Some of the people I lost at 17 were taking visible risks. No helmet. Too fast. The danger was right there. Everyone could name it.</p><h2>The Ones Without Warning Labels</h2><p>Most of these risks wear the mask of productivity.</p><p>There’s another set of risks that are just as deadly. No warning signs. No public campaigns. Until recently, nobody even talked about them.</p><p><strong>Physical inactivity</strong> accounts for 5.9% of global deaths. For comparison, tobacco accounts for 8.7% [8]. Closer than anyone expects. Adults who sit more than 10 hours a day have a 34% higher mortality risk than those who sit for one hour [9]. But here’s the part worth knowing: 60 to 75 minutes of moderate daily activity eliminates that excess risk entirely [10]. A walk between meetings counts.</p><p>After reading that, I checked my own screen time. The hours spent sitting stared back at me.</p><p><strong>Poor sleep</strong> is the quiet multiplier. Sleeping fewer than seven hours is associated with a hazard ratio of 1.12-1.14 [11]. That looks modest on a spreadsheet. But sleep doesn’t act alone. It compounds everything else. Sleep deprivation raises inflammation, messes with your blood sugar control, and wears down the mental sharpness you need to manage every other risk on this list [12]. It’s the compound interest of declining health.</p><p><strong>Social isolation</strong>, meaning having few social contacts, relationships, or community ties, carries a hazard ratio of 1.32 for all-cause mortality [13]. That’s based on a meta-analysis of 90 cohort studies covering 2.2 million people, published in Nature Human Behaviour [13]. For cardiovascular mortality specifically, it’s 1.34 [13]. For cancer mortality, 1.24 [13]. The U.S. Surgeon General’s 2023 advisory framed the mortality risk as comparable to smoking 15 cigarettes a day [14]. The precise equivalence is debatable, but the order of magnitude is consistent across multiple independent analyses.</p><p><strong>Loneliness</strong> is different from isolation. Isolation is structural: how many connections you have. Loneliness is about the feeling: whether those connections actually fill the tank. You can be surrounded by people all day and still be lonely. Both predict early death through different mechanisms. Loneliness carries a hazard ratio of 1.56 for stroke [15] and 1.31 for all-cause dementia [16]. For vascular dementia (the kind caused by reduced blood flow to the brain), it’s 1.74 [16]. A 2024 genetic analysis confirmed what many suspected: loneliness causes depression, and depression causes loneliness. The relationship runs both ways [17]. The WHO Commission on Social Connection published its first report in June 2025, estimating that loneliness accounts for approximately 871,000 deaths worldwide each year [18]. That’s roughly 100 deaths per hour.</p><p>We actually reward these hidden risks. The leader who never sleeps? Dedicated. The executive glued to meetings all day? Committed. The person who hasn’t had a real conversation in weeks? Focused. None of this comes with a warning sign.</p><p>The friends I’m losing at 47.. there’s no sharp curve or motorcycle to point to. Just bodies quietly stacking up risks no one saw coming.</p><p>In the Upward ARC framework, these fall under Recover and Capacity. They’re the ones most professionals ignore because you can’t measure them with a blood test.</p><h2>The Compounding Problem</h2><p>Risk factors don’t add. They multiply. A study of U.S. adults found that people who smoked, were obese, and were physically inactive had 231% greater all-cause mortality than those with none of these risk factors. In age-adjusted terms, that’s the equivalent of being 13 years older [19].</p><p>The invisible risks pile up just as fast. Poor sleep ramps up inflammation in your body [12]. Social isolation messes with your sleep even if you’re in bed for 8 hours [20]. Loneliness flips a switch in your genes: the ones that cause inflammation get louder, the ones that fight off viruses get quieter [21]. It’s a cycle that keeps going.</p><p>You might not smoke, you might eat well and exercise, but if you’re only getting six hours of sleep and haven’t spoken to anyone outside work in weeks, you’re still carrying a heavy risk.</p><p>The world is catching on. The UK appointed a Minister for Loneliness in 2018. Japan followed in 2021. Six European countries now have national loneliness strategies [22]. In 2025, the World Health Assembly made social connection a global health agenda item [18]. Governments are treating this like the public health crisis it is. Just slowly.</p><p>The usual midlife health advice - don’t smoke, lose weight, exercise - only covers what you can see. It misses the two biggest factors for people our age: sleep and connection. Both cost nothing. Both need no equipment. Both are the first to go when life gets busy.</p><h2>Try This Today</h2><p><strong>The Sitting Audit:</strong> Track how many hours you sit each day for three days. If you’re over eight hours, aim for 60-75 minutes of moderate movement daily. That’s the point where the extra risk from sitting vanishes [10]. Walk between meetings. Take the stairs. Stand during calls. You don’t need a gym.</p><p><strong>The Sleep Floor: </strong>Guard seven hours of sleep. No exceptions. Sleeping less doesn’t just leave you tired. It makes every other risk worse [11][12]. If you can’t get the hours, at least make them unbroken. One solid stretch is better than broken sleep, because your brain needs deep, steady rest to clear out waste.</p><p><strong>The Outsider Slot: </strong>Set up a regular meeting with someone outside your work life. A coach, a climbing buddy, a neighbor. Research shows it’s the mix of social roles, not just how many people you know, that boosts your immune system and health [23]. Guard this time like you would a board meeting.</p><p><strong>The Risk Stack Audit:</strong> Write down where you really stand on each factor - smoking, weight, movement, sleep, alcohol, social ties. Most people think they’ve handled the obvious risks and miss the hidden ones. That blind spot is where the real danger is.</p><h2>Back to the Road</h2><p>Last week I drove through the countryside where I grew up. The crosses are still there. Weathered wood, faded paint. Someone still leaves fresh flowers on the one by the crossing outside my village, even after all these years.</p><p>Those crosses told stories everyone understood: a young person, a fast bike, a night gone wrong.</p><p>At 47, the risks don’t leave markers by the road. They’re quieter now, but just as real. Most can be fixed. That’s what matters.</p><p>Start with the one you’ve been ignoring.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><div><hr></div><p>​</p><h2>References</h2><p>[1] Siegel, R. L., Miller, K. D., Wagle, N. S., &amp; Jemal, A. (2024). Cancer statistics, 2024. <em>CA: A Cancer Journal for Clinicians, 74</em>(1), 12-49.</p><p>[2] National Center for Health Statistics. (2025). <em>Mortality in the United States, 2024.</em> NCHS Data Brief No. 548. Centers for Disease Control and Prevention.</p><p>[3] National Center for Health Statistics. (2025). <em>Mortality in the United States: Provisional data, 2024.</em> Vital Statistics Rapid Release. Centers for Disease Control and Prevention.</p><p>[4] Jha, P., Ramasundarahettige, C., Landsman, V., Rostron, B., Thun, M., Anderson, R. N., McAfee, T., &amp; Peto, R. (2013). 21st-century hazards of smoking and benefits of cessation in the United States. <em>New England Journal of Medicine, 368</em>(4), 341-350.</p><p>[5] Inoue-Choi, M., Liao, L. M., Reyes-Guzman, C., Hartge, P., Caporaso, N., &amp; Freedman, N. D. (2017). Association of long-term, low-intensity smoking with all-cause and cause-specific mortality in the National Institutes of Health-AARP Diet and Health Study. <em>JAMA Internal Medicine, 177</em>(1), 87-95.</p><p>[6] Global BMI Mortality Collaboration. (2016). Body-mass index and all-cause mortality: Individual-participant-data meta-analysis of 239 prospective studies in four continents. <em>The Lancet, 388</em>(10046), 776-786.</p><p>[7] Zhao, J., Stockwell, T., Naimi, T., Churchill, S., Clay, J., &amp; Sherk, A. (2023). Association between daily alcohol intake and risk of all-cause mortality: A systematic review and meta-analyses. <em>JAMA Network Open, 6</em>(3), e236185.</p><p>[7a] World Health Organization Regional Office for Europe. (2023, January 4). No level of alcohol consumption is safe for our health. WHO.</p><p>[7b] GBD 2020 Alcohol Collaborators. (2022). Population-level risks of alcohol consumption by amount, geography, age, sex, and year: A systematic analysis for the Global Burden of Disease Study 2020. <em>The Lancet, 400</em>(10346), 185-235.</p><p>[8] World Health Organization. (2024). <em>Noncommunicable diseases fact sheet.</em> WHO.</p><p>[9] Chau, J. Y., Grunseit, A. C., Chey, T., Stamatakis, E., Brown, W. J., Matthews, C. E., Bauman, A. E., &amp; van der Ploeg, H. P. (2013). Daily sitting time and all-cause mortality: A meta-analysis. <em>PLOS ONE, 8</em>(11), e80000.</p><p>[10] Ekelund, U., Steene-Johannessen, J., Brown, W. J., Fagerland, M. W., Owen, N., Powell, K. E., Bauman, A., &amp; Lee, I. M. (2016). Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. <em>The Lancet, 388</em>(10051), 1302-1310.</p><p>[11] Li, Y., Zhang, X., Winkelman, J. W., Redline, S., Hu, F. B., Stampfer, M., Ma, J., &amp; Gao, X. (2025). Imbalanced sleep increases mortality risk by 14-34%: A meta-analysis. <em>GeroScience.</em></p><p>[12] Irwin, M. R. (2015). Why sleep is important for health: A psychoneuroimmunology perspective. <em>Annual Review of Psychology, 66</em>, 143-172.</p><p>[13] Wang, F., Gao, Y., Han, Z., Yu, Y., Long, Z., Jiang, X., Wu, Y., Pei, B., Cao, Y., Ye, J., Li, M., He, Y., Zhang, D., &amp; Yang, B. (2023). A systematic review and meta-analysis of 90 cohort studies of social isolation, loneliness and mortality. <em>Nature Human Behaviour, 7</em>(8), 1307-1319.</p><p>[14] Office of the Surgeon General. (2023). <em>Our epidemic of loneliness and isolation: The U.S. Surgeon General’s advisory on the healing effects of social connection and community.</em> U.S. Department of Health and Human Services.</p><p>[15] Shen, C., Rolls, E., Cheng, W., Kang, J., Dong, G., Xie, C., Zhao, X. M., Sahakian, B. J., &amp; Feng, J. (2024). Chronic loneliness and the risk of incident stroke in middle and late adulthood: A longitudinal cohort study of U.S. older adults. <em>eClinicalMedicine, 72</em>, 102639.</p><p>[16] Luchetti, M., Terracciano, A., Stephan, Y., &amp; Sutin, A. R. (2024). Loneliness and risk of dementia and cognitive impairment: An updated meta-analysis. <em>Nature Mental Health, 2</em>, 1323-1334.</p><p>[17] Holt-Lunstad, J. (2024). Social connection as a critical factor for mental and physical health: Evidence, trends, challenges, and future implications. <em>World Psychiatry, 23</em>(3), 312-332.</p><p>[18] World Health Organization. (2025). <em>From loneliness to social connection: Charting a path to healthier societies. Report of the WHO Commission on Social Connection.</em> WHO.</p><p>[19] Xiang, X., An, R., &amp; Kang, S. W. (2024). The clustering effects of current smoking status, overweight/obesity, and physical inactivity with all-cause and cause-specific mortality risks in U.S. adults. <em>Preventive Medicine Reports, 43</em>, 101578.</p><p>[20] Griffin, S. C., Williams, A. B., Mladen, S. N., Perrin, P. B., Dzierzewski, J. M., &amp; Rybarczyk, B. D. (2020). Loneliness and sleep: A systematic review and meta-analysis. <em>Health Psychology Open, 7</em>(1), 2055102920913235.</p><p>[21] Cole, S. W. (2014). Human social genomics. <em>PLOS Genetics, 10</em>(8), e1004601.</p><p>[22] Interreg Europe. (2024). <em>Loneliness and social connections: Policy learning platform.</em> European Union. See also: UK Government. (2018). PM commits to government-wide drive to tackle loneliness.<a href="https://preview.kit-mail3.com/click/dpheh0hzhmh4/aHR0cDovL2dvdi51aw==" target="_blank" rel="noopener noreferrer"> GOV.UK</a>; Sakamoto, T. (2021). Appointment as Minister of Loneliness. Government of Japan.</p><p>[23] Cohen, S., Doyle, W. J., Skoner, D. P., Rabin, B. S., &amp; Gwaltney, J. M. (1997). Social ties and susceptibility to the common cold. <em>JAMA, 277</em>(24), 1940-1944.</p><p>​<br>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">Smoking, inactivity, poor sleep, alcohol exposure, adiposity, and social disconnection can all matter. Their published estimates cannot be combined into one precise ranking for an individual reader.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Risk ranking:</strong> The cited studies use different populations, ages, outcomes, exposures, follow-up periods, adjustments, and risk scales. Their relative risks cannot be ranked as one league table or used to identify one reader's largest danger. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a> <a href="#correction-ref-2" aria-label="Reference 2">[2]</a> <a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Smoking citation:</strong> The 239 studies and 10.6 million participants identify the Global BMI Mortality Collaboration, not the cited US smoking cohorts. The smoking evidence remains strong, but that sample description was attached to the wrong source. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a> <a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Sitting and activity:</strong> The one-hour versus ten-hour sitting contrast is observational. In the harmonized analysis, high activity statistically attenuated the excess association in the highest sitting group; it did not guarantee that 60 to 75 minutes eliminates sitting risk for every person. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Sleep and connection:</strong> Sleep and social connection are important population risk markers. The cited evidence does not establish that they are the two largest risks at a particular age or that uninterrupted sleep clears brain waste in people. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a> <a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/23343063/" rel="external">Jha, P., Ramasundarahettige, C., Landsman, V., et al. (2013). 21st-century hazards of smoking and benefits of cessation in the United States. New England Journal of Medicine, 368(4), 341–350. https://pubmed.ncbi.nlm.nih.gov/23343063/</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/27423262/" rel="external">Global BMI Mortality Collaboration. (2016). Body-mass index and all-cause mortality: Individual-participant-data meta-analysis of 239 prospective studies in four continents. The Lancet, 388(10046), 776–786. https://pubmed.ncbi.nlm.nih.gov/27423262/</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/27475271/" rel="external">Ekelund, U., Steene-Johannessen, J., Brown, W. J., et al. (2016). Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? The Lancet, 388(10051), 1302–1310. https://pubmed.ncbi.nlm.nih.gov/27475271/</a></li><li id="correction-ref-4"><a href="https://pubmed.ncbi.nlm.nih.gov/27067616/" rel="external">Liu, T.-Z., Xu, C., Rota, M., et al. (2017). Sleep duration and risk of all-cause mortality: A flexible, non-linear, meta-regression of 40 prospective cohort studies. Sleep Medicine Reviews, 32, 28–36. https://pubmed.ncbi.nlm.nih.gov/27067616/</a></li><li id="correction-ref-5"><a href="https://pubmed.ncbi.nlm.nih.gov/37337095/" rel="external">Wang, F., Gao, Y., Han, Z., et al. (2023). A systematic review and meta-analysis of 90 cohort studies of social isolation, loneliness and mortality. Nature Human Behaviour, 7, 1307–1319. https://pubmed.ncbi.nlm.nih.gov/37337095/</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/midlife-mortality-risk">Midlife Mortality Risk: What Actually Moves the Odds →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Your Bones Peaked at 30. Nobody Checked.]]></title>
<description><![CDATA[Cardio does nothing for your bones. Why bone loss starts in your 30s, the scan you have never had, and the heavy lifting that reverses it.]]></description>
<link>https://www.andreheeg.com/archive/your-bones-peaked-at-30-nobody-checked</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/your-bones-peaked-at-30-nobody-checked</guid>
<pubDate>Sun, 22 Mar 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>It’s 1987. I’m eight years old, standing on my grandma’s king-size bed.</p><p>My cousins are with me. One pretends to be knocked out on the pillows. Another acts as the referee, counting to three as seriously as only a second-grader can. The bedframe is solid oak, built to outlast its owners. We ignore that. All that matters to us is WWF wrestling.</p><p>This was the golden age: Hulk Hogan, Andre the Giant, “Macho Man” Randy Savage, Roddy Piper, Ted DiBiase, Ultimate Warrior, Jake “The Snake” Roberts. To us, these wrestlers were heroes. On Saturday afternoons at grandma’s, her bedroom became Madison Square Garden, and we imagined ourselves as all of them.</p><p>I’m on the headboard. The move: diving elbow drop. If you know, you know. If not, just picture a kid launching himself off furniture, convinced physics will play along.</p><p>Physics does not play along.</p><p>I miss the mattress and land on the bedframe instead. My collarbone against the oak. There’s no contest.</p><p>The snap is quiet. The pain isn’t even that bad. The real problem is the next six weeks. Clavicle bandage. Figure-8, tight across my back, arms pulled in. Middle of summer. Everyone else is at the lake or the pool. I’m stuck in this thing that, after a few weeks in July heat, starts to smell like it’s alive. By week six, it basically is.</p><p>The upside: at school, I’m untouchable. A broken bone in primary school buys you a kind of status you can’t earn any other way.</p><p>That was the first break. Not the last. I wrestled for twenty years after that. Not WWF, real wrestling. Olympic freestyle. Nobody’s playing along. Nobody takes a dive. I broke more bones. When your body is the tool and the sport takes what it wants, you pay the price.</p><p>But that first break stayed with me, like a first crush. Vivid, a little ridiculous, and unforgettable.</p><p>The bones in that eight-year-old body were still getting stronger. They’d keep building for another twenty years or so, peaking somewhere around my late twenties [5][6]. Then they’d start quietly falling apart. And nobody would mention that either.</p><p>Bones don’t just sit there. They peak. Then they decline. Without symptoms. Without warnings. And almost nobody in your life, not your doctor, not your trainer, not the longevity podcasts you listen to between meetings, is talking about it until something snaps.</p><div><hr></div><h2>The Scan You’ve Never Had</h2><p>With my history, you’d think I’d have checked if my bones are still holding up.</p><p>I haven’t. Never had a DEXA scan. Not once.</p><p>Have you?</p><p>The US Preventive Services Task Force recommends osteoporosis screening for women at 65 [1]. For men, the evidence is, and I’m quoting, “insufficient” even to make a recommendation [1]. The International Society for Clinical Densitometry suggests 70 for men without risk factors [2]. Think about what that means. If you’re a 45-year-old man whose bones peaked 15 years ago, nobody in the medical system is looking. Nobody will look for another 25 years. Your skeleton could be hollowing out right now, and the official medical position is: we don’t know enough to care.</p><p>Meanwhile, the same system will screen you for prostate cancer, check your cholesterol annually, and send you reminders about your flu shot. But the scaffolding that holds your entire body upright? Come back when you’re 70. Or when something breaks. Whichever comes first.</p><p>You track your performance, check your resting heart rate, know your body fat, and maybe even your VO2 max. But when was the last time you thought about your bones?</p><p>I’ll be in the US soon. I’m booking a DEXA scan. They’re everywhere. Most clinics offer them. Cheap, too. One scan. A baseline data point I should have had years ago.</p><div><hr></div><h2>Your Skeleton Is Keeping Score</h2><p>Most people think bones are like rebar in concrete. Built once, set, done. Not true. Bones are alive. They’re always responding to what you do. They adapt. Leave them alone, and they quietly fade away.</p><p>A German surgeon named Julius Wolff figured this out in 1892. His law is simple: bone adapts its structure to the loads placed on it [3]. Tennis players develop measurably thicker bone in their racquet arm. Weightlifters build denser skeletons than runners. Load it or lose it. Harold Frost took this further with what he called the mechanostat model: your skeleton maintains a set point, and loading above that threshold triggers formation while loading below it triggers resorption [4]. Your body is efficient. It will not maintain infrastructure it doesn’t need.</p><p>The timeline is sobering. Bone mineral builds up from childhood until about age 25 to 30, when you reach peak bone mass [5][6]. After age 40, both men and women lose about 0.5-1% per year [7][8]. Women lose bone faster after menopause, which I’ll discuss later. Men can start losing bone at some sites as early as their mid-30s, earlier than most people think [7]. By age 50, without intervention, you might have lost 10-20% of your peak bone mass. You may feel the same as you did at 30, but your bones are not the same.</p><p>Then there’s the desk. I spent years in consulting, with back-to-back meetings in windowless rooms. I’d sit for twelve hours, fueled by bad coffee and the belief that I was at my best. At 35, I felt invincible, but I wasn’t. Sitting for hours signals to your bones that they don’t need to stay strong [9]. Day after day, your skeleton adapts. It’s been doing this for years.</p><p>You’re either building bone or losing it. There’s no middle ground.</p><div><hr></div><h2>“You’re Too Young to Worry About Bone Health”</h2><p>Osteoporosis lives in our collective imagination as a post-menopausal woman’s condition. And for women, the reality is severe. Women lose up to 20% of their bone density in the five to seven years after menopause [8]. One in two women over 50 will break a bone due to osteoporosis in their lifetime [10]. The screening guidelines reflect this: women get a DEXA recommendation at 65, or earlier if risk factors are present [1]. That part of the system, at least, is working.</p><p>What most people don’t know is how badly the system fails men. Twenty percent of men over 50 will experience a fragility fracture [10]. The lifetime risk of fragility fracture in men actually exceeds the risk of prostate cancer [10]. We screen for prostate cancer. We run campaigns for prostate cancer. We don’t screen for the thing that’s statistically more likely to happen.</p><p>Male osteoporosis is largely underdiagnosed and undertreated [11]. When it does announce itself, it announces itself as a fracture. And in men, that fracture is more lethal. A man with a hip fracture faces a 7.95-fold increased risk of death in the first three months [12]. One-year mortality sits around 35% for men versus 22% for women [12]. One in three men won’t survive the year after a hip fracture. Current data, not a relic from the 1950s.</p><p>The executive profile makes it worse, regardless of gender. Frequent flying, which means reduced vitamin D from living indoors and in airports. Sitting all day, which means mechanical unloading. Meals skipped or eaten between calls, which means protein intake that’s an afterthought. Women in high-performance careers often delay pregnancy or enter perimenopause earlier due to chronic stress, compounding the hormonal drivers of bone loss. Men never get screened because the guidelines say not to bother until 70.</p><div><hr></div><h2>“I’m Active, So I’m Fine”</h2><p>I hear this often, and I get the reasoning. You move, you exercise, and you’re more active than most people. That should be enough, right?</p><p>But it isn’t. Not every type of movement actually builds bone.</p><p>A systematic review specifically examined swimming and cycling and found that neither has a positive effect on bone mineral density [13]. Professional cyclists actually lose bone density during training seasons. This is counterintuitive if you think about how fit these people are, but bone doesn’t care about your cardiovascular fitness. Bone cares about mechanical load. And when you’re floating in a pool or spinning on a bike, there’s very little load going through the skeleton.</p><p>What does work? The LIFTMOR trial followed postmenopausal women who did high-intensity resistance training: five sets of five reps at greater than 85% of their one-rep max, twice a week, for 30 minutes per session. The result was approximately 4% improvement in lumbar spine bone mineral density compared to a low-intensity control group. Adherence was above 90%. No new fractures [14]. A separate 12-month trial tested the effects of resistance training and jumping on bone mass in physically active men with low bone mass, with a mean age of 44. Both interventions increased bone mineral density in the whole body and lumbar spine [15].</p><p>The ranking is straightforward. Heavy lifting is better than impact and jumping. Impact is better than running. Running is better than cycling or swimming. If you’re on your Peloton every morning, that’s great for your heart, but not for your bones. What really helps is lifting heavy weights. Twice a week, for thirty minutes.</p><p>Protein is important too. Higher protein intake means fewer hip fractures. Your bones need the right building blocks to get stronger. Without enough protein, calcium, and vitamin D, stressing your bones won’t help. They won’t have what they need to rebuild.</p><div><hr></div><h2>Try This Today</h2><p><strong>Get a DEXA baseline.</strong> If you have any risk factors at all, and that includes fracture history, family history, low body weight, long-term corticosteroid use, chronic sitting, or low vitamin D, don’t wait for a screening recommendation that may never come. Most clinics offer DEXA as an elective for $75-150. “Insufficient evidence” for screening men doesn’t mean there’s evidence of no benefit. It means the research hasn’t caught up. Talk to your doctor. Know your T-score. Track it over time. If your results are normal and you have no major risk factors or new health changes, most guidelines suggest repeating the scan every 3-5 years. If you have low bone mass, are starting new medications, or have a new fracture or a major change in your health, talk to your doctor about retesting sooner. That way, you can see how your bones respond and recalibrate your plan if needed.</p><p><strong>Heavy compound lifts. Twice a week. Thirty minutes.</strong> Deadlifts, squats, overhead press. The LIFTMOR protocol: five sets of five at greater than 85% of your one-rep max [14]. If you’re new to heavy lifting, get coached first. The protocol was safe for postmenopausal women with osteopenia, so your excuses are limited. Sixty minutes a week. Less time than a strategy meeting that could’ve been an email.</p><p><strong>Add impact loading.</strong> Ten jumps, three times a week. Two minutes total. Do them in your office. In a hotel room. Between calls. Nobody needs to know. The Hinton trial demonstrated significant gains in bone mineral density with a jumping protocol alone [15]. This targets the femoral neck specifically, one of the most fracture-prone sites in the body.</p><p><strong>Get the basics right.</strong> Aim for at least 1.2 grams of protein per kilogram of body weight. For calcium, get 1,000 to 1,200 milligrams a day, ideally from foods like dairy, leafy greens, or sardines [17]. For vitamin D, aim for 600-800 IU daily, or more if you’re often indoors [18]. If you’re not sure what this looks like, here are some ideas: Breakfast could be Greek yogurt with berries and seeds. Lunch might be grilled salmon on a leafy salad with chickpeas or beans. Snack on cottage cheese or almonds. Dinner could be roasted chicken with spinach and broccoli. Even adding a glass of milk, some cheese, or tinned sardines helps with calcium. These aren’t just supplements. They’re what your bones need to get stronger.</p><div><hr></div><h2>The Kids Window</h2><p>If you have kids under 18, this is the most urgent part of the newsletter.</p><p>Kids build 90% of their bone mass by 18 [6]. What they do as kids and teens shapes up to 40% of their adult skeleton [6]. The best time to build bone is late childhood and puberty. Some of the best options: sports and activities that involve jumping, running, and quick changes of direction. Think soccer, basketball, volleyball, gymnastics, tennis, dance, or parkour. Even playground games like tag and hopscotch count. The most active kids end up with 8-10% more bone at the hip as young adults, and that edge lasts [19]. Schools that keep kids moving through puberty see fewer fractures years later [20].</p><p>This window doesn’t stay open. You can’t build bone at 40 the way you could at 14. Again, get your kids moving: sports, climbing, jumping, roughhousing. Even wrestling on grandma’s bed is good, just avoid the elbow drop.</p><div><hr></div><h2>Upward ARC: Capacity</h2><p>This newsletter is part of the Capacity pillar in my Upward ARC framework. Activate keeps your body running, and Recover helps your nervous system reset. Capacity is what lets you perform better over the long term. Bone health is the most direct example of capacity I know. Everything else (your fitness, your career, the years you want with your family) rests on a physical foundation. That foundation is either getting stronger or weaker every day. Unlike your revenue or heart rate, you can’t feel it changing.</p><p>Twenty years of competitive wrestling broke some of my bones, but it also made them stronger. During routine MRI scans, radiologists often commented on how dense and unusually strong my bones were for the areas they checked. One even said I’d likely avoided injuries that would have sidelined others. The same sport that broke some bones was quietly doing what matters most: putting stress on my skeleton year after year, forcing my bones to get stronger.</p><p>That’s Wolff’s Law in a body, not a textbook.</p><p>I’m not competing anymore. But I’m committed to investing in my bones, as I did during training. Heavy lifts. Impact. I know what the science says about what happens when you stop.</p><p>I still do a diving elbow drop, by the way. These days, it’s on the couch with my boy, Magnus. He’s nine. He thinks it’s hilarious. He has no idea he’s building bone density.</p><p>My collarbone healed in six weeks when I was eight. Forty years later, nothing heals that quickly. We’re all losing bone now. The only difference is whether we’re taking action. And whether our kids are building what they need before their window closes.</p><p>Stay healthy.</p><p>Andre</p><div><hr></div><h2>References</h2><p>[1] US Preventive Services Task Force. (2025). Screening for osteoporosis to prevent fractures: US Preventive Services Task Force recommendation statement. <em>JAMA, 333</em>(4), 324-332.</p><p>[2] International Society for Clinical Densitometry. (2019). <em>2019 ISCD official positions: Adult</em>. https://iscd.org/learn/official-positions/adult-positions/</p><p>[3] Frost, H. M. (1994). Wolff’s law and bone’s structural adaptations to mechanical usage: An overview for clinicians. <em>The Angle Orthodontist, 64</em>(3), 175-188.</p><p>[4] Frost, H. M. (2003). Bone’s mechanostat: A 2003 update. <em>The Anatomical Record Part A, 275A</em>(2), 1081-1101.</p><p>[5] Baxter-Jones, A. D. G., Faulkner, R. A., Forwood, M. R., Mirwald, R. L., &amp; Bailey, D. A. (2011). Bone mineral accrual from 8 to 30 years of age: An estimation of peak bone mass. <em>Journal of Bone and Mineral Research, 26</em>(8), 1729-1739.</p><p>[6] Weaver, C. M., Gordon, C. M., Janz, K. F., Kalkwarf, H. J., Lappe, J. M., Lewis, R., O’Karma, M., Wallace, T. C., &amp; Zemel, B. S. (2016). The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: A systematic review and implementation recommendations. <em>Osteoporosis International, 27</em>(4), 1281-1386.</p><p>[7] Khosla, S., &amp; Riggs, B. L. (2005). Pathophysiology of age-related bone loss and osteoporosis. <em>Endocrinology and Metabolism Clinics of North America, 34</em>(4), 1015-1030.</p><p>[8] Demontiero, O., Vidal, C., &amp; Duque, G. (2012). Aging and bone loss: New insights for the clinician. <em>Therapeutic Advances in Musculoskeletal Disease, 4</em>(2), 61-76.</p><p>[9] Gao, Z., Chen, J., &amp; Lin, H. (2023). Correlation between sedentary activity, physical activity and bone mineral density and fat in America: NHANES, 2011-2018. <em>Scientific Reports, 13</em>, Article 9561.</p><p>[10] Clynes, M. A., Harvey, N. C., Curtis, E. M., Fuggle, N. R., Dennison, E. M., &amp; Cooper, C. (2020). The epidemiology of osteoporosis. <em>British Medical Bulletin, 133</em>(1), 105-117.</p><p>[11] Alswat, K. A. (2017). Gender disparities in osteoporosis. <em>Journal of Clinical Medicine Research, 9</em>(5), 382-387.</p><p>[12] Haentjens, P., Magaziner, J., Colon-Emeric, C. S., Vanderschueren, D., Milisen, K., Griep, L., Carpentier, A., &amp; Boonen, S. (2010). Meta-analysis: Excess mortality after hip fracture among older women and men. <em>Annals of Internal Medicine, 152</em>(6), 380-390.</p><p>[13] Abrahin, O., Rodrigues, R. P., Marcal, A. C., Alves, E. A. C., Figueiredo, R. C., &amp; de Sousa, E. C. (2016). Swimming and cycling do not cause positive effects on bone mineral density: A systematic review. <em>Revista Brasileira de Reumatologia, 56</em>(4), 345-351.</p><p>[14] Watson, S. L., Weeks, B. K., Weis, L. J., Harding, A. T., Horan, S. A., &amp; Beck, B. R. (2018). High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: The LIFTMOR randomized controlled trial. <em>Journal of Bone and Mineral Research, 33</em>(2), 211-220.</p><p>[15] Hinton, P. S., Nigh, P., &amp; Thyfault, J. (2015). Effectiveness of resistance training or jumping-exercise to increase bone mineral density in men with low bone mass: A 12-month randomized, clinical trial. <em>Bone, 79</em>, 203-212.</p><p>[16] Shams-White, M. M., Chung, M., Du, M., Fu, Z., Insogna, K. L., Karlsen, M. C., LeBoff, M. S., Shapses, S. A., Sackey, J., Wallace, T. C., &amp; Weaver, C. M. (2017). Dietary protein and bone health: A systematic review and meta-analysis from the National Osteoporosis Foundation. <em>American Journal of Clinical Nutrition, 105</em>(6), 1528-1543.</p><p>[17] National Institutes of Health, Office of Dietary Supplements. (2024). <em>Calcium: Fact sheet for health professionals</em>. U.S. Department of Health and Human Services.</p><p>[18] National Institutes of Health, Office of Dietary Supplements. (2024). <em>Vitamin D: Fact sheet for health professionals</em>. U.S. Department of Health and Human Services.</p><p>[19] Bailey, D. A., McKay, H. A., Mirwald, R. L., Crocker, P. R. E., &amp; Faulkner, R. A. (1999). A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: The University of Saskatchewan Bone Mineral Accrual Study. <em>Journal of Bone and Mineral Research, 14</em>(10), 1672-1679.</p><p>[20] Detter, F., Nilsson, J. A., Karlsson, C., Dencker, M., Rosengren, B. E., &amp; Karlsson, M. K. (2014). A 5-year exercise program in pre- and peripubertal children improves bone mass and bone size without affecting fracture risk. <em>Calcified Tissue International, 95</em>(5), 385-393.</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Evidence corrections and safety update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It sometimes uses ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Screening correction:</strong> A midlife DXA baseline and repeat scan every three to five years are not general population recommendations. USPSTF recommends screening women 65 and older and younger postmenopausal women at increased risk. Evidence is insufficient for population screening in men. Individual testing can still be appropriate with established risk factors, relevant disease, bone-depleting medicines, or a fragility fracture. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Exercise safety:</strong> LIFTMOR was an eight-month, closely supervised trial in 101 screened postmenopausal women with low bone mass. Lumbar-spine bone density increased 2.9% in the intervention group while it fell 1.2% in controls. That result does not make the five-by-five protocol a do-it-yourself prescription or prove that heavy lifting is safe for every unscreened reader. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Exercise qualification:</strong> Bone responds to loading, but the evidence does not support one universal ranking in which heavy lifting always outranks every other activity. Weight-bearing exercise, appropriate resistance or impact work, and balance training can have different roles. Cycling and swimming provide less direct skeletal loading but remain valuable forms of exercise. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Jumping-trial correction:</strong> The cited trial included 38 active men with low bone mass. Both resistance and jump training improved whole-body and lumbar-spine bone density, while only resistance training improved total-hip density. It did not establish that the jumping protocol specifically improved the femoral neck. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>Child-fracture correction:</strong> The cited school-exercise paper was published in 2013 in volume 92, not in 2014 in volume 95. The programme improved some bone measures but did not reduce fractures. Fracture rates were 20.0 versus 18.5 per 1,000 person-years, with a rate ratio of 1.08 and a 95% confidence interval from 0.79 to 1.47. <span class="correction-ref-links"><a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><p><strong>Nutrition qualification:</strong> Calcium and vitamin D figures are age- and sex-specific reference intakes for total intake, not automatic supplement doses. Protein needs and any supplement plan depend on diet, health, kidney function, medicines, and fracture risk. Exercise and nutrition do not replace indicated osteoporosis treatment. <span class="correction-ref-links"><a href="#correction-ref-6" aria-label="Reference 6">[6]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening" rel="external">U.S. Preventive Services Task Force. (2025). Osteoporosis to prevent fractures: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/28975661/" rel="external">Watson, S. L., Weeks, B. K., Weis, L. J., Harding, A. T., Horan, S. A., &amp; Beck, B. R. (2018). High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: The LIFTMOR randomized controlled trial. Journal of Bone and Mineral Research, 33(2), 211–220. https://doi.org/10.1002/jbmr.3284</a></li><li id="correction-ref-3"><a href="https://www.niams.nih.gov/health-topics/osteoporosis/living-with" rel="external">National Institute of Arthritis and Musculoskeletal and Skin Diseases. (n.d.). Osteoporosis: Living with. https://www.niams.nih.gov/health-topics/osteoporosis/living-with</a></li><li id="correction-ref-4"><a href="https://pubmed.ncbi.nlm.nih.gov/26092649/" rel="external">Hinton, P. S., Nigh, P., &amp; Thyfault, J. (2015). Effectiveness of resistance training or jumping-exercise to increase bone mineral density in men with low bone mass: A 12-month randomized clinical trial. Bone, 79, 203–212. https://doi.org/10.1016/j.bone.2015.06.008</a></li><li id="correction-ref-5"><a href="https://doi.org/10.1007/s00223-012-9691-5" rel="external">Detter, F. T. L., Rosengren, B. E., Dencker, M., Nilsson, J.-Å., &amp; Karlsson, M. K. (2013). A 5-year exercise program in pre- and peripubertal children improves bone mass and bone size without affecting fracture risk. Calcified Tissue International, 92(4), 385–393. https://doi.org/10.1007/s00223-012-9691-5</a></li><li id="correction-ref-6"><a href="https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/" rel="external">National Institutes of Health, Office of Dietary Supplements. (n.d.). Calcium: Fact sheet for health professionals. https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/bone-health-screening-and-training">Bone Health in Midlife: When to Scan and How to Train →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Sexual Health Is a Vital Sign. We Just Don't Treat It Like One.]]></title>
<description><![CDATA[The biomarker no executive physical checks. How sexual function flags heart disease years early, plus the meds that quietly suppress the signal.]]></description>
<link>https://www.andreheeg.com/archive/sexual-health-is-a-vital-sign-we</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/sexual-health-is-a-vital-sign-we</guid>
<pubDate>Sun, 15 Mar 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>Hawaii, 2016. Tilda just turned two. She’s sitting on a beach towel eating sand, completely unconcerned with the fact that her parents’ entire life is in a shipping container somewhere between Arizona and New York.</p><p>My wife and I ended up in Maui for four weeks. Not a vacation. We just didn’t have anywhere to live while the moving truck crawled across the country. I had opened a new office for a startup. The kind of job where your phone goes off before your alarm, and you answer both. Twelve-hour days. Midnight calls. My calendar looked like a losing game of Tetris.</p><p>We had been trying for a second child for about a year. Nothing.</p><p>You might see the three-year gap between our kids and think we planned it like consultants. We didn’t. After a year of trying, we booked a fertility specialist. Find out what’s up. See what we can do.</p><p>The appointment couldn’t happen before the move. So instead of a doctor’s office, we got Maui. No office. No Slack. No midnight calls. Just a toddler, the ocean, and more sleep than I’d had in two years.</p><p>We didn’t need the appointment.</p><p>I can’t claim scientific certainty. I was 37. Not a bad age for this. Some would call it my prime. I’d agree. Still am, for the record. But my body couldn’t do one of its basic jobs while I was running it into the ground. The moment the stress lifted, it worked.</p><p>That was the first time I got it, even if it took years to really sink in. Sexual function isn’t separate. It’s not its own category. It’s a readout. Maybe the most honest one your body gives you. It tracks your heart, your hormones, your stress, your sleep. All of it. One signal.</p><p>You’ll tell a colleague your resting heart rate. Compare VO2 max over dinner like it’s a golf handicap. Post CGM graphs on social media.</p><p>But this? Nobody says a word.</p><h2>The Cardiovascular Early Warning System</h2><p>Here’s the number that changed how I think about this topic: erectile dysfunction predicts cardiac events 2 to 5 years before they happen.</p><p>Not months. Years ahead.</p><p>A meta-analysis covering 92,757 participants found that men with ED had a 44% higher risk of cardiovascular events, a 62% higher risk of heart attack, and a 39% higher risk of stroke [1]. This held up after adjusting for age, diabetes, hypertension, smoking, and cholesterol. ED operated as an independent risk factor. That means it predicted cardiac events on its own, even when you accounted for all the usual suspects.</p><p>In younger men, the numbers are staggering. A Mayo Clinic study found that men under 50 with ED had a 50-fold increased risk of developing coronary artery disease over 10 years [2]. I had to read that twice. Not 50 percent. Not double. 50 times.</p><p>The mechanism is simple. Penile arteries are 1 to 2 millimeters wide. Coronary arteries are 3 to 4. Atherosclerosis, the slow buildup of plaque, hits the smallest pipes first [3]. Same disease. Earlier warning. The plumbing clogs by size.</p><p>Think about what gets checked at your annual executive physical. Cholesterol. Blood pressure. Glucose. Liver enzymes. The usual Framingham risk factors. Standard checklist for decades. But nobody adds sexual function. In people with moderate risk, ED predicts heart trouble as well as some of those classic markers [1]. We spend thousands on check-ups and skip the one signal that flags heart events years before a stress test does.</p><p>This isn’t only a male story. In women, the same vascular machinery is involved, but in the opposite direction. A meta-analysis of 54 studies covering 148,946 participants found that cardiovascular disease increases the risk of female sexual dysfunction by 1.5-fold [5]. Hypertension, stroke, and prior heart attack all damage sexual function through the same endothelial pathway. In men, the dysfunction comes first and warns of heart disease. In women, heart disease comes first and affects sexual function: different sequence, same biology. Either way, sexual function and cardiovascular health are reading from the same page.</p><h2>The Hormonal Dashboard</h2><p>Your reproductive hormones are real-time readouts. Not just for fertility. For everything.</p><p>In men, testosterone declines by about 1% per year after age 30. That’s the baseline. Chronic stress and sleep debt accelerate the decline. So does overtraining. A controlled study put healthy young men on five hours of sleep per night for one week and measured what happened. Testosterone dropped 10 to 15% [6]. One week. That’s not aging. That’s a normal work schedule for many people reading this right now.</p><p>I wish more executives knew about the cortisol-to-testosterone ratio. When cortisol is high and testosterone is low, your body is in survival mode. Not performance. Sports scientists use this ratio to spot overtraining in athletes. It works the same way in the boardroom. Your physiology doesn’t care about your job title.</p><p>For women, the parallel story deserves equal attention. And I want to be precise here, because this is an area where the conversation is often sloppy, and the stakes of getting it wrong are high.</p><p>Between 44 and 62% of women report cognitive complaints during perimenopause: difficulty with memory, focus, and concentration [7]. I’m saying “report” deliberately. These are subjective complaints, and the underlying mechanism is not one thing. Sleep disruption, which hits 38 to 47% of perimenopausal women [8], vasomotor symptoms, mood changes, and hormonal shifts all contribute. You can’t cleanly isolate a single cause, and anyone claiming otherwise is oversimplifying a complicated picture. Perimenopause lasts approximately 4 to 7 years according to the STRAW+10 staging criteria, the current clinical standard for staging reproductive aging [9]. Individual variation is wide.</p><p>Why does this matter for performance? Because perimenopause is one of the most overlooked disruptors in professional life. Millions of women go through it while leading teams and making big decisions, often without anyone connecting the dots. The research on sexual function as a biomarker in women is much thinner than for men. Most of what we know comes from ED studies. Women’s sexual health as a signal is understudied. Not unimportant. Just understudied. That gap needs to close.</p><p>A lasting drop in libido, for anyone, isn’t about your relationship or looks. It’s your brain-to-reproductive system axis signaling overload. Libido depends on sleep, stress, hormones, and mental health. If it drops for no clear reason, something upstream broke. Treat it as data. Not drama.</p><h2>The Medication Blind Spot</h2><p>This might be the most useful part of the whole newsletter.</p><p>SSRIs, selective serotonin reuptake inhibitors, are the most commonly prescribed antidepressants. Millions of professionals take them for anxiety and depression. They also cause sexual dysfunction in 30 to 50% of users [10]. If you’re on one and your libido has disappeared, it might not be the stress. It might be the treatment for the stress. Bupropion augmentation (150 to 300mg), a different class of antidepressant, reverses the sexual side effects in roughly 60% of cases [10]. That’s a specific conversation worth bringing to your doctor.</p><p>Statins get blamed for ED and don’t deserve it. A meta-analysis actually found that statin therapy improved erectile function by 3.4 points on the International Index of Erectile Function [11]. That’s about 40% of sildenafil’s effect. If someone told you statins tank your sex drive, the data says the opposite.</p><p>Beta-blockers are the antihypertensive class most likely to cause problems. Switching to nebivolol, a newer beta-blocker with vasodilating properties, restored sexual function in 69% of men within three months [12].</p><p>For women on hormonal contraception, the picture is more nuanced than social media suggests. About 15% of oral contraceptive users report decreased desire, while 85% report no change or improvement [13]. Individual variation is high. But if you’re on the pill and something changed, the connection is worth exploring with your physician.</p><p>Here’s what bothers me as a doctor. Many professionals medicate their stress response and, at the same time, shut down the one signal that would warn them the stress is too high.</p><p>That’s like putting noise-canceling headphones on a fire alarm.</p><h2>One System</h2><p>This sits in the Capacity pillar of my Upward ARC framework. Capacity is the total reserve you’re drawing from. Your cardiovascular fitness, your hormonal balance, how much stress you can absorb, how well you’re sleeping, and how much cognitive bandwidth you have left at the end of the day.</p><p>Sexual function taps into all of it. There’s no separate circuit. The same machinery runs your decisions, your energy, your ability to stay sharp at 4pm on a Thursday.</p><p>I learned this before I had the science. On a beach in Maui, watching my daughter eat sand, feeling my body come back online after months of burnout. Not just fertility. Sleep. Mood. Energy. Clarity. Everything came back because it was never really separate.</p><h2>Try This Today</h2><p>Take stock. This week, rate your sexual function on a 1-to-10 scale. Desire, function, satisfaction. Write it down. Compare it to six months ago. A year ago. If it dropped and nothing obvious changed, that’s not aging. That’s data. Track it monthly, just like you track resting heart rate.</p><p>Try the sleep test. For the next week, get at least 7 hours a night. No screens after 10pm. No alcohol within three hours of bed. One week of good sleep can reverse a 10 to 15% testosterone drop [6]. Cheapest fix you’ll find. Biggest return.</p><p>Have the medication conversation. Before your next doctor visit, write down every medication you take. Check which ones affect sexual function. Bring the list. Ask: Is there an alternative with fewer sexual side effects? Specific questions get real answers. Vague complaints get a shrug and a refill.</p><p>Treat it like any other metric. Track changes in sexual function the way you track resting heart rate or HRV. A lasting drop isn’t a personal failing. It means your system needs something. More sleep. Less training. A medication check. Lower stress. Same logic you’d use for any other number that moves the wrong way.</p><h2>Tilda, Sand, and the Signal</h2><p>I keep coming back to those four weeks.</p><p>There’s a version of this story about fertility. Timing, luck, and a shipping container that forced a break. That’s true. But it’s not the whole story.</p><p>The bigger story is simpler. My body had been sending a signal for a year. Loud and clear. I missed it because I was too busy proving I could handle the load. Every midnight email. Every early call. Every weekend worked. I wore it like a badge. But my body was keeping a different score.</p><p>Maui didn’t fix anything. It just got quiet enough for me to hear what was already there.</p><p>We track everything now. Steps. Heart rate zones. Sleep stages. Glucose spikes. We build dashboards for our bodies and check them before breakfast. But we leave out the one signal that ties it all together. The one that connects heart health, hormones, stress, sleep, recovery. The one that could have warned us something was off long before the blood test did.</p><p>I get why we don’t talk about it. It’s awkward. It feels private. Most people would rather not bring it into the performance conversation.</p><p>But your body doesn’t care about categories. It runs one system. It’s been reporting to you all along.</p><p>Start listening.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><div><hr></div><h2>References</h2><p>[1] Vlachopoulos, C. V., Terentes-Printzios, D. G., Ioakeimidis, N. K., Aznaouridis, K. A., &amp; Stefanadis, C. I. (2013). Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: A systematic review and meta-analysis of cohort studies. Circulation: Cardiovascular Quality and Outcomes, 6(1), 99-109.</p><p>[2] Inman, B. A., Sauver, J. L. St., Jacobson, D. J., McGree, M. E., Nehra, A., Lieber, M. M., Roger, V. L., &amp; Jacobsen, S. J. (2009). A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clinic Proceedings, 84(2), 108-113.</p><p>[3] Montorsi, P., Ravagnani, P. M., Galli, S., Rotatori, F., Briganti, A., Salonia, A., Rigatti, P., &amp; Montorsi, F. (2005). The artery size hypothesis: A macrovascular link between erectile dysfunction and coronary artery disease. American Journal of Cardiology, 96(12B), 19M-23M.</p><p>[5] Zhao, S., Wang, J., Liu, Y., et al. (2024). Association between cardiovascular disease and risk of female sexual dysfunction: A systematic review and meta-analysis. European Journal of Preventive Cardiology, 31(5), 567-577.</p><p>[6] Leproult, R., &amp; Van Cauter, E. (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA, 305(21), 2173-2174.</p><p>[7] Weber, M. T., Maki, P. M., &amp; McDermott, M. P. (2014). Cognition and mood in perimenopause: A systematic review and meta-analysis. Journal of Steroid Biochemistry and Molecular Biology, 142, 90-98.</p><p>[8] Baker, F. C., de Zambotti, M., Colrain, I. M., &amp; Bei, B. (2018). Sleep problems during the menopausal transition: Prevalence, impact, and management challenges. Nature and Science of Sleep, 10, 73-95.</p><p>[9] Harlow, S. D., Gass, M., Hall, J. E., et al. (2012). Executive summary of the Stages of Reproductive Aging Workshop +10: Addressing the unfinished agenda of staging reproductive aging. Journal of Clinical Endocrinology &amp; Metabolism, 97(4), 1159-1168.</p><p>[10] Clayton, A. H., Croft, H. A., &amp; Handiwala, L. (2014). Antidepressants and sexual dysfunction: Mechanisms and clinical implications. Postgraduate Medicine, 126(2), 91-99.</p><p>[11] Kostis, J. B., Dobrzynski, J. M., &amp; Kostis, W. J. (2014). Statins and erectile dysfunction. Current Atherosclerosis Reports, 16(3), 1-7.</p><p>[12] Cordero, A., Bertomeu-Martínez, V., Mazón, P., Fácila, L., Bertomeu-González, V., Conthe, P., &amp; González-Juanatey, J. R. (2010). Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovascular Therapeutics, 28(1), 15-22.</p><p>[13] Pastor, Z., Holla, K., &amp; Chmel, R. (2013). The influence of combined oral contraceptives on female sexual desire: A systematic review. European Journal of Contraception &amp; Reproductive Health Care, 18(1), 27-43.</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">Persistent or distressing sexual symptoms can be worth discussing with a clinician, but they are not a diagnosis and do not establish one cause. The historical edition remains unchanged while treatment and risk claims are clarified.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Cardiovascular signal:</strong> Erectile dysfunction is associated with later cardiovascular events in population studies, with stronger relative associations in some younger groups. It does not predict an event for one person or create a fiftyfold absolute risk. Female sexual dysfunction is also associated with cardiovascular disease, but the evidence does not establish one universal opposite sequence in women. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a> <a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Hormones and sleep:</strong> Testosterone patterns vary with age, health, sleep, medicines, and time of testing. Diagnosis requires symptoms and appropriately repeated measurements. A ten-person sleep-restriction experiment did not test whether one week of sleep recovery reverses sexual or hormonal symptoms. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a> <a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>Bupropion and statins:</strong> Small and mixed studies do not support a general claim that bupropion restores sexual function in 60% of people. A pooled statin result from selected erectile-dysfunction trials cannot be compared directly with sildenafil, and statins are not an erectile-dysfunction treatment. <span class="correction-ref-links"><a href="#correction-ref-5" aria-label="Reference 5">[5]</a> <a href="#correction-ref-6" aria-label="Reference 6">[6]</a></span></p><p><strong>Blood-pressure medicine:</strong> The reported 69% improvement after a switch to nebivolol came from 44 men in an uncontrolled study. Medicine choice and any change in treatment require individual clinical review. <span class="correction-ref-links"><a href="#correction-ref-7" aria-label="Reference 7">[7]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/20367771/" rel="external">Guo, W., Liao, C., Zou, Y., et al. (2010). Erectile dysfunction and risk of clinical cardiovascular events: A meta-analysis of seven cohort studies. The Journal of Sexual Medicine, 7(8), 2805–2816. https://doi.org/10.1111/j.1743-6109.2010.01792.x</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/38297501/" rel="external">Dilixiati, D., Cao, R., Mao, Y., et al. (2024). Association between cardiovascular disease and risk of female sexual dysfunction: A systematic review and meta-analysis. European Journal of Preventive Cardiology, 31(7), 782–800. https://doi.org/10.1093/eurjpc/zwae042</a></li><li id="correction-ref-3"><a href="https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy" rel="external">Endocrine Society. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy</a></li><li id="correction-ref-4"><a href="https://doi.org/10.1001/jama.2011.710" rel="external">Leproult, R., &amp; Van Cauter, E. (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA, 305(21), 2173–2174. https://doi.org/10.1001/jama.2011.710</a></li><li id="correction-ref-5"><a href="https://pubmed.ncbi.nlm.nih.gov/39985829/" rel="external">de Aquino, A. C. Q., Sarmento, A. C. A., Teixeira, R. L. A., et al. (2025). Pharmacological treatment of antidepressant-induced sexual dysfunction in women: A systematic review and meta-analysis of randomized clinical trials. Clinics, 80, 100602. https://doi.org/10.1016/j.clinsp.2025.100602</a></li><li id="correction-ref-6"><a href="https://pubmed.ncbi.nlm.nih.gov/24628781/" rel="external">Cui, Y., Zong, H., Yan, H., &amp; Zhang, Y. (2014). The effect of statins on erectile dysfunction: A systematic review and meta-analysis. The Journal of Sexual Medicine, 11(6), 1367–1375. https://doi.org/10.1111/jsm.12497</a></li><li id="correction-ref-7"><a href="https://pubmed.ncbi.nlm.nih.gov/16491268/" rel="external">Doumas, M., Tsakiris, A., Douma, S., et al. (2006). Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian Journal of Andrology, 8(2), 177–182. https://doi.org/10.1111/j.1745-7262.2006.00076.x</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/sexual-function-as-a-health-signal">Sexual Function as a Health Signal →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[I'm a Doctor. I Know Exactly What Ultra-Processed Food Does. My Kids Still Want KitKats.]]></title>
<description><![CDATA[Childhood health habits track for 80 years. The four that matter, why structure beats explanation, and how to build them wherever you live.]]></description>
<link>https://www.andreheeg.com/archive/im-a-doctor-i-know-exactly-what-ultra</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/im-a-doctor-i-know-exactly-what-ultra</guid>
<pubDate>Sun, 08 Mar 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>Karla walks in from school and drops her backpack on the floor. I open the lunchbox my wife packed this morning. Bell peppers, cucumber, avocado. Biltong, which has become a family favorite since we arrived in South Africa: dried meat, sometimes beef, sometimes ostrich, sometimes game like kudu or springbok. Apple slices and a plum. Dried dates for dessert. More came back than usual. The bell peppers barely touched. The dates gone, obviously.</p><p>“I want chips tomorrow. And a KitKat.”</p><p>She is six. She says this with the confidence of someone giving a quarterly report to a boardroom.</p><p>We’re in Cape Town on sabbatical. Three kids at an international school, new continent, new everything. When we arrived, we did what we always do: packed the same lunches we pack in Berlin, plus the biltong. Vegetables, protein, fruit, real food. It took about three days for the kids to come home with a full report on what the other kids eat. Chips. Sweets. Juice boxes. Things wrapped in plastic with ingredient lists you need a chemistry degree to decode.</p><p>“Nobody eats like us,” Karla announced. Magnus, nine, built a case for why we should adapt to local standards. Tilda, twelve, said nothing and rolled her eyes, which at her age is a position statement.</p><p>I stood in the kitchen doing what I often do: running the science in my head. Ultra-processed food. Dopaminergic reward pathways. Metabolic programming in middle childhood. Insulin sensitivity. I know what this stuff does. I’ve read the literature. I’m a doctor and a health nerd, and my wife will confirm that the second part is the bigger problem.</p><p>None of that makes the veggies more appealing to a six-year-old who just discovered that other kids get KitKats.</p><p>I know we live in a bubble. I know that our standards come from privilege and a medical background that most families don’t have. But the metabolic data doesn’t care about your background. What ultra-processed food does to a developing metabolism, it does to every child. The question isn’t whether you can afford to pack better lunches. It’s whether you understand what’s compounding inside that lunchbox every single day.</p><p>Standing in that kitchen, watching my three kids run their own lobbying campaigns for processed food, I kept thinking about this. I’m not packing lunches. Not really. I’m managing a portfolio. One that will run longer than any career, any fund, any strategy I’ll ever touch.</p><h2>The Market Conditions</h2><p>Here’s what Cape Town taught me that Berlin couldn’t.</p><p>In Berlin, food culture is better. Whole-grain bread everywhere. Good produce. Less processed snacking as a default. On paper, Berlin wins the nutrition round.</p><p>But try getting your kid into a sports club in Berlin. When Magnus was five, we wanted him in a football club. Just football. A boy who wants to run around and kick a ball. He went through a four-week assessment period, probation-style, attending practice sessions while the coaches evaluated him. After four weeks, they declined him. The reason: “He’s not good enough.”</p><p>He was five.</p><p>Come on. You can’t be serious. But this was not unusual. Hockey, basketball, tennis: the same thing happens everywhere in Berlin. There are not enough spots for something as simple as letting a child move. It makes you think about leaving.</p><p>Cape Town flipped the script. Sport is woven into the school day. The options are everywhere. My kids have more access to physical activity here in two months than they had in two years of navigating Berlin’s sports infrastructure.</p><p>But then you look at the lunchboxes.</p><p>Neither city does all four foundations well. Berlin has food. Cape Town has movement. You can’t move to the perfect environment. You have to build the portfolio wherever you are.</p><h2>The Four Asset Classes</h2><p>This sits in the Activate pillar of my Upward ARC framework. Sleep, movement, nutrition: the daily inputs that determine whether your body builds or breaks down. I write about this for executives. For your kids, the math runs the same way. Except that the holding period isn’t the next quarter. It’s 80 years. And hopefully many more.</p><p>Childhood health behaviors track into adulthood with surprising fidelity. What happens between ages 6 and 12 sets a trajectory that becomes progressively harder to redirect. After 15, identity and peer influence take over. The window is now.</p><h3>Sleep is the bond portfolio. Boring. Essential. Compounds quietly.</h3><p>Children aged 6 to 12 need 9 to 12 hours per night [1]. Most get less. Poor childhood sleep predicts adolescent depression, increased risk-taking, and adult cardiovascular disease markers [2]. Sleep problems track at r=0.40, meaning a child who sleeps poorly at 8 is significantly more likely to sleep poorly at 15 [3]. Fragmented sleep is worse than short sleep because it interrupts slow-wave cycles, the same glymphatic clearance process I’ve written about for adults [4].</p><p>Tilda knows all of this. I have explained melatonin suppression to her. She nodded and seemed to understand. Still, I am pretty sure she scrolls under the covers anyway. She is twelve, in the middle of puberty, and knows that if she waits until we close our door, we will not check. At this age, strict rules do not work. If you push too hard, she will find a way around it. So you change the environment. Screens charge in the kitchen. The bedroom stays dark. The boundary is not a discussion. It is built into the room.</p><h3>Movement is the growth equity. High returns. Needs early investment.</h3><p>Organized sport participation tracks from childhood to adulthood at r=0.40 to 0.60 [5]. General physical activity? r=0.14 [5]. Barely a signal. The mechanism: motor competence builds confidence, confidence builds preference. A kid who can throw, run, and swim wants to keep doing it. A kid who can’t, avoids it. That avoidance compounds.</p><p>This is why I am still upset about what happened with Magnus. A five-year-old does not need to be ‘good enough’ for organized sport. He just needs to move. He needs to build the basic skills that will decide if he is active at 25 or not. The WHO says children should get 60 minutes of moderate to vigorous activity each day [6]. Doing more than that does not add much, but doing less adds up quickly in a bad way. Berlin’s sports system almost kept my son from the most important health habit for kids. In Cape Town, he gets it easily.</p><h3>Nutrition is the inflation hedge. Protects against slow erosion you don’t feel until it’s too late.</h3><p>School-age children derive 47-59% of their daily calories from ultra-processed foods [7]. Not a single study has reported a beneficial health outcome from higher ultra-processed food intake [7]. Not one. Higher consumption tracks with obesity, metabolic dysfunction, disrupted gut microbiota, and depressive symptoms [7][8].</p><p>Food preferences form through repeated exposure (15-20 times) and parental modeling [9]. Not lectures. Not sitting your daughter down and explaining food science while she stares at you with the dead eyes of someone who asked for chips and got a TED talk. Kids eat what they see their parents eat and what’s available in the house. Restriction backfires [9]. Pressure backfires. The only approach with evidence: control what’s available, model eating it yourself, and let the child decide how much.</p><p>That lunchbox with the bell peppers and biltong? It’s not a meal. It’s metabolic programming. Every day.</p><h3>Stress regulation is the insurance policy. You don’t notice it until you need it.</h3><p>Your children mirror your stress response. Not your advice about stress. Your actual response. When parents are chronically stressed, their HPA axis (the hypothalamic-pituitary-adrenal axis, your body’s central stress regulation system) becomes dysregulated. That dysregulation transmits to children through measurable biological pathways, including DNA methylation changes at glucocorticoid receptor genes [10]. In plain terms: your chronic stress literally changes how your child’s genes express themselves.</p><p>Parents who use cognitive reappraisal (reframing threat as challenge) have children who develop the same strategies [11]. Parents who avoid or suppress have children who do the same. You can’t hide chronic stress from a twelve-year-old. Tilda understands my physiology better than most of the colleagues I’ve worked with. She knows when I’m tense before I do. She calibrates her behavior to my state, not to my words.</p><p>The protective factor isn’t zero stress. It’s visible regulation. My wife does yoga every day. The kids see it. I work out before they wake up. They know it. We take walks to clear our heads, and we tell them that’s why we’re walking. They’ve tried breathwork with us. We choose nature over screens when we need to reset. They don’t do this because we explained the neuroscience. They do it because they’ve watched us do it a thousand times.</p><p>Most parents focus too much on one area. ‘We eat clean.’ That is good, but do the kids get 10 hours of sleep? ‘They play sports every day.’ That is good, but what do they eat for lunch? The numbers do not lie: two areas at 90 percent and two at zero is worse than all four at 70 percent. Putting all your effort into one part of health is as risky as putting all your money in one investment. Do not do that with your kids’ health.</p><h2>Why Knowing the Science Makes You Worse at This</h2><p>Health-literate parents default to explanation. You describe what happens when they eat sugar. You walk through sleep architecture. You offer choices. You treat your kids like small executives who will make rational decisions given sufficient information.</p><p>The research says the opposite: children aged 6 to 12 benefit more from designed structure than from explanation and choice [9][12]. Choice, in the presence of ultra-processed options, actually worsens eating patterns [9]. I learned this the hard way. You can negotiate with Magnus about food choices, give him options, and explain the trade-offs. He’ll listen, nod, and select whatever has the most sugar. Not because he’s irrational. Because he’s nine, and the dopaminergic pull of hyperpalatable food will beat a rational argument every time. Structure first. Explanation later. Maybe never.</p><p>The same pattern shows up everywhere once you see it. You think your stress is compartmentalized because you don’t yell at dinner. But stress isn’t something you perform or don’t perform. It’s physiological. Your HPA axis is running hot, and your children’s cortisol levels are responding to yours, whether you raise your voice or not [10]. The instinct is to hide it. To push through. To compartmentalize as you do at work. Except the people you live with aren’t colleagues who see you for eight hours. They’re sponges that absorb your baseline state 24 hours a day.</p><p>Then there is the sprint problem. You try for a perfect month of sleep routines, but it falls apart when work gets busy. You start a family dinner habit, but it stops when you travel. You buy healthy food, but after a few weeks, the snacks come back because someone had a hard week. Health does not reward short bursts of perfection. It rewards being steady at 70 percent. A child who sleeps 8 hours five nights and 6 hours two nights does worse than a child who sleeps 7.5 hours every night [13]. The ups and downs are the problem, not the average.</p><p>The temptation for people like us is to reach for advanced tools: cold plunges, supplements, specialized coaching for our kids. But you cannot supplement your way around a pantry full of processed food. The basics still outperform the optimization. Every time.</p><h2>Try This Today</h2><p><strong>Rebalance the Pantry.</strong> This week, remove one category of ultra-processed food from the house. Chips, sugary cereal, juice boxes, pick one. Don’t announce it. Don’t explain. Just do it. Replace with something at the same accessibility level: fruit bowl on the counter, nuts in the snack drawer, cut vegetables at eye level in the fridge. Environment design beats willpower, in adults and in children [9][12]. If it’s not in the house, nobody negotiates for it. Karla can’t demand a KitKat that doesn’t exist.</p><p><strong>Set the Bedtime Floor.</strong> Non-negotiable. Within a 30-minute window, six nights a week. Screens out of bedrooms, charging in a common area. No screens 60 minutes before bed. Behavioral sleep interventions reduce sleep onset latency by 9-19 minutes [14]. Expect 7 to 10 nights of resistance. Hold it. And for the Tildas in your house, the ones old enough to game the system: design the environment so the default is compliance. Screens in the kitchen. Dark bedroom. The boundary isn’t a rule to enforce. It’s a room with no temptation in it.</p><p><strong>Fund Movement.</strong> Ask your kid what they want to try. Not what you think they should do. Organized sport is the single highest-tracking health behavior from childhood to adulthood (r=0.40-0.60) [5], but total daily movement matters too. Aim for 60 minutes of activity per day across everything: the sport, the bike ride to school, the run around the garden, the walk with the family. Let the organized activity anchor the week, and let the rest fill in naturally. And if a club tells your five-year-old he’s “not good enough,” find a different club. Or a different city.</p><p><strong>Make Your Stress Visible.</strong> Pick one strategy that takes under 5 minutes: a walk, breathing, or naming the emotion. Use it in front of your kids when you’re actually stressed. “I’m frustrated. I need a walk.” Walk. Come back. Don’t explain. Don’t make it a lesson. Three to five times a week. Your children will mirror what they see, not what they’re told [11]. This isn’t parenting advice. It’s biology.</p><h2>The 80-Year Portfolio</h2><p>Your career will end. Your job title will be forgotten. The strategy decks you’re proud of will be archived and never reopened.</p><p>But the health account you’re building in your children right now, that one runs for 80 years. And hopefully many more.</p><p>Every lunchbox is a deposit. Every bedtime is a deposit. Every time they watch you take a walk instead of losing your temper, that’s a deposit too. And every bag of chips, every screen glowing past midnight, every time they see you white-knuckle through stress without a single visible coping strategy… those are withdrawals.</p><p>The returns won’t show for decades. The metabolic panel at 40. The stress resilience at 35. The relationship with movement at 50. You won’t see all of it. That’s the point.</p><p>Karla will ask for chips again tomorrow. She will make her case with the conviction of someone who has never lost a negotiation, because she hasn’t. Magnus will test whatever boundary we set, figure out where it bends, and use that information against us. Tilda will say nothing, find a workaround behind our backs, and look genuinely puzzled when we ask about it.</p><p>The portfolio doesn’t require perfection. It requires consistency. The same deposits, made repeatedly, over years.</p><p>In three generations, no one will remember you. But the foundations you built into your children’s daily rhythms? Those compound. Across decades. Across generations. Long after the lunchbox arguments are forgotten, the bedtime negotiations are a family joke, and the kids have kids of their own who refuse to eat their vegetables.</p><p>The best investments outlast the investor.</p><p>Stay healthy.</p><p>Andre</p><p>​<br>​</p><div><hr></div><h2>References</h2><p>[1] American Academy of Sleep Medicine. (2016). Recommended amount of sleep for pediatric populations: A consensus statement. <em>Journal of Clinical Sleep Medicine, 12</em>(6), 785-786.</p><p>[2] Owens, J. A. (2014). Insufficient sleep in adolescents and young adults: An update on causes and consequences. <em>Pediatrics, 134</em>(3), e921-e932.</p><p>[3] Gregory, A. M., &amp; O’Connor, T. G. (2002). Sleep problems in childhood: A longitudinal study of developmental change and association with behavioral problems. <em>Journal of the American Academy of Child &amp; Adolescent Psychiatry, 41</em>(8), 964-971.</p><p>[4] Xie, L., Kang, H., Xu, Q., et al. (2013). Sleep drives metabolite clearance from the adult brain. <em>Science, 342</em>(6156), 373-377.</p><p>[5] Garcia-Hermoso, A., Ramirez-Campillo, R., &amp; Izquierdo, M. (2022). Tracking of physical fitness levels from childhood and adolescence to adulthood: A systematic review and meta-analysis. <em>Translational Pediatrics, 11</em>(3), 474-486.</p><p>[6] World Health Organization. (2020). WHO guidelines on physical activity and sedentary behaviour. Geneva: WHO Press.</p><p>[7] Monteiro, C. A., Cannon, G., Lawrence, M., Costa Louzada, M. L., &amp; Pereira Machado, P. (2019). Ultra-processed foods, diet quality, and health using the NOVA classification system. Rome: FAO.</p><p>[8] Pagliai, G., Dinu, M., Madarena, M. P., Bonaccio, M., Iacoviello, L., &amp; Sofi, F. (2021). Consumption of ultra-processed foods and health status: A systematic review and meta-analysis. <em>British Journal of Nutrition, 125</em>(3), 308-318.</p><p>[9] Birch, L. L., &amp; Fisher, J. O. (1998). Development of eating behaviors among children and adolescents. <em>Pediatrics, 101</em>(S2), 539-549.</p><p>[10] Qi, X., &amp; Yu, Y. (2022). Parental stress transmission in children: Mechanisms, assessment, and intervention. <em>Frontiers in Psychiatry, 13</em>, 991423.</p><p>[11] Eisenberg, N., Cumberland, A., &amp; Spinrad, T. L. (1998). Parental socialization of emotion. <em>Psychological Inquiry, 9</em>(4), 241-273.</p><p>[12] Wood, W., &amp; Neal, D. T. (2016). Healthy through habit: Interventions for initiating and maintaining health behavior change. <em>Behavioral Science and Policy, 2</em>(1), 71-83.</p><p>[13] Tremblay, M. S., Carson, V., Chaput, J. P., et al. (2016). Canadian 24-hour movement guidelines for children and youth. <em>Applied Physiology, Nutrition, and Metabolism, 41</em>(6), S311-S327.</p><p>[14] Mindell, J. A., Kuhn, B., Lewin, D. S., Meltzer, L. J., &amp; Sadeh, A. (2006). Behavioral treatment of bedtime problems and night wakings in infants and young children. <em>Sleep, 29</em>(10), 1263-1276.</p><p>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">Sleep, movement, food quality, and a lower-conflict home environment commonly matter for children. The evidence does not set an eighty-year destiny or validate the newsletter's portfolio arithmetic for one family.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Childhood trajectory:</strong> Ages six to twelve are important, but no cited study establishes a fixed critical window that determines the next eighty years. Development remains responsive to later health, environment, care, and opportunity. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Sleep mechanism:</strong> The cited glymphatic experiment was conducted in adult mice. Children still need adequate sleep, but the study does not demonstrate that sleep clears brain waste in school-aged children. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Movement:</strong> WHO recommends that children and adolescents average at least 60 minutes per day of moderate-to-vigorous activity across the week. It does not say that more activity adds little. The cited tracking review concerned physical fitness, not participation in organized sport. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Family portfolio:</strong> The four-part portfolio and its percentages are an editorial family framework, not validated medical arithmetic. Ultra-processed-food and parental-stress research should not be used to predict disease or gene expression in an individual child. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a> <a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/30212122/" rel="external">Alderman, H., Behrman, J. R., Glewwe, P., Fernald, L., &amp; Walker, S. (2017). Evidence of impact of interventions on growth and development during early and middle childhood. Disease Control Priorities, 8, 79–98. https://pubmed.ncbi.nlm.nih.gov/30212122/</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/24136970/" rel="external">Xie, L., Kang, H., Xu, Q., et al. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342(6156), 373–377. https://doi.org/10.1126/science.1241224</a></li><li id="correction-ref-3"><a href="https://www.who.int/publications/i/item/9789240015128" rel="external">World Health Organization. (2020). WHO guidelines on physical activity and sedentary behaviour. https://www.who.int/publications/i/item/9789240015128</a></li><li id="correction-ref-4"><a href="https://pubmed.ncbi.nlm.nih.gov/38418082/" rel="external">Lane, M. M., Gamage, E., Du, S., et al. (2024). Ultra-processed food exposure and adverse health outcomes: Umbrella review of epidemiological meta-analyses. BMJ, 384, e077310. https://pubmed.ncbi.nlm.nih.gov/38418082/</a></li><li id="correction-ref-5"><a href="https://pubmed.ncbi.nlm.nih.gov/38636551/" rel="external">Ribas, L. H., Montezano, B. B., Nieves, M., Kampmann, L. B., &amp; Jansen, K. (2024). The role of parental stress on emotional and behavioral problems in offspring: A systematic review with meta-analysis. Jornal de Pediatria, 100(6), 565–585. https://doi.org/10.1016/j.jped.2024.02.003</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/child-health-sleep-movement-and-food">Children's Sleep, Movement, Food, and Family Structure →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Surrounded and Starving: The Hidden Biology of Leadership Loneliness]]></title>
<description><![CDATA[Loneliness rewrites your genes and suppresses immunity. Why connected leaders are still isolated, and the single relationship that reverses it.]]></description>
<link>https://www.andreheeg.com/archive/surrounded-and-starving-the-hidden</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/surrounded-and-starving-the-hidden</guid>
<pubDate>Sun, 01 Mar 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>It’s 9pm on a Thursday. You just closed your laptop after the fourth video call that ran over. Your inbox shows 43 unread emails. Slack has been pinging since 8am. There are seven WhatsApp messages you haven’t opened and five texts you haven’t answered.</p><p>Your partner asks how your day was.</p><p>“Fine,” you say. You mean it. And you don’t.</p><p>You’re not depressed. You’re not antisocial. Your calendar is full of human interaction from morning until the kids are in bed. You lead teams, field calls, sit in rooms with smart people all day. There’s no shortage of people in your life.</p><p>There is, apparently, a shortage of connection. And the difference between those two things might be costing you more than you realize.</p><p>What does any of this have to do with a tattoo parlor and a guy inked from the collarbones to the backs of his feet… we’ll get there. First, let’s look at what that nightly “fine” is actually doing to your body.</p><h2><strong>This Isn’t a Feelings Problem</strong></h2><p>The instinct is to dismiss this as soft. Loneliness is for people who don’t have enough going on. You have too much going on. That’s a different problem.</p><p>Except it isn’t. And the data is brutal.</p><p>A meta-analysis of 148 studies covering over 308,000 people found that stronger social relationships are associated with a 50% increase in survival odds [1]. A separate synthesis of 90 cohort studies found that mortality risk from social isolation was 32% higher than baseline [2]. Cardiovascular data: 29% higher coronary heart disease risk, 32% higher stroke risk [3]. Dementia: roughly 31% higher risk across 600,000 people [4]. These associations hit harder in populations under 65 [5], the exact demographic reading this right now.</p><p>The U.S. Surgeon General’s 2023 advisory framed social disconnection’s mortality risk as comparable to smoking 15 cigarettes a day [6]. The precise equivalence is debatable, but the order of magnitude is consistent across multiple meta-analyses. Here’s what bothers me: we banned smoking from offices decades ago. Redesigned buildings, rewrote policies, and ran public health campaigns. But a leader who hasn’t had a genuine conversation in three weeks? We call that “focused.” We reward it. We promote people who have been running that way for years. And unlike cigarettes, nobody warns you on the package.</p><p>Imagine this printed on your laptop lid or office door: “Warning: Isolation may cause cognitive decay, suppressed immunity, and burnout.”</p><h2><strong>How Leadership Makes It Worse</strong></h2><p>These numbers apply to everyone. But leadership has a structural feature that turns a general risk into a personal trap.</p><p>I think of it as the leadership isolation paradox. As you climb, your network expands, and your connection evaporates. If you’ve felt it, you’ll recognize this.</p><p>Status filters vulnerability. You’ve learned that showing struggle reads as weakness, so you perform competence in every room. Including rooms that should feel safe. Confidentiality builds walls. The things weighing on you most are the things you can’t discuss with 95% of people around you. Power dynamics kill honesty. Your team manages you as carefully as you manage them. Feedback often gets curated, disagreements softened. And every interaction turns transactional: people want a decision, a resource, an endorsement. After enough of this, the line between a meeting and a relationship disappears.</p><p>Research confirms what your body already knows. Workplace loneliness correlates with lower job performance (r = -0.35), higher burnout (r = 0.39), and degraded leader-member exchange (r = -0.31) [7]. Loneliness operates as a background threat signal, consuming cognitive resources through hypervigilance and competing directly with the flexible thinking you need most under pressure [8].</p><p>The standard advice for isolated leaders is “expand your network” or “attend more events.” At best, that’s incomplete. At worst, it makes things worse. Most professional socializing is performance under a different label. The conference dinner, where you’re still being evaluated. The industry drinks where every conversation loops back to positioning. These interactions don’t fill the tank. They drain it while pretending to help. You don’t need more contacts. Almost every relationship in your professional life already runs on the same operating system: mutual evaluation, impression management, strategic positioning. More of that doesn’t fix the deficit. It deepens it.</p><p>Some professional relationships do become genuine. But be honest about how many of yours actually have. What matters is whether you have access to any relationship that operates on entirely different terms. Where no one is evaluating you, positioning themselves, or performing success. Where you can exist without your title running in the background.</p><p>Most leaders, when they really think about it, realize that number is close to zero.</p><h2><strong>What Loneliness Actually Does Inside You</strong></h2><p>This is where it stops being psychology and becomes biology.</p><p>When you’re chronically disconnected, your body doesn’t just “feel bad.” It rewrites its operating manual at the genetic level. Researchers have identified the Conserved Transcriptional Response to Adversity (CTRA): chronic social threat shifts gene expression. Pro-inflammatory genes get turned up. Antiviral and antibody genes are downregulated [9]. Your immune system braces for bacterial threats and neglects viral defense. In practical terms: higher baseline inflammation and weaker protection against the infections circulating through your office, your kids’ school, and every airport terminal.</p><p>The strongest causal evidence comes from a study you’d never get approved today. Researchers deliberately gave healthy adults a cold virus. People with fewer social roles had 4.2 times the risk of a cold than those with 6 or more distinct roles. Dose-response. Experimental, not observational [10].</p><p>Quality matters just as much. In a crossover study, couples alternated between conflict and supportive interactions while researchers tracked wound healing. Conflict slowed healing measurably. High-hostility couples healed at roughly 60% the rate of low-hostility couples [11]. We’re not talking about feelings here. A hostile conversation slowed the rate of skin healing.</p><p>The inflammatory markers confirm it: loneliness tracks with elevated IL-6, isolation with fibrinogen and CRP [12], the same markers behind atherosclerosis and neurodegeneration. Loneliness also disrupts sleep quality even when sleep duration holds steady [13]. Poor sleep amplifies inflammation, impairs glucose regulation, erodes executive function. The loop feeds itself.</p><p>That brain fog after weeks of shallow interaction? Not fatigue. Your immune system is running hot, and your prefrontal cortex is paying the bill.</p><p>This is Recover pillar territory in my Upward ARC framework. Most people hear “recovery” and think of sleep and rest days. True. But your nervous system also recovers through safe human contact. Without it, you’re running the engine without ever changing the oil. Activate (sleep, movement, nutrition) and Capacity (fitness, skills, cognitive reserve) both depend on a nervous system that can actually shift out of threat mode. It’s the pillar that keeps the other two standing.</p><h2><strong>Six Hours on a Rib Cage</strong></h2><p>Time for the reveal I promised.</p><p>There’s a version of me that most people I work with have never seen. The version lying face-up in a tattoo chair, shirt off, while an artist drags a needle across bone for the better part of a Saturday afternoon.</p><p>I’m covered in tattoos. The full inventory. I started the week I turned 18 and never really stopped. There’s no small, tasteful something tucked away where it’s easy to ignore. This is all-in. The kind of commitment that either makes you nod in recognition or makes you wonder about someone’s judgment. I’ve gotten both reactions. I’m fine with both.</p><p>I was thoughtful enough to leave out the parts you can’t hide in a professional setting. No forearms, no hands, no neck, no face. Everything a shirt covers is covered. Everything a shirt shows is clean. I’ve sat in boardrooms and hospitals and partner meetings with this arrangement for over twenty years.</p><p>People always want to know why. I used to stumble through answers because the question always felt like it demanded justification, and I don’t have any interest in justifying it. But the honest answers, the ones I’ve only really given when I trusted the person asking, are these: I’ve always felt this compulsion to do something with my body. Push it through sport. Mark it with art. It’s the same impulse, expressed two ways. And then there’s the pain. Six hours on a rib cage does something to your mind that’s hard to explain to anyone who hasn’t been there. You can’t distract yourself. You can’t check your phone. You just sit inside it. Hour after hour. And somewhere around hour three, when you’ve run out of surface-level thoughts, you hit something deeper. It’s not meditation. It’s more like excavation.</p><p>But the real discovery, the one I didn’t see coming, was the people.</p><p>Tattoo artists exist in a world that has nothing to do with mine. No consulting frameworks. No quarterly targets. No awareness of, or interest in, corporate hierarchies. What they have instead caught me off guard: deep readers of human behavior, built from years of managing vulnerable clients through painful experiences. People who’d read more widely and thought more originally than many of the executives I’d sat across from in strategy meetings.</p><p>And in that room, something happened that I couldn’t replicate anywhere in my professional life. I stopped performing. Nobody knew what I did. When someone asked, I’d say “something in healthcare” and leave it at that. No firm name. No title. No posturing. The conversation stayed on whatever it was actually about. Art, life, pain, something funny that happened that morning. The kind of talk that doesn’t need a purpose because the contact itself is the purpose.</p><p>That’s when I noticed the physical shift. My shoulders came down from wherever they’d been living, somewhere around my ears. My jaw loosened. My breathing slowed. And the thing I’d been carrying around, some decision or problem or tension I hadn’t been able to talk about in any professional context, suddenly found words. Not because anyone gave me advice. Nobody did. Because the status vacuum, the complete absence of evaluation, gave my nervous system permission to step off the stage.</p><p>The wellness industry tells leaders to “build deeper connections” and “be more vulnerable.” That advice skips the critical step. You can’t be vulnerable inside a system that evaluates vulnerability. Most leaders stay guarded in professional peer settings, executive dinners, and even friendships with colleagues for a simple reason: the environment punishes openness. More vulnerability training won’t fix that. What works is access to at least one context where vulnerability carries no cost. People from craft, sport, physical work, creative practice, whatever exists outside your incentive structure. Not because they’ll solve your problems. Because they create the conditions under which your body stops running threat detection long enough to actually recover.</p><p>The science backs this up. Social support, combined with safety cues, suppresses the cortisol response to psychosocial stress in controlled settings [14]. Multiple group memberships, especially identity-diverse ones, protect health across life transitions and high-stress periods [15]. And the viral challenge study makes the mechanism clear: it’s not total contacts that predict immune resilience. It’s the diversity of social roles [10].</p><h2><strong>Try This Today</strong></h2><p><strong>The Outsider Slot.</strong> Schedule one recurring interaction with someone who has zero overlap with your professional world. A coach, a climbing partner, a barber who’s known you for years, a ceramics class. Protect it like a board meeting. The only rule: no title disclosure. You’re just a person in the room. Role diversity predicts immune function [10], and group memberships outside your primary identity buffer the health impact of career stress [15].</p><p><strong>The One-Thing Unload.</strong> This week, name the single heaviest thing you’re carrying to one person. Out loud, not via text. Voice activates vagal pathways that typing doesn’t. Don’t confuse this with venting. Speaking a carried load out loud activates vagal tone and lightens physiological burden in ways that texting or thinking never will. Pick the person who will listen without fixing. A walk, a dinner, a drive. Get it out of your head and into the air.</p><p><strong>The Walk-and-Talk Swap.</strong> Next time your phone rings for a catch-up, take it on your feet. Movement combined with voice activates parasympathetic recovery. Works from hotel corridors, airport terminals, parking lots before school pickup. Social support moderates the stressor-strain relationship in demanding work contexts [16]. Movement amplifies it.</p><p><strong>The Conflict Audit.</strong> Identify the one recurring interaction that reliably leaves you worse than before. Not every connection is protective. High-conflict relationships slow immune repair. The wound-healing data prove it [11]. Set one boundary this week. Reduce exposure by one conversation. Reallocate that time to a relationship that restores. The evidence is specific: the presence of a bad connection actively damages, not just the absence of a good one.</p><h2><strong>Back to the Chair</strong></h2><p>There’s a particular afternoon I keep coming back to. Five hours into a session, past the point where small talk dies and something quieter takes over. The artist working. The hum of the machine. A conversation that had wandered from art to fatherhood to failure to what it means to keep showing up when you’re not sure why.</p><p>Nobody in that room knew my professional life. Nobody asked. And for those hours, I didn’t think about a single deliverable or decision. Just existed. Human to human.</p><p>Nobody gave me advice that day. My body had simply stood down long enough for clear thinking to return.</p><p>Your body keeps a ledger. Every week of performance-mode interaction. Every flight where you scrolled instead of calling someone. Every dinner where you said “fine” and meant something more complicated. It tallies up. The inflammation, the immune suppression, the flattened cortisol curves, they compound like interest on a loan you forgot you took out.</p><p>But so does the opposite. One real conversation. One person outside the system. One hour where you stop performing and just exist.</p><p>This is the Recover pillar. Not rest. Not a spa weekend. Recovery infrastructure for your nervous system.</p><p>The outsider doesn’t have to be a tattoo artist. Anyone from a world that has nothing to do with yours. The only requirement: they operate on a different system than the one you’re always running.</p><p>Find that person. Protect that time. Your career won’t notice the hour.</p><p>Your body will.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><div><hr></div><h2><strong>References</strong></h2><p>[1] Holt-Lunstad, J., Smith, T. B., &amp; Layton, J. B. (2010). Social relationships and mortality risk: A meta-analytic review. <em>PLOS Medicine, 7</em>(7), e1000316.</p><p>[2] Wang, F., Gao, Y., Han, Z., et al. (2023). A systematic review and meta-analysis of 90 cohort studies of social isolation, loneliness and mortality. <em>Nature Human Behaviour, 7</em>(8), 1307-1319.</p><p>[3] Valtorta, N. K., Kanaan, M., Gilbody, S., Ronzi, S., &amp; Hanratty, B. (2016). Loneliness and social isolation as risk factors for coronary heart disease and stroke: Systematic review and meta-analysis of longitudinal observational studies. <em>Heart, 102</em>(13), 1009-1016.</p><p>[4] Luchetti, M., Terracciano, A., Stephan, Y., &amp; Sutin, A. R. (2024). Loneliness and risk of dementia and cognitive impairment: An updated meta-analysis. <em>Nature Mental Health, 2</em>, 1323-1334.</p><p>[5] Holt-Lunstad, J., Smith, T. B., Baker, M., Harris, T., &amp; Stephenson, D. (2015). Loneliness and social isolation as risk factors for mortality: A meta-analytic review. <em>Perspectives on Psychological Science, 10</em>(2), 227-237.</p><p>[6] Office of the Surgeon General. (2023). <em>Our epidemic of loneliness and isolation: The U.S. Surgeon General’s advisory on the healing effects of social connection and community</em>. U.S. Department of Health and Human Services.</p><p>[7] Bryan, B. T., Gayed, A., Milligan-Saville, J. S., Madan, I., Calvo, R. A., Glozier, N., &amp; Harvey, S. B. (2023). A systematic review and meta-analysis of workplace loneliness. <em>International Archives of Occupational and Environmental Health, 96</em>(3), 347-372.</p><p>[8] Cacioppo, J. T., &amp; Hawkley, L. C. (2009). Perceived social isolation and cognition. <em>Trends in Cognitive Sciences, 13</em>(10), 447-454.</p><p>[9] Cole, S. W. (2014). Human social genomics. <em>PLOS Genetics, 10</em>(8), e1004601.</p><p>[10] Cohen, S., Doyle, W. J., Skoner, D. P., Rabin, B. S., &amp; Gwaltney, J. M. (1997). Social ties and susceptibility to the common cold. <em>JAMA, 277</em>(24), 1940-1944.</p><p>[11] Kiecolt-Glaser, J. K., Loving, T. J., Stowell, J. R., Malarkey, W. B., Lemeshow, S., Dickinson, S. L., &amp; Glaser, R. (2005). Hostile marital interactions, proinflammatory cytokine production, and wound healing. <em>Archives of General Psychiatry, 62</em>(12), 1377-1384.</p><p>[12] Smith, K. J., Gavey, S., Riddell, N. E., Kontari, P., &amp; Victor, C. (2020). The association between loneliness, social isolation and inflammation: A systematic review and meta-analysis. <em>Neuroscience &amp; Biobehavioral Reviews, 112</em>, 519-541.</p><p>[13] Griffin, S. C., Williams, A. B., Mladen, S. N., Perrin, P. B., Dzierzewski, J. M., &amp; Rybarczyk, B. D. (2020). Loneliness and sleep: A systematic review and meta-analysis. <em>Health Psychology Open, 7</em>(1), 2055102920913235.</p><p>[14] Heinrichs, M., Baumgartner, T., Kirschbaum, C., &amp; Ehlert, U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. <em>Biological Psychiatry, 54</em>(12), 1389-1398.</p><p>[15] Haslam, C., Haslam, S. A., Jetten, J., Cruwys, T., &amp; Steffens, N. K. (2021). Life change, social identity, and health. <em>Annual Review of Psychology, 72</em>, 635-661.</p><p>[16] Viswesvaran, C., Sanchez, J. I., &amp; Fisher, J. (1999). The role of social support in the process of work stress: A meta-analysis. <em>Journal of Vocational Behavior, 54</em>(2), 314-334.</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">Loneliness and social isolation matter, but most long-term evidence is observational. It does not show that a particular leader has immune damage, cognitive injury, or a fixed mortality risk.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Mortality and cardiovascular risk:</strong> Cohort studies find that loneliness and social isolation are associated with mortality and cardiovascular events. These are population averages with residual confounding, not individual predictions or proof that loneliness caused an event. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Cold challenge:</strong> Participants were experimentally exposed to a respiratory virus, but their social-role diversity was observed. The study does not prove that adding social roles prevents infection. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Genes, immunity, and brain fog:</strong> Social-genomics findings are mechanistic and observational. They do not establish a deterministic immune program or prove that loneliness directly causes brain fog in an individual. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Practical ideas:</strong> An outside confidant, walking meetings, and small recurring groups are personal practices, not tested treatment protocols. Persistent distress, depression, or safety concerns deserve individual professional assessment. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/37337095/" rel="external">Wang, F., Gao, Y., Han, Z., et al. (2023). A systematic review and meta-analysis of 90 cohort studies of social isolation, loneliness and mortality. Nature Human Behaviour, 7, 1307–1319. https://pubmed.ncbi.nlm.nih.gov/37337095/</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/9200634/" rel="external">Cohen, S., Doyle, W. J., Skoner, D. P., Rabin, B. S., &amp; Gwaltney, J. M. (1997). Social ties and susceptibility to the common cold. JAMA, 277(24), 1940–1944. https://pubmed.ncbi.nlm.nih.gov/9200634/</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/37275556/" rel="external">Slavich, G. M., Mengelkoch, S., &amp; Cole, S. W. (2023). Human social genomics: Concepts, mechanisms, and implications for health. Lifestyle Medicine, 4(2), e75. https://doi.org/10.1002/lim2.75</a></li><li id="correction-ref-4"><a href="https://www.hhs.gov/surgeongeneral/reports-and-publications/connection/resources/index.html" rel="external">Office of the U.S. Surgeon General. (n.d.). Social connection resources. https://www.hhs.gov/surgeongeneral/reports-and-publications/connection/resources/index.html</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/loneliness-social-connection-and-health">Loneliness, Social Connection, and Health Risk →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Leadership Under Load: Why Your Best People (Including You) Can’t Sustain What They Start]]></title>
<description><![CDATA[Stop telling yourself to push through. The real science of motivation, discipline, and habits, and how to keep performing when your routine breaks.]]></description>
<link>https://www.andreheeg.com/archive/leadership-under-load-why-your-best</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/leadership-under-load-why-your-best</guid>
<pubDate>Sun, 22 Feb 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>The laptop is open. The Notion board is loaded. Fourteen medical bills sit in a column labeled “To Process.” Some have been there for months.</p><p>I know what needs doing. Upload the bills. Assign them to the right person. Dispute the mistake. File the receipts. It should take twenty, maybe thirty minutes. I’ve handled strategy for Fortune 500s. I’ve rebuilt surgical protocols under pressure. This isn’t hard.</p><p>I close the laptop. Walk to the kitchen. Open the fridge, stare, close it. Check my phone. Sit down again. Open the laptop. Look at the board. Close it.</p><p>This has been going on for years.</p><p>It’s not just medical bills. It’s every bill. Taxes. Insurance claims. Anything that means logging in, fighting a bad portal, grinding through work that gives nothing back. The late fees add up. The number would change how people see me.</p><p>I know exactly why.</p><p>Adults with ADHD have real differences in how their prefrontal cortex works. Low-stimulation tasks aren’t just boring. They’re distressing [1]. Dopamine and norepinephrine run low when the task offers no novelty, no challenge, no feedback [2]. So the brain avoids. The relief of putting it off feels better than the dull ache of doing it. The consequences compound. Researchers call this the “ADHD Tax.” Adults with ADHD are four times more likely to have arrears in things like utility bills and road taxes [2].</p><p>That fits.</p><p>But this isn’t an ADHD newsletter. Under chronic load, bad sleep, or lasting stress, every brain starts doing this [3]. The prefrontal cortex degrades for everyone. Executive function isn’t a personality trait. It’s a resource that wears down under pressure. Leadership is one of the fastest ways to wear it down.</p><p>How do you keep yourself and your team doing the work that needs to be done? Especially when it’s boring, thankless, or just hard?</p><p>That’s a <strong>Capacity</strong> question. Not how you work on a good day, but how you show up when things get heavy.</p><h2>The Gap That Nobody Talks About</h2><p>You’ve seen this in every company you’ve worked in.</p><p>The VP who nails investor pitches but hasn’t finished a performance review in months. The task gives her nothing. It sits on her list, quietly accusing, while she builds another deck.</p><p>The product lead who ships features fast but avoids the team dynamic that’s falling apart. Hard conversations get the same treatment as my insurance portal.</p><p>The parent-executive who starts every morning in triage mode. By the first meeting, their brain is already spent on logistics, emotions, and a six-year-old who refuses shoes.</p><p>The standard answer? Be more disciplined. Build better habits. Stay motivated. I hear this from leadership coaches who charge by the hour, from LinkedIn thought leaders who post about things they have never experienced firsthand, and from an industry that sells “morning routine” programs to people who haven’t slept properly since 2019.</p><p>All three are real tools. But they serve different jobs at different stages, and using the wrong one at the wrong time is why most behavior change fails [4][5].</p><h3>Willpower doesn’t last.</h3><p>The “Strength Model” of self-control says willpower is a finite resource, like a muscle that tires. It was tested across 23 labs and 2,141 people. The effect was zero [6][7]. What actually happens when you feel “depleted” is simpler: your brain shifts effort away from unrewarding tasks toward rewarding ones. Not depletion. Reallocation.</p><p>Every coach who says to just push through is using a model that failed in real testing.</p><p>Leadership makes it worse. Job Demands-Resources theory shows that managing people, conflict, coaching, emotional labor, and decision volume increases the cognitive burden beyond the task itself [8][9].</p><p>You’re carrying your whole team. Then someone asks about your expenses. Good luck pushing through that.</p><h2>The Week It All Fell Apart</h2><p>Last year, before the sabbatical, I got pulled to a client meeting in Tokyo on short notice. Red-eye from Europe, eight-hour time difference, a full day of sessions on arrival.</p><p>Back home, I had a calendar block that had been working for weeks. Wednesday mornings at 8am: family admin. Bills, school forms, insurance follow-ups. My wife and I had agreed on it. The block was protected. The cue was simple: Wednesday, coffee, laptop, admin folder. Done by 9am, move on.</p><p>In the Tokyo hotel room, Wednesday morning didn’t exist. I woke up disoriented, eight hours ahead, already behind on client prep. The calendar block was still there, blinking on my phone. I swiped it away and started answering emails.</p><p>Three days later, I landed back home to a wife who was not happy. While I was in Tokyo, being diligent about client work and negligent about everything else, a school deadline had passed. She’d caught it, handled it herself, absorbed the stress of fixing it on a tight turnaround. The look she gave me when I walked through the door said more than any feedback conversation I’ve ever had at work.</p><p>The system worked for weeks. One trip and it broke.</p><p>The research predicts this. Habits depend on context [11][12]. Same cue, same place, same sequence. Change the context, and the behavior goes from automatic to deliberate. Even a three-hour time-zone shift, or an unexpected overnight, can be enough to break the chain and force your brain to make every step a decision again. Now it competes against everything else demanding your attention.</p><p>It loses. Every time.</p><h2>What Actually Sustains Performance</h2><p>Three tools. One order. Get it wrong and everything breaks.</p><p><strong>Motivation is a catalyst. </strong>Behavior connected to your values predicts engagement [13]. Behavior driven by guilt or pressure predicts burnout [14]. There’s a formula: motivation equals value times expectancy. You can value family admin enormously. If the experience of doing it is miserable, motivation collapses. That’s math, not weakness [14].</p><p><strong>Discipline is a bridge, not a lifestyle. </strong>It’s about controlling your attention: set up the right environment, cut friction, reframe the work [7]. The leader who logs out of Slack for deep work isn’t slacking. They’re using the only kind of self-control that works. If you still need willpower after two weeks, the problem isn’t you. It’s the system [4][5].</p><p><strong>Habits are the goal, but they take longer than anyone says.</strong> You want behavior that runs on autopilot. Cue, action, done [11][15]. Everything else is just a bridge. The timelines in self-help books are fiction. Real research says the median is 59 to 66 days, sometimes up to 335 [11][16]. Most people quit around day 40, right before it sticks. The 21-day habit is marketing, not reality.</p><p>The order is simple: motivation picks, intentions translate, habits automate, discipline catches the exceptions. Most people try to get motivated, then stay disciplined forever. The data says that doesn’t work [4][5].</p><h2>Leading Others Through the Same Science</h2><p>If this applies to you, it applies to every person who reports to you.</p><p>If you assign tasks with pressure and surveillance, you get burnout [14]. Give people autonomy and a sense of competence, and it flips [13]. Cut meetings that go nowhere. Stop always-on communication hiding behind the word culture. Protect recovery time. Demands drain people. Resources fuel them. If your team looks burned out, check the system before you question their commitment.</p><p>Incentives work for boring, measurable tasks. For creative work, they backfire by killing the motivation people already had [17][18]. Don’t gamify your team’s thinking. No one ever had a breakthrough because of a leaderboard.</p><p>Team-level habits follow the same logic. “After Monday standup, each person writes their top three priorities.” “After every 1-on-1, the manager sends a three-line recognition note.” The leader models the system, not the grind.</p><h3>Two Operating Modes</h3><p><strong>The Stable Week is your Build Mode: </strong>this is where you focus on building habits. The context stays the same. Line up your work with your body clock [19]: do the hard stuff in the first eight hours after waking, lighter work later, and protect your evenings for recovery. Morning routines live here. Shutdown rituals live here.</p><p><strong>The Variable Week is your Protect Mode:</strong> this is about protecting habits when routines get disrupted. Travel, kid chaos, deadlines. Time-based cues break. Use event-based cues instead: After I put my suitcase down. After I brush my teeth. After my last meeting. These survive chaos [11][12]. Drop to the minimum version. Two minutes of movement counts. A few admin tasks count. The goal isn’t performance. It’s keeping the habit alive, so one missed day doesn’t turn into a collapse.</p><p>Ask yourself: which mode is my team in right now? Are we using the right tools for it?</p><h2>Try This Today</h2><p><strong><span>Temptation Bundling for Dread Work.</span></strong><span> Pick something you enjoy (a podcast, audiobook, or good coffee) and save it for the tasks you hate most. This raises follow-through by 10-14% [21]. I have a podcast I only get while doing admin. The bills still annoy me. The podcast makes them bearable.</span></p><p><strong><span>Two-Layer If-Then Planning. </span></strong><span>Layer 1: Wednesday at 8am after coffee, family admin. Layer 2: If my morning gets hijacked, ten minutes after my last meeting. 94 studies confirm this works [4]. Pre-loading the decision removes the willpower cost. For travel: When the plane lands, hotel gym before email. For meetings: When the call ends, stand and walk for five minutes.</span></p><p><strong><span>Never Miss Twice. </span></strong><span>Expect failure. When a habit breaks, call it a data point, not a character flaw. Do a two-minute minimum version the next day. Anchor it to an event, not a clock. After I put my suitcase down, beats at 6pm. One missed day is noise. Two missed days is when the brain starts telling you a story about who you are [20]. Don’t let it.</span></p><p><strong><span>The Weekly Review.</span></strong><span> Same day each week. Fifteen minutes. Two questions: What broke the cue? What friction can I remove? I do mine on Sunday evenings while the kids argue about what to watch. Might as well make the noise useful.</span></p><h2>Back to the Board</h2><p>Here’s something I’ve never said publicly. I’ve had an executive assistant at work for well over a decade. They kept me on track and flagged what I was avoiding. At work, the system ran. My personal life had no such safety net. The bills piled up. The school forms got missed. My wife picked up what I dropped, and she kept score. Rightfully so.</p><p>This week, I hired a personal assistant for the first time. Starts Monday. If you’ve been waiting for an email from me, there’s hope.</p><p>The Kanban board is still there. Fourteen bills down to nine. The late fees haven’t stopped yet, though.</p><p>The version of you that’s unstoppable when focused doesn’t need systems. They just need something they care about. But the other version, the one staring at the admin board, fresh off a red-eye, whose morning blew up before 7am because a barefoot six-year-old is running the house, needs structure.</p><p>Build it. For yourself. For your team. Not because discipline failed you, but because you stopped pretending it was enough.</p><p>Stay healthy.</p><p>Andre</p><div><hr></div><h2>References</h2><p>[1] Barkley, R. A. (2012). Executive functions: What they are, how they work, and why they evolved. Guilford Press.</p><p>[2] Mowlem, F. D., Rosenqvist, M. A., Martin, J., Lichtenstein, P., Asherson, P., &amp; Larsson, H. (2019). Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment. European Child &amp; Adolescent Psychiatry, 28(4), 481-489. See also: CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder). (2023). Understanding executive function deficits. Retrieved from https://chadd.org</p><p>[3] Lowe, C. J., Safati, A., &amp; Hall, P. A. (2017). The neurocognitive consequences of sleep restriction: A meta-analytic review. Neuroscience &amp; Biobehavioral Reviews, 80, 586-604.</p><p>[4] Gollwitzer, P. M., &amp; Sheeran, P. (2006). Implementation intentions and goal achievement: A meta-analysis of effects and processes. Advances in Experimental Social Psychology, 38, 69-119.</p><p>[5] Gardner, B. (2014). A review and analysis of the use of “habit” in understanding, predicting, and influencing health-related behaviour. Health Psychology Review, 9(3), 277-295.</p><p>[6] Hagger, M. S., Chatzisarantis, N. L. D., Alberts, H., Anggono, C. O., Batailler, C., Birt, A. R., … &amp; Zwienenberg, M. (2016). A multilab preregistered replication of the ego-depletion effect. Perspectives on Psychological Science, 11(4), 546-573.</p><p>[7] Dang, J. (2018). An updated meta-analysis of the ego depletion effect. Psychological Research, 82(4), 645-651.</p><p>[8] Demerouti, E., Bakker, A. B., Nachreiner, F., &amp; Schaufeli, W. B. (2001). The job demands-resources model of burnout. Journal of Applied Psychology, 86(3), 499-512.</p><p>[9] Tummers, L. G., &amp; Bakker, A. B. (2021). Leadership and job demands-resources theory: A systematic review. Frontiers in Psychology, 12, 722080.</p><p>[10] Bakker, A. B., &amp; Demerouti, E. (2023). Job demands-resources theory: Taking stock and looking forward. In P. L. Perrewé, D. C. Ganster, &amp; C. Rosen (Eds.), Research in Occupational Stress and Well-Being. Emerald Publishing.</p><p>[11] Lally, P., van Jaarsveld, C. H. M., Potts, H. W. W., &amp; Wardle, J. (2010). How are habits formed: Modelling habit formation in the real world. European Journal of Social Psychology, 40(6), 998-1009.</p><p>[12] Gardner, B. (2012). Habit as automaticity, not frequency. European Health Psychologist, 14(2), 32-36.</p><p>[13] Ryan, R. M., &amp; Deci, E. L. (2000). Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. American Psychologist, 55(1), 68-78.</p><p>[14] Gagné, M., Parker, S. K., Griffin, M. A., Kashyap, V., Tyber, M., Nuber, C., &amp; Holterman, L. A. (2022). Understanding and shaping the future of work with self-determination theory. Nature Reviews Psychology, 1, 378-392.</p><p>[15] Wood, W., &amp; Neal, D. T. (2016). Healthy through habit: Interventions for initiating and maintaining health behavior change. Behavioral Science &amp; Policy, 2(1), 71-83.</p><p>[16] Singh, B., Olds, T., Curtis, R., Virgara, R., Szeto, K., Maddison, R., … &amp; Maher, C. (2024). Habit formation in health-related behaviours: A systematic review and meta-analysis. Healthcare, 12(3), 283.</p><p>[17] Deci, E. L., Koestner, R., &amp; Ryan, R. M. (1999). A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychological Bulletin, 125(6), 627-668.</p><p>[18] Cerasoli, C. P., Nicklin, J. M., &amp; Ford, M. T. (2014). Intrinsic motivation and extrinsic incentives jointly predict performance: A 40-year meta-analysis. Psychological Bulletin, 140(4), 980-1008.</p><p>[19] Huberman, A. (2021). The science of making and breaking habits. Huberman Lab Podcast, Episode 53. Stanford University.</p><p>[20] Marlatt, G. A., &amp; George, W. H. (1984). Relapse prevention: Introduction and overview of the model. British Journal of Addiction, 79(3), 261-273.</p><p>[21] Milkman, K. L., Minson, J. A., &amp; Volpp, K. G. M. (2014). Holding the Hunger Games hostage at the gym: An evaluation of temptation bundling. Management Science, 60(2), 283-299.</p><p>​</p><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The habit framework is practical editorial guidance. Several precise numbers and mechanisms in the historical edition are not established by the cited research and should not be read as diagnoses or biological rules.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>ADHD claims:</strong> The cited diagnostic paper does not show that low-stimulation work creates a specific neurotransmitter state or that adults with ADHD are four times as likely to fall behind on bills. ADHD-related impairment varies and requires individual assessment. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Habit timing:</strong> The evidence does not establish that a three-hour time shift breaks a habit, that willpower lasts two weeks, or that most people quit on day 40. Those precise rules should be treated as unsupported. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a> <a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Rewards:</strong> External incentives do not always damage creative work. Effects depend on the task, reward, autonomy, timing, and outcome, and intrinsic and extrinsic motivation can coexist. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>Eight-hour rule:</strong> The first eight hours after a behavior are not established as a universal habit-consolidation window. Temptation bundling was tested in a narrow gym and audiobook setting, while “never miss twice” is a memorable personal heuristic rather than a scientific threshold. <span class="correction-ref-links"><a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://pubmed.ncbi.nlm.nih.gov/36876491/" rel="external">Kosheleff, A. R., Mason, O., Jain, R., Koch, J., &amp; Rubin, J. (2023). Functional impairments associated with ADHD in adulthood and the impact of pharmacological treatment. Journal of Attention Disorders, 27(7), 669–697. https://doi.org/10.1177/10870547231158572</a></li><li id="correction-ref-2"><a href="https://doi.org/10.1002/ejsp.674" rel="external">Lally, P., van Jaarsveld, C. H. M., Potts, H. W. W., &amp; Wardle, J. (2010). How are habits formed: Modelling habit formation in the real world. European Journal of Social Psychology, 40(6), 998–1009. https://doi.org/10.1002/ejsp.674</a></li><li id="correction-ref-3"><a href="https://doi.org/10.1177/1745691616652873" rel="external">Hagger, M. S., Chatzisarantis, N. L. D., Alberts, H., et al. (2016). A multilab preregistered replication of the ego-depletion effect. Perspectives on Psychological Science, 11(4), 546–573. https://doi.org/10.1177/1745691616652873</a></li><li id="correction-ref-4"><a href="https://pubmed.ncbi.nlm.nih.gov/24491020/" rel="external">Cerasoli, C. P., Nicklin, J. M., &amp; Ford, M. T. (2014). Intrinsic motivation and extrinsic incentives jointly predict performance: A 40-year meta-analysis. Psychological Bulletin, 140(4), 980–1008. https://pubmed.ncbi.nlm.nih.gov/24491020/</a></li><li id="correction-ref-5"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4381662/" rel="external">Milkman, K. L., Minson, J. A., &amp; Volpp, K. G. M. (2014). Holding the Hunger Games hostage at the gym: An evaluation of temptation bundling. Management Science, 60(2), 283–299. https://pmc.ncbi.nlm.nih.gov/articles/PMC4381662/</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/motivation-habits-and-adhd-under-load">Motivation, Habits, and ADHD Under Load →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Bloodwork That Matters: A Calm, Non-Hyped Executive Guide]]></title>
<description><![CDATA[Stop paying for 100-marker panels. A doctor breaks down the handful of blood tests worth running, what to skip, and how to avoid false positives.]]></description>
<link>https://www.andreheeg.com/archive/bloodwork-that-matters-a-calm-non</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/bloodwork-that-matters-a-calm-non</guid>
<pubDate>Sun, 15 Feb 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>If you search for information about bloodwork online, you’ll find yourself overwhelmed long before you find any real answers.</p><p>You’ll see headlines like “Longevity blood testing: 8 biomarkers to check” or “5 Biomarkers Everyone Should Test.” The articles all sound the same, but the companies behind them are easy to spot. They’re selling you test panels, subscription services, and a subtle sense that you’re not doing enough. I call this tactic “panel-panic marketing.” It’s a strategic move designed to exploit your fears and doubts, all to drive more sales.</p><p>I’ve been on both sides of this. As a competitive wrestler, I started running bloodwork in my late teens, trying to make weight while keeping my body from falling apart. As a physician, I ordered it for patients. And over all those years, the number of blood panels that actually changed what I did? I can count them on one hand. The rest was curiosity dressed up as diligence.</p><p>Let’s look at what’s actually important, what isn’t, and why the real answer is much simpler than what most companies suggest.</p><p>Fair warning: this piece uses medical terms and acronyms. I tried to keep the language plain, but some parts get technical. If you hit a term that doesn’t land, there’s a glossary at the end written for people who don’t spend their days reading lab reports.</p><h2>The FOMO Machine</h2><p>Some companies now offer 100+ biomarker panels with testing “at least twice a year.” Their editorial teams produce content about “critical markers you’re probably missing.” Most of these articles come from companies whose primary interest is their business, not your biology.</p><p>The business model is straightforward: the more tests they sell, the more likely you are to get flagged results, and the more often you’ll come back for more. Your worry is what drives their business.</p><p>The Choosing Wisely initiative has explicitly warned against routine blood tests in asymptomatic patients precisely because of the cascading consequences of false positives [1]. Over 80 medical specialty societies signed on to that recommendation. When that many physicians agree on something, it’s worth paying attention.</p><p>You won’t hear about Choosing Wisely from wellness companies, because it doesn’t support their message.</p><h2>The 64% Problem</h2><p>Even basic statistics show why testing for everything doesn’t make sense.</p><p>Every blood test uses reference ranges based on the central 95% of a population. That means even in a perfectly healthy person, each test carries a 2.5% chance of flagging as abnormal at either end. Sounds small. It isn’t.</p><p>Run 20 independent tests on a healthy person. The probability of at least one abnormal flag: roughly 64%. Run the kind of 100-marker executive panel wellness companies love to sell? The probability approaches 99% [2].</p><p>A flagged result often leads to more tests, imaging, specialist visits, and sometimes even a biopsy. This can mean weeks of unnecessary worry, usually without any real problem.</p><p>A 2024 study in Nature showed that individual homeostatic setpoints are far narrower than population reference ranges [3]. Your white blood cell count could swing from your personal 10th to 90th percentile (a massive inflammatory signal if someone were tracking your trend) while sitting comfortably inside the “normal” range on a standard lab report. Population averages mask individual variation. And individual variation is where the actual signal lives.</p><p><strong>Challenge:</strong> More testing does not mean better health. A 100-marker executive panel statistically yields false positives in healthy individuals. That flag triggers a cascade of follow-up that costs time, money, and peace of mind, usually for nothing. The evidence on this is not ambiguous [1, 2].</p><p>It’s like a car alarm that sounds every time something minor happens. Eventually, you stop paying attention, and you might miss something important when it really matters.</p><p>One published case study illustrates where this ends: a physically active 39-year-old man had mildly elevated liver enzymes flagged on routine bloodwork. He was referred to a gastroenterologist, underwent repeat labs, and was scheduled for a liver biopsy. When he finally stopped exercising for seven days before the next draw, every value was normalized. The diagnostic pathway never once assessed his exercise habits or muscle biomarkers [4].</p><p>I’ve experienced this myself: after a tough training period, I had a flagged result that made me worry for a moment. But when I repeated the test two weeks later, after resting and following the right protocol, everything was normal. This happens more often than most people realize.</p><h2>The Confounders Nobody Mentions</h2><p>Even when you do test, your results are often distorted by factors no one warned you about.</p><p>Strenuous exercise elevates AST and ALT (commonly called “liver enzymes”) for up to seven days post-exertion. These enzymes are abundant in muscle tissue, not just the liver. One study showed that a single hour of heavy weightlifting in healthy men resulted in significantly elevated AST and ALT levels that persisted for at least a week [5]. Hit the gym on Sunday, draw blood on Wednesday, and your “liver function” can look pathological on paper while your liver is perfectly fine.</p><p>Exercise can also spike creatine kinase by thousands of units and transiently raise creatinine, mimicking acute kidney injury in lab results [6]. Testosterone follows a circadian rhythm, peaking around 8 AM and declining throughout the day. A 4 PM draw will give you a misleadingly low number [7]. And vitamin D fluctuates with season and latitude. A February reading in a northern city measures winter, not deficiency [8].</p><p>I’ve seen this happen many times. You come back from a work trip, running on just a few hours of sleep. You still make it to the gym early in the morning, because you never skip a workout. Then you go for your blood draw, since rescheduling isn’t an option. The results show high creatinine, flagged ALT, and low testosterone. These numbers don’t reflect your real health, but just reflect what happened in the day and a half before your test.</p><h2>The Decision Filter</h2><p>Before we get to what to actually test, sit with one question that will save you more money and anxiety than any panel ever will.</p><p>“If this comes back abnormal, what would we do differently?”</p><p>If the answer is unclear or nothing would change, then the test is just adding noise. This is the difference between real medical decision-making and commercial wellness.</p><h2>The Minimal Panel That Actually Matters</h2><p>What passes that filter, and why.</p><p><strong>Blood Pressure.</strong> Still the single strongest predictor of cardiovascular events. Clear treatment thresholds. Clear intervention pathways. USPSTF recommends screening all adults 18 and older [9]. If you measure one thing, measure this.</p><p><strong>Lipids, plus ApoB.</strong> Standard lipid panels give you LDL-C, HDL-C, and triglycerides. Useful. But the addition that matters most: Apolipoprotein B. ApoB directly measures the number of atherogenic particles in your blood, not just the cholesterol they carry. In patients with insulin resistance (high triglycerides, low HDL), LDL-C can look “normal” while particle count is dangerously elevated. The 2024 National Lipid Association Expert Clinical Consensus now explicitly supports ApoB measurement for cardiovascular risk stratification, noting that when ApoB and LDL-C diverge, risk follows ApoB, not LDL-C [10]. One extra line on your lab order. Meaningful additional information.</p><p>Add a one-time <strong>Lipoprotein(a)</strong> measurement. Lp(a) is genetically determined, largely resistant to lifestyle intervention, and elevated levels mandate aggressive management of every other modifiable risk factor. Multiple international guidelines, including the 2024 NLA update, endorse universal or opportunistic screening for Lp(a) [11]. You only need this number once.</p><p><strong>HbA1c and Fasting Glucose.</strong> Prediabetes (HbA1c 5.7 to 6.4%) is reversible with intervention. That’s the whole point: catching it before medication becomes the only option. The American Diabetes Association recommends screening from age 35, or earlier, for overweight individuals with risk factors [12]. The triglyceride-to-HDL ratio is a useful surrogate for insulin resistance. Below 2.0 suggests good sensitivity. A value above 3.0 correlates with resistance and small, dense LDL [13].</p><p><strong>Creatinine and eGFR.</strong> Silent kidney decline changes medication decisions and alters cardiovascular risk profiles. KDIGO 2024 guidelines recommend routine eGFR monitoring [14]. One catch: if you carry significant muscle mass, creatinine-based eGFR can underestimate kidney function. Cystatin C resolves this when creatinine is equivocal.</p><p><strong>ALT and AST, with FIB-4 Calculation.</strong> Your metabolic barometer. But most lab ranges still flag “normal” at 40-50 U/L. Updated AASLD 2023 thresholds are lower: 29 to 33 U/L for men, 19 to 25 U/L for women [15]. FIB-4 (an index combining age, AST, ALT, and platelet count) costs nothing extra and gives you a useful fibrosis risk estimate [16]. Ask your doctor to calculate it.</p><p><strong>CBC (Complete Blood Count).</strong> Broad baseline for anemia, infection clues, and hematologic red flags. The biggest payoff comes from tracking your personal numbers over time rather than comparing against population averages [3].</p><p><strong>Conditional add-ons</strong> (only with specific risk context): Urine albumin-to-creatinine ratio if you have diabetes, hypertension, or CKD risk factors [14]. hs-CRP only when it would change a statin decision in an intermediate-risk patient, not as a general “inflammation check” [17]. Ferritin only with anemia or suggestive symptoms, and remember that ferritin rises as an acute-phase reactant, masking true deficiency [18].</p><h2>What I Skip (And Why)</h2><p>A quick note before this section. I’m a physician by training, and I know that listing tests to avoid could appear as medical advice. It isn’t. What follows is my own approach, based on current guidelines and study results. Your health context is unique to you. Discuss any testing decisions with your own doctor. My intention is to provide a thinking framework, not a prescription. It’s important to recognize that individuals with chronic conditions or significant family medical histories might require personalized panels tailored to their specific health contexts. Consulting with a healthcare provider is essential for those with unique backgrounds to determine the most appropriate testing approach.</p><p>With that said, this is where things get uncomfortable for anyone paying for executive health panels.</p><p><strong>Challenge:</strong> The Endocrine Society’s 2024 Clinical Practice Guideline now recommends against routine vitamin D screening in healthy adults. The guideline panel, co-sponsored by nine medical societies, found no clinical trial evidence supporting routine 25(OH)D testing in the general population and could not determine a specific blood-level threshold for disease prevention [19]. The large-scale VITAL trial failed to show that screening and targeting specific levels improved outcomes. This is a genuine shift in consensus, and a big one. Most wellness companies will never mention it because testing is how they keep you coming back.</p><p>I skip a thyroid screening unless I have symptoms. The USPSTF assigned an “I” (Insufficient Evidence) rating for thyroid screening in asymptomatic adults [20]. If you feel fine, this test adds noise rather than clarity.</p><p>I skip tumor marker panels (CA-125, CEA, PSA outside shared decision-making guidelines). These markers lack the specificity for screening in asymptomatic populations and generate false positives that trigger invasive follow-up [21].</p><p>I also skip broad inflammation panels, cytokine panels, testosterone “optimization” labs without clinical indication, and micronutrient megapanels without deficiency symptoms.</p><p>If your health provider is offering a 100-marker panel with frequent retesting, they’re not focused on your health.. they’re running a business. You don’t have to participate.</p><h2>Try This Today</h2><p><strong>1. The 48-Hour Protocol.</strong> Before your next draw, prepare with this checklist to streamline the process and your preparation for better adherence:</p><p>- Sleep well: Aim for 7-9 hours of quality sleep leading up to your test day.</p><p>- No strenuous exercise for 48 hours prior.</p><p>- Morning appointment before 10 AM.</p><p>- Fast if triglycerides are on the panel.</p><p>- Use the same lab for consistency.</p><p>- Schedule your appointment to allow for 30 minutes of quiet time on a calm Tuesday morning.</p><p>Completing these steps not only helps to ensure accuracy in your results but also turns preparation into an achievable mini-challenge, increasing the likelihood of follow-through on lab day. These steps eliminate the majority of pre-analytical noise that distorts results [5, 6, 7].</p><p><strong>2. Add ApoB.</strong> Request Apolipoprotein B alongside your standard lipid panel. Most doctors still don’t order it routinely, but the NLA consensus now backs it. It captures atherogenic particle burden that LDL-C misses, especially if you carry metabolic risk factors. One extra line on the lab order [10].</p><p><strong>3. The One-Question Filter.</strong> At your next appointment, before agreeing to any test, ask your doctor: “If this comes back abnormal, what would we do differently?” If the answer is vague, skip the test.</p><p><strong>4. Track Trends, Not Snapshots.</strong> Never react to a single abnormal value. Repeat under the same standardized conditions before escalating. A first reading is statistically more likely to show an extreme value (regression to the mean). Two consistent readings under controlled conditions tell you something real. One reading after a red-eye flight tells you nothing.</p><p>You don’t need to get bloodwork every few months. One carefully timed and prepared test each cycle, tracking a few key markers over time, is enough. This means less time waiting and fewer unnecessary scares.</p><h2>The Upward ARC Connection</h2><p>This newsletter addresses the Activate pillar of the Upward ARC framework. Activation means establishing your biological foundation: movement, sleep, nutrition, light exposure, and knowing where your body actually stands.</p><p>Focused, well-interpreted bloodwork is part of that foundation. It gives you a clean baseline that informs everything else in the framework, from how you design Recovery to how you build Capacity over decades.</p><p>Getting too much data from oversized panels, inconsistent testing, or single abnormal results can be more misleading than having no data at all.</p><p>I’ve been doing my own bloodwork for more than 30 years. I’ve had dozens of panels, and most of them just satisfied my curiosity. Only a few actually led me to make changes, but those few were very important. For example, a symptomatic thyroid test revealed a temporary autoimmune reaction, and a lipid panel combined with elevated blood pressure made me think differently about my family history. The real value wasn’t in how many tests I did, but in knowing which ones mattered, and which ones didn’t.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><div><hr></div><h2>Glossary</h2><p><strong>ApoB (Apolipoprotein B).</strong> A protein found on “bad” cholesterol particles. Each dangerous particle has exactly one ApoB molecule. Counting ApoB tells you how many harmful particles you have, which is more useful than measuring how much cholesterol those particles carry.</p><p><strong>ALT and AST.</strong> Two enzymes your body makes. Doctors call them “liver enzymes,” but they also live in your muscles. When muscle tissue breaks down (from exercise, for example), these numbers go up. A high reading can indicate liver trouble or recent exercise.</p><p><strong>Atherogenic.</strong> Anything that helps build plaque inside your arteries. Plaque narrows blood vessels over time and can cause heart attacks or strokes.</p><p><strong>Asymptomatic.</strong> Having no symptoms. You feel fine. Nothing hurts. Nothing seems off.</p><p><strong>CBC (Complete Blood Count).</strong> A basic blood test that counts your red cells, white cells, and platelets. It shows if you’re anemic, fighting an infection, or have a blood disorder.</p><p><strong>Circadian rhythm.</strong> Your body’s 24-hour internal clock. It controls when certain hormones peak and dip. Testosterone, for example, is highest in the morning and lowest in the late afternoon.</p><p><strong>Creatinine.</strong> A waste product your muscles make. Your kidneys filter it out. When the kidneys slow down, creatinine builds up in the blood. But heavy exercise also temporarily raises it, which can make a kidney problem look like it’s on paper.</p><p><strong>Cystatin C.</strong> Another way to check kidney function. Unlike creatinine, it isn’t affected by how much muscle you carry. Useful when creatinine results are confusing.</p><p><strong>eGFR (Estimated Glomerular Filtration Rate).</strong> A number that estimates how well your kidneys filter blood. Higher is better. Calculated from your creatinine level, age, and sex.</p><p><strong>Ferritin.</strong> A protein that stores iron. Low ferritin levels can indicate low iron levels. But ferritin also rises when your body is fighting inflammation, so a “normal” reading can hide a real deficiency.</p><p><strong>FIB-4.</strong> A simple score calculated from four things already on your blood test: your age, AST, ALT, and platelet count. It estimates whether your liver has scarring (fibrosis). No extra blood draw needed.</p><p><strong>Fibrosis.</strong> Scarring of an organ, usually the liver. Scar tissue replaces healthy tissue over time, reducing the organ’s function.</p><p><strong>HbA1c (Glycated Hemoglobin).</strong> A blood test that shows your average blood sugar over the past two to three months. Normal is below 5.7%. Between 5.7% and 6.4% means prediabetes. Above 6.5% means diabetes.</p><p><strong>HDL (High-Density Lipoprotein).</strong> Often called “good” cholesterol. HDL particles help remove cholesterol from your arteries.</p><p><strong>hs-CRP (High-Sensitivity C-Reactive Protein).</strong> A marker of inflammation in the body. It goes up with infections, hard training, stress, and many other things. Useful in narrow clinical situations, but too noisy as a general screen.</p><p><strong>Insulin resistance.</strong> When your cells stop responding well to insulin, the hormone that moves sugar from your blood into your cells. Your body makes more insulin to compensate. Over time, this leads to weight gain, high blood sugar, and eventually type 2 diabetes.</p><p><strong>LDL (Low-Density Lipoprotein).</strong> Often called “bad” cholesterol. LDL particles carry cholesterol into your artery walls, where it builds up as plaque.</p><p><strong>Lp(a) (Lipoprotein-a).</strong> A type of cholesterol particle determined almost entirely by your genes. You can’t change it with diet or exercise. If it’s high, your doctor needs to be more aggressive about managing everything else.</p><p><strong>Prediabetes.</strong> The stage before type 2 diabetes. Blood sugar is above normal but not yet in the diabetic range. With changes to diet and exercise, it can be reversed.</p><p><strong>Pre-analytical.</strong> Everything that happens before the lab analyzes your blood. This includes when you ate, when you exercised, what time of day you drew, how well you slept, and which lab processed the sample. These factors can move your numbers more than your actual health.</p><p><strong>PSA (Prostate-Specific Antigen).</strong> A protein made by the prostate gland. Elevated levels can indicate prostate cancer, but also infection, enlargement, or recent activity. High false-positive rate in screening.</p><p><strong>Reference range.</strong> The “normal” range printed on your lab report. It’s based on the middle 95% of a large group. It does not mean that values outside this range are automatically a problem.</p><p><strong>Triglycerides.</strong> A type of fat in your blood. Your body converts extra calories into triglycerides and stores them in fat cells. High levels are linked to heart disease, especially when combined with low HDL.</p><p><strong>USPSTF (U.S. Preventive Services Task Force).</strong> An independent group of medical experts that reviews evidence and makes recommendations about screening tests and preventive care. Their letter grades (A, B, C, D, I) tell doctors how strong the evidence is for or against a test.</p><p><strong>25(OH)D.</strong> The form of vitamin D measured in blood tests. It reflects how much vitamin D your body has stored from sunlight, food, and supplements.</p><p>​</p><div><hr></div><h2>References</h2><p>[1] Choosing Wisely Canada. (2017). Unnecessary tests and treatments in Canada. Society of General Internal Medicine recommendations.</p><p> https://choosingwiselycanada.org</p><p>​</p><p>[2] Mold, J. W., &amp; Stein, H. F. (1986). The cascade effect in the clinical care of patients. <em>New England Journal of Medicine</em>, 314(8), 512-514.</p><p>[3] Pietzner, M., et al. (2024). Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. <em>Nature Medicine</em>, 30, 1780-1786.</p><p>[4] Keenan, J. I., Muir, R. M., Ayre, K., &amp; Baldi, J. C. (2023). Exercise-induced increases in “liver function tests” in a healthy adult male: Is there a knowledge gap in primary care? <em>Journal of Family Medicine and Primary Care</em>, 12(1), 167-170.</p><p>[5] Pettersson, J., Hindorf, U., Persson, P., Bengtsson, T., Malmqvist, U., Werkstrom, V., &amp; Ekelund, M. (2008). Muscular exercise can cause highly pathological liver function tests in healthy men. <em>British Journal of Clinical Pharmacology</em>, 65(2), 253-259.</p><p>[6] Clarkson, P. M., Kearns, A. K., Rouzier, P., Rubin, R., &amp; Thompson, P. D. (2006). Serum creatine kinase levels and renal function measures in exertional muscle damage. <em>Medicine and Science in Sports and Exercise</em>, 38(4), 623-627.</p><p>[7] Bremner, W. J., Vitiello, M. V., &amp; Prinz, P. N. (1983). Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. <em>Journal of Clinical Endocrinology and Metabolism</em>, 56(6), 1278-1281.</p><p>[8] Klingberg, E., Olerod, G., Konar, J., Petzold, M., &amp; Hammarsten, O. (2015). Seasonal variations in serum 25-hydroxy vitamin D levels in a Swedish cohort. <em>Endocrine</em>, 49(3), 800-808.</p><p>[9] U.S. Preventive Services Task Force. (2023). Screening for hypertension in adults: Recommendation statement. <em>JAMA</em>, 330(16), 1570-1579.</p><p>[10] Soffer, D. E., Marston, N. A., Maki, K. C., Jacobson, T. A., Bittner, V. A., Pena, J. M., … &amp; Remaley, A. T. (2024). Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An expert clinical consensus from the National Lipid Association. <em>Journal of Clinical Lipidology</em>, 18(5), e647-e663.</p><p>[11] Koschinsky, M. L., Bajaj, A., Boffa, M. B., Dixon, D. L., Ferdinand, K. C., Gidding, S. S., … &amp; Tsimikas, S. (2024). A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. <em>Journal of Clinical Lipidology</em>, 18(3), e308-e319.</p><p>[12] American Diabetes Association Professional Practice Committee. (2024). Standards of care in diabetes, 2024. <em>Diabetes Care</em>, 47(Supplement 1), S1-S321.</p><p>[13] Salazar, M. R., Carbajal, H. A., Espeche, W. G., Leiva Sisnieguez, C. E., March, C. E., Balbin, E., … &amp; Palma, R. B. (2013). Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance. <em>Diabetes and Vascular Disease Research</em>, 10(4), 346-352.</p><p>[14] Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. <em>Kidney International</em>, 105(4S), S117-S314.</p><p>[15] Kwo, P. Y., Cohen, S. M., &amp; Lim, J. K. (2017). ACG clinical guideline: Evaluation of abnormal liver chemistries. <em>American Journal of Gastroenterology</em>, 112(1), 18-35. [Updated ALT thresholds: Prati, D., et al. (2002). Updated definitions of healthy ranges for serum alanine aminotransferase levels. <em>Annals of Internal Medicine</em>, 137(1), 1-10; AASLD 2023 Practice Guidance on MASLD.]</p><p>[16] Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., … &amp; Sulkowski, M. S. (2006). Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. <em>Hepatology</em>, 43(6), 1317-1325.</p><p>[17] Ridker, P. M. (2016). A test in context: High-sensitivity C-reactive protein. <em>Journal of the American College of Cardiology</em>, 67(6), 712-723.</p><p>[18] World Health Organization. (2020). <em>WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations</em>. Geneva: WHO.</p><p>[19] Demay, M. B., Pittas, A. G., Bikle, D. D., Diab, D. L., Kiely, M. E., Lazaretti-Castro, M., … &amp; McCartney, C. R. (2024). Vitamin D for the prevention of disease: An Endocrine Society Clinical Practice Guideline. <em>Journal of Clinical Endocrinology and Metabolism</em>, 109(8), 1907-1947.</p><p>[20] U.S. Preventive Services Task Force. (2015). Screening for thyroid dysfunction: Recommendation statement. <em>Annals of Internal Medicine</em>, 162(9), 641-650.</p><p>[21] U.S. Preventive Services Task Force. (2018). Screening for ovarian cancer: Recommendation statement. <em>JAMA</em>, 319(6), 588-594.</p><p>​<br>​</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Evidence corrections and scope update</h2><p class="correction-context">The Upward ARC is an educational newsletter for a general audience, not a medical publication. It sometimes uses ordinary-language metaphors and simplifications to make complex evidence readable. Those phrases are not clinical terminology. The editorial standard remains unchanged: do not fabricate, cite falsely, hide uncertainty, or simplify a point so far that it changes the practical meaning.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Citation correction:</strong> The cited Pietzner paper was published in 2021, not 2024, and examined plasma metabolites and multimorbidity. It does not support the paragraph about personal white-blood-cell set points. That paragraph should not be relied on as evidence for individual biomarker ranges. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Statistical qualification:</strong> The 64% and 99% figures are correct only in a simplified model where every test is independent and each has a 5% chance of falling outside its reference interval. Real laboratory markers can be correlated, and a reference-range flag is not automatically a false positive. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a></span></p><p><strong>Screening scope:</strong> There is no single annual panel for every healthy adult. Blood pressure, diabetes, lipid, kidney, liver, blood-count, hormone, and cancer testing depend on age, symptoms, medicines, family history, prior results, and whether the result could change care. The 2026 dyslipidemia guideline supports one adult Lp(a) measurement and selective, not universal, ApoB use. <span class="correction-ref-links"><a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Kidney and liver qualification:</strong> KDIGO recommends eGFR and urine albumin testing for people at risk of chronic kidney disease. AASLD uses FIB-4 mainly in people with suspected or higher-risk fatty liver disease. Neither source establishes routine testing for every asymptomatic adult. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a></span></p><p><strong>Preparation and abnormal results:</strong> Blood-test preparation is test-specific. One small weightlifting study showed that unfamiliar heavy exercise can alter several markers for days, but it does not establish a universal 48-hour rule. An unexpected result may need confirmation, but the response depends on the marker, magnitude, symptoms, and risk of delay. One result after a red-eye flight does not always mean nothing. <span class="correction-ref-links"><a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><p><strong>Tumour-marker correction:</strong> The cited USPSTF statement concerns ovarian-cancer screening. It does not by itself support a general rule covering CA-125, CEA, and PSA. Screening evidence and shared-decision guidance differ by cancer and population. <span class="correction-ref-links"><a href="#correction-ref-6" aria-label="Reference 6">[6]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://www.nature.com/articles/s41591-021-01266-0" rel="external">Pietzner, M., Stewart, I. D., Raffler, J., et al. (2021). Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nature Medicine, 27(3), 471–479. https://doi.org/10.1038/s41591-021-01266-0</a></li><li id="correction-ref-2"><a href="https://doi.org/10.1056/NEJM198602203140806" rel="external">Ross, R. (1986). The pathogenesis of atherosclerosis—An update. New England Journal of Medicine, 314(8), 488–500. https://doi.org/10.1056/NEJM198602203140806</a></li><li id="correction-ref-3"><a href="https://doi.org/10.1161/CIR.0000000000001423" rel="external">American Heart Association &amp; American College of Cardiology. (2026). 2026 guideline on the management of dyslipidemia. Circulation. https://doi.org/10.1161/CIR.0000000000001423</a></li><li id="correction-ref-4"><a href="https://kdigo.org/guidelines/ckd-evaluation-and-management/" rel="external">Kidney Disease: Improving Global Outcomes. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. https://kdigo.org/guidelines/ckd-evaluation-and-management/</a></li><li id="correction-ref-5"><a href="https://doi.org/10.1111/j.1365-2125.2007.03001.x" rel="external">Pettersson, J., Hindorf, U., Persson, P., et al. (2008). Muscular exercise can cause highly pathological liver function tests in healthy men. British Journal of Clinical Pharmacology, 65(2), 253–259. https://doi.org/10.1111/j.1365-2125.2007.03001.x</a></li><li id="correction-ref-6"><a href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening" rel="external">U.S. Preventive Services Task Force. (2018). Ovarian cancer: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/bloodwork-screening">Bloodwork for Healthy Adults: A Decision-First Screening Guide →</a></aside>]]></content:encoded>
</item>
<item>
<title><![CDATA[Trust Your Gut: The Trillion-Microbe Engine You’re Ignoring]]></title>
<description><![CDATA[Skip the $300 gut test. Here is how your microbiome really works, why most probiotics backfire, and the 3 daily habits that build it.]]></description>
<link>https://www.andreheeg.com/archive/trust-your-gut-the-trillion-microbe</link>
<guid isPermaLink="true">https://www.andreheeg.com/archive/trust-your-gut-the-trillion-microbe</guid>
<pubDate>Sun, 08 Feb 2026 05:00:00 GMT</pubDate>
<dc:creator><![CDATA[Andre Heeg, Dr. med., Dr. med. dent.]]></dc:creator>
<category><![CDATA[UNDER LOAD]]></category>
<content:encoded><![CDATA[<p>My wife is pointing at a pot.</p><p>We’re somewhere outside Rangoon. Early 2010s. Myanmar has barely opened to tourists. We’d flown into Thailand for a few days, then crossed straight into a country that didn’t appear in any guidebook we owned. The “restaurant” is a woman with a gas burner and some plastic stools under a tarp. There’s no menu. There’s no fridge. There are flies, and they seem confident about their dining choices.</p><p>She points. I point. Same pot. Same spoons. Same cheerful disregard for anything a food safety inspector would recognize.</p><p>We walk back to the guesthouse happy and full, feeling like the kind of travelers who say yes to everything.</p><p>The next morning, she can’t move. Not “I feel a bit off” can’t move. The bathroom-floor, bargaining-with-the-universe, reconsidering-every-life-choice kind of sick. It lasted days. I brought her water and crackers and tried to look sympathetic, while honestly feeling completely fine. Not a cramp. Not a rumble. Nothing.</p><p>I spent two days exploring Rangoon alone. Shwedagon Pagoda at sunrise. Tea shops in back alleys. More street food from vendors I couldn’t vet. Zero consequences.</p><p>This wasn’t the first time. It had happened in Nepal. It had happened in half a dozen countries before that. Same plate, opposite outcomes. She called my digestive system “stupid and incapable of detecting the most obvious of germs.” I called it supernatural.</p><p>We never settled the argument. We probably never will.</p><p>But something else about the gut has followed me even longer.</p><p>I spent years at McKinsey and BCG. I’m trained to build fact bases, structure problems, and propose decisions that look rational on paper. I can make a case for almost anything if you give me enough data. But every major private decision I’ve made in life, the ones that actually mattered, I made on feel.</p><p>When I quit consulting to join a startup in New York, I didn’t have a model that justified it. I had a feeling. Deep, steady, and completely immune to counterarguments. That single decision gave us a decade in a city that changed who we are. Two of our three kids were born there. Friendships that still hold after all these years. Experiences we couldn’t have planned, no matter how much analysis we did.</p><p>Gut feel. Every time I followed it, something good came out the other side. Every time I overrode it with logic, I regretted it.</p><p>I never really questioned why that worked. I just trusted it. Turns out, the biology behind it is stranger and more interesting than I expected.</p><h2>The Chemical Plant Between Your Ribs</h2><p>Your gut isn’t a tube that processes lunch. That’s the version you learned in school, and it’s wrong.</p><p>It’s a chemical factory staffed by roughly 100 trillion microorganisms, functioning more like an endocrine organ [1]. It produces bioactive compounds that regulate your metabolism, train your immune system, and directly influence your brain chemistry [2]. You have more bacterial cells in your gut than human cells in your entire body. Let that sit for a moment.</p><p>The core mechanism is simple enough to explain over dinner. When you eat fiber, you can’t fully digest it. Your gut bacteria can. They ferment it, releasing short-chain fatty acids, the most important of which is butyrate. Butyrate provides up to 70% of the energy your colon cells need to function [3]. It suppresses the expression of inflammatory genes [4]. In plain language, it keeps the gut wall sealed tight and your immune system from overreacting to things that aren’t threats.</p><p>When the wall weakens (and it will, if you stop feeding the bacteria that maintain it), fragments of bacterial cell walls called lipopolysaccharides leak into your bloodstream. Your immune system treats this as an invasion. The result is a state researchers call “metabolic endotoxemia” [5]: chronic, low-grade inflammation that hums in the background of your biology. That’s the afternoon brain fog that sleep doesn’t fix. The immune system is running hot with no clear infection. The slow metabolic erosion that shows up in bloodwork years before anyone calls it a diagnosis.</p><p>About 70% of your immune cells live in your gut [6]. The microbiome trains them. Diverse ecosystem, calibrated immune response. Depleted ecosystem, overreaction, and vulnerability. This isn’t a wellness talking point. It’s immunology.</p><p>I didn’t have any of this vocabulary in Myanmar. I just knew my wife got destroyed by the same food that didn’t even register in my body. What I didn’t know was that something I’d never deliberately fed, supplemented, or thought about once was running a defense operation sophisticated enough to make my consulting frameworks look like finger paintings.</p><h2>When Your Calendar Becomes the Enemy</h2><p>I need to be honest about something. For all the years I’ve studied health, tracked biomarkers, and written about longevity, I’ve also been the guy eating room service at midnight after three flights in a week. Popping ibuprofen for travel headaches without a second thought. Running on espressos through back-to-back meetings and calling it a strategy.</p><p>If you’re an ambitious professional, you’ve done some version of this. Probably this week.</p><p>Turns out that lifestyle is exceptionally good at destroying the exact system I just described.</p><p>Chronic stress raises cortisol. Cortisol increases intestinal permeability. But here’s what surprised me: it also activates virulence genes in certain gut bacteria, literally making them more aggressive under your own hormones [7]. Your bacteria don’t just sit there while you white-knuckle through a quarter. They respond. Not helpfully. People under high perceived stress consistently show lower microbial diversity [8]. Fewer species. Fewer defenses. Less resilience.</p><p>Then there’s timing. Your microbiome runs on a 24-hour clock, synchronized to when you eat, not what you eat [9]. Disrupt that rhythm with late-night meals, timezone hopping, or even weekend sleep-ins (researchers call this “social jetlag”), and you promote metabolic dysfunction that has nothing to do with food quality. Eran Elinav’s lab at the Weizmann Institute showed that jet-lagged mice developed obesity-prone microbiome profiles. Transfer those microbes to germ-free mice? Weight gain. Impaired glucose control. From the microbes alone [10].</p><p>And medications. Those PPIs you take for reflux during stressful quarters? They significantly alter the gut microbiome by raising gastric pH, allowing oral bacteria to colonize the lower intestine [11]. NSAIDs damage the lining directly [12].</p><p>Picture the scene. Three time zones this week. Ibuprofen for the headache. A PPI for the reflux that’s been flaring since the board dinner. Midnight burger from room service because you missed a real meal. Every single lever is pulling in the wrong direction at once. My wife would get wrecked by one pot in Myanmar. Many of us are doing this to ourselves five days a week and calling it professional life.</p><h2>Your $300 Gut Test Is Telling You Nothing Your Groceries Can’t Fix</h2><p>The microbiome testing industry wants your credit card. Direct-to-consumer stool tests promise personalized insight into your gut. The problem: they can’t deliver.</p><p>There’s no agreed-upon definition of a “healthy” microbiome. Two perfectly healthy people can share less than 10% of their microbial species and still have identical metabolic function, because different bacteria can do the same jobs [13]. Your stool sample captures what’s passing through (the luminal population), not what’s attached to the intestinal wall, actually talking to your immune system (the mucosal population) [14]. You’re analyzing the ecosystem’s trash, not its residents. Results shift with what you ate this week, how you slept, what medications you took.</p><p>The real problem is actionability. “You have low Akkermansia” leads to the same advice as every other result: eat more fiber, eat more polyphenols, sleep better. The test converges on recommendations you could have gotten for free.</p><p>Skip it. Track functional biomarkers instead: hs-CRP for inflammation, HbA1c for metabolic health, ApoB for cardiovascular risk. Those measure what the microbiome is actually doing downstream. Spend the $300 on groceries.</p><h2>The Highway Between Your Gut and Your Brain</h2><p>Remember when I said I’ve made every important decision on gut feel? There’s a physical highway that explains why that’s not as irrational as it sounds.</p><p>About 90% of your body’s serotonin is produced in the gut [15]. Under normal conditions, microbes support the conversion of tryptophan into serotonin. Under chronic stress, a competing pathway hijacks that tryptophan and diverts it toward neurotoxic metabolites [16]. Less serotonin precursor. More neuroinflammation. A depletion loop that connects gut health directly to mood, sleep quality, and how clearly you think under pressure.</p><p>The vagus nerve carries signals between the brainstem and gut in both directions. In animal studies, the probiotic Lactobacillus rhamnosus altered GABA receptor expression in the brain through vagal signaling. Sever the nerve, and the effect vanishes [17]. In humans, the specific strain Bifidobacterium longum 1714 modulated neural oscillations associated with coping and blunted cortisol response to social stress in healthy volunteers [18]. Not a vague “gut-brain connection.” A measurable biological buffer for people in high-pressure environments.</p><p>The board meeting where you can’t think straight. The negotiation you almost walked away from because something felt off. The career move that made no sense on paper but turned out to be the best decision of your life. That signal had to travel somewhere. It traveled through here.</p><h2>Your Post-Flight Probiotic Ritual Is Probably Backfiring</h2><p>The supplement industry sells gut health the way it sells everything: more is better, broad spectrum, high dose. Pick up any airport probiotic, and you’ll find “50 billion CFU” across 15 strains backed by zero clinical evidence for healthy adults.</p><p>It gets worse. A landmark 2018 study in Cell found that generic multi-strain probiotics taken after antibiotics delayed and impaired native microbiome recovery compared to doing nothing [19]. The probiotic slowed things down, not sped them up.</p><p>Precision matters. Only a handful of strains have real human data. Saccharomyces boulardii CNCM I-745 (a yeast) shows significant efficacy for traveler’s diarrhea prevention across multiple meta-analyses (RR = 0.79, p &lt; 0.001) [20] and antibiotic-associated diarrhea (RR = 0.47, 95% CI 0.35-0.63) [21]. As a yeast, it survives antibiotics. Lactobacillus rhamnosus GG has solid evidence for antibiotic-associated diarrhea taken during the course, separated 2-3 hours from the dose [22]. And B. longum 1714 for stress modulation, as above [18].</p><p>Three strains. With receipts. Everything else on that shelf is marketing.</p><h2>Try This Today</h2><p><strong>The Kitchen Close.</strong> Stop eating 3 hours before bed. Maintain a 12-hour fasting window. This lets the Migrating Motor Complex, your gut’s self-cleaning wave, complete its cycle and keeps your circadian-microbiome coupling intact [9][23]. During travel weeks, this is the single most important thing you control. The minibar is right there. Close the kitchen anyway.</p><p><strong>The Fiber Floor.</strong> 30 grams of mixed fiber daily. Fastest backup: 1 tablespoon of psyllium husk plus 1 teaspoon of inulin in water, takes 30 seconds. But real food first. Lentils (15.6g per cup cooked), chickpeas (12.5g), avocados, berries, oats. Aim for 30 different plant species a week; herbs and spices count [24]. The 2019 Lancet meta-analysis across 185 studies and over 3.5 million participants found that 25-29 grams of daily fiber was associated with 15-30% lower all-cause mortality [25]. That’s one of the strongest dose-response relationships in nutrition science.</p><p><strong>The Fermented Ramp.</strong> One serving of fermented food daily. Kefir, Kimchi, Sauerkraut, yogurt. Built to 3 over 4 weeks. A Stanford trial found that 6 servings per day decreased inflammatory markers and increased microbial diversity more effectively than a high-fiber diet alone over 10 weeks [26]. You don’t need 6. Start with 1.</p><h2>The Investment, Not the Hack</h2><p>This sits in the Activate pillar of my Upward ARC framework. Not Recover. Not Capacity. Activate. Because the microbiome is the biological substrate on which everything else runs. Sleep quality, training adaptation, stress resilience, and immune defense. Degrade this system, and every other investment underperforms.</p><p>It’s not a weekend project. It’s a compounding investment. Fiber, fermented foods, consistent meal timing, and targeted supplementation when warranted. Small inputs, accumulated over weeks and months, build a different biological baseline. Consistency beats perfection. Every single time.</p><p>I’ve trusted my gut my whole life. The iron stomach that carried me through Myanmar while my wife spent two days on a bathroom floor. The instinct that told me to leave a prestigious consulting career for an uncertain startup in New York was a move that gave us everything we didn’t know we needed. She still thinks my digestive system is “stupid.” Maybe it’s time I started feeding the thing that’s been carrying me all along.</p><p>Stay healthy.</p><p>Andre</p><p>​</p><div><hr></div><p>​</p><h2>References</h2><p>[1] Sender, R., Fuchs, S., &amp; Milo, R. (2016). Revised estimates for the number of human and bacteria cells in the body. <em>Cell</em>, 164(3), 337-340.</p><p>[2] Badal, V. D., et al. (2020). The gut microbiome, aging, and longevity: A systematic review. <em>Nutrients</em>, 12(12), 3759.</p><p>[3] Donohoe, D. R., et al. (2011). The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. <em>Cell Metabolism</em>, 13(5), 517-526.</p><p>[4] Davie, J. R. (2003). Inhibition of histone deacetylase activity by butyrate. <em>Journal of Nutrition</em>, 133(7), 2485S-2493S.</p><p>[5] Cani, P. D., et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. <em>Diabetes</em>, 56(7), 1761-1772.</p><p>[6] Vighi, G., et al. (2008). Allergy and the gastrointestinal system. <em>Clinical &amp; Experimental Immunology</em>, 153(Suppl 1), 3-6.</p><p>[7] Lyte, M. (2014). Microbial endocrinology: Host-microbiota neuroendocrine interactions influencing brain and behavior. <em>Gut Microbes</em>, 5(3), 381-389.</p><p>[8] Madison, A., &amp; Kiecolt-Glaser, J. K. (2019). Stress, depression, diet, and the gut microbiota: Human-bacteria interactions at the core of psychoneuroimmunology and nutrition. <em>Current Opinion in Behavioral Sciences</em>, 28, 105-110.</p><p>[9] Thaiss, C. A., et al. (2014). Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. <em>Cell</em>, 159(3), 514-529.</p><p>[10] Thaiss, C. A., et al. (2016). Microbiota diurnal rhythmicity programs host transcriptome oscillations. <em>Cell</em>, 167(6), 1495-1510.</p><p>[11] Imhann, F., et al. (2016). Proton pump inhibitors affect the gut microbiome. <em>Gut</em>, 65(5), 740-748.</p><p>[12] Bjarnason, I., et al. (2018). Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. <em>Gastroenterology</em>, 154(3), 500-514.</p><p>[13] Human Microbiome Project Consortium. (2012). Structure, function and diversity of the healthy human microbiome. <em>Nature</em>, 486(7402), 207-214.</p><p>[14] Zmora, N., et al. (2018). Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. <em>Cell</em>, 174(6), 1388-1405.</p><p>[15] Yano, J. M., et al. (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. <em>Cell</em>, 161(2), 264-276.</p><p>[16] Agus, A., Planchais, J., &amp; Socaci, S. (2018). Gut microbiota regulation of tryptophan metabolism in health and disease. <em>Cell Host &amp; Microbe</em>, 23(6), 716-724.</p><p>[17] Bravo, J. A., et al. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. <em>Proceedings of the National Academy of Sciences</em>, 108(38), 16050-16055.</p><p>[18] Wang, H., et al. (2019). Bifidobacterium longum 1714 strain modulates brain activity of healthy volunteers during social stress. <em>American Journal of Gastroenterology</em>, 114(7), 1152-1162.</p><p>[19] Suez, J., et al. (2018). Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. <em>Cell</em>, 174(6), 1406-1423.</p><p>[20] McFarland, L. V. (2018). Meta-analysis of probiotics for the prevention of traveler’s diarrhea. <em>Travel Medicine and Infectious Disease</em>, 27, 33-37.</p><p>[21] McFarland, L. V. (2010). Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. <em>World Journal of Gastroenterology</em>, 16(18), 2202-2222.</p><p>[22] Szajewska, H., &amp; Kołodziej, M. (2015). Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. <em>Alimentary Pharmacology &amp; Therapeutics</em>, 42(7), 793-801.</p><p>[23] Deloose, E., et al. (2012). The migrating motor complex: Control mechanisms and its role in health and disease. <em>Nature Reviews Gastroenterology &amp; Hepatology</em>, 9(5), 271-285.</p><p>[24] McDonald, D., et al. (2018). American Gut: An open platform for citizen science microbiome research. <em>mSystems</em>, 3(3), e00031-18.</p><p>[25] Reynolds, A., et al. (2019). Carbohydrate quality and human health: A series of systematic reviews and meta-analyses. <em>The Lancet</em>, 393(10170), 434-445.</p><p>[26] Wastyk, H. C., et al. (2021). Gut-microbiota-targeted diets modulate human immune status. <em>Cell</em>, 184(16), 4137-4153.</p><div><hr></div><section class="article-corrections" aria-labelledby="corrections-heading"><p class="correction-kicker">Editor's note</p><h2 id="corrections-heading">Editorial clarification and evidence update</h2><p class="correction-context">The microbiome is biologically important, but many appealing mechanisms come from laboratory, animal, or observational work. They should not be used to diagnose symptoms or prescribe a universal gut routine.</p><p><strong>Updated October 7, 2026.</strong> The historical edition above remains unchanged.</p><p><strong>Cell counts:</strong> A revised estimate put bacterial cells near 3.8 x 10^13 and human cells near 3.0 x 10^13 for one reference adult male, with substantial variation. The older claim of 100 trillion microbes and a large bacterial majority is not supported. <span class="correction-ref-links"><a href="#correction-ref-1" aria-label="Reference 1">[1]</a></span></p><p><strong>Immunity and serotonin:</strong> The gut has a major mucosal immune role, but 70% of all immune cells is not a stable count. Most serotonin is peripheral and does not cross the blood-brain barrier, so gut production does not establish brain availability or mood causation. <span class="correction-ref-links"><a href="#correction-ref-2" aria-label="Reference 2">[2]</a> <a href="#correction-ref-3" aria-label="Reference 3">[3]</a></span></p><p><strong>Probiotics:</strong> Small personalized and post-antibiotic studies do not show that most probiotics backfire for most people. Effects are product, strain, indication, timing, and host specific. Reference 22 evaluated Saccharomyces boulardii, not LGG. <span class="correction-ref-links"><a href="#correction-ref-4" aria-label="Reference 4">[4]</a> <a href="#correction-ref-5" aria-label="Reference 5">[5]</a></span></p><p><strong>Food and timing targets:</strong> Thirty plant foods per week came from cross-sectional citizen science, not a randomized dose trial. The three-hour evening gap, twelve-hour fast, and simple fermented-food serving rule are optional personal routines, not established treatments or universal requirements. <span class="correction-ref-links"><a href="#correction-ref-6" aria-label="Reference 6">[6]</a></span></p><h3 class="correction-references-heading">References</h3><ol class="correction-references"><li id="correction-ref-1"><a href="https://doi.org/10.1371/journal.pbio.1002533" rel="external">Sender, R., Fuchs, S., &amp; Milo, R. (2016). Revised estimates for the number of human and bacteria cells in the body. PLOS Biology, 14(8), e1002533. https://doi.org/10.1371/journal.pbio.1002533</a></li><li id="correction-ref-2"><a href="https://pubmed.ncbi.nlm.nih.gov/37871201/" rel="external">Sender, R., Weiss, Y., Navon, Y., et al. (2023). The total mass, number, and distribution of immune cells in the human body. Proceedings of the National Academy of Sciences, 120(44), e2308511120. https://doi.org/10.1073/pnas.2308511120</a></li><li id="correction-ref-3"><a href="https://pubmed.ncbi.nlm.nih.gov/32479926/" rel="external">Jones, L. A., Sun, E. W., Martin, A. M., &amp; Keating, D. J. (2020). The ever-changing roles of serotonin. International Journal of Biochemistry &amp; Cell Biology, 125, 105776. https://doi.org/10.1016/j.biocel.2020.105776</a></li><li id="correction-ref-4"><a href="https://pubmed.ncbi.nlm.nih.gov/30193113/" rel="external">Suez, J., Zmora, N., Zilberman-Schapira, G., et al. (2018). Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell, 174(6), 1406–1423.e16. https://pubmed.ncbi.nlm.nih.gov/30193113/</a></li><li id="correction-ref-5"><a href="https://pubmed.ncbi.nlm.nih.gov/26216624/" rel="external">Szajewska, H., &amp; Kołodziej, M. (2015). Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology &amp; Therapeutics, 42(7), 793–801. https://doi.org/10.1111/apt.13344</a></li><li id="correction-ref-6"><a href="https://pubmed.ncbi.nlm.nih.gov/34256014/" rel="external">Wastyk, H. C., Fragiadakis, G. K., Perelman, D., et al. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137–4153.e14. https://doi.org/10.1016/j.cell.2021.06.019</a></li></ol><p class="medical-scope-note">For informational and educational purposes only. This page does not provide individual medical advice, diagnosis, or treatment. <a href="/medical-disclaimer">Read the full medical disclaimer.</a></p></section><aside class="article-evidence-link"><span>THE EVIDENCE</span><a href="/evidence/microbiome-probiotics-and-gut-health">The Microbiome, Probiotics, and Everyday Gut Health →</a></aside>]]></content:encoded>
</item>
</channel>
</rss>
